data_2n3e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n3e _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 65.5 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.588 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.6 t -129.12 150.09 74.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 18' ' ' PHE . 42.7 Cg_endo -65.3 -31.98 51.92 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.65 2.233 . . . . 0.0 112.216 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 45.5 p90 -89.35 23.41 2.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 109.445 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.72 -33.67 8.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 108.584 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 t -116.62 161.65 18.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.542 -0.724 . . . . 0.0 109.053 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 4.5 ttpm? -72.61 -41.52 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 109.761 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.82 57.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.546 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 20.4 t30 -71.69 -33.01 68.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.96 -37.57 67.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.98 . . . . 0.0 110.064 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.447 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 87.7 m-20 -56.25 -56.56 19.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.118 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.01 -42.39 62.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 48.1 t80 -58.33 -41.11 83.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.479 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 70' ' ' PHE . 22.1 mm -67.44 -49.34 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.16 -49.16 78.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 t -62.07 -30.76 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.06 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 96' ' ' LEU . 16.3 t80 -66.75 -44.19 82.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 0.0 109.92 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.06 -55.97 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 109.812 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -55.63 -37.54 68.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.825 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -46.25 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.823 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 32' ' ' PHE . . . -62.37 -36.71 83.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.526 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 91.7 p -66.95 -22.33 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.893 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -105.38 7.18 33.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.474 ' HB ' ' HA ' ' A' ' 91' ' ' ALA . 7.7 m -101.19 -73.24 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 110.241 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -107.21 0.87 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -124.83 -64.93 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -1.112 . . . . 0.0 109.736 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 78' ' ' ALA . 34.6 m-85 44.82 72.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.206 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -59.71 165.09 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.33 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -52.28 -30.09 26.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.187 -0.945 . . . . 0.0 109.111 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.58 -36.01 80.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 81' ' ' GLN . 43.0 mt-30 -70.96 -33.11 70.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.309 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 61.8 mtt -63.63 -29.44 70.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 41' ' ' SER . 86.7 tt0 -57.0 -37.26 71.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 108.913 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' CB ' HG22 ' A' ' 77' ' ' ILE . 79.3 m-20 -58.47 -31.69 68.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' ILE . 51.2 ttp -55.7 -31.79 62.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 108.852 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.481 ' OG ' ' CD1' ' A' ' 42' ' ' LEU . 85.4 p -55.64 -24.17 32.17 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.298 -0.876 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.9 mp -106.5 -25.37 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 73' ' ' SER . 88.3 mt -124.54 150.98 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.609 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' C ' ' CG2' ' A' ' 19' ' ' ILE . . . 90.34 -108.36 3.54 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -53.08 -23.11 7.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -1.197 . . . . 0.0 108.709 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -68.14 -34.78 76.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.535 ' CD2' HD22 ' A' ' 66' ' ' LEU . 2.4 tm? -52.32 -34.61 47.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.447 ' HE2' ' HB3' ' A' ' 16' ' ' ASP . 68.2 mtt -58.21 -37.1 74.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -31.39 71.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.41 79.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 109.27 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.453 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 61.2 mtt . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 109.372 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 51.2 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -56.56 -45.3 81.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.09 -43.79 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 47' ' ' LEU . 13.6 tp -69.01 -40.69 78.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.667 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 41.4 t0 -48.77 -43.89 38.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.7 mtm -64.6 -37.04 86.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.548 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.09 -45.15 79.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 19' ' ' ILE . 92.1 t80 -52.94 -40.5 63.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -65.46 -44.1 88.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.648 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 87.3 p -69.27 -37.83 78.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.541 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 79.8 p -70.09 -44.95 68.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 70' ' ' PHE . 11.7 m -65.97 -34.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.1 -46.26 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.65 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 72' ' ' SER . 96.4 mt-30 -58.94 -36.13 74.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 109.969 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 HG22 ' CB ' ' A' ' 39' ' ' ASN . 72.5 mt -68.81 -54.87 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.55 -40.82 33.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 110.524 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.89 -28.81 64.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 109.464 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.4 p -80.89 -20.29 42.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.47 ' HB3' ' NE2' ' A' ' 36' ' ' GLN . 60.2 mm-40 -93.29 117.94 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.639 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.95 101.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -45.01 -36.0 4.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -64.55 92.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 119' ' ' ILE . 6.4 mp -76.11 -8.55 57.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.674 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.2 -44.27 84.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 88' ' ' THR . 9.9 p -70.45 -48.29 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.183 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' CB ' ' A' ' 78' ' ' ALA . 53.4 m -52.37 -36.04 52.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.928 -1.108 . . . . 0.0 108.404 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.493 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 31.9 m -55.53 -49.39 72.77 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 59.6 t30 -70.74 -37.27 73.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.21 -59.21 3.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 96' ' ' LEU . 49.2 mt -62.29 -48.92 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -58.97 -51.21 71.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.607 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -55.3 -45.36 76.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -59.33 -44.1 92.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.21 -0.931 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.513 HD22 ' CE2' ' A' ' 22' ' ' PHE . 2.8 mt -70.09 -33.46 71.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 88.0 m -65.25 -49.04 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -0.859 . . . . 0.0 109.844 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 96.8 p -66.61 -39.69 88.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 0.0 109.813 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -60.85 -40.02 91.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 109.599 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.595 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.8 m-85 -52.97 -56.47 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.568 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.53 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.8 m-85 -72.18 -32.4 66.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.421 -0.799 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 98' ' ' SER . 93.6 mm-40 -70.34 -18.77 63.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.851 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.9 p -107.12 -60.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.116 . . . . 0.0 111.2 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.495 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.47 -42.84 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.647 -1.283 . . . . 0.0 111.156 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 112.14 46.68 0.74 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.7 t -102.87 171.92 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -1.178 . . . . 0.0 108.984 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 110' ' ' ARG . 15.5 m -73.86 120.26 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.595 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 21.1 p-10 -72.18 -29.09 63.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' SER . 94.0 p -58.73 -43.26 90.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 110.502 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.418 ' HB2' HG21 ' A' ' 107' ' ' VAL . 30.8 ttp85 -57.11 -53.7 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.621 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 63.3 t80 -75.19 -53.55 8.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 40.9 mt -56.29 -34.33 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.8 t -55.8 -43.15 76.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.043 -1.035 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 118' ' ' LEU . 97.5 mt-10 -70.78 -36.66 73.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 51.0 mt -72.3 -41.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.415 ' NH1' ' HG2' ' A' ' 116' ' ' ARG . 11.8 ttp85 -54.09 -41.26 68.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.84 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 114' ' ' GLU . 18.1 mt -69.61 -43.97 71.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.875 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.495 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 73.0 mt -57.89 -47.24 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.851 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.97 -27.19 64.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.2 ttm -67.62 -42.35 82.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 97.4 m-85 -59.71 -31.96 70.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HB3' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.558 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.589 ' OG1' ' CE3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -157.98 156.3 27.9 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 40.8 Cg_endo -64.85 -35.49 44.55 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.804 2.336 . . . . 0.0 112.941 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -84.56 12.46 6.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 2.2 m -102.36 -19.53 14.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.943 . . . . 0.0 108.757 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 66.1 m -119.63 158.06 27.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 9.0 ttpt -74.38 -40.31 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.757 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.461 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -78.91 -36.65 41.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 4.9 t-20 -72.37 -29.63 63.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 109.991 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.33 -51.24 21.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 110.308 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' ' 13' ' ' ALA . 1.7 p30 -54.95 -46.77 75.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 16' ' ' ASP . . . -58.53 -40.56 83.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.554 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CE2' ' HG ' ' A' ' 96' ' ' LEU . 51.5 t80 -63.64 -37.21 86.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 109.803 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 70' ' ' PHE . 25.1 mm -71.78 -37.14 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 109.691 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -68.12 -49.42 61.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -64.66 -30.67 71.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 110.186 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 37.9 t80 -63.35 -51.51 65.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.3 mt -60.59 -56.08 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 109.98 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m -59.67 -32.6 70.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -77.66 -45.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.865 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.514 ' CA ' ' HB3' ' A' ' 95' ' ' ALA . . . -67.04 -33.21 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 110.054 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.5 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 62.7 m -63.48 -27.35 69.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 7.52 31.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 110.112 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 25.8 m -92.58 -77.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.963 -1.085 . . . . 0.0 110.057 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -104.08 0.6 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 4.2 m -131.13 -60.45 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -1.1 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.496 ' CE1' ' CB ' ' A' ' 78' ' ' ALA . 8.0 m-85 44.25 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 p -59.71 160.39 7.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -52.8 -41.96 64.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -57.88 -36.02 71.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 98.3 mm-40 -69.96 -32.74 71.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.325 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.5 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 65.5 mtt -63.51 -32.0 73.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' O ' HD13 ' A' ' 42' ' ' LEU . 86.0 tt0 -64.3 -45.26 88.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' HG21 ' A' ' 77' ' ' ILE . 21.8 m120 -55.66 -39.26 70.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' ILE . 63.2 mtt -57.29 -32.05 66.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 108.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 42' ' ' LEU . 30.3 p -70.47 -23.52 62.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.35 -0.844 . . . . 0.0 109.39 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 38' ' ' GLU . 6.7 mp -88.49 -23.46 23.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.554 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 48.6 mt -131.22 143.0 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.162 -0.961 . . . . 0.0 109.296 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 98.65 -83.75 0.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.415 ' N ' HG22 ' A' ' 19' ' ' ILE . 91.1 m-20 -61.3 -27.09 68.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.154 -1.203 . . . . 0.0 108.358 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -68.82 -35.07 76.52 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 66' ' ' LEU . 60.3 mt -53.33 -38.24 63.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.75 . . . . 0.0 109.306 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ttt -52.79 -41.35 64.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.63 70.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.0 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -66.83 -38.0 85.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 109.125 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.457 ' HE1' ' CB ' ' A' ' 15' ' ' ALA . 54.9 mtt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.261 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 15.4 tp . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -55.76 -30.97 62.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.335 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.3 68.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 108.958 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' CD2' HD13 ' A' ' 47' ' ' LEU . 10.4 tt -74.14 -45.2 50.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.256 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.4 t0 -48.66 -42.53 34.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 89.7 mtp -64.39 -45.61 86.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.598 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.59 78.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.395 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 19' ' ' ILE . 70.5 t80 -53.12 -38.93 63.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.3 -39.76 74.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -68.74 -40.79 79.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.561 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 8.9 m -70.05 -47.87 60.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.628 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 70' ' ' PHE . 23.0 m -57.72 -35.08 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' ALA . . . -72.22 -35.19 68.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.8 tt0 -74.34 -44.15 53.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 39' ' ' ASN . 94.0 mt -55.82 -47.21 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.47 -52.8 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 109.803 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . -57.86 -29.22 64.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.166 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 27.6 t -69.61 -20.19 63.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.292 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.2 mt-30 -54.64 -29.93 53.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.19 80.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.1 -156.94 29.09 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 87' ' ' VAL . 55.9 t0 -70.45 98.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -1.213 . . . . 0.0 109.403 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.497 ' CD2' HG22 ' A' ' 119' ' ' ILE . 10.4 tt -57.6 -16.34 10.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.63 -39.06 95.22 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 84' ' ' ASP . 5.7 p -69.77 -37.59 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 109.602 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CB ' ' A' ' 78' ' ' ALA . 44.4 m -51.58 -32.06 27.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.088 -1.008 . . . . 0.0 108.735 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 116' ' ' ARG . 22.1 m -59.94 -47.31 86.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 25.9 m120 -70.86 -33.49 70.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.426 -0.796 . . . . 0.0 109.018 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -71.65 -59.32 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.767 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.427 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 54.8 mt -63.34 -42.53 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' A' ' 112' ' ' ILE . . . -62.86 -52.36 63.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB3' HG23 ' A' ' 29' ' ' THR . 34.1 t0 -55.26 -50.48 69.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 109.332 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HB3' ' CA ' ' A' ' 26' ' ' ALA . . . -55.9 -45.41 78.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.583 ' CD2' ' CD2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -69.97 -33.85 72.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.49 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 94.3 m -68.97 -49.27 59.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.0 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.5 p -62.26 -34.44 76.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.907 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -69.83 -42.65 73.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.3 m-85 -46.94 -54.75 9.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.516 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.4 m-85 -71.66 -32.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 110.491 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 98' ' ' SER . 64.5 mm-40 -80.58 -18.45 48.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 110.129 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 18' ' ' PHE . 54.7 p -101.45 -59.05 1.77 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 111.053 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 23.0 m -126.05 -42.67 1.86 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 110.868 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 107.64 46.69 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 5.0 t -114.69 172.97 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -1.159 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' CG ' ' A' ' 110' ' ' ARG . 2.8 m -73.1 120.5 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.306 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.607 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 12.4 p30 -70.84 -24.14 62.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.615 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 24.8 t -56.07 -30.2 61.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.505 -0.747 . . . . 0.0 110.342 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.513 ' CG ' HG21 ' A' ' 107' ' ' VAL . 35.4 mmt180 -67.94 -54.61 17.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.119 . . . . 0.0 110.234 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.583 ' CD2' ' CD2' ' A' ' 96' ' ' LEU . 1.2 t80 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.527 HG21 ' CB ' ' A' ' 93' ' ' ALA . 52.4 mt -56.41 -29.95 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.548 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 6.0 t -58.13 -47.33 83.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 85.5 tt0 -72.22 -37.7 69.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 71' ' ' ALA . 47.1 mt -56.56 -46.29 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.917 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.524 ' HD3' ' CG2' ' A' ' 89' ' ' THR . 74.3 mtt180 -54.41 -49.12 70.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -59.17 -33.34 70.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.0 109.004 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 83.8 mt -73.75 -40.85 63.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.461 -0.774 . . . . 0.0 110.232 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.497 HG22 ' CD2' ' A' ' 85' ' ' LEU . 56.9 mt -61.08 -34.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 0.0 109.595 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.9 -32.45 70.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -65.64 -42.59 91.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.426 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 96.2 m-85 -63.23 -29.03 70.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 106' ' ' VAL . 16.7 m120 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 4.5 t -143.5 152.51 56.96 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.127 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 42.6 Cg_endo -65.04 -35.4 42.88 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.466 2.111 . . . . 0.0 112.787 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -80.82 7.25 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.626 -1.296 . . . . 0.0 109.737 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.9 OUTLIER -92.31 -20.57 20.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 108.718 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.5 t -136.69 144.66 44.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 108.949 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 22.1 mtmm -60.42 -46.43 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.3 71.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.355 -0.841 . . . . 0.0 109.476 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.52 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 14.1 m120 -72.36 -38.43 68.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.39 -51.8 33.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' OD1' ' HG2' ' A' ' 48' ' ' MET . 17.2 m-20 -54.37 -51.11 65.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.29 91.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 108.7 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.509 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 58.8 t80 -58.56 -37.23 75.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.435 -0.791 . . . . 0.0 109.534 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 70' ' ' PHE . 20.8 mm -71.01 -37.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -68.51 -50.02 55.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CE1' HG11 ' A' ' 74' ' ' VAL . 34.4 t80 -65.12 -49.13 71.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 110.207 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.509 ' CD1' ' ND2' ' A' ' 45' ' ' ASN . 77.2 mt -61.99 -56.18 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -60.21 -32.12 70.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.913 . . . . 0.0 109.868 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.84 -44.46 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.096 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.517 ' N ' ' HB1' ' A' ' 95' ' ' ALA . . . -69.97 -29.27 66.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.243 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -64.68 -28.5 69.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.963 . . . . 0.0 110.13 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.9 7.49 32.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 20.1 m -90.72 -78.5 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 -103.33 0.39 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.9 t -131.24 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -1.132 . . . . 0.0 109.445 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 12.5 m-85 43.73 88.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.315 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.2 m -59.73 161.05 6.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -52.64 -36.57 56.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.61 -36.05 83.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.435 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 99.8 mm-40 -71.91 -33.97 68.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 109.283 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.412 ' HE2' ' O ' ' A' ' 32' ' ' PHE . 65.1 mtt -63.64 -33.71 76.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.08 -47.25 85.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.446 ' ND2' HG12 ' A' ' 77' ' ' ILE . 34.5 t-20 -55.65 -40.71 72.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 43' ' ' ILE . 83.1 mtp -61.49 -31.85 71.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 109.11 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 m -70.3 -23.94 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 42' ' ' LEU . 4.2 mm? -90.55 -23.26 20.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.922 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.525 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 64.0 mt -125.0 157.01 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.583 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 89.42 -83.85 1.41 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.509 ' ND2' ' CD1' ' A' ' 23' ' ' ILE . 92.5 m-20 -62.67 -33.87 75.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -1.217 . . . . 0.0 109.009 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -60.51 -35.28 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.362 -0.836 . . . . 0.0 109.232 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 6.5 mt -57.28 -35.77 70.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 0.0 109.46 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.452 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 69.7 mtm -52.84 -39.92 62.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.274 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.49 -32.93 72.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.875 . . . . 0.0 109.182 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . -63.53 -31.18 72.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.84 . . . . 0.0 109.206 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.431 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 64.6 mtt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.257 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 9' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -54.61 -40.11 68.56 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.359 -0.838 . . . . 0.0 108.955 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.85 68.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 108.959 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tp -73.51 -46.65 46.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.279 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.505 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 31.0 t0 -48.08 -46.79 34.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 109.732 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.55 -38.43 81.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 109.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.75 76.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.517 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 19' ' ' ILE . 84.1 t80 -55.23 -35.36 64.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -66.03 -37.33 85.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.805 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.6 m -67.77 -31.56 71.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.822 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.525 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 92.5 p -69.3 -49.12 58.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.527 HG11 ' CE1' ' A' ' 22' ' ' PHE . 35.3 m -60.82 -35.01 61.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.436 -0.79 . . . . 0.0 109.982 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.57 -47.56 39.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.471 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.3 mt-30 -64.73 -50.47 66.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.887 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' MET . 79.2 mt -55.01 -50.84 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 109.907 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 88' ' ' THR . . . -74.9 -51.86 12.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.92 -30.81 66.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 92.2 p -72.66 -20.47 61.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.432 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.592 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 83.3 mt-30 -49.3 -40.52 35.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.918 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.15 5.19 66.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.05 -155.39 27.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' O ' HG11 ' A' ' 87' ' ' VAL . 53.8 t0 -66.06 105.39 1.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -1.088 . . . . 0.0 109.376 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' CD1' ' CG2' ' A' ' 119' ' ' ILE . 23.7 tp -67.75 -14.01 62.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.03 -32.41 66.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 84' ' ' ASP . 6.2 p -69.88 -35.71 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -1.174 . . . . 0.0 109.527 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.578 ' CG2' ' CD1' ' A' ' 92' ' ' ILE . 73.7 m -51.59 -32.4 28.47 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.1 -1.0 . . . . 0.0 108.679 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 62.8 m -58.65 -46.62 86.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -70.78 -38.24 73.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.467 -0.771 . . . . 0.0 109.096 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' HG21 ' A' ' 29' ' ' THR . . . -68.32 -56.07 9.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.904 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.578 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 61.4 mt -66.7 -44.05 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.761 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.521 ' CA ' HD12 ' A' ' 112' ' ' ILE . . . -64.49 -50.85 65.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 109.892 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 92.2 m-20 -55.32 -43.13 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.946 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.517 ' HB1' ' N ' ' A' ' 26' ' ' ALA . . . -67.91 -40.79 83.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.283 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.53 HD23 ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.11 -34.54 73.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.804 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.559 HG22 ' CE2' ' A' ' 101' ' ' TYR . 55.3 m -67.64 -51.13 53.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.03 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 t -60.14 -35.29 74.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 109.887 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.505 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.85 -43.29 72.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -47.1 -54.97 9.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.027 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.559 ' CE2' HG22 ' A' ' 97' ' ' THR . 5.3 m-85 -71.84 -32.69 67.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.468 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 98' ' ' SER . 96.5 mm-40 -75.9 -18.46 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.217 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 99' ' ' ALA . 55.9 p -104.77 -59.57 1.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.907 -1.12 . . . . 0.0 110.996 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.436 HG23 ' HD3' ' A' ' 8' ' ' PRO . 25.6 p -126.41 -42.81 1.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.702 -1.249 . . . . 0.0 110.921 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.61 46.6 0.96 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.94 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.575 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 5.7 t -108.22 172.44 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.188 -1.183 . . . . 0.0 109.101 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 m -73.4 120.77 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.591 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 14.4 p30 -71.35 -24.09 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.818 . . . . 0.0 109.779 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 113' ' ' SER . 50.2 m -60.18 -30.66 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 110.332 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -68.31 -54.76 15.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.363 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 115' ' ' ILE . 33.1 t80 -75.75 -50.39 15.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.046 -1.034 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.521 HD12 ' CA ' ' A' ' 93' ' ' ALA . 34.4 mt -56.43 -39.09 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.27 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' SER . 22.1 m -59.89 -38.53 82.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.45 -39.83 85.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.411 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 71' ' ' ALA . 84.7 mt -70.82 -42.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.435 ' HD2' HG23 ' A' ' 89' ' ' THR . 16.4 ttt180 -54.34 -42.87 70.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -73.0 -33.76 65.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.964 . . . . 0.0 109.664 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 115' ' ' ILE . 16.7 mt -68.93 -42.4 76.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.808 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.568 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 61.9 mt -57.66 -39.65 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.68 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.59 -28.31 73.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -69.09 -36.76 77.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 109.548 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.27 -35.43 80.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.559 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 68.3 m-20 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.592 HG23 ' CZ2' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -133.77 151.69 77.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.5 Cg_endo -67.78 -31.49 31.95 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.73 2.287 . . . . 0.0 111.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CZ2' HG23 ' A' ' 7' ' ' THR . 40.1 p90 -96.24 -14.26 22.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 m -70.03 -7.22 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -139.6 151.44 46.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HG3' ' HE3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -71.13 -40.28 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.567 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.16 -34.58 61.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.349 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -71.56 -29.37 64.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -69.62 -40.85 76.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.775 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -58.73 -56.42 22.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 21' ' ' SER . . . -55.56 -36.17 66.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.557 ' CE1' ' HB1' ' A' ' 99' ' ' ALA . 68.0 t80 -68.01 -48.88 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.092 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 19' ' ' ILE . 41.1 mt -66.5 -44.54 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.36 -50.71 51.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.129 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 30.3 t -58.26 -30.31 66.48 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' CD2' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -72.31 -50.89 23.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.504 -0.748 . . . . 0.0 109.549 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 19' ' ' ILE . 72.1 mt -62.93 -55.91 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 m -57.19 -35.2 69.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.62 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 21' ' ' SER . . . -77.83 -48.3 16.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.432 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -61.76 -34.61 76.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.775 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.51 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 19.3 m -64.1 -27.92 69.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.725 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.93 7.18 31.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.99 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 91' ' ' ALA . 23.2 m -91.91 -75.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.081 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 -104.02 0.78 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -132.34 -58.65 0.94 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.37 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.544 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 7.5 m-85 44.19 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -59.59 162.89 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -52.66 -38.15 59.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.21 -37.8 84.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.281 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.523 ' NE2' ' CG ' ' A' ' 81' ' ' GLN . 72.3 mt-30 -68.24 -35.43 77.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.313 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.51 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 64.8 mtt -64.32 -36.8 85.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.48 -46.89 85.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.145 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -58.83 -41.21 86.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 43' ' ' ILE . 80.0 mtp -64.96 -32.05 73.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 m -69.99 -24.04 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -95.44 -17.16 21.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 44' ' ' GLY . 80.8 mt -126.39 161.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -0.999 . . . . 0.0 109.509 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -79.98 1.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.48 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -1.116 . . . . 0.0 109.03 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -61.17 -35.36 76.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 0.0 109.038 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.458 HD23 HD21 ' A' ' 66' ' ' LEU . 24.7 tp -56.12 -36.19 67.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.848 . . . . 0.0 109.223 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.418 ' CG ' HD13 ' A' ' 19' ' ' ILE . 93.4 mmm -55.74 -33.01 63.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.13 79.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.96 . . . . 0.0 109.064 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.76 81.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HE3' ' HG3' ' A' ' 12' ' ' LYS . 75.5 mmm . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.079 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 3.7 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . 63.4 tt0 -54.28 -45.58 72.52 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.21 63.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 108.917 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 47' ' ' LEU . 1.6 mt -73.93 -53.9 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.543 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 9' ' ' TRP . 0.8 OUTLIER -48.47 -39.06 21.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.727 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.429 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 92.7 mtp -67.37 -47.35 70.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.23 -44.4 75.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.17 -40.59 67.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -59.85 -40.96 90.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.5 t -69.47 -30.63 68.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 43' ' ' ILE . 36.4 m -70.02 -49.57 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.476 ' HB ' ' CZ ' ' A' ' 22' ' ' PHE . 10.8 m -62.72 -38.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.64 -48.21 34.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.921 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 80' ' ' SER . 63.4 tt0 -59.56 -42.65 92.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' SER . 83.5 mt -61.96 -55.04 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.004 . . . . 0.0 109.984 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.544 ' HB1' ' CE1' ' A' ' 32' ' ' PHE . . . -75.84 -47.2 26.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.45 -0.781 . . . . 0.0 110.184 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.78 -23.85 54.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 76' ' ' GLN . 63.8 m -83.04 -20.58 34.73 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.523 ' CG ' ' NE2' ' A' ' 36' ' ' GLN . 22.2 tp60 -136.89 104.73 5.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.99 103.62 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.45 93.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' O ' HG13 ' A' ' 87' ' ' VAL . 82.8 m-20 -106.56 82.15 1.68 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -1.17 . . . . 0.0 109.141 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 123' ' ' ALA . 6.3 tp -43.64 -26.31 0.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 84' ' ' ASP . . . -61.92 -33.19 84.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.2 p -69.73 -44.52 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.235 . . . . 0.0 109.656 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.535 HG23 ' CB ' ' A' ' 78' ' ' ALA . 84.5 m -51.85 -34.98 43.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 108.535 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 1.1 m -56.71 -49.23 75.77 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.46 ' O ' HG22 ' A' ' 29' ' ' THR . 76.4 m-20 -70.92 -40.79 71.9 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.39 -0.819 . . . . 0.0 109.065 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -63.31 -53.23 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.389 -0.82 . . . . 0.0 109.922 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 96' ' ' LEU . 66.4 mt -72.48 -48.99 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.963 . . . . 0.0 109.952 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -59.83 -46.74 88.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.907 . . . . 0.0 110.248 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.482 ' OD2' ' CG2' ' A' ' 29' ' ' THR . 89.2 m-20 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -58.18 -41.54 84.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.868 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.542 ' CD1' HG22 ' A' ' 92' ' ' ILE . 5.2 mt -69.64 -39.3 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.717 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 38.5 m -61.51 -53.5 55.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.927 . . . . 0.0 110.185 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 m -62.82 -38.29 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 109.944 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -62.36 -45.69 92.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.69 -56.21 7.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.528 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.75 -32.27 67.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 98' ' ' SER . 79.0 mm-40 -77.37 -18.63 57.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 99' ' ' ALA . 74.1 p -104.66 -60.22 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.978 -1.076 . . . . 0.0 110.913 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.494 ' CG2' ' C ' ' A' ' 7' ' ' THR . 19.0 p -127.03 -42.75 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.783 -1.198 . . . . 0.0 110.871 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.09 47.02 0.9 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 16.6 t -106.58 172.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.175 -1.191 . . . . 0.0 108.944 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.459 HG21 ' CB ' ' A' ' 110' ' ' ARG . 19.7 m -71.47 119.67 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.605 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 22.6 p-10 -72.1 -31.68 66.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 113' ' ' SER . 14.9 t -57.44 -44.48 84.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -0.817 . . . . 0.0 110.481 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.459 ' CB ' HG21 ' A' ' 107' ' ' VAL . 62.5 ttt-85 -57.36 -53.55 56.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.992 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -74.67 -53.94 8.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.978 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 28.9 mt -56.34 -37.51 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.078 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' SER . 19.2 m -55.79 -48.54 75.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.065 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.96 -42.58 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.08 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.525 HG12 ' CB ' ' A' ' 71' ' ' ALA . 96.5 mt -70.97 -34.62 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 17.8 ttt180 -54.03 -45.73 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 109.398 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.26 -33.9 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.468 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.88 -41.08 92.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 115' ' ' ILE . 99.0 mt -57.82 -37.13 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -71.18 -34.26 64.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.9 -38.09 89.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -1.167 . . . . 0.0 109.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.443 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 72.0 m-85 -69.97 -38.25 76.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 106' ' ' VAL . 25.4 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 9' ' ' TRP . 0.5 OUTLIER -165.11 156.48 12.92 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 38.4 Cg_endo -61.85 -32.25 85.43 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.561 2.174 . . . . 0.0 112.171 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 19.0 p90 -84.15 9.86 11.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' THR . 5.4 t -99.86 -22.75 15.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 0.0 108.763 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 14' ' ' ASN . 69.9 m -118.89 157.74 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.468 -0.77 . . . . 0.0 109.113 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 24.1 ttpt -74.25 -40.71 62.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.943 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.19 -35.3 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.44 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 1.6 m-20 -72.24 -32.55 66.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.61 -47.21 49.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.087 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 68.1 m-20 -54.75 -56.31 20.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.86 . . . . 0.0 109.909 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . -54.8 -37.9 66.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.111 -0.993 . . . . 0.0 109.159 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.544 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 81.5 t80 -62.11 -41.1 97.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.288 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.514 HG21 ' CE1' ' A' ' 70' ' ' PHE . 19.8 mm -69.34 -49.11 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 16' ' ' ASP . 39.8 m-80 -62.03 -49.75 74.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 17' ' ' ALA . 15.2 p -59.04 -34.91 72.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 96' ' ' LEU . 16.6 t80 -67.14 -36.01 80.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.0 110.161 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 19' ' ' ILE . 66.1 mt -70.13 -56.03 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.17 -0.957 . . . . 0.0 110.315 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -62.7 -33.49 75.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -44.6 26.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -71.8 -29.36 64.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.031 -1.043 . . . . 0.0 110.444 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 2.3 t -60.92 -30.87 70.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.0 110.553 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -106.1 7.4 31.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.012 . . . . 0.0 110.682 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 13.3 m -91.54 -73.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 110.607 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -76.1 -105.4 0.13 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' PHE . 18.1 m -149.46 13.37 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.461 -1.023 . . . . 0.0 109.805 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.622 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 66.0 m-85 -39.77 109.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.1 p -72.21 164.22 26.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -53.29 -35.77 60.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.159 -0.963 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -68.05 -47.17 69.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 32' ' ' PHE . 68.9 mt-30 -64.7 -33.89 77.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 40' ' ' MET . 92.9 mmm -64.31 -30.13 71.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.03 -40.18 76.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.12 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.15 -42.22 85.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.218 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 37' ' ' MET . 58.0 mtt -57.38 -39.06 75.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 109.011 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.3 p -70.42 -23.54 62.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.406 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 tp -87.24 -13.78 42.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 61.9 mt -133.45 168.02 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.597 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 66.53 -68.85 0.16 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ILE . 36.0 t-20 -60.76 -38.94 86.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.228 -1.16 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 m -62.38 -35.62 79.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 0.0 109.051 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 66' ' ' LEU . 8.7 mp -53.9 -37.49 63.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.454 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 60.7 mtm -52.75 -39.85 62.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.249 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.38 73.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.898 . . . . 0.0 109.041 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.12 -25.97 68.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.363 -0.835 . . . . 0.0 109.246 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.464 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 57.0 mtm . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 15.0 tp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -55.05 -29.77 58.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.062 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.79 90.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.287 -0.883 . . . . 0.0 109.078 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 47' ' ' LEU . 9.4 tt -69.07 -38.16 78.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.119 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 48.2 t0 -50.55 -48.81 57.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.557 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.45 -40.44 97.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 109.794 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.53 76.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 19' ' ' ILE . 77.2 t80 -55.71 -35.69 66.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -66.56 -36.93 83.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -69.32 -35.67 76.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.764 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.553 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 52.8 p -70.2 -49.83 46.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 109.821 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 75' ' ' ALA . 4.2 m -58.42 -34.94 52.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.73 -38.87 67.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.677 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.04 -49.88 58.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.176 -0.953 . . . . 0.0 109.763 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 40' ' ' MET . 74.8 mt -55.18 -54.59 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.756 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -69.35 -50.81 42.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 109.855 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.95 -23.91 55.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.261 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.5 t -81.16 -20.3 41.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.622 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 85.1 mt-30 -48.37 -37.28 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 9.57 71.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.94 -175.82 22.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 87' ' ' VAL . 23.9 t0 -55.29 123.97 15.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -1.135 . . . . 0.0 109.363 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 79' ' ' ALA . 1.1 tp -75.79 -19.03 59.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.596 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 89' ' ' THR . . . -56.23 -38.45 77.84 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.5 p -70.69 -41.07 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -1.195 . . . . 0.0 109.82 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 78' ' ' ALA . 25.8 m -51.65 -33.72 34.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.051 -1.031 . . . . 0.0 108.812 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.8 p -58.51 -46.17 87.29 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 26.5 m120 -70.82 -38.25 73.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -66.29 -58.95 4.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.143 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CG1' HG21 ' A' ' 88' ' ' THR . 22.8 mm -62.08 -43.77 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.625 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.45 -44.93 85.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 110.697 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.531 ' CB ' HG22 ' A' ' 29' ' ' THR . 31.8 t0 -55.02 -54.07 47.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.879 -1.138 . . . . 0.0 109.789 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -64.08 -35.82 82.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.14 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.57 HD12 ' CE2' ' A' ' 22' ' ' PHE . 6.0 tp -69.94 -40.23 75.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.603 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.581 HG21 ' CE2' ' A' ' 101' ' ' TYR . 18.4 m -69.11 -52.6 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 16.8 m -60.27 -35.35 75.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.727 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -67.72 -39.33 84.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -53.41 -53.37 52.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' CE2' HG21 ' A' ' 97' ' ' THR . 3.1 m-85 -71.6 -32.08 67.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.502 -0.749 . . . . 0.0 110.465 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 98' ' ' SER . 70.6 mm-40 -78.84 -18.5 53.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 8' ' ' PRO . 66.1 p -102.72 -59.35 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.0 111.108 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.2 m -126.23 -42.54 1.84 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.882 -1.136 . . . . 0.0 110.707 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.58 47.92 1.01 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.5 t -112.85 172.61 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -1.122 . . . . 0.0 109.322 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.519 ' CG2' ' HG3' ' A' ' 110' ' ' ARG . 5.4 m -72.3 121.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.6 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 16.7 p30 -69.9 -23.35 63.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 97.9 p -54.7 -30.6 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.592 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.519 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 23.6 mtp-105 -67.42 -55.01 15.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.499 ' CD2' HD22 ' A' ' 96' ' ' LEU . 3.0 t80 -75.8 -51.03 13.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' A' ' 96' ' ' LEU . 43.7 mt -56.39 -42.23 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 110.412 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' SER . 55.9 m -59.34 -35.26 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 109.677 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 97.7 mt-10 -72.65 -47.37 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CD1' HD22 ' A' ' 96' ' ' LEU . 96.8 mt -66.24 -40.67 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 109.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -54.37 -46.37 73.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 t -72.31 -34.22 67.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.62 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 29.5 mt -68.77 -42.01 78.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 76.7 mt -59.61 -43.01 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.34 93.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.6 ttp -54.47 -44.26 72.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.576 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 98.4 m-85 -59.28 -38.92 81.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.629 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -147.54 145.37 21.33 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.1 Cg_endo -70.8 -35.39 9.67 Favored 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.401 2.067 . . . . 0.0 111.724 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.629 ' CZ2' ' CG2' ' A' ' 7' ' ' THR . 41.8 p90 -85.72 -26.28 25.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.868 -1.145 . . . . 0.0 109.155 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 88.2 p -62.8 -12.09 22.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 79.4 p -129.66 150.12 51.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.125 -0.984 . . . . 0.0 109.336 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 16.4 ttpt -74.36 -37.68 63.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.948 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.96 -50.12 63.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 109.191 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.488 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.3 m120 -72.42 -28.93 63.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.563 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.73 -44.3 93.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' CE ' ' A' ' 48' ' ' MET . 18.8 t0 -68.59 -50.98 47.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.88 . . . . 0.0 109.628 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.29 75.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 73.5 t80 -58.89 -37.23 76.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.446 HG21 ' HE1' ' A' ' 48' ' ' MET . 44.0 mt -74.73 -37.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.761 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -68.48 -50.55 51.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.772 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 31.3 t -60.74 -29.18 69.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.342 -0.849 . . . . 0.0 109.102 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD2' ' HB3' ' A' ' 95' ' ' ALA . 14.0 t80 -66.55 -51.1 60.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 34.5 mm -64.56 -55.74 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.863 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t -60.29 -34.29 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 110.094 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.36 -45.22 26.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.982 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.33 73.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.91 . . . . 0.0 110.026 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.452 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 37.8 m -63.68 -28.46 69.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.088 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -106.25 7.14 31.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.086 -1.009 . . . . 0.0 110.311 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 21.0 m -91.48 -76.64 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.996 -1.065 . . . . 0.0 110.081 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -83.98 -104.2 0.57 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.5 t -134.21 -58.27 0.84 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 15.2 m-85 44.0 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 109.34 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -59.67 157.66 11.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -52.52 -30.8 32.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -71.48 -36.0 70.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.319 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.458 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 95.2 mm-40 -72.71 -32.29 65.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.26 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.452 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 64.5 mtt -63.96 -30.36 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.182 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 41' ' ' SER . 83.8 tt0 -57.49 -44.3 84.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -55.67 -42.07 74.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.955 . . . . 0.0 109.051 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.524 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 64.4 mtt -59.66 -32.08 70.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 38' ' ' GLU . 27.5 p -70.27 -23.72 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.478 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.53 -19.92 22.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 73' ' ' SER . 19.3 mm -129.04 151.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.25 -85.06 1.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' HA ' ' HE1' ' A' ' 48' ' ' MET . 61.8 t-20 -59.88 -33.33 71.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -1.151 . . . . 0.0 108.533 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -63.06 -35.12 79.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.449 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 60.1 mt -56.74 -35.1 68.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.457 ' CE ' ' OD1' ' A' ' 16' ' ' ASP . 56.4 mtt -52.64 -40.91 63.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.047 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.57 73.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -64.57 -35.67 81.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.364 -0.835 . . . . 0.0 109.09 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.458 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 67.5 mtt . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 HD21 ' O ' ' A' ' 9' ' ' TRP . 3.6 mp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.304 0.573 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 68' ' ' MET . 48.8 tt0 -54.15 -46.45 72.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 108.686 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.62 -40.92 66.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.139 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.2 tp -66.49 -52.24 48.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.8 t0 -47.36 -33.42 5.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 90.9 mtp -71.78 -37.29 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.62 -42.28 87.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.642 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' A' ' 19' ' ' ILE . 81.5 t80 -54.98 -37.81 67.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -70.66 -42.09 71.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.866 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -68.62 -30.78 69.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.943 . . . . 0.0 109.943 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.52 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 26.2 m -69.96 -49.12 54.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.722 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 75' ' ' ALA . 35.5 m -58.48 -34.96 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -68.75 -38.7 80.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 80' ' ' SER . 48.6 tt0 -72.12 -44.13 63.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 73' ' ' SER . 89.6 mt -54.07 -53.29 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.671 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.545 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -75.38 -49.28 19.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.842 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.93 -21.07 42.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 109.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 93.3 p -81.72 -20.2 39.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.256 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 72.3 mt-30 -51.79 -33.77 36.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.38 67.4 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.24 -175.62 33.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 87' ' ' VAL . 32.1 t0 -63.09 122.4 16.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 119' ' ' ILE . 5.7 mp -71.33 -16.18 62.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.77 -47.75 69.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 88' ' ' THR . 9.8 p -70.47 -46.23 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.302 -1.116 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.545 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 11.5 m -51.52 -36.27 44.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.075 -1.016 . . . . 0.0 108.393 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 55.0 m -54.96 -46.96 75.09 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.7 m-20 -70.79 -41.55 71.51 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -62.2 -58.77 6.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.615 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.483 HG22 ' CE2' ' A' ' 22' ' ' PHE . 40.6 mt -64.56 -41.66 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -66.14 -44.54 83.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -0.934 . . . . 0.0 109.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' HG21 ' A' ' 29' ' ' THR . 44.0 t0 -55.08 -50.87 68.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 109.473 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . . . -54.7 -44.15 73.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.887 . . . . 0.0 109.232 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.57 HD23 ' CE2' ' A' ' 22' ' ' PHE . 5.2 mt -69.88 -38.68 76.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.209 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.577 ' O ' ' CE2' ' A' ' 101' ' ' TYR . 52.4 m -62.3 -46.56 88.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.803 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 7.8 m -70.62 -49.18 50.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -53.35 -44.99 68.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.61 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.11 -55.22 8.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.238 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 97' ' ' THR . 1.9 m-85 -71.97 -31.81 66.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.504 -0.747 . . . . 0.0 109.594 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' SER . 41.9 mt-30 -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.272 -0.893 . . . . 0.0 109.843 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 99' ' ' ALA . 69.8 p -105.94 -60.35 1.65 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.334 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -126.92 -42.7 1.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.877 -1.139 . . . . 0.0 110.645 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.21 46.14 1.03 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 10.3 t -105.69 172.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.306 -1.114 . . . . 0.0 109.053 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.0 m -73.55 121.01 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.348 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.585 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 10.5 p30 -71.41 -28.35 63.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 113' ' ' SER . 22.9 t -56.93 -44.65 82.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -56.92 -54.15 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.973 -1.079 . . . . 0.0 109.975 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.496 ' CE2' HD11 ' A' ' 115' ' ' ILE . 69.1 t80 -75.58 -52.13 11.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.504 HG22 ' CB ' ' A' ' 93' ' ' ALA . 13.8 mt -56.67 -35.74 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 109' ' ' SER . 42.3 t -58.93 -30.25 67.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.94 -41.74 64.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 93.1 mt -72.59 -39.45 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -54.21 -43.16 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.6 p -72.23 -33.92 67.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -68.61 -45.24 72.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 64.9 mt -57.86 -44.88 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.22 -34.57 67.53 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.7 ttm -66.96 -42.33 85.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 109.467 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -64.66 -32.35 73.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.479 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 m120 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.578 HG22 ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -129.85 163.68 45.48 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 49.9 Cg_endo -83.95 -34.23 0.28 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 C-N-CA 122.526 2.15 . . . . 0.0 111.626 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.4 p90 -90.27 -23.27 21.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.902 -1.124 . . . . 0.0 109.488 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.421 ' OG ' ' OG1' ' A' ' 7' ' ' THR . 71.5 m -60.87 -12.57 11.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 70.5 m -132.01 153.67 50.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.583 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 28.9 mtmt -73.88 -39.19 64.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -65.92 -50.33 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.752 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 17.1 m120 -72.21 -29.06 63.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.35 -55.17 8.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.007 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.519 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 1.8 p30 -55.03 -46.8 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.507 -0.746 . . . . 0.0 109.882 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.44 -39.82 94.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 80.7 t80 -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 109.419 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 15' ' ' ALA . 33.2 mm -71.03 -44.07 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -65.42 -45.2 84.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 6.7 t -67.11 -30.72 70.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CD2' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -66.31 -46.83 75.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.151 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 30.5 mm -64.89 -56.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.522 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 m -60.85 -31.9 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.98 . . . . 0.0 109.919 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -45.45 24.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.06 -34.1 76.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.362 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.433 ' HB3' ' HE3' ' A' ' 37' ' ' MET . 40.3 m -57.35 -33.52 67.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.322 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -106.06 7.36 31.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.128 -0.983 . . . . 0.0 110.687 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 43.5 m -85.89 -81.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.801 -1.187 . . . . 0.0 110.201 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.14 -101.12 0.24 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -132.46 -61.51 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -1.059 . . . . 0.0 109.212 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 4.8 m-85 43.94 91.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.307 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -59.61 161.28 6.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.61 -40.72 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.84 -36.21 76.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.469 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.3 mm-40 -73.2 -32.28 64.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 40' ' ' MET . 61.6 mtt -63.23 -34.18 77.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.0 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.43 -43.11 91.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.855 . . . . 0.0 109.038 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -59.76 -42.58 93.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.502 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 75.1 mtm -66.75 -32.72 74.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.135 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.4 t -70.25 -24.02 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 17.0 tp -87.92 -22.81 24.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 40' ' ' MET . 37.9 mm -116.15 162.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.83 -80.33 1.36 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.0 -38.14 78.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 84.7 m -60.17 -35.33 75.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.354 -0.841 . . . . 0.0 108.805 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.536 ' CD2' HD23 ' A' ' 66' ' ' LEU . 26.9 tp -59.52 -33.94 72.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.247 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.519 ' CE ' ' HB3' ' A' ' 16' ' ' ASP . 60.3 mmm -56.65 -28.14 59.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.31 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 46' ' ' THR . . . -61.37 -38.41 86.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.112 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -22.77 50.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.243 -0.911 . . . . 0.0 108.9 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.533 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 16.6 ttm . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.103 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 9' ' ' TRP . 5.6 tp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.063 0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -54.68 -35.01 63.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 108.73 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -68.45 -43.56 76.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 27.0 t0 -48.57 -34.88 12.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.787 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.5 -37.31 77.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.91 . . . . 0.0 109.931 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.9 65.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' HG12 ' A' ' 74' ' ' VAL . 70.7 t80 -67.01 -35.92 80.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 111' ' ' PHE . . . -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.786 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 25.2 t -69.69 -41.71 75.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 110.023 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB2' HG22 ' A' ' 43' ' ' ILE . 58.0 p -70.09 -47.12 63.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 110.28 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 75' ' ' ALA . 6.2 m -57.2 -37.05 54.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.802 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' N ' HG21 ' A' ' 74' ' ' VAL . . . -73.92 -38.32 64.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 0.0 109.819 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 72' ' ' SER . 94.4 mt-30 -70.27 -46.23 64.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.828 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.434 HD12 ' HG2' ' A' ' 40' ' ' MET . 97.2 mt -56.2 -44.74 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 0.0 109.885 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.54 ' HB1' ' CE1' ' A' ' 32' ' ' PHE . . . -78.36 -50.14 12.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.896 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . -58.04 -22.13 48.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.8 m -76.2 -20.26 57.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.937 . . . . 0.0 109.457 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.469 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.6 mt-30 -55.86 -33.16 64.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.672 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.73 21.82 73.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.48 -149.41 19.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.04 120.65 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.484 HD13 ' CG2' ' A' ' 119' ' ' ILE . 5.3 tp -67.69 -18.46 64.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.287 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -28.36 70.25 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.86 -50.06 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -1.164 . . . . 0.0 109.569 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.563 ' CG2' ' CD1' ' A' ' 92' ' ' ILE . 59.6 m -52.32 -49.52 64.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 56.9 m -51.68 -48.85 63.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.8 m-20 -70.86 -32.11 69.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -77.98 -59.04 2.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 31.3 mt -61.27 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.879 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.107 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.503 ' CB ' HG23 ' A' ' 29' ' ' THR . 42.9 t0 -55.14 -53.62 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -53.98 -42.98 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.494 ' CD1' HG21 ' A' ' 92' ' ' ILE . 6.7 mt -69.47 -40.52 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.571 HG23 ' CE2' ' A' ' 101' ' ' TYR . 76.0 m -62.77 -51.98 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.0 m -62.97 -36.61 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.78 -42.81 73.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.671 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.593 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.7 m-85 -47.3 -55.98 7.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.571 ' CE2' HG23 ' A' ' 97' ' ' THR . 3.4 m-85 -71.06 -32.17 68.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 98' ' ' SER . 89.5 mm-40 -78.56 -18.36 54.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 99' ' ' ALA . 72.4 p -102.55 -59.97 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 111.149 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.03 -42.36 1.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.779 -1.2 . . . . 0.0 110.807 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.34 47.93 0.9 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 21.5 t -113.25 169.14 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.299 -1.118 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.528 ' CG2' ' CG ' ' A' ' 110' ' ' ARG . 15.8 m -67.43 121.22 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.856 . . . . 0.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 11.6 p30 -71.14 -23.63 62.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 113' ' ' SER . 91.3 p -59.29 -33.34 70.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 110.794 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CG ' ' CG2' ' A' ' 107' ' ' VAL . 78.2 mmt-85 -64.1 -55.42 22.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.742 -1.224 . . . . 0.0 110.33 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 75.2 t80 -76.28 -49.67 16.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.518 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 16.2 mt -56.65 -36.71 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 109' ' ' SER . 78.9 p -63.44 -34.79 78.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.04 -1.037 . . . . 0.0 109.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.31 -39.75 74.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 54.3 mt -72.77 -41.99 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -54.46 -42.38 70.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.4 t -72.01 -33.84 68.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.667 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 41.7 mt -68.36 -42.21 79.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.484 ' CG2' HD13 ' A' ' 85' ' ' LEU . 62.6 mt -58.51 -41.55 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -66.67 -30.85 76.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -66.99 -39.48 87.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.595 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.413 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 72.3 m-85 -60.59 -52.06 66.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.555 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.552 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 106' ' ' VAL . 76.4 m-20 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -165.11 145.35 5.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.9 Cg_endo -70.25 -35.12 11.73 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.414 2.076 . . . . 0.0 111.728 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 7' ' ' THR . 39.5 p90 -85.58 -30.89 22.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 109.058 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -58.8 -15.09 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 109.57 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -127.15 143.69 51.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 4.0 ttpp -71.64 -37.14 70.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.461 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -68.45 -48.08 65.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 108.994 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 12.3 m120 -71.56 -28.93 64.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.38 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.23 -41.57 99.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.822 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.8 p30 -68.71 -50.12 53.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -56.57 -37.42 70.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.89 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' N ' HG23 ' A' ' 103' ' ' THR . 69.3 t80 -65.78 -49.36 68.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.02 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 70' ' ' PHE . 42.0 mt -63.14 -46.94 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -67.75 -50.3 57.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 108.945 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 69.4 m -56.11 -30.04 61.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 108.593 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 95' ' ' ALA . 46.8 t80 -71.44 -52.2 19.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.538 -0.726 . . . . 0.0 109.624 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 19' ' ' ILE . 56.8 mt -62.62 -55.74 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -53.76 -40.3 66.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.863 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 21' ' ' SER . . . -77.85 -46.0 22.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.088 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' N ' ' HB1' ' A' ' 95' ' ' ALA . . . -60.42 -30.64 69.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.528 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 17.4 m -64.75 -31.4 72.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.968 . . . . 0.0 110.014 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -105.96 7.35 32.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.54 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 19.3 m -88.68 -75.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.95 -1.094 . . . . 0.0 110.054 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.49 -102.2 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -138.13 -55.64 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -1.115 . . . . 0.0 109.353 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 12.9 m-85 43.84 87.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.158 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.8 p -59.76 161.24 6.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.66 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -52.62 -31.95 39.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.143 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.113 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 82.3 mm-40 -76.19 -34.61 59.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 109.233 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 71.5 mtp -63.42 -36.73 84.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -56.89 -42.52 80.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CG2' ' A' ' 77' ' ' ILE . 23.5 m120 -59.5 -37.0 77.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.865 . . . . 0.0 109.052 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ILE . 90.8 mtp -65.18 -33.47 76.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.356 -0.84 . . . . 0.0 109.25 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -70.1 -24.22 63.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.246 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.9 tp -89.03 -20.61 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' CB ' ' A' ' 73' ' ' SER . 65.0 mt -120.03 160.46 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 109.408 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.503 ' N ' HG21 ' A' ' 43' ' ' ILE . . . 76.33 -88.54 0.91 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.17 -37.18 64.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -1.164 . . . . 0.0 109.157 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 89.1 m -58.13 -34.86 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.267 -0.896 . . . . 0.0 108.81 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 73.5 mt -61.71 -35.88 79.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.423 ' HA ' ' HE1' ' A' ' 51' ' ' MET . 38.7 ttm -52.74 -37.56 59.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.8 -31.11 71.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.245 -0.909 . . . . 0.0 109.122 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -68.07 -41.86 81.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.896 . . . . 0.0 109.239 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.423 ' HE1' ' HA ' ' A' ' 48' ' ' MET . 62.9 mtm . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 0.0 109.251 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 6.5 mt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.75 -49.62 70.4 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 108.591 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.52 -47.48 48.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.056 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.4 -53.32 59.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.9 t0 -47.87 -35.69 10.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.267 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.2 ttm -72.18 -40.89 67.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.59 91.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.57 ' CE1' HG12 ' A' ' 19' ' ' ILE . 75.0 t80 -54.48 -42.78 71.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 115' ' ' ILE . . . -70.26 -38.19 75.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.764 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 84.3 p -69.17 -46.85 66.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.991 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.526 ' CB ' HG22 ' A' ' 43' ' ' ILE . 4.1 m -70.03 -45.33 67.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 22' ' ' PHE . 9.8 p -57.71 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -67.35 -36.54 81.62 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.933 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 80' ' ' SER . 90.8 mt-30 -69.17 -38.3 78.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.834 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.481 ' CG2' ' HB2' ' A' ' 39' ' ' ASN . 56.5 mt -56.68 -55.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.848 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.85 -48.53 14.54 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 109.977 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.87 -22.25 47.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 30.0 t -81.13 -20.92 40.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.892 . . . . 0.0 109.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 75.9 mt-30 -44.68 -40.91 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.81 53.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.96 -158.73 12.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 87' ' ' VAL . 83.7 m-20 -54.33 127.48 27.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 5.5 tp -84.46 -20.87 31.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.71 63.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 88' ' ' THR . 5.5 p -68.95 -47.79 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 109.525 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.547 ' N ' ' CG1' ' A' ' 87' ' ' VAL . 22.5 m -51.7 -37.73 52.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.068 . . . . 0.0 108.251 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -55.34 -51.6 66.22 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 62.2 m-20 -70.86 -39.64 72.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.54 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -60.19 -55.35 34.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.51 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.554 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 43.6 mt -72.23 -49.93 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.455 -0.778 . . . . 0.0 109.852 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -57.09 -46.2 82.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 110.654 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.51 ' HB3' ' CG2' ' A' ' 29' ' ' THR . 41.8 t0 -54.9 -53.77 51.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.941 -1.099 . . . . 0.0 109.89 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' A' ' 22' ' ' PHE . . . -57.14 -40.73 77.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.715 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 92' ' ' ILE . 15.0 mt -68.13 -41.45 81.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.508 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.7 m -58.61 -53.82 54.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.886 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 16.3 m -63.8 -45.14 91.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -53.13 -45.98 68.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.12 -0.987 . . . . 0.0 109.427 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.13 -54.27 10.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.973 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.532 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.76 -32.05 67.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.493 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 98' ' ' SER . 73.1 mt-30 -76.12 -18.51 59.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.821 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 99' ' ' ALA . 47.9 p -105.51 -59.73 1.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 111.209 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 7' ' ' THR . 5.5 m -126.55 -42.58 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.83 -1.169 . . . . 0.0 110.784 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.88 47.7 1.0 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 6' ' ' ASN . 48.1 t -112.78 168.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.309 -1.112 . . . . 0.0 108.945 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.48 ' CG2' ' HG3' ' A' ' 110' ' ' ARG . 6.8 m -67.29 121.04 15.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.3 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 16.1 p-10 -70.53 -23.12 62.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.426 -0.797 . . . . 0.0 109.818 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' SER . 34.0 t -54.45 -30.34 52.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.858 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.48 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 93.5 mtt180 -68.15 -55.31 12.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 71.4 t80 -76.4 -50.66 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 110.343 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 17.3 mt -56.17 -45.77 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.836 . . . . 0.0 110.182 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 109' ' ' SER . 63.1 m -55.66 -39.25 70.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.0 109.392 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 80.8 tt0 -62.1 -49.71 74.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 81.2 mt -67.59 -34.7 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -53.7 -45.69 70.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.38 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.1 t -73.42 -33.68 65.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 49.1 mt -67.92 -45.51 74.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.463 ' O ' HD11 ' A' ' 85' ' ' LEU . 87.5 mt -57.8 -34.54 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.997 . . . . 0.0 109.438 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.52 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -68.23 -36.77 85.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.45 -37.63 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -1.177 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.529 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 63.9 m-85 -66.56 -30.48 70.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.58 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 0.6 OUTLIER -154.8 157.39 32.02 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.064 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 49.0 Cg_endo -69.03 -34.6 16.64 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.566 2.178 . . . . 0.0 112.633 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.58 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 48.9 p90 -83.28 1.48 40.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.964 -1.085 . . . . 0.0 110.074 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.552 ' CB ' HG22 ' A' ' 7' ' ' THR . 17.7 m -90.46 -28.26 18.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 108.933 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -104.23 154.58 19.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.352 -0.843 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -73.53 -37.78 65.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -35.21 25.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.643 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 8.3 t-20 -71.29 -29.17 64.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.43 -45.28 60.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 109.952 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 48' ' ' MET . 58.6 t0 -56.22 -54.06 49.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.99 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.8 -44.17 63.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CE1' ' HB1' ' A' ' 99' ' ' ALA . 72.8 t80 -56.97 -38.78 73.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.507 HD12 ' CE1' ' A' ' 70' ' ' PHE . 34.4 mm -69.35 -42.93 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.862 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -64.95 -49.24 71.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.029 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.6 t -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE2' HD21 ' A' ' 96' ' ' LEU . 12.0 t80 -64.28 -52.2 59.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.164 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 37.9 mm -58.92 -55.97 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.179 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -64.76 -28.99 69.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.907 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.16 -43.07 29.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -74.25 -29.19 61.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.298 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 94.9 p -63.86 -27.68 69.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 110.226 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.06 7.26 31.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 0.0 110.5 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.507 ' CG2' ' OD2' ' A' ' 94' ' ' ASP . 19.1 m -92.08 -77.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.17 . . . . 0.0 110.292 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.0 -104.23 0.4 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' PHE . 35.8 t -131.06 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -1.065 . . . . 0.0 109.409 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 78' ' ' ALA . 18.6 m-85 43.53 87.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.27 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 37.8 p -59.64 160.51 7.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 0.0 109.533 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -52.54 -35.78 54.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.226 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.12 -36.11 83.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.277 -0.89 . . . . 0.0 109.34 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.46 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.4 mm-40 -73.29 -31.88 64.3 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.059 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 63.9 mtt -63.43 -31.37 72.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.436 -0.79 . . . . 0.0 109.097 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -57.25 -44.71 84.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 109.168 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB3' HG12 ' A' ' 77' ' ' ILE . 69.4 m-20 -56.28 -40.97 75.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.196 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.505 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 63.6 mtt -63.02 -32.12 73.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.038 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 m -70.02 -23.5 63.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.166 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.05 -25.67 21.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.695 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.524 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 62.2 mt -124.86 149.41 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' N ' HG21 ' A' ' 43' ' ' ILE . . . 104.37 -81.01 0.32 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -62.29 -29.16 70.23 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.257 -1.143 . . . . 0.0 108.635 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.8 m -64.22 -35.16 79.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.495 -0.753 . . . . 0.0 108.995 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 56.5 mt -54.29 -35.86 63.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.252 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' ' OD2' ' A' ' 16' ' ' ASP . 61.3 ttp -52.68 -40.11 62.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 109.076 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.96 81.34 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -61.96 -23.95 66.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' MET . 65.7 mtt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 9' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.263 0.554 . . . . 0.0 109.633 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -54.41 -39.25 67.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 108.992 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.37 -36.61 68.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.06 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.28 -48.25 29.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.503 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.6 t0 -48.08 -37.92 16.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.319 -0.863 . . . . 0.0 109.702 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -72.22 -32.87 67.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.661 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.68 89.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.507 ' CE1' HD12 ' A' ' 19' ' ' ILE . 91.3 t80 -53.24 -36.31 60.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.952 . . . . 0.0 109.591 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.26 -35.29 73.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 m -69.12 -35.44 76.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.524 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 51.9 m -69.99 -49.25 53.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.714 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.499 HG21 ' N ' ' A' ' 75' ' ' ALA . 16.0 m -58.96 -35.0 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . . . -67.45 -43.39 81.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.5 mt-30 -65.66 -45.85 81.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' MET . 92.3 mt -54.64 -51.42 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 109.692 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.08 -49.06 14.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.714 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.21 -23.96 57.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 88.9 p -80.58 -20.2 43.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 39.7 mt-30 -52.57 -30.67 32.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.97 19.27 70.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 -164.62 24.62 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' HG11 ' A' ' 87' ' ' VAL . 84.2 m-20 -60.0 135.68 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -1.176 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.496 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 6.1 tp -84.43 -18.56 35.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.691 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.02 64.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 88' ' ' THR . 5.7 p -69.0 -46.47 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 109.584 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 78' ' ' ALA . 93.5 m -51.73 -35.75 44.44 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 108.628 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 44.7 m -56.21 -46.51 79.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.7 m-20 -71.01 -40.07 72.01 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -64.46 -59.08 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 92' ' ' ILE . 24.5 mm -63.14 -49.41 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -60.33 -49.98 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' OD2' ' CG2' ' A' ' 29' ' ' THR . 75.7 m-20 -55.26 -44.13 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -61.1 -43.81 98.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.415 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 22' ' ' PHE . 2.7 mt -69.95 -38.62 76.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 52.7 m -60.72 -51.81 67.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 110.046 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 15.5 t -60.37 -47.65 85.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.979 . . . . 0.0 109.842 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -59.01 -41.73 88.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -46.58 -53.83 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.121 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.528 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -72.06 -31.9 66.56 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.518 -0.739 . . . . 0.0 109.995 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 98' ' ' SER . 42.2 mt-30 -78.33 -18.54 55.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 110.128 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.514 HG21 ' N ' ' A' ' 18' ' ' PHE . 51.8 p -105.74 -58.75 1.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.917 -1.115 . . . . 0.0 111.284 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 91.5 m -125.89 -42.64 1.89 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.676 -1.265 . . . . 0.0 110.737 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.3 48.52 1.05 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 4.9 t -111.7 172.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.39 -1.065 . . . . 0.0 109.117 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 110' ' ' ARG . 27.4 m -72.98 121.01 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.585 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 11.3 p30 -71.22 -29.22 64.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 113' ' ' SER . 22.7 t -58.15 -30.53 66.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.404 -0.81 . . . . 0.0 110.693 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.454 ' HB2' HG21 ' A' ' 107' ' ' VAL . 40.5 ttm180 -71.05 -54.34 11.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.884 -1.135 . . . . 0.0 109.994 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 56.4 t80 -75.61 -48.44 22.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.807 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 93' ' ' ALA . 13.2 mt -56.28 -37.76 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.853 . . . . 0.0 109.949 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 109' ' ' SER . 4.9 m -55.8 -39.87 71.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.455 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.6 mt-10 -72.23 -38.82 68.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 49.3 mt -70.91 -43.68 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ttp85 -54.18 -38.14 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.84 . . . . 0.0 109.366 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -72.36 -33.85 67.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 66.4 mt -68.7 -38.79 80.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 75' ' ' ALA . 63.5 mt -57.73 -35.87 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -70.35 -34.44 68.8 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 49.0 ttm -64.83 -38.61 91.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -1.157 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD2' ' HB3' ' A' ' 75' ' ' ALA . 75.7 m-85 -64.52 -41.69 96.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.329 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 m120 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 9.1 t -136.48 150.61 70.99 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 14' ' ' ASN . 44.3 Cg_endo -65.94 -30.93 47.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.603 2.202 . . . . 0.0 112.904 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.593 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 44.0 p90 -81.34 -1.01 43.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.788 -1.195 . . . . 0.0 110.168 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.524 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 78.3 p -89.65 -14.94 33.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 108.86 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 68.8 m -140.94 149.0 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 109.071 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 31.2 mtmt -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.67 -50.34 72.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.755 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.9 m-20 -72.53 -32.83 66.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.862 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 11' ' ' SER . . . -67.15 -49.02 66.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.989 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.07 -56.07 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.938 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.08 -33.84 71.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.002 . . . . 0.0 109.367 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 99' ' ' ALA . 52.3 t80 -67.64 -37.08 81.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.191 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 ' CA ' ' A' ' 44' ' ' GLY . 17.4 mt -74.04 -38.54 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -68.21 -50.29 55.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 p -59.99 -33.56 72.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CD2' HD23 ' A' ' 96' ' ' LEU . 8.4 t80 -64.1 -35.94 82.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 109.844 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.467 HG12 ' CE ' ' A' ' 40' ' ' MET . 67.6 mt -71.6 -56.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -59.76 -30.79 69.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 109.905 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.09 -43.54 28.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 110.238 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.51 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -70.28 -34.46 72.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 0.0 110.396 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.468 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 92.6 p -61.59 -26.77 68.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.045 -1.034 . . . . 0.0 110.084 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -105.87 7.29 32.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 110.373 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.522 HG23 ' CB ' ' A' ' 94' ' ' ASP . 22.8 m -92.28 -78.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.914 -1.116 . . . . 0.0 110.298 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.37 -104.26 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -130.68 -61.17 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -1.084 . . . . 0.0 109.35 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.599 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 8.9 m-85 44.06 83.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 109.177 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -59.56 167.08 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.693 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -52.51 -43.59 65.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -56.19 -36.71 68.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.104 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 90.7 mm-40 -76.27 -35.4 58.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.468 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 62.4 mtt -63.31 -39.85 95.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.4 -43.12 83.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.039 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.3 m-20 -57.15 -39.93 76.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.134 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.467 ' CE ' HG12 ' A' ' 23' ' ' ILE . 77.0 mmm -58.25 -32.22 68.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 108.921 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 t -70.16 -24.19 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' OG1' ' A' ' 46' ' ' THR . 63.0 mt -91.85 -16.83 26.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 HG21 ' N ' ' A' ' 44' ' ' GLY . 64.9 mt -119.6 166.45 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.186 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 19' ' ' ILE . . . 68.35 -81.86 0.2 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.45 -40.23 68.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.035 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -60.06 -35.23 74.68 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 108.979 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.471 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 40.8 mt -55.18 -36.72 66.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.207 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' MET . 61.5 ttp -52.93 -43.16 66.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.902 . . . . 0.0 109.247 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.49 77.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.925 . . . . 0.0 108.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -62.51 -23.17 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 15.9 mmt . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.4 mp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.049 0.452 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -54.22 -38.45 65.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 108.919 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.79 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.276 -0.89 . . . . 0.0 108.687 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 tt -74.1 -43.67 56.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 0.0 109.136 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 37.5 t0 -47.85 -40.23 20.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.835 . . . . 0.0 109.696 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.8 mtp -67.84 -30.67 70.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.86 85.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.8 t80 -54.58 -44.33 72.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.669 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -38.65 74.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.827 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -69.5 -36.68 76.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.975 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.497 ' CB ' HG22 ' A' ' 43' ' ' ILE . 85.7 p -70.12 -45.06 67.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 109.949 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 75' ' ' ALA . 6.9 m -63.8 -35.02 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 74' ' ' VAL . . . -64.81 -39.41 93.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.797 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.33 -45.17 73.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.759 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' HD11 ' A' ' 43' ' ' ILE . 73.8 mt -53.99 -47.65 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' CB ' HG21 ' A' ' 88' ' ' THR . . . -78.49 -49.47 13.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 85' ' ' LEU . . . -57.86 -26.24 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 81' ' ' GLN . 52.3 m -79.19 -20.15 49.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.599 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 79.1 mt-30 -45.2 -39.45 6.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.03 7.47 64.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.67 -159.57 26.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 87' ' ' VAL . 60.1 t0 -64.7 97.91 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -1.184 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 79' ' ' ALA . 20.1 tp -58.89 -15.9 14.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.88 -35.4 84.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.5 p -70.1 -35.71 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -1.154 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 ' CB ' ' A' ' 78' ' ' ALA . 53.3 m -51.4 -33.31 29.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.046 -1.034 . . . . 0.0 108.424 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.7 m -57.03 -47.73 80.2 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 73.9 m-20 -70.97 -38.69 72.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.403 -0.811 . . . . 0.0 109.168 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -66.14 -53.85 32.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.733 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.499 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 62.7 mt -70.45 -45.26 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.727 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.75 -46.75 83.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.522 ' CB ' HG23 ' A' ' 29' ' ' THR . 76.7 m-20 -55.23 -49.65 71.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.67 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 26' ' ' ALA . . . -67.93 -33.72 75.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.966 . . . . 0.0 108.833 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -69.78 -42.56 73.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.547 -0.721 . . . . 0.0 109.587 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.58 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 60.4 m -65.46 -53.82 37.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 83.9 p -57.7 -42.99 84.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -58.3 -46.25 86.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.671 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -47.26 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 109.472 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.58 ' CZ ' HG22 ' A' ' 97' ' ' THR . 1.8 m-85 -68.57 -32.02 71.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.518 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 98' ' ' SER . 33.4 mt-30 -69.63 -18.79 63.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 110.051 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 18' ' ' PHE . 71.9 p -113.5 -59.37 2.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.123 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -125.93 -42.45 1.89 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.764 -1.21 . . . . 0.0 110.639 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.61 47.74 1.02 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 35.1 t -101.19 158.55 4.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -1.149 . . . . 0.0 108.831 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 110' ' ' ARG . 30.4 m -58.35 121.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.601 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.3 p30 -70.83 -26.7 63.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 113' ' ' SER . 96.4 p -64.15 -31.81 73.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.307 -0.871 . . . . 0.0 110.871 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.469 ' CB ' HG22 ' A' ' 107' ' ' VAL . 52.2 ttt180 -66.14 -55.14 17.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.771 -1.205 . . . . 0.0 110.409 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.51 ' CE2' HD13 ' A' ' 115' ' ' ILE . 55.1 t80 -75.92 -50.82 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 109.966 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 22.1 mt -56.28 -40.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.4 t -56.13 -38.85 71.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.82 -49.69 67.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.158 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.512 HG12 ' CB ' ' A' ' 71' ' ' ALA . 96.8 mt -59.13 -34.67 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.149 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.523 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 9.6 ttt180 -53.7 -47.62 70.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.493 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.23 -33.92 65.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 115' ' ' ILE . 10.4 mt -66.1 -45.79 79.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 88.9 mt -57.69 -39.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.12 -36.05 64.17 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.4 ttm -58.18 -40.93 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.585 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.92 -28.41 69.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.261 0.553 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.59 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 2.1 t -131.48 151.63 79.07 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -66.7 -34.36 32.09 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.487 2.124 . . . . 0.0 112.578 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -84.33 15.93 3.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.803 -1.186 . . . . 0.0 110.059 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.535 ' CB ' HG23 ' A' ' 7' ' ' THR . 2.5 m -95.26 -34.85 12.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.064 -1.022 . . . . 0.0 108.461 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 89.3 p -123.08 161.69 23.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -74.04 -41.11 62.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.55 93.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 0.0 109.365 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 8' ' ' PRO . 25.5 t30 -71.6 -40.93 69.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -68.67 -38.64 80.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.877 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' OD2' ' HE3' ' A' ' 48' ' ' MET . 62.6 t0 -54.96 -56.38 20.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.58 66.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.079 -1.013 . . . . 0.0 108.987 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.427 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 59.2 t80 -61.67 -46.98 87.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.126 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.8 mm -63.08 -46.23 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.273 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -50.75 53.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.304 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 33.8 t -54.95 -29.85 57.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 108.903 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 95' ' ' ALA . 30.7 t80 -72.22 -51.74 19.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 109.853 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.81 -55.89 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.048 . . . . 0.0 109.839 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -58.74 -36.55 74.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.892 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.88 -46.5 21.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.935 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -63.25 -33.7 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 110.173 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 45.0 m -64.05 -28.12 69.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.02 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.95 7.33 32.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 110.318 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 17.9 m -92.68 -76.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.865 -1.147 . . . . 0.0 110.187 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.67 -104.4 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.4 -59.09 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -1.09 . . . . 0.0 109.371 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 17.8 m-85 44.41 89.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.345 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 47.6 p -59.81 161.54 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.629 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -52.7 -41.14 63.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.96 -35.55 73.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.228 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.5 mm-40 -72.23 -32.37 66.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.255 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.444 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 60.3 mtt -63.45 -34.29 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' A' ' 41' ' ' SER . 72.1 mm-40 -58.21 -45.54 87.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.041 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB2' HG21 ' A' ' 77' ' ' ILE . 85.0 m-20 -56.66 -43.23 80.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.297 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.494 ' HE3' ' CD1' ' A' ' 32' ' ' PHE . 63.6 mtt -59.47 -32.2 70.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 38' ' ' GLU . 30.5 p -70.25 -23.58 62.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.242 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 12.5 tp -89.71 -25.17 21.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.74 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.531 HG21 ' CB ' ' A' ' 73' ' ' SER . 54.1 mt -125.34 149.75 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 95.25 -79.66 0.85 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.35 -30.59 70.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.265 -1.138 . . . . 0.0 108.454 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.1 m -67.35 -34.79 78.07 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 52.6 mt -52.35 -32.9 40.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.449 -0.782 . . . . 0.0 109.181 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.407 ' HE3' ' OD2' ' A' ' 16' ' ' ASP . 29.4 ttm -57.46 -47.23 82.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.224 -0.922 . . . . 0.0 108.901 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.85 69.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.213 -0.929 . . . . 0.0 108.808 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -67.66 -38.44 83.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.436 ' CE ' HD13 ' A' ' 63' ' ' LEU . 85.3 mmm . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.868 . . . . 0.0 109.015 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 10' ' ' SER . 13.5 tp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -55.67 -28.76 57.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.01 . . . . 0.0 109.179 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.57 91.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.33 -41.38 85.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 38.2 t0 -48.63 -47.85 39.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.52 -39.63 94.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.548 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.44 89.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.68 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 19' ' ' ILE . 87.4 t80 -58.62 -41.58 86.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -63.71 -35.58 81.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.655 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -69.36 -38.68 78.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.666 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.531 ' CB ' HG21 ' A' ' 43' ' ' ILE . 20.4 m -70.24 -48.69 55.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 75' ' ' ALA . 8.5 m -57.35 -34.73 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.254 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 122' ' ' PHE . . . -72.94 -41.73 64.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 80' ' ' SER . 96.9 mt-30 -65.24 -50.3 66.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 39' ' ' ASN . 92.9 mt -53.69 -48.98 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.579 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.54 -52.26 8.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.506 -0.746 . . . . 0.0 109.92 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.97 -23.19 52.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.497 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 90.6 p -81.67 -20.47 39.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 42.9 mt-30 -49.44 -35.11 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 109.381 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.47 9.19 79.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.76 -150.33 26.87 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' VAL . 19.2 t70 -71.23 128.1 34.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -1.204 . . . . 0.0 109.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.447 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 6.2 tp -80.26 -18.67 48.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.862 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.25 -40.13 61.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.7 p -67.0 -44.28 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -1.212 . . . . 0.0 109.695 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.564 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 28.1 m -51.66 -35.57 42.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 108.352 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.56 ' CG2' ' NE ' ' A' ' 116' ' ' ARG . 6.8 m -54.03 -48.22 70.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.6 m120 -71.12 -39.88 71.76 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -62.12 -54.11 45.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.511 HG22 ' CD1' ' A' ' 96' ' ' LEU . 77.2 mt -72.24 -48.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.291 -0.881 . . . . 0.0 109.732 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -59.29 -50.77 72.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.91 . . . . 0.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 91.1 m-20 -55.41 -46.71 76.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.095 -1.003 . . . . 0.0 109.612 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -58.5 -43.46 89.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.382 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 92' ' ' ILE . 3.8 mt -69.91 -33.3 71.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.518 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.501 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 92.7 m -67.57 -53.39 28.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.4 p -59.22 -35.55 73.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.689 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -70.01 -43.45 71.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.25 -56.23 7.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.551 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 8.0 m-85 -72.16 -32.02 66.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.454 -0.779 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 86.5 mm-40 -72.55 -18.74 61.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.7 p -103.6 -60.3 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.846 -1.158 . . . . 0.0 111.232 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.532 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.12 -42.91 1.68 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.691 -1.256 . . . . 0.0 110.875 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 113.71 45.31 0.72 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 10.1 t -106.0 172.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -1.211 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.7 m -75.01 120.18 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 14.3 p30 -71.83 -23.79 61.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 0.0 109.844 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 113' ' ' SER . 29.8 m -59.17 -43.63 92.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 110.591 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -57.0 -53.58 56.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.0 110.027 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.618 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 70.7 t80 -75.29 -51.72 12.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.943 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.515 HG23 ' CB ' ' A' ' 93' ' ' ALA . 16.2 mt -58.71 -36.25 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.275 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.5 m -55.97 -43.3 77.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 0.0 109.83 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.04 -36.89 69.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 28.4 mt -62.78 -43.52 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.56 ' NE ' ' CG2' ' A' ' 89' ' ' THR . 34.6 mtp180 -54.06 -49.3 69.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.4 p -57.46 -33.17 67.69 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.479 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 6.8 mt -73.51 -40.12 64.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.496 -0.752 . . . . 0.0 110.037 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 115' ' ' ILE . 57.8 mt -61.21 -35.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 109.226 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.447 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -71.38 -34.09 64.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -61.99 -44.5 96.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.565 ' CD2' ' HB2' ' A' ' 75' ' ' ALA . 84.5 m-85 -59.1 -42.76 91.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.616 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -154.52 149.99 21.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.165 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.579 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 43.6 Cg_endo -67.0 -35.29 26.32 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.356 2.037 . . . . 0.0 111.977 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.616 ' CZ2' ' CG2' ' A' ' 7' ' ' THR . 45.8 p90 -90.01 -10.71 43.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.3 m -70.62 -8.9 55.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.6 t -143.4 159.03 43.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 25.2 mtmt -74.73 -40.76 61.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.45 69.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -72.21 -29.11 63.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.43 -53.68 13.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -54.82 -56.1 23.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.659 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -0.982 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.582 ' CE1' ' HB1' ' A' ' 99' ' ' ALA . 80.0 t80 -63.44 -38.06 89.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.447 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 HG23 ' CA ' ' A' ' 44' ' ' GLY . 36.0 mt -75.64 -38.3 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -68.33 -50.54 52.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.5 t -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.665 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 96' ' ' LEU . 25.6 t80 -64.79 -46.81 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 110.32 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 40' ' ' MET . 82.8 mt -65.93 -56.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.161 -0.962 . . . . 0.0 110.251 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.4 p -54.05 -34.14 59.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -47.4 18.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 110.011 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.97 77.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.445 ' HB2' ' HE1' ' A' ' 37' ' ' MET . 93.8 p -61.78 -30.1 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.007 . . . . 0.0 110.208 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -106.07 7.47 31.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.469 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.525 ' CG2' ' OD2' ' A' ' 94' ' ' ASP . 23.4 m -91.16 -78.27 0.4 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.13 . . . . 0.0 110.356 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.74 -103.53 0.38 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' PHE . 17.3 p -131.61 -61.34 0.91 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -1.108 . . . . 0.0 109.45 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CG ' ' HE1' ' A' ' 40' ' ' MET . 11.4 m-85 44.42 87.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.063 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -59.51 162.04 5.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -52.54 -39.66 61.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.22 -35.97 76.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.082 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 90.2 mm-40 -73.96 -32.62 63.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.187 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.445 ' HE1' ' HB2' ' A' ' 27' ' ' SER . 58.1 mtt -63.91 -35.88 82.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.003 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -57.12 -49.14 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.397 -0.815 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -55.86 -37.33 68.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.091 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.54 ' HE1' ' CG ' ' A' ' 32' ' ' PHE . 64.1 mtt -57.36 -32.01 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.7 m -69.79 -24.15 63.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' THR . 62.0 mt -91.09 -19.71 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.051 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 73' ' ' SER . 18.9 mm -116.33 167.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 0.0 109.12 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' CA ' HG23 ' A' ' 19' ' ' ILE . . . 69.19 -92.68 0.32 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -53.25 -39.73 64.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.14 . . . . 0.0 109.288 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m -58.71 -38.15 77.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.174 -0.954 . . . . 0.0 108.966 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' HB1' ' A' ' 50' ' ' ALA . 34.2 tp -55.67 -32.96 63.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 109.133 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 51' ' ' MET . 18.1 ttt -54.85 -31.85 59.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.283 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.86 91.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.673 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' HB1' HD12 ' A' ' 47' ' ' LEU . . . -61.78 -26.44 68.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.389 -0.819 . . . . 0.0 108.919 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.523 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 28.5 ttm . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.423 -0.798 . . . . 0.0 109.225 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 9' ' ' TRP . 7.0 mp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -53.54 -35.74 61.06 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.11 68.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 67' ' ' ASP . 10.9 mt -74.12 -51.25 16.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 24.3 t70 -46.9 -39.98 13.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 108.561 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 56.1 mtt -72.17 -45.44 60.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.847 . . . . 0.0 108.944 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.42 91.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 108.94 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.438 ' CD1' ' HA2' ' A' ' 44' ' ' GLY . 79.8 t80 -52.19 -43.4 64.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.133 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . . . -70.79 -39.07 73.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 109.596 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -69.29 -36.71 77.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.541 ' CB ' HG22 ' A' ' 43' ' ' ILE . 5.9 m -69.98 -44.26 69.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 75' ' ' ALA . 8.7 p -67.44 -36.77 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' N ' HG12 ' A' ' 74' ' ' VAL . . . -61.55 -39.16 90.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.49 -39.66 77.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.647 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 73' ' ' SER . 72.2 mt -58.1 -49.58 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -77.38 -48.62 16.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.621 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.89 60.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.1 t -78.17 -20.35 52.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.571 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.5 mt-30 -49.98 -27.62 5.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.527 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.52 77.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.65 -148.18 23.77 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' VAL . 50.7 t0 -67.11 124.21 22.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.31 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 4.3 tp -81.18 -21.77 39.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.255 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.1 -34.56 64.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 88' ' ' THR . 3.6 p -67.11 -42.89 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.105 -1.232 . . . . 0.0 109.72 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CB ' ' A' ' 78' ' ' ALA . 51.9 m -51.54 -34.65 37.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.987 -1.071 . . . . 0.0 108.321 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 m -56.73 -49.8 74.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.1 m120 -70.61 -38.24 73.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 109.039 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 29' ' ' THR . . . -64.77 -53.4 47.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.612 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 119' ' ' ILE . 66.6 mt -72.35 -45.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.866 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.83 -44.94 91.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.525 ' OD2' ' CG2' ' A' ' 29' ' ' THR . 48.7 m-20 -55.2 -48.51 73.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.953 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 22' ' ' PHE . . . -71.4 -33.67 69.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 ' CE2' ' A' ' 22' ' ' PHE . 7.2 tp -70.03 -33.68 72.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.912 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 98.7 m -69.3 -53.82 17.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 14.3 m -62.51 -33.61 75.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 109.878 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.582 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -63.91 -33.68 76.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.0 m-85 -61.39 -56.25 22.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.3 m-85 -71.97 -32.1 66.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 109.683 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 98' ' ' SER . 85.3 mm-40 -71.19 -17.99 62.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.848 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 72.0 p -111.06 -59.65 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 111.254 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.7 p -126.33 -43.02 1.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.797 -1.189 . . . . 0.0 110.968 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.71 45.93 1.01 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.08 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 18.4 t -101.89 171.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.159 -1.201 . . . . 0.0 108.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.514 HG23 ' CB ' ' A' ' 110' ' ' ARG . 29.0 m -71.48 120.55 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 0.0 109.799 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 24.2 p-10 -72.21 -33.32 67.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 109.97 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 113' ' ' SER . 29.8 m -57.82 -33.74 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.514 ' CB ' HG23 ' A' ' 107' ' ' VAL . 67.1 ttt-85 -67.91 -54.47 18.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.832 -1.168 . . . . 0.0 110.095 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.46 -47.04 28.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.64 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.538 HG12 ' CD2' ' A' ' 96' ' ' LEU . 9.5 mt -56.01 -46.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 109' ' ' SER . 60.3 m -55.57 -41.45 73.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.004 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HG2' HD12 ' A' ' 118' ' ' LEU . 83.2 tt0 -58.65 -45.26 89.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.224 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 77.9 mt -66.99 -34.36 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.82 . . . . 0.0 109.162 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.512 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 19.7 ttt-85 -53.54 -49.01 68.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.0 p -70.16 -34.02 72.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD12 ' HG2' ' A' ' 114' ' ' GLU . 13.9 mt -66.62 -44.97 80.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.668 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 92' ' ' ILE . 89.4 mt -57.66 -42.95 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -71.28 -36.9 63.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.2 ttp -56.81 -40.38 75.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.456 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 60.5 m-85 -62.0 -50.66 71.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.535 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.462 -179.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 42.1 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.577 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -146.95 150.14 37.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.607 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.8 Cg_endo -71.78 -35.07 8.05 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 111.543 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.607 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.6 p90 -88.02 -30.71 19.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.011 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 36.0 t -55.63 -25.37 38.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.473 -0.767 . . . . 0.0 109.771 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 1.3 t -113.98 136.64 52.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.971 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 2.5 ttpp -65.27 -37.79 88.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -70.29 -43.9 69.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 11' ' ' SER . 12.6 m120 -71.6 -29.11 64.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.377 -0.827 . . . . 0.0 109.416 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -64.81 -44.15 90.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 110.187 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.7 p30 -64.06 -50.85 66.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.518 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.06 -32.86 73.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 108.903 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.562 ' CG ' ' HB2' ' A' ' 8' ' ' PRO . 56.0 t80 -70.45 -43.45 69.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.546 HG12 ' CE1' ' A' ' 70' ' ' PHE . 27.6 mt -73.18 -44.63 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.525 -0.734 . . . . 0.0 109.041 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -68.08 -50.63 53.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.78 . . . . 0.0 109.182 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 74.1 m -57.46 -30.15 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.606 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE2' HD22 ' A' ' 96' ' ' LEU . 8.6 t80 -72.01 -50.03 32.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.512 -0.743 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 50.8 mm -64.94 -55.73 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.141 -0.974 . . . . 0.0 109.652 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -53.86 -39.71 65.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 0.0 109.909 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -77.72 -46.73 20.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 109.815 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -35.67 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.703 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.52 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 85.8 p -64.05 -28.41 69.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.84 6.92 32.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 20.5 m -91.75 -76.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.047 -1.033 . . . . 0.0 110.033 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.49 -104.68 0.45 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -131.8 -60.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -1.126 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' CB ' ' A' ' 78' ' ' ALA . 15.4 m-85 43.58 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.343 -0.848 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.5 t -59.66 162.81 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -52.63 -39.49 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.373 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.51 -35.96 81.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 91.6 mm-40 -73.65 -32.29 63.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.52 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.5 mtt -63.6 -36.51 84.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.103 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.54 -47.41 84.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HB2' HG21 ' A' ' 77' ' ' ILE . 86.3 m-20 -56.14 -45.26 79.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.526 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 56.2 mtm -57.15 -33.66 67.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 108.829 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.3 p -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 58.8 mt -87.19 -21.26 26.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 73' ' ' SER . 94.9 mt -121.87 143.77 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.244 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 98.78 -88.21 0.84 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.79 -32.45 70.63 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.165 -1.197 . . . . 0.0 108.282 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 91.8 m -59.15 -35.04 72.82 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.64 -40.21 92.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 51' ' ' MET . 89.5 mmm -52.74 -35.01 55.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.95 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.159 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.35 -36.12 78.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.223 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 48' ' ' MET . 54.6 mtt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.208 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 2.0 mp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.404 0.621 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 62.9 tt0 -54.21 -35.69 62.68 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.077 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.69 15.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.683 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' CG ' ' HA ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.6 -46.68 36.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.274 -0.891 . . . . 0.0 110.987 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 9' ' ' TRP . 3.6 p-10 -47.78 -29.87 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.258 . . . . 0.0 109.805 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 68.7 mtp -72.66 -36.26 67.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.29 75.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.546 ' CE1' HG12 ' A' ' 19' ' ' ILE . 66.2 t80 -52.47 -37.13 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . . . -70.46 -47.93 58.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -69.25 -30.77 68.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.039 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 8.3 m -69.8 -45.84 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 22' ' ' PHE . 9.6 p -68.93 -36.66 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' N ' HG12 ' A' ' 74' ' ' VAL . . . -59.69 -40.85 89.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 109.727 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -70.72 -35.02 72.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 HG21 ' HB2' ' A' ' 39' ' ' ASN . 94.2 mt -58.57 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 88' ' ' THR . . . -75.21 -41.64 57.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.672 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -58.24 -25.57 61.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -76.77 -20.36 56.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.465 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.1 mt-30 -50.01 -37.84 34.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 109.46 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.77 81.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.51 -149.18 24.52 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG11 ' A' ' 87' ' ' VAL . 49.4 t0 -66.79 119.72 12.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 119' ' ' ILE . 7.0 tp -74.69 -24.16 58.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.9 64.39 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 84' ' ' ASP . 2.6 p -69.1 -38.17 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.235 . . . . 0.0 109.844 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 78' ' ' ALA . 54.1 m -54.7 -33.59 61.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.908 -1.12 . . . . 0.0 108.367 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.1 m -57.81 -49.25 77.29 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 68.2 m-20 -70.69 -41.06 72.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.494 -0.754 . . . . 0.0 109.154 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -64.54 -52.2 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 32.2 mt -72.81 -38.3 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -72.29 -43.22 64.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 29' ' ' THR . 40.1 t0 -54.97 -45.74 75.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.927 -1.108 . . . . 0.0 109.795 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 22' ' ' PHE . . . -71.81 -35.2 69.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.109 -0.994 . . . . 0.0 109.01 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -69.86 -40.4 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.565 HG22 ' CE2' ' A' ' 101' ' ' TYR . 52.4 m -67.66 -53.87 24.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.1 m -59.81 -44.08 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -55.65 -46.79 77.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.405 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 96' ' ' LEU . 1.5 m-85 -46.94 -56.6 6.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.73 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' CE2' HG22 ' A' ' 97' ' ' THR . 1.3 m-85 -71.99 -32.41 67.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.629 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 40.1 mt-30 -64.86 -18.54 65.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 43.0 p -115.16 -59.35 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 111.333 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.466 ' OG1' HG23 ' A' ' 106' ' ' VAL . 15.9 p -126.16 -43.17 1.81 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.648 -1.283 . . . . 0.0 110.969 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.16 45.37 1.01 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 19.8 t -98.06 163.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.073 -1.251 . . . . 0.0 108.689 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.531 HG21 ' CB ' ' A' ' 110' ' ' ARG . 33.1 m -64.03 121.59 13.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.9 p30 -71.0 -33.69 70.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.057 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 113' ' ' SER . 87.2 p -57.23 -43.72 83.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.967 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.531 ' CB ' HG21 ' A' ' 107' ' ' VAL . 31.8 ttt180 -57.22 -54.58 45.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 0.0 110.156 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 49.0 t80 -75.56 -46.46 31.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 14.8 mt -63.0 -35.65 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 110.15 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.1 t -58.12 -32.84 68.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 96.9 mt-10 -72.34 -40.34 67.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 111' ' ' PHE . 80.6 mt -69.34 -40.7 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -54.34 -44.76 72.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.0 p -72.98 -33.95 66.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 109.557 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 26.7 mt -67.91 -42.43 81.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.516 ' CG2' HD12 ' A' ' 85' ' ' LEU . 65.8 mt -58.01 -39.29 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.388 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -63.56 -34.58 90.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 13.1 tpp -65.91 -38.32 88.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.68 -39.43 84.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.448 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.544 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 52.0 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.577 ' OG1' ' CE3' ' A' ' 9' ' ' TRP . 2.8 t -141.27 151.31 61.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.61 -35.74 21.54 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.598 2.199 . . . . 0.0 112.744 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.577 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -82.13 9.08 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.737 -1.227 . . . . 0.0 109.525 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 7' ' ' THR . 0.4 OUTLIER -95.25 -29.62 14.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 108.577 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.6 p -120.28 155.01 34.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.018 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 7.2 ttpt -71.53 -41.27 69.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.45 70.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -71.7 -28.9 64.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.339 -0.85 . . . . 0.0 109.941 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.04 -48.77 62.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.953 -1.092 . . . . 0.0 110.323 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 88.7 m-20 -58.57 -56.13 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.84 -42.38 65.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.62 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' CB ' ' A' ' 8' ' ' PRO . 87.6 t80 -58.19 -37.05 74.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 70' ' ' PHE . 20.2 mm -70.92 -48.9 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 109.513 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -61.45 -49.75 75.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 109.753 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -58.36 -34.33 70.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CE2' HD21 ' A' ' 96' ' ' LEU . 40.5 t80 -69.68 -35.94 75.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' CG2' ' HE1' ' A' ' 40' ' ' MET . 77.4 mt -70.43 -56.14 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.92 -34.52 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.05 -44.66 25.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 110.392 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.57 -33.08 68.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.01 . . . . 0.0 110.629 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.498 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 57.4 m -60.94 -28.27 68.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.42 7.49 31.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 0.0 110.847 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 91' ' ' ALA . 18.3 m -93.48 -75.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -72.56 -104.08 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.456 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.8 t -148.42 13.29 0.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.495 -1.003 . . . . 0.0 109.904 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' O ' ' CE ' ' A' ' 37' ' ' MET . 44.7 m-85 -38.17 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.644 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' SER . 59.7 p -66.1 168.44 8.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.792 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 33.7 tt0 -52.74 -44.68 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -57.43 -41.72 81.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.287 -0.883 . . . . 0.0 109.332 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.442 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 77.9 mm-40 -74.61 -32.25 62.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.156 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.507 ' CE ' ' O ' ' A' ' 32' ' ' PHE . 66.3 mtt -66.2 -33.43 75.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.256 -0.902 . . . . 0.0 108.966 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 95.7 mt-10 -57.26 -40.39 77.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 109.272 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HB3' HG12 ' A' ' 77' ' ' ILE . 77.0 m-20 -56.1 -38.6 70.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.071 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.47 ' HE1' ' CG2' ' A' ' 23' ' ' ILE . 64.4 mtm -62.49 -31.92 72.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.847 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 p -68.6 -23.71 64.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.405 -0.809 . . . . 0.0 109.062 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.5 tp -92.66 -23.39 18.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 51.6 mt -132.35 149.27 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 97.15 -74.3 0.68 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' O ' ' HE1' ' A' ' 48' ' ' MET . 86.7 m-20 -72.03 -34.93 69.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -1.104 . . . . 0.0 108.203 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -68.14 -34.84 77.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 66' ' ' LEU . 23.9 tp -52.47 -39.24 60.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.417 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 16' ' ' ASP . 70.0 mtm -52.4 -33.75 45.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 108.886 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.27 72.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.311 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.16 80.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.321 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.46 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 51.0 mtt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.255 -0.903 . . . . 0.0 109.271 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 9' ' ' TRP . 14.5 tp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.01 -30.63 66.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.5 70.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.292 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.0 tp -73.68 -39.36 64.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.299 -0.875 . . . . 0.0 109.256 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' TRP . 31.5 t0 -49.46 -46.72 48.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.3 mtm -54.24 -39.14 66.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.435 -0.791 . . . . 0.0 109.798 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.84 72.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD2' HD13 ' A' ' 19' ' ' ILE . 47.4 t80 -60.65 -35.47 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 115' ' ' ILE . . . -69.3 -30.5 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 45.8 m -69.3 -46.68 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 109.921 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.563 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 11.2 t -68.06 -48.49 65.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 92' ' ' ILE . 8.3 p -56.83 -38.53 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.7 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -70.3 -34.63 72.96 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.242 -0.911 . . . . 0.0 109.46 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 72' ' ' SER . 97.0 mt-30 -76.26 -47.46 23.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 39' ' ' ASN . 68.3 mt -53.36 -44.62 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.48 -50.69 11.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.82 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.64 -22.33 44.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.202 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.5 p -81.4 -21.73 38.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.59 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.1 mt-30 -50.37 -32.76 18.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 109.557 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.27 11.02 85.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.29 -151.52 27.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.463 ' O ' HG11 ' A' ' 87' ' ' VAL . 22.6 t70 -69.36 114.22 7.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -1.166 . . . . 0.0 109.256 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.511 ' CD1' HG23 ' A' ' 119' ' ' ILE . 4.7 tp -62.46 -25.21 67.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.51 71.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 84' ' ' ASP . 2.7 p -68.03 -36.88 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.104 -1.233 . . . . 0.0 109.774 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 91.1 m -54.6 -32.24 58.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.982 -1.074 . . . . 0.0 108.513 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 24.9 m -60.2 -51.22 70.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.46 ' O ' HG22 ' A' ' 29' ' ' THR . 69.6 m-20 -70.59 -35.81 73.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -68.31 -55.69 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.582 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.49 ' CD1' HG22 ' A' ' 88' ' ' THR . 39.6 mt -69.56 -50.49 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -56.93 -40.97 77.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.472 ' HB2' HG22 ' A' ' 29' ' ' THR . 7.1 m-20 -57.99 -54.28 48.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -68.08 -32.66 73.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 108.851 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -70.31 -41.05 73.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.732 . . . . 0.0 109.774 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 21.5 m -68.4 -53.99 20.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.015 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 50.9 m -59.81 -43.26 94.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.208 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.491 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -56.09 -46.37 79.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.576 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.5 m-85 -46.86 -54.48 9.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -0.87 . . . . 0.0 109.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.538 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.31 -31.42 67.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.544 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 60.9 mt-30 -70.77 -18.02 62.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.1 p -110.82 -59.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 111.08 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.476 HG22 ' HD3' ' A' ' 8' ' ' PRO . 18.0 p -126.82 -43.31 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.69 -1.256 . . . . 0.0 110.781 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.89 43.54 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.683 -1.246 . . . . 0.0 109.991 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 13.7 t -99.21 169.59 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.104 -1.233 . . . . 0.0 108.62 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 110' ' ' ARG . 29.4 m -69.57 121.66 19.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.376 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.572 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 13.0 p30 -70.52 -24.08 62.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.643 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' SER . 39.9 m -60.91 -29.99 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.549 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.401 ' HB2' HG21 ' A' ' 107' ' ' VAL . 56.3 ttt85 -69.16 -55.0 11.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.123 . . . . 0.0 110.418 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -75.93 -50.6 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 53.1 mt -56.39 -36.51 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.177 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' SER . 3.9 m -56.69 -39.39 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.944 -1.097 . . . . 0.0 109.044 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.26 -42.13 65.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.282 -0.886 . . . . 0.0 109.233 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.582 ' CD1' ' CB ' ' A' ' 71' ' ' ALA . 32.8 mm -62.72 -49.37 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.363 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.528 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 6.8 ttt180 -54.12 -42.68 69.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.012 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.0 m -73.01 -33.42 65.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.0 mt -68.5 -43.39 76.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.803 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.511 HG23 ' CD1' ' A' ' 85' ' ' LEU . 23.3 mt -57.89 -43.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.58 -34.74 87.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.3 ttm -62.74 -43.5 98.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.143 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 84.9 m-85 -59.63 -47.65 84.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.446 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.294 0.569 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.581 HG21 ' CZ2' ' A' ' 9' ' ' TRP . 0.1 OUTLIER -157.46 155.54 27.54 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.67 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 47.2 Cg_endo -69.23 -35.09 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.265 . . . . 0.0 111.386 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.581 ' CZ2' HG21 ' A' ' 7' ' ' THR . 35.8 p90 -91.35 -23.65 20.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 108.998 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' HD13 ' A' ' 63' ' ' LEU . 12.0 m -63.74 -14.47 52.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 108.651 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 73.3 m -140.52 122.58 15.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 109.076 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 13' ' ' ALA . 45.8 pttt -52.53 -43.92 65.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' N ' ' HG3' ' A' ' 12' ' ' LYS . . . -63.19 -36.58 84.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 9.7 t-20 -72.8 -35.22 67.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -66.66 -27.9 68.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.477 ' HA ' ' CE ' ' A' ' 48' ' ' MET . 92.3 m-20 -54.73 -56.71 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.69 66.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 50.8 t80 -71.18 -38.86 72.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.578 HD13 ' CD1' ' A' ' 70' ' ' PHE . 13.9 mm -75.45 -47.74 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.896 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.5 -49.96 73.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 3.7 t -62.68 -30.39 71.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.181 -0.949 . . . . 0.0 110.103 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 29.3 t80 -71.43 -51.92 21.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.481 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 19' ' ' ILE . 41.8 mm -61.24 -56.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.041 -1.037 . . . . 0.0 110.453 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -57.31 -38.21 73.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.943 . . . . 0.0 110.135 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.468 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.07 -45.94 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.962 . . . . 0.0 110.281 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -64.51 -37.56 87.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.458 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.529 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 65.7 p -59.17 -28.94 67.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -0.983 . . . . 0.0 110.5 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.18 7.36 31.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.999 -1.063 . . . . 0.0 110.745 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.515 HG23 ' CB ' ' A' ' 94' ' ' ASP . 18.2 m -94.64 -74.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.776 -1.202 . . . . 0.0 110.883 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.53 -104.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.406 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 33' ' ' SER . 42.5 p -147.74 13.36 1.03 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -1.049 . . . . 0.0 109.742 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' SER . 46.0 m-85 -38.34 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' SER . 31.0 m -60.15 162.33 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -53.09 -44.24 67.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.39 -0.819 . . . . 0.0 109.359 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -56.25 -41.39 75.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.448 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 84.3 mm-40 -72.34 -31.11 65.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.042 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 65.2 mtt -63.05 -32.39 73.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' A' ' 41' ' ' SER . 83.8 tt0 -57.32 -50.12 73.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 109.018 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 43' ' ' ILE . 87.2 mtp -58.51 -37.63 76.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.78 . . . . 0.0 109.157 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 38' ' ' GLU . 79.9 p -70.39 -24.12 62.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 tp -83.42 -20.69 33.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.858 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.544 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 20.2 mm -120.48 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.345 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 100.8 -79.71 0.44 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 46' ' ' THR . 7.1 p30 -65.74 -35.93 82.12 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.272 -1.134 . . . . 0.0 108.195 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 60.5 m -62.14 -35.05 77.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 35.0 tp -61.22 -34.45 75.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.513 -0.742 . . . . 0.0 109.214 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.516 ' HA ' ' CE ' ' A' ' 51' ' ' MET . 54.8 mtt -52.73 -37.96 60.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.166 -0.959 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.65 71.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.54 -49.78 51.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.385 -0.822 . . . . 0.0 108.952 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.516 ' CE ' ' HA ' ' A' ' 48' ' ' MET . 53.5 mtm . . . . . 0 N--CA 1.488 1.435 0 O-C-N 121.398 -0.814 . . . . 0.0 109.209 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 10.0 mt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -53.55 -45.28 69.81 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -72.18 -29.23 63.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 47' ' ' LEU . 7.5 tt -70.49 -53.63 15.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.47 -0.769 . . . . 0.0 109.128 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.577 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 22.0 t0 -48.16 -46.89 35.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.2 mtp -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 65' ' ' ALA . . . -55.4 -48.99 73.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.0 109.5 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD1' HD13 ' A' ' 19' ' ' ILE . 57.4 t80 -58.22 -38.32 76.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -68.22 -36.16 79.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.544 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 19.7 m -70.24 -43.45 70.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.709 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 75' ' ' ALA . 6.0 m -68.37 -35.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 119' ' ' ILE . . . -65.16 -39.92 93.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.77 -45.18 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' A' ' 40' ' ' MET . 91.8 mt -56.67 -46.16 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -67.55 -51.87 45.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.605 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.51 58.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -76.3 -20.43 57.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.448 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 46.5 mt-30 -51.55 -31.87 25.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 10.27 82.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.45 -160.91 26.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.7 t70 -69.58 101.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.518 ' CD1' ' CG2' ' A' ' 119' ' ' ILE . 25.9 tp -52.92 -20.36 3.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.627 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.07 -33.97 87.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 84' ' ' ASP . 8.0 p -69.2 -35.81 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.196 . . . . 0.0 109.703 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.561 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 64.1 m -51.65 -32.15 28.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.034 -1.041 . . . . 0.0 108.623 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 37.5 m -58.33 -45.5 87.99 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 20.5 m120 -70.77 -38.29 73.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.073 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -69.09 -58.82 3.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 109.557 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.535 ' CG1' HG22 ' A' ' 88' ' ' THR . 35.9 mm -61.25 -45.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.86 -49.06 69.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.515 ' CB ' HG23 ' A' ' 29' ' ' THR . 86.0 m-20 -55.29 -46.02 76.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.184 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 26' ' ' ALA . . . -68.62 -38.72 80.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -70.0 -42.96 72.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.516 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 88.7 m -60.57 -50.93 71.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.722 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 102' ' ' GLN . 31.2 t -60.41 -33.98 73.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.967 . . . . 0.0 109.525 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.4 -44.34 68.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.425 -0.797 . . . . 0.0 109.996 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.0 OUTLIER -47.89 -56.34 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.516 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -69.2 -32.11 71.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 98' ' ' SER . 78.4 mm-40 -79.52 -18.49 51.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 99' ' ' ALA . 71.3 p -106.53 -59.15 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.936 -1.103 . . . . 0.0 111.177 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.494 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 48.1 m -125.14 -42.44 2.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.838 -1.164 . . . . 0.0 111.002 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.1 47.33 1.16 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 17.6 t -110.36 172.22 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.287 -1.125 . . . . 0.0 108.915 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 110' ' ' ARG . 35.1 m -68.59 121.17 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 19.2 p-10 -71.08 -23.7 62.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.833 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' SER . 20.6 t -66.88 -30.17 70.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 0.0 110.932 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.427 ' HB2' HG21 ' A' ' 107' ' ' VAL . 15.7 ttt180 -67.67 -55.1 14.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.822 -1.174 . . . . 0.0 110.515 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.466 ' CE1' ' OD2' ' A' ' 67' ' ' ASP . 6.4 t80 -75.79 -49.25 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 110.205 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.516 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 20.5 mt -56.3 -36.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' SER . 4.5 m -60.91 -40.81 94.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.74 -38.33 76.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.234 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CD1' HD11 ' A' ' 96' ' ' LEU . 69.1 mt -69.38 -43.16 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -54.24 -38.99 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.7 m -73.42 -35.9 65.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 109.693 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 20.8 mt -65.2 -38.88 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.829 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.518 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 65.8 mt -61.67 -42.67 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.91 92.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.658 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 23.3 m-85 -64.34 -34.72 78.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.51 ' HB1' ' CD2' ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.2 t -154.46 150.21 21.62 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 41.7 Cg_endo -64.3 -30.65 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 49.1 p90 -88.42 18.74 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.0 109.05 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.478 ' HB2' ' CG2' ' A' ' 7' ' ' THR . 0.5 OUTLIER -105.48 -30.98 9.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 89.8 p -123.59 142.92 50.57 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 0.6 OUTLIER -60.77 -43.77 97.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.946 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.9 m-20 -72.17 -29.57 64.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -65.35 -37.33 86.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.499 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.03 -56.17 12.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.071 -1.018 . . . . 0.0 110.077 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.21 -29.76 15.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 109.567 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 56.3 t80 -69.85 -44.09 70.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' CD1' ' A' ' 70' ' ' PHE . 18.5 mm -68.64 -44.94 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.196 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -68.25 -50.78 51.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.4 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 51.1 m -58.45 -29.64 66.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.049 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' A' ' 95' ' ' ALA . 25.8 t80 -72.23 -51.92 18.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.129 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 19.4 mm -66.21 -55.87 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.007 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -57.44 -36.7 71.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.931 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.96 -44.75 25.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 110.193 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' CB ' ' A' ' 95' ' ' ALA . . . -65.82 -27.36 68.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 55.1 m -65.21 -31.15 72.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.336 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.4 p-10 -105.93 7.71 32.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.065 -1.022 . . . . 0.0 110.364 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.523 HG21 ' CB ' ' A' ' 94' ' ' ASP . 17.5 m -89.0 -77.14 0.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.914 -1.116 . . . . 0.0 110.255 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.81 -102.61 0.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -132.95 -62.38 0.81 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.462 -1.022 . . . . 0.0 109.314 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 14.3 m-85 45.54 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.3 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 35' ' ' ASP . 4.9 m -59.37 158.63 9.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -52.42 -40.0 61.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.431 ' OD1' ' CB ' ' A' ' 33' ' ' SER . 19.0 p-10 -61.38 -36.07 79.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.461 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.7 mm-40 -67.81 -31.65 71.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.219 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.509 ' HA ' ' CE ' ' A' ' 40' ' ' MET . 61.8 mtt -63.28 -36.75 84.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 109.001 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 65.5 mm-40 -58.92 -48.7 80.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.114 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -60.56 -46.13 91.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.858 . . . . 0.0 109.021 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.512 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 70.9 mtm -61.61 -35.88 79.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.424 -0.797 . . . . 0.0 108.851 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -70.23 -24.1 63.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 46' ' ' THR . 12.1 tp -84.45 -22.07 30.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 44' ' ' GLY . 12.0 mm -118.04 149.4 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.503 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 90.06 -77.38 1.6 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 19' ' ' ILE . 89.9 m-20 -65.91 -39.29 90.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.193 -1.18 . . . . 0.0 108.22 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 84.9 m -63.0 -35.27 79.65 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.577 ' CD2' ' CD1' ' A' ' 66' ' ' LEU . 29.1 tp -57.82 -36.48 72.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.659 -0.65 . . . . 0.0 109.532 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 94.6 mmm -52.78 -29.46 27.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.252 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.9 76.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.02 86.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.153 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.457 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 13.0 mmt . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 108.989 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 57.3 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -54.78 -44.54 73.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.945 . . . . 0.0 109.017 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.41 69.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.577 ' CD1' ' CD2' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -74.31 -43.64 55.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.031 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 42.0 t0 -48.53 -43.86 35.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.12 -34.36 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.935 . . . . 0.0 109.813 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.54 79.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 109.816 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CD1' HD11 ' A' ' 19' ' ' ILE . 86.6 t80 -61.51 -36.86 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.7 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 115' ' ' ILE . . . -70.36 -29.05 65.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.935 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -69.32 -46.98 65.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.167 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.1 t -70.07 -45.99 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 75' ' ' ALA . 13.7 m -57.4 -35.41 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 74' ' ' VAL . . . -73.8 -40.81 63.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.781 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 80' ' ' SER . 50.1 tt0 -68.47 -43.24 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 109.724 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 HD12 ' HG2' ' A' ' 40' ' ' MET . 99.4 mt -56.35 -52.38 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -73.33 -50.62 21.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 0.0 109.841 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.41 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.398 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 90.0 p -81.4 -20.65 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 34.8 mt-30 -48.97 -36.96 18.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 22.29 41.9 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.03 -157.39 13.75 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 87' ' ' VAL . 76.8 m-20 -62.6 134.4 56.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.099 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.425 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 6.3 tp -84.95 -19.4 32.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.59 64.82 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 88' ' ' THR . 5.5 p -69.99 -44.93 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 109.696 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 78' ' ' ALA . 80.0 m -51.61 -34.75 38.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.975 -1.078 . . . . 0.0 108.493 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 23.8 m -56.2 -48.7 75.9 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 m120 -70.72 -39.3 73.48 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.169 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HA ' HG23 ' A' ' 29' ' ' THR . . . -65.25 -57.45 8.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.732 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 48.2 mt -66.46 -45.97 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.8 -49.02 74.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 0.0 110.059 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' CB ' HG21 ' A' ' 29' ' ' THR . 91.3 m-20 -54.99 -41.68 71.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.363 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.573 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . . . -62.62 -44.59 95.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.304 -0.873 . . . . 0.0 109.049 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 115' ' ' ILE . 7.1 mt -70.42 -36.01 73.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.505 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.547 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 93.5 m -64.82 -53.7 42.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 110.009 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 14.5 m -62.08 -49.2 76.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.121 -0.987 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -53.5 -44.37 68.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.586 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER -46.96 -55.95 7.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 109.324 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.552 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 4.1 m-85 -71.97 -31.91 66.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.44 -0.787 . . . . 0.0 109.675 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 98' ' ' SER . 65.1 mt-30 -73.19 -18.39 61.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.676 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 99' ' ' ALA . 34.7 p -107.29 -60.22 1.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.936 -1.103 . . . . 0.0 111.173 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.524 HG22 ' CG2' ' A' ' 106' ' ' VAL . 12.3 t -127.05 -43.07 1.69 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.813 -1.179 . . . . 0.0 110.845 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.98 46.82 0.92 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 57.4 t -103.07 167.86 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.271 -1.135 . . . . 0.0 108.937 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.535 HG22 ' CB ' ' A' ' 110' ' ' ARG . 33.5 m -66.07 121.45 15.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.755 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.576 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 20.8 p-10 -71.07 -23.74 62.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.428 -0.795 . . . . 0.0 109.939 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 113' ' ' SER . 90.2 p -68.7 -34.84 76.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CB ' HG22 ' A' ' 107' ' ' VAL . 16.5 tpt180 -62.36 -54.52 39.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.862 -1.148 . . . . 0.0 110.473 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.569 ' CE2' HD13 ' A' ' 115' ' ' ILE . 57.4 t80 -75.73 -53.29 8.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 110.204 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.517 HG22 ' CB ' ' A' ' 93' ' ' ALA . 21.2 mt -56.36 -28.37 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 109' ' ' SER . 9.6 t -58.81 -42.29 88.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.622 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.48 -36.35 65.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.569 HD13 ' CE2' ' A' ' 111' ' ' PHE . 30.8 mt -67.54 -41.22 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.647 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 113' ' ' SER . 31.8 ptt85 -54.04 -43.12 69.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.852 -1.155 . . . . 0.0 109.638 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.492 ' N ' ' CG ' ' A' ' 116' ' ' ARG . 87.0 p -71.44 -33.82 69.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.548 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 18.8 mt -66.45 -38.12 86.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 115' ' ' ILE . 67.3 mt -61.5 -35.71 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.023 . . . . 0.0 109.454 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -67.93 -34.24 81.66 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.0 ttm -60.75 -43.68 97.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.16 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 75' ' ' ALA . 97.7 m-85 -59.14 -50.17 75.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.425 ' O ' ' OG1' ' A' ' 104' ' ' THR . 19.0 m120 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.585 HG23 ' CZ2' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -135.97 151.75 74.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.436 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 47.0 Cg_endo -68.66 -35.39 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.561 2.174 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.585 ' CZ2' HG23 ' A' ' 7' ' ' THR . 45.3 p90 -91.48 -11.39 37.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 109.082 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -72.05 -5.34 34.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.898 . . . . 0.0 109.413 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 1.9 t -140.79 153.9 46.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.361 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 2.5 ttpm? -73.81 -39.7 63.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.612 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.45 -33.01 42.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.259 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 7' ' ' THR . 34.2 t30 -71.53 -29.47 64.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.79 -43.06 72.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -54.36 -56.33 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.717 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 103' ' ' THR . . . -51.9 -35.4 45.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 109.298 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 47.2 t80 -68.73 -52.6 28.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.576 HD12 ' CE1' ' A' ' 70' ' ' PHE . 10.0 mm -60.15 -44.14 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -67.49 -50.87 56.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 33.5 t -57.66 -30.12 65.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.203 -0.936 . . . . 0.0 108.754 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CZ ' ' CG2' ' A' ' 74' ' ' VAL . 19.2 t80 -72.29 -52.21 17.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.5 HG12 ' CE ' ' A' ' 40' ' ' MET . 69.4 mt -61.9 -56.12 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.687 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -53.91 -37.24 63.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -51.54 10.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.924 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.67 64.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.105 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.527 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 45.8 p -68.37 -33.41 74.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.249 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -105.67 7.19 32.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 91' ' ' ALA . 8.9 m -87.16 -77.09 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.956 -1.09 . . . . 0.0 110.224 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -101.4 0.61 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 76.5 p -141.32 -53.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.429 -1.042 . . . . 0.0 109.344 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 15.7 m-85 44.5 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 37' ' ' MET . 32.2 t -59.68 159.97 7.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -52.38 -38.4 58.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.07 -37.18 86.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.115 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.525 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 81.8 mm-40 -76.32 -36.17 58.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.527 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 79.6 mtp -63.97 -37.43 87.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.132 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -56.89 -41.2 77.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.171 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.529 ' HB3' ' CG2' ' A' ' 77' ' ' ILE . 46.0 t-20 -56.07 -35.08 66.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 108.916 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.5 ' CE ' HG12 ' A' ' 23' ' ' ILE . 92.8 mmm -57.12 -31.69 65.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 m -67.55 -24.08 65.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.915 . . . . 0.0 109.28 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 46' ' ' THR . 66.9 mt -92.08 -28.22 17.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 77' ' ' ILE . 63.9 mt -116.81 154.99 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.422 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.53 ' CA ' HG21 ' A' ' 19' ' ' ILE . . . 85.16 -89.79 1.62 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -59.58 -32.4 70.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 108.834 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 34.2 m -65.95 -35.08 79.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 108.922 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 HD23 ' CD2' ' A' ' 66' ' ' LEU . 29.8 tp -54.97 -38.63 68.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.79 . . . . 0.0 109.222 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.425 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 24.9 ttt -52.83 -36.16 58.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.31 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.21 72.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.193 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.83 72.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.425 ' HE2' ' HA ' ' A' ' 48' ' ' MET . 64.0 mtm . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.215 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 2.6 mt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 68' ' ' MET . 85.1 mt-30 -54.75 -48.29 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.123 -0.986 . . . . 0.0 108.628 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.5 55.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.395 -0.816 . . . . 0.0 109.267 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CD2' HD23 ' A' ' 47' ' ' LEU . 1.8 tp -61.54 -50.82 71.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.581 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 26.3 t0 -47.99 -37.01 13.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 63.5 mtt -65.84 -32.13 73.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -59.55 -44.37 93.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CE1' HD12 ' A' ' 19' ' ' ILE . 81.9 t80 -53.59 -38.93 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.875 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -68.94 -40.49 78.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.6 m -69.35 -45.64 68.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.515 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 12.3 m -70.01 -47.24 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 109.766 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.579 ' CG2' ' CZ ' ' A' ' 22' ' ' PHE . 7.5 p -58.4 -44.16 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.603 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' N ' ' CG1' ' A' ' 74' ' ' VAL . . . -62.8 -37.24 85.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.0 tt0 -68.41 -43.12 77.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 78.8 mt -53.78 -52.46 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -50.84 10.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.782 . . . . 0.0 109.931 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . -57.58 -22.54 45.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.979 . . . . 0.0 109.266 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.3 p -81.85 -20.59 38.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.525 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 50.1 mt-30 -45.96 -35.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 3.79 76.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.18 -162.75 33.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -72.06 118.31 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.134 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 119' ' ' ILE . 3.4 mp -62.28 -16.17 52.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.76 -45.74 78.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.3 -47.47 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -1.132 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 44.7 m -53.75 -48.43 69.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 21.6 m -51.27 -47.7 62.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' O ' HG23 ' A' ' 29' ' ' THR . 74.7 m-20 -71.05 -35.32 71.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.443 -0.786 . . . . 0.0 108.93 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.505 ' HA ' HG23 ' A' ' 29' ' ' THR . . . -69.58 -59.13 3.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 0.0 109.689 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 96' ' ' LEU . 69.0 mt -63.98 -49.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.901 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -59.26 -52.52 65.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.331 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 29' ' ' THR . 92.8 m-20 -55.4 -43.12 74.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 109.903 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.576 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -63.54 -39.5 94.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.205 -0.934 . . . . 0.0 109.723 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.567 HD23 ' CD2' ' A' ' 22' ' ' PHE . 6.2 mt -69.88 -35.87 75.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.55 HG23 ' CE2' ' A' ' 101' ' ' TYR . 94.3 m -65.46 -53.65 39.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 20.2 m -60.59 -34.03 73.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.825 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . . . -69.52 -46.3 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.5 m-85 -47.12 -56.21 6.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.55 ' CE2' HG23 ' A' ' 97' ' ' THR . 3.2 m-85 -71.14 -31.78 68.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.828 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 98' ' ' SER . 84.1 mm-40 -73.12 -18.59 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 17' ' ' ALA . 67.5 p -107.45 -59.85 1.77 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.903 -1.123 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.528 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -126.82 -42.84 1.73 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.761 -1.212 . . . . 0.0 110.836 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 111.77 45.36 0.83 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.6 t -102.81 172.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 109.151 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.1 m -74.18 120.23 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 13.0 p30 -72.07 -29.59 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.645 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 113' ' ' SER . 21.7 m -56.92 -46.09 82.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 110.391 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.97 -53.58 56.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.891 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 75.3 t80 -75.0 -50.49 16.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.756 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 11.5 mt -58.56 -42.63 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.065 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 109' ' ' SER . 48.0 t -55.84 -37.97 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.15 -40.41 82.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.513 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 56.2 mt -72.7 -43.34 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -54.22 -39.74 67.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.368 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.7 t -73.15 -34.12 65.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 115' ' ' ILE . 16.8 mt -70.97 -40.71 71.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.492 HG22 ' CD2' ' A' ' 85' ' ' LEU . 84.6 mt -58.2 -39.65 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.03 -27.34 72.27 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.0 ttm -66.97 -38.68 86.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -1.166 . . . . 0.0 109.502 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -60.14 -37.87 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.529 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.586 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 1.5 t -162.25 151.77 13.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.012 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.49 -27.17 39.78 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.466 2.111 . . . . 0.0 112.695 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -92.52 15.91 13.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.849 -1.157 . . . . 0.0 109.845 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.536 ' CB ' HG22 ' A' ' 7' ' ' THR . 68.5 p -105.31 -23.07 12.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.002 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -110.45 160.71 16.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.188 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HG2' ' CE ' ' A' ' 51' ' ' MET . 15.6 ttpp -74.69 -40.88 61.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.049 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -83.28 -31.07 27.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 5.8 t-20 -71.54 -29.38 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.644 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.514 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -73.03 -47.89 40.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.2 p30 -56.79 -49.29 75.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.169 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -55.08 -40.61 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.971 -1.08 . . . . 0.0 109.386 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.465 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 72.2 t80 -61.23 -48.57 80.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mm -60.88 -44.44 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -50.87 48.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.382 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 38.8 t -55.91 -29.98 60.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 108.765 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CD2' ' CD2' ' A' ' 96' ' ' LEU . 39.1 t80 -72.34 -51.92 18.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.511 -0.743 . . . . 0.0 110.047 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.429 ' CG2' ' HE1' ' A' ' 40' ' ' MET . 76.3 mt -60.26 -56.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -59.85 -35.14 74.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.923 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.14 -45.29 23.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -65.82 -40.59 91.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.937 . . . . 0.0 110.323 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 82.7 p -57.15 -27.24 61.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.23 6.99 31.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.571 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 19.5 m -93.12 -77.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.783 -1.198 . . . . 0.0 110.188 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.75 -104.74 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' PHE . 53.0 p -131.31 -61.52 0.91 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.58 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 12.8 m-85 44.02 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 109.236 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m -59.65 162.56 5.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.577 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -52.56 -43.33 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.23 -35.89 76.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.9 mm-40 -71.7 -35.07 70.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.6 mtt -63.47 -34.23 77.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -63.03 -38.31 90.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' HB3' HG12 ' A' ' 77' ' ' ILE . 86.3 m-20 -55.83 -39.69 71.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.256 -0.903 . . . . 0.0 109.118 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 43' ' ' ILE . 75.8 mtm -66.16 -32.04 73.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.083 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 46' ' ' THR . 19.5 m -70.31 -23.62 62.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.409 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 54.7 mt -97.34 -14.31 21.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG23 ' CB ' ' A' ' 73' ' ' SER . 74.8 mt -130.78 166.3 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 0.0 109.548 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 64.8 -69.44 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ILE . 41.1 t30 -74.81 -41.06 60.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.213 -1.169 . . . . 0.0 109.23 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 41' ' ' SER . 46.8 m -58.37 -35.24 71.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 108.739 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.74 -31.19 69.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 108.908 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.461 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 58.1 mmm -56.81 -29.95 63.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.412 -0.805 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.51 97.36 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -22.88 66.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.517 ' CE ' ' HG2' ' A' ' 12' ' ' LYS . 20.4 ttp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.632 -0.667 . . . . 0.0 109.513 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 6.9 mp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.314 0.578 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.67 -42.16 67.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.46 65.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 108.802 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 tp -74.48 -50.77 16.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.575 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.5 t0 -48.26 -39.68 22.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.7 mmm -71.44 -39.4 71.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.69 87.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 19' ' ' ILE . 84.5 t80 -52.88 -36.94 59.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 109.706 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.508 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -64.55 -39.58 94.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.675 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 88.2 p -69.46 -30.63 68.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.826 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.533 ' CB ' HG23 ' A' ' 43' ' ' ILE . 11.5 t -69.96 -44.25 69.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.0 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 75' ' ' ALA . 11.7 m -69.01 -34.63 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.563 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 122' ' ' PHE . . . -69.91 -40.74 75.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.62 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -71.11 -49.36 45.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -53.82 -46.71 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.69 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -53.98 6.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 109.799 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.16 -22.67 52.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.549 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 22.9 m -79.67 -20.72 45.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.465 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 37.6 mt-30 -57.19 -34.14 68.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.82 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.25 17.81 73.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.84 -145.62 19.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 87' ' ' VAL . 58.4 t0 -76.0 106.03 7.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -1.111 . . . . 0.0 109.302 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 10.8 tp -60.18 -23.07 63.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 109.666 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.16 -39.45 72.47 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 84' ' ' ASP . 2.0 p -67.62 -39.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.255 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 24.3 m -51.7 -34.46 38.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.963 -1.085 . . . . 0.0 108.316 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 6.6 m -57.46 -50.93 71.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' A' ' 94' ' ' ASP . 51.0 t30 -70.24 -40.18 74.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.389 -0.819 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.505 ' HA ' HG21 ' A' ' 29' ' ' THR . . . -62.37 -53.55 53.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.298 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 57.0 mt -72.56 -51.25 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.89 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -56.53 -49.23 75.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 93.1 m-20 -54.77 -47.68 73.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.213 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 26' ' ' ALA . . . -57.02 -46.11 82.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.339 -0.851 . . . . 0.0 109.003 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD1' HG21 ' A' ' 92' ' ' ILE . 1.8 mt -70.97 -28.61 64.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.548 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.531 ' CG2' ' OD1' ' A' ' 108' ' ' ASN . 51.7 m -64.46 -54.09 37.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.157 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 87.6 p -66.78 -43.91 82.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 109.438 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -53.14 -42.71 66.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.5 m-85 -50.49 -56.41 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.123 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.535 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 7.5 m-85 -72.07 -31.77 66.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.425 -0.797 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 98' ' ' SER . 28.3 mt-30 -75.71 -17.8 59.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.589 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 99' ' ' ALA . 63.7 p -109.44 -58.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 111.294 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 87.2 m -125.76 -42.75 1.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.746 -1.221 . . . . 0.0 111.212 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.77 47.81 1.07 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 3.6 t -110.92 172.79 2.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.263 -1.139 . . . . 0.0 109.022 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.85 121.12 21.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.52 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.591 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -71.7 -29.69 64.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 109.857 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 113' ' ' SER . 47.5 m -55.95 -30.12 61.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.492 -0.755 . . . . 0.0 110.742 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 23.1 tpt180 -71.54 -55.22 8.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 110.374 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 75.3 t80 -75.92 -46.6 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.526 HG22 ' CB ' ' A' ' 93' ' ' ALA . 12.5 mt -56.13 -47.15 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.453 -0.779 . . . . 0.0 109.852 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' SER . 28.5 t -55.66 -43.56 76.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 95.0 mt-10 -57.19 -48.35 78.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.223 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 74.5 mt -65.46 -34.08 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.533 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 11.5 ttm180 -52.95 -48.96 66.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -69.75 -33.98 73.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.13 -45.61 76.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 85' ' ' LEU . 56.7 mt -57.83 -34.6 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.686 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -69.02 -31.78 72.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 53.2 ttm -71.36 -39.28 71.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.119 . . . . 0.0 109.791 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.532 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 75.6 m-85 -65.57 -33.62 76.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.346 0.593 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.587 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 3.1 t -157.78 151.38 19.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.093 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 43.9 Cg_endo -67.41 -35.09 24.63 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.783 2.322 . . . . 0.0 113.394 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.587 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -81.34 -7.51 59.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.695 -1.253 . . . . 0.0 110.339 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.65 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 5.6 m -88.35 20.14 3.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.656 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -155.69 150.05 25.86 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 1.9 ttpp -73.88 -38.18 64.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -85.85 -33.56 21.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' CB ' ' HB3' ' A' ' 11' ' ' SER . 9.7 t-20 -71.88 -29.28 64.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -73.0 -44.28 61.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.641 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.6 p30 -54.45 -40.28 68.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -63.05 -44.65 95.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.012 -1.055 . . . . 0.0 109.024 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE1' HD23 ' A' ' 96' ' ' LEU . 43.1 t80 -60.77 -44.26 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 70' ' ' PHE . 19.0 mm -66.34 -43.36 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.239 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -50.92 51.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.248 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 43.5 m -58.75 -29.42 66.73 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 108.72 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CZ ' ' CG2' ' A' ' 74' ' ' VAL . 11.8 t80 -71.64 -51.98 20.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.518 ' CD1' ' OD1' ' A' ' 45' ' ' ASN . 74.3 mt -63.67 -56.06 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.908 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.4 m -56.04 -37.07 68.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.677 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -49.4 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.777 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -60.36 -24.19 64.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 110.153 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.482 ' CB ' ' HE3' ' A' ' 37' ' ' MET . 57.8 m -67.3 -34.33 77.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 110.079 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -106.08 7.17 31.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.16 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 11.8 m -84.19 -75.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -86.97 -99.84 0.83 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -142.04 -54.9 0.45 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -1.074 . . . . 0.0 109.293 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.537 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 15.4 m-85 44.17 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 37' ' ' MET . 15.9 m -59.65 159.82 8.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.698 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -52.8 -32.72 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -71.15 -37.95 72.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.326 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.523 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 37.5 mt-30 -76.56 -34.22 58.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.482 ' HE3' ' CB ' ' A' ' 27' ' ' SER . 88.6 mtp -65.04 -34.49 78.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 72.7 mt-10 -56.87 -43.99 81.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HB2' ' CG2' ' A' ' 77' ' ' ILE . 79.9 m-20 -55.9 -33.23 64.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.475 ' CE ' ' HA ' ' A' ' 23' ' ' ILE . 82.3 mtp -61.74 -32.55 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -69.91 -24.68 63.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.373 -0.829 . . . . 0.0 109.453 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 6.1 mp -89.03 -22.43 22.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 73' ' ' SER . 86.9 mt -115.57 164.18 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 73.84 -93.88 0.76 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' OD1' ' CD1' ' A' ' 23' ' ' ILE . 21.2 m120 -52.41 -36.89 55.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -1.185 . . . . 0.0 109.036 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 55.4 m -58.4 -35.31 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 74.6 mt -56.88 -36.45 70.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 109.224 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.445 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 70.8 mtm -52.95 -40.7 63.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.28 -31.5 71.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.972 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -67.2 -34.9 78.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -0.803 . . . . 0.0 109.176 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 35.5 mtt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.067 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.65 ' HG ' ' HA ' ' A' ' 10' ' ' SER . 1.2 tp . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.488 0.661 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -76.81 -46.07 26.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.252 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.24 52.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.266 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 47' ' ' LEU . 17.4 tp -54.94 -50.04 69.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.948 . . . . 0.0 109.028 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 9.8 t0 -48.16 -49.39 32.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.9 mtp -58.81 -43.99 90.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.64 77.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.736 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 19' ' ' ILE . 77.6 t80 -56.86 -45.2 82.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.527 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -66.44 -36.99 84.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -69.6 -52.05 29.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -0.975 . . . . 0.0 110.023 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.526 ' CB ' HG21 ' A' ' 43' ' ' ILE . 10.9 m -70.25 -35.84 74.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' CG2' ' CZ ' ' A' ' 22' ' ' PHE . 8.1 p -66.88 -43.65 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.13 -0.981 . . . . 0.0 109.898 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB2' ' CE2' ' A' ' 122' ' ' PHE . . . -63.68 -32.22 73.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.907 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -72.17 -43.1 65.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 109.875 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 39' ' ' ASN . 64.8 mt -54.47 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.099 -1.001 . . . . 0.0 109.822 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.0 -50.17 12.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.46 -0.775 . . . . 0.0 110.142 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.1 -25.96 61.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.583 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.2 p -76.94 -20.31 56.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.408 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 73.2 mt-30 -46.4 -33.76 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.37 16.11 80.97 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.5 -159.3 19.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.04 105.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -1.164 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -61.21 -18.38 57.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.66 81.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.493 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 46.4 t -68.69 -44.81 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 109.547 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 23.9 m -54.52 -50.15 68.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.0 m -51.31 -48.83 62.23 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 24.0 t-20 -70.83 -33.92 71.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 108.983 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -70.37 -59.15 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.509 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' A' ' 96' ' ' LEU . 55.0 mt -63.21 -49.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.828 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -56.0 -52.23 64.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 29' ' ' THR . 32.0 t0 -55.23 -50.53 69.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.573 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -53.22 -42.88 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.573 HD23 ' CE1' ' A' ' 18' ' ' PHE . 7.1 mt -70.26 -41.05 73.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.569 HG23 ' CE2' ' A' ' 101' ' ' TYR . 99.3 m -62.4 -48.64 78.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 28.7 m -64.43 -34.26 77.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 109.483 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -69.95 -44.99 68.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.9 m-85 -46.97 -56.03 7.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.873 . . . . 0.0 109.698 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 97' ' ' THR . 3.1 m-85 -70.91 -32.09 68.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.762 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 98' ' ' SER . 88.2 mm-40 -75.91 -18.42 59.39 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.781 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 99' ' ' ALA . 61.2 p -103.81 -59.85 1.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.058 -1.026 . . . . 0.0 111.101 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 8' ' ' PRO . 12.6 p -126.73 -42.61 1.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.672 -1.268 . . . . 0.0 110.925 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.82 45.25 0.97 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.43 HG22 ' OG1' ' A' ' 104' ' ' THR . 12.1 t -109.83 172.52 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -1.125 . . . . 0.0 109.219 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 110' ' ' ARG . 3.2 m -73.68 121.16 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.605 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 18.0 p30 -70.74 -23.36 62.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.5 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 113' ' ' SER . 23.3 t -54.78 -30.27 56.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.574 -0.704 . . . . 0.0 110.601 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.47 ' HG2' HG21 ' A' ' 107' ' ' VAL . 24.8 mmt85 -69.04 -55.0 12.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.878 -1.139 . . . . 0.0 110.234 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.578 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 59.8 t80 -76.16 -50.4 14.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.517 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 14.5 mt -56.35 -42.56 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.139 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 109' ' ' SER . 32.2 t -56.23 -46.86 79.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 109.554 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.41 -49.83 74.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.262 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.578 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 89.7 mt -65.93 -34.82 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -54.06 -47.02 72.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 109.52 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.8 p -72.66 -33.9 66.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.63 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.02 -44.16 77.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 HG22 HD23 ' A' ' 85' ' ' LEU . 97.5 mt -57.82 -38.83 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.02 -33.79 75.18 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -61.68 -36.87 82.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 77.1 m-85 -66.23 -36.84 84.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.296 0.569 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.586 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 3.5 t -152.17 151.38 27.57 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 14' ' ' ASN . 42.4 Cg_endo -64.8 -35.5 45.07 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 113.01 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.4 p90 -81.69 -2.16 49.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.661 -1.274 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.4 OUTLIER -82.7 -28.65 30.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 108.688 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 70.8 m -118.82 151.11 38.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.484 -0.76 . . . . 0.0 109.161 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' O ' ' OD2' ' A' ' 16' ' ' ASP . 27.0 mtpt -70.95 -36.16 72.49 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.698 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -67.06 -49.52 64.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.932 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.529 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.5 m-20 -71.37 -29.16 64.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -66.81 -49.88 64.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.433 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.2 p30 -54.8 -53.38 56.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.028 . . . . 0.0 110.149 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -57.65 -35.72 70.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 0.0 108.863 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.525 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 75.5 t80 -61.09 -37.32 82.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.479 -0.763 . . . . 0.0 109.26 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.577 HD12 ' CD1' ' A' ' 70' ' ' PHE . 31.6 mm -75.14 -48.44 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.631 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -62.4 -48.28 80.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 2.1 t -60.75 -30.71 70.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.972 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' CE1' HG11 ' A' ' 74' ' ' VAL . 44.9 t80 -68.7 -52.0 35.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 0.0 110.186 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.15 -56.02 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.99 . . . . 0.0 109.958 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -59.71 -30.88 69.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.01 -45.37 23.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.51 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -70.38 -31.66 69.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 50.3 m -60.5 -30.95 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.5 p-10 -106.29 7.39 31.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.01 . . . . 0.0 110.651 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 29.1 m -89.62 -79.36 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.807 -1.183 . . . . 0.0 110.177 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -81.01 -103.05 0.32 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -132.81 -58.28 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.325 -1.103 . . . . 0.0 109.305 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.545 ' CE1' ' CE ' ' A' ' 40' ' ' MET . 4.4 m-85 43.84 90.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.082 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.514 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 11.1 p -59.54 162.99 4.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -52.72 -36.94 58.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.876 . . . . 0.0 109.278 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.21 -45.51 79.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.533 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 4.2 mp0 -63.93 -35.48 80.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.184 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.449 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 58.3 mtt -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.081 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 94.8 mt-10 -70.36 -37.46 74.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.113 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.434 ' HB2' HG21 ' A' ' 77' ' ' ILE . 83.0 m-20 -68.75 -44.65 73.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.251 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.545 ' CE ' ' CE1' ' A' ' 32' ' ' PHE . 61.2 mtt -56.85 -31.98 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 108.935 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 p -70.13 -23.35 63.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.38 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' A' ' 46' ' ' THR . 62.7 mt -87.88 -26.25 22.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.716 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.496 HG22 ' CB ' ' A' ' 73' ' ' SER . 53.4 mt -121.32 157.09 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.449 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 85.93 -77.2 2.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -65.02 -38.46 90.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -1.162 . . . . 0.0 108.766 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -58.46 -35.1 71.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 71.1 mt -61.06 -34.51 75.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.552 -0.718 . . . . 0.0 109.247 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.424 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 61.4 ttp -52.96 -41.95 65.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 109.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.12 74.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 108.583 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -65.51 -22.8 66.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.424 ' SD ' ' HA ' ' A' ' 48' ' ' MET . 57.6 mtt . . . . . 0 C--N 1.305 -1.358 0 O-C-N 121.563 -0.711 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 9' ' ' TRP . 9.8 mp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.219 0.533 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 96.7 mt-30 -54.71 -40.14 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -37.4 68.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.011 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.16 -52.62 11.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.67 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' MET . 0.3 OUTLIER -48.06 -25.26 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.608 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 56.7 mtp -72.71 -27.42 62.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.963 . . . . 0.0 110.023 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -35.56 65.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 110.038 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 19' ' ' ILE . 88.8 t80 -53.84 -40.71 66.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.792 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . . . -65.69 -36.35 83.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 24.8 m -69.23 -34.16 74.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.783 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.496 ' CB ' HG22 ' A' ' 43' ' ' ILE . 37.1 m -70.3 -49.63 47.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.874 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.566 HG11 ' CE1' ' A' ' 22' ' ' PHE . 19.1 m -57.73 -35.04 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB1' ' CE2' ' A' ' 122' ' ' PHE . . . -70.62 -43.35 69.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 0.0 109.691 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.546 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 26.6 mt-30 -66.22 -50.88 62.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.879 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.434 HG21 ' HB2' ' A' ' 39' ' ' ASN . 89.9 mt -53.49 -50.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.794 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.22 -53.32 7.47 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 110.209 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.63 -24.28 55.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 79.9 p -76.7 -20.23 56.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.533 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 55.2 mt-30 -50.34 -31.54 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 109.51 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.39 14.75 81.68 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.42 -162.88 23.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -1.13 . . . . 0.0 109.437 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' CD2' HG23 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -62.21 -20.21 63.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.98 -38.33 65.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.43 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 72.2 t -70.55 -47.5 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.56 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 19.7 m -51.95 -48.72 64.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 4.3 m -51.07 -46.25 61.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.3 m-20 -71.0 -39.18 72.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.422 -0.799 . . . . 0.0 109.026 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' HG23 ' A' ' 29' ' ' THR . . . -67.48 -59.2 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 69.7 mt -60.33 -47.24 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.54 -51.31 65.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 92.5 m-20 -60.73 -33.54 73.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.877 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 26' ' ' ALA . . . -71.96 -42.59 66.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 108.969 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.38 -38.45 74.71 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.508 -0.745 . . . . 0.0 109.777 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.528 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 77.8 m -63.85 -51.5 64.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 109.917 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 85.7 p -58.4 -34.78 71.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 0.0 109.774 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.23 -44.56 68.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.599 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -46.96 -54.81 9.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.531 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.7 m-85 -72.03 -32.09 66.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 98' ' ' SER . 92.5 mm-40 -77.19 -18.57 57.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 99' ' ' ALA . 81.7 p -104.52 -60.18 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.087 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.461 HG22 ' HD3' ' A' ' 8' ' ' PRO . 29.6 p -127.16 -43.01 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.207 . . . . 0.0 110.762 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.48 44.62 1.05 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.588 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 28.2 t -104.81 170.06 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 108.891 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 110' ' ' ARG . 22.9 m -68.15 121.14 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.599 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 18.9 p-10 -70.59 -23.51 62.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 32.9 t -62.03 -30.56 71.05 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 110.355 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.452 ' HB2' HG21 ' A' ' 107' ' ' VAL . 30.7 ttm-85 -65.81 -54.51 25.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.831 -1.168 . . . . 0.0 110.343 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CD2' HD21 ' A' ' 96' ' ' LEU . 29.1 t80 -75.69 -53.95 7.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.035 . . . . 0.0 110.181 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 54.5 mt -56.92 -34.27 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 12.7 t -55.89 -43.14 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 0.0 109.763 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 74.8 mm-40 -71.73 -38.86 70.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.517 HG12 ' CB ' ' A' ' 71' ' ' ALA . 71.5 mt -59.54 -45.64 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CG2' ' A' ' 89' ' ' THR . 62.3 mtp180 -54.2 -49.09 70.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.689 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.8 m -57.85 -33.71 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 0.0 109.071 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 82.3 mt -74.53 -41.88 59.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 85' ' ' LEU . 72.2 mt -59.24 -35.65 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.199 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.29 63.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.7 ttm -60.83 -45.1 95.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.147 . . . . 0.0 109.515 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.548 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 89.8 m-85 -58.99 -37.28 76.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.489 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.8 mtp -58.45 -36.76 74.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.172 . . . . 0.0 109.474 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.34 10.73 79.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 53.1 tt0 -109.07 156.09 20.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -1.134 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 4' ' ' GLN . . . -154.37 153.85 32.31 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 65.5 m-20 -49.35 -33.23 12.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.409 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.588 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.6 t -129.12 150.09 74.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 18' ' ' PHE . 42.7 Cg_endo -65.3 -31.98 51.92 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.65 2.233 . . . . 0.0 112.216 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 45.5 p90 -89.35 23.41 2.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 109.445 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.72 -33.67 8.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 108.584 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 t -116.62 161.65 18.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.542 -0.724 . . . . 0.0 109.053 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' CG ' HG13 ' A' ' 58' ' ' ILE . 4.5 ttpm? -72.61 -41.52 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 109.761 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.82 57.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.546 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 20.4 t30 -71.69 -33.01 68.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.96 -37.57 67.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.98 . . . . 0.0 110.064 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 87.7 m-20 -56.25 -56.56 19.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.118 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.01 -42.39 62.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 48.1 t80 -58.33 -41.11 83.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.479 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 70' ' ' PHE . 22.1 mm -67.44 -49.34 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.16 -49.16 78.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 t -62.07 -30.76 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.06 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 96' ' ' LEU . 16.3 t80 -66.75 -44.19 82.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 0.0 109.92 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -71.06 -55.97 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 109.812 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -55.63 -37.54 68.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.825 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -46.25 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.823 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB1' ' CE2' ' A' ' 32' ' ' PHE . . . -62.37 -36.71 83.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.526 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 91.7 p -66.95 -22.33 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.893 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -105.38 7.18 33.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.474 ' HB ' ' HA ' ' A' ' 91' ' ' ALA . 7.7 m -101.19 -73.24 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 110.241 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -107.21 0.87 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -124.83 -64.93 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -1.112 . . . . 0.0 109.736 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 78' ' ' ALA . 34.6 m-85 44.82 72.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.206 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -59.71 165.09 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.33 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -52.28 -30.09 26.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.187 -0.945 . . . . 0.0 109.111 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.58 -36.01 80.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 81' ' ' GLN . 43.0 mt-30 -70.96 -33.11 70.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.309 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 61.8 mtt -63.63 -29.44 70.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 41' ' ' SER . 86.7 tt0 -57.0 -37.26 71.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 108.913 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' CB ' HG22 ' A' ' 77' ' ' ILE . 79.3 m-20 -58.47 -31.69 68.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' ILE . 51.2 ttp -55.7 -31.79 62.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 108.852 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.481 ' OG ' ' CD1' ' A' ' 42' ' ' LEU . 85.4 p -55.64 -24.17 32.17 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.298 -0.876 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.9 mp -106.5 -25.37 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 73' ' ' SER . 88.3 mt -124.54 150.98 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.609 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' C ' ' CG2' ' A' ' 19' ' ' ILE . . . 90.34 -108.36 3.54 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -53.08 -23.11 7.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -1.197 . . . . 0.0 108.709 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -68.14 -34.78 76.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.535 ' CD2' HD22 ' A' ' 66' ' ' LEU . 2.4 tm? -52.32 -34.61 47.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.447 ' HE2' ' HB3' ' A' ' 16' ' ' ASP . 68.2 mtt -58.21 -37.1 74.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -31.39 71.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.41 79.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 109.27 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.453 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 61.2 mtt -62.73 -31.12 71.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 109.372 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.52 -30.1 60.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.254 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -68.67 -25.39 64.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 109.204 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.526 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 88.8 mmm -67.44 -29.86 69.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.32 9.27 67.33 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.04 16.34 19.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' CE ' ' A' ' 54' ' ' MET . 16.3 ptt85 -127.8 112.48 14.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -1.123 . . . . 0.0 109.498 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.526 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 20.6 mm -116.07 155.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 p -139.95 164.29 38.72 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 48.4 Cg_endo -69.6 -37.19 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.546 2.164 . . . . 0.0 111.629 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -72.7 -33.11 66.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.296 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HD2' HG22 ' A' ' 59' ' ' THR . 29.9 mttm -74.72 -51.37 14.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 51.2 mt -64.35 -26.98 68.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 57.8 tt0 -56.56 -45.3 81.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.09 -43.79 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 47' ' ' LEU . 13.6 tp -69.01 -40.69 78.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.667 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 41.4 t0 -48.77 -43.89 38.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.7 mtm -64.6 -37.04 86.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.548 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.09 -45.15 79.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 19' ' ' ILE . 92.1 t80 -52.94 -40.5 63.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -65.46 -44.1 88.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.648 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 87.3 p -69.27 -37.83 78.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.541 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 79.8 p -70.09 -44.95 68.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG11 ' CE2' ' A' ' 70' ' ' PHE . 11.7 m -65.97 -34.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.1 -46.26 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.65 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 72' ' ' SER . 96.4 mt-30 -58.94 -36.13 74.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 109.969 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 HG22 ' CB ' ' A' ' 39' ' ' ASN . 72.5 mt -68.81 -54.87 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.55 -40.82 33.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 110.524 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.89 -28.81 64.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 109.464 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.4 p -80.89 -20.29 42.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.47 ' HB3' ' NE2' ' A' ' 36' ' ' GLN . 60.2 mm-40 -93.29 117.94 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.639 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.95 101.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -45.01 -36.0 4.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -64.55 92.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 119' ' ' ILE . 6.4 mp -76.11 -8.55 57.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.674 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.2 -44.27 84.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 88' ' ' THR . 9.9 p -70.45 -48.29 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.183 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' CB ' ' A' ' 78' ' ' ALA . 53.4 m -52.37 -36.04 52.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.928 -1.108 . . . . 0.0 108.404 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.493 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 31.9 m -55.53 -49.39 72.77 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 59.6 t30 -70.74 -37.27 73.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.21 -59.21 3.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 96' ' ' LEU . 49.2 mt -62.29 -48.92 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -58.97 -51.21 71.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.607 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -55.3 -45.36 76.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -59.33 -44.1 92.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.21 -0.931 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.513 HD22 ' CE2' ' A' ' 22' ' ' PHE . 2.8 mt -70.09 -33.46 71.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 88.0 m -65.25 -49.04 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -0.859 . . . . 0.0 109.844 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 96.8 p -66.61 -39.69 88.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 0.0 109.813 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -60.85 -40.02 91.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 109.599 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.595 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.8 m-85 -52.97 -56.47 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.568 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.53 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.8 m-85 -72.18 -32.4 66.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.421 -0.799 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 98' ' ' SER . 93.6 mm-40 -70.34 -18.77 63.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.851 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.9 p -107.12 -60.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.116 . . . . 0.0 111.2 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.495 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.47 -42.84 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.647 -1.283 . . . . 0.0 111.156 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 112.14 46.68 0.74 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.7 t -102.87 171.92 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -1.178 . . . . 0.0 108.984 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 110' ' ' ARG . 15.5 m -73.86 120.26 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.595 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 21.1 p-10 -72.18 -29.09 63.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' SER . 94.0 p -58.73 -43.26 90.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 110.502 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.418 ' HB2' HG21 ' A' ' 107' ' ' VAL . 30.8 ttp85 -57.11 -53.7 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.621 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 63.3 t80 -75.19 -53.55 8.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 40.9 mt -56.29 -34.33 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.8 t -55.8 -43.15 76.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.043 -1.035 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 118' ' ' LEU . 97.5 mt-10 -70.78 -36.66 73.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 51.0 mt -72.3 -41.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.415 ' NH1' ' HG2' ' A' ' 116' ' ' ARG . 11.8 ttp85 -54.09 -41.26 68.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.84 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 114' ' ' GLU . 18.1 mt -69.61 -43.97 71.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.875 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.495 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 73.0 mt -57.89 -47.24 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.851 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.97 -27.19 64.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.2 ttm -67.62 -42.35 82.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 97.4 m-85 -59.71 -31.96 70.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HB3' HD22 ' A' ' 85' ' ' LEU . . . -59.79 -35.92 75.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.558 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.7 -38.58 73.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.29 74.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p -66.01 -25.19 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.456 ' O ' ' CG1' ' A' ' 130' ' ' VAL . . . -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 86.6 m-20 -73.71 -30.65 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.59 -46.05 90.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 131' ' ' TYR . 3.3 p -64.18 -31.76 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.465 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 130' ' ' VAL . 35.9 p90 179.59 175.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.08 124.23 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.3 m -49.7 152.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.538 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.44 28.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.56 -30.22 41.74 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.0 t -115.18 141.36 48.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.96 -35.23 72.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.141 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.46 16.24 60.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -108.37 144.55 35.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 104' ' ' THR . . . -73.19 138.87 45.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.21 -20.16 63.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.589 ' OG1' ' CE3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -157.98 156.3 27.9 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 40.8 Cg_endo -64.85 -35.49 44.55 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.804 2.336 . . . . 0.0 112.941 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -84.56 12.46 6.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 2.2 m -102.36 -19.53 14.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.943 . . . . 0.0 108.757 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 66.1 m -119.63 158.06 27.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' CG ' HG13 ' A' ' 58' ' ' ILE . 9.0 ttpt -74.38 -40.31 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.757 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -78.91 -36.65 41.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 4.9 t-20 -72.37 -29.63 63.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 109.991 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.33 -51.24 21.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 110.308 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' ' 13' ' ' ALA . 1.7 p30 -54.95 -46.77 75.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 16' ' ' ASP . . . -58.53 -40.56 83.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.554 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CE2' ' HG ' ' A' ' 96' ' ' LEU . 51.5 t80 -63.64 -37.21 86.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 109.803 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 70' ' ' PHE . 25.1 mm -71.78 -37.14 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 109.691 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -68.12 -49.42 61.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -64.66 -30.67 71.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 110.186 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 37.9 t80 -63.35 -51.51 65.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.3 mt -60.59 -56.08 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 109.98 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m -59.67 -32.6 70.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -77.66 -45.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.865 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.514 ' CA ' ' HB3' ' A' ' 95' ' ' ALA . . . -67.04 -33.21 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 110.054 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.5 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 62.7 m -63.48 -27.35 69.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 7.52 31.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 110.112 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 25.8 m -92.58 -77.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.963 -1.085 . . . . 0.0 110.057 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -104.08 0.6 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 4.2 m -131.13 -60.45 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -1.1 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.496 ' CE1' ' CB ' ' A' ' 78' ' ' ALA . 8.0 m-85 44.25 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 p -59.71 160.39 7.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -52.8 -41.96 64.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -57.88 -36.02 71.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 98.3 mm-40 -69.96 -32.74 71.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.325 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.5 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 65.5 mtt -63.51 -32.0 73.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' O ' HD13 ' A' ' 42' ' ' LEU . 86.0 tt0 -64.3 -45.26 88.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB2' HG21 ' A' ' 77' ' ' ILE . 21.8 m120 -55.66 -39.26 70.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.476 ' O ' ' O ' ' A' ' 43' ' ' ILE . 63.2 mtt -57.29 -32.05 66.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 108.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 42' ' ' LEU . 30.3 p -70.47 -23.52 62.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.35 -0.844 . . . . 0.0 109.39 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 38' ' ' GLU . 6.7 mp -88.49 -23.46 23.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.554 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 48.6 mt -131.22 143.0 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.162 -0.961 . . . . 0.0 109.296 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 98.65 -83.75 0.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.415 ' N ' HG22 ' A' ' 19' ' ' ILE . 91.1 m-20 -61.3 -27.09 68.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.154 -1.203 . . . . 0.0 108.358 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -68.82 -35.07 76.52 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 66' ' ' LEU . 60.3 mt -53.33 -38.24 63.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.75 . . . . 0.0 109.306 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ttt -52.79 -41.35 64.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.63 70.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.0 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -66.83 -38.0 85.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 109.125 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.457 ' HE1' ' CB ' ' A' ' 15' ' ' ALA . 54.9 mtt -56.7 -30.63 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.261 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -60.15 -29.36 68.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.197 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.17 -25.64 66.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.432 -0.792 . . . . 0.0 109.244 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.525 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 92.2 mmm -62.55 -27.75 69.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.59 8.29 62.48 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.77 11.98 29.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE ' ' A' ' 54' ' ' MET . 16.3 ptt180 -124.11 112.4 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.445 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 26.0 mm -116.54 149.99 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.182 -0.948 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -137.92 159.54 68.2 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 45.0 Cg_endo -66.75 -52.0 0.8 Allowed 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.622 2.215 . . . . 0.0 111.739 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m -46.26 -52.05 13.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.168 -0.958 . . . . 0.0 109.59 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -81.25 -52.38 7.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 110.204 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 59' ' ' THR . 15.4 tp -55.88 -42.68 76.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.55 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 94.7 mt-30 -55.76 -30.97 62.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.335 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.3 68.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 108.958 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' CD2' HD13 ' A' ' 47' ' ' LEU . 10.4 tt -74.14 -45.2 50.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.256 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.4 t0 -48.66 -42.53 34.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 89.7 mtp -64.39 -45.61 86.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.598 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.59 78.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.395 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 19' ' ' ILE . 70.5 t80 -53.12 -38.93 63.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.3 -39.76 74.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -68.74 -40.79 79.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.561 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 8.9 m -70.05 -47.87 60.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.628 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 70' ' ' PHE . 23.0 m -57.72 -35.08 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' ALA . . . -72.22 -35.19 68.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.8 tt0 -74.34 -44.15 53.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 39' ' ' ASN . 94.0 mt -55.82 -47.21 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.47 -52.8 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 109.803 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . -57.86 -29.22 64.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.166 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 27.6 t -69.61 -20.19 63.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.292 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.2 mt-30 -54.64 -29.93 53.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.19 80.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.1 -156.94 29.09 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 87' ' ' VAL . 55.9 t0 -70.45 98.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -1.213 . . . . 0.0 109.403 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.497 ' CD2' HG22 ' A' ' 119' ' ' ILE . 10.4 tt -57.6 -16.34 10.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.63 -39.06 95.22 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 84' ' ' ASP . 5.7 p -69.77 -37.59 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 109.602 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CB ' ' A' ' 78' ' ' ALA . 44.4 m -51.58 -32.06 27.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.088 -1.008 . . . . 0.0 108.735 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 116' ' ' ARG . 22.1 m -59.94 -47.31 86.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 25.9 m120 -70.86 -33.49 70.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.426 -0.796 . . . . 0.0 109.018 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -71.65 -59.32 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.767 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.427 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 54.8 mt -63.34 -42.53 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' A' ' 112' ' ' ILE . . . -62.86 -52.36 63.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB3' HG23 ' A' ' 29' ' ' THR . 34.1 t0 -55.26 -50.48 69.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 109.332 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HB3' ' CA ' ' A' ' 26' ' ' ALA . . . -55.9 -45.41 78.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.583 ' CD2' ' CD2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -69.97 -33.85 72.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.49 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 94.3 m -68.97 -49.27 59.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.0 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.5 p -62.26 -34.44 76.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.907 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -69.83 -42.65 73.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.3 m-85 -46.94 -54.75 9.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.516 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.4 m-85 -71.66 -32.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 110.491 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 98' ' ' SER . 64.5 mm-40 -80.58 -18.45 48.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 110.129 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 18' ' ' PHE . 54.7 p -101.45 -59.05 1.77 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 111.053 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.441 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 23.0 m -126.05 -42.67 1.86 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 110.868 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 107.64 46.69 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 5.0 t -114.69 172.97 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -1.159 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' CG ' ' A' ' 110' ' ' ARG . 2.8 m -73.1 120.5 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.306 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.607 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 12.4 p30 -70.84 -24.14 62.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.615 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 24.8 t -56.07 -30.2 61.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.505 -0.747 . . . . 0.0 110.342 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.513 ' CG ' HG21 ' A' ' 107' ' ' VAL . 35.4 mmt180 -67.94 -54.61 17.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.119 . . . . 0.0 110.234 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.583 ' CD2' ' CD2' ' A' ' 96' ' ' LEU . 1.2 t80 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.527 HG21 ' CB ' ' A' ' 93' ' ' ALA . 52.4 mt -56.41 -29.95 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.548 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 6.0 t -58.13 -47.33 83.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 85.5 tt0 -72.22 -37.7 69.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 71' ' ' ALA . 47.1 mt -56.56 -46.29 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.917 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.524 ' HD3' ' CG2' ' A' ' 89' ' ' THR . 74.3 mtt180 -54.41 -49.12 70.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -59.17 -33.34 70.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.0 109.004 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 83.8 mt -73.75 -40.85 63.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.461 -0.774 . . . . 0.0 110.232 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.497 HG22 ' CD2' ' A' ' 85' ' ' LEU . 56.9 mt -61.08 -34.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 0.0 109.595 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.9 -32.45 70.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -65.64 -42.59 91.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.426 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 96.2 m-85 -63.23 -29.03 70.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 85' ' ' LEU . . . -67.83 -32.86 73.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.42 -31.44 70.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.72 61.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 109.379 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.5 p -74.45 -21.41 59.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 0.0 109.342 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.422 ' O ' ' CG1' ' A' ' 130' ' ' VAL . . . -63.26 -26.31 68.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.87 -16.69 61.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -76.52 -42.62 42.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.235 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 131' ' ' TYR . 4.4 p -64.51 -29.23 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CD1' HG11 ' A' ' 130' ' ' VAL . 41.8 p90 179.15 172.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.03 116.55 21.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.5 m -58.67 156.74 10.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.25 77.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 -166.64 40.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -120.63 148.65 43.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -1.139 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -57.17 -36.77 71.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.61 58.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 1' ' ' GLY . 93.9 mt-30 -115.17 156.99 24.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -1.126 . . . . 0.0 109.456 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . -66.28 140.08 58.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 106' ' ' VAL . 16.7 m120 -52.68 -20.71 3.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 4.5 t -143.5 152.51 56.96 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.127 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 42.6 Cg_endo -65.04 -35.4 42.88 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.466 2.111 . . . . 0.0 112.787 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -80.82 7.25 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.626 -1.296 . . . . 0.0 109.737 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.9 OUTLIER -92.31 -20.57 20.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 108.718 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.5 t -136.69 144.66 44.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 108.949 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD3' ' CD1' ' A' ' 58' ' ' ILE . 22.1 mtmm -60.42 -46.43 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.3 71.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.355 -0.841 . . . . 0.0 109.476 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.52 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 14.1 m120 -72.36 -38.43 68.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.39 -51.8 33.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' OD1' ' HG2' ' A' ' 48' ' ' MET . 17.2 m-20 -54.37 -51.11 65.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.29 91.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 108.7 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.509 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 58.8 t80 -58.56 -37.23 75.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.435 -0.791 . . . . 0.0 109.534 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 70' ' ' PHE . 20.8 mm -71.01 -37.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -68.51 -50.02 55.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CE1' HG11 ' A' ' 74' ' ' VAL . 34.4 t80 -65.12 -49.13 71.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 110.207 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.509 ' CD1' ' ND2' ' A' ' 45' ' ' ASN . 77.2 mt -61.99 -56.18 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -60.21 -32.12 70.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.913 . . . . 0.0 109.868 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.84 -44.46 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.096 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.517 ' N ' ' HB1' ' A' ' 95' ' ' ALA . . . -69.97 -29.27 66.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.243 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -64.68 -28.5 69.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.963 . . . . 0.0 110.13 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.9 7.49 32.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 20.1 m -90.72 -78.5 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 -103.33 0.39 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.9 t -131.24 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -1.132 . . . . 0.0 109.445 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 12.5 m-85 43.73 88.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.315 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.2 m -59.73 161.05 6.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -52.64 -36.57 56.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.61 -36.05 83.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.435 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 99.8 mm-40 -71.91 -33.97 68.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 109.283 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.412 ' HE2' ' O ' ' A' ' 32' ' ' PHE . 65.1 mtt -63.64 -33.71 76.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.08 -47.25 85.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.446 ' ND2' HG12 ' A' ' 77' ' ' ILE . 34.5 t-20 -55.65 -40.71 72.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 43' ' ' ILE . 83.1 mtp -61.49 -31.85 71.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 109.11 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 m -70.3 -23.94 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 42' ' ' LEU . 4.2 mm? -90.55 -23.26 20.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.922 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.525 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 64.0 mt -125.0 157.01 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.583 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 89.42 -83.85 1.41 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.509 ' ND2' ' CD1' ' A' ' 23' ' ' ILE . 92.5 m-20 -62.67 -33.87 75.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -1.217 . . . . 0.0 109.009 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -60.51 -35.28 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.362 -0.836 . . . . 0.0 109.232 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 6.5 mt -57.28 -35.77 70.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 0.0 109.46 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.452 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 69.7 mtm -52.84 -39.92 62.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.274 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.49 -32.93 72.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.875 . . . . 0.0 109.182 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . -63.53 -31.18 72.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.84 . . . . 0.0 109.206 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 54' ' ' MET . 64.6 mtt -56.23 -34.23 66.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.257 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -56.49 -27.92 58.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.194 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -68.77 -23.44 64.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.533 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 75.9 mmm -57.2 -26.62 60.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.71 8.0 88.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.1 21.19 9.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' O ' ' CE ' ' A' ' 54' ' ' MET . 11.8 ptt180 -128.85 111.93 13.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 30.1 mm -118.12 151.3 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 8.5 p -146.3 161.06 40.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 46.7 Cg_endo -68.46 -43.42 4.2 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.629 2.22 . . . . 0.0 111.655 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -62.22 -37.38 85.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.155 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.13 -51.94 9.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.291 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' CD1' HG23 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -62.89 -40.19 96.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.289 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.448 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 59.1 tp60 -54.61 -40.11 68.56 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.359 -0.838 . . . . 0.0 108.955 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.85 68.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 108.959 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tp -73.51 -46.65 46.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.279 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.505 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 31.0 t0 -48.08 -46.79 34.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 109.732 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.55 -38.43 81.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 109.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.75 76.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.517 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 19' ' ' ILE . 84.1 t80 -55.23 -35.36 64.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -66.03 -37.33 85.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.805 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.6 m -67.77 -31.56 71.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.822 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.525 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 92.5 p -69.3 -49.12 58.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.527 HG11 ' CE1' ' A' ' 22' ' ' PHE . 35.3 m -60.82 -35.01 61.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.436 -0.79 . . . . 0.0 109.982 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.57 -47.56 39.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.471 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.3 mt-30 -64.73 -50.47 66.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.887 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' MET . 79.2 mt -55.01 -50.84 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 109.907 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 88' ' ' THR . . . -74.9 -51.86 12.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.92 -30.81 66.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 92.2 p -72.66 -20.47 61.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.432 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.592 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 83.3 mt-30 -49.3 -40.52 35.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.918 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.15 5.19 66.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.05 -155.39 27.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' O ' HG11 ' A' ' 87' ' ' VAL . 53.8 t0 -66.06 105.39 1.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -1.088 . . . . 0.0 109.376 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' CD1' ' CG2' ' A' ' 119' ' ' ILE . 23.7 tp -67.75 -14.01 62.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.03 -32.41 66.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 84' ' ' ASP . 6.2 p -69.88 -35.71 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -1.174 . . . . 0.0 109.527 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.578 ' CG2' ' CD1' ' A' ' 92' ' ' ILE . 73.7 m -51.59 -32.4 28.47 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.1 -1.0 . . . . 0.0 108.679 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 62.8 m -58.65 -46.62 86.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -70.78 -38.24 73.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.467 -0.771 . . . . 0.0 109.096 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' HG21 ' A' ' 29' ' ' THR . . . -68.32 -56.07 9.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.904 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.578 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 61.4 mt -66.7 -44.05 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.761 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.521 ' CA ' HD12 ' A' ' 112' ' ' ILE . . . -64.49 -50.85 65.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 109.892 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 92.2 m-20 -55.32 -43.13 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.946 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.517 ' HB1' ' N ' ' A' ' 26' ' ' ALA . . . -67.91 -40.79 83.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.283 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.53 HD23 ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -70.11 -34.54 73.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.804 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.559 HG22 ' CE2' ' A' ' 101' ' ' TYR . 55.3 m -67.64 -51.13 53.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.03 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 t -60.14 -35.29 74.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 109.887 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.505 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.85 -43.29 72.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -47.1 -54.97 9.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.027 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.559 ' CE2' HG22 ' A' ' 97' ' ' THR . 5.3 m-85 -71.84 -32.69 67.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.468 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 98' ' ' SER . 96.5 mm-40 -75.9 -18.46 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.217 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 99' ' ' ALA . 55.9 p -104.77 -59.57 1.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.907 -1.12 . . . . 0.0 110.996 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.436 HG23 ' HD3' ' A' ' 8' ' ' PRO . 25.6 p -126.41 -42.81 1.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.702 -1.249 . . . . 0.0 110.921 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.61 46.6 0.96 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.94 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.575 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 5.7 t -108.22 172.44 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.188 -1.183 . . . . 0.0 109.101 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.3 m -73.4 120.77 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.591 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 14.4 p30 -71.35 -24.09 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.818 . . . . 0.0 109.779 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 113' ' ' SER . 50.2 m -60.18 -30.66 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 110.332 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -68.31 -54.76 15.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.363 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 115' ' ' ILE . 33.1 t80 -75.75 -50.39 15.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.046 -1.034 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.521 HD12 ' CA ' ' A' ' 93' ' ' ALA . 34.4 mt -56.43 -39.09 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.27 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' SER . 22.1 m -59.89 -38.53 82.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.45 -39.83 85.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.411 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 71' ' ' ALA . 84.7 mt -70.82 -42.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.435 ' HD2' HG23 ' A' ' 89' ' ' THR . 16.4 ttt180 -54.34 -42.87 70.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -73.0 -33.76 65.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.964 . . . . 0.0 109.664 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 115' ' ' ILE . 16.7 mt -68.93 -42.4 76.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.808 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.568 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 61.9 mt -57.66 -39.65 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.68 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.59 -28.31 73.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -69.09 -36.76 77.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 109.548 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.27 -35.43 80.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.559 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.46 -32.48 73.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -70.64 -35.77 73.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.81 74.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -59.5 -32.27 70.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.509 ' O ' ' CG2' ' A' ' 130' ' ' VAL . . . -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -72.32 -26.41 61.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -65.9 -48.23 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.509 ' CG2' ' O ' ' A' ' 127' ' ' ALA . 16.3 m -58.29 -31.49 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 132' ' ' ALA . 37.3 p90 -179.2 -175.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.37 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -83.64 119.99 25.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.3 m -51.05 -38.19 50.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.6 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.13 6.99 66.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.5 m -60.74 -34.29 74.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.477 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -57.88 -37.64 74.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -1.165 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.07 145.36 46.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.15 -35.81 76.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -1.167 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.07 102.94 1.82 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.166 -0.958 . . . . 0.0 109.553 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 68.3 m-20 -88.31 20.42 3.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.592 HG23 ' CZ2' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -133.77 151.69 77.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.5 Cg_endo -67.78 -31.49 31.95 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.73 2.287 . . . . 0.0 111.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CZ2' HG23 ' A' ' 7' ' ' THR . 40.1 p90 -96.24 -14.26 22.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 m -70.03 -7.22 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -139.6 151.44 46.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' CG ' HG13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -71.13 -40.28 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.567 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.16 -34.58 61.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.349 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -71.56 -29.37 64.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -69.62 -40.85 76.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.775 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -58.73 -56.42 22.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 21' ' ' SER . . . -55.56 -36.17 66.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.557 ' CE1' ' HB1' ' A' ' 99' ' ' ALA . 68.0 t80 -68.01 -48.88 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.092 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 19' ' ' ILE . 41.1 mt -66.5 -44.54 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.36 -50.71 51.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.129 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 30.3 t -58.26 -30.31 66.48 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' CD2' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -72.31 -50.89 23.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.504 -0.748 . . . . 0.0 109.549 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 19' ' ' ILE . 72.1 mt -62.93 -55.91 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 m -57.19 -35.2 69.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.62 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 21' ' ' SER . . . -77.83 -48.3 16.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.432 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -61.76 -34.61 76.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.775 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.51 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 19.3 m -64.1 -27.92 69.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.725 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.93 7.18 31.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.99 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 91' ' ' ALA . 23.2 m -91.91 -75.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.081 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 -104.02 0.78 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -132.34 -58.65 0.94 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.37 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.544 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 7.5 m-85 44.19 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -59.59 162.89 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -52.66 -38.15 59.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.21 -37.8 84.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.281 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.523 ' NE2' ' CG ' ' A' ' 81' ' ' GLN . 72.3 mt-30 -68.24 -35.43 77.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.313 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.51 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 64.8 mtt -64.32 -36.8 85.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.48 -46.89 85.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.145 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -58.83 -41.21 86.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 43' ' ' ILE . 80.0 mtp -64.96 -32.05 73.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 m -69.99 -24.04 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -95.44 -17.16 21.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 44' ' ' GLY . 80.8 mt -126.39 161.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -0.999 . . . . 0.0 109.509 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -79.98 1.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.48 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -1.116 . . . . 0.0 109.03 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -61.17 -35.36 76.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 0.0 109.038 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.458 HD23 HD21 ' A' ' 66' ' ' LEU . 24.7 tp -56.12 -36.19 67.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.848 . . . . 0.0 109.223 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.418 ' CG ' HD13 ' A' ' 19' ' ' ILE . 93.4 mmm -55.74 -33.01 63.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.13 79.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.96 . . . . 0.0 109.064 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.76 81.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HE3' ' HG3' ' A' ' 12' ' ' LYS . 75.5 mmm -54.73 -34.06 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -58.85 -28.85 66.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.208 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -59.58 -31.15 69.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.141 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.532 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 85.3 mmm -57.88 -33.33 68.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.354 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.62 27.38 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.11 15.38 33.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 32.8 ptt180 -133.48 112.33 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 0.0 109.572 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' CG2' HD12 ' A' ' 63' ' ' LEU . 37.3 mm -113.73 143.72 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.076 -1.015 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.03 160.76 25.19 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.622 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.67 -42.56 2.38 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.804 2.336 . . . . 0.0 111.699 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 t -67.5 -40.29 85.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.407 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.1 tttm -63.12 -52.15 63.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.374 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 HD12 ' CG2' ' A' ' 58' ' ' ILE . 3.7 mt -56.99 -30.48 64.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . 63.4 tt0 -54.28 -45.58 72.52 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.21 63.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 108.917 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 62' ' ' LYS . 1.6 mt -73.93 -53.9 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.543 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 9' ' ' TRP . 0.8 OUTLIER -48.47 -39.06 21.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.727 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.429 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 92.7 mtp -67.37 -47.35 70.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.23 -44.4 75.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.17 -40.59 67.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -59.85 -40.96 90.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.5 t -69.47 -30.63 68.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 43' ' ' ILE . 36.4 m -70.02 -49.57 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.476 ' HB ' ' CZ ' ' A' ' 22' ' ' PHE . 10.8 m -62.72 -38.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.64 -48.21 34.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.921 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 80' ' ' SER . 63.4 tt0 -59.56 -42.65 92.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 73' ' ' SER . 83.5 mt -61.96 -55.04 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.004 . . . . 0.0 109.984 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.544 ' HB1' ' CE1' ' A' ' 32' ' ' PHE . . . -75.84 -47.2 26.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.45 -0.781 . . . . 0.0 110.184 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.78 -23.85 54.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 76' ' ' GLN . 63.8 m -83.04 -20.58 34.73 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.523 ' CG ' ' NE2' ' A' ' 36' ' ' GLN . 22.2 tp60 -136.89 104.73 5.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.99 103.62 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.45 93.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.486 ' O ' HG13 ' A' ' 87' ' ' VAL . 82.8 m-20 -106.56 82.15 1.68 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -1.17 . . . . 0.0 109.141 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 123' ' ' ALA . 6.3 tp -43.64 -26.31 0.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 84' ' ' ASP . . . -61.92 -33.19 84.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.2 p -69.73 -44.52 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.235 . . . . 0.0 109.656 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.535 HG23 ' CB ' ' A' ' 78' ' ' ALA . 84.5 m -51.85 -34.98 43.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 108.535 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 1.1 m -56.71 -49.23 75.77 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.46 ' O ' HG22 ' A' ' 29' ' ' THR . 76.4 m-20 -70.92 -40.79 71.9 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.39 -0.819 . . . . 0.0 109.065 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -63.31 -53.23 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.389 -0.82 . . . . 0.0 109.922 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 96' ' ' LEU . 66.4 mt -72.48 -48.99 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.963 . . . . 0.0 109.952 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -59.83 -46.74 88.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.907 . . . . 0.0 110.248 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.482 ' OD2' ' CG2' ' A' ' 29' ' ' THR . 89.2 m-20 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -58.18 -41.54 84.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.868 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.542 ' CD1' HG22 ' A' ' 92' ' ' ILE . 5.2 mt -69.64 -39.3 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.717 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 38.5 m -61.51 -53.5 55.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.927 . . . . 0.0 110.185 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 m -62.82 -38.29 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 109.944 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -62.36 -45.69 92.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.69 -56.21 7.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.528 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.75 -32.27 67.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 98' ' ' SER . 79.0 mm-40 -77.37 -18.63 57.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 99' ' ' ALA . 74.1 p -104.66 -60.22 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.978 -1.076 . . . . 0.0 110.913 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.494 ' CG2' ' C ' ' A' ' 7' ' ' THR . 19.0 p -127.03 -42.75 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.783 -1.198 . . . . 0.0 110.871 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.09 47.02 0.9 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 16.6 t -106.58 172.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.175 -1.191 . . . . 0.0 108.944 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.459 HG21 ' CB ' ' A' ' 110' ' ' ARG . 19.7 m -71.47 119.67 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.605 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 22.6 p-10 -72.1 -31.68 66.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 113' ' ' SER . 14.9 t -57.44 -44.48 84.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -0.817 . . . . 0.0 110.481 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.459 ' CB ' HG21 ' A' ' 107' ' ' VAL . 62.5 ttt-85 -57.36 -53.55 56.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.992 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -74.67 -53.94 8.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.978 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 28.9 mt -56.34 -37.51 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.078 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' SER . 19.2 m -55.79 -48.54 75.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.065 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.96 -42.58 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.08 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.525 HG12 ' CB ' ' A' ' 71' ' ' ALA . 96.5 mt -70.97 -34.62 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.438 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 17.8 ttt180 -54.03 -45.73 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 109.398 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.26 -33.9 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.468 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.88 -41.08 92.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 115' ' ' ILE . 99.0 mt -57.82 -37.13 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -71.18 -34.26 64.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.9 -38.09 89.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -1.167 . . . . 0.0 109.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.443 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 72.0 m-85 -69.97 -38.25 76.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . . . -64.0 -32.13 73.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.43 -35.52 75.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.389 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.2 t -59.24 -34.88 72.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.415 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG11 ' A' ' 130' ' ' VAL . . . -63.56 -20.87 66.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 93.8 m-20 -73.19 -28.7 62.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.04 -42.38 89.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.545 HG11 ' CD1' ' A' ' 131' ' ' TYR . 4.7 p -71.28 -30.94 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.545 ' CD1' HG11 ' A' ' 130' ' ' VAL . 41.8 p90 178.7 168.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.9 118.73 18.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.7 p -63.87 165.03 9.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.497 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.36 -28.72 69.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.48 12.53 58.27 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.9 m -56.66 -34.62 67.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.7 mtp -126.47 157.69 38.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -1.159 . . . . 0.0 109.504 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.35 -172.09 37.84 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -118.61 148.67 42.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -1.153 . . . . 0.0 109.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.41 ' HB3' ' OG ' ' A' ' 11' ' ' SER . . . -136.28 162.34 33.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 106' ' ' VAL . 25.4 m120 -78.42 -15.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.678 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 9' ' ' TRP . 0.5 OUTLIER -165.11 156.48 12.92 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 38.4 Cg_endo -61.85 -32.25 85.43 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.561 2.174 . . . . 0.0 112.171 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 19.0 p90 -84.15 9.86 11.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' THR . 5.4 t -99.86 -22.75 15.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 0.0 108.763 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 14' ' ' ASN . 69.9 m -118.89 157.74 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.468 -0.77 . . . . 0.0 109.113 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' CG ' HG13 ' A' ' 58' ' ' ILE . 24.1 ttpt -74.25 -40.71 62.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.943 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.19 -35.3 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 1.6 m-20 -72.24 -32.55 66.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.61 -47.21 49.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.087 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 68.1 m-20 -54.75 -56.31 20.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.86 . . . . 0.0 109.909 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . -54.8 -37.9 66.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.111 -0.993 . . . . 0.0 109.159 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.544 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 81.5 t80 -62.11 -41.1 97.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.288 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.514 HG21 ' CE1' ' A' ' 70' ' ' PHE . 19.8 mm -69.34 -49.11 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 16' ' ' ASP . 39.8 m-80 -62.03 -49.75 74.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 17' ' ' ALA . 15.2 p -59.04 -34.91 72.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 96' ' ' LEU . 16.6 t80 -67.14 -36.01 80.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.0 110.161 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 19' ' ' ILE . 66.1 mt -70.13 -56.03 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.17 -0.957 . . . . 0.0 110.315 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -62.7 -33.49 75.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -44.6 26.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -71.8 -29.36 64.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.031 -1.043 . . . . 0.0 110.444 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 2.3 t -60.92 -30.87 70.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.0 110.553 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -106.1 7.4 31.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.012 . . . . 0.0 110.682 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 13.3 m -91.54 -73.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 110.607 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -76.1 -105.4 0.13 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' PHE . 18.1 m -149.46 13.37 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.461 -1.023 . . . . 0.0 109.805 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.622 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 66.0 m-85 -39.77 109.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.1 p -72.21 164.22 26.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -53.29 -35.77 60.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.159 -0.963 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -68.05 -47.17 69.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 32' ' ' PHE . 68.9 mt-30 -64.7 -33.89 77.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 40' ' ' MET . 92.9 mmm -64.31 -30.13 71.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.03 -40.18 76.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.12 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.15 -42.22 85.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.218 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 37' ' ' MET . 58.0 mtt -57.38 -39.06 75.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 109.011 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.3 p -70.42 -23.54 62.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.406 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 tp -87.24 -13.78 42.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 61.9 mt -133.45 168.02 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.597 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 66.53 -68.85 0.16 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ILE . 36.0 t-20 -60.76 -38.94 86.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.228 -1.16 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 m -62.38 -35.62 79.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 0.0 109.051 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 66' ' ' LEU . 8.7 mp -53.9 -37.49 63.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.454 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 60.7 mtm -52.75 -39.85 62.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.249 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.38 73.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.898 . . . . 0.0 109.041 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.12 -25.97 68.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.363 -0.835 . . . . 0.0 109.246 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.464 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 57.0 mtm -54.35 -29.79 49.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.266 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.75 -30.66 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.191 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.72 -31.04 72.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.166 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.54 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 86.1 mmm -60.63 -29.24 69.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 109.313 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.71 12.35 66.77 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.29 25.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.529 ' O ' ' CE ' ' A' ' 54' ' ' MET . 11.8 ptt180 -128.31 112.46 14.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -1.18 . . . . 0.0 109.696 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.54 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 15.9 mm -116.99 148.91 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -141.58 154.73 66.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.868 . . . . 0.0 109.688 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.38 -11.06 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.68 2.254 . . . . 0.0 111.7 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -82.96 -57.44 3.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.188 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -79.16 -41.69 27.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' CD2' HG21 ' A' ' 58' ' ' ILE . 15.0 tp -55.6 -36.47 66.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -55.05 -29.77 58.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.062 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.79 90.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.287 -0.883 . . . . 0.0 109.078 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 47' ' ' LEU . 9.4 tt -69.07 -38.16 78.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.119 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 48.2 t0 -50.55 -48.81 57.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.557 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.45 -40.44 97.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 109.794 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.53 76.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 19' ' ' ILE . 77.2 t80 -55.71 -35.69 66.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -66.56 -36.93 83.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -69.32 -35.67 76.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.764 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.553 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 52.8 p -70.2 -49.83 46.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 109.821 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 75' ' ' ALA . 4.2 m -58.42 -34.94 52.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.73 -38.87 67.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.677 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.04 -49.88 58.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.176 -0.953 . . . . 0.0 109.763 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 40' ' ' MET . 74.8 mt -55.18 -54.59 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.756 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -69.35 -50.81 42.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 109.855 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.95 -23.91 55.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.261 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.5 t -81.16 -20.3 41.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.622 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 85.1 mt-30 -48.37 -37.28 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 9.57 71.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.94 -175.82 22.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 87' ' ' VAL . 23.9 t0 -55.29 123.97 15.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -1.135 . . . . 0.0 109.363 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 79' ' ' ALA . 1.1 tp -75.79 -19.03 59.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.596 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 89' ' ' THR . . . -56.23 -38.45 77.84 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.5 p -70.69 -41.07 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -1.195 . . . . 0.0 109.82 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 78' ' ' ALA . 25.8 m -51.65 -33.72 34.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.051 -1.031 . . . . 0.0 108.812 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.8 p -58.51 -46.17 87.29 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 26.5 m120 -70.82 -38.25 73.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -66.29 -58.95 4.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.143 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CG1' HG21 ' A' ' 88' ' ' THR . 22.8 mm -62.08 -43.77 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.625 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.45 -44.93 85.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 110.697 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.531 ' CB ' HG22 ' A' ' 29' ' ' THR . 31.8 t0 -55.02 -54.07 47.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.879 -1.138 . . . . 0.0 109.789 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -64.08 -35.82 82.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.14 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.57 HD12 ' CE2' ' A' ' 22' ' ' PHE . 6.0 tp -69.94 -40.23 75.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.603 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.581 HG21 ' CE2' ' A' ' 101' ' ' TYR . 18.4 m -69.11 -52.6 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 16.8 m -60.27 -35.35 75.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.727 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -67.72 -39.33 84.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -53.41 -53.37 52.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' CE2' HG21 ' A' ' 97' ' ' THR . 3.1 m-85 -71.6 -32.08 67.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.502 -0.749 . . . . 0.0 110.465 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 98' ' ' SER . 70.6 mm-40 -78.84 -18.5 53.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 8' ' ' PRO . 66.1 p -102.72 -59.35 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.0 111.108 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.2 m -126.23 -42.54 1.84 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.882 -1.136 . . . . 0.0 110.707 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.58 47.92 1.01 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.5 t -112.85 172.61 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -1.122 . . . . 0.0 109.322 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.519 ' CG2' ' HG3' ' A' ' 110' ' ' ARG . 5.4 m -72.3 121.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.6 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 16.7 p30 -69.9 -23.35 63.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 97.9 p -54.7 -30.6 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.592 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.519 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 23.6 mtp-105 -67.42 -55.01 15.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.499 ' CD2' HD22 ' A' ' 96' ' ' LEU . 3.0 t80 -75.8 -51.03 13.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' A' ' 96' ' ' LEU . 43.7 mt -56.39 -42.23 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 110.412 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' SER . 55.9 m -59.34 -35.26 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 109.677 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 97.7 mt-10 -72.65 -47.37 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CD1' HD22 ' A' ' 96' ' ' LEU . 96.8 mt -66.24 -40.67 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 109.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -54.37 -46.37 73.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 t -72.31 -34.22 67.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.62 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.429 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 29.5 mt -68.77 -42.01 78.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.52 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 76.7 mt -59.61 -43.01 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.34 93.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.6 ttp -54.47 -44.26 72.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.576 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 98.4 m-85 -59.28 -38.92 81.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 85' ' ' LEU . . . -57.23 -33.29 67.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -70.69 -31.44 68.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.16 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.7 p -74.85 -19.87 59.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.923 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 130' ' ' VAL . . . -64.78 -28.39 69.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.554 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.71 -6.76 39.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.634 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -79.01 -39.4 34.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 131' ' ' TYR . 5.6 p -62.89 -29.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.485 ' N ' HG13 ' A' ' 130' ' ' VAL . 40.2 p90 177.6 159.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.75 118.27 11.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.3 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.52 152.86 28.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.516 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.48 71.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 99.5 p -115.92 152.76 32.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -1.141 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.5 mtp -121.97 155.49 35.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.533 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.87 179.61 52.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -65.16 -30.16 71.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -1.16 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.55 34.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -90.22 9.43 28.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.629 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -147.54 145.37 21.33 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.1 Cg_endo -70.8 -35.39 9.67 Favored 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.401 2.067 . . . . 0.0 111.724 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.629 ' CZ2' ' CG2' ' A' ' 7' ' ' THR . 41.8 p90 -85.72 -26.28 25.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.868 -1.145 . . . . 0.0 109.155 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 88.2 p -62.8 -12.09 22.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 79.4 p -129.66 150.12 51.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.125 -0.984 . . . . 0.0 109.336 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 16.4 ttpt -74.36 -37.68 63.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.948 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.96 -50.12 63.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 109.191 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.488 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.3 m120 -72.42 -28.93 63.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.563 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.73 -44.3 93.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' CE ' ' A' ' 48' ' ' MET . 18.8 t0 -68.59 -50.98 47.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.88 . . . . 0.0 109.628 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.29 75.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 73.5 t80 -58.89 -37.23 76.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.446 HG21 ' HE1' ' A' ' 48' ' ' MET . 44.0 mt -74.73 -37.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.761 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -68.48 -50.55 51.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.772 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 31.3 t -60.74 -29.18 69.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.342 -0.849 . . . . 0.0 109.102 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD2' ' HB3' ' A' ' 95' ' ' ALA . 14.0 t80 -66.55 -51.1 60.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 34.5 mm -64.56 -55.74 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.863 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t -60.29 -34.29 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 110.094 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.36 -45.22 26.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.982 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.33 73.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.91 . . . . 0.0 110.026 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.452 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 37.8 m -63.68 -28.46 69.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.088 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -106.25 7.14 31.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.086 -1.009 . . . . 0.0 110.311 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 21.0 m -91.48 -76.64 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.996 -1.065 . . . . 0.0 110.081 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -83.98 -104.2 0.57 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.5 t -134.21 -58.27 0.84 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 15.2 m-85 44.0 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 109.34 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -59.67 157.66 11.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -52.52 -30.8 32.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -71.48 -36.0 70.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.319 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.458 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 95.2 mm-40 -72.71 -32.29 65.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.26 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.452 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 64.5 mtt -63.96 -30.36 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.182 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 41' ' ' SER . 83.8 tt0 -57.49 -44.3 84.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -55.67 -42.07 74.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.955 . . . . 0.0 109.051 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.524 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 64.4 mtt -59.66 -32.08 70.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 38' ' ' GLU . 27.5 p -70.27 -23.72 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.478 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.53 -19.92 22.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 73' ' ' SER . 19.3 mm -129.04 151.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.25 -85.06 1.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' HA ' ' HE1' ' A' ' 48' ' ' MET . 61.8 t-20 -59.88 -33.33 71.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -1.151 . . . . 0.0 108.533 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -63.06 -35.12 79.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.449 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 60.1 mt -56.74 -35.1 68.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.457 ' CE ' ' OD1' ' A' ' 16' ' ' ASP . 56.4 mtt -52.64 -40.91 63.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.047 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.57 73.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -64.57 -35.67 81.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.364 -0.835 . . . . 0.0 109.09 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.458 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 67.5 mtt -55.05 -34.91 63.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 0.0 109.267 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.77 -25.13 66.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.081 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -71.02 -28.87 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.238 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.524 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 90.4 mmm -63.74 -30.13 71.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.07 59.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.41 45.21 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 24.5 ptt85 -125.16 112.05 16.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.599 ' CG2' ' CD1' ' A' ' 63' ' ' LEU . 13.7 mm -117.26 154.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.988 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 p -126.67 159.95 61.11 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 50.1 Cg_endo -70.56 -32.64 14.9 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.698 2.265 . . . . 0.0 111.863 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.3 p -70.43 -46.01 64.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -62.57 -51.13 68.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.599 ' CD1' ' CG2' ' A' ' 58' ' ' ILE . 3.6 mp -62.02 -38.22 87.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 68' ' ' MET . 48.8 tt0 -54.15 -46.45 72.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 108.686 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.62 -40.92 66.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.139 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.2 tp -66.49 -52.24 48.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.8 t0 -47.36 -33.42 5.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 90.9 mtp -71.78 -37.29 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.62 -42.28 87.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.642 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' A' ' 19' ' ' ILE . 81.5 t80 -54.98 -37.81 67.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -70.66 -42.09 71.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.866 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -68.62 -30.78 69.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.943 . . . . 0.0 109.943 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.52 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 26.2 m -69.96 -49.12 54.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.722 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 75' ' ' ALA . 35.5 m -58.48 -34.96 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -68.75 -38.7 80.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 80' ' ' SER . 48.6 tt0 -72.12 -44.13 63.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 73' ' ' SER . 89.6 mt -54.07 -53.29 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.671 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.545 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -75.38 -49.28 19.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.842 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.93 -21.07 42.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 109.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 93.3 p -81.72 -20.2 39.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.256 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 72.3 mt-30 -51.79 -33.77 36.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.38 67.4 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.24 -175.62 33.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 87' ' ' VAL . 32.1 t0 -63.09 122.4 16.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 119' ' ' ILE . 5.7 mp -71.33 -16.18 62.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.77 -47.75 69.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 88' ' ' THR . 9.8 p -70.47 -46.23 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.302 -1.116 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.545 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 11.5 m -51.52 -36.27 44.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.075 -1.016 . . . . 0.0 108.393 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 55.0 m -54.96 -46.96 75.09 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.7 m-20 -70.79 -41.55 71.51 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -62.2 -58.77 6.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.615 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.483 HG22 ' CE2' ' A' ' 22' ' ' PHE . 40.6 mt -64.56 -41.66 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -66.14 -44.54 83.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -0.934 . . . . 0.0 109.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' HG21 ' A' ' 29' ' ' THR . 44.0 t0 -55.08 -50.87 68.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 109.473 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . . . -54.7 -44.15 73.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.887 . . . . 0.0 109.232 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.57 HD23 ' CE2' ' A' ' 22' ' ' PHE . 5.2 mt -69.88 -38.68 76.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.209 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.577 ' O ' ' CE2' ' A' ' 101' ' ' TYR . 52.4 m -62.3 -46.56 88.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.803 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 7.8 m -70.62 -49.18 50.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -53.35 -44.99 68.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.61 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.11 -55.22 8.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.238 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 97' ' ' THR . 1.9 m-85 -71.97 -31.81 66.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.504 -0.747 . . . . 0.0 109.594 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' SER . 41.9 mt-30 -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.272 -0.893 . . . . 0.0 109.843 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 99' ' ' ALA . 69.8 p -105.94 -60.35 1.65 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.334 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.1 m -126.92 -42.7 1.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.877 -1.139 . . . . 0.0 110.645 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.21 46.14 1.03 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 10.3 t -105.69 172.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.306 -1.114 . . . . 0.0 109.053 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.0 m -73.55 121.01 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.348 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.585 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 10.5 p30 -71.41 -28.35 63.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 113' ' ' SER . 22.9 t -56.93 -44.65 82.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -56.92 -54.15 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.973 -1.079 . . . . 0.0 109.975 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.496 ' CE2' HD11 ' A' ' 115' ' ' ILE . 69.1 t80 -75.58 -52.13 11.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.504 HG22 ' CB ' ' A' ' 93' ' ' ALA . 13.8 mt -56.67 -35.74 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 109' ' ' SER . 42.3 t -58.93 -30.25 67.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.94 -41.74 64.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 93.1 mt -72.59 -39.45 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -54.21 -43.16 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.6 p -72.23 -33.92 67.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -68.61 -45.24 72.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 64.9 mt -57.86 -44.88 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.22 -34.57 67.53 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.7 ttm -66.96 -42.33 85.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 109.467 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -64.66 -32.35 73.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' A' ' 85' ' ' LEU . . . -63.17 -33.79 76.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.479 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 127' ' ' ALA . 99.5 mm-40 -70.11 -35.36 74.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.56 80.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.1 p -62.92 -22.8 67.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.411 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.506 ' O ' ' CG2' ' A' ' 130' ' ' VAL . . . -65.94 -23.92 66.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.21 -13.68 60.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -74.62 -46.19 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.536 ' CG2' ' CD1' ' A' ' 131' ' ' TYR . 19.2 m -60.68 -30.44 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.536 ' CD1' ' CG2' ' A' ' 130' ' ' VAL . 49.0 p90 178.39 179.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -74.06 117.66 16.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -100.1 145.04 28.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.576 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.26 154.23 37.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.372 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.91 -172.61 53.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -58.16 -34.24 70.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -1.178 . . . . 0.0 109.466 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.5 mtp -58.27 -34.08 70.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.62 -32.73 39.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -107.04 145.77 31.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -1.125 . . . . 0.0 109.494 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.11 144.68 40.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -62.69 -24.84 67.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.578 HG22 ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -129.85 163.68 45.48 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 49.9 Cg_endo -83.95 -34.23 0.28 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 C-N-CA 122.526 2.15 . . . . 0.0 111.626 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.592 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.4 p90 -90.27 -23.27 21.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.902 -1.124 . . . . 0.0 109.488 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.421 ' OG ' ' OG1' ' A' ' 7' ' ' THR . 71.5 m -60.87 -12.57 11.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 70.5 m -132.01 153.67 50.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.583 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 28.9 mtmt -73.88 -39.19 64.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -65.92 -50.33 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.752 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 17.1 m120 -72.21 -29.06 63.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.35 -55.17 8.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.007 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 1.8 p30 -55.03 -46.8 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.507 -0.746 . . . . 0.0 109.882 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.44 -39.82 94.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 80.7 t80 -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 109.419 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 15' ' ' ALA . 33.2 mm -71.03 -44.07 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -65.42 -45.2 84.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 6.7 t -67.11 -30.72 70.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.57 ' CD2' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -66.31 -46.83 75.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.151 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 30.5 mm -64.89 -56.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.522 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 m -60.85 -31.9 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.98 . . . . 0.0 109.919 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -45.45 24.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.06 -34.1 76.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.362 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.433 ' HB3' ' HE3' ' A' ' 37' ' ' MET . 40.3 m -57.35 -33.52 67.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.322 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -106.06 7.36 31.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.128 -0.983 . . . . 0.0 110.687 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 43.5 m -85.89 -81.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.801 -1.187 . . . . 0.0 110.201 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.14 -101.12 0.24 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -132.46 -61.51 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -1.059 . . . . 0.0 109.212 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 4.8 m-85 43.94 91.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.307 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -59.61 161.28 6.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.61 -40.72 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.84 -36.21 76.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.3 mm-40 -73.2 -32.28 64.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 40' ' ' MET . 61.6 mtt -63.23 -34.18 77.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.0 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.43 -43.11 91.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.855 . . . . 0.0 109.038 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -59.76 -42.58 93.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.502 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 75.1 mtm -66.75 -32.72 74.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.135 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.4 t -70.25 -24.02 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 17.0 tp -87.92 -22.81 24.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 40' ' ' MET . 37.9 mm -116.15 162.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.83 -80.33 1.36 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.0 -38.14 78.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 84.7 m -60.17 -35.33 75.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.354 -0.841 . . . . 0.0 108.805 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.536 ' CD2' HD23 ' A' ' 66' ' ' LEU . 26.9 tp -59.52 -33.94 72.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.247 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.519 ' CE ' ' HB3' ' A' ' 16' ' ' ASP . 60.3 mmm -56.65 -28.14 59.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.31 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 46' ' ' THR . . . -61.37 -38.41 86.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.112 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -22.77 50.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.243 -0.911 . . . . 0.0 108.9 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.533 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 16.6 ttm -54.15 -41.73 68.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -64.07 -26.67 68.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -63.42 -25.46 68.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.859 . . . . 0.0 109.506 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.528 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 81.8 mmm -54.25 -33.99 59.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.14 13.12 79.77 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.33 27.83 7.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' CE ' ' A' ' 54' ' ' MET . 2.5 ptt85 -137.89 112.66 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -1.205 . . . . 0.0 109.673 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.578 ' CG2' ' CD2' ' A' ' 63' ' ' LEU . 36.9 mm -114.36 140.28 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 109.5 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 62' ' ' LYS . 5.4 t -148.19 149.49 32.4 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.554 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.533 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 46.0 Cg_endo -66.86 -34.0 31.78 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.653 2.235 . . . . 0.0 111.887 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -66.26 -50.32 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.975 . . . . 0.0 109.45 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HB2' ' CG2' ' A' ' 59' ' ' THR . 40.7 mttt -81.42 -46.14 15.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.026 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' CD2' ' CG2' ' A' ' 58' ' ' ILE . 5.6 tp -58.96 -48.21 82.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.099 -1.001 . . . . 0.0 109.765 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 91.9 mt-30 -54.68 -35.01 63.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 108.73 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -68.45 -43.56 76.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 27.0 t0 -48.57 -34.88 12.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.787 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.5 -37.31 77.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.91 . . . . 0.0 109.931 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.9 65.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' HG12 ' A' ' 74' ' ' VAL . 70.7 t80 -67.01 -35.92 80.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 111' ' ' PHE . . . -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.786 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 25.2 t -69.69 -41.71 75.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 110.023 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB2' HG22 ' A' ' 43' ' ' ILE . 58.0 p -70.09 -47.12 63.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 110.28 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 75' ' ' ALA . 6.2 m -57.2 -37.05 54.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.802 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' N ' HG21 ' A' ' 74' ' ' VAL . . . -73.92 -38.32 64.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 0.0 109.819 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 72' ' ' SER . 94.4 mt-30 -70.27 -46.23 64.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.828 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.434 HD12 ' HG2' ' A' ' 40' ' ' MET . 97.2 mt -56.2 -44.74 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 0.0 109.885 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.54 ' HB1' ' CE1' ' A' ' 32' ' ' PHE . . . -78.36 -50.14 12.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.896 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . -58.04 -22.13 48.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.8 m -76.2 -20.26 57.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.937 . . . . 0.0 109.457 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.469 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.6 mt-30 -55.86 -33.16 64.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.672 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.73 21.82 73.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.48 -149.41 19.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.04 120.65 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.484 HD13 ' CG2' ' A' ' 119' ' ' ILE . 5.3 tp -67.69 -18.46 64.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.287 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -28.36 70.25 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.86 -50.06 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -1.164 . . . . 0.0 109.569 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.563 ' CG2' ' CD1' ' A' ' 92' ' ' ILE . 59.6 m -52.32 -49.52 64.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 56.9 m -51.68 -48.85 63.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.8 m-20 -70.86 -32.11 69.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -77.98 -59.04 2.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 31.3 mt -61.27 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.879 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.107 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.503 ' CB ' HG23 ' A' ' 29' ' ' THR . 42.9 t0 -55.14 -53.62 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -53.98 -42.98 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.494 ' CD1' HG21 ' A' ' 92' ' ' ILE . 6.7 mt -69.47 -40.52 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.571 HG23 ' CE2' ' A' ' 101' ' ' TYR . 76.0 m -62.77 -51.98 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.0 m -62.97 -36.61 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.78 -42.81 73.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.671 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.593 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.7 m-85 -47.3 -55.98 7.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.571 ' CE2' HG23 ' A' ' 97' ' ' THR . 3.4 m-85 -71.06 -32.17 68.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 98' ' ' SER . 89.5 mm-40 -78.56 -18.36 54.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 99' ' ' ALA . 72.4 p -102.55 -59.97 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 111.149 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.03 -42.36 1.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.779 -1.2 . . . . 0.0 110.807 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.34 47.93 0.9 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 21.5 t -113.25 169.14 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.299 -1.118 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.528 ' CG2' ' CG ' ' A' ' 110' ' ' ARG . 15.8 m -67.43 121.22 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.856 . . . . 0.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 11.6 p30 -71.14 -23.63 62.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 113' ' ' SER . 91.3 p -59.29 -33.34 70.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 110.794 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CG ' ' CG2' ' A' ' 107' ' ' VAL . 78.2 mmt-85 -64.1 -55.42 22.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.742 -1.224 . . . . 0.0 110.33 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 75.2 t80 -76.28 -49.67 16.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.518 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 16.2 mt -56.65 -36.71 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 109' ' ' SER . 78.9 p -63.44 -34.79 78.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.04 -1.037 . . . . 0.0 109.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.31 -39.75 74.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 54.3 mt -72.77 -41.99 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -54.46 -42.38 70.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.4 t -72.01 -33.84 68.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.667 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 41.7 mt -68.36 -42.21 79.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.484 ' CG2' HD13 ' A' ' 85' ' ' LEU . 62.6 mt -58.51 -41.55 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -66.67 -30.85 76.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -66.99 -39.48 87.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.595 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.413 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 72.3 m-85 -60.59 -52.06 66.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.555 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.08 72.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.552 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 95.9 mt-30 -70.44 -30.51 67.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.438 ' HA ' ' ND2' ' A' ' 128' ' ' ASN . . . -62.78 -35.25 79.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.3 m -56.65 -34.93 67.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.442 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.46 ' O ' HG11 ' A' ' 130' ' ' VAL . . . -72.53 -15.37 61.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.509 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 93.3 m-20 -65.8 -27.82 68.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -66.88 -45.52 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.352 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 131' ' ' TYR . 5.9 p -69.41 -30.87 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.569 ' CD1' HG11 ' A' ' 130' ' ' VAL . 39.7 p90 179.1 166.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.96 119.69 16.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.315 -0.865 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 m -60.35 160.1 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.487 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -154.54 154.03 32.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.58 178.36 52.52 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.2 p -124.16 154.33 40.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -1.112 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.7 mtp -125.4 150.28 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.51 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.11 8.35 61.62 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -120.55 139.31 53.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.432 ' CB ' ' OG ' ' A' ' 10' ' ' SER . . . -59.73 -40.98 89.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.895 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 106' ' ' VAL . 76.4 m-20 53.89 35.62 22.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.444 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -165.11 145.35 5.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.9 Cg_endo -70.25 -35.12 11.73 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.414 2.076 . . . . 0.0 111.728 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 7' ' ' THR . 39.5 p90 -85.58 -30.89 22.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 109.058 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.432 ' OG ' ' CB ' ' A' ' 5' ' ' ALA . 87.9 p -58.8 -15.09 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 109.57 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -127.15 143.69 51.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HD3' ' CG1' ' A' ' 58' ' ' ILE . 4.0 ttpp -71.64 -37.14 70.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -68.45 -48.08 65.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 108.994 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 12.3 m120 -71.56 -28.93 64.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.38 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.23 -41.57 99.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.822 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.8 p30 -68.71 -50.12 53.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -56.57 -37.42 70.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.89 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' N ' HG23 ' A' ' 103' ' ' THR . 69.3 t80 -65.78 -49.36 68.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.02 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 70' ' ' PHE . 42.0 mt -63.14 -46.94 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -67.75 -50.3 57.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 108.945 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 69.4 m -56.11 -30.04 61.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 108.593 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 95' ' ' ALA . 46.8 t80 -71.44 -52.2 19.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.538 -0.726 . . . . 0.0 109.624 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 19' ' ' ILE . 56.8 mt -62.62 -55.74 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -53.76 -40.3 66.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.863 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 21' ' ' SER . . . -77.85 -46.0 22.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.088 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' N ' ' HB1' ' A' ' 95' ' ' ALA . . . -60.42 -30.64 69.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.528 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 17.4 m -64.75 -31.4 72.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.968 . . . . 0.0 110.014 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -105.96 7.35 32.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.54 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 19.3 m -88.68 -75.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.95 -1.094 . . . . 0.0 110.054 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.49 -102.2 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -138.13 -55.64 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -1.115 . . . . 0.0 109.353 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 12.9 m-85 43.84 87.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.158 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.8 p -59.76 161.24 6.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.66 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -52.62 -31.95 39.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.143 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.113 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 82.3 mm-40 -76.19 -34.61 59.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 109.233 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 71.5 mtp -63.42 -36.73 84.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -56.89 -42.52 80.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' HB2' ' CG2' ' A' ' 77' ' ' ILE . 23.5 m120 -59.5 -37.0 77.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.865 . . . . 0.0 109.052 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ILE . 90.8 mtp -65.18 -33.47 76.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.356 -0.84 . . . . 0.0 109.25 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -70.1 -24.22 63.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.246 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.9 tp -89.03 -20.61 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 HG22 ' CB ' ' A' ' 73' ' ' SER . 65.0 mt -120.03 160.46 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 109.408 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' N ' HG21 ' A' ' 43' ' ' ILE . . . 76.33 -88.54 0.91 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.17 -37.18 64.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -1.164 . . . . 0.0 109.157 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 89.1 m -58.13 -34.86 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.267 -0.896 . . . . 0.0 108.81 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 73.5 mt -61.71 -35.88 79.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.423 ' HA ' ' HE1' ' A' ' 51' ' ' MET . 38.7 ttm -52.74 -37.56 59.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.8 -31.11 71.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.245 -0.909 . . . . 0.0 109.122 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -68.07 -41.86 81.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.896 . . . . 0.0 109.239 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.423 ' HE1' ' HA ' ' A' ' 48' ' ' MET . 62.9 mtm -60.76 -30.22 69.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 0.0 109.251 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.47 -29.8 69.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.215 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -65.95 -24.02 66.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.244 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.517 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 95.4 mmm -63.96 -33.26 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.862 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.48 10.55 53.45 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.34 10.52 33.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 20.1 ptt180 -125.03 112.3 16.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 109.465 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 HG21 ' CD1' ' A' ' 63' ' ' LEU . 16.6 mm -116.2 136.54 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.568 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 162.81 19.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.87 -33.4 16.24 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.707 2.271 . . . . 0.0 111.675 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -70.61 -44.42 67.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' CD1' HG21 ' A' ' 58' ' ' ILE . 6.5 mt -71.26 -32.26 68.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.75 -49.62 70.4 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 108.591 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.52 -47.48 48.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.056 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.4 -53.32 59.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.9 t0 -47.87 -35.69 10.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.267 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.2 ttm -72.18 -40.89 67.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.59 91.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.57 ' CE1' HG12 ' A' ' 19' ' ' ILE . 75.0 t80 -54.48 -42.78 71.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 115' ' ' ILE . . . -70.26 -38.19 75.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.764 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 84.3 p -69.17 -46.85 66.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.991 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.526 ' CB ' HG22 ' A' ' 43' ' ' ILE . 4.1 m -70.03 -45.33 67.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 22' ' ' PHE . 9.8 p -57.71 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -67.35 -36.54 81.62 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.933 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 80' ' ' SER . 90.8 mt-30 -69.17 -38.3 78.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.834 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.481 ' CG2' ' HB2' ' A' ' 39' ' ' ASN . 56.5 mt -56.68 -55.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.848 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.85 -48.53 14.54 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 109.977 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.87 -22.25 47.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 30.0 t -81.13 -20.92 40.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.892 . . . . 0.0 109.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 75.9 mt-30 -44.68 -40.91 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.81 53.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.96 -158.73 12.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 87' ' ' VAL . 83.7 m-20 -54.33 127.48 27.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 5.5 tp -84.46 -20.87 31.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.71 63.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' A' ' 88' ' ' THR . 5.5 p -68.95 -47.79 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 109.525 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.547 ' N ' ' CG1' ' A' ' 87' ' ' VAL . 22.5 m -51.7 -37.73 52.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.068 . . . . 0.0 108.251 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -55.34 -51.6 66.22 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 62.2 m-20 -70.86 -39.64 72.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.54 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -60.19 -55.35 34.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.51 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.554 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 43.6 mt -72.23 -49.93 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.455 -0.778 . . . . 0.0 109.852 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -57.09 -46.2 82.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 110.654 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.51 ' HB3' ' CG2' ' A' ' 29' ' ' THR . 41.8 t0 -54.9 -53.77 51.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.941 -1.099 . . . . 0.0 109.89 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' A' ' 22' ' ' PHE . . . -57.14 -40.73 77.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.715 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 92' ' ' ILE . 15.0 mt -68.13 -41.45 81.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.508 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.7 m -58.61 -53.82 54.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.886 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 16.3 m -63.8 -45.14 91.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -53.13 -45.98 68.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.12 -0.987 . . . . 0.0 109.427 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.13 -54.27 10.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.973 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.532 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.76 -32.05 67.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.493 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 98' ' ' SER . 73.1 mt-30 -76.12 -18.51 59.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.821 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 99' ' ' ALA . 47.9 p -105.51 -59.73 1.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 111.209 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 7' ' ' THR . 5.5 m -126.55 -42.58 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.83 -1.169 . . . . 0.0 110.784 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.88 47.7 1.0 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 6' ' ' ASN . 48.1 t -112.78 168.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.309 -1.112 . . . . 0.0 108.945 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.48 ' CG2' ' HG3' ' A' ' 110' ' ' ARG . 6.8 m -67.29 121.04 15.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.3 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 16.1 p-10 -70.53 -23.12 62.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.426 -0.797 . . . . 0.0 109.818 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' SER . 34.0 t -54.45 -30.34 52.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.858 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.48 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 93.5 mtt180 -68.15 -55.31 12.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 71.4 t80 -76.4 -50.66 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 110.343 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 17.3 mt -56.17 -45.77 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.836 . . . . 0.0 110.182 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 109' ' ' SER . 63.1 m -55.66 -39.25 70.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.0 109.392 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 80.8 tt0 -62.1 -49.71 74.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 81.2 mt -67.59 -34.7 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -53.7 -45.69 70.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.38 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.1 t -73.42 -33.68 65.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 49.1 mt -67.92 -45.51 74.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.463 ' O ' HD11 ' A' ' 85' ' ' LEU . 87.5 mt -57.8 -34.54 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.997 . . . . 0.0 109.438 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.52 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -68.23 -36.77 85.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.45 -37.63 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -1.177 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.529 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 63.9 m-85 -66.56 -30.48 70.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.69 78.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -70.65 -35.45 72.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.24 69.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.0 p -64.67 -28.65 69.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.436 ' O ' HG11 ' A' ' 130' ' ' VAL . . . -67.71 -16.78 64.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.34 -32.02 73.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 130' ' ' VAL . 46.5 p30 -70.23 -15.07 62.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 2.0 p -58.03 -25.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.603 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER 177.49 -172.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.386 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -46.18 -37.79 7.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.368 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.21 72.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.505 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.62 -165.4 46.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.9 p -60.56 -27.7 67.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -1.143 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.0 mtm -122.23 153.4 38.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -1.165 . . . . 0.0 109.452 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.29 178.07 47.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -65.71 -21.64 66.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -1.184 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 104' ' ' THR . . . -162.48 173.21 14.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.42 -15.77 62.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.58 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 0.6 OUTLIER -154.8 157.39 32.02 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.064 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 49.0 Cg_endo -69.03 -34.6 16.64 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.566 2.178 . . . . 0.0 112.633 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.58 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 48.9 p90 -83.28 1.48 40.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.964 -1.085 . . . . 0.0 110.074 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.552 ' CB ' HG22 ' A' ' 7' ' ' THR . 17.7 m -90.46 -28.26 18.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 108.933 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.5 OUTLIER -104.23 154.58 19.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.352 -0.843 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -73.53 -37.78 65.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -35.21 25.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.643 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 8.3 t-20 -71.29 -29.17 64.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.43 -45.28 60.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 109.952 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 48' ' ' MET . 58.6 t0 -56.22 -54.06 49.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.99 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.8 -44.17 63.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CE1' ' HB1' ' A' ' 99' ' ' ALA . 72.8 t80 -56.97 -38.78 73.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.507 HD12 ' CE1' ' A' ' 70' ' ' PHE . 34.4 mm -69.35 -42.93 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.862 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -64.95 -49.24 71.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.029 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.6 t -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE2' HD21 ' A' ' 96' ' ' LEU . 12.0 t80 -64.28 -52.2 59.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.164 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 37.9 mm -58.92 -55.97 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.179 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -64.76 -28.99 69.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.907 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.16 -43.07 29.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -74.25 -29.19 61.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.298 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 94.9 p -63.86 -27.68 69.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 110.226 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.06 7.26 31.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 0.0 110.5 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.507 ' CG2' ' OD2' ' A' ' 94' ' ' ASP . 19.1 m -92.08 -77.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.17 . . . . 0.0 110.292 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.0 -104.23 0.4 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' PHE . 35.8 t -131.06 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -1.065 . . . . 0.0 109.409 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 78' ' ' ALA . 18.6 m-85 43.53 87.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.27 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 37.8 p -59.64 160.51 7.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 0.0 109.533 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -52.54 -35.78 54.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.226 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.12 -36.11 83.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.277 -0.89 . . . . 0.0 109.34 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.46 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.4 mm-40 -73.29 -31.88 64.3 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.059 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.426 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 63.9 mtt -63.43 -31.37 72.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.436 -0.79 . . . . 0.0 109.097 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -57.25 -44.71 84.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 109.168 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB3' HG12 ' A' ' 77' ' ' ILE . 69.4 m-20 -56.28 -40.97 75.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.196 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.505 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 63.6 mtt -63.02 -32.12 73.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.038 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 m -70.02 -23.5 63.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.166 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.05 -25.67 21.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.695 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.524 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 62.2 mt -124.86 149.41 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' N ' HG21 ' A' ' 43' ' ' ILE . . . 104.37 -81.01 0.32 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -62.29 -29.16 70.23 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.257 -1.143 . . . . 0.0 108.635 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.8 m -64.22 -35.16 79.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.495 -0.753 . . . . 0.0 108.995 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 56.5 mt -54.29 -35.86 63.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.252 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' ' OD2' ' A' ' 16' ' ' ASP . 61.3 ttp -52.68 -40.11 62.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 109.076 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.96 81.34 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -61.96 -23.95 66.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.541 ' O ' ' CG ' ' A' ' 54' ' ' MET . 65.7 mtt -54.89 -30.01 57.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -75.51 -9.75 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 109.721 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -36.59 71.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.91 . . . . 0.0 110.148 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.551 ' SD ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.38 -18.31 16.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.938 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.03 2.68 80.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 114.08 -1.37 24.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' N ' ' SD ' ' A' ' 54' ' ' MET . 9.9 ptt180 -115.67 111.62 20.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.068 -1.254 . . . . 0.0 110.019 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.585 ' CG2' ' CD1' ' A' ' 63' ' ' LEU . 40.9 mm -101.58 143.88 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.564 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 58' ' ' ILE . 4.1 p -140.76 161.79 52.32 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.343 -0.848 . . . . 0.0 109.255 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 46.6 Cg_endo -67.87 -30.19 33.71 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.631 2.22 . . . . 0.0 111.876 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.6 p -72.14 -35.04 68.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.399 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -80.97 -46.77 14.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' CD1' ' CG2' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -68.02 -38.34 82.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 64.7 mt-30 -54.41 -39.25 67.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 108.992 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.37 -36.61 68.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.06 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.28 -48.25 29.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.503 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.6 t0 -48.08 -37.92 16.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.319 -0.863 . . . . 0.0 109.702 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -72.22 -32.87 67.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.661 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.68 89.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.507 ' CE1' HD12 ' A' ' 19' ' ' ILE . 91.3 t80 -53.24 -36.31 60.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.952 . . . . 0.0 109.591 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.26 -35.29 73.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 m -69.12 -35.44 76.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.524 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 51.9 m -69.99 -49.25 53.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.714 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.499 HG21 ' N ' ' A' ' 75' ' ' ALA . 16.0 m -58.96 -35.0 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . . . -67.45 -43.39 81.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.5 mt-30 -65.66 -45.85 81.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' HG2' ' A' ' 40' ' ' MET . 92.3 mt -54.64 -51.42 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 109.692 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.08 -49.06 14.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.714 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.21 -23.96 57.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 88.9 p -80.58 -20.2 43.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 39.7 mt-30 -52.57 -30.67 32.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.97 19.27 70.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 -164.62 24.62 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' HG11 ' A' ' 87' ' ' VAL . 84.2 m-20 -60.0 135.68 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -1.176 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.496 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 6.1 tp -84.43 -18.56 35.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.691 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.02 64.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 88' ' ' THR . 5.7 p -69.0 -46.47 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 109.584 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 78' ' ' ALA . 93.5 m -51.73 -35.75 44.44 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 108.628 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 44.7 m -56.21 -46.51 79.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.7 m-20 -71.01 -40.07 72.01 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -64.46 -59.08 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 92' ' ' ILE . 24.5 mm -63.14 -49.41 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -60.33 -49.98 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.507 ' OD2' ' CG2' ' A' ' 29' ' ' THR . 75.7 m-20 -55.26 -44.13 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -61.1 -43.81 98.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.415 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 22' ' ' PHE . 2.7 mt -69.95 -38.62 76.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 52.7 m -60.72 -51.81 67.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 110.046 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 15.5 t -60.37 -47.65 85.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.979 . . . . 0.0 109.842 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -59.01 -41.73 88.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -46.58 -53.83 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.121 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.528 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -72.06 -31.9 66.56 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.518 -0.739 . . . . 0.0 109.995 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 98' ' ' SER . 42.2 mt-30 -78.33 -18.54 55.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 110.128 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.514 HG21 ' N ' ' A' ' 18' ' ' PHE . 51.8 p -105.74 -58.75 1.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.917 -1.115 . . . . 0.0 111.284 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 91.5 m -125.89 -42.64 1.89 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.676 -1.265 . . . . 0.0 110.737 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.3 48.52 1.05 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.545 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 4.9 t -111.7 172.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.39 -1.065 . . . . 0.0 109.117 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 110' ' ' ARG . 27.4 m -72.98 121.01 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.585 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 11.3 p30 -71.22 -29.22 64.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 113' ' ' SER . 22.7 t -58.15 -30.53 66.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.404 -0.81 . . . . 0.0 110.693 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.454 ' HB2' HG21 ' A' ' 107' ' ' VAL . 40.5 ttm180 -71.05 -54.34 11.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.884 -1.135 . . . . 0.0 109.994 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 56.4 t80 -75.61 -48.44 22.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.807 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 93' ' ' ALA . 13.2 mt -56.28 -37.76 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.853 . . . . 0.0 109.949 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 109' ' ' SER . 4.9 m -55.8 -39.87 71.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.455 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.6 mt-10 -72.23 -38.82 68.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 49.3 mt -70.91 -43.68 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ttp85 -54.18 -38.14 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.84 . . . . 0.0 109.366 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -72.36 -33.85 67.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 66.4 mt -68.7 -38.79 80.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 75' ' ' ALA . 63.5 mt -57.73 -35.87 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -70.35 -34.44 68.8 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 49.0 ttm -64.83 -38.61 91.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -1.157 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD2' ' HB3' ' A' ' 75' ' ' ALA . 75.7 m-85 -64.52 -41.69 96.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.18 71.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.329 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 120' ' ' GLY . 98.9 mm-40 -70.64 -31.21 68.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.398 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.76 81.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.9 p -61.73 -26.66 68.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.455 ' O ' ' CG1' ' A' ' 130' ' ' VAL . . . -69.11 -26.27 64.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 82.5 m-20 -57.79 -17.85 18.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -69.01 -49.64 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.371 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.587 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 6.3 p -61.55 -30.84 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.587 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 49.7 p90 178.49 178.18 0.42 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.16 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.406 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -73.44 121.04 19.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.9 m -94.34 157.35 16.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 109.39 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.84 -157.39 37.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.9 m -118.25 148.31 42.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.147 . . . . 0.0 109.4 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.481 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -122.95 162.16 22.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.31 -174.39 41.96 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 5' ' ' ALA . 90.5 mm-40 -97.4 155.58 16.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 109.647 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.487 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . 43.25 82.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -63.79 -15.03 57.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 9.1 t -136.48 150.61 70.99 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 14' ' ' ASN . 44.3 Cg_endo -65.94 -30.93 47.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.603 2.202 . . . . 0.0 112.904 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.593 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 44.0 p90 -81.34 -1.01 43.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.788 -1.195 . . . . 0.0 110.168 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.524 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 78.3 p -89.65 -14.94 33.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 108.86 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 68.8 m -140.94 149.0 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 109.071 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HD3' ' CG1' ' A' ' 58' ' ' ILE . 31.2 mtmt -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.67 -50.34 72.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.755 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.9 m-20 -72.53 -32.83 66.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.862 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 11' ' ' SER . . . -67.15 -49.02 66.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.989 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.07 -56.07 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.938 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.08 -33.84 71.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.002 . . . . 0.0 109.367 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 99' ' ' ALA . 52.3 t80 -67.64 -37.08 81.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.191 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.534 HG23 ' CA ' ' A' ' 44' ' ' GLY . 17.4 mt -74.04 -38.54 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -68.21 -50.29 55.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 p -59.99 -33.56 72.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CD2' HD23 ' A' ' 96' ' ' LEU . 8.4 t80 -64.1 -35.94 82.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 109.844 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.467 HG12 ' CE ' ' A' ' 40' ' ' MET . 67.6 mt -71.6 -56.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -59.76 -30.79 69.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 109.905 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.09 -43.54 28.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 110.238 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.51 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -70.28 -34.46 72.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 0.0 110.396 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.468 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 92.6 p -61.59 -26.77 68.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.045 -1.034 . . . . 0.0 110.084 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -105.87 7.29 32.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 110.373 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.522 HG23 ' CB ' ' A' ' 94' ' ' ASP . 22.8 m -92.28 -78.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.914 -1.116 . . . . 0.0 110.298 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.37 -104.26 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -130.68 -61.17 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -1.084 . . . . 0.0 109.35 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.599 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 8.9 m-85 44.06 83.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 109.177 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -59.56 167.08 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.693 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -52.51 -43.59 65.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -56.19 -36.71 68.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.104 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 90.7 mm-40 -76.27 -35.4 58.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.468 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 62.4 mtt -63.31 -39.85 95.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.4 -43.12 83.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.039 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.3 m-20 -57.15 -39.93 76.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.134 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.467 ' CE ' HG12 ' A' ' 23' ' ' ILE . 77.0 mmm -58.25 -32.22 68.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 108.921 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 t -70.16 -24.19 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 ' O ' ' OG1' ' A' ' 46' ' ' THR . 63.0 mt -91.85 -16.83 26.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 HG21 ' N ' ' A' ' 44' ' ' GLY . 64.9 mt -119.6 166.45 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.186 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' CA ' HG23 ' A' ' 19' ' ' ILE . . . 68.35 -81.86 0.2 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.45 -40.23 68.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.035 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -60.06 -35.23 74.68 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 108.979 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.471 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 40.8 mt -55.18 -36.72 66.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.207 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' MET . 61.5 ttp -52.93 -43.16 66.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.902 . . . . 0.0 109.247 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.49 77.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.925 . . . . 0.0 108.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . . . -62.51 -23.17 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.529 ' O ' ' CG ' ' A' ' 54' ' ' MET . 15.9 mmt -54.44 -33.41 59.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -74.46 -8.47 56.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.241 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 50' ' ' ALA . 93.4 m-20 -69.89 -32.2 70.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.547 ' CE ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -62.86 -14.45 46.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.92 -11.53 56.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 130.18 0.39 5.51 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' N ' ' SD ' ' A' ' 54' ' ' MET . 21.6 ptt85 -116.85 113.12 22.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -1.197 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.57 ' CG2' ' CD2' ' A' ' 63' ' ' LEU . 44.5 mm -104.55 148.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.256 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -147.3 165.34 19.23 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 50.2 Cg_endo -70.46 -36.94 8.14 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.852 2.368 . . . . 0.0 111.847 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 t -70.39 -34.71 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.751 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -80.96 -48.12 12.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.96 . . . . 0.0 109.797 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.57 ' CD2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 mp -67.37 -41.54 84.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.808 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 69.6 mt-30 -54.22 -38.45 65.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 108.919 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.79 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.276 -0.89 . . . . 0.0 108.687 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 tt -74.1 -43.67 56.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 0.0 109.136 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 37.5 t0 -47.85 -40.23 20.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.835 . . . . 0.0 109.696 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.8 mtp -67.84 -30.67 70.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.86 85.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.8 t80 -54.58 -44.33 72.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.669 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -38.65 74.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.827 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -69.5 -36.68 76.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.975 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.497 ' CB ' HG22 ' A' ' 43' ' ' ILE . 85.7 p -70.12 -45.06 67.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 109.949 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 75' ' ' ALA . 6.9 m -63.8 -35.02 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 74' ' ' VAL . . . -64.81 -39.41 93.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.797 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.33 -45.17 73.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.759 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' HD11 ' A' ' 43' ' ' ILE . 73.8 mt -53.99 -47.65 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' CB ' HG21 ' A' ' 88' ' ' THR . . . -78.49 -49.47 13.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 85' ' ' LEU . . . -57.86 -26.24 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 81' ' ' GLN . 52.3 m -79.19 -20.15 49.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.599 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 79.1 mt-30 -45.2 -39.45 6.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.03 7.47 64.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.67 -159.57 26.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 87' ' ' VAL . 60.1 t0 -64.7 97.91 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -1.184 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 79' ' ' ALA . 20.1 tp -58.89 -15.9 14.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.88 -35.4 84.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.5 p -70.1 -35.71 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -1.154 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 ' CB ' ' A' ' 78' ' ' ALA . 53.3 m -51.4 -33.31 29.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.046 -1.034 . . . . 0.0 108.424 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.7 m -57.03 -47.73 80.2 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 73.9 m-20 -70.97 -38.69 72.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.403 -0.811 . . . . 0.0 109.168 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -66.14 -53.85 32.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.733 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.499 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 62.7 mt -70.45 -45.26 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.727 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.75 -46.75 83.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.522 ' CB ' HG23 ' A' ' 29' ' ' THR . 76.7 m-20 -55.23 -49.65 71.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.67 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 26' ' ' ALA . . . -67.93 -33.72 75.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.966 . . . . 0.0 108.833 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -69.78 -42.56 73.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.547 -0.721 . . . . 0.0 109.587 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.58 HG22 ' CZ ' ' A' ' 101' ' ' TYR . 60.4 m -65.46 -53.82 37.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 83.9 p -57.7 -42.99 84.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . . . -58.3 -46.25 86.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.671 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.601 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -47.26 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 109.472 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.58 ' CZ ' HG22 ' A' ' 97' ' ' THR . 1.8 m-85 -68.57 -32.02 71.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.518 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 98' ' ' SER . 33.4 mt-30 -69.63 -18.79 63.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 110.051 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 18' ' ' PHE . 71.9 p -113.5 -59.37 2.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.123 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -125.93 -42.45 1.89 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.764 -1.21 . . . . 0.0 110.639 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.61 47.74 1.02 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 35.1 t -101.19 158.55 4.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -1.149 . . . . 0.0 108.831 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 110' ' ' ARG . 30.4 m -58.35 121.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.601 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.3 p30 -70.83 -26.7 63.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 113' ' ' SER . 96.4 p -64.15 -31.81 73.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.307 -0.871 . . . . 0.0 110.871 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.469 ' CB ' HG22 ' A' ' 107' ' ' VAL . 52.2 ttt180 -66.14 -55.14 17.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.771 -1.205 . . . . 0.0 110.409 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.51 ' CE2' HD13 ' A' ' 115' ' ' ILE . 55.1 t80 -75.92 -50.82 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 109.966 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 22.1 mt -56.28 -40.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.4 t -56.13 -38.85 71.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.82 -49.69 67.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.158 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.512 HG12 ' CB ' ' A' ' 71' ' ' ALA . 96.8 mt -59.13 -34.67 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.149 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.523 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 9.6 ttt180 -53.7 -47.62 70.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.493 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.23 -33.92 65.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 115' ' ' ILE . 10.4 mt -66.1 -45.79 79.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 88.9 mt -57.69 -39.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.12 -36.05 64.17 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.4 ttm -58.18 -40.93 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.585 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.92 -28.41 69.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.17 77.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -70.66 -34.24 71.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.6 -28.1 69.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.435 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.2 p -66.07 -28.64 68.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 130' ' ' VAL . . . -63.17 -22.96 67.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 89.0 m-20 -67.7 -24.81 65.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.51 -49.79 65.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 131' ' ' TYR . 16.6 m -61.7 -31.87 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.546 ' CD1' HG21 ' A' ' 130' ' ' VAL . 37.6 p90 179.66 171.04 1.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.95 123.51 26.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 97.3 p -54.04 -29.29 43.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.399 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 150.9 27.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.87 -174.15 49.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.8 m -56.81 -35.59 68.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.148 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.8 mmm -61.92 -31.6 71.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -1.128 . . . . 0.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.29 43.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -69.1 -24.12 64.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.11 136.68 15.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -49.17 -31.93 9.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.59 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 2.1 t -131.48 151.63 79.07 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -66.7 -34.36 32.09 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.487 2.124 . . . . 0.0 112.578 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -84.33 15.93 3.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.803 -1.186 . . . . 0.0 110.059 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.535 ' CB ' HG23 ' A' ' 7' ' ' THR . 2.5 m -95.26 -34.85 12.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.064 -1.022 . . . . 0.0 108.461 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 89.3 p -123.08 161.69 23.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.485 ' HG3' HG13 ' A' ' 58' ' ' ILE . 22.5 mtmt -74.04 -41.11 62.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.55 93.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 0.0 109.365 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 8' ' ' PRO . 25.5 t30 -71.6 -40.93 69.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -68.67 -38.64 80.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.877 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' OD2' ' HE3' ' A' ' 48' ' ' MET . 62.6 t0 -54.96 -56.38 20.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.58 66.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.079 -1.013 . . . . 0.0 108.987 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.427 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 59.2 t80 -61.67 -46.98 87.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.126 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.8 mm -63.08 -46.23 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.273 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -50.75 53.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.304 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 33.8 t -54.95 -29.85 57.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 108.903 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 95' ' ' ALA . 30.7 t80 -72.22 -51.74 19.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 109.853 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.81 -55.89 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.048 . . . . 0.0 109.839 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -58.74 -36.55 74.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.892 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.88 -46.5 21.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.935 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -63.25 -33.7 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 110.173 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 45.0 m -64.05 -28.12 69.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.02 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.95 7.33 32.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 110.318 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 17.9 m -92.68 -76.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.865 -1.147 . . . . 0.0 110.187 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.67 -104.4 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.4 -59.09 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -1.09 . . . . 0.0 109.371 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 17.8 m-85 44.41 89.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.345 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 47.6 p -59.81 161.54 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.629 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -52.7 -41.14 63.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.96 -35.55 73.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.228 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.5 mm-40 -72.23 -32.37 66.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.255 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.444 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 60.3 mtt -63.45 -34.29 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' A' ' 41' ' ' SER . 72.1 mm-40 -58.21 -45.54 87.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.041 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB2' HG21 ' A' ' 77' ' ' ILE . 85.0 m-20 -56.66 -43.23 80.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.297 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.494 ' HE3' ' CD1' ' A' ' 32' ' ' PHE . 63.6 mtt -59.47 -32.2 70.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 38' ' ' GLU . 30.5 p -70.25 -23.58 62.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.242 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 12.5 tp -89.71 -25.17 21.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.74 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.531 HG21 ' CB ' ' A' ' 73' ' ' SER . 54.1 mt -125.34 149.75 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 95.25 -79.66 0.85 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.35 -30.59 70.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.265 -1.138 . . . . 0.0 108.454 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.1 m -67.35 -34.79 78.07 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 52.6 mt -52.35 -32.9 40.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.449 -0.782 . . . . 0.0 109.181 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.407 ' HE3' ' OD2' ' A' ' 16' ' ' ASP . 29.4 ttm -57.46 -47.23 82.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.224 -0.922 . . . . 0.0 108.901 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.85 69.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.213 -0.929 . . . . 0.0 108.808 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -67.66 -38.44 83.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.452 ' HE3' HD13 ' A' ' 58' ' ' ILE . 85.3 mmm -54.19 -29.66 46.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.868 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -58.22 -27.27 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.424 -0.798 . . . . 0.0 109.163 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.48 -25.63 64.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.266 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 79.4 mmm -52.04 -22.73 4.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.85 87.24 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 27.95 7.37 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' O ' ' CE ' ' A' ' 54' ' ' MET . 7.3 ptt85 -136.46 111.77 9.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -1.186 . . . . 0.0 109.599 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 25.0 mm -117.68 139.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.655 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 17.0 p -147.75 158.29 42.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 64' ' ' GLN . 43.0 Cg_endo -65.55 -52.83 0.91 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.83 2.353 . . . . 0.0 112.07 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.3 m -52.52 -46.58 66.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.578 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -81.15 -52.71 7.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 59' ' ' THR . 13.5 tp -59.1 -36.5 75.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 109.635 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 65.2 tt0 -55.67 -28.76 57.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.01 . . . . 0.0 109.179 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.57 91.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.33 -41.38 85.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 38.2 t0 -48.63 -47.85 39.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.52 -39.63 94.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.548 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.44 89.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.68 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 19' ' ' ILE . 87.4 t80 -58.62 -41.58 86.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -63.71 -35.58 81.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.655 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -69.36 -38.68 78.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.666 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.531 ' CB ' HG21 ' A' ' 43' ' ' ILE . 20.4 m -70.24 -48.69 55.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 75' ' ' ALA . 8.5 m -57.35 -34.73 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.254 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 122' ' ' PHE . . . -72.94 -41.73 64.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 80' ' ' SER . 96.9 mt-30 -65.24 -50.3 66.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 39' ' ' ASN . 92.9 mt -53.69 -48.98 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.579 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.54 -52.26 8.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.506 -0.746 . . . . 0.0 109.92 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.97 -23.19 52.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.497 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 90.6 p -81.67 -20.47 39.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 42.9 mt-30 -49.44 -35.11 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 109.381 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.47 9.19 79.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.76 -150.33 26.87 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' VAL . 19.2 t70 -71.23 128.1 34.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -1.204 . . . . 0.0 109.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.447 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 6.2 tp -80.26 -18.67 48.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.862 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.25 -40.13 61.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.7 p -67.0 -44.28 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -1.212 . . . . 0.0 109.695 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.564 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 28.1 m -51.66 -35.57 42.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 108.352 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.56 ' CG2' ' NE ' ' A' ' 116' ' ' ARG . 6.8 m -54.03 -48.22 70.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.6 m120 -71.12 -39.88 71.76 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -62.12 -54.11 45.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.511 HG22 ' CD1' ' A' ' 96' ' ' LEU . 77.2 mt -72.24 -48.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.291 -0.881 . . . . 0.0 109.732 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -59.29 -50.77 72.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.91 . . . . 0.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 91.1 m-20 -55.41 -46.71 76.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.095 -1.003 . . . . 0.0 109.612 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -58.5 -43.46 89.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.382 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 92' ' ' ILE . 3.8 mt -69.91 -33.3 71.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.518 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.501 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 92.7 m -67.57 -53.39 28.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.4 p -59.22 -35.55 73.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.689 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -70.01 -43.45 71.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.25 -56.23 7.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.551 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 8.0 m-85 -72.16 -32.02 66.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.454 -0.779 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 86.5 mm-40 -72.55 -18.74 61.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 72.7 p -103.6 -60.3 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.846 -1.158 . . . . 0.0 111.232 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.532 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.12 -42.91 1.68 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.691 -1.256 . . . . 0.0 110.875 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 113.71 45.31 0.72 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 10.1 t -106.0 172.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -1.211 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.7 m -75.01 120.18 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 14.3 p30 -71.83 -23.79 61.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 0.0 109.844 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 113' ' ' SER . 29.8 m -59.17 -43.63 92.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 110.591 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -57.0 -53.58 56.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.0 110.027 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.618 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 70.7 t80 -75.29 -51.72 12.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.943 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.515 HG23 ' CB ' ' A' ' 93' ' ' ALA . 16.2 mt -58.71 -36.25 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.275 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.5 m -55.97 -43.3 77.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 0.0 109.83 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.04 -36.89 69.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 28.4 mt -62.78 -43.52 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.56 ' NE ' ' CG2' ' A' ' 89' ' ' THR . 34.6 mtp180 -54.06 -49.3 69.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.4 p -57.46 -33.17 67.69 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.479 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 6.8 mt -73.51 -40.12 64.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.496 -0.752 . . . . 0.0 110.037 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 115' ' ' ILE . 57.8 mt -61.21 -35.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 109.226 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 124' ' ' GLN . . . -71.38 -34.09 64.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -61.99 -44.5 96.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.565 ' CD2' ' HB2' ' A' ' 75' ' ' ALA . 84.5 m-85 -59.1 -42.76 91.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.76 -30.98 71.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 93.1 mt-30 -68.59 -31.15 70.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.22 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.7 p -62.18 -30.26 70.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 130' ' ' VAL . . . -64.18 -25.31 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 131' ' ' TYR . 41.0 t-20 -59.12 -25.15 63.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.43 -23.4 66.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.618 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 2.1 p -66.87 -26.65 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER 176.58 174.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.92 128.43 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.004 . . . . 0.0 109.614 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -53.57 -31.38 46.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.38 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' ' OXT' ' A' ' 137' ' ' GLY . . . -55.32 -36.25 66.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.39 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.62 -166.41 45.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.1 t -58.23 -34.49 70.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -1.118 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.456 ' OXT' ' O ' ' A' ' 134' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -128.11 161.21 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -1.165 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.34 11.62 55.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.419 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 64.4 tt0 -107.96 158.91 16.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.522 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.471 ' HB2' ' ND2' ' A' ' 14' ' ' ASN . . . -154.53 163.56 40.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -0.845 . . . . 0.0 109.508 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -76.74 -8.67 57.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.616 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -154.52 149.99 21.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.165 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.579 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 43.6 Cg_endo -67.0 -35.29 26.32 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.356 2.037 . . . . 0.0 111.977 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.616 ' CZ2' ' CG2' ' A' ' 7' ' ' THR . 45.8 p90 -90.01 -10.71 43.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.3 m -70.62 -8.9 55.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.6 t -143.4 159.03 43.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 25.2 mtmt -74.73 -40.76 61.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.45 69.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -72.21 -29.11 63.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.43 -53.68 13.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -54.82 -56.1 23.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.659 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -0.982 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.582 ' CE1' ' HB1' ' A' ' 99' ' ' ALA . 80.0 t80 -63.44 -38.06 89.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.447 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 HG23 ' CA ' ' A' ' 44' ' ' GLY . 36.0 mt -75.64 -38.3 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -68.33 -50.54 52.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.5 t -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.665 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 96' ' ' LEU . 25.6 t80 -64.79 -46.81 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 110.32 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 40' ' ' MET . 82.8 mt -65.93 -56.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.161 -0.962 . . . . 0.0 110.251 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.4 p -54.05 -34.14 59.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -47.4 18.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 110.011 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.97 77.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.445 ' HB2' ' HE1' ' A' ' 37' ' ' MET . 93.8 p -61.78 -30.1 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.007 . . . . 0.0 110.208 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -106.07 7.47 31.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.469 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.525 ' CG2' ' OD2' ' A' ' 94' ' ' ASP . 23.4 m -91.16 -78.27 0.4 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.13 . . . . 0.0 110.356 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.74 -103.53 0.38 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' PHE . 17.3 p -131.61 -61.34 0.91 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -1.108 . . . . 0.0 109.45 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CG ' ' HE1' ' A' ' 40' ' ' MET . 11.4 m-85 44.42 87.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.063 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -59.51 162.04 5.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -52.54 -39.66 61.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.22 -35.97 76.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.082 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 90.2 mm-40 -73.96 -32.62 63.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.187 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.445 ' HE1' ' HB2' ' A' ' 27' ' ' SER . 58.1 mtt -63.91 -35.88 82.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.003 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -57.12 -49.14 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.397 -0.815 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -55.86 -37.33 68.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.091 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.54 ' HE1' ' CG ' ' A' ' 32' ' ' PHE . 64.1 mtt -57.36 -32.01 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.7 m -69.79 -24.15 63.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' THR . 62.0 mt -91.09 -19.71 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.051 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 73' ' ' SER . 18.9 mm -116.33 167.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 0.0 109.12 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' CA ' HG23 ' A' ' 19' ' ' ILE . . . 69.19 -92.68 0.32 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -53.25 -39.73 64.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.14 . . . . 0.0 109.288 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m -58.71 -38.15 77.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.174 -0.954 . . . . 0.0 108.966 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' HB1' ' A' ' 50' ' ' ALA . 34.2 tp -55.67 -32.96 63.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 109.133 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 51' ' ' MET . 18.1 ttt -54.85 -31.85 59.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.283 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.86 91.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.673 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' HB1' HD12 ' A' ' 47' ' ' LEU . . . -61.78 -26.44 68.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.389 -0.819 . . . . 0.0 108.919 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.523 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 28.5 ttm -54.48 -32.94 58.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.423 -0.798 . . . . 0.0 109.225 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -74.38 -26.85 60.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.404 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -60.5 -21.46 62.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.535 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 68.6 mmm -64.28 -43.91 93.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.47 66.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 16.57 13.79 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' O ' ' CE ' ' A' ' 54' ' ' MET . 28.3 ptt85 -126.78 112.13 15.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -1.18 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 63' ' ' LEU . 28.3 mm -116.3 149.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -148.72 165.97 16.61 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 64' ' ' GLN . 48.8 Cg_endo -69.64 -36.17 11.61 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.65 2.233 . . . . 0.0 111.525 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -68.04 -34.89 77.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -78.1 -50.82 11.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.405 -0.809 . . . . 0.0 109.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.538 HD23 ' CG2' ' A' ' 58' ' ' ILE . 7.0 mp -67.2 -46.27 74.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 33.3 tp60 -53.54 -35.74 61.06 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.11 68.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 67' ' ' ASP . 10.9 mt -74.12 -51.25 16.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 24.3 t70 -46.9 -39.98 13.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 108.561 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 56.1 mtt -72.17 -45.44 60.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.847 . . . . 0.0 108.944 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.42 91.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 108.94 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.438 ' CD1' ' HA2' ' A' ' 44' ' ' GLY . 79.8 t80 -52.19 -43.4 64.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.133 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . . . -70.79 -39.07 73.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 109.596 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -69.29 -36.71 77.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.541 ' CB ' HG22 ' A' ' 43' ' ' ILE . 5.9 m -69.98 -44.26 69.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 75' ' ' ALA . 8.7 p -67.44 -36.77 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' N ' HG12 ' A' ' 74' ' ' VAL . . . -61.55 -39.16 90.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.49 -39.66 77.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.647 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 73' ' ' SER . 72.2 mt -58.1 -49.58 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -77.38 -48.62 16.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.621 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.89 60.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.1 t -78.17 -20.35 52.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.571 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.5 mt-30 -49.98 -27.62 5.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.527 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.52 77.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.65 -148.18 23.77 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' VAL . 50.7 t0 -67.11 124.21 22.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.31 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 4.3 tp -81.18 -21.77 39.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.255 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.1 -34.56 64.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 88' ' ' THR . 3.6 p -67.11 -42.89 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.105 -1.232 . . . . 0.0 109.72 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CB ' ' A' ' 78' ' ' ALA . 51.9 m -51.54 -34.65 37.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.987 -1.071 . . . . 0.0 108.321 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 m -56.73 -49.8 74.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.1 m120 -70.61 -38.24 73.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 109.039 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 29' ' ' THR . . . -64.77 -53.4 47.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.612 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.513 HD11 ' CD1' ' A' ' 119' ' ' ILE . 66.6 mt -72.35 -45.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.866 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.83 -44.94 91.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.525 ' OD2' ' CG2' ' A' ' 29' ' ' THR . 48.7 m-20 -55.2 -48.51 73.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.953 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 22' ' ' PHE . . . -71.4 -33.67 69.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD12 ' CE2' ' A' ' 22' ' ' PHE . 7.2 tp -70.03 -33.68 72.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.912 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 98.7 m -69.3 -53.82 17.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 14.3 m -62.51 -33.61 75.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 109.878 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.582 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -63.91 -33.68 76.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.0 m-85 -61.39 -56.25 22.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.3 m-85 -71.97 -32.1 66.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 109.683 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 98' ' ' SER . 85.3 mm-40 -71.19 -17.99 62.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.848 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 72.0 p -111.06 -59.65 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 111.254 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.7 p -126.33 -43.02 1.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.797 -1.189 . . . . 0.0 110.968 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.71 45.93 1.01 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.08 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 18.4 t -101.89 171.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.159 -1.201 . . . . 0.0 108.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.514 HG23 ' CB ' ' A' ' 110' ' ' ARG . 29.0 m -71.48 120.55 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 0.0 109.799 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 24.2 p-10 -72.21 -33.32 67.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 109.97 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 113' ' ' SER . 29.8 m -57.82 -33.74 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.514 ' CB ' HG23 ' A' ' 107' ' ' VAL . 67.1 ttt-85 -67.91 -54.47 18.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.832 -1.168 . . . . 0.0 110.095 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.46 -47.04 28.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.64 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.538 HG12 ' CD2' ' A' ' 96' ' ' LEU . 9.5 mt -56.01 -46.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 109' ' ' SER . 60.3 m -55.57 -41.45 73.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.004 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HG2' HD12 ' A' ' 118' ' ' LEU . 83.2 tt0 -58.65 -45.26 89.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.224 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 77.9 mt -66.99 -34.36 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.82 . . . . 0.0 109.162 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.512 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 19.7 ttt-85 -53.54 -49.01 68.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.0 p -70.16 -34.02 72.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD12 ' HG2' ' A' ' 114' ' ' GLU . 13.9 mt -66.62 -44.97 80.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.668 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 92' ' ' ILE . 89.4 mt -57.66 -42.95 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -71.28 -36.9 63.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.2 ttp -56.81 -40.38 75.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.456 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 60.5 m-85 -62.0 -50.66 71.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.535 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.15 -32.73 73.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.462 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -70.61 -32.9 70.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.585 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.51 75.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 m -58.74 -33.02 69.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' A' ' 130' ' ' VAL . . . -73.15 -15.62 61.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 56.0 t-20 -66.22 -34.43 78.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.21 -51.37 61.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 131' ' ' TYR . 5.2 p -63.56 -33.95 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.352 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.571 ' CD2' HG12 ' A' ' 130' ' ' VAL . 40.9 p90 -176.94 168.74 2.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.338 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.82 115.61 14.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.7 t -63.94 153.4 37.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -109.7 147.74 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.79 149.67 51.46 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.2 m -121.7 148.82 44.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.5 mtt -121.39 154.3 36.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -1.139 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.16 3.61 85.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.77 -29.35 70.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.98 148.13 20.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.583 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 42.1 p-10 -120.18 24.55 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.577 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -146.95 150.14 37.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.607 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.8 Cg_endo -71.78 -35.07 8.05 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 111.543 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.607 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.6 p90 -88.02 -30.71 19.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.011 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 36.0 t -55.63 -25.37 38.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.473 -0.767 . . . . 0.0 109.771 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 1.3 t -113.98 136.64 52.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.971 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 58' ' ' ILE . 2.5 ttpp -65.27 -37.79 88.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -70.29 -43.9 69.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 11' ' ' SER . 12.6 m120 -71.6 -29.11 64.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.377 -0.827 . . . . 0.0 109.416 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -64.81 -44.15 90.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 110.187 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.7 p30 -64.06 -50.85 66.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.518 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.06 -32.86 73.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 108.903 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.562 ' CG ' ' HB2' ' A' ' 8' ' ' PRO . 56.0 t80 -70.45 -43.45 69.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.546 HG12 ' CE1' ' A' ' 70' ' ' PHE . 27.6 mt -73.18 -44.63 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.525 -0.734 . . . . 0.0 109.041 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -68.08 -50.63 53.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.78 . . . . 0.0 109.182 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 74.1 m -57.46 -30.15 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.606 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE2' HD22 ' A' ' 96' ' ' LEU . 8.6 t80 -72.01 -50.03 32.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.512 -0.743 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 50.8 mm -64.94 -55.73 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.141 -0.974 . . . . 0.0 109.652 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -53.86 -39.71 65.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 0.0 109.909 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -77.72 -46.73 20.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 109.815 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.9 -35.67 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.703 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.52 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 85.8 p -64.05 -28.41 69.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.84 6.92 32.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 20.5 m -91.75 -76.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.047 -1.033 . . . . 0.0 110.033 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.49 -104.68 0.45 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -131.8 -60.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -1.126 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' CB ' ' A' ' 78' ' ' ALA . 15.4 m-85 43.58 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.343 -0.848 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.5 t -59.66 162.81 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -52.63 -39.49 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.373 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.51 -35.96 81.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 91.6 mm-40 -73.65 -32.29 63.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.52 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.5 mtt -63.6 -36.51 84.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.103 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.54 -47.41 84.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HB2' HG21 ' A' ' 77' ' ' ILE . 86.3 m-20 -56.14 -45.26 79.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.526 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 56.2 mtm -57.15 -33.66 67.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 108.829 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.3 p -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 58.8 mt -87.19 -21.26 26.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 73' ' ' SER . 94.9 mt -121.87 143.77 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.244 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 98.78 -88.21 0.84 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.79 -32.45 70.63 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.165 -1.197 . . . . 0.0 108.282 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 91.8 m -59.15 -35.04 72.82 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.64 -40.21 92.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 51' ' ' MET . 89.5 mmm -52.74 -35.01 55.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.95 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.159 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.35 -36.12 78.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.223 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 48' ' ' MET . 54.6 mtt -60.06 -29.85 68.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.208 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.1 -31.54 67.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.952 . . . . 0.0 109.332 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -63.71 -27.86 69.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.228 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.531 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 92.4 mmm -55.95 -33.93 65.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.13 56.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.16 11.29 24.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.522 ' O ' ' CE ' ' A' ' 54' ' ' MET . 7.4 ptm180 -125.91 113.94 17.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.523 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.541 ' CG2' HD21 ' A' ' 63' ' ' LEU . 16.8 mm -117.04 147.46 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 160.38 41.06 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.57 -27.09 23.03 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.703 2.269 . . . . 0.0 111.773 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 m -74.55 -48.04 29.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.465 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 66' ' ' LEU . 38.1 tttm -59.21 -51.55 69.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.345 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 58' ' ' ILE . 2.0 mp -61.48 -41.23 96.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.433 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 62.9 tt0 -54.21 -35.69 62.68 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.077 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.69 15.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.683 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' CG ' ' HA ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.6 -46.68 36.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.274 -0.891 . . . . 0.0 110.987 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 9' ' ' TRP . 3.6 p-10 -47.78 -29.87 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.258 . . . . 0.0 109.805 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 68.7 mtp -72.66 -36.26 67.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.29 75.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.546 ' CE1' HG12 ' A' ' 19' ' ' ILE . 66.2 t80 -52.47 -37.13 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . . . -70.46 -47.93 58.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -69.25 -30.77 68.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.039 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.521 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 8.3 m -69.8 -45.84 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 22' ' ' PHE . 9.6 p -68.93 -36.66 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' N ' HG12 ' A' ' 74' ' ' VAL . . . -59.69 -40.85 89.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 109.727 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -70.72 -35.02 72.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 HG21 ' HB2' ' A' ' 39' ' ' ASN . 94.2 mt -58.57 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB3' ' CG2' ' A' ' 88' ' ' THR . . . -75.21 -41.64 57.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.672 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -58.24 -25.57 61.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -76.77 -20.36 56.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.465 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.1 mt-30 -50.01 -37.84 34.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 109.46 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.77 81.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.51 -149.18 24.52 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG11 ' A' ' 87' ' ' VAL . 49.4 t0 -66.79 119.72 12.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 119' ' ' ILE . 7.0 tp -74.69 -24.16 58.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.9 64.39 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 84' ' ' ASP . 2.6 p -69.1 -38.17 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.235 . . . . 0.0 109.844 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 78' ' ' ALA . 54.1 m -54.7 -33.59 61.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.908 -1.12 . . . . 0.0 108.367 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.1 m -57.81 -49.25 77.29 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 68.2 m-20 -70.69 -41.06 72.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.494 -0.754 . . . . 0.0 109.154 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -64.54 -52.2 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 32.2 mt -72.81 -38.3 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -72.29 -43.22 64.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 29' ' ' THR . 40.1 t0 -54.97 -45.74 75.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.927 -1.108 . . . . 0.0 109.795 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 22' ' ' PHE . . . -71.81 -35.2 69.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.109 -0.994 . . . . 0.0 109.01 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.611 ' CD1' ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -69.86 -40.4 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.565 HG22 ' CE2' ' A' ' 101' ' ' TYR . 52.4 m -67.66 -53.87 24.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.1 m -59.81 -44.08 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -55.65 -46.79 77.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.405 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 96' ' ' LEU . 1.5 m-85 -46.94 -56.6 6.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.73 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' CE2' HG22 ' A' ' 97' ' ' THR . 1.3 m-85 -71.99 -32.41 67.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.629 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 40.1 mt-30 -64.86 -18.54 65.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 43.0 p -115.16 -59.35 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 111.333 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.466 ' OG1' HG23 ' A' ' 106' ' ' VAL . 15.9 p -126.16 -43.17 1.81 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.648 -1.283 . . . . 0.0 110.969 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.16 45.37 1.01 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 19.8 t -98.06 163.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.073 -1.251 . . . . 0.0 108.689 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.531 HG21 ' CB ' ' A' ' 110' ' ' ARG . 33.1 m -64.03 121.59 13.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.9 p30 -71.0 -33.69 70.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.057 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 113' ' ' SER . 87.2 p -57.23 -43.72 83.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.967 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.531 ' CB ' HG21 ' A' ' 107' ' ' VAL . 31.8 ttt180 -57.22 -54.58 45.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 0.0 110.156 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 49.0 t80 -75.56 -46.46 31.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 14.8 mt -63.0 -35.65 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 110.15 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.1 t -58.12 -32.84 68.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 96.9 mt-10 -72.34 -40.34 67.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 111' ' ' PHE . 80.6 mt -69.34 -40.7 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -54.34 -44.76 72.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.0 p -72.98 -33.95 66.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 109.557 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 26.7 mt -67.91 -42.43 81.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.516 ' CG2' HD12 ' A' ' 85' ' ' LEU . 65.8 mt -58.01 -39.29 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.388 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.508 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -63.56 -34.58 90.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 13.1 tpp -65.91 -38.32 88.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.68 -39.43 84.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 127' ' ' ALA . . . -63.16 -31.45 72.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 94.8 mt-30 -64.51 -36.55 84.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.325 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.73 -46.91 77.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.4 p -73.81 -24.3 59.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.381 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 123' ' ' ALA . . . -69.71 -17.67 63.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 109.491 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 26.3 m120 -75.92 -29.29 58.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.88 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -66.59 -44.62 81.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.557 HG12 ' CD1' ' A' ' 131' ' ' TYR . 4.0 p -66.75 -29.56 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.179 -0.951 . . . . 0.0 109.351 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CD1' HG12 ' A' ' 130' ' ' VAL . 42.6 p90 178.46 175.65 0.55 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.08 120.07 24.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.334 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -44.55 162.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.68 -33.87 66.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.16 -179.75 51.76 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.4 t -116.99 143.81 45.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -1.117 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.49 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.0 ttm -109.21 140.69 42.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -1.089 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.85 -0.03 62.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -114.97 148.07 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -1.174 . . . . 0.0 109.468 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.38 136.48 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 52.0 m-20 -54.04 -26.71 28.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.577 ' OG1' ' CE3' ' A' ' 9' ' ' TRP . 2.8 t -141.27 151.31 61.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.61 -35.74 21.54 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.598 2.199 . . . . 0.0 112.744 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.577 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -82.13 9.08 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.737 -1.227 . . . . 0.0 109.525 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 7' ' ' THR . 0.4 OUTLIER -95.25 -29.62 14.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 108.577 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.6 p -120.28 155.01 34.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.018 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 58' ' ' ILE . 7.2 ttpt -71.53 -41.27 69.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.45 70.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -71.7 -28.9 64.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.339 -0.85 . . . . 0.0 109.941 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.04 -48.77 62.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.953 -1.092 . . . . 0.0 110.323 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 88.7 m-20 -58.57 -56.13 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.84 -42.38 65.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.62 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' CB ' ' A' ' 8' ' ' PRO . 87.6 t80 -58.19 -37.05 74.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 70' ' ' PHE . 20.2 mm -70.92 -48.9 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 109.513 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -61.45 -49.75 75.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 109.753 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -58.36 -34.33 70.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CE2' HD21 ' A' ' 96' ' ' LEU . 40.5 t80 -69.68 -35.94 75.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' CG2' ' HE1' ' A' ' 40' ' ' MET . 77.4 mt -70.43 -56.14 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.92 -34.52 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.05 -44.66 25.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 110.392 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.57 -33.08 68.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.01 . . . . 0.0 110.629 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.498 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 57.4 m -60.94 -28.27 68.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.42 7.49 31.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 0.0 110.847 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 91' ' ' ALA . 18.3 m -93.48 -75.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -72.56 -104.08 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.456 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.8 t -148.42 13.29 0.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.495 -1.003 . . . . 0.0 109.904 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' O ' ' CE ' ' A' ' 37' ' ' MET . 44.7 m-85 -38.17 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.644 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' SER . 59.7 p -66.1 168.44 8.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.792 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 33.7 tt0 -52.74 -44.68 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -57.43 -41.72 81.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.287 -0.883 . . . . 0.0 109.332 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.442 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 77.9 mm-40 -74.61 -32.25 62.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.156 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.507 ' CE ' ' O ' ' A' ' 32' ' ' PHE . 66.3 mtt -66.2 -33.43 75.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.256 -0.902 . . . . 0.0 108.966 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 95.7 mt-10 -57.26 -40.39 77.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 109.272 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HB3' HG12 ' A' ' 77' ' ' ILE . 77.0 m-20 -56.1 -38.6 70.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.071 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.47 ' HE1' ' CG2' ' A' ' 23' ' ' ILE . 64.4 mtm -62.49 -31.92 72.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.847 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 p -68.6 -23.71 64.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.405 -0.809 . . . . 0.0 109.062 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.5 tp -92.66 -23.39 18.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 51.6 mt -132.35 149.27 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 97.15 -74.3 0.68 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' O ' ' HE1' ' A' ' 48' ' ' MET . 86.7 m-20 -72.03 -34.93 69.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -1.104 . . . . 0.0 108.203 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -68.14 -34.84 77.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 66' ' ' LEU . 23.9 tp -52.47 -39.24 60.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.417 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' A' ' 16' ' ' ASP . 70.0 mtm -52.4 -33.75 45.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 108.886 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.27 72.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.311 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.16 80.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.321 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.46 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 51.0 mtt -56.42 -32.02 64.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.255 -0.903 . . . . 0.0 109.271 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -54.23 -33.34 58.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.22 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -62.53 -29.55 70.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.081 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.539 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 87.9 mmm -58.4 -26.93 63.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.817 . . . . 0.0 109.321 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 9.05 70.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.98 17.61 20.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' O ' ' CE ' ' A' ' 54' ' ' MET . 31.2 ptt85 -127.63 112.27 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.539 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 15.2 mm -117.52 145.14 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.546 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 3.3 t -134.71 149.01 69.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 45.0 Cg_endo -66.28 -26.95 48.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.691 2.261 . . . . 0.0 111.834 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -66.72 -54.52 22.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -81.05 -47.71 13.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.858 . . . . 0.0 109.612 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.532 ' CD2' HG23 ' A' ' 58' ' ' ILE . 14.5 tp -48.84 -39.87 27.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.253 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.01 -30.63 66.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.5 70.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.292 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.0 tp -73.68 -39.36 64.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.299 -0.875 . . . . 0.0 109.256 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' TRP . 31.5 t0 -49.46 -46.72 48.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.3 mtm -54.24 -39.14 66.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.435 -0.791 . . . . 0.0 109.798 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.84 72.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD2' HD13 ' A' ' 19' ' ' ILE . 47.4 t80 -60.65 -35.47 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 115' ' ' ILE . . . -69.3 -30.5 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 45.8 m -69.3 -46.68 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 109.921 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.563 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 11.2 t -68.06 -48.49 65.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 92' ' ' ILE . 8.3 p -56.83 -38.53 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.7 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -70.3 -34.63 72.96 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.242 -0.911 . . . . 0.0 109.46 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 72' ' ' SER . 97.0 mt-30 -76.26 -47.46 23.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 39' ' ' ASN . 68.3 mt -53.36 -44.62 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.48 -50.69 11.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.82 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.64 -22.33 44.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.202 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.5 p -81.4 -21.73 38.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.59 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.1 mt-30 -50.37 -32.76 18.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 109.557 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.27 11.02 85.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.29 -151.52 27.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.463 ' O ' HG11 ' A' ' 87' ' ' VAL . 22.6 t70 -69.36 114.22 7.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -1.166 . . . . 0.0 109.256 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.511 ' CD1' HG23 ' A' ' 119' ' ' ILE . 4.7 tp -62.46 -25.21 67.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.51 71.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 84' ' ' ASP . 2.7 p -68.03 -36.88 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.104 -1.233 . . . . 0.0 109.774 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 91.1 m -54.6 -32.24 58.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.982 -1.074 . . . . 0.0 108.513 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 24.9 m -60.2 -51.22 70.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.46 ' O ' HG22 ' A' ' 29' ' ' THR . 69.6 m-20 -70.59 -35.81 73.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.487 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -68.31 -55.69 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.582 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.49 ' CD1' HG22 ' A' ' 88' ' ' THR . 39.6 mt -69.56 -50.49 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -56.93 -40.97 77.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' HB2' HG22 ' A' ' 29' ' ' THR . 7.1 m-20 -57.99 -54.28 48.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -68.08 -32.66 73.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 108.851 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -70.31 -41.05 73.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.732 . . . . 0.0 109.774 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 21.5 m -68.4 -53.99 20.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.015 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 50.9 m -59.81 -43.26 94.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.208 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.491 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -56.09 -46.37 79.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.576 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.5 m-85 -46.86 -54.48 9.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -0.87 . . . . 0.0 109.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.538 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.31 -31.42 67.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.544 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 60.9 mt-30 -70.77 -18.02 62.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 59.1 p -110.82 -59.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 111.08 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.476 HG22 ' HD3' ' A' ' 8' ' ' PRO . 18.0 p -126.82 -43.31 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.69 -1.256 . . . . 0.0 110.781 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.89 43.54 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.683 -1.246 . . . . 0.0 109.991 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 13.7 t -99.21 169.59 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.104 -1.233 . . . . 0.0 108.62 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 110' ' ' ARG . 29.4 m -69.57 121.66 19.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.376 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.572 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 13.0 p30 -70.52 -24.08 62.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.643 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' SER . 39.9 m -60.91 -29.99 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.549 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.401 ' HB2' HG21 ' A' ' 107' ' ' VAL . 56.3 ttt85 -69.16 -55.0 11.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.123 . . . . 0.0 110.418 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -75.93 -50.6 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 53.1 mt -56.39 -36.51 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.177 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' SER . 3.9 m -56.69 -39.39 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.944 -1.097 . . . . 0.0 109.044 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.26 -42.13 65.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.282 -0.886 . . . . 0.0 109.233 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.582 ' CD1' ' CB ' ' A' ' 71' ' ' ALA . 32.8 mm -62.72 -49.37 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.363 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.528 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 6.8 ttt180 -54.12 -42.68 69.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.012 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.0 m -73.01 -33.42 65.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.0 mt -68.5 -43.39 76.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.803 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.511 HG23 ' CD1' ' A' ' 85' ' ' LEU . 23.3 mt -57.89 -43.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 124' ' ' GLN . . . -60.58 -34.74 87.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.3 ttm -62.74 -43.5 98.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.143 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 84.9 m-85 -59.63 -47.65 84.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.446 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . -56.77 -30.67 63.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 96.8 mt-30 -70.62 -32.1 69.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.92 -35.72 73.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.13 -30.5 62.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.401 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.457 ' O ' HG13 ' A' ' 130' ' ' VAL . . . -66.08 -19.75 65.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 23.8 m120 -63.1 -23.05 67.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.61 -47.54 46.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.331 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.542 HG13 ' CD1' ' A' ' 131' ' ' TYR . 6.3 p -66.86 -29.24 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.542 ' CD1' HG13 ' A' ' 130' ' ' VAL . 42.1 p90 178.24 173.98 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.43 116.43 19.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.5 p -70.11 165.55 21.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.75 146.84 47.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.428 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.79 35.88 27.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.1 m -57.01 -35.04 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 109.459 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.963 -1.465 . . . . 0.0 109.481 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.1 mmm -59.11 -35.28 73.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.13 . . . . 0.0 109.403 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.52 -157.22 37.97 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -95.79 155.07 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.188 . . . . 0.0 109.486 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 104' ' ' THR . . . -84.46 123.27 30.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -68.96 -6.54 28.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.581 HG21 ' CZ2' ' A' ' 9' ' ' TRP . 0.1 OUTLIER -157.46 155.54 27.54 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.67 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ALA . 47.2 Cg_endo -69.23 -35.09 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.265 . . . . 0.0 111.386 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.581 ' CZ2' HG21 ' A' ' 7' ' ' THR . 35.8 p90 -91.35 -23.65 20.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 108.998 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' HD13 ' A' ' 63' ' ' LEU . 12.0 m -63.74 -14.47 52.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 108.651 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 73.3 m -140.52 122.58 15.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 109.076 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 13' ' ' ALA . 45.8 pttt -52.53 -43.92 65.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' N ' ' HG3' ' A' ' 12' ' ' LYS . . . -63.19 -36.58 84.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 9.7 t-20 -72.8 -35.22 67.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -66.66 -27.9 68.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.477 ' HA ' ' CE ' ' A' ' 48' ' ' MET . 92.3 m-20 -54.73 -56.71 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.69 66.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 50.8 t80 -71.18 -38.86 72.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.578 HD13 ' CD1' ' A' ' 70' ' ' PHE . 13.9 mm -75.45 -47.74 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.896 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.5 -49.96 73.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 3.7 t -62.68 -30.39 71.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.181 -0.949 . . . . 0.0 110.103 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 29.3 t80 -71.43 -51.92 21.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.481 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 19' ' ' ILE . 41.8 mm -61.24 -56.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.041 -1.037 . . . . 0.0 110.453 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -57.31 -38.21 73.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.943 . . . . 0.0 110.135 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.468 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.07 -45.94 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.962 . . . . 0.0 110.281 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -64.51 -37.56 87.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.458 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.529 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 65.7 p -59.17 -28.94 67.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -0.983 . . . . 0.0 110.5 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.18 7.36 31.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.999 -1.063 . . . . 0.0 110.745 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.515 HG23 ' CB ' ' A' ' 94' ' ' ASP . 18.2 m -94.64 -74.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.776 -1.202 . . . . 0.0 110.883 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -73.53 -104.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.406 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 33' ' ' SER . 42.5 p -147.74 13.36 1.03 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -1.049 . . . . 0.0 109.742 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' SER . 46.0 m-85 -38.34 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' SER . 31.0 m -60.15 162.33 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -53.09 -44.24 67.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.39 -0.819 . . . . 0.0 109.359 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -56.25 -41.39 75.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.448 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 84.3 mm-40 -72.34 -31.11 65.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.042 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 65.2 mtt -63.05 -32.39 73.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' A' ' 41' ' ' SER . 83.8 tt0 -57.32 -50.12 73.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 109.018 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 43' ' ' ILE . 87.2 mtp -58.51 -37.63 76.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.78 . . . . 0.0 109.157 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 38' ' ' GLU . 79.9 p -70.39 -24.12 62.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 tp -83.42 -20.69 33.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.858 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.544 ' CG2' ' CB ' ' A' ' 73' ' ' SER . 20.2 mm -120.48 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.345 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 100.8 -79.71 0.44 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 46' ' ' THR . 7.1 p30 -65.74 -35.93 82.12 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.272 -1.134 . . . . 0.0 108.195 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 60.5 m -62.14 -35.05 77.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 35.0 tp -61.22 -34.45 75.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.513 -0.742 . . . . 0.0 109.214 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.516 ' HA ' ' CE ' ' A' ' 51' ' ' MET . 54.8 mtt -52.73 -37.96 60.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.166 -0.959 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.65 71.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.54 -49.78 51.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.385 -0.822 . . . . 0.0 108.952 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.516 ' CE ' ' HA ' ' A' ' 48' ' ' MET . 53.5 mtm -60.76 -29.62 69.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.398 -0.814 . . . . 0.0 109.209 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.07 -27.14 68.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -63.16 -32.14 73.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.298 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 98.5 mmm -50.56 -48.24 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.398 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.39 15.79 20.16 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.37 3.74 44.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' CE ' ' A' ' 54' ' ' MET . 31.6 ptt85 -119.54 112.44 19.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 0.0 109.509 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CG2' HD11 ' A' ' 63' ' ' LEU . 13.2 mm -116.21 160.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.518 ' OG1' ' CB ' ' A' ' 62' ' ' LYS . 68.5 p -119.34 157.06 52.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.42 -39.55 5.14 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.777 2.318 . . . . 0.0 111.731 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 76.4 p -74.31 -34.56 63.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 22.6 tttp -67.8 -49.9 59.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.371 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' CD2' ' O ' ' A' ' 9' ' ' TRP . 10.0 mt -62.47 -31.06 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -53.55 -45.28 69.81 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' ALA . . . -72.18 -29.23 63.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 47' ' ' LEU . 7.5 tt -70.49 -53.63 15.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.47 -0.769 . . . . 0.0 109.128 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.577 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 22.0 t0 -48.16 -46.89 35.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.2 mtp -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 65' ' ' ALA . . . -55.4 -48.99 73.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.0 109.5 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD1' HD13 ' A' ' 19' ' ' ILE . 57.4 t80 -58.22 -38.32 76.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -68.22 -36.16 79.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.544 ' CB ' ' CG2' ' A' ' 43' ' ' ILE . 19.7 m -70.24 -43.45 70.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.709 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 75' ' ' ALA . 6.0 m -68.37 -35.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 119' ' ' ILE . . . -65.16 -39.92 93.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.77 -45.18 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' A' ' 40' ' ' MET . 91.8 mt -56.67 -46.16 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -67.55 -51.87 45.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.605 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.51 58.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -76.3 -20.43 57.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.448 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 46.5 mt-30 -51.55 -31.87 25.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 10.27 82.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.45 -160.91 26.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.447 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.7 t70 -69.58 101.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.518 ' CD1' ' CG2' ' A' ' 119' ' ' ILE . 25.9 tp -52.92 -20.36 3.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.627 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.07 -33.97 87.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 84' ' ' ASP . 8.0 p -69.2 -35.81 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.196 . . . . 0.0 109.703 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.561 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 64.1 m -51.65 -32.15 28.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.034 -1.041 . . . . 0.0 108.623 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 37.5 m -58.33 -45.5 87.99 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 20.5 m120 -70.77 -38.29 73.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.073 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 29' ' ' THR . . . -69.09 -58.82 3.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 109.557 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.535 ' CG1' HG22 ' A' ' 88' ' ' THR . 35.9 mm -61.25 -45.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.86 -49.06 69.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' CB ' HG23 ' A' ' 29' ' ' THR . 86.0 m-20 -55.29 -46.02 76.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.184 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 26' ' ' ALA . . . -68.62 -38.72 80.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -70.0 -42.96 72.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.516 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 88.7 m -60.57 -50.93 71.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.722 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 102' ' ' GLN . 31.2 t -60.41 -33.98 73.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.967 . . . . 0.0 109.525 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.4 -44.34 68.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.425 -0.797 . . . . 0.0 109.996 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.0 OUTLIER -47.89 -56.34 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.516 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -69.2 -32.11 71.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 98' ' ' SER . 78.4 mm-40 -79.52 -18.49 51.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 99' ' ' ALA . 71.3 p -106.53 -59.15 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.936 -1.103 . . . . 0.0 111.177 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.494 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 48.1 m -125.14 -42.44 2.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.838 -1.164 . . . . 0.0 111.002 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.1 47.33 1.16 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 17.6 t -110.36 172.22 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.287 -1.125 . . . . 0.0 108.915 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 110' ' ' ARG . 35.1 m -68.59 121.17 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 19.2 p-10 -71.08 -23.7 62.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.833 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' SER . 20.6 t -66.88 -30.17 70.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 0.0 110.932 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.427 ' HB2' HG21 ' A' ' 107' ' ' VAL . 15.7 ttt180 -67.67 -55.1 14.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.822 -1.174 . . . . 0.0 110.515 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.466 ' CE1' ' OD2' ' A' ' 67' ' ' ASP . 6.4 t80 -75.79 -49.25 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 110.205 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.516 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 20.5 mt -56.3 -36.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' SER . 4.5 m -60.91 -40.81 94.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.74 -38.33 76.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.234 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CD1' HD11 ' A' ' 96' ' ' LEU . 69.1 mt -69.38 -43.16 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -54.24 -38.99 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.7 m -73.42 -35.9 65.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 109.693 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 20.8 mt -65.2 -38.88 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.829 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.518 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 65.8 mt -61.67 -42.67 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.91 92.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.658 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 23.3 m-85 -64.34 -34.72 78.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.51 ' HB1' ' CD2' ' A' ' 85' ' ' LEU . . . -68.74 -31.1 69.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.51 -32.86 70.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.489 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.29 67.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.454 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 m -64.0 -33.25 75.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.813 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 130' ' ' VAL . . . -67.59 -15.79 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.394 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.25 -21.22 42.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.66 -42.26 86.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 109.376 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 131' ' ' TYR . 16.0 m -64.14 -32.63 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 130' ' ' VAL . 34.9 p90 -179.11 174.94 1.01 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.489 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 135' ' ' GLY . . . -80.47 122.58 27.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 m -52.7 -38.35 60.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.48 73.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 132' ' ' ALA . . . 178.87 -176.76 48.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.4 t -122.08 142.36 50.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.497 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.04 -23.12 63.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -1.199 . . . . 0.0 109.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.26 -164.93 40.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -72.65 -3.46 25.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -1.131 . . . . 0.0 109.611 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.31 155.12 9.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -73.34 -13.4 61.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.2 t -154.46 150.21 21.62 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 41.7 Cg_endo -64.3 -30.65 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 49.1 p90 -88.42 18.74 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.0 109.05 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.478 ' HB2' ' CG2' ' A' ' 7' ' ' THR . 0.5 OUTLIER -105.48 -30.98 9.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 89.8 p -123.59 142.92 50.57 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' CG ' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -60.77 -43.77 97.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.946 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.9 m-20 -72.17 -29.57 64.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -65.35 -37.33 86.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.499 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.03 -56.17 12.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.071 -1.018 . . . . 0.0 110.077 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.21 -29.76 15.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 109.567 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 56.3 t80 -69.85 -44.09 70.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD11 ' CD1' ' A' ' 70' ' ' PHE . 18.5 mm -68.64 -44.94 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.196 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -68.25 -50.78 51.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.4 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 51.1 m -58.45 -29.64 66.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.049 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' A' ' 95' ' ' ALA . 25.8 t80 -72.23 -51.92 18.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.129 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 ' CD1' ' HB3' ' A' ' 40' ' ' MET . 19.4 mm -66.21 -55.87 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.007 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -57.44 -36.7 71.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.931 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.96 -44.75 25.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 110.193 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' ' CB ' ' A' ' 95' ' ' ALA . . . -65.82 -27.36 68.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 55.1 m -65.21 -31.15 72.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.336 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.4 p-10 -105.93 7.71 32.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.065 -1.022 . . . . 0.0 110.364 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.523 HG21 ' CB ' ' A' ' 94' ' ' ASP . 17.5 m -89.0 -77.14 0.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.914 -1.116 . . . . 0.0 110.255 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.81 -102.61 0.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -132.95 -62.38 0.81 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.462 -1.022 . . . . 0.0 109.314 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 14.3 m-85 45.54 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.3 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 35' ' ' ASP . 4.9 m -59.37 158.63 9.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -52.42 -40.0 61.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.431 ' OD1' ' CB ' ' A' ' 33' ' ' SER . 19.0 p-10 -61.38 -36.07 79.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.461 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.7 mm-40 -67.81 -31.65 71.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.219 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.509 ' HA ' ' CE ' ' A' ' 40' ' ' MET . 61.8 mtt -63.28 -36.75 84.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 109.001 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 65.5 mm-40 -58.92 -48.7 80.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.114 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -60.56 -46.13 91.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.858 . . . . 0.0 109.021 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.512 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 70.9 mtm -61.61 -35.88 79.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.424 -0.797 . . . . 0.0 108.851 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -70.23 -24.1 63.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 46' ' ' THR . 12.1 tp -84.45 -22.07 30.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 44' ' ' GLY . 12.0 mm -118.04 149.4 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 90.06 -77.38 1.6 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 19' ' ' ILE . 89.9 m-20 -65.91 -39.29 90.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.193 -1.18 . . . . 0.0 108.22 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 84.9 m -63.0 -35.27 79.65 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.577 ' CD2' ' CD1' ' A' ' 66' ' ' LEU . 29.1 tp -57.82 -36.48 72.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.659 -0.65 . . . . 0.0 109.532 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 94.6 mmm -52.78 -29.46 27.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.252 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.9 76.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.02 86.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.153 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.457 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 13.0 mmt -54.73 -29.8 54.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 108.989 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -54.69 -33.03 60.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.305 -0.872 . . . . 0.0 109.139 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -62.68 -31.73 72.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.193 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 88.8 mmm -57.48 -27.95 62.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 109.317 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.14 14.57 58.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.74 22.3 23.99 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' CE ' ' A' ' 54' ' ' MET . 25.3 ptt180 -135.51 112.37 10.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -1.09 . . . . 0.0 109.324 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' A' ' 63' ' ' LEU . 28.4 mm -113.76 158.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 0.0 109.824 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 62' ' ' LYS . 3.0 p -126.84 160.57 58.31 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 0.0 109.541 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 52.4 Cg_endo -72.17 -50.47 0.25 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.756 2.304 . . . . 0.0 111.908 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.2 p -60.35 -35.13 74.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 81.6 mttt -72.7 -52.38 15.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.38 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 57.3 mt -61.86 -27.34 68.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.021 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -54.78 -44.54 73.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.945 . . . . 0.0 109.017 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.41 69.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.577 ' CD1' ' CD2' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -74.31 -43.64 55.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.031 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 42.0 t0 -48.53 -43.86 35.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.12 -34.36 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.935 . . . . 0.0 109.813 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.54 79.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 109.816 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CD1' HD11 ' A' ' 19' ' ' ILE . 86.6 t80 -61.51 -36.86 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.7 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 115' ' ' ILE . . . -70.36 -29.05 65.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.935 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -69.32 -46.98 65.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.167 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.1 t -70.07 -45.99 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 75' ' ' ALA . 13.7 m -57.4 -35.41 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 74' ' ' VAL . . . -73.8 -40.81 63.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.781 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 80' ' ' SER . 50.1 tt0 -68.47 -43.24 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 109.724 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 HD12 ' HG2' ' A' ' 40' ' ' MET . 99.4 mt -56.35 -52.38 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -73.33 -50.62 21.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 0.0 109.841 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.41 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.398 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 90.0 p -81.4 -20.65 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 34.8 mt-30 -48.97 -36.96 18.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 22.29 41.9 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.03 -157.39 13.75 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 87' ' ' VAL . 76.8 m-20 -62.6 134.4 56.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.099 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.425 ' CD2' ' HA2' ' A' ' 120' ' ' GLY . 6.3 tp -84.95 -19.4 32.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.59 64.82 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 88' ' ' THR . 5.5 p -69.99 -44.93 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 109.696 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 78' ' ' ALA . 80.0 m -51.61 -34.75 38.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.975 -1.078 . . . . 0.0 108.493 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 23.8 m -56.2 -48.7 75.9 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 m120 -70.72 -39.3 73.48 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.169 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HA ' HG23 ' A' ' 29' ' ' THR . . . -65.25 -57.45 8.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.732 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 48.2 mt -66.46 -45.97 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.8 -49.02 74.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 0.0 110.059 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.523 ' CB ' HG21 ' A' ' 29' ' ' THR . 91.3 m-20 -54.99 -41.68 71.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.363 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.573 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . . . -62.62 -44.59 95.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.304 -0.873 . . . . 0.0 109.049 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 115' ' ' ILE . 7.1 mt -70.42 -36.01 73.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.505 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.547 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 93.5 m -64.82 -53.7 42.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 110.009 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 14.5 m -62.08 -49.2 76.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.121 -0.987 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -53.5 -44.37 68.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.586 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER -46.96 -55.95 7.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 109.324 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.552 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 4.1 m-85 -71.97 -31.91 66.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.44 -0.787 . . . . 0.0 109.675 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 98' ' ' SER . 65.1 mt-30 -73.19 -18.39 61.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.676 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 99' ' ' ALA . 34.7 p -107.29 -60.22 1.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.936 -1.103 . . . . 0.0 111.173 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.524 HG22 ' CG2' ' A' ' 106' ' ' VAL . 12.3 t -127.05 -43.07 1.69 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.813 -1.179 . . . . 0.0 110.845 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.98 46.82 0.92 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 57.4 t -103.07 167.86 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.271 -1.135 . . . . 0.0 108.937 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.535 HG22 ' CB ' ' A' ' 110' ' ' ARG . 33.5 m -66.07 121.45 15.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.755 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.576 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 20.8 p-10 -71.07 -23.74 62.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.428 -0.795 . . . . 0.0 109.939 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 113' ' ' SER . 90.2 p -68.7 -34.84 76.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CB ' HG22 ' A' ' 107' ' ' VAL . 16.5 tpt180 -62.36 -54.52 39.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.862 -1.148 . . . . 0.0 110.473 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' CE2' HD13 ' A' ' 115' ' ' ILE . 57.4 t80 -75.73 -53.29 8.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 110.204 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.517 HG22 ' CB ' ' A' ' 93' ' ' ALA . 21.2 mt -56.36 -28.37 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 109' ' ' SER . 9.6 t -58.81 -42.29 88.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.622 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.48 -36.35 65.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.569 HD13 ' CE2' ' A' ' 111' ' ' PHE . 30.8 mt -67.54 -41.22 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.647 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 113' ' ' SER . 31.8 ptt85 -54.04 -43.12 69.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.852 -1.155 . . . . 0.0 109.638 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.492 ' N ' ' CG ' ' A' ' 116' ' ' ARG . 87.0 p -71.44 -33.82 69.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.548 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 18.8 mt -66.45 -38.12 86.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 115' ' ' ILE . 67.3 mt -61.5 -35.71 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.023 . . . . 0.0 109.454 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 124' ' ' GLN . . . -67.93 -34.24 81.66 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.0 ttm -60.75 -43.68 97.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.16 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 75' ' ' ALA . 97.7 m-85 -59.14 -50.17 75.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.27 -31.73 54.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 120' ' ' GLY . 99.6 mm-40 -70.66 -32.67 70.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.458 ' HA ' ' ND2' ' A' ' 128' ' ' ASN . . . -57.8 -31.85 66.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -35.48 69.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' O ' ' CG1' ' A' ' 130' ' ' VAL . . . -59.78 -27.95 66.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 125' ' ' ALA . 78.4 m-20 -54.09 -18.78 4.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.86 -35.05 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 131' ' ' TYR . 7.5 p -65.48 -29.63 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.604 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 130' ' ' VAL . 37.1 p90 177.71 160.99 0.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.321 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.89 116.67 11.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' ALA . 39.7 p -59.39 158.17 9.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 109.481 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' SER . . . 45.45 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.24 -0.912 . . . . 0.0 109.485 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.02 -173.23 48.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -123.43 141.48 51.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -1.144 . . . . 0.0 109.496 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.442 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 65.0 mtt -59.11 -38.09 78.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.459 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.473 ' C ' ' NE2' ' A' ' 4' ' ' GLN . . . 97.51 0.87 59.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' NE2' ' C ' ' A' ' 3' ' ' GLY . 10.0 mp0 -120.67 153.98 36.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -1.191 . . . . 0.0 109.355 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -146.83 92.57 2.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.684 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.425 ' O ' ' OG1' ' A' ' 104' ' ' THR . 19.0 m120 -57.97 -17.28 16.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.585 HG23 ' CZ2' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -135.97 151.75 74.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.436 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 47.0 Cg_endo -68.66 -35.39 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.561 2.174 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.585 ' CZ2' HG23 ' A' ' 7' ' ' THR . 45.3 p90 -91.48 -11.39 37.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 109.082 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -72.05 -5.34 34.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.898 . . . . 0.0 109.413 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 1.9 t -140.79 153.9 46.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.361 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' CG ' HG13 ' A' ' 58' ' ' ILE . 2.5 ttpm? -73.81 -39.7 63.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.612 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.45 -33.01 42.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.259 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HB1' ' A' ' 5' ' ' ALA . 34.2 t30 -71.53 -29.47 64.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.79 -43.06 72.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -54.36 -56.33 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.717 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 103' ' ' THR . . . -51.9 -35.4 45.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 109.298 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 47.2 t80 -68.73 -52.6 28.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.576 HD12 ' CE1' ' A' ' 70' ' ' PHE . 10.0 mm -60.15 -44.14 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -67.49 -50.87 56.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 33.5 t -57.66 -30.12 65.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.203 -0.936 . . . . 0.0 108.754 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CZ ' ' CG2' ' A' ' 74' ' ' VAL . 19.2 t80 -72.29 -52.21 17.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.5 HG12 ' CE ' ' A' ' 40' ' ' MET . 69.4 mt -61.9 -56.12 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.687 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -53.91 -37.24 63.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -51.54 10.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.924 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.67 64.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.105 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.527 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 45.8 p -68.37 -33.41 74.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.249 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -105.67 7.19 32.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 91' ' ' ALA . 8.9 m -87.16 -77.09 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.956 -1.09 . . . . 0.0 110.224 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -101.4 0.61 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 76.5 p -141.32 -53.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.429 -1.042 . . . . 0.0 109.344 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 15.7 m-85 44.5 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 37' ' ' MET . 32.2 t -59.68 159.97 7.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -52.38 -38.4 58.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.07 -37.18 86.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.115 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.525 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 81.8 mm-40 -76.32 -36.17 58.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.527 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 79.6 mtp -63.97 -37.43 87.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.132 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -56.89 -41.2 77.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.171 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.529 ' HB3' ' CG2' ' A' ' 77' ' ' ILE . 46.0 t-20 -56.07 -35.08 66.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 108.916 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.5 ' CE ' HG12 ' A' ' 23' ' ' ILE . 92.8 mmm -57.12 -31.69 65.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 m -67.55 -24.08 65.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.915 . . . . 0.0 109.28 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 46' ' ' THR . 66.9 mt -92.08 -28.22 17.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 77' ' ' ILE . 63.9 mt -116.81 154.99 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.422 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.53 ' CA ' HG21 ' A' ' 19' ' ' ILE . . . 85.16 -89.79 1.62 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -59.58 -32.4 70.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 108.834 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 34.2 m -65.95 -35.08 79.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 108.922 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD23 ' CD2' ' A' ' 66' ' ' LEU . 29.8 tp -54.97 -38.63 68.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.79 . . . . 0.0 109.222 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.425 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 24.9 ttt -52.83 -36.16 58.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.31 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.21 72.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.193 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.83 72.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.443 ' HB3' HD13 ' A' ' 58' ' ' ILE . 64.0 mtm -59.17 -29.91 67.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.215 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.76 -31.66 69.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -60.88 -29.32 69.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.241 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.524 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 89.8 mmm -57.84 -33.18 68.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.364 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.28 12.9 34.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.23 9.55 44.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 18.8 ptt180 -125.09 112.28 16.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.129 . . . . 0.0 109.551 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.553 ' CG2' HD12 ' A' ' 63' ' ' LEU . 31.3 mm -116.03 142.05 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.51 ' OG1' ' CB ' ' A' ' 62' ' ' LYS . 7.6 p -97.9 157.02 35.32 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 50.5 Cg_endo -70.67 -42.11 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.677 2.251 . . . . 0.0 111.59 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 22.9 t -71.67 -36.08 70.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.51 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 17.1 tttp -64.51 -49.81 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.315 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' A' ' 58' ' ' ILE . 2.6 mt -57.04 -32.3 66.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 68' ' ' MET . 85.1 mt-30 -54.75 -48.29 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.123 -0.986 . . . . 0.0 108.628 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.5 55.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.395 -0.816 . . . . 0.0 109.267 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CD2' HD23 ' A' ' 47' ' ' LEU . 1.8 tp -61.54 -50.82 71.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.581 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 26.3 t0 -47.99 -37.01 13.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 63.5 mtt -65.84 -32.13 73.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -59.55 -44.37 93.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CE1' HD12 ' A' ' 19' ' ' ILE . 81.9 t80 -53.59 -38.93 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.875 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -68.94 -40.49 78.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.6 m -69.35 -45.64 68.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.515 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 12.3 m -70.01 -47.24 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 109.766 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.579 ' CG2' ' CZ ' ' A' ' 22' ' ' PHE . 7.5 p -58.4 -44.16 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.603 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' N ' ' CG1' ' A' ' 74' ' ' VAL . . . -62.8 -37.24 85.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.0 tt0 -68.41 -43.12 77.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 78.8 mt -53.78 -52.46 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -50.84 10.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.782 . . . . 0.0 109.931 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 75' ' ' ALA . . . -57.58 -22.54 45.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.979 . . . . 0.0 109.266 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.3 p -81.85 -20.59 38.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.525 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 50.1 mt-30 -45.96 -35.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 3.79 76.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.18 -162.75 33.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -72.06 118.31 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.134 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 119' ' ' ILE . 3.4 mp -62.28 -16.17 52.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.76 -45.74 78.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.3 -47.47 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -1.132 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 44.7 m -53.75 -48.43 69.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 21.6 m -51.27 -47.7 62.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' O ' HG23 ' A' ' 29' ' ' THR . 74.7 m-20 -71.05 -35.32 71.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.443 -0.786 . . . . 0.0 108.93 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.505 ' HA ' HG23 ' A' ' 29' ' ' THR . . . -69.58 -59.13 3.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 0.0 109.689 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 96' ' ' LEU . 69.0 mt -63.98 -49.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.901 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -59.26 -52.52 65.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.331 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 29' ' ' THR . 92.8 m-20 -55.4 -43.12 74.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 109.903 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.576 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -63.54 -39.5 94.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.205 -0.934 . . . . 0.0 109.723 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.567 HD23 ' CD2' ' A' ' 22' ' ' PHE . 6.2 mt -69.88 -35.87 75.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.55 HG23 ' CE2' ' A' ' 101' ' ' TYR . 94.3 m -65.46 -53.65 39.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 20.2 m -60.59 -34.03 73.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.825 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . . . -69.52 -46.3 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.5 m-85 -47.12 -56.21 6.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.55 ' CE2' HG23 ' A' ' 97' ' ' THR . 3.2 m-85 -71.14 -31.78 68.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.828 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 98' ' ' SER . 84.1 mm-40 -73.12 -18.59 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 17' ' ' ALA . 67.5 p -107.45 -59.85 1.77 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.903 -1.123 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.528 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -126.82 -42.84 1.73 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.761 -1.212 . . . . 0.0 110.836 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 111.77 45.36 0.83 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.6 t -102.81 172.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 109.151 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.1 m -74.18 120.23 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 13.0 p30 -72.07 -29.59 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.645 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 113' ' ' SER . 21.7 m -56.92 -46.09 82.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 110.391 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.97 -53.58 56.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.891 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 75.3 t80 -75.0 -50.49 16.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.756 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 11.5 mt -58.56 -42.63 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.065 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 109' ' ' SER . 48.0 t -55.84 -37.97 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.15 -40.41 82.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.513 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 56.2 mt -72.7 -43.34 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -54.22 -39.74 67.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.368 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.7 t -73.15 -34.12 65.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 115' ' ' ILE . 16.8 mt -70.97 -40.71 71.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.492 HG22 ' CD2' ' A' ' 85' ' ' LEU . 84.6 mt -58.2 -39.65 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.03 -27.34 72.27 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.0 ttm -66.97 -38.68 86.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -1.166 . . . . 0.0 109.502 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -60.14 -37.87 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.529 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.94 -32.07 72.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -70.82 -32.02 68.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.47 -28.61 69.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.1 p -61.26 -29.13 69.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -65.51 -28.33 69.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.607 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' ALA . 87.3 m-20 -44.72 -24.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.871 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.575 ' O ' ' CZ ' ' A' ' 131' ' ' TYR . 92.5 m-20 -95.17 -65.82 0.95 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.063 -1.023 . . . . 0.0 110.187 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 13.4 m -98.65 -15.26 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.083 -1.011 . . . . 0.0 111.66 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.603 ' CD1' ' C ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER 43.82 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.176 -0.952 . . . . 0.0 109.947 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . -150.59 86.61 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.931 -1.105 . . . . 0.0 108.966 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 132' ' ' ALA . 37.4 p -43.52 165.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.723 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.71 72.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.93 10.4 55.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.5 m -58.9 -34.0 71.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -1.164 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.2 mmm -109.05 142.22 40.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -51.7 -36.41 40.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -112.46 153.68 27.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 104' ' ' THR . . . -66.63 157.32 32.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -77.19 -10.84 59.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.586 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 1.5 t -162.25 151.77 13.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.012 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.49 -27.17 39.78 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.466 2.111 . . . . 0.0 112.695 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -92.52 15.91 13.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.849 -1.157 . . . . 0.0 109.845 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.536 ' CB ' HG22 ' A' ' 7' ' ' THR . 68.5 p -105.31 -23.07 12.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.002 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -110.45 160.71 16.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.188 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HG2' ' CE ' ' A' ' 51' ' ' MET . 15.6 ttpp -74.69 -40.88 61.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.049 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -83.28 -31.07 27.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 5.8 t-20 -71.54 -29.38 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.644 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.514 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -73.03 -47.89 40.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.2 p30 -56.79 -49.29 75.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.169 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -55.08 -40.61 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.971 -1.08 . . . . 0.0 109.386 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.465 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 72.2 t80 -61.23 -48.57 80.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mm -60.88 -44.44 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -50.87 48.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.382 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 38.8 t -55.91 -29.98 60.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 108.765 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CD2' ' CD2' ' A' ' 96' ' ' LEU . 39.1 t80 -72.34 -51.92 18.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.511 -0.743 . . . . 0.0 110.047 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' CG2' ' HE1' ' A' ' 40' ' ' MET . 76.3 mt -60.26 -56.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -59.85 -35.14 74.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.923 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.14 -45.29 23.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -65.82 -40.59 91.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.937 . . . . 0.0 110.323 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 82.7 p -57.15 -27.24 61.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.23 6.99 31.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.571 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 19.5 m -93.12 -77.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.783 -1.198 . . . . 0.0 110.188 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.75 -104.74 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' PHE . 53.0 p -131.31 -61.52 0.91 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.58 ' CE1' ' HB1' ' A' ' 78' ' ' ALA . 12.8 m-85 44.02 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 109.236 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m -59.65 162.56 5.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.577 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -52.56 -43.33 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.23 -35.89 76.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.9 mm-40 -71.7 -35.07 70.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.6 mtt -63.47 -34.23 77.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -63.03 -38.31 90.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' HB3' HG12 ' A' ' 77' ' ' ILE . 86.3 m-20 -55.83 -39.69 71.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.256 -0.903 . . . . 0.0 109.118 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.471 ' O ' ' O ' ' A' ' 43' ' ' ILE . 75.8 mtm -66.16 -32.04 73.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.083 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 46' ' ' THR . 19.5 m -70.31 -23.62 62.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.409 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 54.7 mt -97.34 -14.31 21.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG23 ' CB ' ' A' ' 73' ' ' SER . 74.8 mt -130.78 166.3 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 0.0 109.548 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 64.8 -69.44 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ILE . 41.1 t30 -74.81 -41.06 60.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.213 -1.169 . . . . 0.0 109.23 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 41' ' ' SER . 46.8 m -58.37 -35.24 71.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 108.739 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.74 -31.19 69.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 108.908 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.461 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 58.1 mmm -56.81 -29.95 63.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.412 -0.805 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' ASP . . . -60.7 -42.51 97.36 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -22.88 66.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.517 ' CE ' ' HG2' ' A' ' 12' ' ' LYS . 20.4 ttp -58.7 -30.86 67.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.632 -0.667 . . . . 0.0 109.513 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 50.4 p30 -73.69 -13.36 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 86.5 m-20 -71.04 -28.2 64.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.852 . . . . 0.0 109.184 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.525 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 90.7 mmm -53.41 -34.43 57.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.66 4.71 60.44 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.35 10.49 19.82 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE ' ' A' ' 54' ' ' MET . 9.9 ptt180 -122.92 115.22 21.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -1.162 . . . . 0.0 109.661 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' A' ' 63' ' ' LEU . 22.9 mm -116.68 155.93 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.855 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.493 ' CG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -143.54 166.27 20.69 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.493 ' HD2' ' CG2' ' A' ' 59' ' ' THR . 50.5 Cg_endo -70.81 -41.14 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.672 2.248 . . . . 0.0 111.883 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.9 p -65.77 -33.71 76.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -75.63 -50.43 15.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' A' ' 58' ' ' ILE . 6.9 mp -70.16 -33.47 71.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.67 -42.16 67.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.46 65.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 108.802 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 tp -74.48 -50.77 16.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.575 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.5 t0 -48.26 -39.68 22.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.7 mmm -71.44 -39.4 71.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.69 87.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 19' ' ' ILE . 84.5 t80 -52.88 -36.94 59.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 109.706 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.508 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -64.55 -39.58 94.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.675 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 88.2 p -69.46 -30.63 68.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.826 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.533 ' CB ' HG23 ' A' ' 43' ' ' ILE . 11.5 t -69.96 -44.25 69.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.0 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 75' ' ' ALA . 11.7 m -69.01 -34.63 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.563 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 122' ' ' PHE . . . -69.91 -40.74 75.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.62 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -71.11 -49.36 45.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -53.82 -46.71 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.69 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -53.98 6.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 109.799 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.16 -22.67 52.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.549 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 22.9 m -79.67 -20.72 45.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.465 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 37.6 mt-30 -57.19 -34.14 68.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.82 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.25 17.81 73.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.84 -145.62 19.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 87' ' ' VAL . 58.4 t0 -76.0 106.03 7.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -1.111 . . . . 0.0 109.302 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 10.8 tp -60.18 -23.07 63.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 109.666 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.16 -39.45 72.47 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 84' ' ' ASP . 2.0 p -67.62 -39.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.255 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 24.3 m -51.7 -34.46 38.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.963 -1.085 . . . . 0.0 108.316 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 6.6 m -57.46 -50.93 71.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' A' ' 94' ' ' ASP . 51.0 t30 -70.24 -40.18 74.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.389 -0.819 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.505 ' HA ' HG21 ' A' ' 29' ' ' THR . . . -62.37 -53.55 53.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.298 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 57.0 mt -72.56 -51.25 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.89 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -56.53 -49.23 75.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 93.1 m-20 -54.77 -47.68 73.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.213 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 26' ' ' ALA . . . -57.02 -46.11 82.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.339 -0.851 . . . . 0.0 109.003 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD1' HG21 ' A' ' 92' ' ' ILE . 1.8 mt -70.97 -28.61 64.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.548 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.531 ' CG2' ' OD1' ' A' ' 108' ' ' ASN . 51.7 m -64.46 -54.09 37.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.157 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 87.6 p -66.78 -43.91 82.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 109.438 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -53.14 -42.71 66.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.5 m-85 -50.49 -56.41 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.123 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.535 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 7.5 m-85 -72.07 -31.77 66.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.425 -0.797 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 98' ' ' SER . 28.3 mt-30 -75.71 -17.8 59.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.589 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 99' ' ' ALA . 63.7 p -109.44 -58.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 111.294 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 5' ' ' ALA . 87.2 m -125.76 -42.75 1.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.746 -1.221 . . . . 0.0 111.212 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.77 47.81 1.07 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 3.6 t -110.92 172.79 2.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.263 -1.139 . . . . 0.0 109.022 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.85 121.12 21.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.52 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.591 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -71.7 -29.69 64.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 109.857 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 113' ' ' SER . 47.5 m -55.95 -30.12 61.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.492 -0.755 . . . . 0.0 110.742 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 23.1 tpt180 -71.54 -55.22 8.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 110.374 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 75.3 t80 -75.92 -46.6 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.526 HG22 ' CB ' ' A' ' 93' ' ' ALA . 12.5 mt -56.13 -47.15 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.453 -0.779 . . . . 0.0 109.852 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' SER . 28.5 t -55.66 -43.56 76.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 95.0 mt-10 -57.19 -48.35 78.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.223 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 74.5 mt -65.46 -34.08 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.533 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 11.5 ttm180 -52.95 -48.96 66.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -69.75 -33.98 73.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.13 -45.61 76.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.682 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 85' ' ' LEU . 56.7 mt -57.83 -34.6 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.686 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' A' ' 85' ' ' LEU . . . -69.02 -31.78 72.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 53.2 ttm -71.36 -39.28 71.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.119 . . . . 0.0 109.791 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.532 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 75.6 m-85 -65.57 -33.62 76.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 85' ' ' LEU . . . -68.95 -27.72 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.65 -34.05 71.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.83 -33.02 74.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.371 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -62.72 -30.83 71.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.276 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.95 -11.96 61.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.331 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -83.76 -18.51 37.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -77.1 -44.16 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.241 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.545 ' CG1' ' CD2' ' A' ' 131' ' ' TYR . 7.5 p -59.37 -25.78 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 109.194 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.545 ' CD2' ' CG1' ' A' ' 130' ' ' VAL . 39.8 p90 178.3 176.59 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.213 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.25 117.12 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.657 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 t -53.71 -37.07 62.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 0.0 109.307 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.1 -39.33 63.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.98 -162.37 32.51 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.8 p -64.23 -28.1 69.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.37 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.72 161.22 28.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.77 -125.27 25.3 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -111.32 151.47 28.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -1.139 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.12 140.73 52.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -85.91 14.01 6.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.951 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.587 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 3.1 t -157.78 151.38 19.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.093 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 43.9 Cg_endo -67.41 -35.09 24.63 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.783 2.322 . . . . 0.0 113.394 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.587 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -81.34 -7.51 59.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.695 -1.253 . . . . 0.0 110.339 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.65 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 5.6 m -88.35 20.14 3.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.656 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -155.69 150.05 25.86 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 58' ' ' ILE . 1.9 ttpp -73.88 -38.18 64.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -85.85 -33.56 21.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' CB ' ' HB3' ' A' ' 11' ' ' SER . 9.7 t-20 -71.88 -29.28 64.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -73.0 -44.28 61.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.641 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.6 p30 -54.45 -40.28 68.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -63.05 -44.65 95.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.012 -1.055 . . . . 0.0 109.024 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE1' HD23 ' A' ' 96' ' ' LEU . 43.1 t80 -60.77 -44.26 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 70' ' ' PHE . 19.0 mm -66.34 -43.36 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.239 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -50.92 51.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.248 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 43.5 m -58.75 -29.42 66.73 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 108.72 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CZ ' ' CG2' ' A' ' 74' ' ' VAL . 11.8 t80 -71.64 -51.98 20.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.518 ' CD1' ' OD1' ' A' ' 45' ' ' ASN . 74.3 mt -63.67 -56.06 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.908 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.4 m -56.04 -37.07 68.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.677 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -49.4 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.777 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -60.36 -24.19 64.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 110.153 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.482 ' CB ' ' HE3' ' A' ' 37' ' ' MET . 57.8 m -67.3 -34.33 77.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 110.079 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -106.08 7.17 31.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.16 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 11.8 m -84.19 -75.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -86.97 -99.84 0.83 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -142.04 -54.9 0.45 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -1.074 . . . . 0.0 109.293 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.537 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 15.4 m-85 44.17 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 37' ' ' MET . 15.9 m -59.65 159.82 8.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.698 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -52.8 -32.72 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -71.15 -37.95 72.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.326 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.523 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 37.5 mt-30 -76.56 -34.22 58.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.482 ' HE3' ' CB ' ' A' ' 27' ' ' SER . 88.6 mtp -65.04 -34.49 78.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 72.7 mt-10 -56.87 -43.99 81.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HB2' ' CG2' ' A' ' 77' ' ' ILE . 79.9 m-20 -55.9 -33.23 64.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.475 ' CE ' ' HA ' ' A' ' 23' ' ' ILE . 82.3 mtp -61.74 -32.55 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -69.91 -24.68 63.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.373 -0.829 . . . . 0.0 109.453 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 6.1 mp -89.03 -22.43 22.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 73' ' ' SER . 86.9 mt -115.57 164.18 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 43' ' ' ILE . . . 73.84 -93.88 0.76 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' OD1' ' CD1' ' A' ' 23' ' ' ILE . 21.2 m120 -52.41 -36.89 55.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -1.185 . . . . 0.0 109.036 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 55.4 m -58.4 -35.31 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 74.6 mt -56.88 -36.45 70.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 109.224 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.445 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 70.8 mtm -52.95 -40.7 63.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.28 -31.5 71.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.972 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . -67.2 -34.9 78.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -0.803 . . . . 0.0 109.176 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 35.5 mtt -58.96 -30.93 68.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.11 -25.85 64.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.85 -30.33 70.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.381 -0.824 . . . . 0.0 109.264 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 94.8 mmm -63.69 -36.15 82.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.69 12.14 48.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.47 12.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' CE ' ' A' ' 54' ' ' MET . 17.6 ptt85 -138.1 114.35 10.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.528 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 25.1 mm -111.38 128.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -89.45 166.57 20.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 47.4 Cg_endo -69.17 -21.35 36.38 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.595 2.196 . . . . 0.0 111.769 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 t -74.78 -44.52 49.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.268 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -74.02 -30.35 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 0.0 108.855 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.65 ' HG ' ' HA ' ' A' ' 10' ' ' SER . 1.2 tp -49.68 -52.52 30.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -76.81 -46.07 26.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.252 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.24 52.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.266 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 47' ' ' LEU . 17.4 tp -54.94 -50.04 69.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.948 . . . . 0.0 109.028 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 9.8 t0 -48.16 -49.39 32.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.9 mtp -58.81 -43.99 90.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.64 77.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.736 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 19' ' ' ILE . 77.6 t80 -56.86 -45.2 82.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.527 ' CB ' HG12 ' A' ' 115' ' ' ILE . . . -66.44 -36.99 84.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -69.6 -52.05 29.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -0.975 . . . . 0.0 110.023 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.526 ' CB ' HG21 ' A' ' 43' ' ' ILE . 10.9 m -70.25 -35.84 74.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' CG2' ' CZ ' ' A' ' 22' ' ' PHE . 8.1 p -66.88 -43.65 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.13 -0.981 . . . . 0.0 109.898 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB2' ' CE2' ' A' ' 122' ' ' PHE . . . -63.68 -32.22 73.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.907 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -72.17 -43.1 65.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 109.875 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 39' ' ' ASN . 64.8 mt -54.47 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.099 -1.001 . . . . 0.0 109.822 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.0 -50.17 12.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.46 -0.775 . . . . 0.0 110.142 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.1 -25.96 61.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.583 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.2 p -76.94 -20.31 56.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.408 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 73.2 mt-30 -46.4 -33.76 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.37 16.11 80.97 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.5 -159.3 19.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.04 105.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -1.164 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -61.21 -18.38 57.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.66 81.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.493 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 46.4 t -68.69 -44.81 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 109.547 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 23.9 m -54.52 -50.15 68.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.0 m -51.31 -48.83 62.23 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 24.0 t-20 -70.83 -33.92 71.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 108.983 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -70.37 -59.15 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.509 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' A' ' 96' ' ' LEU . 55.0 mt -63.21 -49.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.828 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -56.0 -52.23 64.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 29' ' ' THR . 32.0 t0 -55.23 -50.53 69.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.573 ' HB1' ' CD2' ' A' ' 22' ' ' PHE . . . -53.22 -42.88 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.573 HD23 ' CE1' ' A' ' 18' ' ' PHE . 7.1 mt -70.26 -41.05 73.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.569 HG23 ' CE2' ' A' ' 101' ' ' TYR . 99.3 m -62.4 -48.64 78.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 28.7 m -64.43 -34.26 77.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 109.483 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -69.95 -44.99 68.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.9 m-85 -46.97 -56.03 7.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.873 . . . . 0.0 109.698 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 97' ' ' THR . 3.1 m-85 -70.91 -32.09 68.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.762 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 98' ' ' SER . 88.2 mm-40 -75.91 -18.42 59.39 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.781 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 99' ' ' ALA . 61.2 p -103.81 -59.85 1.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.058 -1.026 . . . . 0.0 111.101 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 8' ' ' PRO . 12.6 p -126.73 -42.61 1.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.672 -1.268 . . . . 0.0 110.925 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.82 45.25 0.97 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.43 HG22 ' OG1' ' A' ' 104' ' ' THR . 12.1 t -109.83 172.52 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -1.125 . . . . 0.0 109.219 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 110' ' ' ARG . 3.2 m -73.68 121.16 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.605 ' HA ' ' CE2' ' A' ' 100' ' ' PHE . 18.0 p30 -70.74 -23.36 62.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.5 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 113' ' ' SER . 23.3 t -54.78 -30.27 56.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.574 -0.704 . . . . 0.0 110.601 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.47 ' HG2' HG21 ' A' ' 107' ' ' VAL . 24.8 mmt85 -69.04 -55.0 12.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.878 -1.139 . . . . 0.0 110.234 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.578 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 59.8 t80 -76.16 -50.4 14.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.517 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 14.5 mt -56.35 -42.56 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.139 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 109' ' ' SER . 32.2 t -56.23 -46.86 79.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 109.554 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.41 -49.83 74.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.262 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.578 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 89.7 mt -65.93 -34.82 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -54.06 -47.02 72.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 109.52 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.8 p -72.66 -33.9 66.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.63 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.02 -44.16 77.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 HG22 HD23 ' A' ' 85' ' ' LEU . 97.5 mt -57.82 -38.83 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.02 -33.79 75.18 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -61.68 -36.87 82.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 77.1 m-85 -66.23 -36.84 84.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . . . -65.08 -27.99 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -69.98 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.56 72.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.3 p -70.35 -22.46 62.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.419 ' O ' HG11 ' A' ' 130' ' ' VAL . . . -67.74 -21.12 65.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -72.36 -27.68 62.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -66.72 -45.74 77.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 131' ' ' TYR . 3.9 p -65.85 -30.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.542 ' CD1' HG11 ' A' ' 130' ' ' VAL . 39.4 p90 178.66 169.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.287 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.86 122.29 23.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.5 p -57.94 -28.45 64.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.97 -32.65 54.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.1 -31.89 41.72 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 87.4 p -62.78 -27.5 69.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 109.397 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.6 mtp -59.89 -35.49 74.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -1.105 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.29 -176.09 48.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -139.41 160.18 40.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.439 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -66.22 144.09 56.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -62.53 -15.46 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.586 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 3.5 t -152.17 151.38 27.57 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 14' ' ' ASN . 42.4 Cg_endo -64.8 -35.5 45.07 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 113.01 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.4 p90 -81.69 -2.16 49.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.661 -1.274 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.4 OUTLIER -82.7 -28.65 30.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 108.688 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 5' ' ' ALA . 70.8 m -118.82 151.11 38.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.484 -0.76 . . . . 0.0 109.161 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HD3' HG13 ' A' ' 58' ' ' ILE . 27.0 mtpt -70.95 -36.16 72.49 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.698 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -67.06 -49.52 64.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.932 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.529 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.5 m-20 -71.37 -29.16 64.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -66.81 -49.88 64.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.433 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.2 p30 -54.8 -53.38 56.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.028 . . . . 0.0 110.149 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -57.65 -35.72 70.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 0.0 108.863 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.525 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 75.5 t80 -61.09 -37.32 82.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.479 -0.763 . . . . 0.0 109.26 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.577 HD12 ' CD1' ' A' ' 70' ' ' PHE . 31.6 mm -75.14 -48.44 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.631 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -62.4 -48.28 80.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 2.1 t -60.75 -30.71 70.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.972 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' CE1' HG11 ' A' ' 74' ' ' VAL . 44.9 t80 -68.7 -52.0 35.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 0.0 110.186 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.15 -56.02 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.99 . . . . 0.0 109.958 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -59.71 -30.88 69.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.01 -45.37 23.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.51 ' N ' ' HB3' ' A' ' 95' ' ' ALA . . . -70.38 -31.66 69.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 50.3 m -60.5 -30.95 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.5 p-10 -106.29 7.39 31.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.01 . . . . 0.0 110.651 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 29.1 m -89.62 -79.36 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.807 -1.183 . . . . 0.0 110.177 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -81.01 -103.05 0.32 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -132.81 -58.28 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.325 -1.103 . . . . 0.0 109.305 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.545 ' CE1' ' CE ' ' A' ' 40' ' ' MET . 4.4 m-85 43.84 90.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.082 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.514 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 11.1 p -59.54 162.99 4.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -52.72 -36.94 58.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.876 . . . . 0.0 109.278 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.21 -45.51 79.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.533 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 4.2 mp0 -63.93 -35.48 80.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.184 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.449 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 58.3 mtt -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.081 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 94.8 mt-10 -70.36 -37.46 74.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.113 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.434 ' HB2' HG21 ' A' ' 77' ' ' ILE . 83.0 m-20 -68.75 -44.65 73.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.251 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.545 ' CE ' ' CE1' ' A' ' 32' ' ' PHE . 61.2 mtt -56.85 -31.98 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 108.935 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 p -70.13 -23.35 63.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.38 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' A' ' 46' ' ' THR . 62.7 mt -87.88 -26.25 22.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.716 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.496 HG22 ' CB ' ' A' ' 73' ' ' SER . 53.4 mt -121.32 157.09 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.449 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 43' ' ' ILE . . . 85.93 -77.2 2.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -65.02 -38.46 90.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -1.162 . . . . 0.0 108.766 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -58.46 -35.1 71.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 71.1 mt -61.06 -34.51 75.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.552 -0.718 . . . . 0.0 109.247 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.424 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 61.4 ttp -52.96 -41.95 65.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 109.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.12 74.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 108.583 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -65.51 -22.8 66.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 54' ' ' MET . 57.6 mtt -60.05 -29.76 68.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.563 -0.711 . . . . 0.0 109.433 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -76.0 -8.22 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' GLY . 97.6 m-20 -70.84 -42.53 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.568 ' HG2' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.29 -21.89 0.1 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.235 -0.916 . . . . 0.0 110.601 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' ' SD ' ' A' ' 54' ' ' MET . . . 85.9 -24.97 7.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 140.8 30.7 0.17 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 20.1 ptt85 -139.28 114.93 9.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.019 -1.283 . . . . 0.0 109.606 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' CG2' ' CD2' ' A' ' 63' ' ' LEU . 27.6 mm -117.11 147.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.835 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.458 ' N ' HG23 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -145.59 169.35 9.91 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 49.9 Cg_endo -69.6 -48.11 0.82 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.0 112.036 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -60.68 -36.29 78.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.938 . . . . 0.0 109.684 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -75.04 -48.0 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.738 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.571 ' CD2' ' CG2' ' A' ' 58' ' ' ILE . 9.8 mp -74.35 -46.16 42.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 96.7 mt-30 -54.71 -40.14 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -37.4 68.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.011 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.16 -52.62 11.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.67 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 68' ' ' MET . 0.3 OUTLIER -48.06 -25.26 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.608 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 56.7 mtp -72.71 -27.42 62.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.963 . . . . 0.0 110.023 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -35.56 65.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 110.038 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 19' ' ' ILE . 88.8 t80 -53.84 -40.71 66.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.792 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . . . -65.69 -36.35 83.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 24.8 m -69.23 -34.16 74.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.783 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.496 ' CB ' HG22 ' A' ' 43' ' ' ILE . 37.1 m -70.3 -49.63 47.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.874 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.566 HG11 ' CE1' ' A' ' 22' ' ' PHE . 19.1 m -57.73 -35.04 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB1' ' CE2' ' A' ' 122' ' ' PHE . . . -70.62 -43.35 69.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 0.0 109.691 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.546 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 26.6 mt-30 -66.22 -50.88 62.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.879 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.434 HG21 ' HB2' ' A' ' 39' ' ' ASN . 89.9 mt -53.49 -50.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.794 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.22 -53.32 7.47 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 110.209 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.63 -24.28 55.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 79.9 p -76.7 -20.23 56.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.533 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 55.2 mt-30 -50.34 -31.54 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 109.51 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.39 14.75 81.68 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.42 -162.88 23.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -1.13 . . . . 0.0 109.437 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' CD2' HG23 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -62.21 -20.21 63.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.98 -38.33 65.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.43 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 72.2 t -70.55 -47.5 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.56 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 19.7 m -51.95 -48.72 64.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 4.3 m -51.07 -46.25 61.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.3 m-20 -71.0 -39.18 72.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.422 -0.799 . . . . 0.0 109.026 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HA ' HG23 ' A' ' 29' ' ' THR . . . -67.48 -59.2 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' ' CG2' ' A' ' 88' ' ' THR . 69.7 mt -60.33 -47.24 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.54 -51.31 65.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 29' ' ' THR . 92.5 m-20 -60.73 -33.54 73.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.877 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 26' ' ' ALA . . . -71.96 -42.59 66.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 108.969 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.38 -38.45 74.71 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.508 -0.745 . . . . 0.0 109.777 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.528 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 77.8 m -63.85 -51.5 64.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 109.917 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 85.7 p -58.4 -34.78 71.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 0.0 109.774 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.23 -44.56 68.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.599 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -46.96 -54.81 9.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.531 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.7 m-85 -72.03 -32.09 66.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 98' ' ' SER . 92.5 mm-40 -77.19 -18.57 57.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 99' ' ' ALA . 81.7 p -104.52 -60.18 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.087 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.461 HG22 ' HD3' ' A' ' 8' ' ' PRO . 29.6 p -127.16 -43.01 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.207 . . . . 0.0 110.762 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.48 44.62 1.05 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.588 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 28.2 t -104.81 170.06 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 108.891 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 110' ' ' ARG . 22.9 m -68.15 121.14 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.599 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 18.9 p-10 -70.59 -23.51 62.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 32.9 t -62.03 -30.56 71.05 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 110.355 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.452 ' HB2' HG21 ' A' ' 107' ' ' VAL . 30.7 ttm-85 -65.81 -54.51 25.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.831 -1.168 . . . . 0.0 110.343 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CD2' HD21 ' A' ' 96' ' ' LEU . 29.1 t80 -75.69 -53.95 7.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.035 . . . . 0.0 110.181 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 54.5 mt -56.92 -34.27 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 12.7 t -55.89 -43.14 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 0.0 109.763 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 74.8 mm-40 -71.73 -38.86 70.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.517 HG12 ' CB ' ' A' ' 71' ' ' ALA . 71.5 mt -59.54 -45.64 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CG2' ' A' ' 89' ' ' THR . 62.3 mtp180 -54.2 -49.09 70.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.689 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.8 m -57.85 -33.71 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 0.0 109.071 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 82.3 mt -74.53 -41.88 59.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 85' ' ' LEU . 72.2 mt -59.24 -35.65 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.199 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.29 63.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.7 ttm -60.83 -45.1 95.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.147 . . . . 0.0 109.515 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.548 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 89.8 m-85 -58.99 -37.28 76.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.66 72.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.489 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.27 -33.39 74.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.89 69.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.376 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -55.81 -36.32 67.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.503 ' O ' ' CG2' ' A' ' 130' ' ' VAL . . . -66.85 -25.11 66.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 34.7 t30 -58.8 -16.19 15.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.311 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.27 -43.29 78.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.463 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.553 ' CG2' ' CD1' ' A' ' 131' ' ' TYR . 21.6 m -67.57 -30.13 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.553 ' CD1' ' CG2' ' A' ' 130' ' ' VAL . 48.9 p90 178.22 -173.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 109.11 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -77.76 113.66 15.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 134' ' ' ALA . 33.1 t -107.59 139.43 42.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' SER . . . 48.32 96.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.552 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.41 74.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.1 p -71.82 163.81 27.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -1.126 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.493 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 65.5 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.662 ' HA ' HG21 ' A' ' 104' ' ' THR . 6.6 t -129.12 150.09 74.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HG3' ' CD2' ' A' ' 18' ' ' PHE . 42.7 Cg_endo -65.3 -31.98 51.92 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.65 2.233 . . . . 0.0 112.216 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 45.5 p90 -89.35 23.41 2.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 109.445 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.72 -33.67 8.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 108.584 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 3.2 t -116.62 161.65 18.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.542 -0.724 . . . . 0.0 109.053 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 4.5 ttpm? -72.61 -41.52 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 109.761 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.82 57.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.546 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 20.4 t30 -71.69 -33.01 68.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.96 -37.57 67.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.98 . . . . 0.0 110.064 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 48' ' ' MET . 87.7 m-20 -56.25 -56.56 19.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.118 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.01 -42.39 62.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 48.1 t80 -58.33 -41.11 83.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.479 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.681 HG21 ' C ' ' A' ' 44' ' ' GLY . 22.1 mm -67.44 -49.34 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.16 -49.16 78.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 t -62.07 -30.76 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.06 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 16.3 t80 -66.75 -44.19 82.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 0.0 109.92 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 40' ' ' MET . 44.2 mm -71.06 -55.97 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 109.812 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -55.63 -37.54 68.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.825 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -46.25 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.823 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -62.37 -36.71 83.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 91.7 p -66.95 -22.33 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.893 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -105.38 7.18 33.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 94' ' ' ASP . 7.7 m -101.19 -73.24 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 110.241 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -107.21 0.87 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -124.83 -64.93 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -1.112 . . . . 0.0 109.736 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.701 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 34.6 m-85 44.82 72.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.206 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -59.71 165.09 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.33 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -52.28 -30.09 26.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.187 -0.945 . . . . 0.0 109.111 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.58 -36.01 80.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 81' ' ' GLN . 43.0 mt-30 -70.96 -33.11 70.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.309 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.548 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 61.8 mtt -63.63 -29.44 70.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' OG ' ' A' ' 41' ' ' SER . 86.7 tt0 -57.0 -37.26 71.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 108.913 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' HG12 ' A' ' 77' ' ' ILE . 32.4 m120 -58.47 -31.69 68.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 23' ' ' ILE . 51.2 ttp -55.7 -31.79 62.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 108.852 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.735 ' OG ' HD12 ' A' ' 42' ' ' LEU . 85.4 p -55.64 -24.17 32.17 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.298 -0.876 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.9 mp -106.5 -25.37 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD11 ' A' ' 77' ' ' ILE . 88.3 mt -124.54 150.98 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.609 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.681 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.34 -108.36 3.54 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -53.08 -23.11 7.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -1.197 . . . . 0.0 108.709 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -68.14 -34.78 76.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.977 ' O ' HD13 ' A' ' 47' ' ' LEU . 2.4 tm? -52.32 -34.61 47.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 16' ' ' ASP . 68.2 mtt -58.21 -37.1 74.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -31.39 71.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.41 79.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 109.27 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.483 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 61.2 mtt . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 109.372 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 51.2 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -56.56 -45.3 81.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.09 -43.79 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.942 HD21 HD11 ' A' ' 47' ' ' LEU . 13.6 tp -69.01 -40.69 78.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.667 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 41.4 t0 -48.77 -43.89 38.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.7 mtm -64.6 -37.04 86.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.548 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.09 -45.15 79.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.93 ' O ' HG13 ' A' ' 74' ' ' VAL . 92.1 t80 -52.94 -40.5 63.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.46 -44.1 88.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.648 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 87.3 p -69.27 -37.83 78.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 43' ' ' ILE . 79.8 p -70.09 -44.95 68.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 70' ' ' PHE . 11.7 m -65.97 -34.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.1 -46.26 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.65 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 72' ' ' SER . 96.4 mt-30 -58.94 -36.13 74.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 109.969 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' A' ' 43' ' ' ILE . 72.5 mt -68.81 -54.87 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.701 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.55 -40.82 33.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 110.524 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.89 -28.81 64.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 109.464 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.4 p -80.89 -20.29 42.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HB3' ' NE2' ' A' ' 36' ' ' GLN . 60.2 mm-40 -93.29 117.94 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.639 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.95 101.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.01 -36.0 4.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -64.55 92.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 123' ' ' ALA . 6.4 mp -76.11 -8.55 57.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.674 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.2 -44.27 84.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' N ' ' A' ' 88' ' ' THR . 9.9 p -70.45 -48.29 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.183 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.607 ' N ' HG13 ' A' ' 87' ' ' VAL . 53.4 m -52.37 -36.04 52.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.928 -1.108 . . . . 0.0 108.404 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.493 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 31.9 m -55.53 -49.39 72.77 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 59.6 t30 -70.74 -37.27 73.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.21 -59.21 3.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 96' ' ' LEU . 49.2 mt -62.29 -48.92 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -58.97 -51.21 71.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.607 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.872 ' HB2' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -55.3 -45.36 76.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -59.33 -44.1 92.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.21 -0.931 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 92' ' ' ILE . 2.8 mt -70.09 -33.46 71.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.0 m -65.25 -49.04 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -0.859 . . . . 0.0 109.844 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 96.8 p -66.61 -39.69 88.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 0.0 109.813 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 103' ' ' THR . . . -60.85 -40.02 91.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 109.599 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.8 m-85 -52.97 -56.47 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.568 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.8 m-85 -72.18 -32.4 66.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.421 -0.799 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 98' ' ' SER . 93.6 mm-40 -70.34 -18.77 63.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.851 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.9 p -107.12 -60.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.116 . . . . 0.0 111.2 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -127.47 -42.84 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.647 -1.283 . . . . 0.0 111.156 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 112.14 46.68 0.74 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.7 t -102.87 171.92 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -1.178 . . . . 0.0 108.984 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 106' ' ' VAL . 15.5 m -73.86 120.26 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.598 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 21.1 p-10 -72.18 -29.09 63.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' SER . 94.0 p -58.73 -43.26 90.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 110.502 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -57.11 -53.7 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 1.108 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.3 t80 -75.19 -53.55 8.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 40.9 mt -56.29 -34.33 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.8 t -55.8 -43.15 76.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.043 -1.035 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.78 -36.66 73.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.108 HD11 ' CE2' ' A' ' 111' ' ' PHE . 51.0 mt -72.3 -41.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 116' ' ' ARG . 11.8 ttp85 -54.09 -41.26 68.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.84 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.1 mt -69.61 -43.97 71.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.875 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.704 HG22 HD23 ' A' ' 85' ' ' LEU . 73.0 mt -57.89 -47.24 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.851 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.97 -27.19 64.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.2 ttm -67.62 -42.35 82.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 97.4 m-85 -59.71 -31.96 70.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.558 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.666 HG23 ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -157.98 156.3 27.9 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 40.8 Cg_endo -64.85 -35.49 44.55 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.804 2.336 . . . . 0.0 112.941 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -84.56 12.46 6.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.666 ' CB ' HG23 ' A' ' 7' ' ' THR . 2.2 m -102.36 -19.53 14.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.943 . . . . 0.0 108.757 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 66.1 m -119.63 158.06 27.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 9.0 ttpt -74.38 -40.31 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.757 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -78.91 -36.65 41.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.542 HD22 ' C ' ' A' ' 103' ' ' THR . 0.2 OUTLIER -72.37 -29.63 63.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 109.991 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.33 -51.24 21.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 110.308 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 13' ' ' ALA . 1.7 p30 -54.95 -46.77 75.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 16' ' ' ASP . . . -58.53 -40.56 83.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.554 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.792 ' HA ' HG21 ' A' ' 103' ' ' THR . 51.5 t80 -63.64 -37.21 86.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 109.803 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.889 HG23 ' CE1' ' A' ' 70' ' ' PHE . 25.1 mm -71.78 -37.14 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 109.691 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -68.12 -49.42 61.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -64.66 -30.67 71.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 110.186 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.918 ' CE2' HD12 ' A' ' 96' ' ' LEU . 37.9 t80 -63.35 -51.51 65.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.98 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.3 mt -60.59 -56.08 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 109.98 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m -59.67 -32.6 70.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -77.66 -45.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.865 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -67.04 -33.21 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 110.054 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.499 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 62.7 m -63.48 -27.35 69.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 7.52 31.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 110.112 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 94' ' ' ASP . 25.8 m -92.58 -77.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.963 -1.085 . . . . 0.0 110.057 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -104.08 0.6 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 4.2 m -131.13 -60.45 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -1.1 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 8.0 m-85 44.25 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 p -59.71 160.39 7.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -52.8 -41.96 64.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -57.88 -36.02 71.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.477 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 98.3 mm-40 -69.96 -32.74 71.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.325 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.499 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 65.5 mtt -63.51 -32.0 73.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.3 -45.26 88.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -55.66 -39.26 70.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.98 ' SD ' HG23 ' A' ' 23' ' ' ILE . 63.2 mtt -57.29 -32.05 66.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 108.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.556 ' OG ' HD12 ' A' ' 42' ' ' LEU . 30.3 p -70.47 -23.52 62.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.35 -0.844 . . . . 0.0 109.39 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.556 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.7 mp -88.49 -23.46 23.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.554 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.008 HG21 ' CB ' ' A' ' 73' ' ' SER . 48.6 mt -131.22 143.0 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.162 -0.961 . . . . 0.0 109.296 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.65 -83.75 0.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.574 HD21 HD12 ' A' ' 23' ' ' ILE . 91.1 m-20 -61.3 -27.09 68.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.154 -1.203 . . . . 0.0 108.358 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -68.82 -35.07 76.52 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 66' ' ' LEU . 60.3 mt -53.33 -38.24 63.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.75 . . . . 0.0 109.306 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ttt -52.79 -41.35 64.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.63 70.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.0 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.83 -38.0 85.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 109.125 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 54.9 mtt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.261 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 15.4 tp . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -55.76 -30.97 62.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.335 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.3 68.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 108.958 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 47' ' ' LEU . 10.4 tt -74.14 -45.2 50.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.256 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.4 t0 -48.66 -42.53 34.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 89.7 mtp -64.39 -45.61 86.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.598 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.59 78.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.395 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.909 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.5 t80 -53.12 -38.93 63.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.3 -39.76 74.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -68.74 -40.79 79.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 43' ' ' ILE . 8.9 m -70.05 -47.87 60.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.628 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 70' ' ' PHE . 23.0 m -57.72 -35.08 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 119' ' ' ILE . . . -72.22 -35.19 68.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.8 tt0 -74.34 -44.15 53.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.82 -47.21 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.51 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.47 -52.8 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 109.803 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.86 -29.22 64.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.166 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 27.6 t -69.61 -20.19 63.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.292 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.477 ' OE1' ' HG3' ' A' ' 36' ' ' GLN . 45.2 mt-30 -54.64 -29.93 53.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.19 80.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.1 -156.94 29.09 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.602 ' O ' HG12 ' A' ' 87' ' ' VAL . 55.9 t0 -70.45 98.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -1.213 . . . . 0.0 109.403 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.048 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.4 tt -57.6 -16.34 10.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.63 -39.06 95.22 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.7 p -69.77 -37.59 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 109.602 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 78' ' ' ALA . 44.4 m -51.58 -32.06 27.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.088 -1.008 . . . . 0.0 108.735 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.79 HG23 ' HG2' ' A' ' 116' ' ' ARG . 22.1 m -59.94 -47.31 86.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 25.9 m120 -70.86 -33.49 70.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.426 -0.796 . . . . 0.0 109.018 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -71.65 -59.32 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.767 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.717 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 54.8 mt -63.34 -42.53 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -62.86 -52.36 63.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.628 ' HB3' HG21 ' A' ' 29' ' ' THR . 34.1 t0 -55.26 -50.48 69.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 109.332 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -55.9 -45.41 78.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.918 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.97 -33.85 72.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.897 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -68.97 -49.27 59.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.0 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.5 p -62.26 -34.44 76.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.907 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.83 -42.65 73.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.3 m-85 -46.94 -54.75 9.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.545 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.4 m-85 -71.66 -32.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 110.491 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 98' ' ' SER . 64.5 mm-40 -80.58 -18.45 48.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 110.129 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 18' ' ' PHE . 54.7 p -101.45 -59.05 1.77 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 111.053 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.452 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 23.0 m -126.05 -42.67 1.86 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 110.868 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 107.64 46.69 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 107' ' ' VAL . 5.0 t -114.69 172.97 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -1.159 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.605 ' H ' HG12 ' A' ' 106' ' ' VAL . 2.8 m -73.1 120.5 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.306 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.897 ' ND2' HG23 ' A' ' 97' ' ' THR . 12.4 p30 -70.84 -24.14 62.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.615 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 24.8 t -56.07 -30.2 61.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.505 -0.747 . . . . 0.0 110.342 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.482 ' HG3' HG23 ' A' ' 107' ' ' VAL . 35.4 mmt180 -67.94 -54.61 17.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.119 . . . . 0.0 110.234 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.908 ' CD2' HD21 ' A' ' 96' ' ' LEU . 1.2 t80 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.496 HD12 ' OD1' ' A' ' 108' ' ' ASN . 52.4 mt -56.41 -29.95 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.548 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 6.0 t -58.13 -47.33 83.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 85.5 tt0 -72.22 -37.7 69.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.681 HG12 ' HB1' ' A' ' 71' ' ' ALA . 47.1 mt -56.56 -46.29 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.917 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG23 ' A' ' 89' ' ' THR . 74.3 mtt180 -54.41 -49.12 70.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -59.17 -33.34 70.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.0 109.004 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 83.8 mt -73.75 -40.85 63.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.461 -0.774 . . . . 0.0 110.232 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.839 HG22 HD21 ' A' ' 85' ' ' LEU . 56.9 mt -61.08 -34.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 0.0 109.595 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.9 -32.45 70.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -65.64 -42.59 91.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.426 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 96.2 m-85 -63.23 -29.03 70.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.048 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 16.7 m120 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.557 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 4.5 t -143.5 152.51 56.96 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.127 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 42.6 Cg_endo -65.04 -35.4 42.88 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.466 2.111 . . . . 0.0 112.787 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.716 ' O ' HD22 ' A' ' 63' ' ' LEU . 49.5 p90 -80.82 7.25 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.626 -1.296 . . . . 0.0 109.737 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.9 OUTLIER -92.31 -20.57 20.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 108.718 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -136.69 144.66 44.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 108.949 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 22.1 mtmm -60.42 -46.43 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.3 71.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.355 -0.841 . . . . 0.0 109.476 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 14.1 m120 -72.36 -38.43 68.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -69.39 -51.8 33.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 48' ' ' MET . 17.2 m-20 -54.37 -51.11 65.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.29 91.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 108.7 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.517 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 58.8 t80 -58.56 -37.23 75.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.435 -0.791 . . . . 0.0 109.534 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.773 HD12 ' CD1' ' A' ' 70' ' ' PHE . 20.8 mm -71.01 -37.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -68.51 -50.02 55.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 34.4 t80 -65.12 -49.13 71.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 110.207 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.713 HD12 HD21 ' A' ' 45' ' ' ASN . 77.2 mt -61.99 -56.18 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -60.21 -32.12 70.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.913 . . . . 0.0 109.868 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.84 -44.46 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.096 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -69.97 -29.27 66.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.243 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -64.68 -28.5 69.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.963 . . . . 0.0 110.13 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.9 7.49 32.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 20.1 m -90.72 -78.5 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 -103.33 0.39 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.9 t -131.24 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -1.132 . . . . 0.0 109.445 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 12.5 m-85 43.73 88.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.315 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.2 m -59.73 161.05 6.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -52.64 -36.57 56.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.61 -36.05 83.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 99.8 mm-40 -71.91 -33.97 68.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 109.283 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.64 -33.71 76.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.08 -47.25 85.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.463 ' ND2' HG12 ' A' ' 77' ' ' ILE . 34.5 t-20 -55.65 -40.71 72.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.578 ' HE2' HG12 ' A' ' 23' ' ' ILE . 83.1 mtp -61.49 -31.85 71.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 109.11 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 m -70.3 -23.94 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 42' ' ' LEU . 4.2 mm? -90.55 -23.26 20.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.922 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.636 HG21 ' CB ' ' A' ' 73' ' ' SER . 64.0 mt -125.0 157.01 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.583 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.704 ' HA2' HD12 ' A' ' 47' ' ' LEU . . . 89.42 -83.85 1.41 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.726 ' OD1' HG22 ' A' ' 19' ' ' ILE . 92.5 m-20 -62.67 -33.87 75.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -1.217 . . . . 0.0 109.009 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -60.51 -35.28 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.362 -0.836 . . . . 0.0 109.232 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.704 HD12 ' HA2' ' A' ' 44' ' ' GLY . 6.5 mt -57.28 -35.77 70.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 0.0 109.46 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.44 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 69.7 mtm -52.84 -39.92 62.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.274 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.49 -32.93 72.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.875 . . . . 0.0 109.182 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.18 72.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.84 . . . . 0.0 109.206 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.462 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 64.6 mtt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.257 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 9' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -54.61 -40.11 68.56 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.359 -0.838 . . . . 0.0 108.955 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.85 68.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 108.959 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tp -73.51 -46.65 46.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.279 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.505 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 31.0 t0 -48.08 -46.79 34.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 109.732 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.55 -38.43 81.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 109.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.75 76.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.517 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 19' ' ' ILE . 84.1 t80 -55.23 -35.36 64.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.03 -37.33 85.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.805 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.6 m -67.77 -31.56 71.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.822 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.636 ' CB ' HG21 ' A' ' 43' ' ' ILE . 92.5 p -69.3 -49.12 58.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HD11 ' A' ' 92' ' ' ILE . 35.3 m -60.82 -35.01 61.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.436 -0.79 . . . . 0.0 109.982 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.57 -47.56 39.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.471 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.3 mt-30 -64.73 -50.47 66.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.887 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.505 HD13 ' HG2' ' A' ' 40' ' ' MET . 79.2 mt -55.01 -50.84 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 109.907 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.612 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -74.9 -51.86 12.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.815 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.92 -30.81 66.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 92.2 p -72.66 -20.47 61.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.432 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.452 ' HG2' ' CD ' ' A' ' 36' ' ' GLN . 28.1 mt-30 -49.3 -40.52 35.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.918 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.15 5.19 66.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.05 -155.39 27.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' HG12 ' A' ' 87' ' ' VAL . 53.8 t0 -66.06 105.39 1.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -1.088 . . . . 0.0 109.376 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 119' ' ' ILE . 23.7 tp -67.75 -14.01 62.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.03 -32.41 66.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.2 p -69.88 -35.71 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -1.174 . . . . 0.0 109.527 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 92' ' ' ILE . 73.7 m -51.59 -32.4 28.47 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.1 -1.0 . . . . 0.0 108.679 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 62.8 m -58.65 -46.62 86.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 79.7 m-20 -70.78 -38.24 73.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.467 -0.771 . . . . 0.0 109.096 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -68.32 -56.07 9.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.904 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.76 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 61.4 mt -66.7 -44.05 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.761 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -64.49 -50.85 65.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 109.892 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.2 m-20 -55.32 -43.13 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.946 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -67.91 -40.79 83.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.283 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -70.11 -34.54 73.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.804 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.674 HG23 ' ND2' ' A' ' 108' ' ' ASN . 55.3 m -67.64 -51.13 53.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.03 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 t -60.14 -35.29 74.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 109.887 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.85 -43.29 72.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -47.1 -54.97 9.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.027 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.3 m-85 -71.84 -32.69 67.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.468 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 98' ' ' SER . 96.5 mm-40 -75.9 -18.46 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.217 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 99' ' ' ALA . 55.9 p -104.77 -59.57 1.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.907 -1.12 . . . . 0.0 110.996 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 106' ' ' VAL . 25.6 p -126.41 -42.81 1.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.702 -1.249 . . . . 0.0 110.921 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.61 46.6 0.96 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.94 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.671 HG23 ' OG1' ' A' ' 104' ' ' THR . 5.7 t -108.22 172.44 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.188 -1.183 . . . . 0.0 109.101 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.593 ' H ' HG12 ' A' ' 106' ' ' VAL . 11.3 m -73.4 120.77 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.674 ' ND2' HG23 ' A' ' 97' ' ' THR . 14.4 p30 -71.35 -24.09 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.818 . . . . 0.0 109.779 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 113' ' ' SER . 50.2 m -60.18 -30.66 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 110.332 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -68.31 -54.76 15.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.363 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 115' ' ' ILE . 33.1 t80 -75.75 -50.39 15.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.046 -1.034 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.633 HG21 ' HB1' ' A' ' 93' ' ' ALA . 34.4 mt -56.43 -39.09 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.27 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' SER . 22.1 m -59.89 -38.53 82.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.45 -39.83 85.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.411 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 111' ' ' PHE . 84.7 mt -70.82 -42.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 16.4 ttt180 -54.34 -42.87 70.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -73.0 -33.76 65.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.964 . . . . 0.0 109.664 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.7 mt -68.93 -42.4 76.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.808 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' A' ' 85' ' ' LEU . 61.9 mt -57.66 -39.65 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.68 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.59 -28.31 73.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -69.09 -36.76 77.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 109.548 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.27 -35.43 80.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.559 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 68.3 m-20 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.944 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -133.77 151.69 77.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD2' HG22 ' A' ' 7' ' ' THR . 46.5 Cg_endo -67.78 -31.49 31.95 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.73 2.287 . . . . 0.0 111.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.817 ' O ' HD22 ' A' ' 63' ' ' LEU . 40.1 p90 -96.24 -14.26 22.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 m -70.03 -7.22 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -139.6 151.44 46.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -71.13 -40.28 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.567 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.16 -34.58 61.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.349 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 54.3 m-20 -71.56 -29.37 64.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -69.62 -40.85 76.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.775 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -58.73 -56.42 22.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 21' ' ' SER . . . -55.56 -36.17 66.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 8' ' ' PRO . 68.0 t80 -68.01 -48.88 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.092 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' A' ' 70' ' ' PHE . 41.1 mt -66.5 -44.54 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.36 -50.71 51.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.129 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 30.3 t -58.26 -30.31 66.48 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.867 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -72.31 -50.89 23.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.504 -0.748 . . . . 0.0 109.549 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 19' ' ' ILE . 72.1 mt -62.93 -55.91 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 m -57.19 -35.2 69.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.62 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.83 -48.3 16.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 32' ' ' PHE . . . -61.76 -34.61 76.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.775 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 19.3 m -64.1 -27.92 69.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.725 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.93 7.18 31.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.99 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.2 m -91.91 -75.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.081 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 -104.02 0.78 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -132.34 -58.65 0.94 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.37 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 7.5 m-85 44.19 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -59.59 162.89 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -52.66 -38.15 59.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.21 -37.8 84.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.281 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.541 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 72.3 mt-30 -68.24 -35.43 77.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.313 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.508 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 64.8 mtt -64.32 -36.8 85.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.48 -46.89 85.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.145 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -58.83 -41.21 86.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 43' ' ' ILE . 80.0 mtp -64.96 -32.05 73.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 m -69.99 -24.04 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -95.44 -17.16 21.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 80.8 mt -126.39 161.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -0.999 . . . . 0.0 109.509 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.514 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -79.98 1.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.48 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -1.116 . . . . 0.0 109.03 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -61.17 -35.36 76.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 0.0 109.038 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 HD23 ' A' ' 66' ' ' LEU . 24.7 tp -56.12 -36.19 67.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.848 . . . . 0.0 109.223 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.438 ' CG ' HD12 ' A' ' 19' ' ' ILE . 93.4 mmm -55.74 -33.01 63.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.13 79.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.96 . . . . 0.0 109.064 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.76 81.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 75.5 mmm . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.079 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.817 HD22 ' O ' ' A' ' 9' ' ' TRP . 3.7 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . 63.4 tt0 -54.28 -45.58 72.52 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.21 63.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 108.917 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.716 HD23 HD21 ' A' ' 47' ' ' LEU . 1.6 mt -73.93 -53.9 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.543 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 9' ' ' TRP . 0.8 OUTLIER -48.47 -39.06 21.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.727 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.429 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 92.7 mtp -67.37 -47.35 70.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.23 -44.4 75.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.841 ' CE1' HG23 ' A' ' 19' ' ' ILE . 82.7 t80 -54.17 -40.59 67.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.984 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -59.85 -40.96 90.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.5 t -69.47 -30.63 68.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 43' ' ' ILE . 36.4 m -70.02 -49.57 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 22' ' ' PHE . 10.8 m -62.72 -38.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.64 -48.21 34.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.921 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.56 -42.65 92.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 73' ' ' SER . 83.5 mt -61.96 -55.04 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.004 . . . . 0.0 109.984 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.84 -47.2 26.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.45 -0.781 . . . . 0.0 110.184 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 122' ' ' PHE . . . -57.78 -23.85 54.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.8 m -83.04 -20.58 34.73 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.541 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 22.2 tp60 -136.89 104.73 5.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.99 103.62 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.45 93.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 87' ' ' VAL . 82.8 m-20 -106.56 82.15 1.68 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -1.17 . . . . 0.0 109.141 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 123' ' ' ALA . 6.3 tp -43.64 -26.31 0.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 84' ' ' ASP . . . -61.92 -33.19 84.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.2 p -69.73 -44.52 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.235 . . . . 0.0 109.656 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 92' ' ' ILE . 84.5 m -51.85 -34.98 43.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 108.535 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 1.1 m -56.71 -49.23 75.77 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 76.4 m-20 -70.92 -40.79 71.9 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.39 -0.819 . . . . 0.0 109.065 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -63.31 -53.23 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.389 -0.82 . . . . 0.0 109.922 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 96' ' ' LEU . 66.4 mt -72.48 -48.99 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.963 . . . . 0.0 109.952 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.83 -46.74 88.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.907 . . . . 0.0 110.248 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' THR . 89.2 m-20 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.18 -41.54 84.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.868 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 92' ' ' ILE . 5.2 mt -69.64 -39.3 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.717 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 108' ' ' ASN . 38.5 m -61.51 -53.5 55.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.927 . . . . 0.0 110.185 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 m -62.82 -38.29 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 109.944 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -62.36 -45.69 92.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.612 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.69 -56.21 7.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.75 -32.27 67.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 98' ' ' SER . 79.0 mm-40 -77.37 -18.63 57.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 99' ' ' ALA . 74.1 p -104.66 -60.22 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.978 -1.076 . . . . 0.0 110.913 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.93 HG21 ' C ' ' A' ' 7' ' ' THR . 19.0 p -127.03 -42.75 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.783 -1.198 . . . . 0.0 110.871 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.09 47.02 0.9 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.675 HG23 ' OG1' ' A' ' 104' ' ' THR . 16.6 t -106.58 172.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.175 -1.191 . . . . 0.0 108.944 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -71.47 119.67 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' A' ' 97' ' ' THR . 22.6 p-10 -72.1 -31.68 66.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 113' ' ' SER . 14.9 t -57.44 -44.48 84.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -0.817 . . . . 0.0 110.481 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -57.36 -53.55 56.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.992 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.6 t80 -74.67 -53.94 8.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.978 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 93' ' ' ALA . 28.9 mt -56.34 -37.51 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.078 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' SER . 19.2 m -55.79 -48.54 75.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.065 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.96 -42.58 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.08 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.984 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.5 mt -70.97 -34.62 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 17.8 ttt180 -54.03 -45.73 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 109.398 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.26 -33.9 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.468 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 115' ' ' ILE . 19.2 mt -65.88 -41.08 92.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.799 HG22 HD11 ' A' ' 85' ' ' LEU . 99.0 mt -57.82 -37.13 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.18 -34.26 64.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.9 -38.09 89.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -1.167 . . . . 0.0 109.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 72.0 m-85 -69.97 -38.25 76.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 106' ' ' VAL . 25.4 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 9' ' ' TRP . 0.5 OUTLIER -165.11 156.48 12.92 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 38.4 Cg_endo -61.85 -32.25 85.43 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.561 2.174 . . . . 0.0 112.171 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 19.0 p90 -84.15 9.86 11.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 7' ' ' THR . 5.4 t -99.86 -22.75 15.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 0.0 108.763 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.459 ' HB2' ' CG ' ' A' ' 14' ' ' ASN . 69.9 m -118.89 157.74 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.468 -0.77 . . . . 0.0 109.113 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 24.1 ttpt -74.25 -40.71 62.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.943 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.19 -35.3 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 1.6 m-20 -72.24 -32.55 66.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.61 -47.21 49.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.087 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 68.1 m-20 -54.75 -56.31 20.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.86 . . . . 0.0 109.909 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.9 66.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.111 -0.993 . . . . 0.0 109.159 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 81.5 t80 -62.11 -41.1 97.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.288 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.768 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.8 mm -69.34 -49.11 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 16' ' ' ASP . 39.8 m-80 -62.03 -49.75 74.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -59.04 -34.91 72.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.751 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 16.6 t80 -67.14 -36.01 80.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.0 110.161 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 19' ' ' ILE . 66.1 mt -70.13 -56.03 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.17 -0.957 . . . . 0.0 110.315 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -62.7 -33.49 75.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -44.6 26.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.612 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.8 -29.36 64.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.031 -1.043 . . . . 0.0 110.444 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 2.3 t -60.92 -30.87 70.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.0 110.553 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -106.1 7.4 31.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.012 . . . . 0.0 110.682 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.816 HG21 ' CB ' ' A' ' 94' ' ' ASP . 13.3 m -91.54 -73.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 110.607 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -76.1 -105.4 0.13 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' PHE . 18.1 m -149.46 13.37 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.461 -1.023 . . . . 0.0 109.805 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 66.0 m-85 -39.77 109.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.1 p -72.21 164.22 26.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -53.29 -35.77 60.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.159 -0.963 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -68.05 -47.17 69.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 32' ' ' PHE . 68.9 mt-30 -64.7 -33.89 77.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 40' ' ' MET . 92.9 mmm -64.31 -30.13 71.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.03 -40.18 76.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.12 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.15 -42.22 85.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.218 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.708 ' HG3' HD13 ' A' ' 77' ' ' ILE . 58.0 mtt -57.38 -39.06 75.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 109.011 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.3 p -70.42 -23.54 62.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.406 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 tp -87.24 -13.78 42.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.743 HG21 ' CB ' ' A' ' 73' ' ' SER . 61.9 mt -133.45 168.02 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.597 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 66.53 -68.85 0.16 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ILE . 36.0 t-20 -60.76 -38.94 86.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.228 -1.16 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 m -62.38 -35.62 79.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 0.0 109.051 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 66' ' ' LEU . 8.7 mp -53.9 -37.49 63.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.731 ' O ' ' HE2' ' A' ' 51' ' ' MET . 60.7 mtm -52.75 -39.85 62.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.249 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.38 73.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.898 . . . . 0.0 109.041 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.12 -25.97 68.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.363 -0.835 . . . . 0.0 109.246 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.731 ' HE2' ' O ' ' A' ' 48' ' ' MET . 57.0 mtm . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 15.0 tp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -55.05 -29.77 58.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.062 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.79 90.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.287 -0.883 . . . . 0.0 109.078 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 47' ' ' LEU . 9.4 tt -69.07 -38.16 78.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.119 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 48.2 t0 -50.55 -48.81 57.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.557 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.45 -40.44 97.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 109.794 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.53 76.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.785 ' O ' HG13 ' A' ' 74' ' ' VAL . 77.2 t80 -55.71 -35.69 66.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.712 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.56 -36.93 83.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -69.32 -35.67 76.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.764 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.743 ' CB ' HG21 ' A' ' 43' ' ' ILE . 52.8 p -70.2 -49.83 46.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 109.821 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 70' ' ' PHE . 4.2 m -58.42 -34.94 52.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.73 -38.87 67.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.677 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.04 -49.88 58.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.176 -0.953 . . . . 0.0 109.763 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' HG3' ' A' ' 40' ' ' MET . 74.8 mt -55.18 -54.59 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.756 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -69.35 -50.81 42.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 109.855 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 1.029 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.95 -23.91 55.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.261 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.5 t -81.16 -20.3 41.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' OE1' ' CD1' ' A' ' 32' ' ' PHE . 24.1 mt-30 -48.37 -37.28 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 9.57 71.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.94 -175.82 22.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 87' ' ' VAL . 23.9 t0 -55.29 123.97 15.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -1.135 . . . . 0.0 109.363 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.029 HD11 ' HA ' ' A' ' 79' ' ' ALA . 1.1 tp -75.79 -19.03 59.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.596 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.23 -38.45 77.84 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.5 p -70.69 -41.07 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -1.195 . . . . 0.0 109.82 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.482 ' N ' HG13 ' A' ' 87' ' ' VAL . 25.8 m -51.65 -33.72 34.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.051 -1.031 . . . . 0.0 108.812 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.8 p -58.51 -46.17 87.29 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 26.5 m120 -70.82 -38.25 73.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.711 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -66.29 -58.95 4.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.143 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.751 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 22.8 mm -62.08 -43.77 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.625 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.45 -44.93 85.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 110.697 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 29' ' ' THR . 31.8 t0 -55.02 -54.07 47.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.879 -1.138 . . . . 0.0 109.789 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -64.08 -35.82 82.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.14 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.873 HD21 ' CD2' ' A' ' 111' ' ' PHE . 6.0 tp -69.94 -40.23 75.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.603 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.693 HG23 HD22 ' A' ' 108' ' ' ASN . 18.4 m -69.11 -52.6 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 16.8 m -60.27 -35.35 75.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.727 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -67.72 -39.33 84.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -53.41 -53.37 52.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -71.6 -32.08 67.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.502 -0.749 . . . . 0.0 110.465 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 98' ' ' SER . 70.6 mm-40 -78.84 -18.5 53.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 18' ' ' PHE . 66.1 p -102.72 -59.35 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.0 111.108 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.2 m -126.23 -42.54 1.84 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.882 -1.136 . . . . 0.0 110.707 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.58 47.92 1.01 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 6' ' ' ASN . 6.5 t -112.85 172.61 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -1.122 . . . . 0.0 109.322 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 110' ' ' ARG . 5.4 m -72.3 121.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.693 HD22 HG23 ' A' ' 97' ' ' THR . 16.7 p30 -69.9 -23.35 63.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 97.9 p -54.7 -30.6 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.592 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.788 ' HG3' HG23 ' A' ' 107' ' ' VAL . 23.6 mtp-105 -67.42 -55.01 15.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.873 ' CD2' HD21 ' A' ' 96' ' ' LEU . 3.0 t80 -75.8 -51.03 13.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.654 ' CG1' HD23 ' A' ' 96' ' ' LEU . 43.7 mt -56.39 -42.23 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 110.412 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' SER . 55.9 m -59.34 -35.26 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 109.677 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.7 mt-10 -72.65 -47.37 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.712 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -66.24 -40.67 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 109.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -54.37 -46.37 73.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 t -72.31 -34.22 67.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.62 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 118' ' ' LEU . 29.5 mt -68.77 -42.01 78.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' CD2' ' A' ' 85' ' ' LEU . 76.7 mt -59.61 -43.01 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.34 93.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.6 ttp -54.47 -44.26 72.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.576 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 98.4 m-85 -59.28 -38.92 81.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.805 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.694 ' C ' HG21 ' A' ' 104' ' ' THR . 72.9 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.629 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -147.54 145.37 21.33 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.1 Cg_endo -70.8 -35.39 9.67 Favored 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.401 2.067 . . . . 0.0 111.724 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.878 ' O ' HD23 ' A' ' 63' ' ' LEU . 41.8 p90 -85.72 -26.28 25.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.868 -1.145 . . . . 0.0 109.155 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.413 ' CB ' ' HG1' ' A' ' 7' ' ' THR . 88.2 p -62.8 -12.09 22.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 79.4 p -129.66 150.12 51.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.125 -0.984 . . . . 0.0 109.336 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 16.4 ttpt -74.36 -37.68 63.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.948 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.96 -50.12 63.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 109.191 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.3 m120 -72.42 -28.93 63.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.563 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -63.73 -44.3 93.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' CE ' ' A' ' 48' ' ' MET . 18.8 t0 -68.59 -50.98 47.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.88 . . . . 0.0 109.628 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.29 75.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.554 ' CA ' HG21 ' A' ' 103' ' ' THR . 73.5 t80 -58.89 -37.23 76.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 70' ' ' PHE . 44.0 mt -74.73 -37.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.761 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -50.55 51.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.772 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 31.3 t -60.74 -29.18 69.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.342 -0.849 . . . . 0.0 109.102 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.931 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 14.0 t80 -66.55 -51.1 60.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.017 HD12 ' HB3' ' A' ' 40' ' ' MET . 34.5 mm -64.56 -55.74 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.863 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t -60.29 -34.29 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 110.094 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.36 -45.22 26.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.982 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.33 73.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.91 . . . . 0.0 110.026 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 37.8 m -63.68 -28.46 69.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.088 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -106.25 7.14 31.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.086 -1.009 . . . . 0.0 110.311 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.604 HG21 ' CB ' ' A' ' 94' ' ' ASP . 21.0 m -91.48 -76.64 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.996 -1.065 . . . . 0.0 110.081 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 -104.2 0.57 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.5 t -134.21 -58.27 0.84 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.2 m-85 44.0 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 109.34 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -59.67 157.66 11.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -52.52 -30.8 32.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -71.48 -36.0 70.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.319 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 95.2 mm-40 -72.71 -32.29 65.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.26 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.438 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 64.5 mtt -63.96 -30.36 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.182 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.49 -44.3 84.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.699 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.3 m-20 -55.67 -42.07 74.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.955 . . . . 0.0 109.051 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.017 ' HB3' HD12 ' A' ' 23' ' ' ILE . 64.4 mtt -59.66 -32.08 70.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 p -70.27 -23.72 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.478 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 43' ' ' ILE . 73.7 mt -91.53 -19.92 22.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.927 HG21 ' HB3' ' A' ' 73' ' ' SER . 19.3 mm -129.04 151.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 86.25 -85.06 1.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.472 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 61.8 t-20 -59.88 -33.33 71.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -1.151 . . . . 0.0 108.533 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -63.06 -35.12 79.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 66' ' ' LEU . 60.1 mt -56.74 -35.1 68.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 45' ' ' ASN . 56.4 mtt -52.64 -40.91 63.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.047 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.57 73.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.67 81.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.364 -0.835 . . . . 0.0 109.09 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 67.5 mtt . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.878 HD23 ' O ' ' A' ' 9' ' ' TRP . 3.6 mp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.304 0.573 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 68' ' ' MET . 48.8 tt0 -54.15 -46.45 72.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 108.686 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.62 -40.92 66.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.139 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 HD13 ' A' ' 47' ' ' LEU . 32.2 tp -66.49 -52.24 48.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.8 t0 -47.36 -33.42 5.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 90.9 mtp -71.78 -37.29 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.62 -42.28 87.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.642 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.5 t80 -54.98 -37.81 67.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.006 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.66 -42.09 71.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.866 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -68.62 -30.78 69.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.943 . . . . 0.0 109.943 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.927 ' HB3' HG21 ' A' ' 43' ' ' ILE . 26.2 m -69.96 -49.12 54.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.722 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 71' ' ' ALA . 35.5 m -58.48 -34.96 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -68.75 -38.7 80.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -72.12 -44.13 63.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 39' ' ' ASN . 89.6 mt -54.07 -53.29 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.671 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -75.38 -49.28 19.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.842 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.93 -21.07 42.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 109.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 93.3 p -81.72 -20.2 39.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.256 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.48 ' HG2' ' OE1' ' A' ' 36' ' ' GLN . 25.4 mt-30 -51.79 -33.77 36.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.38 67.4 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.24 -175.62 33.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 87' ' ' VAL . 32.1 t0 -63.09 122.4 16.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.982 HD22 ' HB2' ' A' ' 123' ' ' ALA . 5.7 mp -71.33 -16.18 62.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.77 -47.75 69.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 88' ' ' THR . 9.8 p -70.47 -46.23 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.302 -1.116 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.605 ' N ' HG13 ' A' ' 87' ' ' VAL . 11.5 m -51.52 -36.27 44.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.075 -1.016 . . . . 0.0 108.393 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 55.0 m -54.96 -46.96 75.09 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.7 m-20 -70.79 -41.55 71.51 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -62.2 -58.77 6.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.615 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.811 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 40.6 mt -64.56 -41.66 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -66.14 -44.54 83.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -0.934 . . . . 0.0 109.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.604 ' CB ' HG21 ' A' ' 29' ' ' THR . 44.0 t0 -55.08 -50.87 68.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 109.473 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -54.7 -44.15 73.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.887 . . . . 0.0 109.232 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 93' ' ' ALA . 5.2 mt -69.88 -38.68 76.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.209 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.657 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.4 m -62.3 -46.56 88.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.803 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 7.8 m -70.62 -49.18 50.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.35 -44.99 68.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.61 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.11 -55.22 8.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.238 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 97' ' ' THR . 1.9 m-85 -71.97 -31.81 66.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.504 -0.747 . . . . 0.0 109.594 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' SER . 41.9 mt-30 -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.272 -0.893 . . . . 0.0 109.843 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 99' ' ' ALA . 69.8 p -105.94 -60.35 1.65 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.334 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.694 HG21 ' C ' ' A' ' 6' ' ' ASN . 17.1 m -126.92 -42.7 1.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.877 -1.139 . . . . 0.0 110.645 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.21 46.14 1.03 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.3 t -105.69 172.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.306 -1.114 . . . . 0.0 109.053 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 106' ' ' VAL . 23.0 m -73.55 121.01 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.348 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.657 ' ND2' HG23 ' A' ' 97' ' ' THR . 10.5 p30 -71.41 -28.35 63.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 113' ' ' SER . 22.9 t -56.93 -44.65 82.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -56.92 -54.15 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.973 -1.079 . . . . 0.0 109.975 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 69.1 t80 -75.58 -52.13 11.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.537 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.8 mt -56.67 -35.74 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 109' ' ' SER . 42.3 t -58.93 -30.25 67.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.94 -41.74 64.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.006 HG12 ' HB1' ' A' ' 71' ' ' ALA . 93.1 mt -72.59 -39.45 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -54.21 -43.16 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.6 p -72.23 -33.92 67.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -68.61 -45.24 72.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.865 HG22 HD23 ' A' ' 85' ' ' LEU . 64.9 mt -57.86 -44.88 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.22 -34.57 67.53 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.7 ttm -66.96 -42.33 85.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 109.467 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -64.66 -32.35 73.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.982 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.479 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 m120 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -129.85 163.68 45.48 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 49.9 Cg_endo -83.95 -34.23 0.28 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 C-N-CA 122.526 2.15 . . . . 0.0 111.626 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.606 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.4 p90 -90.27 -23.27 21.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.902 -1.124 . . . . 0.0 109.488 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -60.87 -12.57 11.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 70.5 m -132.01 153.67 50.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.583 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 28.9 mtmt -73.88 -39.19 64.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -65.92 -50.33 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.752 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 17.1 m120 -72.21 -29.06 63.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.35 -55.17 8.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.007 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 1.8 p30 -55.03 -46.8 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.507 -0.746 . . . . 0.0 109.882 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.44 -39.82 94.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 80.7 t80 -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 109.419 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' ALA . 33.2 mm -71.03 -44.07 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.42 -45.2 84.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 t -67.11 -30.72 70.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.884 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -66.31 -46.83 75.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.151 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 40' ' ' MET . 30.5 mm -64.89 -56.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.522 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 m -60.85 -31.9 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.98 . . . . 0.0 109.919 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -45.45 24.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.06 -34.1 76.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.362 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 m -57.35 -33.52 67.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.322 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -106.06 7.36 31.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.128 -0.983 . . . . 0.0 110.687 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.659 HG21 ' CB ' ' A' ' 94' ' ' ASP . 43.5 m -85.89 -81.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.801 -1.187 . . . . 0.0 110.201 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.14 -101.12 0.24 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -132.46 -61.51 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -1.059 . . . . 0.0 109.212 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.8 m-85 43.94 91.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.307 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.417 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 53.7 p -59.61 161.28 6.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.61 -40.72 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.84 -36.21 76.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.472 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.3 mm-40 -73.2 -32.28 64.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.66 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.6 mtt -63.23 -34.18 77.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.0 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.43 -43.11 91.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.855 . . . . 0.0 109.038 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -59.76 -42.58 93.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.912 ' HB3' HD12 ' A' ' 23' ' ' ILE . 75.1 mtm -66.75 -32.72 74.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.135 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.4 t -70.25 -24.02 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 17.0 tp -87.92 -22.81 24.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB2' ' A' ' 73' ' ' SER . 37.9 mm -116.15 162.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 90.83 -80.33 1.36 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.0 -38.14 78.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.7 m -60.17 -35.33 75.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.354 -0.841 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 66' ' ' LEU . 26.9 tp -59.52 -33.94 72.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.247 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 16' ' ' ASP . 60.3 mmm -56.65 -28.14 59.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.31 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.41 86.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.112 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -22.77 50.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.243 -0.911 . . . . 0.0 108.9 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.543 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 16.6 ttm . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.103 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 5.6 tp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.063 0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -54.68 -35.01 63.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 108.73 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -68.45 -43.56 76.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 27.0 t0 -48.57 -34.88 12.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.787 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.5 -37.31 77.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.91 . . . . 0.0 109.931 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.9 65.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.7 t80 -67.01 -35.92 80.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.786 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 25.2 t -69.69 -41.71 75.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 110.023 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB2' HG21 ' A' ' 43' ' ' ILE . 58.0 p -70.09 -47.12 63.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 110.28 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.2 m -57.2 -37.05 54.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.802 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' N ' HG23 ' A' ' 74' ' ' VAL . . . -73.92 -38.32 64.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 0.0 109.819 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 72' ' ' SER . 94.4 mt-30 -70.27 -46.23 64.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.828 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.438 HG21 ' HG3' ' A' ' 40' ' ' MET . 97.2 mt -56.2 -44.74 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 0.0 109.885 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.36 -50.14 12.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.896 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.13 48.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.8 m -76.2 -20.26 57.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.937 . . . . 0.0 109.457 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.6 mt-30 -55.86 -33.16 64.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.672 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.73 21.82 73.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.48 -149.41 19.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.04 120.65 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.016 HD11 HG22 ' A' ' 119' ' ' ILE . 5.3 tp -67.69 -18.46 64.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.287 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -28.36 70.25 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.86 -50.06 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -1.164 . . . . 0.0 109.569 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 92' ' ' ILE . 59.6 m -52.32 -49.52 64.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 56.9 m -51.68 -48.85 63.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.8 m-20 -70.86 -32.11 69.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -77.98 -59.04 2.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.763 HG22 HD11 ' A' ' 96' ' ' LEU . 31.3 mt -61.27 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.879 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.107 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.659 ' CB ' HG21 ' A' ' 29' ' ' THR . 42.9 t0 -55.14 -53.62 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.884 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.98 -42.98 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.763 HD11 HG22 ' A' ' 92' ' ' ILE . 6.7 mt -69.47 -40.52 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.748 HG23 HD22 ' A' ' 108' ' ' ASN . 76.0 m -62.77 -51.98 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.0 m -62.97 -36.61 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.602 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.78 -42.81 73.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.671 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.7 m-85 -47.3 -55.98 7.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.53 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.4 m-85 -71.06 -32.17 68.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 98' ' ' SER . 89.5 mm-40 -78.56 -18.36 54.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 18' ' ' PHE . 72.4 p -102.55 -59.97 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 111.149 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.598 HG21 ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.03 -42.36 1.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.779 -1.2 . . . . 0.0 110.807 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.34 47.93 0.9 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 107' ' ' VAL . 21.5 t -113.25 169.14 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.299 -1.118 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.581 HG23 ' CG ' ' A' ' 110' ' ' ARG . 15.8 m -67.43 121.22 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.856 . . . . 0.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.748 HD22 HG23 ' A' ' 97' ' ' THR . 11.6 p30 -71.14 -23.63 62.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 113' ' ' SER . 91.3 p -59.29 -33.34 70.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 110.794 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.581 ' CG ' HG23 ' A' ' 107' ' ' VAL . 78.2 mmt-85 -64.1 -55.42 22.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.742 -1.224 . . . . 0.0 110.33 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.2 t80 -76.28 -49.67 16.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.566 HG21 ' HB1' ' A' ' 93' ' ' ALA . 16.2 mt -56.65 -36.71 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 109' ' ' SER . 78.9 p -63.44 -34.79 78.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.04 -1.037 . . . . 0.0 109.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.31 -39.75 74.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.033 HD11 ' CE2' ' A' ' 111' ' ' PHE . 54.3 mt -72.77 -41.99 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -54.46 -42.38 70.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.4 t -72.01 -33.84 68.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.667 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 41.7 mt -68.36 -42.21 79.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.016 HG22 HD11 ' A' ' 85' ' ' LEU . 62.6 mt -58.51 -41.55 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -66.67 -30.85 76.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -66.99 -39.48 87.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.595 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.433 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 72.3 m-85 -60.59 -52.06 66.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.555 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.552 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.757 ' O ' HG21 ' A' ' 106' ' ' VAL . 76.4 m-20 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -165.11 145.35 5.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.9 Cg_endo -70.25 -35.12 11.73 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.414 2.076 . . . . 0.0 111.728 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.865 ' O ' HD13 ' A' ' 63' ' ' LEU . 39.5 p90 -85.58 -30.89 22.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 109.058 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -58.8 -15.09 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 109.57 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 51.0 m -127.15 143.69 51.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 109.343 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 4.0 ttpp -71.64 -37.14 70.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -68.45 -48.08 65.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 108.994 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 12.3 m120 -71.56 -28.93 64.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.38 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.23 -41.57 99.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.822 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.8 p30 -68.71 -50.12 53.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -56.57 -37.42 70.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.89 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.627 ' CA ' HG21 ' A' ' 103' ' ' THR . 69.3 t80 -65.78 -49.36 68.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.02 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.828 HG23 ' HE1' ' A' ' 70' ' ' PHE . 42.0 mt -63.14 -46.94 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -67.75 -50.3 57.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 108.945 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 69.4 m -56.11 -30.04 61.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 108.593 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 92' ' ' ILE . 46.8 t80 -71.44 -52.2 19.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.538 -0.726 . . . . 0.0 109.624 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 ' HE2' ' A' ' 40' ' ' MET . 56.8 mt -62.62 -55.74 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -53.76 -40.3 66.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.863 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.85 -46.0 22.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.088 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -60.42 -30.64 69.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 17.4 m -64.75 -31.4 72.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.968 . . . . 0.0 110.014 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.96 7.35 32.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' HB3' ' A' ' 94' ' ' ASP . 19.3 m -88.68 -75.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.95 -1.094 . . . . 0.0 110.054 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -88.49 -102.2 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -138.13 -55.64 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -1.115 . . . . 0.0 109.353 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.9 m-85 43.84 87.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.158 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.8 p -59.76 161.24 6.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.66 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -52.62 -31.95 39.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.143 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.113 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.502 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 82.3 mm-40 -76.19 -34.61 59.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 109.233 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 71.5 mtp -63.42 -36.73 84.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -56.89 -42.52 80.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.908 ' HB2' HG23 ' A' ' 77' ' ' ILE . 87.0 m-20 -59.5 -37.0 77.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.865 . . . . 0.0 109.052 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.584 ' HA ' HD13 ' A' ' 77' ' ' ILE . 90.8 mtp -65.18 -33.47 76.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.356 -0.84 . . . . 0.0 109.25 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -70.1 -24.22 63.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.246 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.9 tp -89.03 -20.61 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.747 ' HB ' HD11 ' A' ' 77' ' ' ILE . 65.0 mt -120.03 160.46 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 109.408 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -88.54 0.91 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.17 -37.18 64.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -1.164 . . . . 0.0 109.157 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 89.1 m -58.13 -34.86 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.267 -0.896 . . . . 0.0 108.81 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.71 -35.88 79.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.37 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 38.7 ttm -52.74 -37.56 59.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.291 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.8 -31.11 71.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.245 -0.909 . . . . 0.0 109.122 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.86 81.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.896 . . . . 0.0 109.239 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.427 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 62.9 mtm . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 0.0 109.251 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 9' ' ' TRP . 6.5 mt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.75 -49.62 70.4 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 108.591 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.52 -47.48 48.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.056 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.4 -53.32 59.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.9 t0 -47.87 -35.69 10.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.267 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.2 ttm -72.18 -40.89 67.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.59 91.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.828 ' HE1' HG23 ' A' ' 19' ' ' ILE . 75.0 t80 -54.48 -42.78 71.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.886 ' HB1' ' CG1' ' A' ' 115' ' ' ILE . . . -70.26 -38.19 75.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.764 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 84.3 p -69.17 -46.85 66.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.991 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.659 ' HB3' HD13 ' A' ' 43' ' ' ILE . 4.1 m -70.03 -45.33 67.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.71 ' HA ' HD12 ' A' ' 77' ' ' ILE . 9.8 p -57.71 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -67.35 -36.54 81.62 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.933 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 90.8 mt-30 -69.17 -38.3 78.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.834 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.908 HG23 ' HB2' ' A' ' 39' ' ' ASN . 56.5 mt -56.68 -55.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.848 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.68 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -78.85 -48.53 14.54 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 109.977 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.87 -22.25 47.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 30.0 t -81.13 -20.92 40.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.892 . . . . 0.0 109.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 31.5 mt-30 -44.68 -40.91 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.81 53.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.96 -158.73 12.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 87' ' ' VAL . 83.7 m-20 -54.33 127.48 27.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.783 HD11 HG22 ' A' ' 119' ' ' ILE . 5.5 tp -84.46 -20.87 31.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.71 63.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -68.95 -47.79 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 109.525 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . 22.5 m -51.7 -37.73 52.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.068 . . . . 0.0 108.251 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -55.34 -51.6 66.22 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 62.2 m-20 -70.86 -39.64 72.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -60.19 -55.35 34.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.51 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 22' ' ' PHE . 43.6 mt -72.23 -49.93 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.455 -0.778 . . . . 0.0 109.852 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -57.09 -46.2 82.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 110.654 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.781 ' HB3' HG21 ' A' ' 29' ' ' THR . 41.8 t0 -54.9 -53.77 51.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.941 -1.099 . . . . 0.0 109.89 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.718 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -57.14 -40.73 77.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.715 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 92' ' ' ILE . 15.0 mt -68.13 -41.45 81.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.7 m -58.61 -53.82 54.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.886 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 16.3 m -63.8 -45.14 91.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.13 -45.98 68.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.12 -0.987 . . . . 0.0 109.427 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.13 -54.27 10.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.973 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.76 -32.05 67.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.493 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 98' ' ' SER . 73.1 mt-30 -76.12 -18.51 59.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.821 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 99' ' ' ALA . 47.9 p -105.51 -59.73 1.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 111.209 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.558 HG21 ' N ' ' A' ' 7' ' ' THR . 5.5 m -126.55 -42.58 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.83 -1.169 . . . . 0.0 110.784 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.88 47.7 1.0 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.757 HG21 ' O ' ' A' ' 6' ' ' ASN . 48.1 t -112.78 168.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.309 -1.112 . . . . 0.0 108.945 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.8 m -67.29 121.04 15.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.3 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.689 ' ND2' HG23 ' A' ' 97' ' ' THR . 16.1 p-10 -70.53 -23.12 62.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.426 -0.797 . . . . 0.0 109.818 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' SER . 34.0 t -54.45 -30.34 52.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.858 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' A' ' 107' ' ' VAL . 93.5 mtt180 -68.15 -55.31 12.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.817 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 71.4 t80 -76.4 -50.66 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 110.343 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.531 HD11 ' N ' ' A' ' 97' ' ' THR . 17.3 mt -56.17 -45.77 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.836 . . . . 0.0 110.182 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 109' ' ' SER . 63.1 m -55.66 -39.25 70.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.0 109.392 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 80.8 tt0 -62.1 -49.71 74.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.886 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 81.2 mt -67.59 -34.7 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -53.7 -45.69 70.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.38 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.1 t -73.42 -33.68 65.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 49.1 mt -67.92 -45.51 74.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.783 HG22 HD11 ' A' ' 85' ' ' LEU . 87.5 mt -57.8 -34.54 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.997 . . . . 0.0 109.438 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.76 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -68.23 -36.77 85.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.45 -37.63 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -1.177 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 63.9 m-85 -66.56 -30.48 70.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.743 HG22 ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.8 157.39 32.02 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.064 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 49.0 Cg_endo -69.03 -34.6 16.64 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.566 2.178 . . . . 0.0 112.633 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.776 ' O ' HD22 ' A' ' 63' ' ' LEU . 48.9 p90 -83.28 1.48 40.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.964 -1.085 . . . . 0.0 110.074 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.743 ' OG ' HG22 ' A' ' 7' ' ' THR . 17.7 m -90.46 -28.26 18.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 108.933 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -104.23 154.58 19.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.352 -0.843 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -73.53 -37.78 65.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -35.21 25.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.643 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.68 HD22 ' C ' ' A' ' 103' ' ' THR . 0.2 OUTLIER -71.29 -29.17 64.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 109.602 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.43 -45.28 60.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 109.952 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 48' ' ' MET . 58.6 t0 -56.22 -54.06 49.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.99 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.8 -44.17 63.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.719 ' CA ' HG21 ' A' ' 103' ' ' THR . 72.8 t80 -56.97 -38.78 73.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.886 HG23 ' CE1' ' A' ' 70' ' ' PHE . 34.4 mm -69.35 -42.93 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.862 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -64.95 -49.24 71.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.029 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.6 t -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 12.0 t80 -64.28 -52.2 59.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.164 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' A' ' 40' ' ' MET . 37.9 mm -58.92 -55.97 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.179 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -64.76 -28.99 69.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.907 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.16 -43.07 29.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -74.25 -29.19 61.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.298 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 94.9 p -63.86 -27.68 69.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 110.226 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.06 7.26 31.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 0.0 110.5 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.1 m -92.08 -77.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.17 . . . . 0.0 110.292 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.0 -104.23 0.4 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' PHE . 35.8 t -131.06 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -1.065 . . . . 0.0 109.409 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.799 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 18.6 m-85 43.53 87.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.27 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 37.8 p -59.64 160.51 7.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 0.0 109.533 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -52.54 -35.78 54.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.226 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.12 -36.11 83.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.277 -0.89 . . . . 0.0 109.34 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.45 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.4 mm-40 -73.29 -31.88 64.3 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.059 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.437 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 63.9 mtt -63.43 -31.37 72.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.436 -0.79 . . . . 0.0 109.097 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -57.25 -44.71 84.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 109.168 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 77' ' ' ILE . 69.4 m-20 -56.28 -40.97 75.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.196 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.942 ' HB3' HD12 ' A' ' 23' ' ' ILE . 63.6 mtt -63.02 -32.12 73.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.038 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 m -70.02 -23.5 63.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.166 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.4 tp -89.05 -25.67 21.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.962 HG21 ' CB ' ' A' ' 73' ' ' SER . 62.2 mt -124.86 149.41 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 104.37 -81.01 0.32 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -62.29 -29.16 70.23 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.257 -1.143 . . . . 0.0 108.635 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.8 m -64.22 -35.16 79.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.495 -0.753 . . . . 0.0 108.995 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.29 -35.86 63.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' ' OD2' ' A' ' 16' ' ' ASP . 61.3 ttp -52.68 -40.11 62.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 109.076 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.96 81.34 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.95 66.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 48' ' ' MET . 65.7 mtt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 9' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.263 0.554 . . . . 0.0 109.633 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -54.41 -39.25 67.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 108.992 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.37 -36.61 68.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.06 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 66' ' ' LEU . 32.4 tp -74.28 -48.25 29.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.503 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.6 t0 -48.08 -37.92 16.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.319 -0.863 . . . . 0.0 109.702 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -72.22 -32.87 67.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.661 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.68 89.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.886 ' CE1' HG23 ' A' ' 19' ' ' ILE . 91.3 t80 -53.24 -36.31 60.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.952 . . . . 0.0 109.591 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -70.26 -35.29 73.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 m -69.12 -35.44 76.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.962 ' CB ' HG21 ' A' ' 43' ' ' ILE . 51.9 m -69.99 -49.25 53.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.714 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 70' ' ' PHE . 16.0 m -58.96 -35.0 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -67.45 -43.39 81.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.5 mt-30 -65.66 -45.85 81.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.3 mt -54.64 -51.42 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 109.692 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.799 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.08 -49.06 14.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.714 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.21 -23.96 57.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 88.9 p -80.58 -20.2 43.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 39.7 mt-30 -52.57 -30.67 32.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.97 19.27 70.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 -164.62 24.62 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 87' ' ' VAL . 84.2 m-20 -60.0 135.68 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -1.176 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.764 HD11 HG22 ' A' ' 119' ' ' ILE . 6.1 tp -84.43 -18.56 35.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.691 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.02 64.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 88' ' ' THR . 5.7 p -69.0 -46.47 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 109.584 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.565 ' N ' HG13 ' A' ' 87' ' ' VAL . 93.5 m -51.73 -35.75 44.44 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 108.628 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 44.7 m -56.21 -46.51 79.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.7 m-20 -71.01 -40.07 72.01 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.46 -59.08 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.745 HG22 HD11 ' A' ' 96' ' ' LEU . 24.5 mm -63.14 -49.41 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.33 -49.98 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 75.7 m-20 -55.26 -44.13 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -61.1 -43.81 98.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.415 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.745 HD11 HG22 ' A' ' 92' ' ' ILE . 2.7 mt -69.95 -38.62 76.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.7 m -60.72 -51.81 67.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 110.046 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 15.5 t -60.37 -47.65 85.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.979 . . . . 0.0 109.842 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 103' ' ' THR . . . -59.01 -41.73 88.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.595 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -46.58 -53.83 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.121 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -72.06 -31.9 66.56 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.518 -0.739 . . . . 0.0 109.995 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' SER . 42.2 mt-30 -78.33 -18.54 55.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 110.128 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.719 HG21 ' CA ' ' A' ' 18' ' ' PHE . 51.8 p -105.74 -58.75 1.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.917 -1.115 . . . . 0.0 111.284 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.5 m -125.89 -42.64 1.89 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.676 -1.265 . . . . 0.0 110.737 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.3 48.52 1.05 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 107' ' ' VAL . 4.9 t -111.7 172.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.39 -1.065 . . . . 0.0 109.117 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' H ' HG12 ' A' ' 106' ' ' VAL . 27.4 m -72.98 121.01 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 97' ' ' THR . 11.3 p30 -71.22 -29.22 64.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -58.15 -30.53 66.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.404 -0.81 . . . . 0.0 110.693 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -71.05 -54.34 11.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.884 -1.135 . . . . 0.0 109.994 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 1.121 ' CE2' HD11 ' A' ' 115' ' ' ILE . 56.4 t80 -75.61 -48.44 22.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.807 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.2 mt -56.28 -37.76 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.853 . . . . 0.0 109.949 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -55.8 -39.87 71.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.455 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.6 mt-10 -72.23 -38.82 68.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.121 HD11 ' CE2' ' A' ' 111' ' ' PHE . 49.3 mt -70.91 -43.68 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ttp85 -54.18 -38.14 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.84 . . . . 0.0 109.366 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -72.36 -33.85 67.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 66.4 mt -68.7 -38.79 80.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.764 HG22 HD11 ' A' ' 85' ' ' LEU . 63.5 mt -57.73 -35.87 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.745 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -70.35 -34.44 68.8 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 49.0 ttm -64.83 -38.61 91.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -1.157 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -64.52 -41.69 96.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.329 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 m120 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.581 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 9.1 t -136.48 150.61 70.99 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -65.94 -30.93 47.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.603 2.202 . . . . 0.0 112.904 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.581 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 44.0 p90 -81.34 -1.01 43.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.788 -1.195 . . . . 0.0 110.168 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 78.3 p -89.65 -14.94 33.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 108.86 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -140.94 149.0 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 109.071 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 31.2 mtmt -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.67 -50.34 72.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.755 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.9 m-20 -72.53 -32.83 66.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.862 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -67.15 -49.02 66.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.989 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.07 -56.07 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.938 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.08 -33.84 71.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.002 . . . . 0.0 109.367 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 52.3 t80 -67.64 -37.08 81.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.191 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.861 HG23 ' CE1' ' A' ' 70' ' ' PHE . 17.4 mt -74.04 -38.54 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -68.21 -50.29 55.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 p -59.99 -33.56 72.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 8.4 t80 -64.1 -35.94 82.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 109.844 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.474 HG12 ' CE ' ' A' ' 40' ' ' MET . 67.6 mt -71.6 -56.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -59.76 -30.79 69.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 109.905 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.09 -43.54 28.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 110.238 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -70.28 -34.46 72.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 0.0 110.396 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.475 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 92.6 p -61.59 -26.77 68.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.045 -1.034 . . . . 0.0 110.084 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -105.87 7.29 32.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 110.373 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.987 HG21 ' HB2' ' A' ' 94' ' ' ASP . 22.8 m -92.28 -78.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.914 -1.116 . . . . 0.0 110.298 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.37 -104.26 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -130.68 -61.17 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -1.084 . . . . 0.0 109.35 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 8.9 m-85 44.06 83.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 109.177 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -59.56 167.08 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.693 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -52.51 -43.59 65.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -56.19 -36.71 68.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.104 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.446 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 90.7 mm-40 -76.27 -35.4 58.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.475 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 62.4 mtt -63.31 -39.85 95.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.4 -43.12 83.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.039 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.3 m-20 -57.15 -39.93 76.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.134 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.474 ' CE ' HG12 ' A' ' 23' ' ' ILE . 77.0 mmm -58.25 -32.22 68.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 108.921 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 t -70.16 -24.19 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 46' ' ' THR . 63.0 mt -91.85 -16.83 26.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 77' ' ' ILE . 64.9 mt -119.6 166.45 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.186 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.688 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 68.35 -81.86 0.2 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.45 -40.23 68.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.035 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -60.06 -35.23 74.68 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 108.979 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt -55.18 -36.72 66.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.207 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.5 ttp -52.93 -43.16 66.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.902 . . . . 0.0 109.247 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.49 77.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.925 . . . . 0.0 108.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.51 -23.17 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.495 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 15.9 mmt . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.4 mp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.049 0.452 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -54.22 -38.45 65.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 108.919 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.79 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.276 -0.89 . . . . 0.0 108.687 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -74.1 -43.67 56.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 0.0 109.136 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 37.5 t0 -47.85 -40.23 20.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.835 . . . . 0.0 109.696 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.8 mtp -67.84 -30.67 70.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.86 85.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.861 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.8 t80 -54.58 -44.33 72.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.669 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.033 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -38.65 74.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.827 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -69.5 -36.68 76.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.975 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.616 ' HB2' HD13 ' A' ' 43' ' ' ILE . 85.7 p -70.12 -45.06 67.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 109.949 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.9 m -63.8 -35.02 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.41 93.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.797 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.33 -45.17 73.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.759 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -53.99 -47.65 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.49 -49.47 13.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.939 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.86 -26.24 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 81' ' ' GLN . 52.3 m -79.19 -20.15 49.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.462 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 26.6 mt-30 -45.2 -39.45 6.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.03 7.47 64.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.67 -159.57 26.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 87' ' ' VAL . 60.1 t0 -64.7 97.91 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -1.184 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.939 HD13 ' HA ' ' A' ' 79' ' ' ALA . 20.1 tp -58.89 -15.9 14.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.88 -35.4 84.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.5 p -70.1 -35.71 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -1.154 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.612 HG22 HD12 ' A' ' 92' ' ' ILE . 53.3 m -51.4 -33.31 29.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.046 -1.034 . . . . 0.0 108.424 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.542 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 3.7 m -57.03 -47.73 80.2 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 73.9 m-20 -70.97 -38.69 72.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.403 -0.811 . . . . 0.0 109.168 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.14 -53.85 32.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.733 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.72 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 62.7 mt -70.45 -45.26 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.727 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.75 -46.75 83.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.987 ' HB2' HG21 ' A' ' 29' ' ' THR . 76.7 m-20 -55.23 -49.65 71.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.67 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.664 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -67.93 -33.72 75.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.966 . . . . 0.0 108.833 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.78 -42.56 73.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.547 -0.721 . . . . 0.0 109.587 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 101' ' ' TYR . 60.4 m -65.46 -53.82 37.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 83.9 p -57.7 -42.99 84.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -58.3 -46.25 86.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.671 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -47.26 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 109.472 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 97' ' ' THR . 1.8 m-85 -68.57 -32.02 71.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.518 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 33.4 mt-30 -69.63 -18.79 63.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 110.051 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 18' ' ' PHE . 71.9 p -113.5 -59.37 2.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.123 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 106' ' ' VAL . 29.9 p -125.93 -42.45 1.89 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.764 -1.21 . . . . 0.0 110.639 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.61 47.74 1.02 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.59 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 35.1 t -101.19 158.55 4.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -1.149 . . . . 0.0 108.831 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 107' ' ' VAL . 30.4 m -58.35 121.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.608 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.3 p30 -70.83 -26.7 63.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 113' ' ' SER . 96.4 p -64.15 -31.81 73.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.307 -0.871 . . . . 0.0 110.871 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -66.14 -55.14 17.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.771 -1.205 . . . . 0.0 110.409 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 115' ' ' ILE . 55.1 t80 -75.92 -50.82 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 109.966 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.69 HG21 ' HB1' ' A' ' 93' ' ' ALA . 22.1 mt -56.28 -40.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.4 t -56.13 -38.85 71.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.82 -49.69 67.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.158 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.033 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -59.13 -34.67 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.149 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.542 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 9.6 ttt180 -53.7 -47.62 70.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.493 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.23 -33.92 65.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 115' ' ' ILE . 10.4 mt -66.1 -45.79 79.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.891 ' CG2' HD11 ' A' ' 85' ' ' LEU . 88.9 mt -57.69 -39.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.12 -36.05 64.17 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.4 ttm -58.18 -40.93 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.585 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.92 -28.41 69.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.261 0.553 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.83 HG22 ' OG ' ' A' ' 10' ' ' SER . 2.1 t -131.48 151.63 79.07 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -66.7 -34.36 32.09 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.487 2.124 . . . . 0.0 112.578 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -84.33 15.93 3.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.803 -1.186 . . . . 0.0 110.059 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.83 ' OG ' HG22 ' A' ' 7' ' ' THR . 2.5 m -95.26 -34.85 12.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.064 -1.022 . . . . 0.0 108.461 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 89.3 p -123.08 161.69 23.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 22.5 mtmt -74.04 -41.11 62.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.55 93.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 0.0 109.365 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 8' ' ' PRO . 25.5 t30 -71.6 -40.93 69.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -68.67 -38.64 80.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.877 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -54.96 -56.38 20.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.58 66.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.079 -1.013 . . . . 0.0 108.987 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 59.2 t80 -61.67 -46.98 87.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.126 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.665 HG21 ' C ' ' A' ' 44' ' ' GLY . 19.8 mm -63.08 -46.23 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.273 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -50.75 53.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.304 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 33.8 t -54.95 -29.85 57.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 108.903 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.608 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 30.7 t80 -72.22 -51.74 19.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 109.853 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.81 -55.89 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.048 . . . . 0.0 109.839 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -58.74 -36.55 74.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.892 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.88 -46.5 21.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.935 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -63.25 -33.7 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 110.173 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.434 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 45.0 m -64.05 -28.12 69.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.02 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.95 7.33 32.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 110.318 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 1.006 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.9 m -92.68 -76.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.865 -1.147 . . . . 0.0 110.187 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -84.67 -104.4 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.4 -59.09 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -1.09 . . . . 0.0 109.371 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 17.8 m-85 44.41 89.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.345 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 47.6 p -59.81 161.54 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.629 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -52.7 -41.14 63.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.96 -35.55 73.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.228 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 97.5 mm-40 -72.23 -32.37 66.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.255 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.434 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 60.3 mtt -63.45 -34.29 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -58.21 -45.54 87.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.041 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.0 m-20 -56.66 -43.23 80.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.297 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.486 ' O ' ' O ' ' A' ' 43' ' ' ILE . 63.6 mtt -59.47 -32.2 70.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 p -70.25 -23.58 62.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 12.5 tp -89.71 -25.17 21.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.74 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.982 HG21 ' HB3' ' A' ' 73' ' ' SER . 54.1 mt -125.34 149.75 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.665 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 95.25 -79.66 0.85 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.35 -30.59 70.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.265 -1.138 . . . . 0.0 108.454 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.1 m -67.35 -34.79 78.07 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 66' ' ' LEU . 52.6 mt -52.35 -32.9 40.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.449 -0.782 . . . . 0.0 109.181 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.4 ttm -57.46 -47.23 82.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.224 -0.922 . . . . 0.0 108.901 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.85 69.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.213 -0.929 . . . . 0.0 108.808 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.44 83.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.466 ' HE1' HD13 ' A' ' 63' ' ' LEU . 85.3 mmm . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.868 . . . . 0.0 109.015 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.66 HD23 ' C ' ' A' ' 10' ' ' SER . 13.5 tp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -55.67 -28.76 57.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.01 . . . . 0.0 109.179 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.57 91.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.584 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -67.33 -41.38 85.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 38.2 t0 -48.63 -47.85 39.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.52 -39.63 94.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.548 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.44 89.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.68 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.741 ' O ' HG13 ' A' ' 74' ' ' VAL . 87.4 t80 -58.62 -41.58 86.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -63.71 -35.58 81.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.655 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -69.36 -38.68 78.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.666 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.982 ' HB3' HG21 ' A' ' 43' ' ' ILE . 20.4 m -70.24 -48.69 55.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 70' ' ' PHE . 8.5 m -57.35 -34.73 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.254 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.94 -41.73 64.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 80' ' ' SER . 96.9 mt-30 -65.24 -50.3 66.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.449 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.9 mt -53.69 -48.98 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.579 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.54 -52.26 8.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.506 -0.746 . . . . 0.0 109.92 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.97 -23.19 52.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.497 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 90.6 p -81.67 -20.47 39.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 42.9 mt-30 -49.44 -35.11 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 109.381 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.47 9.19 79.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.76 -150.33 26.87 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 87' ' ' VAL . 19.2 t70 -71.23 128.1 34.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -1.204 . . . . 0.0 109.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.739 HD11 HG22 ' A' ' 119' ' ' ILE . 6.2 tp -80.26 -18.67 48.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.862 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.25 -40.13 61.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 88' ' ' THR . 4.7 p -67.0 -44.28 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -1.212 . . . . 0.0 109.695 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.565 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 28.1 m -51.66 -35.57 42.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 108.352 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 116' ' ' ARG . 6.8 m -54.03 -48.22 70.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.6 m120 -71.12 -39.88 71.76 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -62.12 -54.11 45.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.848 HG22 HD11 ' A' ' 96' ' ' LEU . 77.2 mt -72.24 -48.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.291 -0.881 . . . . 0.0 109.732 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.29 -50.77 72.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.91 . . . . 0.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 1.006 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.1 m-20 -55.41 -46.71 76.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.095 -1.003 . . . . 0.0 109.612 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.5 -43.46 89.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.382 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.848 HD11 HG22 ' A' ' 92' ' ' ILE . 3.8 mt -69.91 -33.3 71.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.518 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.731 HG23 ' OD1' ' A' ' 108' ' ' ASN . 92.7 m -67.57 -53.39 28.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.4 p -59.22 -35.55 73.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.689 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -70.01 -43.45 71.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.25 -56.23 7.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.551 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.552 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 8.0 m-85 -72.16 -32.02 66.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.454 -0.779 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 86.5 mm-40 -72.55 -18.74 61.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.7 p -103.6 -60.3 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.846 -1.158 . . . . 0.0 111.232 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.544 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.12 -42.91 1.68 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.691 -1.256 . . . . 0.0 110.875 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 113.71 45.31 0.72 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.1 t -106.0 172.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -1.211 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.581 ' H ' HG12 ' A' ' 106' ' ' VAL . 8.7 m -75.01 120.18 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.731 ' OD1' HG23 ' A' ' 97' ' ' THR . 1.2 p-10 -71.83 -23.79 61.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 0.0 109.844 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 113' ' ' SER . 29.8 m -59.17 -43.63 92.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 110.591 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -57.0 -53.58 56.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.0 110.027 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 1.153 ' CE2' HD11 ' A' ' 115' ' ' ILE . 70.7 t80 -75.29 -51.72 12.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.943 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.687 HD12 HD21 ' A' ' 108' ' ' ASN . 16.2 mt -58.71 -36.25 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.275 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.5 m -55.97 -43.3 77.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 0.0 109.83 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.04 -36.89 69.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.153 HD11 ' CE2' ' A' ' 111' ' ' PHE . 28.4 mt -62.78 -43.52 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.598 ' HG2' HG23 ' A' ' 89' ' ' THR . 34.6 mtp180 -54.06 -49.3 69.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.4 p -57.46 -33.17 67.69 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 115' ' ' ILE . 6.8 mt -73.51 -40.12 64.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.496 -0.752 . . . . 0.0 110.037 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.739 HG22 HD11 ' A' ' 85' ' ' LEU . 57.8 mt -61.21 -35.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 109.226 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.726 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.38 -34.09 64.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -61.99 -44.5 96.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 84.5 m-85 -59.1 -42.76 91.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.646 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -154.52 149.99 21.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.165 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 7' ' ' THR . 43.6 Cg_endo -67.0 -35.29 26.32 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.356 2.037 . . . . 0.0 111.977 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 7' ' ' THR . 45.8 p90 -90.01 -10.71 43.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 63' ' ' LEU . 58.3 m -70.62 -8.9 55.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -143.4 159.03 43.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.53 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 25.2 mtmt -74.73 -40.76 61.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.45 69.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -72.21 -29.11 63.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -71.43 -53.68 13.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -54.82 -56.1 23.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.659 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -0.982 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 80.0 t80 -63.44 -38.06 89.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.447 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.85 HG23 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -75.64 -38.3 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -68.33 -50.54 52.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.5 t -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.665 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 74' ' ' VAL . 25.6 t80 -64.79 -46.81 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 110.32 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.445 HG23 ' SD ' ' A' ' 40' ' ' MET . 82.8 mt -65.93 -56.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.161 -0.962 . . . . 0.0 110.251 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.4 p -54.05 -34.14 59.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.92 -47.4 18.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 110.011 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -62.34 -34.97 77.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.443 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 93.8 p -61.78 -30.1 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.007 . . . . 0.0 110.208 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -106.07 7.47 31.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.469 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.967 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.4 m -91.16 -78.27 0.4 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.13 . . . . 0.0 110.356 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.74 -103.53 0.38 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' PHE . 17.3 p -131.61 -61.34 0.91 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -1.108 . . . . 0.0 109.45 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 11.4 m-85 44.42 87.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.063 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -59.51 162.04 5.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -52.54 -39.66 61.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.22 -35.97 76.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.082 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.476 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 90.2 mm-40 -73.96 -32.62 63.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.187 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.443 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 58.1 mtt -63.91 -35.88 82.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.003 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -57.12 -49.14 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.397 -0.815 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 77' ' ' ILE . 74.5 m-20 -55.86 -37.33 68.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.091 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.476 ' HE3' ' CG ' ' A' ' 32' ' ' PHE . 64.1 mtt -57.36 -32.01 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.7 m -69.79 -24.15 63.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' THR . 62.0 mt -91.09 -19.71 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.051 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 44' ' ' GLY . 18.9 mm -116.33 167.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 0.0 109.12 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.637 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 69.19 -92.68 0.32 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -53.25 -39.73 64.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.14 . . . . 0.0 109.288 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m -58.71 -38.15 77.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.174 -0.954 . . . . 0.0 108.966 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 66' ' ' LEU . 34.2 tp -55.67 -32.96 63.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 109.133 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 51' ' ' MET . 18.1 ttt -54.85 -31.85 59.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.283 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.86 91.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.673 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.78 -26.44 68.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.389 -0.819 . . . . 0.0 108.919 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.53 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 28.5 ttm . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.423 -0.798 . . . . 0.0 109.225 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.0 mp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -53.54 -35.74 61.06 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.11 68.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 47' ' ' LEU . 10.9 mt -74.12 -51.25 16.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 24.3 t70 -46.9 -39.98 13.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 108.561 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 56.1 mtt -72.17 -45.44 60.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.847 . . . . 0.0 108.944 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.42 91.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 108.94 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 19' ' ' ILE . 79.8 t80 -52.19 -43.4 64.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.133 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.79 -39.07 73.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 109.596 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -69.29 -36.71 77.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.488 ' CB ' HG21 ' A' ' 43' ' ' ILE . 5.9 m -69.98 -44.26 69.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.807 HG21 ' CE1' ' A' ' 22' ' ' PHE . 8.7 p -67.44 -36.77 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 74' ' ' VAL . . . -61.55 -39.16 90.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.49 -39.66 77.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.647 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.2 mt -58.1 -49.58 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -77.38 -48.62 16.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.621 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.89 60.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.1 t -78.17 -20.35 52.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.571 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.5 mt-30 -49.98 -27.62 5.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.527 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.52 77.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.65 -148.18 23.77 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 87' ' ' VAL . 50.7 t0 -67.11 124.21 22.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.31 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 119' ' ' ILE . 4.3 tp -81.18 -21.77 39.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.255 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.1 -34.56 64.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 84' ' ' ASP . 3.6 p -67.11 -42.89 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.105 -1.232 . . . . 0.0 109.72 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 92' ' ' ILE . 51.9 m -51.54 -34.65 37.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.987 -1.071 . . . . 0.0 108.321 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 m -56.73 -49.8 74.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.1 m120 -70.61 -38.24 73.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 109.039 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.77 -53.4 47.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.612 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.77 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 66.6 mt -72.35 -45.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.866 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.83 -44.94 91.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.967 ' HB2' HG21 ' A' ' 29' ' ' THR . 48.7 m-20 -55.2 -48.51 73.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.953 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.4 -33.67 69.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.9 HD22 HD12 ' A' ' 115' ' ' ILE . 7.2 tp -70.03 -33.68 72.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.912 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 98.7 m -69.3 -53.82 17.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 14.3 m -62.51 -33.61 75.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 109.878 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -63.91 -33.68 76.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.0 m-85 -61.39 -56.25 22.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.558 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.3 m-85 -71.97 -32.1 66.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 109.683 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 98' ' ' SER . 85.3 mm-40 -71.19 -17.99 62.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.848 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 72.0 p -111.06 -59.65 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 111.254 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.667 HG21 ' C ' ' A' ' 7' ' ' THR . 26.7 p -126.33 -43.02 1.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.797 -1.189 . . . . 0.0 110.968 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.71 45.93 1.01 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.08 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.598 HG23 ' OG1' ' A' ' 104' ' ' THR . 18.4 t -101.89 171.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.159 -1.201 . . . . 0.0 108.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.0 m -71.48 120.55 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 0.0 109.799 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.604 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 24.2 p-10 -72.21 -33.32 67.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 109.97 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 113' ' ' SER . 29.8 m -57.82 -33.74 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 107' ' ' VAL . 67.1 ttt-85 -67.91 -54.47 18.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.832 -1.168 . . . . 0.0 110.095 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.757 ' CD2' HD21 ' A' ' 96' ' ' LEU . 32.3 t80 -75.46 -47.04 28.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.898 HG12 HD23 ' A' ' 96' ' ' LEU . 9.5 mt -56.01 -46.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 109' ' ' SER . 60.3 m -55.57 -41.45 73.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.004 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.65 -45.26 89.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.224 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.967 HG12 ' HB1' ' A' ' 71' ' ' ALA . 77.9 mt -66.99 -34.36 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.82 . . . . 0.0 109.162 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.527 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 19.7 ttt-85 -53.54 -49.01 68.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.0 p -70.16 -34.02 72.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 115' ' ' ILE . 13.9 mt -66.62 -44.97 80.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.668 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 85' ' ' LEU . 89.4 mt -57.66 -42.95 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.788 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.28 -36.9 63.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.2 ttp -56.81 -40.38 75.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 60.5 m-85 -62.0 -50.66 71.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.535 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.462 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 42.1 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.761 ' C ' HG21 ' A' ' 104' ' ' THR . 0.0 OUTLIER -146.95 150.14 37.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.8 Cg_endo -71.78 -35.07 8.05 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 111.543 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.927 ' O ' HD23 ' A' ' 63' ' ' LEU . 37.6 p90 -88.02 -30.71 19.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.011 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 36.0 t -55.63 -25.37 38.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.473 -0.767 . . . . 0.0 109.771 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 1.3 t -113.98 136.64 52.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.971 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 2.5 ttpp -65.27 -37.79 88.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -70.29 -43.9 69.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 11' ' ' SER . 12.6 m120 -71.6 -29.11 64.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.377 -0.827 . . . . 0.0 109.416 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -64.81 -44.15 90.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 110.187 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.636 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 2.7 p30 -64.06 -50.85 66.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.518 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.06 -32.86 73.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 108.903 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CG ' ' HB2' ' A' ' 8' ' ' PRO . 56.0 t80 -70.45 -43.45 69.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.816 HG23 ' HE1' ' A' ' 70' ' ' PHE . 27.6 mt -73.18 -44.63 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.525 -0.734 . . . . 0.0 109.041 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -68.08 -50.63 53.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.78 . . . . 0.0 109.182 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 74.1 m -57.46 -30.15 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.606 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' A' ' 74' ' ' VAL . 8.6 t80 -72.01 -50.03 32.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.512 -0.743 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 40' ' ' MET . 50.8 mm -64.94 -55.73 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.141 -0.974 . . . . 0.0 109.652 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -53.86 -39.71 65.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 0.0 109.909 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.72 -46.73 20.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 109.815 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.556 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -58.9 -35.67 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.703 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.529 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 85.8 p -64.05 -28.41 69.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.84 6.92 32.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.81 HG21 ' HB3' ' A' ' 94' ' ' ASP . 20.5 m -91.75 -76.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.047 -1.033 . . . . 0.0 110.033 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -82.49 -104.68 0.45 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -131.8 -60.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -1.126 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.793 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 43.58 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.343 -0.848 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.5 t -59.66 162.81 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -52.63 -39.49 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.373 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.51 -35.96 81.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 91.6 mm-40 -73.65 -32.29 63.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.5 mtt -63.6 -36.51 84.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.103 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.54 -47.41 84.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB2' HG23 ' A' ' 77' ' ' ILE . 86.3 m-20 -56.14 -45.26 79.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.0 ' HB3' HD12 ' A' ' 23' ' ' ILE . 56.2 mtm -57.15 -33.66 67.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 108.829 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.3 p -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 58.8 mt -87.19 -21.26 26.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 73' ' ' SER . 94.9 mt -121.87 143.77 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.244 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.78 -88.21 0.84 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.79 -32.45 70.63 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.165 -1.197 . . . . 0.0 108.282 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 91.8 m -59.15 -35.04 72.82 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 47' ' ' LEU . 69.0 mt -65.64 -40.21 92.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.636 ' HE2' ' HB3' ' A' ' 16' ' ' ASP . 89.5 mmm -52.74 -35.01 55.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.95 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.159 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.35 -36.12 78.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.223 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 54.6 mtt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.208 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.927 HD23 ' O ' ' A' ' 9' ' ' TRP . 2.0 mp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.404 0.621 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 62.9 tt0 -54.21 -35.69 62.68 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.077 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.69 15.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.683 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.621 HD21 HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.6 -46.68 36.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.274 -0.891 . . . . 0.0 110.987 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 9' ' ' TRP . 3.6 p-10 -47.78 -29.87 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.258 . . . . 0.0 109.805 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 68.7 mtp -72.66 -36.26 67.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.29 75.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.816 ' HE1' HG23 ' A' ' 19' ' ' ILE . 66.2 t80 -52.47 -37.13 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.46 -47.93 58.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -69.25 -30.77 68.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.039 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 43' ' ' ILE . 8.3 m -69.8 -45.84 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.881 HG21 ' CE1' ' A' ' 22' ' ' PHE . 9.6 p -68.93 -36.66 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -59.69 -40.85 89.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 109.727 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -70.72 -35.02 72.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 74' ' ' VAL . 94.2 mt -58.57 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.793 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.21 -41.64 57.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.672 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.57 61.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -76.77 -20.36 56.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.1 mt-30 -50.01 -37.84 34.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 109.46 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.77 81.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.51 -149.18 24.52 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.4 t0 -66.79 119.72 12.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 119' ' ' ILE . 7.0 tp -74.69 -24.16 58.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.9 64.39 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.6 p -69.1 -38.17 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.235 . . . . 0.0 109.844 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.616 HG22 HD12 ' A' ' 92' ' ' ILE . 54.1 m -54.7 -33.59 61.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.908 -1.12 . . . . 0.0 108.367 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.1 m -57.81 -49.25 77.29 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 68.2 m-20 -70.69 -41.06 72.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.494 -0.754 . . . . 0.0 109.154 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -64.54 -52.2 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.799 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 32.2 mt -72.81 -38.3 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -72.29 -43.22 64.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.81 ' HB3' HG21 ' A' ' 29' ' ' THR . 40.1 t0 -54.97 -45.74 75.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.927 -1.108 . . . . 0.0 109.795 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.81 -35.2 69.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.109 -0.994 . . . . 0.0 109.01 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.86 -40.4 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.563 HG23 ' OH ' ' A' ' 101' ' ' TYR . 52.4 m -67.66 -53.87 24.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.1 m -59.81 -44.08 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -55.65 -46.79 77.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.405 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 96' ' ' LEU . 1.5 m-85 -46.94 -56.6 6.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.73 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.576 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.99 -32.41 67.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.629 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 40.1 mt-30 -64.86 -18.54 65.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 43.0 p -115.16 -59.35 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 111.333 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.761 HG21 ' C ' ' A' ' 7' ' ' THR . 15.9 p -126.16 -43.17 1.81 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.648 -1.283 . . . . 0.0 110.969 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.16 45.37 1.01 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 19.8 t -98.06 163.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.073 -1.251 . . . . 0.0 108.689 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 107' ' ' VAL . 33.1 m -64.03 121.59 13.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.588 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.9 p30 -71.0 -33.69 70.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.057 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 113' ' ' SER . 87.2 p -57.23 -43.72 83.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.967 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.413 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.8 ttt180 -57.22 -54.58 45.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 0.0 110.156 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.845 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 49.0 t80 -75.56 -46.46 31.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 14.8 mt -63.0 -35.65 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 110.15 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.1 t -58.12 -32.84 68.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 96.9 mt-10 -72.34 -40.34 67.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.931 HG12 ' HB1' ' A' ' 71' ' ' ALA . 80.6 mt -69.34 -40.7 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -54.34 -44.76 72.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.0 p -72.98 -33.95 66.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 109.557 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 26.7 mt -67.91 -42.43 81.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 85' ' ' LEU . 65.8 mt -58.01 -39.29 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.388 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.793 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -63.56 -34.58 90.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 13.1 tpp -65.91 -38.32 88.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.68 -39.43 84.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.544 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 52.0 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.788 HG23 ' HB2' ' A' ' 10' ' ' SER . 2.8 t -141.27 151.31 61.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.61 -35.74 21.54 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.598 2.199 . . . . 0.0 112.744 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.577 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -82.13 9.08 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.737 -1.227 . . . . 0.0 109.525 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -95.25 -29.62 14.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 108.577 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.436 ' HG ' ' CG ' ' A' ' 14' ' ' ASN . 2.6 p -120.28 155.01 34.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.018 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 7.2 ttpt -71.53 -41.27 69.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.45 70.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 11' ' ' SER . 15.3 m120 -71.7 -28.9 64.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.339 -0.85 . . . . 0.0 109.941 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.04 -48.77 62.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.953 -1.092 . . . . 0.0 110.323 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 88.7 m-20 -58.57 -56.13 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.84 -42.38 65.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.62 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' HB2' HG21 ' A' ' 103' ' ' THR . 87.6 t80 -58.19 -37.05 74.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 70' ' ' PHE . 20.2 mm -70.92 -48.9 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 109.513 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -61.45 -49.75 75.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 109.753 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -58.36 -34.33 70.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 40.5 t80 -69.68 -35.94 75.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.587 HG23 ' HE3' ' A' ' 40' ' ' MET . 77.4 mt -70.43 -56.14 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.92 -34.52 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.05 -44.66 25.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 110.392 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.683 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.57 -33.08 68.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.01 . . . . 0.0 110.629 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.497 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 57.4 m -60.94 -28.27 68.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.42 7.49 31.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 0.0 110.847 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.955 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.3 m -93.48 -75.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.738 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -72.56 -104.08 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.456 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.8 t -148.42 13.29 0.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.495 -1.003 . . . . 0.0 109.904 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 44.7 m-85 -38.17 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.644 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' SER . 59.7 p -66.1 168.44 8.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.792 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 33.7 tt0 -52.74 -44.68 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -57.43 -41.72 81.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.287 -0.883 . . . . 0.0 109.332 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.463 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 77.9 mm-40 -74.61 -32.25 62.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.156 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.507 ' CE ' ' O ' ' A' ' 32' ' ' PHE . 66.3 mtt -66.2 -33.43 75.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.256 -0.902 . . . . 0.0 108.966 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 95.7 mt-10 -57.26 -40.39 77.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 109.272 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 77.0 m-20 -56.1 -38.6 70.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.071 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.587 ' HE3' HG23 ' A' ' 23' ' ' ILE . 64.4 mtm -62.49 -31.92 72.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.847 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 p -68.6 -23.71 64.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.405 -0.809 . . . . 0.0 109.062 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.5 tp -92.66 -23.39 18.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.055 HG21 ' CB ' ' A' ' 73' ' ' SER . 51.6 mt -132.35 149.27 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 97.15 -74.3 0.68 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.03 -34.93 69.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -1.104 . . . . 0.0 108.203 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -68.14 -34.84 77.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 66' ' ' LEU . 23.9 tp -52.47 -39.24 60.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.417 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 16' ' ' ASP . 70.0 mtm -52.4 -33.75 45.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 108.886 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.27 72.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.311 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.16 80.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.321 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.499 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 51.0 mtt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.255 -0.903 . . . . 0.0 109.271 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 14.5 tp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.01 -30.63 66.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HA ' ' HE2' ' A' ' 68' ' ' MET . . . -71.42 -34.5 70.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.292 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 47' ' ' LEU . 2.0 tp -73.68 -39.36 64.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.299 -0.875 . . . . 0.0 109.256 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' TRP . 31.5 t0 -49.46 -46.72 48.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 70.3 mtm -54.24 -39.14 66.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.435 -0.791 . . . . 0.0 109.798 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.84 72.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CD2' HD12 ' A' ' 19' ' ' ILE . 47.4 t80 -60.65 -35.47 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 115' ' ' ILE . . . -69.3 -30.5 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 m -69.3 -46.68 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 109.921 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 1.055 ' CB ' HG21 ' A' ' 43' ' ' ILE . 11.2 t -68.06 -48.49 65.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 92' ' ' ILE . 8.3 p -56.83 -38.53 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.7 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 122' ' ' PHE . . . -70.3 -34.63 72.96 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.242 -0.911 . . . . 0.0 109.46 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -76.26 -47.46 23.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 68.3 mt -53.36 -44.62 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.48 -50.69 11.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.82 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.33 44.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.202 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.5 p -81.4 -21.73 38.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.59 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG2' ' OE1' ' A' ' 36' ' ' GLN . 45.1 mt-30 -50.37 -32.76 18.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 109.557 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.27 11.02 85.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.29 -151.52 27.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.726 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.6 t70 -69.36 114.22 7.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -1.166 . . . . 0.0 109.256 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 119' ' ' ILE . 4.7 tp -62.46 -25.21 67.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.51 71.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.7 p -68.03 -36.88 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.104 -1.233 . . . . 0.0 109.774 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 92' ' ' ILE . 91.1 m -54.6 -32.24 58.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.982 -1.074 . . . . 0.0 108.513 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 24.9 m -60.2 -51.22 70.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 69.6 m-20 -70.59 -35.81 73.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.738 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -68.31 -55.69 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.582 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.742 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 39.6 mt -69.56 -50.49 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -56.93 -40.97 77.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.955 ' HB2' HG21 ' A' ' 29' ' ' THR . 7.1 m-20 -57.99 -54.28 48.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.683 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -68.08 -32.66 73.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 108.851 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.571 ' HB3' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -70.31 -41.05 73.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.732 . . . . 0.0 109.774 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.66 HG23 HD22 ' A' ' 108' ' ' ASN . 21.5 m -68.4 -53.99 20.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.015 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 50.9 m -59.81 -43.26 94.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.208 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -56.09 -46.37 79.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.5 m-85 -46.86 -54.48 9.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -0.87 . . . . 0.0 109.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.31 -31.42 67.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.544 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 60.9 mt-30 -70.77 -18.02 62.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 18' ' ' PHE . 59.1 p -110.82 -59.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 111.08 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 106' ' ' VAL . 18.0 p -126.82 -43.31 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.69 -1.256 . . . . 0.0 110.781 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.89 43.54 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.683 -1.246 . . . . 0.0 109.991 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.672 HG23 ' OG1' ' A' ' 104' ' ' THR . 13.7 t -99.21 169.59 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.104 -1.233 . . . . 0.0 108.62 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.4 m -69.57 121.66 19.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.376 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.66 HD22 HG23 ' A' ' 97' ' ' THR . 13.0 p30 -70.52 -24.08 62.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.643 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' SER . 39.9 m -60.91 -29.99 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.549 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -69.16 -55.0 11.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.123 . . . . 0.0 110.418 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' A' ' 115' ' ' ILE . 88.4 t80 -75.93 -50.6 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.571 HD11 ' HB3' ' A' ' 96' ' ' LEU . 53.1 mt -56.39 -36.51 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.177 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' SER . 3.9 m -56.69 -39.39 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.944 -1.097 . . . . 0.0 109.044 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.26 -42.13 65.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.282 -0.886 . . . . 0.0 109.233 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.739 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 32.8 mm -62.72 -49.37 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.363 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.523 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 6.8 ttt180 -54.12 -42.68 69.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.012 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.0 m -73.01 -33.42 65.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 115' ' ' ILE . 22.0 mt -68.5 -43.39 76.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.803 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.916 HG22 HD11 ' A' ' 85' ' ' LEU . 23.3 mt -57.89 -43.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -60.58 -34.74 87.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.3 ttm -62.74 -43.5 98.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.143 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE2' ' CB ' ' A' ' 75' ' ' ALA . 84.9 m-85 -59.63 -47.65 84.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.446 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.642 ' C ' HG21 ' A' ' 104' ' ' THR . 36.5 m-20 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.294 0.569 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -157.46 155.54 27.54 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.67 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.2 Cg_endo -69.23 -35.09 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.265 . . . . 0.0 111.386 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.854 ' O ' HD22 ' A' ' 63' ' ' LEU . 35.8 p90 -91.35 -23.65 20.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 108.998 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 63' ' ' LEU . 12.0 m -63.74 -14.47 52.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 108.651 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 73.3 m -140.52 122.58 15.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 109.076 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 13' ' ' ALA . 45.8 pttt -52.53 -43.92 65.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 12' ' ' LYS . . . -63.19 -36.58 84.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.8 -35.22 67.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -66.66 -27.9 68.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' CE ' ' A' ' 48' ' ' MET . 92.3 m-20 -54.73 -56.71 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.69 66.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' HA ' HG21 ' A' ' 103' ' ' THR . 50.8 t80 -71.18 -38.86 72.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.752 HG21 ' C ' ' A' ' 44' ' ' GLY . 13.9 mm -75.45 -47.74 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.896 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -62.5 -49.96 73.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -62.68 -30.39 71.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.181 -0.949 . . . . 0.0 110.103 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.766 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 29.3 t80 -71.43 -51.92 21.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.481 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 40' ' ' MET . 41.8 mm -61.24 -56.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.041 -1.037 . . . . 0.0 110.453 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -57.31 -38.21 73.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.943 . . . . 0.0 110.135 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.07 -45.94 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.962 . . . . 0.0 110.281 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -64.51 -37.56 87.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.458 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 65.7 p -59.17 -28.94 67.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -0.983 . . . . 0.0 110.5 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.18 7.36 31.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.999 -1.063 . . . . 0.0 110.745 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 1.01 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.2 m -94.64 -74.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.776 -1.202 . . . . 0.0 110.883 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -73.53 -104.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 33' ' ' SER . 42.5 p -147.74 13.36 1.03 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -1.049 . . . . 0.0 109.742 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 46.0 m-85 -38.34 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' SER . 31.0 m -60.15 162.33 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -53.09 -44.24 67.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.39 -0.819 . . . . 0.0 109.359 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -56.25 -41.39 75.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 84.3 mm-40 -72.34 -31.11 65.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.042 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 65.2 mtt -63.05 -32.39 73.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.32 -50.12 73.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 109.018 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.666 ' HB3' HD12 ' A' ' 23' ' ' ILE . 87.2 mtp -58.51 -37.63 76.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.78 . . . . 0.0 109.157 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.9 p -70.39 -24.12 62.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.233 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 tp -83.42 -20.69 33.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.858 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.05 HG21 ' CB ' ' A' ' 73' ' ' SER . 20.2 mm -120.48 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.345 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.752 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 100.8 -79.71 0.44 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 46' ' ' THR . 7.1 p30 -65.74 -35.93 82.12 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.272 -1.134 . . . . 0.0 108.195 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 60.5 m -62.14 -35.05 77.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.924 HD21 ' HG ' ' A' ' 66' ' ' LEU . 35.0 tp -61.22 -34.45 75.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.513 -0.742 . . . . 0.0 109.214 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 51' ' ' MET . 54.8 mtt -52.73 -37.96 60.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.166 -0.959 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.65 71.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.54 -49.78 51.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.385 -0.822 . . . . 0.0 108.952 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 66' ' ' LEU . 53.5 mtm . . . . . 0 N--CA 1.488 1.435 0 O-C-N 121.398 -0.814 . . . . 0.0 109.209 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.854 HD22 ' O ' ' A' ' 9' ' ' TRP . 10.0 mt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -53.55 -45.28 69.81 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.23 63.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.924 ' HG ' HD21 ' A' ' 47' ' ' LEU . 7.5 tt -70.49 -53.63 15.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.47 -0.769 . . . . 0.0 109.128 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.577 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 22.0 t0 -48.16 -46.89 35.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.2 mtp -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.99 73.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.0 109.5 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.674 ' O ' HG13 ' A' ' 74' ' ' VAL . 57.4 t80 -58.22 -38.32 76.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -68.22 -36.16 79.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 1.05 ' CB ' HG21 ' A' ' 43' ' ' ILE . 19.7 m -70.24 -43.45 70.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.709 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.0 m -68.37 -35.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 119' ' ' ILE . . . -65.16 -39.92 93.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.77 -45.18 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 40' ' ' MET . 91.8 mt -56.67 -46.16 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.666 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -67.55 -51.87 45.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.605 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -58.09 -24.51 58.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -76.3 -20.43 57.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 46.5 mt-30 -51.55 -31.87 25.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 10.27 82.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.45 -160.91 26.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.68 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.7 t70 -69.58 101.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 119' ' ' ILE . 25.9 tp -52.92 -20.36 3.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.627 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.07 -33.97 87.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 84' ' ' ASP . 8.0 p -69.2 -35.81 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.196 . . . . 0.0 109.703 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.666 ' OG1' ' HB1' ' A' ' 78' ' ' ALA . 64.1 m -51.65 -32.15 28.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.034 -1.041 . . . . 0.0 108.623 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 37.5 m -58.33 -45.5 87.99 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 83.2 m-20 -70.77 -38.29 73.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.073 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.627 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -69.09 -58.82 3.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 109.557 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.766 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 35.9 mm -61.25 -45.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 112' ' ' ILE . . . -65.86 -49.06 69.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 1.01 ' HB2' HG21 ' A' ' 29' ' ' THR . 86.0 m-20 -55.29 -46.02 76.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.184 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -68.62 -38.72 80.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.0 -42.96 72.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.526 HG22 ' CE2' ' A' ' 101' ' ' TYR . 88.7 m -60.57 -50.93 71.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.722 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 102' ' ' GLN . 31.2 t -60.41 -33.98 73.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.967 . . . . 0.0 109.525 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.4 -44.34 68.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.425 -0.797 . . . . 0.0 109.996 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.0 OUTLIER -47.89 -56.34 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -69.2 -32.11 71.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 98' ' ' SER . 78.4 mm-40 -79.52 -18.49 51.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 18' ' ' PHE . 71.3 p -106.53 -59.15 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.936 -1.103 . . . . 0.0 111.177 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.642 HG21 ' C ' ' A' ' 6' ' ' ASN . 48.1 m -125.14 -42.44 2.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.838 -1.164 . . . . 0.0 111.002 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.1 47.33 1.16 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 17.6 t -110.36 172.22 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.287 -1.125 . . . . 0.0 108.915 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.569 ' H ' HG12 ' A' ' 106' ' ' VAL . 35.1 m -68.59 121.17 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.609 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 19.2 p-10 -71.08 -23.7 62.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.833 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 113' ' ' SER . 20.6 t -66.88 -30.17 70.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 0.0 110.932 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.67 -55.1 14.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.822 -1.174 . . . . 0.0 110.515 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.841 ' HD2' HD21 ' A' ' 96' ' ' LEU . 6.4 t80 -75.79 -49.25 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 110.205 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.599 HG21 ' CB ' ' A' ' 93' ' ' ALA . 20.5 mt -56.3 -36.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' SER . 4.5 m -60.91 -40.81 94.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.74 -38.33 76.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.234 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 118' ' ' LEU . 69.1 mt -69.38 -43.16 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -54.24 -38.99 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.7 m -73.42 -35.9 65.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 109.693 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 115' ' ' ILE . 20.8 mt -65.2 -38.88 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.829 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.961 ' CG2' HD11 ' A' ' 85' ' ' LEU . 65.8 mt -61.67 -42.67 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.91 92.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.658 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 23.3 m-85 -64.34 -34.72 78.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.687 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.2 t -154.46 150.21 21.62 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 41.7 Cg_endo -64.3 -30.65 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 49.1 p90 -88.42 18.74 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.0 109.05 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.5 OUTLIER -105.48 -30.98 9.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -123.59 142.92 50.57 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 0.6 OUTLIER -60.77 -43.77 97.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.946 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.9 m-20 -72.17 -29.57 64.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -65.35 -37.33 86.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.499 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.03 -56.17 12.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.071 -1.018 . . . . 0.0 110.077 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.21 -29.76 15.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 109.567 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 56.3 t80 -69.85 -44.09 70.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.754 HG21 ' C ' ' A' ' 44' ' ' GLY . 18.5 mm -68.64 -44.94 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.196 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -68.25 -50.78 51.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.4 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 51.1 m -58.45 -29.64 66.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.049 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.716 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 25.8 t80 -72.23 -51.92 18.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.129 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.935 HD12 ' HB3' ' A' ' 40' ' ' MET . 19.4 mm -66.21 -55.87 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.007 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -57.44 -36.7 71.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.931 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.96 -44.75 25.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 110.193 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -27.36 68.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 55.1 m -65.21 -31.15 72.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.336 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.4 p-10 -105.93 7.71 32.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.065 -1.022 . . . . 0.0 110.364 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.5 m -89.0 -77.14 0.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.914 -1.116 . . . . 0.0 110.255 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.81 -102.61 0.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -132.95 -62.38 0.81 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.462 -1.022 . . . . 0.0 109.314 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 14.3 m-85 45.54 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.3 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 m -59.37 158.63 9.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -52.42 -40.0 61.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 33' ' ' SER . 19.0 p-10 -61.38 -36.07 79.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.7 mm-40 -67.81 -31.65 71.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.219 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.567 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.8 mtt -63.28 -36.75 84.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 109.001 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 65.5 mm-40 -58.92 -48.7 80.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.114 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -60.56 -46.13 91.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.858 . . . . 0.0 109.021 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.935 ' HB3' HD12 ' A' ' 23' ' ' ILE . 70.9 mtm -61.61 -35.88 79.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.424 -0.797 . . . . 0.0 108.851 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -70.23 -24.1 63.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 46' ' ' THR . 12.1 tp -84.45 -22.07 30.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.836 HG21 ' CB ' ' A' ' 73' ' ' SER . 12.0 mm -118.04 149.4 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.754 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.06 -77.38 1.6 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.91 -39.29 90.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.193 -1.18 . . . . 0.0 108.22 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 84.9 m -63.0 -35.27 79.65 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.099 HD21 ' CD1' ' A' ' 66' ' ' LEU . 29.1 tp -57.82 -36.48 72.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.659 -0.65 . . . . 0.0 109.532 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 94.6 mmm -52.78 -29.46 27.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.252 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.9 76.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.02 86.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.153 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 13.0 mmt . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 108.989 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 57.3 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -54.78 -44.54 73.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.945 . . . . 0.0 109.017 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.41 69.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.099 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -74.31 -43.64 55.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.031 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 42.0 t0 -48.53 -43.86 35.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.12 -34.36 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.935 . . . . 0.0 109.813 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.54 79.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 109.816 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.843 ' O ' HG13 ' A' ' 74' ' ' VAL . 86.6 t80 -61.51 -36.86 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.7 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.36 -29.05 65.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.935 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -69.32 -46.98 65.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.167 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.836 ' CB ' HG21 ' A' ' 43' ' ' ILE . 1.1 t -70.07 -45.99 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 70' ' ' PHE . 13.7 m -57.4 -35.41 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -73.8 -40.81 63.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.781 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 80' ' ' SER . 50.1 tt0 -68.47 -43.24 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 109.724 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.602 HG21 ' CG ' ' A' ' 40' ' ' MET . 99.4 mt -56.35 -52.38 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -73.33 -50.62 21.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 0.0 109.841 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.41 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.398 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 90.0 p -81.4 -20.65 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 34.8 mt-30 -48.97 -36.96 18.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 22.29 41.9 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.03 -157.39 13.75 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 76.8 m-20 -62.6 134.4 56.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.099 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 119' ' ' ILE . 6.3 tp -84.95 -19.4 32.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.59 64.82 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -69.99 -44.93 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 109.696 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 87' ' ' VAL . 80.0 m -51.61 -34.75 38.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.975 -1.078 . . . . 0.0 108.493 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 23.8 m -56.2 -48.7 75.9 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 m120 -70.72 -39.3 73.48 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.169 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -65.25 -57.45 8.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.732 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' LEU . 48.2 mt -66.46 -45.97 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.8 -49.02 74.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 0.0 110.059 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.3 m-20 -54.99 -41.68 71.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.363 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -62.62 -44.59 95.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.304 -0.873 . . . . 0.0 109.049 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.963 HD13 HD12 ' A' ' 115' ' ' ILE . 7.1 mt -70.42 -36.01 73.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.505 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.556 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 93.5 m -64.82 -53.7 42.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 110.009 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 14.5 m -62.08 -49.2 76.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.121 -0.987 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.5 -44.37 68.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER -46.96 -55.95 7.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 109.324 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.573 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 4.1 m-85 -71.97 -31.91 66.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.44 -0.787 . . . . 0.0 109.675 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 98' ' ' SER . 65.1 mt-30 -73.19 -18.39 61.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.676 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 99' ' ' ALA . 34.7 p -107.29 -60.22 1.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.936 -1.103 . . . . 0.0 111.173 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.831 ' CG2' HG23 ' A' ' 106' ' ' VAL . 12.3 t -127.05 -43.07 1.69 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.813 -1.179 . . . . 0.0 110.845 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.98 46.82 0.92 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 104' ' ' THR . 57.4 t -103.07 167.86 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.271 -1.135 . . . . 0.0 108.937 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 107' ' ' VAL . 33.5 m -66.07 121.45 15.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.755 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 20.8 p-10 -71.07 -23.74 62.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.428 -0.795 . . . . 0.0 109.939 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 113' ' ' SER . 90.2 p -68.7 -34.84 76.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -62.36 -54.52 39.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.862 -1.148 . . . . 0.0 110.473 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 115' ' ' ILE . 57.4 t80 -75.73 -53.29 8.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 110.204 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 93' ' ' ALA . 21.2 mt -56.36 -28.37 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 109' ' ' SER . 9.6 t -58.81 -42.29 88.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.622 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.48 -36.35 65.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 111' ' ' PHE . 30.8 mt -67.54 -41.22 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.647 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 113' ' ' SER . 31.8 ptt85 -54.04 -43.12 69.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.852 -1.155 . . . . 0.0 109.638 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.492 ' N ' ' CG ' ' A' ' 116' ' ' ARG . 87.0 p -71.44 -33.82 69.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.548 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.8 mt -66.45 -38.12 86.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.766 HG22 HD11 ' A' ' 85' ' ' LEU . 67.3 mt -61.5 -35.71 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.023 . . . . 0.0 109.454 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -67.93 -34.24 81.66 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.0 ttm -60.75 -43.68 97.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.16 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 97.7 m-85 -59.14 -50.17 75.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' O ' ' OG1' ' A' ' 104' ' ' THR . 19.0 m120 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.927 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -135.97 151.75 74.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.436 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.0 Cg_endo -68.66 -35.39 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.561 2.174 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.836 ' O ' HD22 ' A' ' 63' ' ' LEU . 45.3 p90 -91.48 -11.39 37.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 109.082 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -72.05 -5.34 34.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.898 . . . . 0.0 109.413 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 1.9 t -140.79 153.9 46.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.361 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 2.5 ttpm? -73.81 -39.7 63.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.612 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.45 -33.01 42.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.259 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 7' ' ' THR . 34.2 t30 -71.53 -29.47 64.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.79 -43.06 72.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -54.36 -56.33 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.717 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.4 45.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 109.298 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 47.2 t80 -68.73 -52.6 28.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.898 HG23 ' CE1' ' A' ' 70' ' ' PHE . 10.0 mm -60.15 -44.14 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -67.49 -50.87 56.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -57.66 -30.12 65.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.203 -0.936 . . . . 0.0 108.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 19.2 t80 -72.29 -52.21 17.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG12 ' CE ' ' A' ' 40' ' ' MET . 69.4 mt -61.9 -56.12 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.687 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -53.91 -37.24 63.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -51.54 10.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.924 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.67 64.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.105 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.635 ' HB2' ' HE1' ' A' ' 37' ' ' MET . 45.8 p -68.37 -33.41 74.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.249 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -105.67 7.19 32.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 94' ' ' ASP . 8.9 m -87.16 -77.09 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.956 -1.09 . . . . 0.0 110.224 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -101.4 0.61 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 76.5 p -141.32 -53.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.429 -1.042 . . . . 0.0 109.344 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 15.7 m-85 44.5 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 37' ' ' MET . 32.2 t -59.68 159.97 7.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -52.38 -38.4 58.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.07 -37.18 86.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.115 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.526 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 81.8 mm-40 -76.32 -36.17 58.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.635 ' HE1' ' HB2' ' A' ' 27' ' ' SER . 79.6 mtp -63.97 -37.43 87.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.132 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -56.89 -41.2 77.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.171 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.78 ' HB3' HG23 ' A' ' 77' ' ' ILE . 46.0 t-20 -56.07 -35.08 66.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 108.916 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.52 ' SD ' HD13 ' A' ' 77' ' ' ILE . 92.8 mmm -57.12 -31.69 65.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 m -67.55 -24.08 65.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.915 . . . . 0.0 109.28 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 46' ' ' THR . 66.9 mt -92.08 -28.22 17.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.0 ' HB ' HD11 ' A' ' 77' ' ' ILE . 63.9 mt -116.81 154.99 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.422 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.852 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.16 -89.79 1.62 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -59.58 -32.4 70.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 108.834 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 34.2 m -65.95 -35.08 79.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 108.922 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 66' ' ' LEU . 29.8 tp -54.97 -38.63 68.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.79 . . . . 0.0 109.222 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.9 ttt -52.83 -36.16 58.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.31 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.21 72.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.193 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.83 72.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 64.0 mtm . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.215 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 9' ' ' TRP . 2.6 mt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' MET . 85.1 mt-30 -54.75 -48.29 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.123 -0.986 . . . . 0.0 108.628 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.5 55.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.395 -0.816 . . . . 0.0 109.267 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 47' ' ' LEU . 1.8 tp -61.54 -50.82 71.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.581 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 26.3 t0 -47.99 -37.01 13.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 63.5 mtt -65.84 -32.13 73.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.37 93.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.9 t80 -53.59 -38.93 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.875 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.744 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -68.94 -40.49 78.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.6 m -69.35 -45.64 68.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.776 ' HB3' HD13 ' A' ' 43' ' ' ILE . 12.3 m -70.01 -47.24 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 109.766 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 7.5 p -58.4 -44.16 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.603 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -62.8 -37.24 85.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.0 tt0 -68.41 -43.12 77.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 43' ' ' ILE . 78.8 mt -53.78 -52.46 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.591 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.46 -50.84 10.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.782 . . . . 0.0 109.931 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.58 -22.54 45.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.979 . . . . 0.0 109.266 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.3 p -81.85 -20.59 38.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 50.1 mt-30 -45.96 -35.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 3.79 76.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.18 -162.75 33.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -72.06 118.31 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.134 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.089 HD23 HG22 ' A' ' 119' ' ' ILE . 3.4 mp -62.28 -16.17 52.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.76 -45.74 78.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.3 -47.47 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -1.132 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.591 HG23 ' CB ' ' A' ' 78' ' ' ALA . 44.7 m -53.75 -48.43 69.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 21.6 m -51.27 -47.7 62.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 74.7 m-20 -71.05 -35.32 71.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.443 -0.786 . . . . 0.0 108.93 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.487 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -69.58 -59.13 3.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 0.0 109.689 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 96' ' ' LEU . 69.0 mt -63.98 -49.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.901 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.26 -52.52 65.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.331 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.887 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.8 m-20 -55.4 -43.12 74.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 109.903 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -63.54 -39.5 94.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.205 -0.934 . . . . 0.0 109.723 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD11 HG22 ' A' ' 92' ' ' ILE . 6.2 mt -69.88 -35.87 75.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.797 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -65.46 -53.65 39.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 20.2 m -60.59 -34.03 73.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.825 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -69.52 -46.3 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.5 m-85 -47.12 -56.21 6.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -71.14 -31.78 68.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.828 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 98' ' ' SER . 84.1 mm-40 -73.12 -18.59 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 99' ' ' ALA . 67.5 p -107.45 -59.85 1.77 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.903 -1.123 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -126.82 -42.84 1.73 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.761 -1.212 . . . . 0.0 110.836 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 111.77 45.36 0.83 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 107' ' ' VAL . 6.6 t -102.81 172.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 109.151 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 14.1 m -74.18 120.23 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.797 ' ND2' HG23 ' A' ' 97' ' ' THR . 13.0 p30 -72.07 -29.59 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.645 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 113' ' ' SER . 21.7 m -56.92 -46.09 82.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 110.391 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.97 -53.58 56.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.891 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.98 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.0 -50.49 16.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.756 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.514 HD12 ' OD1' ' A' ' 108' ' ' ASN . 11.5 mt -58.56 -42.63 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.065 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 109' ' ' SER . 48.0 t -55.84 -37.97 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.15 -40.41 82.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.513 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.98 HD11 ' CE2' ' A' ' 111' ' ' PHE . 56.2 mt -72.7 -43.34 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -54.22 -39.74 67.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.368 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.7 t -73.15 -34.12 65.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.8 mt -70.97 -40.71 71.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.089 HG22 HD23 ' A' ' 85' ' ' LEU . 84.6 mt -58.2 -39.65 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.03 -27.34 72.27 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.0 ttm -66.97 -38.68 86.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -1.166 . . . . 0.0 109.502 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -60.14 -37.87 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.529 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.472 ' C ' HG21 ' A' ' 104' ' ' THR . 65.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 10' ' ' SER . 1.5 t -162.25 151.77 13.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.012 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 46.0 Cg_endo -67.49 -27.17 39.78 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.466 2.111 . . . . 0.0 112.695 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -92.52 15.91 13.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.849 -1.157 . . . . 0.0 109.845 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.5 p -105.31 -23.07 12.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.002 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -110.45 160.71 16.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.188 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 51' ' ' MET . 15.6 ttpp -74.69 -40.88 61.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.049 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -83.28 -31.07 27.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.637 HD22 ' C ' ' A' ' 103' ' ' THR . 0.2 OUTLIER -71.54 -29.38 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.644 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.514 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -73.03 -47.89 40.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.567 ' CB ' ' HE2' ' A' ' 48' ' ' MET . 1.2 p30 -56.79 -49.29 75.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.169 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -55.08 -40.61 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.971 -1.08 . . . . 0.0 109.386 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HA ' HG21 ' A' ' 103' ' ' THR . 72.2 t80 -61.23 -48.57 80.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.028 HG23 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mm -60.88 -44.44 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -50.87 48.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.382 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 38.8 t -55.91 -29.98 60.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 108.765 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 39.1 t80 -72.34 -51.92 18.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.511 -0.743 . . . . 0.0 110.047 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 40' ' ' MET . 76.3 mt -60.26 -56.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -59.85 -35.14 74.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.923 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.14 -45.29 23.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -40.59 91.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.937 . . . . 0.0 110.323 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 82.7 p -57.15 -27.24 61.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.23 6.99 31.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.571 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.972 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.5 m -93.12 -77.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.783 -1.198 . . . . 0.0 110.188 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -81.75 -104.74 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' PHE . 53.0 p -131.31 -61.52 0.91 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.8 m-85 44.02 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 109.236 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m -59.65 162.56 5.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.577 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -52.56 -43.33 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.23 -35.89 76.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.464 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.9 mm-40 -71.7 -35.07 70.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.6 mtt -63.47 -34.23 77.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -63.03 -38.31 90.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 86.3 m-20 -55.83 -39.69 71.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.256 -0.903 . . . . 0.0 109.118 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 23' ' ' ILE . 75.8 mtm -66.16 -32.04 73.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.083 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 46' ' ' THR . 19.5 m -70.31 -23.62 62.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 54.7 mt -97.34 -14.31 21.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 44' ' ' GLY . 74.8 mt -130.78 166.3 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 0.0 109.548 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 64.8 -69.44 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ILE . 41.1 t30 -74.81 -41.06 60.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.213 -1.169 . . . . 0.0 109.23 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 41' ' ' SER . 46.8 m -58.37 -35.24 71.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 108.739 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.74 -31.19 69.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 108.908 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 58.1 mmm -56.81 -29.95 63.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.412 -0.805 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.51 97.36 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -22.88 66.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.537 ' CE ' ' HG2' ' A' ' 12' ' ' LYS . 20.4 ttp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.632 -0.667 . . . . 0.0 109.513 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 6.9 mp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.314 0.578 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.67 -42.16 67.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.46 65.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 108.802 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 tp -74.48 -50.77 16.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.575 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.5 t0 -48.26 -39.68 22.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.7 mmm -71.44 -39.4 71.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.69 87.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.028 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.5 t80 -52.88 -36.94 59.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 109.706 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.916 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -64.55 -39.58 94.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.675 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 88.2 p -69.46 -30.63 68.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.826 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 43' ' ' ILE . 11.5 t -69.96 -44.25 69.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.0 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 71' ' ' ALA . 11.7 m -69.01 -34.63 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.563 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.91 -40.74 75.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.62 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -71.11 -49.36 45.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -53.82 -46.71 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.69 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -53.98 6.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 109.799 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.16 -22.67 52.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.549 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 22.9 m -79.67 -20.72 45.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 37.6 mt-30 -57.19 -34.14 68.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.82 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.25 17.81 73.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.84 -145.62 19.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.579 ' O ' HG12 ' A' ' 87' ' ' VAL . 58.4 t0 -76.0 106.03 7.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -1.111 . . . . 0.0 109.302 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.98 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.8 tp -60.18 -23.07 63.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 109.666 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.16 -39.45 72.47 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.0 p -67.62 -39.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.255 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 24.3 m -51.7 -34.46 38.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.963 -1.085 . . . . 0.0 108.316 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.548 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 6.6 m -57.46 -50.93 71.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' A' ' 94' ' ' ASP . 51.0 t30 -70.24 -40.18 74.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.389 -0.819 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.6 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -62.37 -53.55 53.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.298 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.847 HG22 HD11 ' A' ' 96' ' ' LEU . 57.0 mt -72.56 -51.25 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.89 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.53 -49.23 75.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.972 ' HB2' HG21 ' A' ' 29' ' ' THR . 93.1 m-20 -54.77 -47.68 73.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.213 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -57.02 -46.11 82.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.339 -0.851 . . . . 0.0 109.003 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.847 HD11 HG22 ' A' ' 92' ' ' ILE . 1.8 mt -70.97 -28.61 64.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.548 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.924 HG23 ' OD1' ' A' ' 108' ' ' ASN . 51.7 m -64.46 -54.09 37.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.157 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 87.6 p -66.78 -43.91 82.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 109.438 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.14 -42.71 66.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.5 m-85 -50.49 -56.41 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.123 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 7.5 m-85 -72.07 -31.77 66.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.425 -0.797 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 98' ' ' SER . 28.3 mt-30 -75.71 -17.8 59.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.589 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 18' ' ' PHE . 63.7 p -109.44 -58.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 111.294 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.472 HG21 ' C ' ' A' ' 6' ' ' ASN . 87.2 m -125.76 -42.75 1.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.746 -1.221 . . . . 0.0 111.212 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.77 47.81 1.07 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 107' ' ' VAL . 3.6 t -110.92 172.79 2.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.263 -1.139 . . . . 0.0 109.022 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 107' ' ' VAL . 33.2 m -71.85 121.12 21.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.52 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.924 ' OD1' HG23 ' A' ' 97' ' ' THR . 0.3 OUTLIER -71.7 -29.69 64.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 109.857 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 113' ' ' SER . 47.5 m -55.95 -30.12 61.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.492 -0.755 . . . . 0.0 110.742 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 23.1 tpt180 -71.54 -55.22 8.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 110.374 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.92 -46.6 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HB1' ' A' ' 93' ' ' ALA . 12.5 mt -56.13 -47.15 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.453 -0.779 . . . . 0.0 109.852 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 109' ' ' SER . 28.5 t -55.66 -43.56 76.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 95.0 mt-10 -57.19 -48.35 78.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.223 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.916 HG12 ' HB1' ' A' ' 71' ' ' ALA . 74.5 mt -65.46 -34.08 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.548 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 11.5 ttm180 -52.95 -48.96 66.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -69.75 -33.98 73.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -67.13 -45.61 76.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.682 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.909 HG22 HD11 ' A' ' 85' ' ' LEU . 56.7 mt -57.83 -34.6 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.686 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.865 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -69.02 -31.78 72.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 53.2 ttm -71.36 -39.28 71.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.119 . . . . 0.0 109.791 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.468 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 75.6 m-85 -65.57 -33.62 76.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.346 0.593 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' ' 10' ' ' SER . 3.1 t -157.78 151.38 19.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.093 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 43.9 Cg_endo -67.41 -35.09 24.63 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.783 2.322 . . . . 0.0 113.394 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.587 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -81.34 -7.51 59.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.695 -1.253 . . . . 0.0 110.339 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.89 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 m -88.35 20.14 3.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.656 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -155.69 150.05 25.86 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 1.9 ttpp -73.88 -38.18 64.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -85.85 -33.56 21.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' CB ' ' HB3' ' A' ' 11' ' ' SER . 0.2 OUTLIER -71.88 -29.28 64.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.608 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -73.0 -44.28 61.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.641 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.6 p30 -54.45 -40.28 68.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -63.05 -44.65 95.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.012 -1.055 . . . . 0.0 109.024 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CE1' HD23 ' A' ' 96' ' ' LEU . 43.1 t80 -60.77 -44.26 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 70' ' ' PHE . 19.0 mm -66.34 -43.36 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.239 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -50.92 51.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.248 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 43.5 m -58.75 -29.42 66.73 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 108.72 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.783 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.8 t80 -71.64 -51.98 20.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.91 ' HA ' ' HE1' ' A' ' 40' ' ' MET . 74.3 mt -63.67 -56.06 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.908 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.4 m -56.04 -37.07 68.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.677 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -49.4 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.777 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -60.36 -24.19 64.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 110.153 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.6 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 57.8 m -67.3 -34.33 77.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 110.079 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -106.08 7.17 31.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.16 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 94' ' ' ASP . 11.8 m -84.19 -75.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -86.97 -99.84 0.83 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -142.04 -54.9 0.45 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -1.074 . . . . 0.0 109.293 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 44.17 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 15.9 m -59.65 159.82 8.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.698 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -52.8 -32.72 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -71.15 -37.95 72.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.326 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.529 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 37.5 mt-30 -76.56 -34.22 58.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.6 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 88.6 mtp -65.04 -34.49 78.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 72.7 mt-10 -56.87 -43.99 81.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.866 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.9 m-20 -55.9 -33.23 64.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.91 ' HE1' ' HA ' ' A' ' 23' ' ' ILE . 82.3 mtp -61.74 -32.55 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -69.91 -24.68 63.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.373 -0.829 . . . . 0.0 109.453 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.729 ' N ' HD12 ' A' ' 42' ' ' LEU . 6.1 mp -89.03 -22.43 22.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.81 ' HB ' HD11 ' A' ' 77' ' ' ILE . 86.9 mt -115.57 164.18 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.647 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 73.84 -93.88 0.76 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' OD1' ' CD1' ' A' ' 23' ' ' ILE . 21.2 m120 -52.41 -36.89 55.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -1.185 . . . . 0.0 109.036 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 55.4 m -58.4 -35.31 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 66' ' ' LEU . 74.6 mt -56.88 -36.45 70.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 109.224 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 70.8 mtm -52.95 -40.7 63.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.28 -31.5 71.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.972 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.9 78.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -0.803 . . . . 0.0 109.176 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 35.5 mtt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.067 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.89 HD21 ' O ' ' A' ' 10' ' ' SER . 1.2 tp . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.488 0.661 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -76.81 -46.07 26.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.252 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.24 52.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.266 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 47' ' ' LEU . 17.4 tp -54.94 -50.04 69.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.948 . . . . 0.0 109.028 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 9.8 t0 -48.16 -49.39 32.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.9 mtp -58.81 -43.99 90.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.64 77.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.736 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE1' HG23 ' A' ' 19' ' ' ILE . 77.6 t80 -56.86 -45.2 82.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.44 -36.99 84.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -69.6 -52.05 29.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -0.975 . . . . 0.0 110.023 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.687 ' HB3' HD13 ' A' ' 43' ' ' ILE . 10.9 m -70.25 -35.84 74.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.709 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 8.1 p -66.88 -43.65 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.13 -0.981 . . . . 0.0 109.898 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -63.68 -32.22 73.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.907 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -72.17 -43.1 65.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 109.875 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.866 HG23 ' HB2' ' A' ' 39' ' ' ASN . 64.8 mt -54.47 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.099 -1.001 . . . . 0.0 109.822 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.0 -50.17 12.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.46 -0.775 . . . . 0.0 110.142 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.1 -25.96 61.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.583 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.2 p -76.94 -20.31 56.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.408 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.529 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 26.7 mt-30 -46.4 -33.76 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.37 16.11 80.97 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.5 -159.3 19.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.04 105.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -1.164 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.01 HD23 HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -61.21 -18.38 57.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.66 81.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 46.4 t -68.69 -44.81 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 109.547 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.616 HG23 ' CB ' ' A' ' 78' ' ' ALA . 23.9 m -54.52 -50.15 68.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.0 m -51.31 -48.83 62.23 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 24.0 t-20 -70.83 -33.92 71.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 108.983 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -70.37 -59.15 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.509 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.738 HG22 HD11 ' A' ' 96' ' ' LEU . 55.0 mt -63.21 -49.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.828 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.0 -52.23 64.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.77 ' HB3' HG21 ' A' ' 29' ' ' THR . 32.0 t0 -55.23 -50.53 69.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.22 -42.88 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.738 HD11 HG22 ' A' ' 92' ' ' ILE . 7.1 mt -70.26 -41.05 73.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.671 HG23 ' OD1' ' A' ' 108' ' ' ASN . 99.3 m -62.4 -48.64 78.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 28.7 m -64.43 -34.26 77.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 109.483 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.95 -44.99 68.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.9 m-85 -46.97 -56.03 7.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.873 . . . . 0.0 109.698 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.537 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -70.91 -32.09 68.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.762 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 98' ' ' SER . 88.2 mm-40 -75.91 -18.42 59.39 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.781 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 61.2 p -103.81 -59.85 1.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.058 -1.026 . . . . 0.0 111.101 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.781 ' OG1' HG23 ' A' ' 106' ' ' VAL . 12.6 p -126.73 -42.61 1.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.672 -1.268 . . . . 0.0 110.925 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.82 45.25 0.97 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.781 HG23 ' OG1' ' A' ' 104' ' ' THR . 12.1 t -109.83 172.52 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -1.125 . . . . 0.0 109.219 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.2 m -73.68 121.16 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.714 ' ND2' HD12 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -70.74 -23.36 62.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.5 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 113' ' ' SER . 23.3 t -54.78 -30.27 56.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.574 -0.704 . . . . 0.0 110.601 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -69.04 -55.0 12.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.878 -1.139 . . . . 0.0 110.234 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 115' ' ' ILE . 59.8 t80 -76.16 -50.4 14.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.714 HD12 ' ND2' ' A' ' 108' ' ' ASN . 14.5 mt -56.35 -42.56 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.139 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 109' ' ' SER . 32.2 t -56.23 -46.86 79.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 109.554 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.41 -49.83 74.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.262 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.885 HG12 ' HB1' ' A' ' 71' ' ' ALA . 89.7 mt -65.93 -34.82 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -54.06 -47.02 72.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 109.52 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.8 p -72.66 -33.9 66.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.63 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.02 -44.16 77.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.01 HG22 HD23 ' A' ' 85' ' ' LEU . 97.5 mt -57.82 -38.83 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.02 -33.79 75.18 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -61.68 -36.87 82.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.491 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 77.1 m-85 -66.23 -36.84 84.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.296 0.569 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.712 ' C ' HG21 ' A' ' 104' ' ' THR . 3.5 t -152.17 151.38 27.57 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.645 ' N ' HG21 ' A' ' 104' ' ' THR . 42.4 Cg_endo -64.8 -35.5 45.07 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 113.01 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.547 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 49.4 p90 -81.69 -2.16 49.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.661 -1.274 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.691 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -82.7 -28.65 30.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 108.688 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 m -118.82 151.11 38.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.484 -0.76 . . . . 0.0 109.161 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' O ' ' OD2' ' A' ' 16' ' ' ASP . 27.0 mtpt -70.95 -36.16 72.49 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.698 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -67.06 -49.52 64.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.932 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.5 m-20 -71.37 -29.16 64.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -66.81 -49.88 64.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.433 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.2 p30 -54.8 -53.38 56.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.028 . . . . 0.0 110.149 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -57.65 -35.72 70.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 0.0 108.863 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 75.5 t80 -61.09 -37.32 82.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.479 -0.763 . . . . 0.0 109.26 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 70' ' ' PHE . 31.6 mm -75.14 -48.44 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.631 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -62.4 -48.28 80.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 2.1 t -60.75 -30.71 70.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.972 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.765 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 44.9 t80 -68.7 -52.0 35.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 0.0 110.186 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.404 HD12 ' ND2' ' A' ' 45' ' ' ASN . 67.2 mt -63.15 -56.02 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.99 . . . . 0.0 109.958 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -59.71 -30.88 69.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.01 -45.37 23.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -70.38 -31.66 69.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 50.3 m -60.5 -30.95 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.5 p-10 -106.29 7.39 31.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.01 . . . . 0.0 110.651 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.995 HG21 ' HB2' ' A' ' 94' ' ' ASP . 29.1 m -89.62 -79.36 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.807 -1.183 . . . . 0.0 110.177 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -81.01 -103.05 0.32 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -132.81 -58.28 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.325 -1.103 . . . . 0.0 109.305 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.4 m-85 43.84 90.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.082 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 11.1 p -59.54 162.99 4.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -52.72 -36.94 58.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.876 . . . . 0.0 109.278 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.21 -45.51 79.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.547 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 4.2 mp0 -63.93 -35.48 80.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.184 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 58.3 mtt -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.081 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 94.8 mt-10 -70.36 -37.46 74.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.113 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -68.75 -44.65 73.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.251 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.545 ' CE ' ' CE1' ' A' ' 32' ' ' PHE . 61.2 mtt -56.85 -31.98 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 108.935 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 p -70.13 -23.35 63.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.38 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 38' ' ' GLU . 62.7 mt -87.88 -26.25 22.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.716 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 73' ' ' SER . 53.4 mt -121.32 157.09 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.449 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.93 -77.2 2.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.404 ' ND2' HD12 ' A' ' 23' ' ' ILE . 95.6 m-20 -65.02 -38.46 90.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -1.162 . . . . 0.0 108.766 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -58.46 -35.1 71.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.06 -34.51 75.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.552 -0.718 . . . . 0.0 109.247 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 61.4 ttp -52.96 -41.95 65.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 109.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.12 74.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 108.583 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.8 66.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 48' ' ' MET . 57.6 mtt . . . . . 0 C--N 1.305 -1.358 0 O-C-N 121.563 -0.711 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 9.8 mp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.219 0.533 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 96.7 mt-30 -54.71 -40.14 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -37.4 68.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.011 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.16 -52.62 11.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.67 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -48.06 -25.26 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.608 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 56.7 mtp -72.71 -27.42 62.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.963 . . . . 0.0 110.023 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -35.56 65.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 110.038 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.615 ' CE1' HG23 ' A' ' 19' ' ' ILE . 88.8 t80 -53.84 -40.71 66.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.792 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.951 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.69 -36.35 83.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 24.8 m -69.23 -34.16 74.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.783 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 43' ' ' ILE . 37.1 m -70.3 -49.63 47.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.874 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' ALA . 19.1 m -57.73 -35.04 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -70.62 -43.35 69.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 0.0 109.691 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.567 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 87.2 mt-30 -66.22 -50.88 62.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.879 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -53.49 -50.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.22 -53.32 7.47 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 110.209 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.63 -24.28 55.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 79.9 p -76.7 -20.23 56.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.547 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 55.2 mt-30 -50.34 -31.54 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 109.51 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.39 14.75 81.68 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.42 -162.88 23.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -1.13 . . . . 0.0 109.437 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.047 HD23 HG22 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -62.21 -20.21 63.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.98 -38.33 65.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.446 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 72.2 t -70.55 -47.5 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.569 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 19.7 m -51.95 -48.72 64.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 116' ' ' ARG . 4.3 m -51.07 -46.25 61.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 81.3 m-20 -71.0 -39.18 72.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.422 -0.799 . . . . 0.0 109.026 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -67.48 -59.2 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.765 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 69.7 mt -60.33 -47.24 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.54 -51.31 65.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.995 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.5 m-20 -60.73 -33.54 73.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.877 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -71.96 -42.59 66.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 108.969 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -70.38 -38.45 74.71 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.508 -0.745 . . . . 0.0 109.777 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.563 HG22 ' CE2' ' A' ' 101' ' ' TYR . 77.8 m -63.85 -51.5 64.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 109.917 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 85.7 p -58.4 -34.78 71.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 0.0 109.774 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.23 -44.56 68.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -46.96 -54.81 9.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.563 ' CE2' HG22 ' A' ' 97' ' ' THR . 3.7 m-85 -72.03 -32.09 66.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 98' ' ' SER . 92.5 mm-40 -77.19 -18.57 57.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 18' ' ' PHE . 81.7 p -104.52 -60.18 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.087 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.712 HG21 ' C ' ' A' ' 7' ' ' THR . 29.6 p -127.16 -43.01 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.207 . . . . 0.0 110.762 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.48 44.62 1.05 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 28.2 t -104.81 170.06 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 108.891 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.586 ' N ' HG12 ' A' ' 106' ' ' VAL . 22.9 m -68.15 121.14 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.61 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 18.9 p-10 -70.59 -23.51 62.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 32.9 t -62.03 -30.56 71.05 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 110.355 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -65.81 -54.51 25.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.831 -1.168 . . . . 0.0 110.343 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 29.1 t80 -75.69 -53.95 7.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.035 . . . . 0.0 110.181 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 54.5 mt -56.92 -34.27 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 12.7 t -55.89 -43.14 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 0.0 109.763 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 74.8 mm-40 -71.73 -38.86 70.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.951 HG12 ' HB1' ' A' ' 71' ' ' ALA . 71.5 mt -59.54 -45.64 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 89' ' ' THR . 62.3 mtp180 -54.2 -49.09 70.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.689 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.8 m -57.85 -33.71 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 0.0 109.071 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 82.3 mt -74.53 -41.88 59.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.047 HG22 HD23 ' A' ' 85' ' ' LEU . 72.2 mt -59.24 -35.65 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.199 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.29 63.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.7 ttm -60.83 -45.1 95.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.147 . . . . 0.0 109.515 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 89.8 m-85 -58.99 -37.28 76.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.489 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.8 mtp -58.45 -36.76 74.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.172 . . . . 0.0 109.474 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.34 10.73 79.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.466 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 53.1 tt0 -109.07 156.09 20.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -1.134 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.466 ' N ' ' HG2' ' A' ' 4' ' ' GLN . . . -154.37 153.85 32.31 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 65.5 m-20 -49.35 -33.23 12.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.409 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.662 ' HA ' HG21 ' A' ' 104' ' ' THR . 6.6 t -129.12 150.09 74.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HG3' ' CD2' ' A' ' 18' ' ' PHE . 42.7 Cg_endo -65.3 -31.98 51.92 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.65 2.233 . . . . 0.0 112.216 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 45.5 p90 -89.35 23.41 2.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 109.445 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.72 -33.67 8.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 108.584 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 3.2 t -116.62 161.65 18.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.542 -0.724 . . . . 0.0 109.053 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' CG ' HG13 ' A' ' 58' ' ' ILE . 4.5 ttpm? -72.61 -41.52 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 109.761 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.82 57.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.546 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 20.4 t30 -71.69 -33.01 68.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.96 -37.57 67.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.98 . . . . 0.0 110.064 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 48' ' ' MET . 87.7 m-20 -56.25 -56.56 19.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.118 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.01 -42.39 62.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 48.1 t80 -58.33 -41.11 83.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.479 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.681 HG21 ' C ' ' A' ' 44' ' ' GLY . 22.1 mm -67.44 -49.34 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.16 -49.16 78.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 t -62.07 -30.76 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.06 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 16.3 t80 -66.75 -44.19 82.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 0.0 109.92 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 40' ' ' MET . 44.2 mm -71.06 -55.97 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 109.812 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -55.63 -37.54 68.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.825 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -46.25 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.823 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -62.37 -36.71 83.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 91.7 p -66.95 -22.33 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.893 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -105.38 7.18 33.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 94' ' ' ASP . 7.7 m -101.19 -73.24 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 110.241 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -107.21 0.87 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -124.83 -64.93 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -1.112 . . . . 0.0 109.736 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.701 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 34.6 m-85 44.82 72.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.206 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -59.71 165.09 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.33 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -52.28 -30.09 26.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.187 -0.945 . . . . 0.0 109.111 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.58 -36.01 80.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 81' ' ' GLN . 43.0 mt-30 -70.96 -33.11 70.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.309 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.548 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 61.8 mtt -63.63 -29.44 70.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' OG ' ' A' ' 41' ' ' SER . 86.7 tt0 -57.0 -37.26 71.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 108.913 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' HG12 ' A' ' 77' ' ' ILE . 32.4 m120 -58.47 -31.69 68.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 23' ' ' ILE . 51.2 ttp -55.7 -31.79 62.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 108.852 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.735 ' OG ' HD12 ' A' ' 42' ' ' LEU . 85.4 p -55.64 -24.17 32.17 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.298 -0.876 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.9 mp -106.5 -25.37 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD11 ' A' ' 77' ' ' ILE . 88.3 mt -124.54 150.98 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.609 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.681 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.34 -108.36 3.54 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -53.08 -23.11 7.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -1.197 . . . . 0.0 108.709 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -68.14 -34.78 76.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.977 ' O ' HD13 ' A' ' 47' ' ' LEU . 2.4 tm? -52.32 -34.61 47.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 16' ' ' ASP . 68.2 mtt -58.21 -37.1 74.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -31.39 71.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.41 79.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 109.27 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.483 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 61.2 mtt -62.73 -31.12 71.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 109.372 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.52 -30.1 60.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.254 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -68.67 -25.39 64.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 109.204 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.53 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 88.8 mmm -67.44 -29.86 69.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.32 9.27 67.33 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.04 16.34 19.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' HD13 ' A' ' 58' ' ' ILE . 16.3 ptt85 -127.8 112.48 14.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -1.123 . . . . 0.0 109.498 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.992 HG21 HD11 ' A' ' 63' ' ' LEU . 20.6 mm -116.07 155.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 p -139.95 164.29 38.72 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 48.4 Cg_endo -69.6 -37.19 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.546 2.164 . . . . 0.0 111.629 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -72.7 -33.11 66.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.296 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HD2' HG23 ' A' ' 59' ' ' THR . 29.9 mttm -74.72 -51.37 14.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.992 HD11 HG21 ' A' ' 58' ' ' ILE . 51.2 mt -64.35 -26.98 68.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 57.8 tt0 -56.56 -45.3 81.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.09 -43.79 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.942 HD21 HD11 ' A' ' 47' ' ' LEU . 13.6 tp -69.01 -40.69 78.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.667 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 41.4 t0 -48.77 -43.89 38.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.7 mtm -64.6 -37.04 86.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.548 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.09 -45.15 79.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.93 ' O ' HG13 ' A' ' 74' ' ' VAL . 92.1 t80 -52.94 -40.5 63.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.46 -44.1 88.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.648 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 87.3 p -69.27 -37.83 78.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 43' ' ' ILE . 79.8 p -70.09 -44.95 68.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 70' ' ' PHE . 11.7 m -65.97 -34.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.1 -46.26 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.65 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 72' ' ' SER . 96.4 mt-30 -58.94 -36.13 74.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 109.969 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' A' ' 43' ' ' ILE . 72.5 mt -68.81 -54.87 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.701 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.55 -40.82 33.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 110.524 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.89 -28.81 64.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 109.464 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.4 p -80.89 -20.29 42.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HB3' ' NE2' ' A' ' 36' ' ' GLN . 60.2 mm-40 -93.29 117.94 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.639 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.95 101.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.01 -36.0 4.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -64.55 92.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 123' ' ' ALA . 6.4 mp -76.11 -8.55 57.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.674 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.2 -44.27 84.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' N ' ' A' ' 88' ' ' THR . 9.9 p -70.45 -48.29 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.183 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.607 ' N ' HG13 ' A' ' 87' ' ' VAL . 53.4 m -52.37 -36.04 52.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.928 -1.108 . . . . 0.0 108.404 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.493 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 31.9 m -55.53 -49.39 72.77 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 59.6 t30 -70.74 -37.27 73.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.21 -59.21 3.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 96' ' ' LEU . 49.2 mt -62.29 -48.92 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -58.97 -51.21 71.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.607 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.872 ' HB2' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -55.3 -45.36 76.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -59.33 -44.1 92.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.21 -0.931 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 92' ' ' ILE . 2.8 mt -70.09 -33.46 71.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.0 m -65.25 -49.04 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -0.859 . . . . 0.0 109.844 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 96.8 p -66.61 -39.69 88.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 0.0 109.813 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 103' ' ' THR . . . -60.85 -40.02 91.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 109.599 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.8 m-85 -52.97 -56.47 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.568 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.8 m-85 -72.18 -32.4 66.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.421 -0.799 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 98' ' ' SER . 93.6 mm-40 -70.34 -18.77 63.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.851 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.9 p -107.12 -60.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.116 . . . . 0.0 111.2 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -127.47 -42.84 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.647 -1.283 . . . . 0.0 111.156 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 112.14 46.68 0.74 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.7 t -102.87 171.92 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -1.178 . . . . 0.0 108.984 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 106' ' ' VAL . 15.5 m -73.86 120.26 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.598 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 21.1 p-10 -72.18 -29.09 63.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' SER . 94.0 p -58.73 -43.26 90.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 110.502 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -57.11 -53.7 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.108 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.3 t80 -75.19 -53.55 8.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 40.9 mt -56.29 -34.33 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.8 t -55.8 -43.15 76.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.043 -1.035 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.78 -36.66 73.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.108 HD11 ' CE2' ' A' ' 111' ' ' PHE . 51.0 mt -72.3 -41.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 116' ' ' ARG . 11.8 ttp85 -54.09 -41.26 68.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.84 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.1 mt -69.61 -43.97 71.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.875 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.704 HG22 HD23 ' A' ' 85' ' ' LEU . 73.0 mt -57.89 -47.24 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.851 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.97 -27.19 64.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.2 ttm -67.62 -42.35 82.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 97.4 m-85 -59.71 -31.96 70.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -59.79 -35.92 75.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.558 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.7 -38.58 73.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.29 74.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p -66.01 -25.19 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.491 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 86.6 m-20 -73.71 -30.65 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.59 -46.05 90.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.841 HG13 ' CD1' ' A' ' 131' ' ' TYR . 3.3 p -64.18 -31.76 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.465 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.841 ' CD1' HG13 ' A' ' 130' ' ' VAL . 35.9 p90 179.59 175.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.08 124.23 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.3 m -49.7 152.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.538 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.44 28.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.56 -30.22 41.74 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.0 t -115.18 141.36 48.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.96 -35.23 72.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.141 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.46 16.24 60.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -108.37 144.55 35.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -73.19 138.87 45.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.21 -20.16 63.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.666 HG23 ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -157.98 156.3 27.9 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 40.8 Cg_endo -64.85 -35.49 44.55 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.804 2.336 . . . . 0.0 112.941 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -84.56 12.46 6.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.666 ' CB ' HG23 ' A' ' 7' ' ' THR . 2.2 m -102.36 -19.53 14.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.943 . . . . 0.0 108.757 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 66.1 m -119.63 158.06 27.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' CG ' HG13 ' A' ' 58' ' ' ILE . 9.0 ttpt -74.38 -40.31 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.757 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -78.91 -36.65 41.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.542 HD22 ' C ' ' A' ' 103' ' ' THR . 0.2 OUTLIER -72.37 -29.63 63.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 109.991 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.33 -51.24 21.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 110.308 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 13' ' ' ALA . 1.7 p30 -54.95 -46.77 75.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 16' ' ' ASP . . . -58.53 -40.56 83.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.554 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.792 ' HA ' HG21 ' A' ' 103' ' ' THR . 51.5 t80 -63.64 -37.21 86.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 109.803 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.889 HG23 ' CE1' ' A' ' 70' ' ' PHE . 25.1 mm -71.78 -37.14 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 109.691 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -68.12 -49.42 61.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -64.66 -30.67 71.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 110.186 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.918 ' CE2' HD12 ' A' ' 96' ' ' LEU . 37.9 t80 -63.35 -51.51 65.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.98 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.3 mt -60.59 -56.08 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 109.98 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m -59.67 -32.6 70.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -77.66 -45.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.865 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -67.04 -33.21 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 110.054 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.499 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 62.7 m -63.48 -27.35 69.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 7.52 31.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 110.112 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 94' ' ' ASP . 25.8 m -92.58 -77.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.963 -1.085 . . . . 0.0 110.057 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -104.08 0.6 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 4.2 m -131.13 -60.45 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -1.1 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 8.0 m-85 44.25 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 p -59.71 160.39 7.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -52.8 -41.96 64.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -57.88 -36.02 71.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.477 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 98.3 mm-40 -69.96 -32.74 71.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.325 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.499 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 65.5 mtt -63.51 -32.0 73.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.3 -45.26 88.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -55.66 -39.26 70.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.98 ' SD ' HG23 ' A' ' 23' ' ' ILE . 63.2 mtt -57.29 -32.05 66.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 108.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.556 ' OG ' HD12 ' A' ' 42' ' ' LEU . 30.3 p -70.47 -23.52 62.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.35 -0.844 . . . . 0.0 109.39 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.556 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.7 mp -88.49 -23.46 23.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.554 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.008 HG21 ' CB ' ' A' ' 73' ' ' SER . 48.6 mt -131.22 143.0 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.162 -0.961 . . . . 0.0 109.296 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.65 -83.75 0.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.574 HD21 HD12 ' A' ' 23' ' ' ILE . 91.1 m-20 -61.3 -27.09 68.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.154 -1.203 . . . . 0.0 108.358 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -68.82 -35.07 76.52 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 66' ' ' LEU . 60.3 mt -53.33 -38.24 63.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.75 . . . . 0.0 109.306 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ttt -52.79 -41.35 64.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.63 70.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.0 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.83 -38.0 85.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 109.125 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 54.9 mtt -56.7 -30.63 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.261 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -60.15 -29.36 68.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.197 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.17 -25.64 66.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.432 -0.792 . . . . 0.0 109.244 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.613 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 92.2 mmm -62.55 -27.75 69.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.59 8.29 62.48 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.77 11.98 29.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' ' HE2' ' A' ' 54' ' ' MET . 16.3 ptt180 -124.11 112.4 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.445 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.871 HG21 HD22 ' A' ' 63' ' ' LEU . 26.0 mm -116.54 149.99 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.182 -0.948 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -137.92 159.54 68.2 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 45.0 Cg_endo -66.75 -52.0 0.8 Allowed 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.622 2.215 . . . . 0.0 111.739 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m -46.26 -52.05 13.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.168 -0.958 . . . . 0.0 109.59 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -81.25 -52.38 7.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 110.204 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 58' ' ' ILE . 15.4 tp -55.88 -42.68 76.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.55 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 94.7 mt-30 -55.76 -30.97 62.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.335 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.3 68.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 108.958 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 47' ' ' LEU . 10.4 tt -74.14 -45.2 50.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.256 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.4 t0 -48.66 -42.53 34.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 89.7 mtp -64.39 -45.61 86.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.598 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.59 78.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.395 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.909 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.5 t80 -53.12 -38.93 63.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.3 -39.76 74.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -68.74 -40.79 79.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 43' ' ' ILE . 8.9 m -70.05 -47.87 60.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.628 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 70' ' ' PHE . 23.0 m -57.72 -35.08 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 119' ' ' ILE . . . -72.22 -35.19 68.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.8 tt0 -74.34 -44.15 53.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.82 -47.21 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.51 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.47 -52.8 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 109.803 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.86 -29.22 64.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.166 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 27.6 t -69.61 -20.19 63.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.292 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.477 ' OE1' ' HG3' ' A' ' 36' ' ' GLN . 45.2 mt-30 -54.64 -29.93 53.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.19 80.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.1 -156.94 29.09 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.602 ' O ' HG12 ' A' ' 87' ' ' VAL . 55.9 t0 -70.45 98.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -1.213 . . . . 0.0 109.403 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.048 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.4 tt -57.6 -16.34 10.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.63 -39.06 95.22 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.7 p -69.77 -37.59 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 109.602 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 78' ' ' ALA . 44.4 m -51.58 -32.06 27.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.088 -1.008 . . . . 0.0 108.735 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.79 HG23 ' HG2' ' A' ' 116' ' ' ARG . 22.1 m -59.94 -47.31 86.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 25.9 m120 -70.86 -33.49 70.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.426 -0.796 . . . . 0.0 109.018 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -71.65 -59.32 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.767 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.717 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 54.8 mt -63.34 -42.53 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -62.86 -52.36 63.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' HB3' HG21 ' A' ' 29' ' ' THR . 34.1 t0 -55.26 -50.48 69.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 109.332 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -55.9 -45.41 78.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.918 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.97 -33.85 72.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.897 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -68.97 -49.27 59.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.0 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.5 p -62.26 -34.44 76.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.907 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.83 -42.65 73.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.3 m-85 -46.94 -54.75 9.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.545 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.4 m-85 -71.66 -32.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 110.491 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 98' ' ' SER . 64.5 mm-40 -80.58 -18.45 48.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 110.129 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 18' ' ' PHE . 54.7 p -101.45 -59.05 1.77 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 111.053 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.452 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 23.0 m -126.05 -42.67 1.86 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 110.868 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 107.64 46.69 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 107' ' ' VAL . 5.0 t -114.69 172.97 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -1.159 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.605 ' H ' HG12 ' A' ' 106' ' ' VAL . 2.8 m -73.1 120.5 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.306 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.897 ' ND2' HG23 ' A' ' 97' ' ' THR . 12.4 p30 -70.84 -24.14 62.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.615 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 24.8 t -56.07 -30.2 61.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.505 -0.747 . . . . 0.0 110.342 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' HG3' HG23 ' A' ' 107' ' ' VAL . 35.4 mmt180 -67.94 -54.61 17.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.119 . . . . 0.0 110.234 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.908 ' CD2' HD21 ' A' ' 96' ' ' LEU . 1.2 t80 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.496 HD12 ' OD1' ' A' ' 108' ' ' ASN . 52.4 mt -56.41 -29.95 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.548 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 6.0 t -58.13 -47.33 83.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 85.5 tt0 -72.22 -37.7 69.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.681 HG12 ' HB1' ' A' ' 71' ' ' ALA . 47.1 mt -56.56 -46.29 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.917 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG23 ' A' ' 89' ' ' THR . 74.3 mtt180 -54.41 -49.12 70.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -59.17 -33.34 70.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.0 109.004 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 83.8 mt -73.75 -40.85 63.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.461 -0.774 . . . . 0.0 110.232 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.839 HG22 HD21 ' A' ' 85' ' ' LEU . 56.9 mt -61.08 -34.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 0.0 109.595 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.9 -32.45 70.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -65.64 -42.59 91.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.426 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 96.2 m-85 -63.23 -29.03 70.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.048 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -67.83 -32.86 73.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.42 -31.44 70.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.72 61.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 109.379 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.5 p -74.45 -21.41 59.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 0.0 109.342 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.607 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -63.26 -26.31 68.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.87 -16.69 61.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -76.52 -42.62 42.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.235 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.908 HG13 ' CD1' ' A' ' 131' ' ' TYR . 4.4 p -64.51 -29.23 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.908 ' CD1' HG13 ' A' ' 130' ' ' VAL . 41.8 p90 179.15 172.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.03 116.55 21.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.5 m -58.67 156.74 10.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.25 77.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 -166.64 40.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -120.63 148.65 43.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -1.139 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -57.17 -36.77 71.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.61 58.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 1' ' ' GLY . 93.9 mt-30 -115.17 156.99 24.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -1.126 . . . . 0.0 109.456 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 11' ' ' SER . . . -66.28 140.08 58.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 16.7 m120 -52.68 -20.71 3.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.557 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 4.5 t -143.5 152.51 56.96 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.127 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 42.6 Cg_endo -65.04 -35.4 42.88 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.466 2.111 . . . . 0.0 112.787 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.716 ' O ' HD22 ' A' ' 63' ' ' LEU . 49.5 p90 -80.82 7.25 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.626 -1.296 . . . . 0.0 109.737 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.9 OUTLIER -92.31 -20.57 20.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 108.718 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 5' ' ' ALA . 1.5 t -136.69 144.66 44.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 108.949 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HD3' HD11 ' A' ' 58' ' ' ILE . 22.1 mtmm -60.42 -46.43 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.3 71.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.355 -0.841 . . . . 0.0 109.476 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 14.1 m120 -72.36 -38.43 68.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -69.39 -51.8 33.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 48' ' ' MET . 17.2 m-20 -54.37 -51.11 65.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.29 91.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 108.7 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.517 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 58.8 t80 -58.56 -37.23 75.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.435 -0.791 . . . . 0.0 109.534 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.773 HD12 ' CD1' ' A' ' 70' ' ' PHE . 20.8 mm -71.01 -37.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -68.51 -50.02 55.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 34.4 t80 -65.12 -49.13 71.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 110.207 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.713 HD12 HD21 ' A' ' 45' ' ' ASN . 77.2 mt -61.99 -56.18 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -60.21 -32.12 70.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.913 . . . . 0.0 109.868 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.84 -44.46 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.096 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -69.97 -29.27 66.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.243 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -64.68 -28.5 69.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.963 . . . . 0.0 110.13 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.9 7.49 32.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 20.1 m -90.72 -78.5 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 -103.33 0.39 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.9 t -131.24 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -1.132 . . . . 0.0 109.445 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 12.5 m-85 43.73 88.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.315 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.2 m -59.73 161.05 6.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -52.64 -36.57 56.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.61 -36.05 83.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 99.8 mm-40 -71.91 -33.97 68.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 109.283 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.64 -33.71 76.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.08 -47.25 85.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' ND2' HG12 ' A' ' 77' ' ' ILE . 34.5 t-20 -55.65 -40.71 72.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.578 ' HE2' HG12 ' A' ' 23' ' ' ILE . 83.1 mtp -61.49 -31.85 71.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 109.11 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 m -70.3 -23.94 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 42' ' ' LEU . 4.2 mm? -90.55 -23.26 20.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.922 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.636 HG21 ' CB ' ' A' ' 73' ' ' SER . 64.0 mt -125.0 157.01 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.583 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.704 ' HA2' HD12 ' A' ' 47' ' ' LEU . . . 89.42 -83.85 1.41 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.726 ' OD1' HG22 ' A' ' 19' ' ' ILE . 92.5 m-20 -62.67 -33.87 75.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -1.217 . . . . 0.0 109.009 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -60.51 -35.28 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.362 -0.836 . . . . 0.0 109.232 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.704 HD12 ' HA2' ' A' ' 44' ' ' GLY . 6.5 mt -57.28 -35.77 70.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 0.0 109.46 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.44 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 69.7 mtm -52.84 -39.92 62.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.274 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.49 -32.93 72.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.875 . . . . 0.0 109.182 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.18 72.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.84 . . . . 0.0 109.206 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.468 ' O ' ' HG2' ' A' ' 54' ' ' MET . 64.6 mtt -56.23 -34.23 66.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.257 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -56.49 -27.92 58.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.194 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -68.77 -23.44 64.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.533 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 75.9 mmm -57.2 -26.62 60.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.71 8.0 88.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.1 21.19 9.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' O ' ' CE ' ' A' ' 54' ' ' MET . 11.8 ptt180 -128.85 111.93 13.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.66 ' CG2' HD12 ' A' ' 63' ' ' LEU . 30.1 mm -118.12 151.3 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 8.5 p -146.3 161.06 40.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 46.7 Cg_endo -68.46 -43.42 4.2 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.629 2.22 . . . . 0.0 111.655 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -62.22 -37.38 85.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.155 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.13 -51.94 9.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.291 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 9' ' ' TRP . 1.0 OUTLIER -62.89 -40.19 96.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.289 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 59.1 tp60 -54.61 -40.11 68.56 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.359 -0.838 . . . . 0.0 108.955 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.85 68.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 108.959 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tp -73.51 -46.65 46.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.279 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.505 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 31.0 t0 -48.08 -46.79 34.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 109.732 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.55 -38.43 81.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 109.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.75 76.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.517 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 19' ' ' ILE . 84.1 t80 -55.23 -35.36 64.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.03 -37.33 85.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.805 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.6 m -67.77 -31.56 71.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.822 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.636 ' CB ' HG21 ' A' ' 43' ' ' ILE . 92.5 p -69.3 -49.12 58.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HD11 ' A' ' 92' ' ' ILE . 35.3 m -60.82 -35.01 61.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.436 -0.79 . . . . 0.0 109.982 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.57 -47.56 39.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.471 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.3 mt-30 -64.73 -50.47 66.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.887 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.505 HD13 ' HG2' ' A' ' 40' ' ' MET . 79.2 mt -55.01 -50.84 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 109.907 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.612 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -74.9 -51.86 12.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.815 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.92 -30.81 66.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 92.2 p -72.66 -20.47 61.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.432 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.452 ' HG2' ' CD ' ' A' ' 36' ' ' GLN . 28.1 mt-30 -49.3 -40.52 35.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.918 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.15 5.19 66.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.05 -155.39 27.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' HG12 ' A' ' 87' ' ' VAL . 53.8 t0 -66.06 105.39 1.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -1.088 . . . . 0.0 109.376 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 119' ' ' ILE . 23.7 tp -67.75 -14.01 62.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.03 -32.41 66.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.2 p -69.88 -35.71 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -1.174 . . . . 0.0 109.527 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 92' ' ' ILE . 73.7 m -51.59 -32.4 28.47 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.1 -1.0 . . . . 0.0 108.679 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 62.8 m -58.65 -46.62 86.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 79.7 m-20 -70.78 -38.24 73.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.467 -0.771 . . . . 0.0 109.096 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -68.32 -56.07 9.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.904 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.76 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 61.4 mt -66.7 -44.05 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.761 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -64.49 -50.85 65.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 109.892 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.2 m-20 -55.32 -43.13 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.946 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -67.91 -40.79 83.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.283 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -70.11 -34.54 73.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.804 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.674 HG23 ' ND2' ' A' ' 108' ' ' ASN . 55.3 m -67.64 -51.13 53.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.03 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 t -60.14 -35.29 74.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 109.887 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.85 -43.29 72.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -47.1 -54.97 9.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.027 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.3 m-85 -71.84 -32.69 67.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.468 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 98' ' ' SER . 96.5 mm-40 -75.9 -18.46 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.217 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 99' ' ' ALA . 55.9 p -104.77 -59.57 1.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.907 -1.12 . . . . 0.0 110.996 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 106' ' ' VAL . 25.6 p -126.41 -42.81 1.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.702 -1.249 . . . . 0.0 110.921 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.61 46.6 0.96 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.94 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.671 HG23 ' OG1' ' A' ' 104' ' ' THR . 5.7 t -108.22 172.44 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.188 -1.183 . . . . 0.0 109.101 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' H ' HG12 ' A' ' 106' ' ' VAL . 11.3 m -73.4 120.77 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.674 ' ND2' HG23 ' A' ' 97' ' ' THR . 14.4 p30 -71.35 -24.09 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.818 . . . . 0.0 109.779 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 113' ' ' SER . 50.2 m -60.18 -30.66 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 110.332 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -68.31 -54.76 15.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.363 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 115' ' ' ILE . 33.1 t80 -75.75 -50.39 15.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.046 -1.034 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.633 HG21 ' HB1' ' A' ' 93' ' ' ALA . 34.4 mt -56.43 -39.09 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.27 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' SER . 22.1 m -59.89 -38.53 82.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.45 -39.83 85.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.411 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 111' ' ' PHE . 84.7 mt -70.82 -42.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 16.4 ttt180 -54.34 -42.87 70.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -73.0 -33.76 65.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.964 . . . . 0.0 109.664 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.7 mt -68.93 -42.4 76.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.808 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' A' ' 85' ' ' LEU . 61.9 mt -57.66 -39.65 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.68 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.59 -28.31 73.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -69.09 -36.76 77.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 109.548 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.27 -35.43 80.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.559 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -63.46 -32.48 73.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -70.64 -35.77 73.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.81 74.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -59.5 -32.27 70.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.59 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -72.32 -26.41 61.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -65.9 -48.23 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.816 HG23 ' CD1' ' A' ' 131' ' ' TYR . 16.3 m -58.29 -31.49 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.816 ' CD1' HG23 ' A' ' 130' ' ' VAL . 37.3 p90 -179.2 -175.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.37 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -83.64 119.99 25.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.3 m -51.05 -38.19 50.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.6 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.13 6.99 66.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.5 m -60.74 -34.29 74.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.477 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -57.88 -37.64 74.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -1.165 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.07 145.36 46.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.15 -35.81 76.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -1.167 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.07 102.94 1.82 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.166 -0.958 . . . . 0.0 109.553 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 68.3 m-20 -88.31 20.42 3.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.944 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -133.77 151.69 77.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD2' HG22 ' A' ' 7' ' ' THR . 46.5 Cg_endo -67.78 -31.49 31.95 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.73 2.287 . . . . 0.0 111.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.817 ' O ' HD22 ' A' ' 63' ' ' LEU . 40.1 p90 -96.24 -14.26 22.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 m -70.03 -7.22 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -139.6 151.44 46.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.528 ' CG ' HG13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -71.13 -40.28 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.567 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.16 -34.58 61.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.349 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 54.3 m-20 -71.56 -29.37 64.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -69.62 -40.85 76.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.775 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -58.73 -56.42 22.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 21' ' ' SER . . . -55.56 -36.17 66.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 8' ' ' PRO . 68.0 t80 -68.01 -48.88 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.092 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' A' ' 70' ' ' PHE . 41.1 mt -66.5 -44.54 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.36 -50.71 51.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.129 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 30.3 t -58.26 -30.31 66.48 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.867 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -72.31 -50.89 23.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.504 -0.748 . . . . 0.0 109.549 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 19' ' ' ILE . 72.1 mt -62.93 -55.91 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 m -57.19 -35.2 69.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.62 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.83 -48.3 16.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 32' ' ' PHE . . . -61.76 -34.61 76.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.775 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 19.3 m -64.1 -27.92 69.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.725 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.93 7.18 31.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.99 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.2 m -91.91 -75.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.081 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 -104.02 0.78 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -132.34 -58.65 0.94 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.37 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 7.5 m-85 44.19 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -59.59 162.89 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -52.66 -38.15 59.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.21 -37.8 84.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.281 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 72.3 mt-30 -68.24 -35.43 77.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.313 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.508 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 64.8 mtt -64.32 -36.8 85.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.48 -46.89 85.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.145 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -58.83 -41.21 86.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 43' ' ' ILE . 80.0 mtp -64.96 -32.05 73.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 m -69.99 -24.04 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -95.44 -17.16 21.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 80.8 mt -126.39 161.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -0.999 . . . . 0.0 109.509 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.514 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -79.98 1.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.48 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -1.116 . . . . 0.0 109.03 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -61.17 -35.36 76.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 0.0 109.038 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 HD23 ' A' ' 66' ' ' LEU . 24.7 tp -56.12 -36.19 67.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.848 . . . . 0.0 109.223 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.438 ' CG ' HD12 ' A' ' 19' ' ' ILE . 93.4 mmm -55.74 -33.01 63.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.13 79.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.96 . . . . 0.0 109.064 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.76 81.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 1.004 ' HE3' HD12 ' A' ' 58' ' ' ILE . 75.5 mmm -54.73 -34.06 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -58.85 -28.85 66.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.208 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -59.58 -31.15 69.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.141 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.648 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 85.3 mmm -57.88 -33.33 68.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.354 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.62 27.38 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.11 15.38 33.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.648 ' O ' ' HE2' ' A' ' 54' ' ' MET . 32.8 ptt180 -133.48 112.33 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 0.0 109.572 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.004 HD12 ' HE3' ' A' ' 51' ' ' MET . 37.3 mm -113.73 143.72 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.076 -1.015 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.03 160.76 25.19 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.622 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.67 -42.56 2.38 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.804 2.336 . . . . 0.0 111.699 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 t -67.5 -40.29 85.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.407 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.1 tttm -63.12 -52.15 63.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.374 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.817 HD22 ' O ' ' A' ' 9' ' ' TRP . 3.7 mt -56.99 -30.48 64.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . 63.4 tt0 -54.28 -45.58 72.52 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.21 63.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 108.917 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.716 HD23 HD21 ' A' ' 47' ' ' LEU . 1.6 mt -73.93 -53.9 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.543 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 9' ' ' TRP . 0.8 OUTLIER -48.47 -39.06 21.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.727 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.429 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 92.7 mtp -67.37 -47.35 70.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.23 -44.4 75.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.841 ' CE1' HG23 ' A' ' 19' ' ' ILE . 82.7 t80 -54.17 -40.59 67.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.984 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -59.85 -40.96 90.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.5 t -69.47 -30.63 68.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 43' ' ' ILE . 36.4 m -70.02 -49.57 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 22' ' ' PHE . 10.8 m -62.72 -38.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.64 -48.21 34.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.921 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.56 -42.65 92.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 73' ' ' SER . 83.5 mt -61.96 -55.04 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.004 . . . . 0.0 109.984 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.84 -47.2 26.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.45 -0.781 . . . . 0.0 110.184 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 122' ' ' PHE . . . -57.78 -23.85 54.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.8 m -83.04 -20.58 34.73 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.541 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 22.2 tp60 -136.89 104.73 5.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.99 103.62 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.45 93.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 87' ' ' VAL . 82.8 m-20 -106.56 82.15 1.68 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -1.17 . . . . 0.0 109.141 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 123' ' ' ALA . 6.3 tp -43.64 -26.31 0.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 84' ' ' ASP . . . -61.92 -33.19 84.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.2 p -69.73 -44.52 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.235 . . . . 0.0 109.656 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 92' ' ' ILE . 84.5 m -51.85 -34.98 43.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 108.535 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 1.1 m -56.71 -49.23 75.77 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 76.4 m-20 -70.92 -40.79 71.9 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.39 -0.819 . . . . 0.0 109.065 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -63.31 -53.23 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.389 -0.82 . . . . 0.0 109.922 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 96' ' ' LEU . 66.4 mt -72.48 -48.99 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.963 . . . . 0.0 109.952 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.83 -46.74 88.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.907 . . . . 0.0 110.248 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' THR . 89.2 m-20 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.18 -41.54 84.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.868 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 92' ' ' ILE . 5.2 mt -69.64 -39.3 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.717 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 108' ' ' ASN . 38.5 m -61.51 -53.5 55.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.927 . . . . 0.0 110.185 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 m -62.82 -38.29 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 109.944 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -62.36 -45.69 92.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.612 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.69 -56.21 7.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.75 -32.27 67.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 98' ' ' SER . 79.0 mm-40 -77.37 -18.63 57.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 99' ' ' ALA . 74.1 p -104.66 -60.22 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.978 -1.076 . . . . 0.0 110.913 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.93 HG21 ' C ' ' A' ' 7' ' ' THR . 19.0 p -127.03 -42.75 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.783 -1.198 . . . . 0.0 110.871 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.09 47.02 0.9 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.675 HG23 ' OG1' ' A' ' 104' ' ' THR . 16.6 t -106.58 172.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.175 -1.191 . . . . 0.0 108.944 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -71.47 119.67 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' A' ' 97' ' ' THR . 22.6 p-10 -72.1 -31.68 66.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 113' ' ' SER . 14.9 t -57.44 -44.48 84.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -0.817 . . . . 0.0 110.481 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -57.36 -53.55 56.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.992 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.6 t80 -74.67 -53.94 8.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.978 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 93' ' ' ALA . 28.9 mt -56.34 -37.51 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.078 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' SER . 19.2 m -55.79 -48.54 75.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.065 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.96 -42.58 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.08 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.984 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.5 mt -70.97 -34.62 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 17.8 ttt180 -54.03 -45.73 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 109.398 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.26 -33.9 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.468 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 115' ' ' ILE . 19.2 mt -65.88 -41.08 92.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.799 HG22 HD11 ' A' ' 85' ' ' LEU . 99.0 mt -57.82 -37.13 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.18 -34.26 64.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.9 -38.09 89.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -1.167 . . . . 0.0 109.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 72.0 m-85 -69.97 -38.25 76.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -64.0 -32.13 73.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.43 -35.52 75.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.389 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.2 t -59.24 -34.88 72.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.415 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -63.56 -20.87 66.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 93.8 m-20 -73.19 -28.7 62.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.04 -42.38 89.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.904 HG13 ' CD1' ' A' ' 131' ' ' TYR . 4.7 p -71.28 -30.94 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.904 ' CD1' HG13 ' A' ' 130' ' ' VAL . 41.8 p90 178.7 168.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.9 118.73 18.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.7 p -63.87 165.03 9.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.497 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.36 -28.72 69.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.48 12.53 58.27 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.9 m -56.66 -34.62 67.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.7 mtp -126.47 157.69 38.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -1.159 . . . . 0.0 109.504 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.35 -172.09 37.84 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -118.61 148.67 42.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -1.153 . . . . 0.0 109.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.578 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -136.28 162.34 33.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 106' ' ' VAL . 25.4 m120 -78.42 -15.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.678 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 9' ' ' TRP . 0.5 OUTLIER -165.11 156.48 12.92 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 38.4 Cg_endo -61.85 -32.25 85.43 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.561 2.174 . . . . 0.0 112.171 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 19.0 p90 -84.15 9.86 11.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 7' ' ' THR . 5.4 t -99.86 -22.75 15.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 0.0 108.763 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.578 ' OG ' ' HB2' ' A' ' 5' ' ' ALA . 69.9 m -118.89 157.74 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.468 -0.77 . . . . 0.0 109.113 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.542 ' CG ' HG13 ' A' ' 58' ' ' ILE . 24.1 ttpt -74.25 -40.71 62.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.943 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.19 -35.3 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.558 HD22 ' HB3' ' A' ' 5' ' ' ALA . 1.6 m-20 -72.24 -32.55 66.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.61 -47.21 49.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.087 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 68.1 m-20 -54.75 -56.31 20.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.86 . . . . 0.0 109.909 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.9 66.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.111 -0.993 . . . . 0.0 109.159 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 81.5 t80 -62.11 -41.1 97.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.288 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.768 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.8 mm -69.34 -49.11 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 16' ' ' ASP . 39.8 m-80 -62.03 -49.75 74.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -59.04 -34.91 72.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.751 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 16.6 t80 -67.14 -36.01 80.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.0 110.161 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 19' ' ' ILE . 66.1 mt -70.13 -56.03 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.17 -0.957 . . . . 0.0 110.315 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -62.7 -33.49 75.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -44.6 26.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.612 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.8 -29.36 64.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.031 -1.043 . . . . 0.0 110.444 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 2.3 t -60.92 -30.87 70.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.0 110.553 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -106.1 7.4 31.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.012 . . . . 0.0 110.682 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.816 HG21 ' CB ' ' A' ' 94' ' ' ASP . 13.3 m -91.54 -73.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 110.607 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -76.1 -105.4 0.13 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' PHE . 18.1 m -149.46 13.37 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.461 -1.023 . . . . 0.0 109.805 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 66.0 m-85 -39.77 109.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.1 p -72.21 164.22 26.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -53.29 -35.77 60.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.159 -0.963 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -68.05 -47.17 69.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 32' ' ' PHE . 68.9 mt-30 -64.7 -33.89 77.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 40' ' ' MET . 92.9 mmm -64.31 -30.13 71.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.03 -40.18 76.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.12 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.15 -42.22 85.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.218 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.708 ' HG3' HD13 ' A' ' 77' ' ' ILE . 58.0 mtt -57.38 -39.06 75.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 109.011 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.3 p -70.42 -23.54 62.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.406 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 tp -87.24 -13.78 42.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.743 HG21 ' CB ' ' A' ' 73' ' ' SER . 61.9 mt -133.45 168.02 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.597 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 66.53 -68.85 0.16 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ILE . 36.0 t-20 -60.76 -38.94 86.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.228 -1.16 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 m -62.38 -35.62 79.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 0.0 109.051 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 66' ' ' LEU . 8.7 mp -53.9 -37.49 63.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.731 ' O ' ' HE2' ' A' ' 51' ' ' MET . 60.7 mtm -52.75 -39.85 62.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.249 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.38 73.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.898 . . . . 0.0 109.041 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.12 -25.97 68.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.363 -0.835 . . . . 0.0 109.246 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.731 ' HE2' ' O ' ' A' ' 48' ' ' MET . 57.0 mtm -54.35 -29.79 49.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.266 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.75 -30.66 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.191 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.72 -31.04 72.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.166 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.597 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 86.1 mmm -60.63 -29.24 69.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 109.313 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.71 12.35 66.77 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.29 25.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' O ' HD13 ' A' ' 58' ' ' ILE . 11.8 ptt180 -128.31 112.46 14.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -1.18 . . . . 0.0 109.696 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.847 ' CG2' HD22 ' A' ' 63' ' ' LEU . 15.9 mm -116.99 148.91 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -141.58 154.73 66.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.868 . . . . 0.0 109.688 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 49.1 Cg_endo -69.38 -11.06 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.68 2.254 . . . . 0.0 111.7 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -82.96 -57.44 3.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.188 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -79.16 -41.69 27.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.847 HD22 ' CG2' ' A' ' 58' ' ' ILE . 15.0 tp -55.6 -36.47 66.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 51.4 tt0 -55.05 -29.77 58.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.062 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.79 90.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.287 -0.883 . . . . 0.0 109.078 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 47' ' ' LEU . 9.4 tt -69.07 -38.16 78.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.119 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 48.2 t0 -50.55 -48.81 57.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.557 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.45 -40.44 97.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 109.794 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.53 76.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.785 ' O ' HG13 ' A' ' 74' ' ' VAL . 77.2 t80 -55.71 -35.69 66.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.712 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.56 -36.93 83.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -69.32 -35.67 76.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.764 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.743 ' CB ' HG21 ' A' ' 43' ' ' ILE . 52.8 p -70.2 -49.83 46.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 109.821 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 70' ' ' PHE . 4.2 m -58.42 -34.94 52.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.73 -38.87 67.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.677 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.04 -49.88 58.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.176 -0.953 . . . . 0.0 109.763 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' HG3' ' A' ' 40' ' ' MET . 74.8 mt -55.18 -54.59 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.756 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -69.35 -50.81 42.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 109.855 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.029 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.95 -23.91 55.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.261 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.5 t -81.16 -20.3 41.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' OE1' ' CD1' ' A' ' 32' ' ' PHE . 24.1 mt-30 -48.37 -37.28 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 9.57 71.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.94 -175.82 22.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 87' ' ' VAL . 23.9 t0 -55.29 123.97 15.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -1.135 . . . . 0.0 109.363 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.029 HD11 ' HA ' ' A' ' 79' ' ' ALA . 1.1 tp -75.79 -19.03 59.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.596 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.23 -38.45 77.84 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.5 p -70.69 -41.07 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -1.195 . . . . 0.0 109.82 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.482 ' N ' HG13 ' A' ' 87' ' ' VAL . 25.8 m -51.65 -33.72 34.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.051 -1.031 . . . . 0.0 108.812 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.8 p -58.51 -46.17 87.29 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 26.5 m120 -70.82 -38.25 73.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.711 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -66.29 -58.95 4.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.143 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.751 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 22.8 mm -62.08 -43.77 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.625 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.45 -44.93 85.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 110.697 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 29' ' ' THR . 31.8 t0 -55.02 -54.07 47.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.879 -1.138 . . . . 0.0 109.789 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -64.08 -35.82 82.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.14 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.873 HD21 ' CD2' ' A' ' 111' ' ' PHE . 6.0 tp -69.94 -40.23 75.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.603 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.693 HG23 HD22 ' A' ' 108' ' ' ASN . 18.4 m -69.11 -52.6 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 16.8 m -60.27 -35.35 75.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.727 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -67.72 -39.33 84.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -53.41 -53.37 52.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -71.6 -32.08 67.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.502 -0.749 . . . . 0.0 110.465 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 98' ' ' SER . 70.6 mm-40 -78.84 -18.5 53.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 18' ' ' PHE . 66.1 p -102.72 -59.35 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.0 111.108 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.2 m -126.23 -42.54 1.84 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.882 -1.136 . . . . 0.0 110.707 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.58 47.92 1.01 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 6' ' ' ASN . 6.5 t -112.85 172.61 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -1.122 . . . . 0.0 109.322 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 110' ' ' ARG . 5.4 m -72.3 121.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.693 HD22 HG23 ' A' ' 97' ' ' THR . 16.7 p30 -69.9 -23.35 63.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 97.9 p -54.7 -30.6 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.592 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.788 ' HG3' HG23 ' A' ' 107' ' ' VAL . 23.6 mtp-105 -67.42 -55.01 15.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.873 ' CD2' HD21 ' A' ' 96' ' ' LEU . 3.0 t80 -75.8 -51.03 13.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.654 ' CG1' HD23 ' A' ' 96' ' ' LEU . 43.7 mt -56.39 -42.23 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 110.412 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' SER . 55.9 m -59.34 -35.26 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 109.677 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.7 mt-10 -72.65 -47.37 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.712 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -66.24 -40.67 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 109.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -54.37 -46.37 73.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 t -72.31 -34.22 67.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.62 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 118' ' ' LEU . 29.5 mt -68.77 -42.01 78.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' CD2' ' A' ' 85' ' ' LEU . 76.7 mt -59.61 -43.01 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.34 93.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.6 ttp -54.47 -44.26 72.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.576 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 98.4 m-85 -59.28 -38.92 81.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.805 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -57.23 -33.29 67.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -70.69 -31.44 68.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.16 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.7 p -74.85 -19.87 59.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.923 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -64.78 -28.39 69.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.554 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.71 -6.76 39.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.634 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -79.01 -39.4 34.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.846 HG13 ' CD2' ' A' ' 131' ' ' TYR . 5.6 p -62.89 -29.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.846 ' CD2' HG13 ' A' ' 130' ' ' VAL . 40.2 p90 177.6 159.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.75 118.27 11.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.3 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.52 152.86 28.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.516 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.48 71.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 99.5 p -115.92 152.76 32.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -1.141 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.5 mtp -121.97 155.49 35.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.533 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.87 179.61 52.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -65.16 -30.16 71.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -1.16 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.55 34.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.694 ' C ' HG21 ' A' ' 104' ' ' THR . 72.9 m-20 -90.22 9.43 28.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.629 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -147.54 145.37 21.33 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.1 Cg_endo -70.8 -35.39 9.67 Favored 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.401 2.067 . . . . 0.0 111.724 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.878 ' O ' HD23 ' A' ' 63' ' ' LEU . 41.8 p90 -85.72 -26.28 25.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.868 -1.145 . . . . 0.0 109.155 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.413 ' CB ' ' HG1' ' A' ' 7' ' ' THR . 88.2 p -62.8 -12.09 22.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 79.4 p -129.66 150.12 51.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.125 -0.984 . . . . 0.0 109.336 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 16.4 ttpt -74.36 -37.68 63.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.948 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.96 -50.12 63.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 109.191 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.3 m120 -72.42 -28.93 63.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.563 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -63.73 -44.3 93.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' CE ' ' A' ' 48' ' ' MET . 18.8 t0 -68.59 -50.98 47.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.88 . . . . 0.0 109.628 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.29 75.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.554 ' CA ' HG21 ' A' ' 103' ' ' THR . 73.5 t80 -58.89 -37.23 76.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 70' ' ' PHE . 44.0 mt -74.73 -37.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.761 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -50.55 51.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.772 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 31.3 t -60.74 -29.18 69.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.342 -0.849 . . . . 0.0 109.102 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.931 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 14.0 t80 -66.55 -51.1 60.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.017 HD12 ' HB3' ' A' ' 40' ' ' MET . 34.5 mm -64.56 -55.74 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.863 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t -60.29 -34.29 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 110.094 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.36 -45.22 26.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.982 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.33 73.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.91 . . . . 0.0 110.026 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 37.8 m -63.68 -28.46 69.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.088 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -106.25 7.14 31.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.086 -1.009 . . . . 0.0 110.311 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.604 HG21 ' CB ' ' A' ' 94' ' ' ASP . 21.0 m -91.48 -76.64 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.996 -1.065 . . . . 0.0 110.081 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 -104.2 0.57 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.5 t -134.21 -58.27 0.84 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.2 m-85 44.0 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 109.34 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -59.67 157.66 11.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -52.52 -30.8 32.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -71.48 -36.0 70.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.319 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 95.2 mm-40 -72.71 -32.29 65.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.26 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.438 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 64.5 mtt -63.96 -30.36 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.182 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.49 -44.3 84.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.699 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.3 m-20 -55.67 -42.07 74.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.955 . . . . 0.0 109.051 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.017 ' HB3' HD12 ' A' ' 23' ' ' ILE . 64.4 mtt -59.66 -32.08 70.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 p -70.27 -23.72 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.478 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 43' ' ' ILE . 73.7 mt -91.53 -19.92 22.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.927 HG21 ' HB3' ' A' ' 73' ' ' SER . 19.3 mm -129.04 151.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 86.25 -85.06 1.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.472 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 61.8 t-20 -59.88 -33.33 71.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -1.151 . . . . 0.0 108.533 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -63.06 -35.12 79.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 66' ' ' LEU . 60.1 mt -56.74 -35.1 68.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 45' ' ' ASN . 56.4 mtt -52.64 -40.91 63.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.047 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.57 73.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.67 81.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.364 -0.835 . . . . 0.0 109.09 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 67.5 mtt -55.05 -34.91 63.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 0.0 109.267 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.77 -25.13 66.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.081 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -71.02 -28.87 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.238 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.604 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 90.4 mmm -63.74 -30.13 71.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.07 59.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.41 45.21 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.661 ' O ' HD13 ' A' ' 58' ' ' ILE . 24.5 ptt85 -125.16 112.05 16.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 57' ' ' ARG . 13.7 mm -117.26 154.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.988 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 p -126.67 159.95 61.11 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 50.1 Cg_endo -70.56 -32.64 14.9 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.698 2.265 . . . . 0.0 111.863 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.3 p -70.43 -46.01 64.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -62.57 -51.13 68.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.878 HD23 ' O ' ' A' ' 9' ' ' TRP . 3.6 mp -62.02 -38.22 87.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 68' ' ' MET . 48.8 tt0 -54.15 -46.45 72.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 108.686 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.62 -40.92 66.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.139 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 HD13 ' A' ' 47' ' ' LEU . 32.2 tp -66.49 -52.24 48.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.8 t0 -47.36 -33.42 5.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 90.9 mtp -71.78 -37.29 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.62 -42.28 87.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.642 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.5 t80 -54.98 -37.81 67.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.006 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.66 -42.09 71.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.866 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -68.62 -30.78 69.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.943 . . . . 0.0 109.943 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.927 ' HB3' HG21 ' A' ' 43' ' ' ILE . 26.2 m -69.96 -49.12 54.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.722 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 71' ' ' ALA . 35.5 m -58.48 -34.96 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -68.75 -38.7 80.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -72.12 -44.13 63.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 39' ' ' ASN . 89.6 mt -54.07 -53.29 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.671 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -75.38 -49.28 19.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.842 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.93 -21.07 42.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 109.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 93.3 p -81.72 -20.2 39.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.256 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.48 ' HG2' ' OE1' ' A' ' 36' ' ' GLN . 25.4 mt-30 -51.79 -33.77 36.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.38 67.4 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.24 -175.62 33.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 87' ' ' VAL . 32.1 t0 -63.09 122.4 16.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.982 HD22 ' HB2' ' A' ' 123' ' ' ALA . 5.7 mp -71.33 -16.18 62.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.77 -47.75 69.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 88' ' ' THR . 9.8 p -70.47 -46.23 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.302 -1.116 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.605 ' N ' HG13 ' A' ' 87' ' ' VAL . 11.5 m -51.52 -36.27 44.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.075 -1.016 . . . . 0.0 108.393 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 55.0 m -54.96 -46.96 75.09 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.7 m-20 -70.79 -41.55 71.51 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -62.2 -58.77 6.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.615 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.811 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 40.6 mt -64.56 -41.66 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -66.14 -44.54 83.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -0.934 . . . . 0.0 109.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.604 ' CB ' HG21 ' A' ' 29' ' ' THR . 44.0 t0 -55.08 -50.87 68.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 109.473 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -54.7 -44.15 73.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.887 . . . . 0.0 109.232 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 93' ' ' ALA . 5.2 mt -69.88 -38.68 76.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.209 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.657 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.4 m -62.3 -46.56 88.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.803 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 7.8 m -70.62 -49.18 50.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.35 -44.99 68.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.61 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.11 -55.22 8.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.238 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 97' ' ' THR . 1.9 m-85 -71.97 -31.81 66.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.504 -0.747 . . . . 0.0 109.594 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' SER . 41.9 mt-30 -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.272 -0.893 . . . . 0.0 109.843 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 99' ' ' ALA . 69.8 p -105.94 -60.35 1.65 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.334 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.694 HG21 ' C ' ' A' ' 6' ' ' ASN . 17.1 m -126.92 -42.7 1.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.877 -1.139 . . . . 0.0 110.645 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.21 46.14 1.03 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.3 t -105.69 172.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.306 -1.114 . . . . 0.0 109.053 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 106' ' ' VAL . 23.0 m -73.55 121.01 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.348 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.657 ' ND2' HG23 ' A' ' 97' ' ' THR . 10.5 p30 -71.41 -28.35 63.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 113' ' ' SER . 22.9 t -56.93 -44.65 82.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -56.92 -54.15 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.973 -1.079 . . . . 0.0 109.975 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 69.1 t80 -75.58 -52.13 11.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.537 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.8 mt -56.67 -35.74 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 109' ' ' SER . 42.3 t -58.93 -30.25 67.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.94 -41.74 64.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.006 HG12 ' HB1' ' A' ' 71' ' ' ALA . 93.1 mt -72.59 -39.45 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -54.21 -43.16 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.6 p -72.23 -33.92 67.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -68.61 -45.24 72.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.865 HG22 HD23 ' A' ' 85' ' ' LEU . 64.9 mt -57.86 -44.88 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.22 -34.57 67.53 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.7 ttm -66.96 -42.33 85.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 109.467 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -64.66 -32.35 73.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.982 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -63.17 -33.79 76.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.479 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -70.11 -35.36 74.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.56 80.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.1 p -62.92 -22.8 67.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.411 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.788 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -65.94 -23.92 66.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.21 -13.68 60.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -74.62 -46.19 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.945 HG23 ' CD1' ' A' ' 131' ' ' TYR . 19.2 m -60.68 -30.44 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.945 ' CD1' HG23 ' A' ' 130' ' ' VAL . 49.0 p90 178.39 179.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -74.06 117.66 16.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -100.1 145.04 28.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.576 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.26 154.23 37.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.372 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.91 -172.61 53.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -58.16 -34.24 70.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -1.178 . . . . 0.0 109.466 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.5 mtp -58.27 -34.08 70.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.62 -32.73 39.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -107.04 145.77 31.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -1.125 . . . . 0.0 109.494 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . . . -76.11 144.68 40.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -62.69 -24.84 67.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -129.85 163.68 45.48 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 49.9 Cg_endo -83.95 -34.23 0.28 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 C-N-CA 122.526 2.15 . . . . 0.0 111.626 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.606 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.4 p90 -90.27 -23.27 21.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.902 -1.124 . . . . 0.0 109.488 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -60.87 -12.57 11.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 70.5 m -132.01 153.67 50.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.583 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 28.9 mtmt -73.88 -39.19 64.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -65.92 -50.33 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.752 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 5' ' ' ALA . 17.1 m120 -72.21 -29.06 63.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.35 -55.17 8.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.007 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 1.8 p30 -55.03 -46.8 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.507 -0.746 . . . . 0.0 109.882 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.44 -39.82 94.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 80.7 t80 -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 109.419 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' ALA . 33.2 mm -71.03 -44.07 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.42 -45.2 84.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 t -67.11 -30.72 70.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.884 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -66.31 -46.83 75.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.151 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 40' ' ' MET . 30.5 mm -64.89 -56.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.522 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 m -60.85 -31.9 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.98 . . . . 0.0 109.919 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -45.45 24.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.06 -34.1 76.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.362 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 m -57.35 -33.52 67.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.322 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -106.06 7.36 31.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.128 -0.983 . . . . 0.0 110.687 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.659 HG21 ' CB ' ' A' ' 94' ' ' ASP . 43.5 m -85.89 -81.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.801 -1.187 . . . . 0.0 110.201 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.14 -101.12 0.24 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -132.46 -61.51 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -1.059 . . . . 0.0 109.212 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.8 m-85 43.94 91.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.307 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.417 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 53.7 p -59.61 161.28 6.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.61 -40.72 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.84 -36.21 76.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.472 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.3 mm-40 -73.2 -32.28 64.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.66 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.6 mtt -63.23 -34.18 77.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.0 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.43 -43.11 91.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.855 . . . . 0.0 109.038 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -59.76 -42.58 93.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.912 ' HB3' HD12 ' A' ' 23' ' ' ILE . 75.1 mtm -66.75 -32.72 74.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.135 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.4 t -70.25 -24.02 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 17.0 tp -87.92 -22.81 24.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB2' ' A' ' 73' ' ' SER . 37.9 mm -116.15 162.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 90.83 -80.33 1.36 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.0 -38.14 78.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.7 m -60.17 -35.33 75.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.354 -0.841 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 66' ' ' LEU . 26.9 tp -59.52 -33.94 72.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.247 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 16' ' ' ASP . 60.3 mmm -56.65 -28.14 59.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.31 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.41 86.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.112 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -22.77 50.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.243 -0.911 . . . . 0.0 108.9 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.543 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 16.6 ttm -54.15 -41.73 68.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -64.07 -26.67 68.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -63.42 -25.46 68.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.859 . . . . 0.0 109.506 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.528 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 81.8 mmm -54.25 -33.99 59.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.14 13.12 79.77 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.33 27.83 7.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' CE ' ' A' ' 54' ' ' MET . 2.5 ptt85 -137.89 112.66 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -1.205 . . . . 0.0 109.673 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.937 ' CG2' HD22 ' A' ' 63' ' ' LEU . 36.9 mm -114.36 140.28 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 109.5 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 62' ' ' LYS . 5.4 t -148.19 149.49 32.4 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.554 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.533 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 46.0 Cg_endo -66.86 -34.0 31.78 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.653 2.235 . . . . 0.0 111.887 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -66.26 -50.32 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.975 . . . . 0.0 109.45 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.591 ' H ' HG23 ' A' ' 59' ' ' THR . 40.7 mttt -81.42 -46.14 15.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.026 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.937 HD22 ' CG2' ' A' ' 58' ' ' ILE . 5.6 tp -58.96 -48.21 82.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.099 -1.001 . . . . 0.0 109.765 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 91.9 mt-30 -54.68 -35.01 63.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 108.73 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -68.45 -43.56 76.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 27.0 t0 -48.57 -34.88 12.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.787 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.5 -37.31 77.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.91 . . . . 0.0 109.931 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.9 65.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.7 t80 -67.01 -35.92 80.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.786 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 25.2 t -69.69 -41.71 75.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 110.023 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB2' HG21 ' A' ' 43' ' ' ILE . 58.0 p -70.09 -47.12 63.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 110.28 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.2 m -57.2 -37.05 54.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.802 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' N ' HG23 ' A' ' 74' ' ' VAL . . . -73.92 -38.32 64.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 0.0 109.819 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 72' ' ' SER . 94.4 mt-30 -70.27 -46.23 64.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.828 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.438 HG21 ' HG3' ' A' ' 40' ' ' MET . 97.2 mt -56.2 -44.74 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 0.0 109.885 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.36 -50.14 12.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.896 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.13 48.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.8 m -76.2 -20.26 57.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.937 . . . . 0.0 109.457 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.6 mt-30 -55.86 -33.16 64.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.672 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.73 21.82 73.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.48 -149.41 19.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.04 120.65 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.016 HD11 HG22 ' A' ' 119' ' ' ILE . 5.3 tp -67.69 -18.46 64.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.287 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -28.36 70.25 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.86 -50.06 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -1.164 . . . . 0.0 109.569 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 92' ' ' ILE . 59.6 m -52.32 -49.52 64.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 56.9 m -51.68 -48.85 63.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.8 m-20 -70.86 -32.11 69.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -77.98 -59.04 2.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.763 HG22 HD11 ' A' ' 96' ' ' LEU . 31.3 mt -61.27 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.879 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.107 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' CB ' HG21 ' A' ' 29' ' ' THR . 42.9 t0 -55.14 -53.62 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.884 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.98 -42.98 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.763 HD11 HG22 ' A' ' 92' ' ' ILE . 6.7 mt -69.47 -40.52 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.748 HG23 HD22 ' A' ' 108' ' ' ASN . 76.0 m -62.77 -51.98 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.0 m -62.97 -36.61 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.602 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.78 -42.81 73.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.671 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.7 m-85 -47.3 -55.98 7.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.53 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.4 m-85 -71.06 -32.17 68.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 98' ' ' SER . 89.5 mm-40 -78.56 -18.36 54.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 18' ' ' PHE . 72.4 p -102.55 -59.97 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 111.149 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.598 HG21 ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.03 -42.36 1.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.779 -1.2 . . . . 0.0 110.807 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.34 47.93 0.9 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 107' ' ' VAL . 21.5 t -113.25 169.14 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.299 -1.118 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.581 HG23 ' CG ' ' A' ' 110' ' ' ARG . 15.8 m -67.43 121.22 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.856 . . . . 0.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.748 HD22 HG23 ' A' ' 97' ' ' THR . 11.6 p30 -71.14 -23.63 62.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 113' ' ' SER . 91.3 p -59.29 -33.34 70.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 110.794 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.581 ' CG ' HG23 ' A' ' 107' ' ' VAL . 78.2 mmt-85 -64.1 -55.42 22.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.742 -1.224 . . . . 0.0 110.33 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.2 t80 -76.28 -49.67 16.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.566 HG21 ' HB1' ' A' ' 93' ' ' ALA . 16.2 mt -56.65 -36.71 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 109' ' ' SER . 78.9 p -63.44 -34.79 78.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.04 -1.037 . . . . 0.0 109.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.31 -39.75 74.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.033 HD11 ' CE2' ' A' ' 111' ' ' PHE . 54.3 mt -72.77 -41.99 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -54.46 -42.38 70.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.4 t -72.01 -33.84 68.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.667 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 41.7 mt -68.36 -42.21 79.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.016 HG22 HD11 ' A' ' 85' ' ' LEU . 62.6 mt -58.51 -41.55 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -66.67 -30.85 76.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -66.99 -39.48 87.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.595 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.433 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 72.3 m-85 -60.59 -52.06 66.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.555 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.08 72.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.552 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 95.9 mt-30 -70.44 -30.51 67.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.447 ' HA ' ' ND2' ' A' ' 128' ' ' ASN . . . -62.78 -35.25 79.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.3 m -56.65 -34.93 67.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.442 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -72.53 -15.37 61.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.509 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 93.3 m-20 -65.8 -27.82 68.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -66.88 -45.52 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.352 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.917 HG13 ' CD1' ' A' ' 131' ' ' TYR . 5.9 p -69.41 -30.87 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.917 ' CD1' HG13 ' A' ' 130' ' ' VAL . 39.7 p90 179.1 166.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.96 119.69 16.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.315 -0.865 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 m -60.35 160.1 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.487 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -154.54 154.03 32.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.58 178.36 52.52 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.2 p -124.16 154.33 40.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -1.112 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.7 mtp -125.4 150.28 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.51 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.11 8.35 61.62 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -120.55 139.31 53.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.95 ' HB1' ' OG ' ' A' ' 10' ' ' SER . . . -59.73 -40.98 89.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.895 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.757 ' O ' HG21 ' A' ' 106' ' ' VAL . 76.4 m-20 53.89 35.62 22.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.444 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -165.11 145.35 5.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.9 Cg_endo -70.25 -35.12 11.73 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.414 2.076 . . . . 0.0 111.728 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.865 ' O ' HD13 ' A' ' 63' ' ' LEU . 39.5 p90 -85.58 -30.89 22.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 109.058 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.95 ' OG ' ' HB1' ' A' ' 5' ' ' ALA . 87.9 p -58.8 -15.09 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 109.57 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 51.0 m -127.15 143.69 51.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 109.343 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.49 ' HB2' HG13 ' A' ' 58' ' ' ILE . 4.0 ttpp -71.64 -37.14 70.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -68.45 -48.08 65.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 108.994 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 12.3 m120 -71.56 -28.93 64.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.38 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.23 -41.57 99.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.822 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.8 p30 -68.71 -50.12 53.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -56.57 -37.42 70.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.89 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.627 ' CA ' HG21 ' A' ' 103' ' ' THR . 69.3 t80 -65.78 -49.36 68.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.02 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.828 HG23 ' HE1' ' A' ' 70' ' ' PHE . 42.0 mt -63.14 -46.94 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -67.75 -50.3 57.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 108.945 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 69.4 m -56.11 -30.04 61.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 108.593 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 92' ' ' ILE . 46.8 t80 -71.44 -52.2 19.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.538 -0.726 . . . . 0.0 109.624 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 ' HE2' ' A' ' 40' ' ' MET . 56.8 mt -62.62 -55.74 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -53.76 -40.3 66.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.863 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.85 -46.0 22.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.088 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -60.42 -30.64 69.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 17.4 m -64.75 -31.4 72.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.968 . . . . 0.0 110.014 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.96 7.35 32.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' HB3' ' A' ' 94' ' ' ASP . 19.3 m -88.68 -75.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.95 -1.094 . . . . 0.0 110.054 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -88.49 -102.2 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -138.13 -55.64 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -1.115 . . . . 0.0 109.353 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.9 m-85 43.84 87.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.158 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.8 p -59.76 161.24 6.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.66 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -52.62 -31.95 39.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.143 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.113 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.502 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 82.3 mm-40 -76.19 -34.61 59.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 109.233 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 71.5 mtp -63.42 -36.73 84.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -56.89 -42.52 80.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.908 ' HB2' HG23 ' A' ' 77' ' ' ILE . 87.0 m-20 -59.5 -37.0 77.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.865 . . . . 0.0 109.052 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.584 ' HA ' HD13 ' A' ' 77' ' ' ILE . 90.8 mtp -65.18 -33.47 76.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.356 -0.84 . . . . 0.0 109.25 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -70.1 -24.22 63.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.246 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.9 tp -89.03 -20.61 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.747 ' HB ' HD11 ' A' ' 77' ' ' ILE . 65.0 mt -120.03 160.46 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 109.408 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -88.54 0.91 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.17 -37.18 64.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -1.164 . . . . 0.0 109.157 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 89.1 m -58.13 -34.86 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.267 -0.896 . . . . 0.0 108.81 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.71 -35.88 79.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.37 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 38.7 ttm -52.74 -37.56 59.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.291 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.8 -31.11 71.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.245 -0.909 . . . . 0.0 109.122 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.86 81.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.896 . . . . 0.0 109.239 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.427 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 62.9 mtm -60.76 -30.22 69.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 0.0 109.251 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.47 -29.8 69.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.215 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -65.95 -24.02 66.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.244 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.542 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 95.4 mmm -63.96 -33.26 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.862 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.48 10.55 53.45 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.34 10.52 33.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.6 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.1 ptt180 -125.03 112.3 16.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 109.465 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 57' ' ' ARG . 16.6 mm -116.2 136.54 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.568 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 162.81 19.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.87 -33.4 16.24 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.707 2.271 . . . . 0.0 111.675 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -70.61 -44.42 67.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 9' ' ' TRP . 6.5 mt -71.26 -32.26 68.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.75 -49.62 70.4 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 108.591 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.52 -47.48 48.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.056 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.4 -53.32 59.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.9 t0 -47.87 -35.69 10.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.267 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.2 ttm -72.18 -40.89 67.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.59 91.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.828 ' HE1' HG23 ' A' ' 19' ' ' ILE . 75.0 t80 -54.48 -42.78 71.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.886 ' HB1' ' CG1' ' A' ' 115' ' ' ILE . . . -70.26 -38.19 75.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.764 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 84.3 p -69.17 -46.85 66.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.991 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.659 ' HB3' HD13 ' A' ' 43' ' ' ILE . 4.1 m -70.03 -45.33 67.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.71 ' HA ' HD12 ' A' ' 77' ' ' ILE . 9.8 p -57.71 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -67.35 -36.54 81.62 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.933 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 90.8 mt-30 -69.17 -38.3 78.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.834 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.908 HG23 ' HB2' ' A' ' 39' ' ' ASN . 56.5 mt -56.68 -55.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.848 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.68 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -78.85 -48.53 14.54 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 109.977 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.87 -22.25 47.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 30.0 t -81.13 -20.92 40.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.892 . . . . 0.0 109.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 31.5 mt-30 -44.68 -40.91 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.81 53.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.96 -158.73 12.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 87' ' ' VAL . 83.7 m-20 -54.33 127.48 27.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.783 HD11 HG22 ' A' ' 119' ' ' ILE . 5.5 tp -84.46 -20.87 31.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.71 63.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -68.95 -47.79 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 109.525 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . 22.5 m -51.7 -37.73 52.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.068 . . . . 0.0 108.251 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -55.34 -51.6 66.22 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 62.2 m-20 -70.86 -39.64 72.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -60.19 -55.35 34.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.51 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 22' ' ' PHE . 43.6 mt -72.23 -49.93 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.455 -0.778 . . . . 0.0 109.852 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -57.09 -46.2 82.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 110.654 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.781 ' HB3' HG21 ' A' ' 29' ' ' THR . 41.8 t0 -54.9 -53.77 51.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.941 -1.099 . . . . 0.0 109.89 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.718 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -57.14 -40.73 77.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.715 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 92' ' ' ILE . 15.0 mt -68.13 -41.45 81.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.7 m -58.61 -53.82 54.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.886 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 16.3 m -63.8 -45.14 91.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.13 -45.98 68.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.12 -0.987 . . . . 0.0 109.427 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.13 -54.27 10.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.973 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.76 -32.05 67.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.493 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 98' ' ' SER . 73.1 mt-30 -76.12 -18.51 59.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.821 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 99' ' ' ALA . 47.9 p -105.51 -59.73 1.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 111.209 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.558 HG21 ' N ' ' A' ' 7' ' ' THR . 5.5 m -126.55 -42.58 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.83 -1.169 . . . . 0.0 110.784 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.88 47.7 1.0 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.757 HG21 ' O ' ' A' ' 6' ' ' ASN . 48.1 t -112.78 168.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.309 -1.112 . . . . 0.0 108.945 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.8 m -67.29 121.04 15.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.3 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.689 ' ND2' HG23 ' A' ' 97' ' ' THR . 16.1 p-10 -70.53 -23.12 62.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.426 -0.797 . . . . 0.0 109.818 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' SER . 34.0 t -54.45 -30.34 52.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.858 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' A' ' 107' ' ' VAL . 93.5 mtt180 -68.15 -55.31 12.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.817 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 71.4 t80 -76.4 -50.66 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 110.343 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.531 HD11 ' N ' ' A' ' 97' ' ' THR . 17.3 mt -56.17 -45.77 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.836 . . . . 0.0 110.182 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 109' ' ' SER . 63.1 m -55.66 -39.25 70.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.0 109.392 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 80.8 tt0 -62.1 -49.71 74.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.886 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 81.2 mt -67.59 -34.7 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -53.7 -45.69 70.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.38 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.1 t -73.42 -33.68 65.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 49.1 mt -67.92 -45.51 74.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.783 HG22 HD11 ' A' ' 85' ' ' LEU . 87.5 mt -57.8 -34.54 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.997 . . . . 0.0 109.438 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.76 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -68.23 -36.77 85.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.45 -37.63 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -1.177 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 63.9 m-85 -66.56 -30.48 70.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -61.46 -35.69 78.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -70.65 -35.45 72.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.24 69.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.0 p -64.67 -28.65 69.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -67.71 -16.78 64.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.34 -32.02 73.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 130' ' ' VAL . 46.5 p30 -70.23 -15.07 62.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 2.0 p -58.03 -25.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.603 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER 177.49 -172.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.386 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -46.18 -37.79 7.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.368 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.21 72.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.505 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.62 -165.4 46.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.9 p -60.56 -27.7 67.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -1.143 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.0 mtm -122.23 153.4 38.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -1.165 . . . . 0.0 109.452 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.29 178.07 47.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -65.71 -21.64 66.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -1.184 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.21 14.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.42 -15.77 62.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.743 HG22 ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.8 157.39 32.02 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.064 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 49.0 Cg_endo -69.03 -34.6 16.64 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.566 2.178 . . . . 0.0 112.633 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.776 ' O ' HD22 ' A' ' 63' ' ' LEU . 48.9 p90 -83.28 1.48 40.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.964 -1.085 . . . . 0.0 110.074 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.743 ' OG ' HG22 ' A' ' 7' ' ' THR . 17.7 m -90.46 -28.26 18.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 108.933 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -104.23 154.58 19.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.352 -0.843 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -73.53 -37.78 65.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -35.21 25.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.643 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.68 HD22 ' C ' ' A' ' 103' ' ' THR . 0.2 OUTLIER -71.29 -29.17 64.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 109.602 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.43 -45.28 60.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 109.952 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 48' ' ' MET . 58.6 t0 -56.22 -54.06 49.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.99 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.8 -44.17 63.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.719 ' CA ' HG21 ' A' ' 103' ' ' THR . 72.8 t80 -56.97 -38.78 73.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.886 HG23 ' CE1' ' A' ' 70' ' ' PHE . 34.4 mm -69.35 -42.93 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.862 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -64.95 -49.24 71.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.029 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.6 t -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 12.0 t80 -64.28 -52.2 59.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.164 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' A' ' 40' ' ' MET . 37.9 mm -58.92 -55.97 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.179 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -64.76 -28.99 69.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.907 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.16 -43.07 29.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -74.25 -29.19 61.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.298 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 94.9 p -63.86 -27.68 69.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 110.226 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.06 7.26 31.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 0.0 110.5 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.1 m -92.08 -77.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.17 . . . . 0.0 110.292 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.0 -104.23 0.4 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' PHE . 35.8 t -131.06 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -1.065 . . . . 0.0 109.409 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.799 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 18.6 m-85 43.53 87.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.27 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 37.8 p -59.64 160.51 7.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 0.0 109.533 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -52.54 -35.78 54.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.226 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.12 -36.11 83.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.277 -0.89 . . . . 0.0 109.34 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.4 mm-40 -73.29 -31.88 64.3 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.059 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.437 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 63.9 mtt -63.43 -31.37 72.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.436 -0.79 . . . . 0.0 109.097 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -57.25 -44.71 84.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 109.168 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 77' ' ' ILE . 69.4 m-20 -56.28 -40.97 75.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.196 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.942 ' HB3' HD12 ' A' ' 23' ' ' ILE . 63.6 mtt -63.02 -32.12 73.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.038 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 m -70.02 -23.5 63.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.166 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.4 tp -89.05 -25.67 21.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.962 HG21 ' CB ' ' A' ' 73' ' ' SER . 62.2 mt -124.86 149.41 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 104.37 -81.01 0.32 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -62.29 -29.16 70.23 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.257 -1.143 . . . . 0.0 108.635 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.8 m -64.22 -35.16 79.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.495 -0.753 . . . . 0.0 108.995 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.29 -35.86 63.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' ' OD2' ' A' ' 16' ' ' ASP . 61.3 ttp -52.68 -40.11 62.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 109.076 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.96 81.34 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.95 66.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.541 ' O ' ' CG ' ' A' ' 54' ' ' MET . 65.7 mtt -54.89 -30.01 57.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -75.51 -9.75 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 109.721 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -36.59 71.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.91 . . . . 0.0 110.148 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.551 ' SD ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.38 -18.31 16.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.938 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.03 2.68 80.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 114.08 -1.37 24.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 54' ' ' MET . 9.9 ptt180 -115.67 111.62 20.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.068 -1.254 . . . . 0.0 110.019 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.84 ' CG2' HD12 ' A' ' 63' ' ' LEU . 40.9 mm -101.58 143.88 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.564 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 4.1 p -140.76 161.79 52.32 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.343 -0.848 . . . . 0.0 109.255 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 46.6 Cg_endo -67.87 -30.19 33.71 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.631 2.22 . . . . 0.0 111.876 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.6 p -72.14 -35.04 68.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.399 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -80.97 -46.77 14.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.84 HD12 ' CG2' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -68.02 -38.34 82.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 64.7 mt-30 -54.41 -39.25 67.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 108.992 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.37 -36.61 68.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.06 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 66' ' ' LEU . 32.4 tp -74.28 -48.25 29.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.503 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.6 t0 -48.08 -37.92 16.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.319 -0.863 . . . . 0.0 109.702 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -72.22 -32.87 67.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.661 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.68 89.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.886 ' CE1' HG23 ' A' ' 19' ' ' ILE . 91.3 t80 -53.24 -36.31 60.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.952 . . . . 0.0 109.591 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -70.26 -35.29 73.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 m -69.12 -35.44 76.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.962 ' CB ' HG21 ' A' ' 43' ' ' ILE . 51.9 m -69.99 -49.25 53.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.714 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 70' ' ' PHE . 16.0 m -58.96 -35.0 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -67.45 -43.39 81.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.5 mt-30 -65.66 -45.85 81.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.3 mt -54.64 -51.42 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 109.692 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.799 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.08 -49.06 14.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.714 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.21 -23.96 57.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 88.9 p -80.58 -20.2 43.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 39.7 mt-30 -52.57 -30.67 32.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.97 19.27 70.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 -164.62 24.62 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 87' ' ' VAL . 84.2 m-20 -60.0 135.68 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -1.176 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.764 HD11 HG22 ' A' ' 119' ' ' ILE . 6.1 tp -84.43 -18.56 35.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.691 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.02 64.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 88' ' ' THR . 5.7 p -69.0 -46.47 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 109.584 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.565 ' N ' HG13 ' A' ' 87' ' ' VAL . 93.5 m -51.73 -35.75 44.44 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 108.628 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 44.7 m -56.21 -46.51 79.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.7 m-20 -71.01 -40.07 72.01 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.46 -59.08 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.745 HG22 HD11 ' A' ' 96' ' ' LEU . 24.5 mm -63.14 -49.41 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.33 -49.98 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 75.7 m-20 -55.26 -44.13 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -61.1 -43.81 98.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.415 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.745 HD11 HG22 ' A' ' 92' ' ' ILE . 2.7 mt -69.95 -38.62 76.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.7 m -60.72 -51.81 67.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 110.046 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 15.5 t -60.37 -47.65 85.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.979 . . . . 0.0 109.842 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 103' ' ' THR . . . -59.01 -41.73 88.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.595 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -46.58 -53.83 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.121 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -72.06 -31.9 66.56 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.518 -0.739 . . . . 0.0 109.995 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' SER . 42.2 mt-30 -78.33 -18.54 55.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 110.128 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.719 HG21 ' CA ' ' A' ' 18' ' ' PHE . 51.8 p -105.74 -58.75 1.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.917 -1.115 . . . . 0.0 111.284 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.5 m -125.89 -42.64 1.89 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.676 -1.265 . . . . 0.0 110.737 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.3 48.52 1.05 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 107' ' ' VAL . 4.9 t -111.7 172.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.39 -1.065 . . . . 0.0 109.117 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' H ' HG12 ' A' ' 106' ' ' VAL . 27.4 m -72.98 121.01 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 97' ' ' THR . 11.3 p30 -71.22 -29.22 64.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -58.15 -30.53 66.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.404 -0.81 . . . . 0.0 110.693 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -71.05 -54.34 11.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.884 -1.135 . . . . 0.0 109.994 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.121 ' CE2' HD11 ' A' ' 115' ' ' ILE . 56.4 t80 -75.61 -48.44 22.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.807 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.2 mt -56.28 -37.76 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.853 . . . . 0.0 109.949 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -55.8 -39.87 71.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.455 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.6 mt-10 -72.23 -38.82 68.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.121 HD11 ' CE2' ' A' ' 111' ' ' PHE . 49.3 mt -70.91 -43.68 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ttp85 -54.18 -38.14 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.84 . . . . 0.0 109.366 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -72.36 -33.85 67.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 66.4 mt -68.7 -38.79 80.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.764 HG22 HD11 ' A' ' 85' ' ' LEU . 63.5 mt -57.73 -35.87 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.745 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -70.35 -34.44 68.8 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 49.0 ttm -64.83 -38.61 91.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -1.157 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -64.52 -41.69 96.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -63.52 -30.18 71.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.329 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 120' ' ' GLY . 98.9 mm-40 -70.64 -31.21 68.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.398 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.76 81.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.9 p -61.73 -26.66 68.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.83 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -69.11 -26.27 64.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 82.5 m-20 -57.79 -17.85 18.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -69.01 -49.64 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.371 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.008 HG13 ' CD1' ' A' ' 131' ' ' TYR . 6.3 p -61.55 -30.84 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 1.008 ' CD1' HG13 ' A' ' 130' ' ' VAL . 49.7 p90 178.49 178.18 0.42 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.16 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.406 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -73.44 121.04 19.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.9 m -94.34 157.35 16.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 109.39 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.84 -157.39 37.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.9 m -118.25 148.31 42.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.147 . . . . 0.0 109.4 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.481 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -122.95 162.16 22.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.31 -174.39 41.96 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 5' ' ' ALA . 90.5 mm-40 -97.4 155.58 16.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 109.647 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.593 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . 43.25 82.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -63.79 -15.03 57.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.581 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 9.1 t -136.48 150.61 70.99 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -65.94 -30.93 47.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.603 2.202 . . . . 0.0 112.904 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.581 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 44.0 p90 -81.34 -1.01 43.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.788 -1.195 . . . . 0.0 110.168 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 78.3 p -89.65 -14.94 33.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 108.86 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -140.94 149.0 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 109.071 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HD3' ' CG1' ' A' ' 58' ' ' ILE . 31.2 mtmt -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.67 -50.34 72.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.755 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' A' ' 5' ' ' ALA . 6.9 m-20 -72.53 -32.83 66.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.862 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -67.15 -49.02 66.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.989 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.07 -56.07 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.938 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.08 -33.84 71.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.002 . . . . 0.0 109.367 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 52.3 t80 -67.64 -37.08 81.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.191 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.861 HG23 ' CE1' ' A' ' 70' ' ' PHE . 17.4 mt -74.04 -38.54 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -68.21 -50.29 55.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 p -59.99 -33.56 72.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 8.4 t80 -64.1 -35.94 82.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 109.844 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.474 HG12 ' CE ' ' A' ' 40' ' ' MET . 67.6 mt -71.6 -56.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -59.76 -30.79 69.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 109.905 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.09 -43.54 28.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 110.238 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -70.28 -34.46 72.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 0.0 110.396 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.475 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 92.6 p -61.59 -26.77 68.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.045 -1.034 . . . . 0.0 110.084 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -105.87 7.29 32.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 110.373 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.987 HG21 ' HB2' ' A' ' 94' ' ' ASP . 22.8 m -92.28 -78.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.914 -1.116 . . . . 0.0 110.298 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.37 -104.26 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -130.68 -61.17 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -1.084 . . . . 0.0 109.35 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 8.9 m-85 44.06 83.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 109.177 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -59.56 167.08 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.693 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -52.51 -43.59 65.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -56.19 -36.71 68.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.104 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.446 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 90.7 mm-40 -76.27 -35.4 58.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.475 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 62.4 mtt -63.31 -39.85 95.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.4 -43.12 83.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.039 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.3 m-20 -57.15 -39.93 76.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.134 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.474 ' CE ' HG12 ' A' ' 23' ' ' ILE . 77.0 mmm -58.25 -32.22 68.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 108.921 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 t -70.16 -24.19 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 46' ' ' THR . 63.0 mt -91.85 -16.83 26.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 77' ' ' ILE . 64.9 mt -119.6 166.45 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.186 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.688 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 68.35 -81.86 0.2 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.45 -40.23 68.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.035 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -60.06 -35.23 74.68 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 108.979 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt -55.18 -36.72 66.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.207 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.5 ttp -52.93 -43.16 66.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.902 . . . . 0.0 109.247 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.49 77.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.925 . . . . 0.0 108.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . . . -62.51 -23.17 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.529 ' O ' ' CG ' ' A' ' 54' ' ' MET . 15.9 mmt -54.44 -33.41 59.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -74.46 -8.47 56.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.241 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 50' ' ' ALA . 93.4 m-20 -69.89 -32.2 70.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.86 -14.45 46.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.92 -11.53 56.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 130.18 0.39 5.51 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' N ' ' SD ' ' A' ' 54' ' ' MET . 21.6 ptt85 -116.85 113.12 22.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -1.197 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.824 HG23 ' CD1' ' A' ' 63' ' ' LEU . 44.5 mm -104.55 148.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.256 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -147.3 165.34 19.23 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 50.2 Cg_endo -70.46 -36.94 8.14 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.852 2.368 . . . . 0.0 111.847 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 t -70.39 -34.71 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.751 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -80.96 -48.12 12.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.96 . . . . 0.0 109.797 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.824 ' CD1' HG23 ' A' ' 58' ' ' ILE . 7.4 mp -67.37 -41.54 84.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.808 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 69.6 mt-30 -54.22 -38.45 65.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 108.919 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.79 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.276 -0.89 . . . . 0.0 108.687 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -74.1 -43.67 56.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 0.0 109.136 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 37.5 t0 -47.85 -40.23 20.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.835 . . . . 0.0 109.696 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.8 mtp -67.84 -30.67 70.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.86 85.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.861 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.8 t80 -54.58 -44.33 72.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.669 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.033 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -38.65 74.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.827 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -69.5 -36.68 76.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.975 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.616 ' HB2' HD13 ' A' ' 43' ' ' ILE . 85.7 p -70.12 -45.06 67.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 109.949 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.9 m -63.8 -35.02 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.41 93.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.797 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.33 -45.17 73.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.759 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -53.99 -47.65 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.49 -49.47 13.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.939 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.86 -26.24 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 81' ' ' GLN . 52.3 m -79.19 -20.15 49.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.462 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 26.6 mt-30 -45.2 -39.45 6.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.03 7.47 64.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.67 -159.57 26.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 87' ' ' VAL . 60.1 t0 -64.7 97.91 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -1.184 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.939 HD13 ' HA ' ' A' ' 79' ' ' ALA . 20.1 tp -58.89 -15.9 14.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.88 -35.4 84.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.5 p -70.1 -35.71 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -1.154 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.612 HG22 HD12 ' A' ' 92' ' ' ILE . 53.3 m -51.4 -33.31 29.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.046 -1.034 . . . . 0.0 108.424 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.542 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 3.7 m -57.03 -47.73 80.2 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 73.9 m-20 -70.97 -38.69 72.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.403 -0.811 . . . . 0.0 109.168 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.14 -53.85 32.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.733 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.72 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 62.7 mt -70.45 -45.26 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.727 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.75 -46.75 83.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.987 ' HB2' HG21 ' A' ' 29' ' ' THR . 76.7 m-20 -55.23 -49.65 71.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.67 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.664 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -67.93 -33.72 75.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.966 . . . . 0.0 108.833 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.78 -42.56 73.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.547 -0.721 . . . . 0.0 109.587 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 101' ' ' TYR . 60.4 m -65.46 -53.82 37.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 83.9 p -57.7 -42.99 84.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -58.3 -46.25 86.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.671 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -47.26 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 109.472 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 97' ' ' THR . 1.8 m-85 -68.57 -32.02 71.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.518 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 33.4 mt-30 -69.63 -18.79 63.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 110.051 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 18' ' ' PHE . 71.9 p -113.5 -59.37 2.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.123 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 106' ' ' VAL . 29.9 p -125.93 -42.45 1.89 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.764 -1.21 . . . . 0.0 110.639 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.61 47.74 1.02 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.59 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 35.1 t -101.19 158.55 4.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -1.149 . . . . 0.0 108.831 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 107' ' ' VAL . 30.4 m -58.35 121.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.608 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.3 p30 -70.83 -26.7 63.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 113' ' ' SER . 96.4 p -64.15 -31.81 73.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.307 -0.871 . . . . 0.0 110.871 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -66.14 -55.14 17.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.771 -1.205 . . . . 0.0 110.409 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 115' ' ' ILE . 55.1 t80 -75.92 -50.82 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 109.966 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.69 HG21 ' HB1' ' A' ' 93' ' ' ALA . 22.1 mt -56.28 -40.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.4 t -56.13 -38.85 71.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.82 -49.69 67.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.158 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.033 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -59.13 -34.67 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.149 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.542 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 9.6 ttt180 -53.7 -47.62 70.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.493 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.23 -33.92 65.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 115' ' ' ILE . 10.4 mt -66.1 -45.79 79.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.891 ' CG2' HD11 ' A' ' 85' ' ' LEU . 88.9 mt -57.69 -39.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.12 -36.05 64.17 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.4 ttm -58.18 -40.93 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.585 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.92 -28.41 69.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.17 77.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -70.66 -34.24 71.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.6 -28.1 69.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.435 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.2 p -66.07 -28.64 68.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -63.17 -22.96 67.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 89.0 m-20 -67.7 -24.81 65.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.51 -49.79 65.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.838 HG23 ' CD1' ' A' ' 131' ' ' TYR . 16.6 m -61.7 -31.87 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.838 ' CD1' HG23 ' A' ' 130' ' ' VAL . 37.6 p90 179.66 171.04 1.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.95 123.51 26.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 97.3 p -54.04 -29.29 43.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.399 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 150.9 27.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.87 -174.15 49.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.8 m -56.81 -35.59 68.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.148 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.8 mmm -61.92 -31.6 71.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -1.128 . . . . 0.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.29 43.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -69.1 -24.12 64.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.11 136.68 15.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -49.17 -31.93 9.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.83 HG22 ' OG ' ' A' ' 10' ' ' SER . 2.1 t -131.48 151.63 79.07 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -66.7 -34.36 32.09 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.487 2.124 . . . . 0.0 112.578 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -84.33 15.93 3.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.803 -1.186 . . . . 0.0 110.059 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.83 ' OG ' HG22 ' A' ' 7' ' ' THR . 2.5 m -95.26 -34.85 12.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.064 -1.022 . . . . 0.0 108.461 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 89.3 p -123.08 161.69 23.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HG3' HG13 ' A' ' 58' ' ' ILE . 22.5 mtmt -74.04 -41.11 62.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.55 93.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 0.0 109.365 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 8' ' ' PRO . 25.5 t30 -71.6 -40.93 69.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -68.67 -38.64 80.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.877 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -54.96 -56.38 20.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.58 66.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.079 -1.013 . . . . 0.0 108.987 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 59.2 t80 -61.67 -46.98 87.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.126 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.665 HG21 ' C ' ' A' ' 44' ' ' GLY . 19.8 mm -63.08 -46.23 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.273 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -50.75 53.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.304 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 33.8 t -54.95 -29.85 57.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 108.903 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.608 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 30.7 t80 -72.22 -51.74 19.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 109.853 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.81 -55.89 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.048 . . . . 0.0 109.839 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -58.74 -36.55 74.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.892 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.88 -46.5 21.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.935 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -63.25 -33.7 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 110.173 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.434 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 45.0 m -64.05 -28.12 69.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.02 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.95 7.33 32.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 110.318 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 1.006 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.9 m -92.68 -76.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.865 -1.147 . . . . 0.0 110.187 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -84.67 -104.4 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.4 -59.09 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -1.09 . . . . 0.0 109.371 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 17.8 m-85 44.41 89.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.345 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 47.6 p -59.81 161.54 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.629 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -52.7 -41.14 63.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.96 -35.55 73.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.228 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 97.5 mm-40 -72.23 -32.37 66.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.255 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.434 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 60.3 mtt -63.45 -34.29 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -58.21 -45.54 87.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.041 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.0 m-20 -56.66 -43.23 80.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.297 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.486 ' O ' ' O ' ' A' ' 43' ' ' ILE . 63.6 mtt -59.47 -32.2 70.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 p -70.25 -23.58 62.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 12.5 tp -89.71 -25.17 21.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.74 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.982 HG21 ' HB3' ' A' ' 73' ' ' SER . 54.1 mt -125.34 149.75 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.665 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 95.25 -79.66 0.85 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.35 -30.59 70.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.265 -1.138 . . . . 0.0 108.454 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.1 m -67.35 -34.79 78.07 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 66' ' ' LEU . 52.6 mt -52.35 -32.9 40.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.449 -0.782 . . . . 0.0 109.181 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.4 ttm -57.46 -47.23 82.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.224 -0.922 . . . . 0.0 108.901 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.85 69.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.213 -0.929 . . . . 0.0 108.808 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.44 83.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.466 ' HE1' HD13 ' A' ' 63' ' ' LEU . 85.3 mmm -54.19 -29.66 46.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.868 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -58.22 -27.27 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.424 -0.798 . . . . 0.0 109.163 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.48 -25.63 64.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.266 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 79.4 mmm -52.04 -22.73 4.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.85 87.24 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 27.95 7.37 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.561 ' O ' HD13 ' A' ' 58' ' ' ILE . 7.3 ptt85 -136.46 111.77 9.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -1.186 . . . . 0.0 109.599 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.939 ' CG2' HD22 ' A' ' 63' ' ' LEU . 25.0 mm -117.68 139.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.655 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 17.0 p -147.75 158.29 42.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 64' ' ' GLN . 43.0 Cg_endo -65.55 -52.83 0.91 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.83 2.353 . . . . 0.0 112.07 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.3 m -52.52 -46.58 66.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.578 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -81.15 -52.71 7.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.939 HD22 ' CG2' ' A' ' 58' ' ' ILE . 13.5 tp -59.1 -36.5 75.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 109.635 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 65.2 tt0 -55.67 -28.76 57.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.01 . . . . 0.0 109.179 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.57 91.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.584 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -67.33 -41.38 85.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 38.2 t0 -48.63 -47.85 39.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.52 -39.63 94.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.548 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.44 89.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.68 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.741 ' O ' HG13 ' A' ' 74' ' ' VAL . 87.4 t80 -58.62 -41.58 86.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -63.71 -35.58 81.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.655 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -69.36 -38.68 78.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.666 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.982 ' HB3' HG21 ' A' ' 43' ' ' ILE . 20.4 m -70.24 -48.69 55.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 70' ' ' PHE . 8.5 m -57.35 -34.73 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.254 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.94 -41.73 64.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 80' ' ' SER . 96.9 mt-30 -65.24 -50.3 66.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.449 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.9 mt -53.69 -48.98 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.579 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.54 -52.26 8.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.506 -0.746 . . . . 0.0 109.92 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.97 -23.19 52.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.497 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 90.6 p -81.67 -20.47 39.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 42.9 mt-30 -49.44 -35.11 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 109.381 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.47 9.19 79.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.76 -150.33 26.87 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 87' ' ' VAL . 19.2 t70 -71.23 128.1 34.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -1.204 . . . . 0.0 109.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.739 HD11 HG22 ' A' ' 119' ' ' ILE . 6.2 tp -80.26 -18.67 48.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.862 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.25 -40.13 61.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 88' ' ' THR . 4.7 p -67.0 -44.28 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -1.212 . . . . 0.0 109.695 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.565 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 28.1 m -51.66 -35.57 42.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 108.352 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 116' ' ' ARG . 6.8 m -54.03 -48.22 70.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.6 m120 -71.12 -39.88 71.76 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -62.12 -54.11 45.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.848 HG22 HD11 ' A' ' 96' ' ' LEU . 77.2 mt -72.24 -48.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.291 -0.881 . . . . 0.0 109.732 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.29 -50.77 72.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.91 . . . . 0.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 1.006 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.1 m-20 -55.41 -46.71 76.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.095 -1.003 . . . . 0.0 109.612 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.5 -43.46 89.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.382 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.848 HD11 HG22 ' A' ' 92' ' ' ILE . 3.8 mt -69.91 -33.3 71.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.518 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.731 HG23 ' OD1' ' A' ' 108' ' ' ASN . 92.7 m -67.57 -53.39 28.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.4 p -59.22 -35.55 73.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.689 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -70.01 -43.45 71.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.25 -56.23 7.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.551 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.552 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 8.0 m-85 -72.16 -32.02 66.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.454 -0.779 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 86.5 mm-40 -72.55 -18.74 61.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.7 p -103.6 -60.3 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.846 -1.158 . . . . 0.0 111.232 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.544 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.12 -42.91 1.68 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.691 -1.256 . . . . 0.0 110.875 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 113.71 45.31 0.72 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.1 t -106.0 172.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -1.211 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.581 ' H ' HG12 ' A' ' 106' ' ' VAL . 8.7 m -75.01 120.18 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.731 ' OD1' HG23 ' A' ' 97' ' ' THR . 1.2 p-10 -71.83 -23.79 61.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 0.0 109.844 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 113' ' ' SER . 29.8 m -59.17 -43.63 92.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 110.591 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -57.0 -53.58 56.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.0 110.027 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 1.153 ' CE2' HD11 ' A' ' 115' ' ' ILE . 70.7 t80 -75.29 -51.72 12.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.943 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.687 HD12 HD21 ' A' ' 108' ' ' ASN . 16.2 mt -58.71 -36.25 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.275 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.5 m -55.97 -43.3 77.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 0.0 109.83 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.04 -36.89 69.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.153 HD11 ' CE2' ' A' ' 111' ' ' PHE . 28.4 mt -62.78 -43.52 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.598 ' HG2' HG23 ' A' ' 89' ' ' THR . 34.6 mtp180 -54.06 -49.3 69.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.4 p -57.46 -33.17 67.69 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 115' ' ' ILE . 6.8 mt -73.51 -40.12 64.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.496 -0.752 . . . . 0.0 110.037 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.739 HG22 HD11 ' A' ' 85' ' ' LEU . 57.8 mt -61.21 -35.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 109.226 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.726 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.38 -34.09 64.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -61.99 -44.5 96.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 84.5 m-85 -59.1 -42.76 91.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.646 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -62.76 -30.98 71.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 93.1 mt-30 -68.59 -31.15 70.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.22 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.7 p -62.18 -30.26 70.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -64.18 -25.31 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 131' ' ' TYR . 41.0 t-20 -59.12 -25.15 63.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.43 -23.4 66.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.618 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 2.1 p -66.87 -26.65 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER 176.58 174.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.92 128.43 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.004 . . . . 0.0 109.614 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -53.57 -31.38 46.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.38 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' ' OXT' ' A' ' 137' ' ' GLY . . . -55.32 -36.25 66.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.39 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.62 -166.41 45.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.1 t -58.23 -34.49 70.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -1.118 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.456 ' OXT' ' O ' ' A' ' 134' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -128.11 161.21 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -1.165 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.34 11.62 55.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.433 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 64.4 tt0 -107.96 158.91 16.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.522 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.644 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -154.53 163.56 40.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -0.845 . . . . 0.0 109.508 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -76.74 -8.67 57.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -154.52 149.99 21.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.165 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 7' ' ' THR . 43.6 Cg_endo -67.0 -35.29 26.32 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.356 2.037 . . . . 0.0 111.977 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 7' ' ' THR . 45.8 p90 -90.01 -10.71 43.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 63' ' ' LEU . 58.3 m -70.62 -8.9 55.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -143.4 159.03 43.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HD3' HD11 ' A' ' 58' ' ' ILE . 25.2 mtmt -74.73 -40.76 61.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.45 69.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.644 ' ND2' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -72.21 -29.11 63.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -71.43 -53.68 13.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -54.82 -56.1 23.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.659 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -0.982 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 80.0 t80 -63.44 -38.06 89.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.447 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.85 HG23 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -75.64 -38.3 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -68.33 -50.54 52.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.5 t -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.665 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 74' ' ' VAL . 25.6 t80 -64.79 -46.81 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 110.32 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.445 HG23 ' SD ' ' A' ' 40' ' ' MET . 82.8 mt -65.93 -56.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.161 -0.962 . . . . 0.0 110.251 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.4 p -54.05 -34.14 59.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.92 -47.4 18.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 110.011 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -62.34 -34.97 77.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.443 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 93.8 p -61.78 -30.1 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.007 . . . . 0.0 110.208 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -106.07 7.47 31.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.469 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.967 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.4 m -91.16 -78.27 0.4 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.13 . . . . 0.0 110.356 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.74 -103.53 0.38 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' PHE . 17.3 p -131.61 -61.34 0.91 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -1.108 . . . . 0.0 109.45 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 11.4 m-85 44.42 87.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.063 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -59.51 162.04 5.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -52.54 -39.66 61.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.22 -35.97 76.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.082 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.476 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 90.2 mm-40 -73.96 -32.62 63.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.187 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.443 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 58.1 mtt -63.91 -35.88 82.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.003 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -57.12 -49.14 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.397 -0.815 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 77' ' ' ILE . 74.5 m-20 -55.86 -37.33 68.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.091 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.476 ' HE3' ' CG ' ' A' ' 32' ' ' PHE . 64.1 mtt -57.36 -32.01 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.7 m -69.79 -24.15 63.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' THR . 62.0 mt -91.09 -19.71 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.051 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 44' ' ' GLY . 18.9 mm -116.33 167.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 0.0 109.12 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.637 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 69.19 -92.68 0.32 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -53.25 -39.73 64.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.14 . . . . 0.0 109.288 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m -58.71 -38.15 77.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.174 -0.954 . . . . 0.0 108.966 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 66' ' ' LEU . 34.2 tp -55.67 -32.96 63.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 109.133 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 51' ' ' MET . 18.1 ttt -54.85 -31.85 59.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.283 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.86 91.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.673 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.78 -26.44 68.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.389 -0.819 . . . . 0.0 108.919 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.53 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 28.5 ttm -54.48 -32.94 58.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.423 -0.798 . . . . 0.0 109.225 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -74.38 -26.85 60.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.404 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -60.5 -21.46 62.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.645 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 68.6 mmm -64.28 -43.91 93.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.47 66.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 16.57 13.79 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.645 ' O ' ' HE2' ' A' ' 54' ' ' MET . 28.3 ptt85 -126.78 112.13 15.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -1.18 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.599 HG23 HD11 ' A' ' 63' ' ' LEU . 28.3 mm -116.3 149.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -148.72 165.97 16.61 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 64' ' ' GLN . 48.8 Cg_endo -69.64 -36.17 11.61 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.65 2.233 . . . . 0.0 111.525 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -68.04 -34.89 77.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -78.1 -50.82 11.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.405 -0.809 . . . . 0.0 109.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.0 mp -67.2 -46.27 74.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 33.3 tp60 -53.54 -35.74 61.06 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.11 68.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 47' ' ' LEU . 10.9 mt -74.12 -51.25 16.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 24.3 t70 -46.9 -39.98 13.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 108.561 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 56.1 mtt -72.17 -45.44 60.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.847 . . . . 0.0 108.944 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.42 91.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 108.94 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 19' ' ' ILE . 79.8 t80 -52.19 -43.4 64.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.133 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.79 -39.07 73.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 109.596 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -69.29 -36.71 77.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.488 ' CB ' HG21 ' A' ' 43' ' ' ILE . 5.9 m -69.98 -44.26 69.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.807 HG21 ' CE1' ' A' ' 22' ' ' PHE . 8.7 p -67.44 -36.77 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 74' ' ' VAL . . . -61.55 -39.16 90.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.49 -39.66 77.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.647 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.2 mt -58.1 -49.58 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -77.38 -48.62 16.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.621 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.89 60.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.1 t -78.17 -20.35 52.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.571 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.5 mt-30 -49.98 -27.62 5.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.527 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.52 77.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.65 -148.18 23.77 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 87' ' ' VAL . 50.7 t0 -67.11 124.21 22.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.31 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 119' ' ' ILE . 4.3 tp -81.18 -21.77 39.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.255 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.1 -34.56 64.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 84' ' ' ASP . 3.6 p -67.11 -42.89 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.105 -1.232 . . . . 0.0 109.72 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 92' ' ' ILE . 51.9 m -51.54 -34.65 37.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.987 -1.071 . . . . 0.0 108.321 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 m -56.73 -49.8 74.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.1 m120 -70.61 -38.24 73.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 109.039 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.77 -53.4 47.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.612 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.77 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 66.6 mt -72.35 -45.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.866 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.83 -44.94 91.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.967 ' HB2' HG21 ' A' ' 29' ' ' THR . 48.7 m-20 -55.2 -48.51 73.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.953 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.4 -33.67 69.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.9 HD22 HD12 ' A' ' 115' ' ' ILE . 7.2 tp -70.03 -33.68 72.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.912 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 98.7 m -69.3 -53.82 17.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 14.3 m -62.51 -33.61 75.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 109.878 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -63.91 -33.68 76.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.0 m-85 -61.39 -56.25 22.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.558 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.3 m-85 -71.97 -32.1 66.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 109.683 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 98' ' ' SER . 85.3 mm-40 -71.19 -17.99 62.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.848 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 72.0 p -111.06 -59.65 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 111.254 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.667 HG21 ' C ' ' A' ' 7' ' ' THR . 26.7 p -126.33 -43.02 1.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.797 -1.189 . . . . 0.0 110.968 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.71 45.93 1.01 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.08 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.598 HG23 ' OG1' ' A' ' 104' ' ' THR . 18.4 t -101.89 171.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.159 -1.201 . . . . 0.0 108.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.0 m -71.48 120.55 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 0.0 109.799 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.604 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 24.2 p-10 -72.21 -33.32 67.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 109.97 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 113' ' ' SER . 29.8 m -57.82 -33.74 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 107' ' ' VAL . 67.1 ttt-85 -67.91 -54.47 18.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.832 -1.168 . . . . 0.0 110.095 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.757 ' CD2' HD21 ' A' ' 96' ' ' LEU . 32.3 t80 -75.46 -47.04 28.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.898 HG12 HD23 ' A' ' 96' ' ' LEU . 9.5 mt -56.01 -46.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 109' ' ' SER . 60.3 m -55.57 -41.45 73.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.004 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.65 -45.26 89.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.224 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.967 HG12 ' HB1' ' A' ' 71' ' ' ALA . 77.9 mt -66.99 -34.36 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.82 . . . . 0.0 109.162 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.527 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 19.7 ttt-85 -53.54 -49.01 68.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.0 p -70.16 -34.02 72.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 115' ' ' ILE . 13.9 mt -66.62 -44.97 80.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.668 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 85' ' ' LEU . 89.4 mt -57.66 -42.95 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.788 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.28 -36.9 63.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.2 ttp -56.81 -40.38 75.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 60.5 m-85 -62.0 -50.66 71.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.535 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -62.15 -32.73 73.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.462 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -70.61 -32.9 70.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.585 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.51 75.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 m -58.74 -33.02 69.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 131' ' ' TYR . . . -73.15 -15.62 61.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 56.0 t-20 -66.22 -34.43 78.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.21 -51.37 61.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.809 HG13 ' CD2' ' A' ' 131' ' ' TYR . 5.2 p -63.56 -33.95 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.352 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.809 ' CD2' HG13 ' A' ' 130' ' ' VAL . 40.9 p90 -176.94 168.74 2.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.338 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.82 115.61 14.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.7 t -63.94 153.4 37.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -109.7 147.74 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.79 149.67 51.46 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.2 m -121.7 148.82 44.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.5 mtt -121.39 154.3 36.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -1.139 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.16 3.61 85.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.77 -29.35 70.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.98 148.13 20.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.583 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 42.1 p-10 -120.18 24.55 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.761 ' C ' HG21 ' A' ' 104' ' ' THR . 0.0 OUTLIER -146.95 150.14 37.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.8 Cg_endo -71.78 -35.07 8.05 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 111.543 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.927 ' O ' HD23 ' A' ' 63' ' ' LEU . 37.6 p90 -88.02 -30.71 19.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.011 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 36.0 t -55.63 -25.37 38.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.473 -0.767 . . . . 0.0 109.771 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 1.3 t -113.98 136.64 52.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.971 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HB2' HG13 ' A' ' 58' ' ' ILE . 2.5 ttpp -65.27 -37.79 88.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -70.29 -43.9 69.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 11' ' ' SER . 12.6 m120 -71.6 -29.11 64.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.377 -0.827 . . . . 0.0 109.416 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -64.81 -44.15 90.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 110.187 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.636 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 2.7 p30 -64.06 -50.85 66.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.518 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.06 -32.86 73.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 108.903 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CG ' ' HB2' ' A' ' 8' ' ' PRO . 56.0 t80 -70.45 -43.45 69.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.816 HG23 ' HE1' ' A' ' 70' ' ' PHE . 27.6 mt -73.18 -44.63 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.525 -0.734 . . . . 0.0 109.041 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -68.08 -50.63 53.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.78 . . . . 0.0 109.182 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 74.1 m -57.46 -30.15 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.606 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' A' ' 74' ' ' VAL . 8.6 t80 -72.01 -50.03 32.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.512 -0.743 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 40' ' ' MET . 50.8 mm -64.94 -55.73 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.141 -0.974 . . . . 0.0 109.652 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -53.86 -39.71 65.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 0.0 109.909 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.72 -46.73 20.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 109.815 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.556 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -58.9 -35.67 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.703 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.529 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 85.8 p -64.05 -28.41 69.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.84 6.92 32.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.81 HG21 ' HB3' ' A' ' 94' ' ' ASP . 20.5 m -91.75 -76.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.047 -1.033 . . . . 0.0 110.033 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -82.49 -104.68 0.45 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -131.8 -60.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -1.126 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.793 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 43.58 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.343 -0.848 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.5 t -59.66 162.81 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -52.63 -39.49 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.373 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.51 -35.96 81.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 91.6 mm-40 -73.65 -32.29 63.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.5 mtt -63.6 -36.51 84.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.103 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.54 -47.41 84.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB2' HG23 ' A' ' 77' ' ' ILE . 86.3 m-20 -56.14 -45.26 79.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.0 ' HB3' HD12 ' A' ' 23' ' ' ILE . 56.2 mtm -57.15 -33.66 67.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 108.829 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.3 p -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 58.8 mt -87.19 -21.26 26.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 73' ' ' SER . 94.9 mt -121.87 143.77 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.244 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.78 -88.21 0.84 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.79 -32.45 70.63 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.165 -1.197 . . . . 0.0 108.282 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 91.8 m -59.15 -35.04 72.82 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 47' ' ' LEU . 69.0 mt -65.64 -40.21 92.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.636 ' HE2' ' HB3' ' A' ' 16' ' ' ASP . 89.5 mmm -52.74 -35.01 55.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.95 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.159 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.35 -36.12 78.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.223 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 54.6 mtt -60.06 -29.85 68.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.208 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.1 -31.54 67.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.952 . . . . 0.0 109.332 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -63.71 -27.86 69.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.228 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.686 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 92.4 mmm -55.95 -33.93 65.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.13 56.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.16 11.29 24.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.686 ' O ' ' HE2' ' A' ' 54' ' ' MET . 7.4 ptm180 -125.91 113.94 17.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.523 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 63' ' ' LEU . 16.8 mm -117.04 147.46 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 160.38 41.06 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.57 -27.09 23.03 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.703 2.269 . . . . 0.0 111.773 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 m -74.55 -48.04 29.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.465 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HG2' ' CD2' ' A' ' 66' ' ' LEU . 38.1 tttm -59.21 -51.55 69.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.345 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.927 HD23 ' O ' ' A' ' 9' ' ' TRP . 2.0 mp -61.48 -41.23 96.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.433 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 62.9 tt0 -54.21 -35.69 62.68 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.077 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.69 15.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.683 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.621 HD21 HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.6 -46.68 36.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.274 -0.891 . . . . 0.0 110.987 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 9' ' ' TRP . 3.6 p-10 -47.78 -29.87 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.258 . . . . 0.0 109.805 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 68.7 mtp -72.66 -36.26 67.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.29 75.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.816 ' HE1' HG23 ' A' ' 19' ' ' ILE . 66.2 t80 -52.47 -37.13 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.46 -47.93 58.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -69.25 -30.77 68.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.039 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 43' ' ' ILE . 8.3 m -69.8 -45.84 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.881 HG21 ' CE1' ' A' ' 22' ' ' PHE . 9.6 p -68.93 -36.66 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -59.69 -40.85 89.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 109.727 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -70.72 -35.02 72.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 74' ' ' VAL . 94.2 mt -58.57 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.793 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.21 -41.64 57.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.672 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.57 61.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -76.77 -20.36 56.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.1 mt-30 -50.01 -37.84 34.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 109.46 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.77 81.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.51 -149.18 24.52 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.4 t0 -66.79 119.72 12.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 119' ' ' ILE . 7.0 tp -74.69 -24.16 58.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.9 64.39 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.6 p -69.1 -38.17 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.235 . . . . 0.0 109.844 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.616 HG22 HD12 ' A' ' 92' ' ' ILE . 54.1 m -54.7 -33.59 61.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.908 -1.12 . . . . 0.0 108.367 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.1 m -57.81 -49.25 77.29 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 68.2 m-20 -70.69 -41.06 72.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.494 -0.754 . . . . 0.0 109.154 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -64.54 -52.2 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.799 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 32.2 mt -72.81 -38.3 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -72.29 -43.22 64.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.81 ' HB3' HG21 ' A' ' 29' ' ' THR . 40.1 t0 -54.97 -45.74 75.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.927 -1.108 . . . . 0.0 109.795 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.81 -35.2 69.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.109 -0.994 . . . . 0.0 109.01 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.86 -40.4 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.563 HG23 ' OH ' ' A' ' 101' ' ' TYR . 52.4 m -67.66 -53.87 24.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.1 m -59.81 -44.08 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -55.65 -46.79 77.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.405 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 96' ' ' LEU . 1.5 m-85 -46.94 -56.6 6.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.73 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.576 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.99 -32.41 67.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.629 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 40.1 mt-30 -64.86 -18.54 65.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 43.0 p -115.16 -59.35 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 111.333 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.761 HG21 ' C ' ' A' ' 7' ' ' THR . 15.9 p -126.16 -43.17 1.81 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.648 -1.283 . . . . 0.0 110.969 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.16 45.37 1.01 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 19.8 t -98.06 163.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.073 -1.251 . . . . 0.0 108.689 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 107' ' ' VAL . 33.1 m -64.03 121.59 13.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.588 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.9 p30 -71.0 -33.69 70.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.057 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 113' ' ' SER . 87.2 p -57.23 -43.72 83.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.967 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.413 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.8 ttt180 -57.22 -54.58 45.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 0.0 110.156 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.845 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 49.0 t80 -75.56 -46.46 31.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 14.8 mt -63.0 -35.65 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 110.15 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.1 t -58.12 -32.84 68.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 96.9 mt-10 -72.34 -40.34 67.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.931 HG12 ' HB1' ' A' ' 71' ' ' ALA . 80.6 mt -69.34 -40.7 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -54.34 -44.76 72.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.0 p -72.98 -33.95 66.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 109.557 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 26.7 mt -67.91 -42.43 81.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 85' ' ' LEU . 65.8 mt -58.01 -39.29 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.388 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.793 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -63.56 -34.58 90.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 13.1 tpp -65.91 -38.32 88.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.68 -39.43 84.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -63.16 -31.45 72.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 94.8 mt-30 -64.51 -36.55 84.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.325 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.73 -46.91 77.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.4 p -73.81 -24.3 59.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.381 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.71 -17.67 63.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 85.6 m-20 -75.92 -29.29 58.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.88 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -66.59 -44.62 81.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.923 HG13 ' CD1' ' A' ' 131' ' ' TYR . 4.0 p -66.75 -29.56 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.179 -0.951 . . . . 0.0 109.351 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.923 ' CD1' HG13 ' A' ' 130' ' ' VAL . 42.6 p90 178.46 175.65 0.55 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.08 120.07 24.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.334 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -44.55 162.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.68 -33.87 66.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.16 -179.75 51.76 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.4 t -116.99 143.81 45.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -1.117 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.49 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.0 ttm -109.21 140.69 42.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -1.089 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.85 -0.03 62.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -114.97 148.07 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -1.174 . . . . 0.0 109.468 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 11' ' ' SER . . . -80.38 136.48 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 52.0 m-20 -54.04 -26.71 28.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.788 HG23 ' HB2' ' A' ' 10' ' ' SER . 2.8 t -141.27 151.31 61.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.61 -35.74 21.54 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.598 2.199 . . . . 0.0 112.744 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.577 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -82.13 9.08 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.737 -1.227 . . . . 0.0 109.525 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -95.25 -29.62 14.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 108.577 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 5' ' ' ALA . 2.6 p -120.28 155.01 34.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.018 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 7.2 ttpt -71.53 -41.27 69.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.45 70.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 11' ' ' SER . 15.3 m120 -71.7 -28.9 64.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.339 -0.85 . . . . 0.0 109.941 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.04 -48.77 62.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.953 -1.092 . . . . 0.0 110.323 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 88.7 m-20 -58.57 -56.13 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.84 -42.38 65.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.62 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' HB2' HG21 ' A' ' 103' ' ' THR . 87.6 t80 -58.19 -37.05 74.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 70' ' ' PHE . 20.2 mm -70.92 -48.9 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 109.513 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -61.45 -49.75 75.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 109.753 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -58.36 -34.33 70.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 40.5 t80 -69.68 -35.94 75.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.587 HG23 ' HE3' ' A' ' 40' ' ' MET . 77.4 mt -70.43 -56.14 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.92 -34.52 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.05 -44.66 25.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 110.392 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.683 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.57 -33.08 68.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.01 . . . . 0.0 110.629 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.497 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 57.4 m -60.94 -28.27 68.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.42 7.49 31.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 0.0 110.847 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.955 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.3 m -93.48 -75.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.738 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -72.56 -104.08 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.456 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.8 t -148.42 13.29 0.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.495 -1.003 . . . . 0.0 109.904 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 44.7 m-85 -38.17 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.644 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' SER . 59.7 p -66.1 168.44 8.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.792 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 33.7 tt0 -52.74 -44.68 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -57.43 -41.72 81.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.287 -0.883 . . . . 0.0 109.332 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.463 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 77.9 mm-40 -74.61 -32.25 62.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.156 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.507 ' CE ' ' O ' ' A' ' 32' ' ' PHE . 66.3 mtt -66.2 -33.43 75.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.256 -0.902 . . . . 0.0 108.966 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 95.7 mt-10 -57.26 -40.39 77.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 109.272 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 77.0 m-20 -56.1 -38.6 70.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.071 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.587 ' HE3' HG23 ' A' ' 23' ' ' ILE . 64.4 mtm -62.49 -31.92 72.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.847 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 p -68.6 -23.71 64.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.405 -0.809 . . . . 0.0 109.062 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.5 tp -92.66 -23.39 18.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.055 HG21 ' CB ' ' A' ' 73' ' ' SER . 51.6 mt -132.35 149.27 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 97.15 -74.3 0.68 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.03 -34.93 69.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -1.104 . . . . 0.0 108.203 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -68.14 -34.84 77.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 66' ' ' LEU . 23.9 tp -52.47 -39.24 60.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.417 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 16' ' ' ASP . 70.0 mtm -52.4 -33.75 45.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 108.886 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.27 72.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.311 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.16 80.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.321 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.499 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 51.0 mtt -56.42 -32.02 64.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.255 -0.903 . . . . 0.0 109.271 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -54.23 -33.34 58.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.22 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -62.53 -29.55 70.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.081 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.719 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 87.9 mmm -58.4 -26.93 63.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.817 . . . . 0.0 109.321 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 9.05 70.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.98 17.61 20.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.719 ' O ' ' HE2' ' A' ' 54' ' ' MET . 31.2 ptt85 -127.63 112.27 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.888 ' CG2' HD22 ' A' ' 63' ' ' LEU . 15.2 mm -117.52 145.14 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.546 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 3.3 t -134.71 149.01 69.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 45.0 Cg_endo -66.28 -26.95 48.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.691 2.261 . . . . 0.0 111.834 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -66.72 -54.52 22.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 59' ' ' THR . 83.6 mttt -81.05 -47.71 13.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.858 . . . . 0.0 109.612 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.888 HD22 ' CG2' ' A' ' 58' ' ' ILE . 14.5 tp -48.84 -39.87 27.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.253 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.01 -30.63 66.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HA ' ' HE2' ' A' ' 68' ' ' MET . . . -71.42 -34.5 70.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.292 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 47' ' ' LEU . 2.0 tp -73.68 -39.36 64.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.299 -0.875 . . . . 0.0 109.256 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' TRP . 31.5 t0 -49.46 -46.72 48.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 70.3 mtm -54.24 -39.14 66.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.435 -0.791 . . . . 0.0 109.798 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.84 72.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CD2' HD12 ' A' ' 19' ' ' ILE . 47.4 t80 -60.65 -35.47 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 115' ' ' ILE . . . -69.3 -30.5 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 m -69.3 -46.68 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 109.921 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 1.055 ' CB ' HG21 ' A' ' 43' ' ' ILE . 11.2 t -68.06 -48.49 65.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 92' ' ' ILE . 8.3 p -56.83 -38.53 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.7 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 122' ' ' PHE . . . -70.3 -34.63 72.96 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.242 -0.911 . . . . 0.0 109.46 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -76.26 -47.46 23.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 68.3 mt -53.36 -44.62 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.48 -50.69 11.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.82 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.33 44.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.202 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.5 p -81.4 -21.73 38.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.59 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG2' ' OE1' ' A' ' 36' ' ' GLN . 45.1 mt-30 -50.37 -32.76 18.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 109.557 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.27 11.02 85.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.29 -151.52 27.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.726 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.6 t70 -69.36 114.22 7.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -1.166 . . . . 0.0 109.256 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 119' ' ' ILE . 4.7 tp -62.46 -25.21 67.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.51 71.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.7 p -68.03 -36.88 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.104 -1.233 . . . . 0.0 109.774 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 92' ' ' ILE . 91.1 m -54.6 -32.24 58.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.982 -1.074 . . . . 0.0 108.513 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 24.9 m -60.2 -51.22 70.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 69.6 m-20 -70.59 -35.81 73.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.738 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -68.31 -55.69 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.582 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.742 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 39.6 mt -69.56 -50.49 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -56.93 -40.97 77.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.955 ' HB2' HG21 ' A' ' 29' ' ' THR . 7.1 m-20 -57.99 -54.28 48.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.683 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -68.08 -32.66 73.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 108.851 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.571 ' HB3' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -70.31 -41.05 73.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.732 . . . . 0.0 109.774 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.66 HG23 HD22 ' A' ' 108' ' ' ASN . 21.5 m -68.4 -53.99 20.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.015 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 50.9 m -59.81 -43.26 94.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.208 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -56.09 -46.37 79.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.5 m-85 -46.86 -54.48 9.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -0.87 . . . . 0.0 109.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.31 -31.42 67.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.544 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 60.9 mt-30 -70.77 -18.02 62.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 18' ' ' PHE . 59.1 p -110.82 -59.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 111.08 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 106' ' ' VAL . 18.0 p -126.82 -43.31 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.69 -1.256 . . . . 0.0 110.781 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.89 43.54 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.683 -1.246 . . . . 0.0 109.991 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.672 HG23 ' OG1' ' A' ' 104' ' ' THR . 13.7 t -99.21 169.59 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.104 -1.233 . . . . 0.0 108.62 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 107' ' ' VAL . 29.4 m -69.57 121.66 19.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.376 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.66 HD22 HG23 ' A' ' 97' ' ' THR . 13.0 p30 -70.52 -24.08 62.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.643 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' SER . 39.9 m -60.91 -29.99 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.549 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -69.16 -55.0 11.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.123 . . . . 0.0 110.418 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' A' ' 115' ' ' ILE . 88.4 t80 -75.93 -50.6 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.571 HD11 ' HB3' ' A' ' 96' ' ' LEU . 53.1 mt -56.39 -36.51 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.177 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' SER . 3.9 m -56.69 -39.39 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.944 -1.097 . . . . 0.0 109.044 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.26 -42.13 65.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.282 -0.886 . . . . 0.0 109.233 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.739 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 32.8 mm -62.72 -49.37 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.363 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.523 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 6.8 ttt180 -54.12 -42.68 69.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.012 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.0 m -73.01 -33.42 65.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 115' ' ' ILE . 22.0 mt -68.5 -43.39 76.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.803 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.916 HG22 HD11 ' A' ' 85' ' ' LEU . 23.3 mt -57.89 -43.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -60.58 -34.74 87.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.3 ttm -62.74 -43.5 98.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.143 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE2' ' CB ' ' A' ' 75' ' ' ALA . 84.9 m-85 -59.63 -47.65 84.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.446 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -56.77 -30.67 63.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.62 -32.1 69.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.92 -35.72 73.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.13 -30.5 62.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.401 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -66.08 -19.75 65.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 23.8 m120 -63.1 -23.05 67.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.61 -47.54 46.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.331 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.954 HG13 ' CD1' ' A' ' 131' ' ' TYR . 6.3 p -66.86 -29.24 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.954 ' CD1' HG13 ' A' ' 130' ' ' VAL . 42.1 p90 178.24 173.98 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.43 116.43 19.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.5 p -70.11 165.55 21.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.75 146.84 47.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.428 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.79 35.88 27.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.1 m -57.01 -35.04 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 109.459 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.963 -1.465 . . . . 0.0 109.481 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.1 mmm -59.11 -35.28 73.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.13 . . . . 0.0 109.403 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.52 -157.22 37.97 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -95.79 155.07 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.188 . . . . 0.0 109.486 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . . . -84.46 123.27 30.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.642 ' C ' HG21 ' A' ' 104' ' ' THR . 36.5 m-20 -68.96 -6.54 28.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -157.46 155.54 27.54 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.67 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.2 Cg_endo -69.23 -35.09 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.265 . . . . 0.0 111.386 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.854 ' O ' HD22 ' A' ' 63' ' ' LEU . 35.8 p90 -91.35 -23.65 20.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 108.998 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 63' ' ' LEU . 12.0 m -63.74 -14.47 52.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 108.651 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 73.3 m -140.52 122.58 15.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 109.076 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.948 ' HD3' HD11 ' A' ' 58' ' ' ILE . 45.8 pttt -52.53 -43.92 65.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 12' ' ' LYS . . . -63.19 -36.58 84.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 11' ' ' SER . 0.3 OUTLIER -72.8 -35.22 67.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -66.66 -27.9 68.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' CE ' ' A' ' 48' ' ' MET . 92.3 m-20 -54.73 -56.71 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.69 66.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' HA ' HG21 ' A' ' 103' ' ' THR . 50.8 t80 -71.18 -38.86 72.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.752 HG21 ' C ' ' A' ' 44' ' ' GLY . 13.9 mm -75.45 -47.74 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.896 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -62.5 -49.96 73.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -62.68 -30.39 71.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.181 -0.949 . . . . 0.0 110.103 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.766 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 29.3 t80 -71.43 -51.92 21.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.481 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 40' ' ' MET . 41.8 mm -61.24 -56.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.041 -1.037 . . . . 0.0 110.453 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -57.31 -38.21 73.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.943 . . . . 0.0 110.135 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.07 -45.94 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.962 . . . . 0.0 110.281 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -64.51 -37.56 87.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.458 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 65.7 p -59.17 -28.94 67.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -0.983 . . . . 0.0 110.5 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.18 7.36 31.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.999 -1.063 . . . . 0.0 110.745 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 1.01 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.2 m -94.64 -74.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.776 -1.202 . . . . 0.0 110.883 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -73.53 -104.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 33' ' ' SER . 42.5 p -147.74 13.36 1.03 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -1.049 . . . . 0.0 109.742 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 46.0 m-85 -38.34 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' SER . 31.0 m -60.15 162.33 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -53.09 -44.24 67.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.39 -0.819 . . . . 0.0 109.359 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -56.25 -41.39 75.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 84.3 mm-40 -72.34 -31.11 65.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.042 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 65.2 mtt -63.05 -32.39 73.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.32 -50.12 73.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 109.018 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.666 ' HB3' HD12 ' A' ' 23' ' ' ILE . 87.2 mtp -58.51 -37.63 76.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.78 . . . . 0.0 109.157 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.9 p -70.39 -24.12 62.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.233 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 tp -83.42 -20.69 33.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.858 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.05 HG21 ' CB ' ' A' ' 73' ' ' SER . 20.2 mm -120.48 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.345 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.752 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 100.8 -79.71 0.44 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 46' ' ' THR . 7.1 p30 -65.74 -35.93 82.12 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.272 -1.134 . . . . 0.0 108.195 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 60.5 m -62.14 -35.05 77.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.924 HD21 ' HG ' ' A' ' 66' ' ' LEU . 35.0 tp -61.22 -34.45 75.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.513 -0.742 . . . . 0.0 109.214 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 51' ' ' MET . 54.8 mtt -52.73 -37.96 60.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.166 -0.959 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.65 71.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.54 -49.78 51.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.385 -0.822 . . . . 0.0 108.952 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 66' ' ' LEU . 53.5 mtm -60.76 -29.62 69.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.398 -0.814 . . . . 0.0 109.209 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.07 -27.14 68.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -63.16 -32.14 73.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.298 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.609 ' HG3' HD13 ' A' ' 58' ' ' ILE . 98.5 mmm -50.56 -48.24 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.398 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.39 15.79 20.16 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.37 3.74 44.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' CE ' ' A' ' 54' ' ' MET . 31.6 ptt85 -119.54 112.44 19.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 0.0 109.509 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.948 HD11 ' HD3' ' A' ' 12' ' ' LYS . 13.2 mm -116.21 160.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.518 ' OG1' ' CB ' ' A' ' 62' ' ' LYS . 68.5 p -119.34 157.06 52.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.42 -39.55 5.14 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.777 2.318 . . . . 0.0 111.731 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 76.4 p -74.31 -34.56 63.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 22.6 tttp -67.8 -49.9 59.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.371 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.854 HD22 ' O ' ' A' ' 9' ' ' TRP . 10.0 mt -62.47 -31.06 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -53.55 -45.28 69.81 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.23 63.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.924 ' HG ' HD21 ' A' ' 47' ' ' LEU . 7.5 tt -70.49 -53.63 15.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.47 -0.769 . . . . 0.0 109.128 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.577 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 22.0 t0 -48.16 -46.89 35.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.2 mtp -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.99 73.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.0 109.5 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.674 ' O ' HG13 ' A' ' 74' ' ' VAL . 57.4 t80 -58.22 -38.32 76.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -68.22 -36.16 79.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 1.05 ' CB ' HG21 ' A' ' 43' ' ' ILE . 19.7 m -70.24 -43.45 70.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.709 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.0 m -68.37 -35.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 119' ' ' ILE . . . -65.16 -39.92 93.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.77 -45.18 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 40' ' ' MET . 91.8 mt -56.67 -46.16 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.666 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -67.55 -51.87 45.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.605 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -58.09 -24.51 58.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -76.3 -20.43 57.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 46.5 mt-30 -51.55 -31.87 25.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 10.27 82.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.45 -160.91 26.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.68 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.7 t70 -69.58 101.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 119' ' ' ILE . 25.9 tp -52.92 -20.36 3.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.627 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.07 -33.97 87.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 84' ' ' ASP . 8.0 p -69.2 -35.81 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.196 . . . . 0.0 109.703 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.666 ' OG1' ' HB1' ' A' ' 78' ' ' ALA . 64.1 m -51.65 -32.15 28.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.034 -1.041 . . . . 0.0 108.623 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 37.5 m -58.33 -45.5 87.99 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 83.2 m-20 -70.77 -38.29 73.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.073 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.627 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -69.09 -58.82 3.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 109.557 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.766 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 35.9 mm -61.25 -45.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 112' ' ' ILE . . . -65.86 -49.06 69.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 1.01 ' HB2' HG21 ' A' ' 29' ' ' THR . 86.0 m-20 -55.29 -46.02 76.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.184 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -68.62 -38.72 80.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.0 -42.96 72.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.526 HG22 ' CE2' ' A' ' 101' ' ' TYR . 88.7 m -60.57 -50.93 71.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.722 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 102' ' ' GLN . 31.2 t -60.41 -33.98 73.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.967 . . . . 0.0 109.525 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.4 -44.34 68.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.425 -0.797 . . . . 0.0 109.996 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.0 OUTLIER -47.89 -56.34 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -69.2 -32.11 71.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 98' ' ' SER . 78.4 mm-40 -79.52 -18.49 51.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 18' ' ' PHE . 71.3 p -106.53 -59.15 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.936 -1.103 . . . . 0.0 111.177 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.642 HG21 ' C ' ' A' ' 6' ' ' ASN . 48.1 m -125.14 -42.44 2.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.838 -1.164 . . . . 0.0 111.002 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.1 47.33 1.16 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 17.6 t -110.36 172.22 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.287 -1.125 . . . . 0.0 108.915 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.569 ' H ' HG12 ' A' ' 106' ' ' VAL . 35.1 m -68.59 121.17 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.609 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 19.2 p-10 -71.08 -23.7 62.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.833 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 113' ' ' SER . 20.6 t -66.88 -30.17 70.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 0.0 110.932 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.67 -55.1 14.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.822 -1.174 . . . . 0.0 110.515 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.841 ' HD2' HD21 ' A' ' 96' ' ' LEU . 6.4 t80 -75.79 -49.25 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 110.205 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.599 HG21 ' CB ' ' A' ' 93' ' ' ALA . 20.5 mt -56.3 -36.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' SER . 4.5 m -60.91 -40.81 94.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.74 -38.33 76.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.234 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 118' ' ' LEU . 69.1 mt -69.38 -43.16 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -54.24 -38.99 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.7 m -73.42 -35.9 65.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 109.693 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 115' ' ' ILE . 20.8 mt -65.2 -38.88 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.829 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.961 ' CG2' HD11 ' A' ' 85' ' ' LEU . 65.8 mt -61.67 -42.67 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.91 92.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.658 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 23.3 m-85 -64.34 -34.72 78.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.687 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -68.74 -31.1 69.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.51 -32.86 70.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.489 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.29 67.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.454 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 m -64.0 -33.25 75.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.813 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -67.59 -15.79 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.394 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.25 -21.22 42.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.66 -42.26 86.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 109.376 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.805 HG23 ' CD1' ' A' ' 131' ' ' TYR . 16.0 m -64.14 -32.63 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.805 ' CD1' HG23 ' A' ' 130' ' ' VAL . 34.9 p90 -179.11 174.94 1.01 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.489 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 135' ' ' GLY . . . -80.47 122.58 27.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 m -52.7 -38.35 60.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.48 73.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 132' ' ' ALA . . . 178.87 -176.76 48.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.4 t -122.08 142.36 50.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.497 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.04 -23.12 63.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -1.199 . . . . 0.0 109.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.26 -164.93 40.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -72.65 -3.46 25.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -1.131 . . . . 0.0 109.611 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.632 ' HB3' HD22 ' A' ' 14' ' ' ASN . . . -167.31 155.12 9.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -73.34 -13.4 61.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.2 t -154.46 150.21 21.62 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 41.7 Cg_endo -64.3 -30.65 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 49.1 p90 -88.42 18.74 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.0 109.05 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.5 OUTLIER -105.48 -30.98 9.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -123.59 142.92 50.57 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' CG ' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -60.77 -43.77 97.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.946 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.632 HD22 ' HB3' ' A' ' 5' ' ' ALA . 7.9 m-20 -72.17 -29.57 64.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -65.35 -37.33 86.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.499 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.03 -56.17 12.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.071 -1.018 . . . . 0.0 110.077 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.21 -29.76 15.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 109.567 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 56.3 t80 -69.85 -44.09 70.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.754 HG21 ' C ' ' A' ' 44' ' ' GLY . 18.5 mm -68.64 -44.94 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.196 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -68.25 -50.78 51.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.4 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 51.1 m -58.45 -29.64 66.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.049 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.716 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 25.8 t80 -72.23 -51.92 18.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.129 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.935 HD12 ' HB3' ' A' ' 40' ' ' MET . 19.4 mm -66.21 -55.87 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.007 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -57.44 -36.7 71.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.931 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.96 -44.75 25.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 110.193 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -27.36 68.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 55.1 m -65.21 -31.15 72.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.336 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.4 p-10 -105.93 7.71 32.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.065 -1.022 . . . . 0.0 110.364 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.5 m -89.0 -77.14 0.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.914 -1.116 . . . . 0.0 110.255 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.81 -102.61 0.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -132.95 -62.38 0.81 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.462 -1.022 . . . . 0.0 109.314 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 14.3 m-85 45.54 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.3 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 m -59.37 158.63 9.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -52.42 -40.0 61.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 33' ' ' SER . 19.0 p-10 -61.38 -36.07 79.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.7 mm-40 -67.81 -31.65 71.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.219 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.567 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.8 mtt -63.28 -36.75 84.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 109.001 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 65.5 mm-40 -58.92 -48.7 80.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.114 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -60.56 -46.13 91.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.858 . . . . 0.0 109.021 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.935 ' HB3' HD12 ' A' ' 23' ' ' ILE . 70.9 mtm -61.61 -35.88 79.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.424 -0.797 . . . . 0.0 108.851 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -70.23 -24.1 63.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 46' ' ' THR . 12.1 tp -84.45 -22.07 30.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.836 HG21 ' CB ' ' A' ' 73' ' ' SER . 12.0 mm -118.04 149.4 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.754 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.06 -77.38 1.6 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.91 -39.29 90.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.193 -1.18 . . . . 0.0 108.22 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 84.9 m -63.0 -35.27 79.65 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.099 HD21 ' CD1' ' A' ' 66' ' ' LEU . 29.1 tp -57.82 -36.48 72.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.659 -0.65 . . . . 0.0 109.532 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 94.6 mmm -52.78 -29.46 27.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.252 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.9 76.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.02 86.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.153 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 13.0 mmt -54.73 -29.8 54.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 108.989 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -54.69 -33.03 60.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.305 -0.872 . . . . 0.0 109.139 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -62.68 -31.73 72.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.193 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.572 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 88.8 mmm -57.48 -27.95 62.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 109.317 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.14 14.57 58.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.74 22.3 23.99 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' O ' ' HE2' ' A' ' 54' ' ' MET . 25.3 ptt180 -135.51 112.37 10.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -1.09 . . . . 0.0 109.324 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.001 HG21 HD11 ' A' ' 63' ' ' LEU . 28.4 mm -113.76 158.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 0.0 109.824 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 62' ' ' LYS . 3.0 p -126.84 160.57 58.31 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 0.0 109.541 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 52.4 Cg_endo -72.17 -50.47 0.25 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.756 2.304 . . . . 0.0 111.908 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.2 p -60.35 -35.13 74.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 81.6 mttt -72.7 -52.38 15.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.38 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.001 HD11 HG21 ' A' ' 58' ' ' ILE . 57.3 mt -61.86 -27.34 68.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.021 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -54.78 -44.54 73.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.945 . . . . 0.0 109.017 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.41 69.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.099 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -74.31 -43.64 55.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.031 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 42.0 t0 -48.53 -43.86 35.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.12 -34.36 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.935 . . . . 0.0 109.813 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.54 79.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 109.816 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.843 ' O ' HG13 ' A' ' 74' ' ' VAL . 86.6 t80 -61.51 -36.86 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.7 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.36 -29.05 65.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.935 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -69.32 -46.98 65.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.167 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.836 ' CB ' HG21 ' A' ' 43' ' ' ILE . 1.1 t -70.07 -45.99 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 70' ' ' PHE . 13.7 m -57.4 -35.41 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -73.8 -40.81 63.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.781 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 80' ' ' SER . 50.1 tt0 -68.47 -43.24 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 109.724 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.602 HG21 ' CG ' ' A' ' 40' ' ' MET . 99.4 mt -56.35 -52.38 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -73.33 -50.62 21.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 0.0 109.841 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.41 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.398 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 90.0 p -81.4 -20.65 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 34.8 mt-30 -48.97 -36.96 18.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 22.29 41.9 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.03 -157.39 13.75 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 76.8 m-20 -62.6 134.4 56.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.099 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 119' ' ' ILE . 6.3 tp -84.95 -19.4 32.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.59 64.82 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -69.99 -44.93 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 109.696 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 87' ' ' VAL . 80.0 m -51.61 -34.75 38.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.975 -1.078 . . . . 0.0 108.493 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 23.8 m -56.2 -48.7 75.9 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 m120 -70.72 -39.3 73.48 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.169 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -65.25 -57.45 8.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.732 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' LEU . 48.2 mt -66.46 -45.97 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.8 -49.02 74.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 0.0 110.059 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.3 m-20 -54.99 -41.68 71.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.363 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -62.62 -44.59 95.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.304 -0.873 . . . . 0.0 109.049 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.963 HD13 HD12 ' A' ' 115' ' ' ILE . 7.1 mt -70.42 -36.01 73.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.505 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.556 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 93.5 m -64.82 -53.7 42.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 110.009 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 14.5 m -62.08 -49.2 76.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.121 -0.987 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.5 -44.37 68.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER -46.96 -55.95 7.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 109.324 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.573 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 4.1 m-85 -71.97 -31.91 66.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.44 -0.787 . . . . 0.0 109.675 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 98' ' ' SER . 65.1 mt-30 -73.19 -18.39 61.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.676 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 99' ' ' ALA . 34.7 p -107.29 -60.22 1.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.936 -1.103 . . . . 0.0 111.173 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.831 ' CG2' HG23 ' A' ' 106' ' ' VAL . 12.3 t -127.05 -43.07 1.69 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.813 -1.179 . . . . 0.0 110.845 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.98 46.82 0.92 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 104' ' ' THR . 57.4 t -103.07 167.86 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.271 -1.135 . . . . 0.0 108.937 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 107' ' ' VAL . 33.5 m -66.07 121.45 15.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.755 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 20.8 p-10 -71.07 -23.74 62.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.428 -0.795 . . . . 0.0 109.939 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 113' ' ' SER . 90.2 p -68.7 -34.84 76.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -62.36 -54.52 39.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.862 -1.148 . . . . 0.0 110.473 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 115' ' ' ILE . 57.4 t80 -75.73 -53.29 8.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 110.204 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 93' ' ' ALA . 21.2 mt -56.36 -28.37 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 109' ' ' SER . 9.6 t -58.81 -42.29 88.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.622 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.48 -36.35 65.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 111' ' ' PHE . 30.8 mt -67.54 -41.22 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.647 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 113' ' ' SER . 31.8 ptt85 -54.04 -43.12 69.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.852 -1.155 . . . . 0.0 109.638 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.492 ' N ' ' CG ' ' A' ' 116' ' ' ARG . 87.0 p -71.44 -33.82 69.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.548 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.8 mt -66.45 -38.12 86.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.766 HG22 HD11 ' A' ' 85' ' ' LEU . 67.3 mt -61.5 -35.71 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.023 . . . . 0.0 109.454 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -67.93 -34.24 81.66 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.0 ttm -60.75 -43.68 97.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.16 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 97.7 m-85 -59.14 -50.17 75.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -54.27 -31.73 54.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 120' ' ' GLY . 99.6 mm-40 -70.66 -32.67 70.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HA ' ' ND2' ' A' ' 128' ' ' ASN . . . -57.8 -31.85 66.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -35.48 69.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 1.013 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -59.78 -27.95 66.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 125' ' ' ALA . 78.4 m-20 -54.09 -18.78 4.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.86 -35.05 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.013 HG12 ' O ' ' A' ' 127' ' ' ALA . 7.5 p -65.48 -29.63 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.604 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.851 ' CD2' HG13 ' A' ' 130' ' ' VAL . 37.1 p90 177.71 160.99 0.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.321 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.89 116.67 11.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' ALA . 39.7 p -59.39 158.17 9.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 109.481 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' SER . . . 45.45 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.24 -0.912 . . . . 0.0 109.485 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.02 -173.23 48.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -123.43 141.48 51.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -1.144 . . . . 0.0 109.496 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.442 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 65.0 mtt -59.11 -38.09 78.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.459 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.473 ' C ' ' NE2' ' A' ' 4' ' ' GLN . . . 97.51 0.87 59.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' NE2' ' C ' ' A' ' 3' ' ' GLY . 10.0 mp0 -120.67 153.98 36.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -1.191 . . . . 0.0 109.355 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 104' ' ' THR . . . -146.83 92.57 2.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.684 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' O ' ' OG1' ' A' ' 104' ' ' THR . 19.0 m120 -57.97 -17.28 16.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.927 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -135.97 151.75 74.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.436 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.0 Cg_endo -68.66 -35.39 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.561 2.174 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.836 ' O ' HD22 ' A' ' 63' ' ' LEU . 45.3 p90 -91.48 -11.39 37.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 109.082 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -72.05 -5.34 34.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.898 . . . . 0.0 109.413 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 1.9 t -140.79 153.9 46.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.361 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.502 ' CG ' HG13 ' A' ' 58' ' ' ILE . 2.5 ttpm? -73.81 -39.7 63.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.612 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.45 -33.01 42.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.259 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 7' ' ' THR . 34.2 t30 -71.53 -29.47 64.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.79 -43.06 72.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -54.36 -56.33 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.717 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.4 45.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 109.298 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 47.2 t80 -68.73 -52.6 28.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.898 HG23 ' CE1' ' A' ' 70' ' ' PHE . 10.0 mm -60.15 -44.14 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -67.49 -50.87 56.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -57.66 -30.12 65.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.203 -0.936 . . . . 0.0 108.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 19.2 t80 -72.29 -52.21 17.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG12 ' CE ' ' A' ' 40' ' ' MET . 69.4 mt -61.9 -56.12 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.687 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -53.91 -37.24 63.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -51.54 10.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.924 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.67 64.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.105 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.635 ' HB2' ' HE1' ' A' ' 37' ' ' MET . 45.8 p -68.37 -33.41 74.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.249 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -105.67 7.19 32.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 94' ' ' ASP . 8.9 m -87.16 -77.09 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.956 -1.09 . . . . 0.0 110.224 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -101.4 0.61 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 76.5 p -141.32 -53.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.429 -1.042 . . . . 0.0 109.344 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 15.7 m-85 44.5 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 37' ' ' MET . 32.2 t -59.68 159.97 7.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -52.38 -38.4 58.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.07 -37.18 86.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.115 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.526 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 81.8 mm-40 -76.32 -36.17 58.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.635 ' HE1' ' HB2' ' A' ' 27' ' ' SER . 79.6 mtp -63.97 -37.43 87.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.132 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -56.89 -41.2 77.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.171 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.78 ' HB3' HG23 ' A' ' 77' ' ' ILE . 46.0 t-20 -56.07 -35.08 66.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 108.916 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.52 ' SD ' HD13 ' A' ' 77' ' ' ILE . 92.8 mmm -57.12 -31.69 65.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 m -67.55 -24.08 65.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.915 . . . . 0.0 109.28 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 46' ' ' THR . 66.9 mt -92.08 -28.22 17.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.0 ' HB ' HD11 ' A' ' 77' ' ' ILE . 63.9 mt -116.81 154.99 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.422 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.852 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.16 -89.79 1.62 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -59.58 -32.4 70.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 108.834 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 34.2 m -65.95 -35.08 79.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 108.922 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 66' ' ' LEU . 29.8 tp -54.97 -38.63 68.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.79 . . . . 0.0 109.222 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.9 ttt -52.83 -36.16 58.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.31 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.21 72.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.193 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.83 72.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 64.0 mtm -59.17 -29.91 67.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.215 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.76 -31.66 69.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -60.88 -29.32 69.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.241 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.557 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 89.8 mmm -57.84 -33.18 68.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.364 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.28 12.9 34.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.23 9.55 44.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' HE2' ' A' ' 54' ' ' MET . 18.8 ptt180 -125.09 112.28 16.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.129 . . . . 0.0 109.551 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG21 HD11 ' A' ' 63' ' ' LEU . 31.3 mm -116.03 142.05 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.51 ' OG1' ' CB ' ' A' ' 62' ' ' LYS . 7.6 p -97.9 157.02 35.32 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.67 -42.11 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.677 2.251 . . . . 0.0 111.59 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 22.9 t -71.67 -36.08 70.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.51 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 17.1 tttp -64.51 -49.81 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.315 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 9' ' ' TRP . 2.6 mt -57.04 -32.3 66.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' MET . 85.1 mt-30 -54.75 -48.29 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.123 -0.986 . . . . 0.0 108.628 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.5 55.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.395 -0.816 . . . . 0.0 109.267 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 47' ' ' LEU . 1.8 tp -61.54 -50.82 71.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.581 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 26.3 t0 -47.99 -37.01 13.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 63.5 mtt -65.84 -32.13 73.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.37 93.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.9 t80 -53.59 -38.93 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.875 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.744 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -68.94 -40.49 78.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.6 m -69.35 -45.64 68.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.776 ' HB3' HD13 ' A' ' 43' ' ' ILE . 12.3 m -70.01 -47.24 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 109.766 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 7.5 p -58.4 -44.16 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.603 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -62.8 -37.24 85.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.0 tt0 -68.41 -43.12 77.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 43' ' ' ILE . 78.8 mt -53.78 -52.46 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.591 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.46 -50.84 10.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.782 . . . . 0.0 109.931 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.58 -22.54 45.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.979 . . . . 0.0 109.266 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.3 p -81.85 -20.59 38.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 50.1 mt-30 -45.96 -35.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 3.79 76.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.18 -162.75 33.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -72.06 118.31 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.134 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.089 HD23 HG22 ' A' ' 119' ' ' ILE . 3.4 mp -62.28 -16.17 52.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.76 -45.74 78.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.3 -47.47 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -1.132 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.591 HG23 ' CB ' ' A' ' 78' ' ' ALA . 44.7 m -53.75 -48.43 69.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 21.6 m -51.27 -47.7 62.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 74.7 m-20 -71.05 -35.32 71.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.443 -0.786 . . . . 0.0 108.93 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.487 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -69.58 -59.13 3.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 0.0 109.689 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 96' ' ' LEU . 69.0 mt -63.98 -49.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.901 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.26 -52.52 65.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.331 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.887 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.8 m-20 -55.4 -43.12 74.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 109.903 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -63.54 -39.5 94.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.205 -0.934 . . . . 0.0 109.723 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD11 HG22 ' A' ' 92' ' ' ILE . 6.2 mt -69.88 -35.87 75.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.797 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -65.46 -53.65 39.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 20.2 m -60.59 -34.03 73.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.825 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -69.52 -46.3 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.5 m-85 -47.12 -56.21 6.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -71.14 -31.78 68.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.828 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 98' ' ' SER . 84.1 mm-40 -73.12 -18.59 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 99' ' ' ALA . 67.5 p -107.45 -59.85 1.77 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.903 -1.123 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -126.82 -42.84 1.73 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.761 -1.212 . . . . 0.0 110.836 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 111.77 45.36 0.83 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 107' ' ' VAL . 6.6 t -102.81 172.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 109.151 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 14.1 m -74.18 120.23 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.797 ' ND2' HG23 ' A' ' 97' ' ' THR . 13.0 p30 -72.07 -29.59 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.645 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 113' ' ' SER . 21.7 m -56.92 -46.09 82.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 110.391 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.97 -53.58 56.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.891 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.98 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.0 -50.49 16.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.756 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.514 HD12 ' OD1' ' A' ' 108' ' ' ASN . 11.5 mt -58.56 -42.63 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.065 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 109' ' ' SER . 48.0 t -55.84 -37.97 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.15 -40.41 82.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.513 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.98 HD11 ' CE2' ' A' ' 111' ' ' PHE . 56.2 mt -72.7 -43.34 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -54.22 -39.74 67.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.368 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.7 t -73.15 -34.12 65.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.8 mt -70.97 -40.71 71.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.089 HG22 HD23 ' A' ' 85' ' ' LEU . 84.6 mt -58.2 -39.65 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.03 -27.34 72.27 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.0 ttm -66.97 -38.68 86.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -1.166 . . . . 0.0 109.502 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -60.14 -37.87 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.529 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.94 -32.07 72.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -70.82 -32.02 68.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.47 -28.61 69.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.1 p -61.26 -29.13 69.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.888 ' HB1' ' HA ' ' A' ' 131' ' ' TYR . . . -65.51 -28.33 69.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.607 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' ALA . 87.3 m-20 -44.72 -24.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.871 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.575 ' O ' ' CZ ' ' A' ' 131' ' ' TYR . 92.5 m-20 -95.17 -65.82 0.95 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.063 -1.023 . . . . 0.0 110.187 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 13.4 m -98.65 -15.26 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.083 -1.011 . . . . 0.0 111.66 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.888 ' HA ' ' HB1' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 43.82 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.176 -0.952 . . . . 0.0 109.947 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . -150.59 86.61 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.931 -1.105 . . . . 0.0 108.966 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 132' ' ' ALA . 37.4 p -43.52 165.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.723 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.71 72.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.93 10.4 55.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.5 m -58.9 -34.0 71.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -1.164 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.2 mmm -109.05 142.22 40.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -51.7 -36.41 40.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -112.46 153.68 27.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 104' ' ' THR . . . -66.63 157.32 32.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.472 ' C ' HG21 ' A' ' 104' ' ' THR . 65.1 m-20 -77.19 -10.84 59.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.273 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 10' ' ' SER . 1.5 t -162.25 151.77 13.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.012 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 46.0 Cg_endo -67.49 -27.17 39.78 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.466 2.111 . . . . 0.0 112.695 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -92.52 15.91 13.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.849 -1.157 . . . . 0.0 109.845 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.5 p -105.31 -23.07 12.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.002 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -110.45 160.71 16.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.188 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 51' ' ' MET . 15.6 ttpp -74.69 -40.88 61.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.049 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -83.28 -31.07 27.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.637 HD22 ' C ' ' A' ' 103' ' ' THR . 0.2 OUTLIER -71.54 -29.38 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.644 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.514 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -73.03 -47.89 40.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.567 ' CB ' ' HE2' ' A' ' 48' ' ' MET . 1.2 p30 -56.79 -49.29 75.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.169 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -55.08 -40.61 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.971 -1.08 . . . . 0.0 109.386 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HA ' HG21 ' A' ' 103' ' ' THR . 72.2 t80 -61.23 -48.57 80.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.028 HG23 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mm -60.88 -44.44 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -50.87 48.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.382 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 38.8 t -55.91 -29.98 60.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 108.765 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 39.1 t80 -72.34 -51.92 18.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.511 -0.743 . . . . 0.0 110.047 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 40' ' ' MET . 76.3 mt -60.26 -56.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -59.85 -35.14 74.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.923 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.14 -45.29 23.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -40.59 91.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.937 . . . . 0.0 110.323 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 82.7 p -57.15 -27.24 61.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.23 6.99 31.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.571 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.972 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.5 m -93.12 -77.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.783 -1.198 . . . . 0.0 110.188 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -81.75 -104.74 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' PHE . 53.0 p -131.31 -61.52 0.91 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.8 m-85 44.02 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 109.236 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m -59.65 162.56 5.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.577 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -52.56 -43.33 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.23 -35.89 76.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.464 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.9 mm-40 -71.7 -35.07 70.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.6 mtt -63.47 -34.23 77.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -63.03 -38.31 90.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 86.3 m-20 -55.83 -39.69 71.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.256 -0.903 . . . . 0.0 109.118 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 23' ' ' ILE . 75.8 mtm -66.16 -32.04 73.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.083 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 46' ' ' THR . 19.5 m -70.31 -23.62 62.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 54.7 mt -97.34 -14.31 21.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 44' ' ' GLY . 74.8 mt -130.78 166.3 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 0.0 109.548 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 64.8 -69.44 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ILE . 41.1 t30 -74.81 -41.06 60.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.213 -1.169 . . . . 0.0 109.23 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 41' ' ' SER . 46.8 m -58.37 -35.24 71.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 108.739 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.74 -31.19 69.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 108.908 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 58.1 mmm -56.81 -29.95 63.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.412 -0.805 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' ASP . . . -60.7 -42.51 97.36 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -22.88 66.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.537 ' CE ' ' HG2' ' A' ' 12' ' ' LYS . 20.4 ttp -58.7 -30.86 67.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.632 -0.667 . . . . 0.0 109.513 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 50.4 p30 -73.69 -13.36 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 86.5 m-20 -71.04 -28.2 64.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.852 . . . . 0.0 109.184 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.526 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 90.7 mmm -53.41 -34.43 57.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.66 4.71 60.44 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.35 10.49 19.82 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.55 ' O ' HD13 ' A' ' 58' ' ' ILE . 9.9 ptt180 -122.92 115.22 21.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -1.162 . . . . 0.0 109.661 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.766 HG21 HD21 ' A' ' 63' ' ' LEU . 22.9 mm -116.68 155.93 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.855 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.744 HG22 ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -143.54 166.27 20.69 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.744 ' HD2' HG22 ' A' ' 59' ' ' THR . 50.5 Cg_endo -70.81 -41.14 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.672 2.248 . . . . 0.0 111.883 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.9 p -65.77 -33.71 76.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -75.63 -50.43 15.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.766 HD21 HG21 ' A' ' 58' ' ' ILE . 6.9 mp -70.16 -33.47 71.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 60.5 tt0 -53.67 -42.16 67.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.46 65.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 108.802 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 tp -74.48 -50.77 16.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.575 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.5 t0 -48.26 -39.68 22.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.7 mmm -71.44 -39.4 71.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.69 87.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.028 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.5 t80 -52.88 -36.94 59.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 109.706 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.916 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -64.55 -39.58 94.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.675 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 88.2 p -69.46 -30.63 68.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.826 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 43' ' ' ILE . 11.5 t -69.96 -44.25 69.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.0 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 71' ' ' ALA . 11.7 m -69.01 -34.63 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.563 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.91 -40.74 75.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.62 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -71.11 -49.36 45.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -53.82 -46.71 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.69 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -53.98 6.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 109.799 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.16 -22.67 52.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.549 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 22.9 m -79.67 -20.72 45.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 37.6 mt-30 -57.19 -34.14 68.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.82 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.25 17.81 73.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.84 -145.62 19.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.579 ' O ' HG12 ' A' ' 87' ' ' VAL . 58.4 t0 -76.0 106.03 7.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -1.111 . . . . 0.0 109.302 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.98 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.8 tp -60.18 -23.07 63.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 109.666 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.16 -39.45 72.47 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.0 p -67.62 -39.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.255 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 24.3 m -51.7 -34.46 38.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.963 -1.085 . . . . 0.0 108.316 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.548 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 6.6 m -57.46 -50.93 71.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' A' ' 94' ' ' ASP . 51.0 t30 -70.24 -40.18 74.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.389 -0.819 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.6 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -62.37 -53.55 53.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.298 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.847 HG22 HD11 ' A' ' 96' ' ' LEU . 57.0 mt -72.56 -51.25 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.89 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.53 -49.23 75.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.972 ' HB2' HG21 ' A' ' 29' ' ' THR . 93.1 m-20 -54.77 -47.68 73.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.213 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -57.02 -46.11 82.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.339 -0.851 . . . . 0.0 109.003 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.847 HD11 HG22 ' A' ' 92' ' ' ILE . 1.8 mt -70.97 -28.61 64.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.548 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.924 HG23 ' OD1' ' A' ' 108' ' ' ASN . 51.7 m -64.46 -54.09 37.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.157 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 87.6 p -66.78 -43.91 82.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 109.438 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.14 -42.71 66.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.5 m-85 -50.49 -56.41 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.123 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 7.5 m-85 -72.07 -31.77 66.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.425 -0.797 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 98' ' ' SER . 28.3 mt-30 -75.71 -17.8 59.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.589 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 18' ' ' PHE . 63.7 p -109.44 -58.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 111.294 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 5' ' ' ALA . 87.2 m -125.76 -42.75 1.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.746 -1.221 . . . . 0.0 111.212 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.77 47.81 1.07 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 107' ' ' VAL . 3.6 t -110.92 172.79 2.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.263 -1.139 . . . . 0.0 109.022 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 107' ' ' VAL . 33.2 m -71.85 121.12 21.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.52 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.924 ' OD1' HG23 ' A' ' 97' ' ' THR . 0.3 OUTLIER -71.7 -29.69 64.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 109.857 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 113' ' ' SER . 47.5 m -55.95 -30.12 61.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.492 -0.755 . . . . 0.0 110.742 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 23.1 tpt180 -71.54 -55.22 8.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 110.374 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.92 -46.6 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HB1' ' A' ' 93' ' ' ALA . 12.5 mt -56.13 -47.15 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.453 -0.779 . . . . 0.0 109.852 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 109' ' ' SER . 28.5 t -55.66 -43.56 76.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 95.0 mt-10 -57.19 -48.35 78.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.223 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.916 HG12 ' HB1' ' A' ' 71' ' ' ALA . 74.5 mt -65.46 -34.08 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.548 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 11.5 ttm180 -52.95 -48.96 66.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -69.75 -33.98 73.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -67.13 -45.61 76.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.682 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.909 HG22 HD11 ' A' ' 85' ' ' LEU . 56.7 mt -57.83 -34.6 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.686 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.865 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -69.02 -31.78 72.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 53.2 ttm -71.36 -39.28 71.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.119 . . . . 0.0 109.791 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.468 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 75.6 m-85 -65.57 -33.62 76.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -68.95 -27.72 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.65 -34.05 71.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.83 -33.02 74.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.371 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -62.72 -30.83 71.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.276 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -68.95 -11.96 61.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.331 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -83.76 -18.51 37.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -77.1 -44.16 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.241 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.003 HG13 ' CD2' ' A' ' 131' ' ' TYR . 7.5 p -59.37 -25.78 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 109.194 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 130' ' ' VAL . 39.8 p90 178.3 176.59 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.213 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.25 117.12 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.657 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 t -53.71 -37.07 62.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 0.0 109.307 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.1 -39.33 63.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.98 -162.37 32.51 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.8 p -64.23 -28.1 69.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.37 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.72 161.22 28.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.77 -125.27 25.3 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -111.32 151.47 28.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -1.139 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.12 140.73 52.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -85.91 14.01 6.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.951 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' ' 10' ' ' SER . 3.1 t -157.78 151.38 19.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.093 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 43.9 Cg_endo -67.41 -35.09 24.63 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.783 2.322 . . . . 0.0 113.394 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.587 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -81.34 -7.51 59.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.695 -1.253 . . . . 0.0 110.339 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.89 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 m -88.35 20.14 3.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.656 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -155.69 150.05 25.86 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' HB2' HG13 ' A' ' 58' ' ' ILE . 1.9 ttpp -73.88 -38.18 64.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -85.85 -33.56 21.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' CB ' ' HB3' ' A' ' 11' ' ' SER . 0.2 OUTLIER -71.88 -29.28 64.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.608 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -73.0 -44.28 61.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.641 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.6 p30 -54.45 -40.28 68.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -63.05 -44.65 95.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.012 -1.055 . . . . 0.0 109.024 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CE1' HD23 ' A' ' 96' ' ' LEU . 43.1 t80 -60.77 -44.26 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 70' ' ' PHE . 19.0 mm -66.34 -43.36 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.239 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -50.92 51.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.248 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 43.5 m -58.75 -29.42 66.73 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 108.72 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.783 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.8 t80 -71.64 -51.98 20.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.91 ' HA ' ' HE1' ' A' ' 40' ' ' MET . 74.3 mt -63.67 -56.06 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.908 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.4 m -56.04 -37.07 68.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.677 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -49.4 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.777 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -60.36 -24.19 64.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 110.153 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.6 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 57.8 m -67.3 -34.33 77.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 110.079 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -106.08 7.17 31.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.16 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 94' ' ' ASP . 11.8 m -84.19 -75.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -86.97 -99.84 0.83 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -142.04 -54.9 0.45 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -1.074 . . . . 0.0 109.293 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 44.17 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 15.9 m -59.65 159.82 8.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.698 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -52.8 -32.72 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -71.15 -37.95 72.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.326 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.529 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 37.5 mt-30 -76.56 -34.22 58.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.6 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 88.6 mtp -65.04 -34.49 78.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 72.7 mt-10 -56.87 -43.99 81.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.866 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.9 m-20 -55.9 -33.23 64.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.91 ' HE1' ' HA ' ' A' ' 23' ' ' ILE . 82.3 mtp -61.74 -32.55 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -69.91 -24.68 63.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.373 -0.829 . . . . 0.0 109.453 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.1 mp -89.03 -22.43 22.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.81 ' HB ' HD11 ' A' ' 77' ' ' ILE . 86.9 mt -115.57 164.18 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.647 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 73.84 -93.88 0.76 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' OD1' ' CD1' ' A' ' 23' ' ' ILE . 21.2 m120 -52.41 -36.89 55.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -1.185 . . . . 0.0 109.036 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 55.4 m -58.4 -35.31 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 66' ' ' LEU . 74.6 mt -56.88 -36.45 70.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 109.224 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 70.8 mtm -52.95 -40.7 63.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.28 -31.5 71.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.972 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.9 78.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -0.803 . . . . 0.0 109.176 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 35.5 mtt -58.96 -30.93 68.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.11 -25.85 64.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.85 -30.33 70.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.381 -0.824 . . . . 0.0 109.264 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 94.8 mmm -63.69 -36.15 82.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.69 12.14 48.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.47 12.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' CE ' ' A' ' 54' ' ' MET . 17.6 ptt85 -138.1 114.35 10.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.528 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.526 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 25.1 mm -111.38 128.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -89.45 166.57 20.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 47.4 Cg_endo -69.17 -21.35 36.38 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.595 2.196 . . . . 0.0 111.769 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 t -74.78 -44.52 49.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.268 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 21.3 mttm -74.02 -30.35 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 0.0 108.855 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.89 HD21 ' O ' ' A' ' 10' ' ' SER . 1.2 tp -49.68 -52.52 30.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -76.81 -46.07 26.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.252 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . . . -50.82 -51.24 52.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 47' ' ' LEU . 17.4 tp -54.94 -50.04 69.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.948 . . . . 0.0 109.028 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 9.8 t0 -48.16 -49.39 32.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.9 mtp -58.81 -43.99 90.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.64 77.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.736 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE1' HG23 ' A' ' 19' ' ' ILE . 77.6 t80 -56.86 -45.2 82.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.44 -36.99 84.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -69.6 -52.05 29.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -0.975 . . . . 0.0 110.023 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.687 ' HB3' HD13 ' A' ' 43' ' ' ILE . 10.9 m -70.25 -35.84 74.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.709 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 8.1 p -66.88 -43.65 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.13 -0.981 . . . . 0.0 109.898 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -63.68 -32.22 73.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.907 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -72.17 -43.1 65.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 109.875 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.866 HG23 ' HB2' ' A' ' 39' ' ' ASN . 64.8 mt -54.47 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.099 -1.001 . . . . 0.0 109.822 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.0 -50.17 12.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.46 -0.775 . . . . 0.0 110.142 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.1 -25.96 61.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.583 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.2 p -76.94 -20.31 56.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.408 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.529 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 26.7 mt-30 -46.4 -33.76 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.37 16.11 80.97 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.5 -159.3 19.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.04 105.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -1.164 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.01 HD23 HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -61.21 -18.38 57.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.66 81.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 46.4 t -68.69 -44.81 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 109.547 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.616 HG23 ' CB ' ' A' ' 78' ' ' ALA . 23.9 m -54.52 -50.15 68.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.0 m -51.31 -48.83 62.23 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 24.0 t-20 -70.83 -33.92 71.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 108.983 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -70.37 -59.15 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.509 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.738 HG22 HD11 ' A' ' 96' ' ' LEU . 55.0 mt -63.21 -49.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.828 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.0 -52.23 64.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.77 ' HB3' HG21 ' A' ' 29' ' ' THR . 32.0 t0 -55.23 -50.53 69.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.22 -42.88 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.738 HD11 HG22 ' A' ' 92' ' ' ILE . 7.1 mt -70.26 -41.05 73.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.671 HG23 ' OD1' ' A' ' 108' ' ' ASN . 99.3 m -62.4 -48.64 78.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 28.7 m -64.43 -34.26 77.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 109.483 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.95 -44.99 68.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.9 m-85 -46.97 -56.03 7.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.873 . . . . 0.0 109.698 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.537 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -70.91 -32.09 68.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.762 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 98' ' ' SER . 88.2 mm-40 -75.91 -18.42 59.39 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.781 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 61.2 p -103.81 -59.85 1.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.058 -1.026 . . . . 0.0 111.101 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.781 ' OG1' HG23 ' A' ' 106' ' ' VAL . 12.6 p -126.73 -42.61 1.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.672 -1.268 . . . . 0.0 110.925 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.82 45.25 0.97 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.781 HG23 ' OG1' ' A' ' 104' ' ' THR . 12.1 t -109.83 172.52 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -1.125 . . . . 0.0 109.219 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.2 m -73.68 121.16 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.714 ' ND2' HD12 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -70.74 -23.36 62.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.5 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 113' ' ' SER . 23.3 t -54.78 -30.27 56.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.574 -0.704 . . . . 0.0 110.601 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -69.04 -55.0 12.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.878 -1.139 . . . . 0.0 110.234 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 115' ' ' ILE . 59.8 t80 -76.16 -50.4 14.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.714 HD12 ' ND2' ' A' ' 108' ' ' ASN . 14.5 mt -56.35 -42.56 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.139 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 109' ' ' SER . 32.2 t -56.23 -46.86 79.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 109.554 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.41 -49.83 74.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.262 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.885 HG12 ' HB1' ' A' ' 71' ' ' ALA . 89.7 mt -65.93 -34.82 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -54.06 -47.02 72.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 109.52 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.8 p -72.66 -33.9 66.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.63 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.02 -44.16 77.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.01 HG22 HD23 ' A' ' 85' ' ' LEU . 97.5 mt -57.82 -38.83 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.02 -33.79 75.18 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -61.68 -36.87 82.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.491 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 77.1 m-85 -66.23 -36.84 84.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -65.08 -27.99 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -69.98 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.56 72.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.3 p -70.35 -22.46 62.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -67.74 -21.12 65.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 51.3 t-20 -72.36 -27.68 62.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -66.72 -45.74 77.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.895 HG13 ' CD1' ' A' ' 131' ' ' TYR . 3.9 p -65.85 -30.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.895 ' CD1' HG13 ' A' ' 130' ' ' VAL . 39.4 p90 178.66 169.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.287 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.86 122.29 23.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.5 p -57.94 -28.45 64.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.97 -32.65 54.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.1 -31.89 41.72 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 87.4 p -62.78 -27.5 69.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 109.397 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.6 mtp -59.89 -35.49 74.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -1.105 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.29 -176.09 48.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -139.41 160.18 40.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.766 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -66.22 144.09 56.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -62.53 -15.46 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.712 ' C ' HG21 ' A' ' 104' ' ' THR . 3.5 t -152.17 151.38 27.57 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.645 ' N ' HG21 ' A' ' 104' ' ' THR . 42.4 Cg_endo -64.8 -35.5 45.07 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 113.01 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.547 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 49.4 p90 -81.69 -2.16 49.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.661 -1.274 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.691 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -82.7 -28.65 30.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 108.688 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.766 ' OG ' ' HB2' ' A' ' 5' ' ' ALA . 70.8 m -118.82 151.11 38.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.484 -0.76 . . . . 0.0 109.161 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD3' HG13 ' A' ' 58' ' ' ILE . 27.0 mtpt -70.95 -36.16 72.49 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.698 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -67.06 -49.52 64.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.932 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.5 m-20 -71.37 -29.16 64.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -66.81 -49.88 64.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.433 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.2 p30 -54.8 -53.38 56.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.028 . . . . 0.0 110.149 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -57.65 -35.72 70.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 0.0 108.863 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 75.5 t80 -61.09 -37.32 82.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.479 -0.763 . . . . 0.0 109.26 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 70' ' ' PHE . 31.6 mm -75.14 -48.44 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.631 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -62.4 -48.28 80.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 2.1 t -60.75 -30.71 70.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.972 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.765 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 44.9 t80 -68.7 -52.0 35.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 0.0 110.186 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.404 HD12 ' ND2' ' A' ' 45' ' ' ASN . 67.2 mt -63.15 -56.02 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.99 . . . . 0.0 109.958 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -59.71 -30.88 69.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.01 -45.37 23.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -70.38 -31.66 69.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 50.3 m -60.5 -30.95 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.5 p-10 -106.29 7.39 31.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.01 . . . . 0.0 110.651 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.995 HG21 ' HB2' ' A' ' 94' ' ' ASP . 29.1 m -89.62 -79.36 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.807 -1.183 . . . . 0.0 110.177 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -81.01 -103.05 0.32 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -132.81 -58.28 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.325 -1.103 . . . . 0.0 109.305 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.4 m-85 43.84 90.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.082 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 11.1 p -59.54 162.99 4.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -52.72 -36.94 58.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.876 . . . . 0.0 109.278 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.21 -45.51 79.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.547 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 4.2 mp0 -63.93 -35.48 80.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.184 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 58.3 mtt -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.081 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 94.8 mt-10 -70.36 -37.46 74.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.113 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -68.75 -44.65 73.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.251 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.545 ' CE ' ' CE1' ' A' ' 32' ' ' PHE . 61.2 mtt -56.85 -31.98 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 108.935 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 p -70.13 -23.35 63.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.38 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 38' ' ' GLU . 62.7 mt -87.88 -26.25 22.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.716 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 73' ' ' SER . 53.4 mt -121.32 157.09 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.449 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.93 -77.2 2.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.404 ' ND2' HD12 ' A' ' 23' ' ' ILE . 95.6 m-20 -65.02 -38.46 90.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -1.162 . . . . 0.0 108.766 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -58.46 -35.1 71.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.06 -34.51 75.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.552 -0.718 . . . . 0.0 109.247 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 61.4 ttp -52.96 -41.95 65.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 109.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.12 74.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 108.583 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.8 66.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.536 ' O ' ' HG3' ' A' ' 54' ' ' MET . 57.6 mtt -60.05 -29.76 68.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.563 -0.711 . . . . 0.0 109.433 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -76.0 -8.22 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' GLY . 97.6 m-20 -70.84 -42.53 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.872 ' HG2' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.29 -21.89 0.1 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.235 -0.916 . . . . 0.0 110.601 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' ' SD ' ' A' ' 54' ' ' MET . . . 85.9 -24.97 7.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.481 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 140.8 30.7 0.17 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 20.1 ptt85 -139.28 114.93 9.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.019 -1.283 . . . . 0.0 109.606 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.872 HD11 ' HG2' ' A' ' 54' ' ' MET . 27.6 mm -117.11 147.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.835 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -145.59 169.35 9.91 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 49.9 Cg_endo -69.6 -48.11 0.82 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.0 112.036 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -60.68 -36.29 78.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.938 . . . . 0.0 109.684 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -75.04 -48.0 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.738 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.796 HD11 HG23 ' A' ' 58' ' ' ILE . 9.8 mp -74.35 -46.16 42.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 96.7 mt-30 -54.71 -40.14 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -37.4 68.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.011 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.16 -52.62 11.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.67 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -48.06 -25.26 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.608 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 56.7 mtp -72.71 -27.42 62.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.963 . . . . 0.0 110.023 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -35.56 65.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 110.038 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.615 ' CE1' HG23 ' A' ' 19' ' ' ILE . 88.8 t80 -53.84 -40.71 66.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.792 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.951 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.69 -36.35 83.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 24.8 m -69.23 -34.16 74.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.783 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 43' ' ' ILE . 37.1 m -70.3 -49.63 47.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.874 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' ALA . 19.1 m -57.73 -35.04 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -70.62 -43.35 69.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 0.0 109.691 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.567 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 87.2 mt-30 -66.22 -50.88 62.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.879 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -53.49 -50.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.22 -53.32 7.47 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 110.209 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.63 -24.28 55.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 79.9 p -76.7 -20.23 56.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.547 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 55.2 mt-30 -50.34 -31.54 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 109.51 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.39 14.75 81.68 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.42 -162.88 23.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -1.13 . . . . 0.0 109.437 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.047 HD23 HG22 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -62.21 -20.21 63.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.98 -38.33 65.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.446 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 72.2 t -70.55 -47.5 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.569 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 19.7 m -51.95 -48.72 64.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 116' ' ' ARG . 4.3 m -51.07 -46.25 61.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 81.3 m-20 -71.0 -39.18 72.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.422 -0.799 . . . . 0.0 109.026 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -67.48 -59.2 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.765 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 69.7 mt -60.33 -47.24 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.54 -51.31 65.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.995 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.5 m-20 -60.73 -33.54 73.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.877 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -71.96 -42.59 66.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 108.969 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -70.38 -38.45 74.71 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.508 -0.745 . . . . 0.0 109.777 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.563 HG22 ' CE2' ' A' ' 101' ' ' TYR . 77.8 m -63.85 -51.5 64.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 109.917 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 85.7 p -58.4 -34.78 71.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 0.0 109.774 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.23 -44.56 68.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -46.96 -54.81 9.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.563 ' CE2' HG22 ' A' ' 97' ' ' THR . 3.7 m-85 -72.03 -32.09 66.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 98' ' ' SER . 92.5 mm-40 -77.19 -18.57 57.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 18' ' ' PHE . 81.7 p -104.52 -60.18 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.087 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.712 HG21 ' C ' ' A' ' 7' ' ' THR . 29.6 p -127.16 -43.01 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.207 . . . . 0.0 110.762 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.48 44.62 1.05 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 28.2 t -104.81 170.06 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 108.891 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.586 ' N ' HG12 ' A' ' 106' ' ' VAL . 22.9 m -68.15 121.14 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.61 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 18.9 p-10 -70.59 -23.51 62.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 32.9 t -62.03 -30.56 71.05 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 110.355 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -65.81 -54.51 25.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.831 -1.168 . . . . 0.0 110.343 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 29.1 t80 -75.69 -53.95 7.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.035 . . . . 0.0 110.181 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 54.5 mt -56.92 -34.27 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 12.7 t -55.89 -43.14 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 0.0 109.763 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 74.8 mm-40 -71.73 -38.86 70.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.951 HG12 ' HB1' ' A' ' 71' ' ' ALA . 71.5 mt -59.54 -45.64 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 89' ' ' THR . 62.3 mtp180 -54.2 -49.09 70.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.689 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.8 m -57.85 -33.71 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 0.0 109.071 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 82.3 mt -74.53 -41.88 59.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.047 HG22 HD23 ' A' ' 85' ' ' LEU . 72.2 mt -59.24 -35.65 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.199 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.29 63.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.7 ttm -60.83 -45.1 95.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.147 . . . . 0.0 109.515 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 89.8 m-85 -58.99 -37.28 76.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -65.24 -31.66 72.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.489 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.27 -33.39 74.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.89 69.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.376 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -55.81 -36.32 67.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.881 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -66.85 -25.11 66.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 34.7 t30 -58.8 -16.19 15.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.311 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.27 -43.29 78.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.463 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.968 HG23 ' CD1' ' A' ' 131' ' ' TYR . 21.6 m -67.57 -30.13 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.968 ' CD1' HG23 ' A' ' 130' ' ' VAL . 48.9 p90 178.22 -173.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 109.11 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -77.76 113.66 15.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 134' ' ' ALA . 33.1 t -107.59 139.43 42.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' SER . . . 48.32 96.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.552 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.41 74.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.1 p -71.82 163.81 27.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -1.126 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.493 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 65.5 m-20 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.662 ' HA ' HG21 ' A' ' 104' ' ' THR . 6.6 t -129.12 150.09 74.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HG3' ' CD2' ' A' ' 18' ' ' PHE . 42.7 Cg_endo -65.3 -31.98 51.92 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.65 2.233 . . . . 0.0 112.216 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 45.5 p90 -89.35 23.41 2.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 109.445 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.72 -33.67 8.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 108.584 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 3.2 t -116.62 161.65 18.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.542 -0.724 . . . . 0.0 109.053 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 4.5 ttpm? -72.61 -41.52 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 109.761 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.82 57.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.546 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 20.4 t30 -71.69 -33.01 68.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.96 -37.57 67.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.98 . . . . 0.0 110.064 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.683 ' HB3' ' HE1' ' A' ' 48' ' ' MET . 87.7 m-20 -56.25 -56.56 19.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.118 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.01 -42.39 62.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 48.1 t80 -58.33 -41.11 83.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.479 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.681 HG21 ' C ' ' A' ' 44' ' ' GLY . 22.1 mm -67.44 -49.34 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.16 -49.16 78.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 t -62.07 -30.76 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.06 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 16.3 t80 -66.75 -44.19 82.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 0.0 109.92 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 40' ' ' MET . 44.2 mm -71.06 -55.97 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 109.812 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -55.63 -37.54 68.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.825 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -46.25 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.823 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -62.37 -36.71 83.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 91.7 p -66.95 -22.33 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.893 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -105.38 7.18 33.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 94' ' ' ASP . 7.7 m -101.19 -73.24 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 110.241 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -107.21 0.87 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -124.83 -64.93 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -1.112 . . . . 0.0 109.736 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.701 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 34.6 m-85 44.82 72.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.206 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -59.71 165.09 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.33 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -52.28 -30.09 26.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.187 -0.945 . . . . 0.0 109.111 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.58 -36.01 80.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 81' ' ' GLN . 43.0 mt-30 -70.96 -33.11 70.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.309 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.548 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 61.8 mtt -63.63 -29.44 70.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' OG ' ' A' ' 41' ' ' SER . 86.7 tt0 -57.0 -37.26 71.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 108.913 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' HG12 ' A' ' 77' ' ' ILE . 79.3 m-20 -58.47 -31.69 68.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 23' ' ' ILE . 51.2 ttp -55.7 -31.79 62.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 108.852 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.735 ' OG ' HD12 ' A' ' 42' ' ' LEU . 85.4 p -55.64 -24.17 32.17 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.298 -0.876 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.9 mp -106.5 -25.37 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD11 ' A' ' 77' ' ' ILE . 88.3 mt -124.54 150.98 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.609 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.681 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.34 -108.36 3.54 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -53.08 -23.11 7.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -1.197 . . . . 0.0 108.709 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -68.14 -34.78 76.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.977 ' O ' HD13 ' A' ' 47' ' ' LEU . 2.4 tm? -52.32 -34.61 47.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.683 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 68.2 mtt -58.21 -37.1 74.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -31.39 71.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.41 79.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 109.27 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.483 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 61.2 mtt . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 109.372 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 51.2 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -56.56 -45.3 81.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.09 -43.79 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.942 HD21 HD11 ' A' ' 47' ' ' LEU . 13.6 tp -69.01 -40.69 78.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.667 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 41.4 t0 -48.77 -43.89 38.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.7 mtm -64.6 -37.04 86.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.548 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.09 -45.15 79.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.93 ' O ' HG13 ' A' ' 74' ' ' VAL . 92.1 t80 -52.94 -40.5 63.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.46 -44.1 88.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.648 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 87.3 p -69.27 -37.83 78.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 43' ' ' ILE . 79.8 p -70.09 -44.95 68.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 70' ' ' PHE . 11.7 m -65.97 -34.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.1 -46.26 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.65 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 72' ' ' SER . 96.4 mt-30 -58.94 -36.13 74.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 109.969 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' A' ' 43' ' ' ILE . 72.5 mt -68.81 -54.87 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.701 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.55 -40.82 33.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 110.524 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.89 -28.81 64.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 109.464 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.4 p -80.89 -20.29 42.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HB3' ' NE2' ' A' ' 36' ' ' GLN . 60.2 mm-40 -93.29 117.94 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.639 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.95 101.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.01 -36.0 4.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -64.55 92.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 123' ' ' ALA . 6.4 mp -76.11 -8.55 57.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.674 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.2 -44.27 84.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' N ' ' A' ' 88' ' ' THR . 9.9 p -70.45 -48.29 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.183 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.607 ' N ' HG13 ' A' ' 87' ' ' VAL . 53.4 m -52.37 -36.04 52.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.928 -1.108 . . . . 0.0 108.404 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.493 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 31.9 m -55.53 -49.39 72.77 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 59.6 t30 -70.74 -37.27 73.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.21 -59.21 3.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 96' ' ' LEU . 49.2 mt -62.29 -48.92 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -58.97 -51.21 71.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.607 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.872 ' HB2' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -55.3 -45.36 76.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -59.33 -44.1 92.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.21 -0.931 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 92' ' ' ILE . 2.8 mt -70.09 -33.46 71.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.0 m -65.25 -49.04 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -0.859 . . . . 0.0 109.844 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 96.8 p -66.61 -39.69 88.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 0.0 109.813 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 103' ' ' THR . . . -60.85 -40.02 91.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 109.599 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.8 m-85 -52.97 -56.47 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.568 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.8 m-85 -72.18 -32.4 66.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.421 -0.799 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 98' ' ' SER . 93.6 mm-40 -70.34 -18.77 63.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.851 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.9 p -107.12 -60.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.116 . . . . 0.0 111.2 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -127.47 -42.84 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.647 -1.283 . . . . 0.0 111.156 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 112.14 46.68 0.74 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.7 t -102.87 171.92 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -1.178 . . . . 0.0 108.984 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 106' ' ' VAL . 15.5 m -73.86 120.26 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.598 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 21.1 p-10 -72.18 -29.09 63.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' SER . 94.0 p -58.73 -43.26 90.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 110.502 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -57.11 -53.7 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 1.108 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.3 t80 -75.19 -53.55 8.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 40.9 mt -56.29 -34.33 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.8 t -55.8 -43.15 76.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.043 -1.035 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.78 -36.66 73.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.108 HD11 ' CE2' ' A' ' 111' ' ' PHE . 51.0 mt -72.3 -41.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 116' ' ' ARG . 11.8 ttp85 -54.09 -41.26 68.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.84 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.1 mt -69.61 -43.97 71.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.875 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.704 HG22 HD23 ' A' ' 85' ' ' LEU . 73.0 mt -57.89 -47.24 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.851 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.97 -27.19 64.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.2 ttm -67.62 -42.35 82.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 97.4 m-85 -59.71 -31.96 70.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.558 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.666 HG23 ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -157.98 156.3 27.9 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 40.8 Cg_endo -64.85 -35.49 44.55 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.804 2.336 . . . . 0.0 112.941 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -84.56 12.46 6.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.666 ' CB ' HG23 ' A' ' 7' ' ' THR . 2.2 m -102.36 -19.53 14.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.943 . . . . 0.0 108.757 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 66.1 m -119.63 158.06 27.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 9.0 ttpt -74.38 -40.31 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.757 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -78.91 -36.65 41.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 4.9 t-20 -72.37 -29.63 63.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 109.991 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.33 -51.24 21.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 110.308 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 13' ' ' ALA . 1.7 p30 -54.95 -46.77 75.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 16' ' ' ASP . . . -58.53 -40.56 83.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.554 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.792 ' HA ' HG21 ' A' ' 103' ' ' THR . 51.5 t80 -63.64 -37.21 86.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 109.803 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.889 HG23 ' CE1' ' A' ' 70' ' ' PHE . 25.1 mm -71.78 -37.14 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 109.691 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -68.12 -49.42 61.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -64.66 -30.67 71.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 110.186 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.918 ' CE2' HD12 ' A' ' 96' ' ' LEU . 37.9 t80 -63.35 -51.51 65.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.98 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.3 mt -60.59 -56.08 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 109.98 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m -59.67 -32.6 70.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -77.66 -45.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.865 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -67.04 -33.21 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 110.054 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.499 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 62.7 m -63.48 -27.35 69.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 7.52 31.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 110.112 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 94' ' ' ASP . 25.8 m -92.58 -77.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.963 -1.085 . . . . 0.0 110.057 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -104.08 0.6 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 4.2 m -131.13 -60.45 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -1.1 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 8.0 m-85 44.25 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 p -59.71 160.39 7.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -52.8 -41.96 64.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -57.88 -36.02 71.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.477 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 98.3 mm-40 -69.96 -32.74 71.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.325 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.499 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 65.5 mtt -63.51 -32.0 73.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.3 -45.26 88.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -55.66 -39.26 70.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.98 ' SD ' HG23 ' A' ' 23' ' ' ILE . 63.2 mtt -57.29 -32.05 66.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 108.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.556 ' OG ' HD12 ' A' ' 42' ' ' LEU . 30.3 p -70.47 -23.52 62.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.35 -0.844 . . . . 0.0 109.39 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.556 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.7 mp -88.49 -23.46 23.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.554 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.008 HG21 ' CB ' ' A' ' 73' ' ' SER . 48.6 mt -131.22 143.0 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.162 -0.961 . . . . 0.0 109.296 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.65 -83.75 0.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.574 HD21 HD12 ' A' ' 23' ' ' ILE . 91.1 m-20 -61.3 -27.09 68.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.154 -1.203 . . . . 0.0 108.358 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -68.82 -35.07 76.52 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 66' ' ' LEU . 60.3 mt -53.33 -38.24 63.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.75 . . . . 0.0 109.306 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ttt -52.79 -41.35 64.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.63 70.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.0 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.83 -38.0 85.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 109.125 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 54.9 mtt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.261 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 15.4 tp . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -55.76 -30.97 62.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.335 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.3 68.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 108.958 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 47' ' ' LEU . 10.4 tt -74.14 -45.2 50.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.256 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.578 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.4 t0 -48.66 -42.53 34.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 89.7 mtp -64.39 -45.61 86.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.598 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.59 78.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.395 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.909 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.5 t80 -53.12 -38.93 63.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.3 -39.76 74.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -68.74 -40.79 79.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 43' ' ' ILE . 8.9 m -70.05 -47.87 60.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.628 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 70' ' ' PHE . 23.0 m -57.72 -35.08 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 119' ' ' ILE . . . -72.22 -35.19 68.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.8 tt0 -74.34 -44.15 53.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.82 -47.21 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.51 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.47 -52.8 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 109.803 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.86 -29.22 64.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.166 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 27.6 t -69.61 -20.19 63.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.292 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.477 ' OE1' ' HG3' ' A' ' 36' ' ' GLN . 45.2 mt-30 -54.64 -29.93 53.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.19 80.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.1 -156.94 29.09 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.602 ' O ' HG12 ' A' ' 87' ' ' VAL . 55.9 t0 -70.45 98.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -1.213 . . . . 0.0 109.403 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.048 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.4 tt -57.6 -16.34 10.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.63 -39.06 95.22 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.7 p -69.77 -37.59 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 109.602 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 78' ' ' ALA . 44.4 m -51.58 -32.06 27.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.088 -1.008 . . . . 0.0 108.735 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.79 HG23 ' HG2' ' A' ' 116' ' ' ARG . 22.1 m -59.94 -47.31 86.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 25.9 m120 -70.86 -33.49 70.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.426 -0.796 . . . . 0.0 109.018 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -71.65 -59.32 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.767 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.717 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 54.8 mt -63.34 -42.53 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -62.86 -52.36 63.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.628 ' HB3' HG21 ' A' ' 29' ' ' THR . 34.1 t0 -55.26 -50.48 69.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 109.332 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -55.9 -45.41 78.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.918 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.97 -33.85 72.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.897 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -68.97 -49.27 59.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.0 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.5 p -62.26 -34.44 76.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.907 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.83 -42.65 73.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.3 m-85 -46.94 -54.75 9.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.545 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.4 m-85 -71.66 -32.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 110.491 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 98' ' ' SER . 64.5 mm-40 -80.58 -18.45 48.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 110.129 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 18' ' ' PHE . 54.7 p -101.45 -59.05 1.77 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 111.053 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.452 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 23.0 m -126.05 -42.67 1.86 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 110.868 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 107.64 46.69 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 107' ' ' VAL . 5.0 t -114.69 172.97 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -1.159 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.605 ' H ' HG12 ' A' ' 106' ' ' VAL . 2.8 m -73.1 120.5 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.306 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.897 ' ND2' HG23 ' A' ' 97' ' ' THR . 12.4 p30 -70.84 -24.14 62.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.615 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 24.8 t -56.07 -30.2 61.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.505 -0.747 . . . . 0.0 110.342 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.482 ' HG3' HG23 ' A' ' 107' ' ' VAL . 35.4 mmt180 -67.94 -54.61 17.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.119 . . . . 0.0 110.234 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.908 ' CD2' HD21 ' A' ' 96' ' ' LEU . 1.2 t80 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.496 HD12 ' OD1' ' A' ' 108' ' ' ASN . 52.4 mt -56.41 -29.95 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.548 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 6.0 t -58.13 -47.33 83.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 85.5 tt0 -72.22 -37.7 69.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.681 HG12 ' HB1' ' A' ' 71' ' ' ALA . 47.1 mt -56.56 -46.29 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.917 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG23 ' A' ' 89' ' ' THR . 74.3 mtt180 -54.41 -49.12 70.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -59.17 -33.34 70.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.0 109.004 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 83.8 mt -73.75 -40.85 63.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.461 -0.774 . . . . 0.0 110.232 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.839 HG22 HD21 ' A' ' 85' ' ' LEU . 56.9 mt -61.08 -34.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 0.0 109.595 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.9 -32.45 70.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -65.64 -42.59 91.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.426 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 96.2 m-85 -63.23 -29.03 70.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.048 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 16.7 m120 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.557 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 4.5 t -143.5 152.51 56.96 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.127 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 42.6 Cg_endo -65.04 -35.4 42.88 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.466 2.111 . . . . 0.0 112.787 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.716 ' O ' HD22 ' A' ' 63' ' ' LEU . 49.5 p90 -80.82 7.25 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.626 -1.296 . . . . 0.0 109.737 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.9 OUTLIER -92.31 -20.57 20.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 108.718 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -136.69 144.66 44.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 108.949 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 22.1 mtmm -60.42 -46.43 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.3 71.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.355 -0.841 . . . . 0.0 109.476 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 14.1 m120 -72.36 -38.43 68.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -69.39 -51.8 33.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 48' ' ' MET . 17.2 m-20 -54.37 -51.11 65.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.29 91.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 108.7 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.517 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 58.8 t80 -58.56 -37.23 75.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.435 -0.791 . . . . 0.0 109.534 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.773 HD12 ' CD1' ' A' ' 70' ' ' PHE . 20.8 mm -71.01 -37.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -68.51 -50.02 55.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 34.4 t80 -65.12 -49.13 71.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 110.207 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.713 HD12 HD21 ' A' ' 45' ' ' ASN . 77.2 mt -61.99 -56.18 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -60.21 -32.12 70.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.913 . . . . 0.0 109.868 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.84 -44.46 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.096 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -69.97 -29.27 66.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.243 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -64.68 -28.5 69.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.963 . . . . 0.0 110.13 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.9 7.49 32.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 20.1 m -90.72 -78.5 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 -103.33 0.39 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.9 t -131.24 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -1.132 . . . . 0.0 109.445 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 12.5 m-85 43.73 88.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.315 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.2 m -59.73 161.05 6.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -52.64 -36.57 56.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.61 -36.05 83.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 99.8 mm-40 -71.91 -33.97 68.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 109.283 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.64 -33.71 76.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.08 -47.25 85.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.463 ' ND2' HG12 ' A' ' 77' ' ' ILE . 34.5 t-20 -55.65 -40.71 72.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.578 ' HE2' HG12 ' A' ' 23' ' ' ILE . 83.1 mtp -61.49 -31.85 71.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 109.11 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 m -70.3 -23.94 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.491 ' N ' HD22 ' A' ' 42' ' ' LEU . 4.2 mm? -90.55 -23.26 20.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.922 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.636 HG21 ' CB ' ' A' ' 73' ' ' SER . 64.0 mt -125.0 157.01 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.583 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.704 ' HA2' HD12 ' A' ' 47' ' ' LEU . . . 89.42 -83.85 1.41 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.726 ' OD1' HG22 ' A' ' 19' ' ' ILE . 92.5 m-20 -62.67 -33.87 75.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -1.217 . . . . 0.0 109.009 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -60.51 -35.28 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.362 -0.836 . . . . 0.0 109.232 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.704 HD12 ' HA2' ' A' ' 44' ' ' GLY . 6.5 mt -57.28 -35.77 70.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 0.0 109.46 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.44 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 69.7 mtm -52.84 -39.92 62.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.274 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.49 -32.93 72.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.875 . . . . 0.0 109.182 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.18 72.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.84 . . . . 0.0 109.206 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.462 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 64.6 mtt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.257 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 9' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -54.61 -40.11 68.56 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.359 -0.838 . . . . 0.0 108.955 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.85 68.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 108.959 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tp -73.51 -46.65 46.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.279 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.505 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 31.0 t0 -48.08 -46.79 34.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 109.732 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.55 -38.43 81.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 109.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.75 76.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.517 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 19' ' ' ILE . 84.1 t80 -55.23 -35.36 64.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.03 -37.33 85.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.805 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.6 m -67.77 -31.56 71.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.822 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.636 ' CB ' HG21 ' A' ' 43' ' ' ILE . 92.5 p -69.3 -49.12 58.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HD11 ' A' ' 92' ' ' ILE . 35.3 m -60.82 -35.01 61.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.436 -0.79 . . . . 0.0 109.982 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.57 -47.56 39.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.471 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.3 mt-30 -64.73 -50.47 66.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.887 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.505 HD13 ' HG2' ' A' ' 40' ' ' MET . 79.2 mt -55.01 -50.84 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 109.907 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.612 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -74.9 -51.86 12.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.815 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.92 -30.81 66.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 92.2 p -72.66 -20.47 61.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.432 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.592 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 83.3 mt-30 -49.3 -40.52 35.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.918 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.15 5.19 66.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.05 -155.39 27.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' HG12 ' A' ' 87' ' ' VAL . 53.8 t0 -66.06 105.39 1.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -1.088 . . . . 0.0 109.376 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 119' ' ' ILE . 23.7 tp -67.75 -14.01 62.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.03 -32.41 66.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.2 p -69.88 -35.71 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -1.174 . . . . 0.0 109.527 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 92' ' ' ILE . 73.7 m -51.59 -32.4 28.47 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.1 -1.0 . . . . 0.0 108.679 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 62.8 m -58.65 -46.62 86.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 79.7 m-20 -70.78 -38.24 73.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.467 -0.771 . . . . 0.0 109.096 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -68.32 -56.07 9.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.904 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.76 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 61.4 mt -66.7 -44.05 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.761 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -64.49 -50.85 65.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 109.892 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.2 m-20 -55.32 -43.13 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.946 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -67.91 -40.79 83.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.283 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -70.11 -34.54 73.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.804 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.674 HG23 ' ND2' ' A' ' 108' ' ' ASN . 55.3 m -67.64 -51.13 53.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.03 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 t -60.14 -35.29 74.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 109.887 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.85 -43.29 72.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -47.1 -54.97 9.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.027 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.3 m-85 -71.84 -32.69 67.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.468 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 98' ' ' SER . 96.5 mm-40 -75.9 -18.46 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.217 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 99' ' ' ALA . 55.9 p -104.77 -59.57 1.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.907 -1.12 . . . . 0.0 110.996 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 106' ' ' VAL . 25.6 p -126.41 -42.81 1.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.702 -1.249 . . . . 0.0 110.921 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.61 46.6 0.96 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.94 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.671 HG23 ' OG1' ' A' ' 104' ' ' THR . 5.7 t -108.22 172.44 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.188 -1.183 . . . . 0.0 109.101 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.593 ' H ' HG12 ' A' ' 106' ' ' VAL . 11.3 m -73.4 120.77 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.674 ' ND2' HG23 ' A' ' 97' ' ' THR . 14.4 p30 -71.35 -24.09 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.818 . . . . 0.0 109.779 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 113' ' ' SER . 50.2 m -60.18 -30.66 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 110.332 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -68.31 -54.76 15.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.363 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 115' ' ' ILE . 33.1 t80 -75.75 -50.39 15.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.046 -1.034 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.633 HG21 ' HB1' ' A' ' 93' ' ' ALA . 34.4 mt -56.43 -39.09 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.27 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' SER . 22.1 m -59.89 -38.53 82.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.45 -39.83 85.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.411 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 111' ' ' PHE . 84.7 mt -70.82 -42.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 16.4 ttt180 -54.34 -42.87 70.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -73.0 -33.76 65.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.964 . . . . 0.0 109.664 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.7 mt -68.93 -42.4 76.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.808 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' A' ' 85' ' ' LEU . 61.9 mt -57.66 -39.65 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.68 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.59 -28.31 73.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -69.09 -36.76 77.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 109.548 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.27 -35.43 80.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.559 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 68.3 m-20 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.944 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -133.77 151.69 77.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD2' HG22 ' A' ' 7' ' ' THR . 46.5 Cg_endo -67.78 -31.49 31.95 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.73 2.287 . . . . 0.0 111.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.817 ' O ' HD22 ' A' ' 63' ' ' LEU . 40.1 p90 -96.24 -14.26 22.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 m -70.03 -7.22 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -139.6 151.44 46.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -71.13 -40.28 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.567 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.16 -34.58 61.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.349 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 54.3 m-20 -71.56 -29.37 64.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -69.62 -40.85 76.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.775 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -58.73 -56.42 22.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 21' ' ' SER . . . -55.56 -36.17 66.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 8' ' ' PRO . 68.0 t80 -68.01 -48.88 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.092 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' A' ' 70' ' ' PHE . 41.1 mt -66.5 -44.54 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.36 -50.71 51.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.129 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 30.3 t -58.26 -30.31 66.48 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.867 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -72.31 -50.89 23.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.504 -0.748 . . . . 0.0 109.549 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 19' ' ' ILE . 72.1 mt -62.93 -55.91 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 m -57.19 -35.2 69.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.62 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.83 -48.3 16.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 32' ' ' PHE . . . -61.76 -34.61 76.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.775 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 19.3 m -64.1 -27.92 69.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.725 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.93 7.18 31.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.99 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.2 m -91.91 -75.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.081 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 -104.02 0.78 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -132.34 -58.65 0.94 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.37 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 7.5 m-85 44.19 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -59.59 162.89 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -52.66 -38.15 59.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.21 -37.8 84.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.281 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.541 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 72.3 mt-30 -68.24 -35.43 77.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.313 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.508 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 64.8 mtt -64.32 -36.8 85.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.48 -46.89 85.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.145 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -58.83 -41.21 86.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 43' ' ' ILE . 80.0 mtp -64.96 -32.05 73.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 m -69.99 -24.04 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -95.44 -17.16 21.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 80.8 mt -126.39 161.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -0.999 . . . . 0.0 109.509 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.514 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -79.98 1.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.48 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -1.116 . . . . 0.0 109.03 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -61.17 -35.36 76.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 0.0 109.038 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 HD23 ' A' ' 66' ' ' LEU . 24.7 tp -56.12 -36.19 67.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.848 . . . . 0.0 109.223 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.438 ' CG ' HD12 ' A' ' 19' ' ' ILE . 93.4 mmm -55.74 -33.01 63.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.13 79.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.96 . . . . 0.0 109.064 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.76 81.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 75.5 mmm . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.079 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.817 HD22 ' O ' ' A' ' 9' ' ' TRP . 3.7 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . 63.4 tt0 -54.28 -45.58 72.52 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.21 63.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 108.917 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.716 HD23 HD21 ' A' ' 47' ' ' LEU . 1.6 mt -73.93 -53.9 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.543 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 9' ' ' TRP . 0.8 OUTLIER -48.47 -39.06 21.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.727 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.429 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 92.7 mtp -67.37 -47.35 70.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.23 -44.4 75.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.841 ' CE1' HG23 ' A' ' 19' ' ' ILE . 82.7 t80 -54.17 -40.59 67.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.984 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -59.85 -40.96 90.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.5 t -69.47 -30.63 68.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 43' ' ' ILE . 36.4 m -70.02 -49.57 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 22' ' ' PHE . 10.8 m -62.72 -38.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.64 -48.21 34.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.921 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.56 -42.65 92.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 73' ' ' SER . 83.5 mt -61.96 -55.04 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.004 . . . . 0.0 109.984 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.84 -47.2 26.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.45 -0.781 . . . . 0.0 110.184 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 122' ' ' PHE . . . -57.78 -23.85 54.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.8 m -83.04 -20.58 34.73 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.541 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 22.2 tp60 -136.89 104.73 5.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.99 103.62 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.45 93.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 87' ' ' VAL . 82.8 m-20 -106.56 82.15 1.68 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -1.17 . . . . 0.0 109.141 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 123' ' ' ALA . 6.3 tp -43.64 -26.31 0.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 84' ' ' ASP . . . -61.92 -33.19 84.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.2 p -69.73 -44.52 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.235 . . . . 0.0 109.656 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 92' ' ' ILE . 84.5 m -51.85 -34.98 43.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 108.535 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 1.1 m -56.71 -49.23 75.77 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 76.4 m-20 -70.92 -40.79 71.9 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.39 -0.819 . . . . 0.0 109.065 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -63.31 -53.23 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.389 -0.82 . . . . 0.0 109.922 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 96' ' ' LEU . 66.4 mt -72.48 -48.99 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.963 . . . . 0.0 109.952 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.83 -46.74 88.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.907 . . . . 0.0 110.248 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' THR . 89.2 m-20 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.18 -41.54 84.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.868 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 92' ' ' ILE . 5.2 mt -69.64 -39.3 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.717 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 108' ' ' ASN . 38.5 m -61.51 -53.5 55.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.927 . . . . 0.0 110.185 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 m -62.82 -38.29 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 109.944 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -62.36 -45.69 92.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.612 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.69 -56.21 7.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.75 -32.27 67.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 98' ' ' SER . 79.0 mm-40 -77.37 -18.63 57.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 99' ' ' ALA . 74.1 p -104.66 -60.22 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.978 -1.076 . . . . 0.0 110.913 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.93 HG21 ' C ' ' A' ' 7' ' ' THR . 19.0 p -127.03 -42.75 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.783 -1.198 . . . . 0.0 110.871 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.09 47.02 0.9 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.675 HG23 ' OG1' ' A' ' 104' ' ' THR . 16.6 t -106.58 172.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.175 -1.191 . . . . 0.0 108.944 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -71.47 119.67 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' A' ' 97' ' ' THR . 22.6 p-10 -72.1 -31.68 66.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 113' ' ' SER . 14.9 t -57.44 -44.48 84.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -0.817 . . . . 0.0 110.481 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -57.36 -53.55 56.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.992 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.6 t80 -74.67 -53.94 8.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.978 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 93' ' ' ALA . 28.9 mt -56.34 -37.51 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.078 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' SER . 19.2 m -55.79 -48.54 75.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.065 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.96 -42.58 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.08 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.984 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.5 mt -70.97 -34.62 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 17.8 ttt180 -54.03 -45.73 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 109.398 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.26 -33.9 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.468 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 115' ' ' ILE . 19.2 mt -65.88 -41.08 92.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.799 HG22 HD11 ' A' ' 85' ' ' LEU . 99.0 mt -57.82 -37.13 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.18 -34.26 64.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.9 -38.09 89.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -1.167 . . . . 0.0 109.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 72.0 m-85 -69.97 -38.25 76.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 106' ' ' VAL . 25.4 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 9' ' ' TRP . 0.5 OUTLIER -165.11 156.48 12.92 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 38.4 Cg_endo -61.85 -32.25 85.43 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.561 2.174 . . . . 0.0 112.171 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 19.0 p90 -84.15 9.86 11.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 7' ' ' THR . 5.4 t -99.86 -22.75 15.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 0.0 108.763 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.459 ' HB2' ' CG ' ' A' ' 14' ' ' ASN . 69.9 m -118.89 157.74 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.468 -0.77 . . . . 0.0 109.113 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 24.1 ttpt -74.25 -40.71 62.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.943 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.19 -35.3 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 1.6 m-20 -72.24 -32.55 66.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.61 -47.21 49.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.087 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 68.1 m-20 -54.75 -56.31 20.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.86 . . . . 0.0 109.909 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.9 66.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.111 -0.993 . . . . 0.0 109.159 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 81.5 t80 -62.11 -41.1 97.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.288 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.768 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.8 mm -69.34 -49.11 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 16' ' ' ASP . 39.8 m-80 -62.03 -49.75 74.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -59.04 -34.91 72.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.751 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 16.6 t80 -67.14 -36.01 80.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.0 110.161 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 19' ' ' ILE . 66.1 mt -70.13 -56.03 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.17 -0.957 . . . . 0.0 110.315 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -62.7 -33.49 75.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -44.6 26.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.612 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.8 -29.36 64.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.031 -1.043 . . . . 0.0 110.444 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 2.3 t -60.92 -30.87 70.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.0 110.553 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -106.1 7.4 31.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.012 . . . . 0.0 110.682 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.816 HG21 ' CB ' ' A' ' 94' ' ' ASP . 13.3 m -91.54 -73.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 110.607 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -76.1 -105.4 0.13 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' PHE . 18.1 m -149.46 13.37 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.461 -1.023 . . . . 0.0 109.805 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 66.0 m-85 -39.77 109.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.1 p -72.21 164.22 26.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -53.29 -35.77 60.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.159 -0.963 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -68.05 -47.17 69.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 32' ' ' PHE . 68.9 mt-30 -64.7 -33.89 77.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 40' ' ' MET . 92.9 mmm -64.31 -30.13 71.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.03 -40.18 76.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.12 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.15 -42.22 85.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.218 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.708 ' HG3' HD13 ' A' ' 77' ' ' ILE . 58.0 mtt -57.38 -39.06 75.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 109.011 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.3 p -70.42 -23.54 62.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.406 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 tp -87.24 -13.78 42.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.743 HG21 ' CB ' ' A' ' 73' ' ' SER . 61.9 mt -133.45 168.02 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.597 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 66.53 -68.85 0.16 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ILE . 36.0 t-20 -60.76 -38.94 86.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.228 -1.16 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 m -62.38 -35.62 79.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 0.0 109.051 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 66' ' ' LEU . 8.7 mp -53.9 -37.49 63.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.731 ' O ' ' HE2' ' A' ' 51' ' ' MET . 60.7 mtm -52.75 -39.85 62.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.249 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.38 73.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.898 . . . . 0.0 109.041 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.12 -25.97 68.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.363 -0.835 . . . . 0.0 109.246 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.731 ' HE2' ' O ' ' A' ' 48' ' ' MET . 57.0 mtm . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 15.0 tp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -55.05 -29.77 58.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.062 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.79 90.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.287 -0.883 . . . . 0.0 109.078 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 47' ' ' LEU . 9.4 tt -69.07 -38.16 78.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.119 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 48.2 t0 -50.55 -48.81 57.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.557 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.45 -40.44 97.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 109.794 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.53 76.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.785 ' O ' HG13 ' A' ' 74' ' ' VAL . 77.2 t80 -55.71 -35.69 66.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.712 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.56 -36.93 83.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -69.32 -35.67 76.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.764 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.743 ' CB ' HG21 ' A' ' 43' ' ' ILE . 52.8 p -70.2 -49.83 46.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 109.821 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 70' ' ' PHE . 4.2 m -58.42 -34.94 52.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.73 -38.87 67.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.677 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.04 -49.88 58.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.176 -0.953 . . . . 0.0 109.763 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' HG3' ' A' ' 40' ' ' MET . 74.8 mt -55.18 -54.59 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.756 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -69.35 -50.81 42.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 109.855 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 1.029 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.95 -23.91 55.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.261 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.5 t -81.16 -20.3 41.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.622 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 85.1 mt-30 -48.37 -37.28 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 9.57 71.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.94 -175.82 22.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 87' ' ' VAL . 23.9 t0 -55.29 123.97 15.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -1.135 . . . . 0.0 109.363 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.029 HD11 ' HA ' ' A' ' 79' ' ' ALA . 1.1 tp -75.79 -19.03 59.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.596 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.23 -38.45 77.84 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.5 p -70.69 -41.07 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -1.195 . . . . 0.0 109.82 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.482 ' N ' HG13 ' A' ' 87' ' ' VAL . 25.8 m -51.65 -33.72 34.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.051 -1.031 . . . . 0.0 108.812 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.8 p -58.51 -46.17 87.29 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 26.5 m120 -70.82 -38.25 73.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.711 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -66.29 -58.95 4.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.143 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.751 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 22.8 mm -62.08 -43.77 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.625 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.45 -44.93 85.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 110.697 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 29' ' ' THR . 31.8 t0 -55.02 -54.07 47.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.879 -1.138 . . . . 0.0 109.789 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -64.08 -35.82 82.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.14 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.873 HD21 ' CD2' ' A' ' 111' ' ' PHE . 6.0 tp -69.94 -40.23 75.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.603 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.693 HG23 HD22 ' A' ' 108' ' ' ASN . 18.4 m -69.11 -52.6 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 16.8 m -60.27 -35.35 75.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.727 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -67.72 -39.33 84.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -53.41 -53.37 52.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -71.6 -32.08 67.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.502 -0.749 . . . . 0.0 110.465 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 98' ' ' SER . 70.6 mm-40 -78.84 -18.5 53.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 18' ' ' PHE . 66.1 p -102.72 -59.35 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.0 111.108 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.2 m -126.23 -42.54 1.84 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.882 -1.136 . . . . 0.0 110.707 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.58 47.92 1.01 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 6' ' ' ASN . 6.5 t -112.85 172.61 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -1.122 . . . . 0.0 109.322 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 110' ' ' ARG . 5.4 m -72.3 121.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.693 HD22 HG23 ' A' ' 97' ' ' THR . 16.7 p30 -69.9 -23.35 63.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 97.9 p -54.7 -30.6 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.592 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.788 ' HG3' HG23 ' A' ' 107' ' ' VAL . 23.6 mtp-105 -67.42 -55.01 15.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.873 ' CD2' HD21 ' A' ' 96' ' ' LEU . 3.0 t80 -75.8 -51.03 13.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.654 ' CG1' HD23 ' A' ' 96' ' ' LEU . 43.7 mt -56.39 -42.23 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 110.412 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' SER . 55.9 m -59.34 -35.26 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 109.677 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.7 mt-10 -72.65 -47.37 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.712 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -66.24 -40.67 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 109.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -54.37 -46.37 73.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 t -72.31 -34.22 67.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.62 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 118' ' ' LEU . 29.5 mt -68.77 -42.01 78.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' CD2' ' A' ' 85' ' ' LEU . 76.7 mt -59.61 -43.01 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.34 93.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.6 ttp -54.47 -44.26 72.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.576 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 98.4 m-85 -59.28 -38.92 81.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.805 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.694 ' C ' HG21 ' A' ' 104' ' ' THR . 72.9 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.629 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -147.54 145.37 21.33 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.1 Cg_endo -70.8 -35.39 9.67 Favored 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.401 2.067 . . . . 0.0 111.724 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.878 ' O ' HD23 ' A' ' 63' ' ' LEU . 41.8 p90 -85.72 -26.28 25.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.868 -1.145 . . . . 0.0 109.155 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.413 ' CB ' ' HG1' ' A' ' 7' ' ' THR . 88.2 p -62.8 -12.09 22.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 79.4 p -129.66 150.12 51.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.125 -0.984 . . . . 0.0 109.336 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 16.4 ttpt -74.36 -37.68 63.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.948 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.96 -50.12 63.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 109.191 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.3 m120 -72.42 -28.93 63.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.563 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -63.73 -44.3 93.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' CE ' ' A' ' 48' ' ' MET . 18.8 t0 -68.59 -50.98 47.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.88 . . . . 0.0 109.628 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.29 75.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.554 ' CA ' HG21 ' A' ' 103' ' ' THR . 73.5 t80 -58.89 -37.23 76.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 70' ' ' PHE . 44.0 mt -74.73 -37.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.761 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -68.48 -50.55 51.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.772 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 31.3 t -60.74 -29.18 69.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.342 -0.849 . . . . 0.0 109.102 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.931 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 14.0 t80 -66.55 -51.1 60.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.017 HD12 ' HB3' ' A' ' 40' ' ' MET . 34.5 mm -64.56 -55.74 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.863 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t -60.29 -34.29 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 110.094 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.36 -45.22 26.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.982 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.33 73.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.91 . . . . 0.0 110.026 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 37.8 m -63.68 -28.46 69.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.088 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -106.25 7.14 31.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.086 -1.009 . . . . 0.0 110.311 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.604 HG21 ' CB ' ' A' ' 94' ' ' ASP . 21.0 m -91.48 -76.64 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.996 -1.065 . . . . 0.0 110.081 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 -104.2 0.57 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.5 t -134.21 -58.27 0.84 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.2 m-85 44.0 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 109.34 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -59.67 157.66 11.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -52.52 -30.8 32.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -71.48 -36.0 70.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.319 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 95.2 mm-40 -72.71 -32.29 65.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.26 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.438 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 64.5 mtt -63.96 -30.36 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.182 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.49 -44.3 84.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.699 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.3 m-20 -55.67 -42.07 74.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.955 . . . . 0.0 109.051 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.017 ' HB3' HD12 ' A' ' 23' ' ' ILE . 64.4 mtt -59.66 -32.08 70.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 p -70.27 -23.72 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.478 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 43' ' ' ILE . 73.7 mt -91.53 -19.92 22.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.927 HG21 ' HB3' ' A' ' 73' ' ' SER . 19.3 mm -129.04 151.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 86.25 -85.06 1.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.472 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 61.8 t-20 -59.88 -33.33 71.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -1.151 . . . . 0.0 108.533 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -63.06 -35.12 79.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 66' ' ' LEU . 60.1 mt -56.74 -35.1 68.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 45' ' ' ASN . 56.4 mtt -52.64 -40.91 63.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.047 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.57 73.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.67 81.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.364 -0.835 . . . . 0.0 109.09 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 67.5 mtt . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.878 HD23 ' O ' ' A' ' 9' ' ' TRP . 3.6 mp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.304 0.573 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 68' ' ' MET . 48.8 tt0 -54.15 -46.45 72.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 108.686 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.62 -40.92 66.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.139 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 HD13 ' A' ' 47' ' ' LEU . 32.2 tp -66.49 -52.24 48.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.8 t0 -47.36 -33.42 5.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 90.9 mtp -71.78 -37.29 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.62 -42.28 87.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.642 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.5 t80 -54.98 -37.81 67.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.006 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.66 -42.09 71.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.866 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -68.62 -30.78 69.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.943 . . . . 0.0 109.943 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.927 ' HB3' HG21 ' A' ' 43' ' ' ILE . 26.2 m -69.96 -49.12 54.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.722 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 71' ' ' ALA . 35.5 m -58.48 -34.96 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -68.75 -38.7 80.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -72.12 -44.13 63.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 39' ' ' ASN . 89.6 mt -54.07 -53.29 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.671 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -75.38 -49.28 19.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.842 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.93 -21.07 42.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 109.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 93.3 p -81.72 -20.2 39.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.256 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 72.3 mt-30 -51.79 -33.77 36.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.38 67.4 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.24 -175.62 33.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 87' ' ' VAL . 32.1 t0 -63.09 122.4 16.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.982 HD22 ' HB2' ' A' ' 123' ' ' ALA . 5.7 mp -71.33 -16.18 62.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.77 -47.75 69.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 88' ' ' THR . 9.8 p -70.47 -46.23 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.302 -1.116 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.605 ' N ' HG13 ' A' ' 87' ' ' VAL . 11.5 m -51.52 -36.27 44.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.075 -1.016 . . . . 0.0 108.393 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 55.0 m -54.96 -46.96 75.09 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.7 m-20 -70.79 -41.55 71.51 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -62.2 -58.77 6.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.615 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.811 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 40.6 mt -64.56 -41.66 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -66.14 -44.54 83.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -0.934 . . . . 0.0 109.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.604 ' CB ' HG21 ' A' ' 29' ' ' THR . 44.0 t0 -55.08 -50.87 68.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 109.473 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -54.7 -44.15 73.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.887 . . . . 0.0 109.232 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 93' ' ' ALA . 5.2 mt -69.88 -38.68 76.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.209 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.657 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.4 m -62.3 -46.56 88.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.803 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 7.8 m -70.62 -49.18 50.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.35 -44.99 68.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.61 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.11 -55.22 8.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.238 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 97' ' ' THR . 1.9 m-85 -71.97 -31.81 66.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.504 -0.747 . . . . 0.0 109.594 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' SER . 41.9 mt-30 -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.272 -0.893 . . . . 0.0 109.843 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 99' ' ' ALA . 69.8 p -105.94 -60.35 1.65 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.334 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.694 HG21 ' C ' ' A' ' 6' ' ' ASN . 17.1 m -126.92 -42.7 1.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.877 -1.139 . . . . 0.0 110.645 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.21 46.14 1.03 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.3 t -105.69 172.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.306 -1.114 . . . . 0.0 109.053 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 106' ' ' VAL . 23.0 m -73.55 121.01 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.348 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.657 ' ND2' HG23 ' A' ' 97' ' ' THR . 10.5 p30 -71.41 -28.35 63.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 113' ' ' SER . 22.9 t -56.93 -44.65 82.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -56.92 -54.15 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.973 -1.079 . . . . 0.0 109.975 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 69.1 t80 -75.58 -52.13 11.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.537 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.8 mt -56.67 -35.74 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 109' ' ' SER . 42.3 t -58.93 -30.25 67.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.94 -41.74 64.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.006 HG12 ' HB1' ' A' ' 71' ' ' ALA . 93.1 mt -72.59 -39.45 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -54.21 -43.16 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.6 p -72.23 -33.92 67.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -68.61 -45.24 72.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.865 HG22 HD23 ' A' ' 85' ' ' LEU . 64.9 mt -57.86 -44.88 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.22 -34.57 67.53 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.7 ttm -66.96 -42.33 85.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 109.467 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -64.66 -32.35 73.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.982 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.479 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 m120 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -129.85 163.68 45.48 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 49.9 Cg_endo -83.95 -34.23 0.28 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 C-N-CA 122.526 2.15 . . . . 0.0 111.626 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.606 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.4 p90 -90.27 -23.27 21.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.902 -1.124 . . . . 0.0 109.488 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -60.87 -12.57 11.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 70.5 m -132.01 153.67 50.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.583 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 28.9 mtmt -73.88 -39.19 64.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -65.92 -50.33 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.752 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 17.1 m120 -72.21 -29.06 63.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.35 -55.17 8.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.007 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 1.8 p30 -55.03 -46.8 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.507 -0.746 . . . . 0.0 109.882 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.44 -39.82 94.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 80.7 t80 -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 109.419 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' ALA . 33.2 mm -71.03 -44.07 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -65.42 -45.2 84.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 t -67.11 -30.72 70.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.884 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -66.31 -46.83 75.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.151 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 40' ' ' MET . 30.5 mm -64.89 -56.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.522 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 m -60.85 -31.9 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.98 . . . . 0.0 109.919 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -45.45 24.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.06 -34.1 76.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.362 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 m -57.35 -33.52 67.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.322 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -106.06 7.36 31.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.128 -0.983 . . . . 0.0 110.687 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.659 HG21 ' CB ' ' A' ' 94' ' ' ASP . 43.5 m -85.89 -81.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.801 -1.187 . . . . 0.0 110.201 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.14 -101.12 0.24 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -132.46 -61.51 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -1.059 . . . . 0.0 109.212 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.8 m-85 43.94 91.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.307 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.417 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 53.7 p -59.61 161.28 6.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.61 -40.72 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.84 -36.21 76.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.472 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.3 mm-40 -73.2 -32.28 64.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.66 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.6 mtt -63.23 -34.18 77.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.0 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.43 -43.11 91.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.855 . . . . 0.0 109.038 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -59.76 -42.58 93.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.912 ' HB3' HD12 ' A' ' 23' ' ' ILE . 75.1 mtm -66.75 -32.72 74.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.135 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.4 t -70.25 -24.02 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 17.0 tp -87.92 -22.81 24.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB2' ' A' ' 73' ' ' SER . 37.9 mm -116.15 162.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 90.83 -80.33 1.36 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.0 -38.14 78.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.7 m -60.17 -35.33 75.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.354 -0.841 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 66' ' ' LEU . 26.9 tp -59.52 -33.94 72.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.247 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 16' ' ' ASP . 60.3 mmm -56.65 -28.14 59.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.31 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.41 86.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.112 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -22.77 50.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.243 -0.911 . . . . 0.0 108.9 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.543 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 16.6 ttm . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.103 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 5.6 tp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.063 0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -54.68 -35.01 63.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 108.73 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -68.45 -43.56 76.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 27.0 t0 -48.57 -34.88 12.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.787 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.5 -37.31 77.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.91 . . . . 0.0 109.931 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.9 65.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.7 t80 -67.01 -35.92 80.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.786 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 25.2 t -69.69 -41.71 75.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 110.023 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB2' HG21 ' A' ' 43' ' ' ILE . 58.0 p -70.09 -47.12 63.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 110.28 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.2 m -57.2 -37.05 54.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.802 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' N ' HG23 ' A' ' 74' ' ' VAL . . . -73.92 -38.32 64.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 0.0 109.819 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 72' ' ' SER . 94.4 mt-30 -70.27 -46.23 64.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.828 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.438 HG21 ' HG3' ' A' ' 40' ' ' MET . 97.2 mt -56.2 -44.74 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 0.0 109.885 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.36 -50.14 12.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.896 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.13 48.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.8 m -76.2 -20.26 57.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.937 . . . . 0.0 109.457 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.6 mt-30 -55.86 -33.16 64.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.672 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.73 21.82 73.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.48 -149.41 19.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.04 120.65 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.016 HD11 HG22 ' A' ' 119' ' ' ILE . 5.3 tp -67.69 -18.46 64.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.287 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -28.36 70.25 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.86 -50.06 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -1.164 . . . . 0.0 109.569 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 92' ' ' ILE . 59.6 m -52.32 -49.52 64.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 56.9 m -51.68 -48.85 63.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.8 m-20 -70.86 -32.11 69.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -77.98 -59.04 2.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.763 HG22 HD11 ' A' ' 96' ' ' LEU . 31.3 mt -61.27 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.879 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.107 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.659 ' CB ' HG21 ' A' ' 29' ' ' THR . 42.9 t0 -55.14 -53.62 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.884 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.98 -42.98 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.763 HD11 HG22 ' A' ' 92' ' ' ILE . 6.7 mt -69.47 -40.52 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.748 HG23 HD22 ' A' ' 108' ' ' ASN . 76.0 m -62.77 -51.98 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.0 m -62.97 -36.61 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.602 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.78 -42.81 73.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.671 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.7 m-85 -47.3 -55.98 7.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.53 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.4 m-85 -71.06 -32.17 68.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 98' ' ' SER . 89.5 mm-40 -78.56 -18.36 54.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 18' ' ' PHE . 72.4 p -102.55 -59.97 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 111.149 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.598 HG21 ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.03 -42.36 1.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.779 -1.2 . . . . 0.0 110.807 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.34 47.93 0.9 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 107' ' ' VAL . 21.5 t -113.25 169.14 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.299 -1.118 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.581 HG23 ' CG ' ' A' ' 110' ' ' ARG . 15.8 m -67.43 121.22 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.856 . . . . 0.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.748 HD22 HG23 ' A' ' 97' ' ' THR . 11.6 p30 -71.14 -23.63 62.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 113' ' ' SER . 91.3 p -59.29 -33.34 70.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 110.794 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.581 ' CG ' HG23 ' A' ' 107' ' ' VAL . 78.2 mmt-85 -64.1 -55.42 22.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.742 -1.224 . . . . 0.0 110.33 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.2 t80 -76.28 -49.67 16.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.566 HG21 ' HB1' ' A' ' 93' ' ' ALA . 16.2 mt -56.65 -36.71 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 109' ' ' SER . 78.9 p -63.44 -34.79 78.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.04 -1.037 . . . . 0.0 109.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.31 -39.75 74.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.033 HD11 ' CE2' ' A' ' 111' ' ' PHE . 54.3 mt -72.77 -41.99 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -54.46 -42.38 70.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.4 t -72.01 -33.84 68.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.667 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 41.7 mt -68.36 -42.21 79.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.016 HG22 HD11 ' A' ' 85' ' ' LEU . 62.6 mt -58.51 -41.55 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -66.67 -30.85 76.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -66.99 -39.48 87.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.595 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.433 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 72.3 m-85 -60.59 -52.06 66.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.555 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.552 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.757 ' O ' HG21 ' A' ' 106' ' ' VAL . 76.4 m-20 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -165.11 145.35 5.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.9 Cg_endo -70.25 -35.12 11.73 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.414 2.076 . . . . 0.0 111.728 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.865 ' O ' HD13 ' A' ' 63' ' ' LEU . 39.5 p90 -85.58 -30.89 22.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 109.058 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.9 p -58.8 -15.09 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 109.57 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 51.0 m -127.15 143.69 51.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 109.343 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 4.0 ttpp -71.64 -37.14 70.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -68.45 -48.08 65.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 108.994 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 12.3 m120 -71.56 -28.93 64.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.38 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.23 -41.57 99.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.822 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.8 p30 -68.71 -50.12 53.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -56.57 -37.42 70.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.89 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.627 ' CA ' HG21 ' A' ' 103' ' ' THR . 69.3 t80 -65.78 -49.36 68.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.02 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.828 HG23 ' HE1' ' A' ' 70' ' ' PHE . 42.0 mt -63.14 -46.94 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -67.75 -50.3 57.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 108.945 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 69.4 m -56.11 -30.04 61.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 108.593 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 92' ' ' ILE . 46.8 t80 -71.44 -52.2 19.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.538 -0.726 . . . . 0.0 109.624 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 ' HE2' ' A' ' 40' ' ' MET . 56.8 mt -62.62 -55.74 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -53.76 -40.3 66.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.863 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.85 -46.0 22.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.088 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -60.42 -30.64 69.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 17.4 m -64.75 -31.4 72.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.968 . . . . 0.0 110.014 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -105.96 7.35 32.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' HB3' ' A' ' 94' ' ' ASP . 19.3 m -88.68 -75.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.95 -1.094 . . . . 0.0 110.054 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -88.49 -102.2 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -138.13 -55.64 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -1.115 . . . . 0.0 109.353 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.9 m-85 43.84 87.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.158 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.8 p -59.76 161.24 6.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.66 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -52.62 -31.95 39.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.143 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.113 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.502 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 82.3 mm-40 -76.19 -34.61 59.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 109.233 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 71.5 mtp -63.42 -36.73 84.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -56.89 -42.52 80.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.908 ' HB2' HG23 ' A' ' 77' ' ' ILE . 23.5 m120 -59.5 -37.0 77.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.865 . . . . 0.0 109.052 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.584 ' HA ' HD13 ' A' ' 77' ' ' ILE . 90.8 mtp -65.18 -33.47 76.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.356 -0.84 . . . . 0.0 109.25 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -70.1 -24.22 63.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.246 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.9 tp -89.03 -20.61 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.747 ' HB ' HD11 ' A' ' 77' ' ' ILE . 65.0 mt -120.03 160.46 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 109.408 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -88.54 0.91 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.17 -37.18 64.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -1.164 . . . . 0.0 109.157 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 89.1 m -58.13 -34.86 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.267 -0.896 . . . . 0.0 108.81 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.71 -35.88 79.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.37 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 38.7 ttm -52.74 -37.56 59.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.291 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.8 -31.11 71.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.245 -0.909 . . . . 0.0 109.122 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.86 81.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.896 . . . . 0.0 109.239 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.427 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 62.9 mtm . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 0.0 109.251 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 9' ' ' TRP . 6.5 mt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.75 -49.62 70.4 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 108.591 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.52 -47.48 48.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.056 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.4 -53.32 59.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.9 t0 -47.87 -35.69 10.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.267 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.2 ttm -72.18 -40.89 67.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.59 91.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.828 ' HE1' HG23 ' A' ' 19' ' ' ILE . 75.0 t80 -54.48 -42.78 71.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.886 ' HB1' ' CG1' ' A' ' 115' ' ' ILE . . . -70.26 -38.19 75.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.764 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 84.3 p -69.17 -46.85 66.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.991 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.659 ' HB3' HD13 ' A' ' 43' ' ' ILE . 4.1 m -70.03 -45.33 67.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.71 ' HA ' HD12 ' A' ' 77' ' ' ILE . 9.8 p -57.71 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -67.35 -36.54 81.62 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.933 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 90.8 mt-30 -69.17 -38.3 78.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.834 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.908 HG23 ' HB2' ' A' ' 39' ' ' ASN . 56.5 mt -56.68 -55.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.848 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.68 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -78.85 -48.53 14.54 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 109.977 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.87 -22.25 47.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 30.0 t -81.13 -20.92 40.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.892 . . . . 0.0 109.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 75.9 mt-30 -44.68 -40.91 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.81 53.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.96 -158.73 12.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 87' ' ' VAL . 83.7 m-20 -54.33 127.48 27.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.783 HD11 HG22 ' A' ' 119' ' ' ILE . 5.5 tp -84.46 -20.87 31.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.71 63.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -68.95 -47.79 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 109.525 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . 22.5 m -51.7 -37.73 52.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.068 . . . . 0.0 108.251 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -55.34 -51.6 66.22 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 62.2 m-20 -70.86 -39.64 72.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -60.19 -55.35 34.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.51 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 22' ' ' PHE . 43.6 mt -72.23 -49.93 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.455 -0.778 . . . . 0.0 109.852 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -57.09 -46.2 82.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 110.654 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.781 ' HB3' HG21 ' A' ' 29' ' ' THR . 41.8 t0 -54.9 -53.77 51.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.941 -1.099 . . . . 0.0 109.89 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.718 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -57.14 -40.73 77.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.715 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 92' ' ' ILE . 15.0 mt -68.13 -41.45 81.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.7 m -58.61 -53.82 54.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.886 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 16.3 m -63.8 -45.14 91.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.13 -45.98 68.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.12 -0.987 . . . . 0.0 109.427 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.13 -54.27 10.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.973 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.76 -32.05 67.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.493 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 98' ' ' SER . 73.1 mt-30 -76.12 -18.51 59.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.821 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 99' ' ' ALA . 47.9 p -105.51 -59.73 1.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 111.209 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.558 HG21 ' N ' ' A' ' 7' ' ' THR . 5.5 m -126.55 -42.58 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.83 -1.169 . . . . 0.0 110.784 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.88 47.7 1.0 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.757 HG21 ' O ' ' A' ' 6' ' ' ASN . 48.1 t -112.78 168.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.309 -1.112 . . . . 0.0 108.945 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.8 m -67.29 121.04 15.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.3 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.689 ' ND2' HG23 ' A' ' 97' ' ' THR . 16.1 p-10 -70.53 -23.12 62.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.426 -0.797 . . . . 0.0 109.818 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' SER . 34.0 t -54.45 -30.34 52.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.858 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' A' ' 107' ' ' VAL . 93.5 mtt180 -68.15 -55.31 12.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.817 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 71.4 t80 -76.4 -50.66 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 110.343 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.531 HD11 ' N ' ' A' ' 97' ' ' THR . 17.3 mt -56.17 -45.77 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.836 . . . . 0.0 110.182 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 109' ' ' SER . 63.1 m -55.66 -39.25 70.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.0 109.392 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 80.8 tt0 -62.1 -49.71 74.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.886 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 81.2 mt -67.59 -34.7 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -53.7 -45.69 70.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.38 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.1 t -73.42 -33.68 65.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 49.1 mt -67.92 -45.51 74.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.783 HG22 HD11 ' A' ' 85' ' ' LEU . 87.5 mt -57.8 -34.54 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.997 . . . . 0.0 109.438 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.76 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -68.23 -36.77 85.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.45 -37.63 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -1.177 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 63.9 m-85 -66.56 -30.48 70.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.743 HG22 ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.8 157.39 32.02 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.064 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 49.0 Cg_endo -69.03 -34.6 16.64 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.566 2.178 . . . . 0.0 112.633 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.776 ' O ' HD22 ' A' ' 63' ' ' LEU . 48.9 p90 -83.28 1.48 40.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.964 -1.085 . . . . 0.0 110.074 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.743 ' OG ' HG22 ' A' ' 7' ' ' THR . 17.7 m -90.46 -28.26 18.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 108.933 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -104.23 154.58 19.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.352 -0.843 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -73.53 -37.78 65.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -35.21 25.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.643 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 8.3 t-20 -71.29 -29.17 64.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.43 -45.28 60.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 109.952 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 48' ' ' MET . 58.6 t0 -56.22 -54.06 49.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.99 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.8 -44.17 63.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.719 ' CA ' HG21 ' A' ' 103' ' ' THR . 72.8 t80 -56.97 -38.78 73.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.886 HG23 ' CE1' ' A' ' 70' ' ' PHE . 34.4 mm -69.35 -42.93 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.862 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -64.95 -49.24 71.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.029 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.6 t -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 t80 -64.28 -52.2 59.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.164 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' A' ' 40' ' ' MET . 37.9 mm -58.92 -55.97 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.179 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -64.76 -28.99 69.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.907 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.16 -43.07 29.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -74.25 -29.19 61.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.298 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 94.9 p -63.86 -27.68 69.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 110.226 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.06 7.26 31.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 0.0 110.5 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.1 m -92.08 -77.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.17 . . . . 0.0 110.292 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.0 -104.23 0.4 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' PHE . 35.8 t -131.06 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -1.065 . . . . 0.0 109.409 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.799 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 18.6 m-85 43.53 87.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.27 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 37.8 p -59.64 160.51 7.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 0.0 109.533 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -52.54 -35.78 54.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.226 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.12 -36.11 83.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.277 -0.89 . . . . 0.0 109.34 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.45 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.4 mm-40 -73.29 -31.88 64.3 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.059 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.437 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 63.9 mtt -63.43 -31.37 72.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.436 -0.79 . . . . 0.0 109.097 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -57.25 -44.71 84.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 109.168 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 77' ' ' ILE . 69.4 m-20 -56.28 -40.97 75.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.196 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.942 ' HB3' HD12 ' A' ' 23' ' ' ILE . 63.6 mtt -63.02 -32.12 73.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.038 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 m -70.02 -23.5 63.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.166 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.4 tp -89.05 -25.67 21.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.962 HG21 ' CB ' ' A' ' 73' ' ' SER . 62.2 mt -124.86 149.41 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 104.37 -81.01 0.32 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -62.29 -29.16 70.23 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.257 -1.143 . . . . 0.0 108.635 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.8 m -64.22 -35.16 79.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.495 -0.753 . . . . 0.0 108.995 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.29 -35.86 63.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' ' OD2' ' A' ' 16' ' ' ASP . 61.3 ttp -52.68 -40.11 62.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 109.076 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.96 81.34 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.95 66.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 48' ' ' MET . 65.7 mtt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 9' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.263 0.554 . . . . 0.0 109.633 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -54.41 -39.25 67.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 108.992 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.37 -36.61 68.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.06 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 66' ' ' LEU . 32.4 tp -74.28 -48.25 29.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.503 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.6 t0 -48.08 -37.92 16.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.319 -0.863 . . . . 0.0 109.702 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -72.22 -32.87 67.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.661 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.68 89.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.886 ' CE1' HG23 ' A' ' 19' ' ' ILE . 91.3 t80 -53.24 -36.31 60.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.952 . . . . 0.0 109.591 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -70.26 -35.29 73.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 m -69.12 -35.44 76.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.962 ' CB ' HG21 ' A' ' 43' ' ' ILE . 51.9 m -69.99 -49.25 53.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.714 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 70' ' ' PHE . 16.0 m -58.96 -35.0 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -67.45 -43.39 81.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.5 mt-30 -65.66 -45.85 81.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.3 mt -54.64 -51.42 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 109.692 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.799 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.08 -49.06 14.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.714 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.21 -23.96 57.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 88.9 p -80.58 -20.2 43.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 39.7 mt-30 -52.57 -30.67 32.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.97 19.27 70.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 -164.62 24.62 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 87' ' ' VAL . 84.2 m-20 -60.0 135.68 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -1.176 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.764 HD11 HG22 ' A' ' 119' ' ' ILE . 6.1 tp -84.43 -18.56 35.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.691 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.02 64.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 88' ' ' THR . 5.7 p -69.0 -46.47 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 109.584 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.565 ' N ' HG13 ' A' ' 87' ' ' VAL . 93.5 m -51.73 -35.75 44.44 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 108.628 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 44.7 m -56.21 -46.51 79.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.7 m-20 -71.01 -40.07 72.01 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.46 -59.08 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.745 HG22 HD11 ' A' ' 96' ' ' LEU . 24.5 mm -63.14 -49.41 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.33 -49.98 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 75.7 m-20 -55.26 -44.13 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -61.1 -43.81 98.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.415 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.745 HD11 HG22 ' A' ' 92' ' ' ILE . 2.7 mt -69.95 -38.62 76.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.7 m -60.72 -51.81 67.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 110.046 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 15.5 t -60.37 -47.65 85.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.979 . . . . 0.0 109.842 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 103' ' ' THR . . . -59.01 -41.73 88.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.595 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -46.58 -53.83 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.121 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -72.06 -31.9 66.56 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.518 -0.739 . . . . 0.0 109.995 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' SER . 42.2 mt-30 -78.33 -18.54 55.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 110.128 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.719 HG21 ' CA ' ' A' ' 18' ' ' PHE . 51.8 p -105.74 -58.75 1.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.917 -1.115 . . . . 0.0 111.284 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 91.5 m -125.89 -42.64 1.89 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.676 -1.265 . . . . 0.0 110.737 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.3 48.52 1.05 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 107' ' ' VAL . 4.9 t -111.7 172.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.39 -1.065 . . . . 0.0 109.117 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.599 ' H ' HG12 ' A' ' 106' ' ' VAL . 27.4 m -72.98 121.01 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 97' ' ' THR . 11.3 p30 -71.22 -29.22 64.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -58.15 -30.53 66.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.404 -0.81 . . . . 0.0 110.693 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -71.05 -54.34 11.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.884 -1.135 . . . . 0.0 109.994 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 1.121 ' CE2' HD11 ' A' ' 115' ' ' ILE . 56.4 t80 -75.61 -48.44 22.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.807 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.2 mt -56.28 -37.76 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.853 . . . . 0.0 109.949 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -55.8 -39.87 71.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.455 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.6 mt-10 -72.23 -38.82 68.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.121 HD11 ' CE2' ' A' ' 111' ' ' PHE . 49.3 mt -70.91 -43.68 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ttp85 -54.18 -38.14 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.84 . . . . 0.0 109.366 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -72.36 -33.85 67.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 66.4 mt -68.7 -38.79 80.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.764 HG22 HD11 ' A' ' 85' ' ' LEU . 63.5 mt -57.73 -35.87 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.745 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -70.35 -34.44 68.8 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 49.0 ttm -64.83 -38.61 91.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -1.157 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -64.52 -41.69 96.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.329 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 m120 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.581 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 9.1 t -136.48 150.61 70.99 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -65.94 -30.93 47.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.603 2.202 . . . . 0.0 112.904 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.581 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 44.0 p90 -81.34 -1.01 43.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.788 -1.195 . . . . 0.0 110.168 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 78.3 p -89.65 -14.94 33.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 108.86 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -140.94 149.0 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 109.071 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 31.2 mtmt -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.67 -50.34 72.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.755 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.9 m-20 -72.53 -32.83 66.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.862 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -67.15 -49.02 66.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.989 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.07 -56.07 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.938 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.08 -33.84 71.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.002 . . . . 0.0 109.367 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 52.3 t80 -67.64 -37.08 81.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.191 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.861 HG23 ' CE1' ' A' ' 70' ' ' PHE . 17.4 mt -74.04 -38.54 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -68.21 -50.29 55.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 p -59.99 -33.56 72.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 8.4 t80 -64.1 -35.94 82.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 109.844 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.474 HG12 ' CE ' ' A' ' 40' ' ' MET . 67.6 mt -71.6 -56.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -59.76 -30.79 69.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 109.905 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.09 -43.54 28.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 110.238 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -70.28 -34.46 72.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 0.0 110.396 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.475 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 92.6 p -61.59 -26.77 68.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.045 -1.034 . . . . 0.0 110.084 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -105.87 7.29 32.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 110.373 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.987 HG21 ' HB2' ' A' ' 94' ' ' ASP . 22.8 m -92.28 -78.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.914 -1.116 . . . . 0.0 110.298 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.37 -104.26 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -130.68 -61.17 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -1.084 . . . . 0.0 109.35 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.599 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 8.9 m-85 44.06 83.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 109.177 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -59.56 167.08 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.693 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -52.51 -43.59 65.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -56.19 -36.71 68.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.104 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.446 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 90.7 mm-40 -76.27 -35.4 58.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.475 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 62.4 mtt -63.31 -39.85 95.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.4 -43.12 83.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.039 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.3 m-20 -57.15 -39.93 76.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.134 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.474 ' CE ' HG12 ' A' ' 23' ' ' ILE . 77.0 mmm -58.25 -32.22 68.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 108.921 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 t -70.16 -24.19 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 46' ' ' THR . 63.0 mt -91.85 -16.83 26.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 77' ' ' ILE . 64.9 mt -119.6 166.45 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.186 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.688 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 68.35 -81.86 0.2 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.45 -40.23 68.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.035 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -60.06 -35.23 74.68 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 108.979 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 47' ' ' LEU . 40.8 mt -55.18 -36.72 66.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.207 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.5 ttp -52.93 -43.16 66.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.902 . . . . 0.0 109.247 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.49 77.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.925 . . . . 0.0 108.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.51 -23.17 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.495 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 15.9 mmt . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.4 mp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.049 0.452 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -54.22 -38.45 65.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 108.919 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.79 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.276 -0.89 . . . . 0.0 108.687 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -74.1 -43.67 56.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 0.0 109.136 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 37.5 t0 -47.85 -40.23 20.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.835 . . . . 0.0 109.696 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.8 mtp -67.84 -30.67 70.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.86 85.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.861 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.8 t80 -54.58 -44.33 72.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.669 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.033 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -38.65 74.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.827 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -69.5 -36.68 76.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.975 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.616 ' HB2' HD13 ' A' ' 43' ' ' ILE . 85.7 p -70.12 -45.06 67.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 109.949 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.9 m -63.8 -35.02 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.41 93.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.797 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.33 -45.17 73.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.759 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -53.99 -47.65 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.49 -49.47 13.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.939 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.86 -26.24 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 81' ' ' GLN . 52.3 m -79.19 -20.15 49.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.599 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 79.1 mt-30 -45.2 -39.45 6.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.03 7.47 64.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.67 -159.57 26.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 87' ' ' VAL . 60.1 t0 -64.7 97.91 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -1.184 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.939 HD13 ' HA ' ' A' ' 79' ' ' ALA . 20.1 tp -58.89 -15.9 14.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.88 -35.4 84.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.5 p -70.1 -35.71 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -1.154 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.612 HG22 HD12 ' A' ' 92' ' ' ILE . 53.3 m -51.4 -33.31 29.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.046 -1.034 . . . . 0.0 108.424 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.542 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 3.7 m -57.03 -47.73 80.2 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 73.9 m-20 -70.97 -38.69 72.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.403 -0.811 . . . . 0.0 109.168 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.14 -53.85 32.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.733 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.72 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 62.7 mt -70.45 -45.26 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.727 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.75 -46.75 83.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.987 ' HB2' HG21 ' A' ' 29' ' ' THR . 76.7 m-20 -55.23 -49.65 71.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.67 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.664 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -67.93 -33.72 75.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.966 . . . . 0.0 108.833 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.78 -42.56 73.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.547 -0.721 . . . . 0.0 109.587 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 101' ' ' TYR . 60.4 m -65.46 -53.82 37.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 83.9 p -57.7 -42.99 84.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -58.3 -46.25 86.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.671 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -47.26 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 109.472 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 97' ' ' THR . 1.8 m-85 -68.57 -32.02 71.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.518 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 33.4 mt-30 -69.63 -18.79 63.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 110.051 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 18' ' ' PHE . 71.9 p -113.5 -59.37 2.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.123 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 106' ' ' VAL . 29.9 p -125.93 -42.45 1.89 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.764 -1.21 . . . . 0.0 110.639 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.61 47.74 1.02 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.59 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 35.1 t -101.19 158.55 4.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -1.149 . . . . 0.0 108.831 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 107' ' ' VAL . 30.4 m -58.35 121.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.608 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.3 p30 -70.83 -26.7 63.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 113' ' ' SER . 96.4 p -64.15 -31.81 73.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.307 -0.871 . . . . 0.0 110.871 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -66.14 -55.14 17.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.771 -1.205 . . . . 0.0 110.409 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 115' ' ' ILE . 55.1 t80 -75.92 -50.82 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 109.966 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.69 HG21 ' HB1' ' A' ' 93' ' ' ALA . 22.1 mt -56.28 -40.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.4 t -56.13 -38.85 71.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.82 -49.69 67.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.158 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.033 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -59.13 -34.67 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.149 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.542 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 9.6 ttt180 -53.7 -47.62 70.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.493 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.23 -33.92 65.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 115' ' ' ILE . 10.4 mt -66.1 -45.79 79.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.891 ' CG2' HD11 ' A' ' 85' ' ' LEU . 88.9 mt -57.69 -39.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.12 -36.05 64.17 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.4 ttm -58.18 -40.93 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.585 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.92 -28.41 69.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.261 0.553 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.83 HG22 ' OG ' ' A' ' 10' ' ' SER . 2.1 t -131.48 151.63 79.07 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -66.7 -34.36 32.09 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.487 2.124 . . . . 0.0 112.578 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -84.33 15.93 3.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.803 -1.186 . . . . 0.0 110.059 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.83 ' OG ' HG22 ' A' ' 7' ' ' THR . 2.5 m -95.26 -34.85 12.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.064 -1.022 . . . . 0.0 108.461 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 89.3 p -123.08 161.69 23.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 22.5 mtmt -74.04 -41.11 62.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.55 93.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 0.0 109.365 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 8' ' ' PRO . 25.5 t30 -71.6 -40.93 69.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -68.67 -38.64 80.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.877 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -54.96 -56.38 20.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.58 66.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.079 -1.013 . . . . 0.0 108.987 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 59.2 t80 -61.67 -46.98 87.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.126 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.665 HG21 ' C ' ' A' ' 44' ' ' GLY . 19.8 mm -63.08 -46.23 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.273 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -50.75 53.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.304 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 33.8 t -54.95 -29.85 57.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 108.903 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.608 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 30.7 t80 -72.22 -51.74 19.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 109.853 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.81 -55.89 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.048 . . . . 0.0 109.839 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -58.74 -36.55 74.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.892 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.88 -46.5 21.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.935 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -63.25 -33.7 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 110.173 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.434 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 45.0 m -64.05 -28.12 69.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.02 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.95 7.33 32.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 110.318 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 1.006 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.9 m -92.68 -76.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.865 -1.147 . . . . 0.0 110.187 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -84.67 -104.4 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.4 -59.09 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -1.09 . . . . 0.0 109.371 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 17.8 m-85 44.41 89.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.345 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 47.6 p -59.81 161.54 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.629 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -52.7 -41.14 63.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.96 -35.55 73.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.228 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 97.5 mm-40 -72.23 -32.37 66.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.255 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.434 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 60.3 mtt -63.45 -34.29 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -58.21 -45.54 87.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.041 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.0 m-20 -56.66 -43.23 80.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.297 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.486 ' O ' ' O ' ' A' ' 43' ' ' ILE . 63.6 mtt -59.47 -32.2 70.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 p -70.25 -23.58 62.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 12.5 tp -89.71 -25.17 21.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.74 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.982 HG21 ' HB3' ' A' ' 73' ' ' SER . 54.1 mt -125.34 149.75 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.665 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 95.25 -79.66 0.85 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.35 -30.59 70.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.265 -1.138 . . . . 0.0 108.454 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.1 m -67.35 -34.79 78.07 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 66' ' ' LEU . 52.6 mt -52.35 -32.9 40.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.449 -0.782 . . . . 0.0 109.181 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.4 ttm -57.46 -47.23 82.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.224 -0.922 . . . . 0.0 108.901 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.85 69.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.213 -0.929 . . . . 0.0 108.808 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.44 83.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.466 ' HE1' HD13 ' A' ' 63' ' ' LEU . 85.3 mmm . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.868 . . . . 0.0 109.015 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.66 HD23 ' C ' ' A' ' 10' ' ' SER . 13.5 tp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -55.67 -28.76 57.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.01 . . . . 0.0 109.179 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.57 91.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.584 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -67.33 -41.38 85.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 38.2 t0 -48.63 -47.85 39.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.52 -39.63 94.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.548 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.44 89.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.68 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.741 ' O ' HG13 ' A' ' 74' ' ' VAL . 87.4 t80 -58.62 -41.58 86.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -63.71 -35.58 81.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.655 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -69.36 -38.68 78.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.666 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.982 ' HB3' HG21 ' A' ' 43' ' ' ILE . 20.4 m -70.24 -48.69 55.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 70' ' ' PHE . 8.5 m -57.35 -34.73 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.254 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.94 -41.73 64.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 80' ' ' SER . 96.9 mt-30 -65.24 -50.3 66.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.449 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.9 mt -53.69 -48.98 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.579 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.54 -52.26 8.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.506 -0.746 . . . . 0.0 109.92 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.97 -23.19 52.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.497 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 90.6 p -81.67 -20.47 39.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 42.9 mt-30 -49.44 -35.11 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 109.381 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.47 9.19 79.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.76 -150.33 26.87 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 87' ' ' VAL . 19.2 t70 -71.23 128.1 34.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -1.204 . . . . 0.0 109.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.739 HD11 HG22 ' A' ' 119' ' ' ILE . 6.2 tp -80.26 -18.67 48.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.862 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.25 -40.13 61.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 88' ' ' THR . 4.7 p -67.0 -44.28 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -1.212 . . . . 0.0 109.695 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.565 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 28.1 m -51.66 -35.57 42.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 108.352 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 116' ' ' ARG . 6.8 m -54.03 -48.22 70.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.6 m120 -71.12 -39.88 71.76 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -62.12 -54.11 45.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.848 HG22 HD11 ' A' ' 96' ' ' LEU . 77.2 mt -72.24 -48.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.291 -0.881 . . . . 0.0 109.732 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.29 -50.77 72.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.91 . . . . 0.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 1.006 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.1 m-20 -55.41 -46.71 76.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.095 -1.003 . . . . 0.0 109.612 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.5 -43.46 89.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.382 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.848 HD11 HG22 ' A' ' 92' ' ' ILE . 3.8 mt -69.91 -33.3 71.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.518 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.88 HG23 ' ND2' ' A' ' 108' ' ' ASN . 92.7 m -67.57 -53.39 28.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.4 p -59.22 -35.55 73.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.689 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -70.01 -43.45 71.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.25 -56.23 7.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.551 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.552 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 8.0 m-85 -72.16 -32.02 66.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.454 -0.779 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 86.5 mm-40 -72.55 -18.74 61.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.7 p -103.6 -60.3 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.846 -1.158 . . . . 0.0 111.232 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.544 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.12 -42.91 1.68 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.691 -1.256 . . . . 0.0 110.875 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 113.71 45.31 0.72 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.1 t -106.0 172.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -1.211 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.581 ' H ' HG12 ' A' ' 106' ' ' VAL . 8.7 m -75.01 120.18 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.88 ' ND2' HG23 ' A' ' 97' ' ' THR . 14.3 p30 -71.83 -23.79 61.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 0.0 109.844 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 113' ' ' SER . 29.8 m -59.17 -43.63 92.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 110.591 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -57.0 -53.58 56.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.0 110.027 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 1.153 ' CE2' HD11 ' A' ' 115' ' ' ILE . 70.7 t80 -75.29 -51.72 12.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.943 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.528 HG21 ' HB1' ' A' ' 93' ' ' ALA . 16.2 mt -58.71 -36.25 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.275 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.5 m -55.97 -43.3 77.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 0.0 109.83 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.04 -36.89 69.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.153 HD11 ' CE2' ' A' ' 111' ' ' PHE . 28.4 mt -62.78 -43.52 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.598 ' HG2' HG23 ' A' ' 89' ' ' THR . 34.6 mtp180 -54.06 -49.3 69.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.4 p -57.46 -33.17 67.69 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 115' ' ' ILE . 6.8 mt -73.51 -40.12 64.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.496 -0.752 . . . . 0.0 110.037 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.739 HG22 HD11 ' A' ' 85' ' ' LEU . 57.8 mt -61.21 -35.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 109.226 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.726 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.38 -34.09 64.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -61.99 -44.5 96.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 84.5 m-85 -59.1 -42.76 91.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.646 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -154.52 149.99 21.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.165 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 7' ' ' THR . 43.6 Cg_endo -67.0 -35.29 26.32 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.356 2.037 . . . . 0.0 111.977 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 7' ' ' THR . 45.8 p90 -90.01 -10.71 43.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 63' ' ' LEU . 58.3 m -70.62 -8.9 55.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -143.4 159.03 43.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.53 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 25.2 mtmt -74.73 -40.76 61.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.45 69.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -72.21 -29.11 63.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -71.43 -53.68 13.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -54.82 -56.1 23.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.659 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -0.982 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 80.0 t80 -63.44 -38.06 89.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.447 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.85 HG23 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -75.64 -38.3 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -68.33 -50.54 52.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.5 t -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.665 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 74' ' ' VAL . 25.6 t80 -64.79 -46.81 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 110.32 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.445 HG23 ' SD ' ' A' ' 40' ' ' MET . 82.8 mt -65.93 -56.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.161 -0.962 . . . . 0.0 110.251 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.4 p -54.05 -34.14 59.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.92 -47.4 18.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 110.011 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.49 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -62.34 -34.97 77.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.443 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 93.8 p -61.78 -30.1 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.007 . . . . 0.0 110.208 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -106.07 7.47 31.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.469 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.967 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.4 m -91.16 -78.27 0.4 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.13 . . . . 0.0 110.356 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.74 -103.53 0.38 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' PHE . 17.3 p -131.61 -61.34 0.91 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -1.108 . . . . 0.0 109.45 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 11.4 m-85 44.42 87.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.063 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -59.51 162.04 5.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -52.54 -39.66 61.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.22 -35.97 76.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.082 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.476 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 90.2 mm-40 -73.96 -32.62 63.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.187 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.443 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 58.1 mtt -63.91 -35.88 82.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.003 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -57.12 -49.14 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.397 -0.815 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 77' ' ' ILE . 74.5 m-20 -55.86 -37.33 68.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.091 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.476 ' HE3' ' CG ' ' A' ' 32' ' ' PHE . 64.1 mtt -57.36 -32.01 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.7 m -69.79 -24.15 63.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' THR . 62.0 mt -91.09 -19.71 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.051 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 44' ' ' GLY . 18.9 mm -116.33 167.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 0.0 109.12 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.637 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 69.19 -92.68 0.32 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -53.25 -39.73 64.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.14 . . . . 0.0 109.288 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m -58.71 -38.15 77.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.174 -0.954 . . . . 0.0 108.966 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 66' ' ' LEU . 34.2 tp -55.67 -32.96 63.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 109.133 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 51' ' ' MET . 18.1 ttt -54.85 -31.85 59.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.283 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.86 91.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.673 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.78 -26.44 68.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.389 -0.819 . . . . 0.0 108.919 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.53 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 28.5 ttm . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.423 -0.798 . . . . 0.0 109.225 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.0 mp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -53.54 -35.74 61.06 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.11 68.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 47' ' ' LEU . 10.9 mt -74.12 -51.25 16.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 24.3 t70 -46.9 -39.98 13.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 108.561 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 56.1 mtt -72.17 -45.44 60.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.847 . . . . 0.0 108.944 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.42 91.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 108.94 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 19' ' ' ILE . 79.8 t80 -52.19 -43.4 64.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.133 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.79 -39.07 73.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 109.596 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -69.29 -36.71 77.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.488 ' CB ' HG21 ' A' ' 43' ' ' ILE . 5.9 m -69.98 -44.26 69.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.807 HG21 ' CE1' ' A' ' 22' ' ' PHE . 8.7 p -67.44 -36.77 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 74' ' ' VAL . . . -61.55 -39.16 90.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.49 -39.66 77.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.647 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.2 mt -58.1 -49.58 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -77.38 -48.62 16.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.621 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.89 60.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.1 t -78.17 -20.35 52.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.571 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.5 mt-30 -49.98 -27.62 5.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.527 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.52 77.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.65 -148.18 23.77 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 87' ' ' VAL . 50.7 t0 -67.11 124.21 22.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.31 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 119' ' ' ILE . 4.3 tp -81.18 -21.77 39.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.255 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.1 -34.56 64.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 84' ' ' ASP . 3.6 p -67.11 -42.89 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.105 -1.232 . . . . 0.0 109.72 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 92' ' ' ILE . 51.9 m -51.54 -34.65 37.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.987 -1.071 . . . . 0.0 108.321 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 m -56.73 -49.8 74.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.1 m120 -70.61 -38.24 73.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 109.039 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.77 -53.4 47.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.612 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.77 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 66.6 mt -72.35 -45.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.866 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.83 -44.94 91.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.967 ' HB2' HG21 ' A' ' 29' ' ' THR . 48.7 m-20 -55.2 -48.51 73.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.953 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.4 -33.67 69.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.9 HD22 HD12 ' A' ' 115' ' ' ILE . 7.2 tp -70.03 -33.68 72.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.912 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 98.7 m -69.3 -53.82 17.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 14.3 m -62.51 -33.61 75.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 109.878 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -63.91 -33.68 76.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.0 m-85 -61.39 -56.25 22.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.558 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.3 m-85 -71.97 -32.1 66.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 109.683 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 98' ' ' SER . 85.3 mm-40 -71.19 -17.99 62.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.848 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 72.0 p -111.06 -59.65 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 111.254 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.667 HG21 ' C ' ' A' ' 7' ' ' THR . 26.7 p -126.33 -43.02 1.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.797 -1.189 . . . . 0.0 110.968 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.71 45.93 1.01 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.08 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.598 HG23 ' OG1' ' A' ' 104' ' ' THR . 18.4 t -101.89 171.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.159 -1.201 . . . . 0.0 108.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 107' ' ' VAL . 29.0 m -71.48 120.55 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 0.0 109.799 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.604 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 24.2 p-10 -72.21 -33.32 67.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 109.97 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 113' ' ' SER . 29.8 m -57.82 -33.74 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 107' ' ' VAL . 67.1 ttt-85 -67.91 -54.47 18.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.832 -1.168 . . . . 0.0 110.095 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.757 ' CD2' HD21 ' A' ' 96' ' ' LEU . 32.3 t80 -75.46 -47.04 28.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.898 HG12 HD23 ' A' ' 96' ' ' LEU . 9.5 mt -56.01 -46.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 109' ' ' SER . 60.3 m -55.57 -41.45 73.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.004 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.65 -45.26 89.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.224 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.967 HG12 ' HB1' ' A' ' 71' ' ' ALA . 77.9 mt -66.99 -34.36 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.82 . . . . 0.0 109.162 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.527 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 19.7 ttt-85 -53.54 -49.01 68.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.0 p -70.16 -34.02 72.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 115' ' ' ILE . 13.9 mt -66.62 -44.97 80.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.668 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 85' ' ' LEU . 89.4 mt -57.66 -42.95 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.788 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.28 -36.9 63.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.2 ttp -56.81 -40.38 75.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 60.5 m-85 -62.0 -50.66 71.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.535 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.462 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 42.1 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.761 ' C ' HG21 ' A' ' 104' ' ' THR . 0.0 OUTLIER -146.95 150.14 37.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.8 Cg_endo -71.78 -35.07 8.05 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 111.543 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.927 ' O ' HD23 ' A' ' 63' ' ' LEU . 37.6 p90 -88.02 -30.71 19.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.011 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 36.0 t -55.63 -25.37 38.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.473 -0.767 . . . . 0.0 109.771 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 1.3 t -113.98 136.64 52.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.971 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 2.5 ttpp -65.27 -37.79 88.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -70.29 -43.9 69.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 11' ' ' SER . 12.6 m120 -71.6 -29.11 64.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.377 -0.827 . . . . 0.0 109.416 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -64.81 -44.15 90.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 110.187 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.636 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 2.7 p30 -64.06 -50.85 66.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.518 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.06 -32.86 73.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 108.903 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CG ' ' HB2' ' A' ' 8' ' ' PRO . 56.0 t80 -70.45 -43.45 69.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.816 HG23 ' HE1' ' A' ' 70' ' ' PHE . 27.6 mt -73.18 -44.63 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.525 -0.734 . . . . 0.0 109.041 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -68.08 -50.63 53.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.78 . . . . 0.0 109.182 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 74.1 m -57.46 -30.15 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.606 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' A' ' 74' ' ' VAL . 8.6 t80 -72.01 -50.03 32.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.512 -0.743 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 40' ' ' MET . 50.8 mm -64.94 -55.73 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.141 -0.974 . . . . 0.0 109.652 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -53.86 -39.71 65.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 0.0 109.909 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.72 -46.73 20.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 109.815 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.556 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -58.9 -35.67 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.703 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.529 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 85.8 p -64.05 -28.41 69.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.84 6.92 32.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.81 HG21 ' HB3' ' A' ' 94' ' ' ASP . 20.5 m -91.75 -76.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.047 -1.033 . . . . 0.0 110.033 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -82.49 -104.68 0.45 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -131.8 -60.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -1.126 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.793 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 43.58 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.343 -0.848 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.5 t -59.66 162.81 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -52.63 -39.49 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.373 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.51 -35.96 81.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 91.6 mm-40 -73.65 -32.29 63.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.5 mtt -63.6 -36.51 84.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.103 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.54 -47.41 84.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB2' HG23 ' A' ' 77' ' ' ILE . 86.3 m-20 -56.14 -45.26 79.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.0 ' HB3' HD12 ' A' ' 23' ' ' ILE . 56.2 mtm -57.15 -33.66 67.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 108.829 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.3 p -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 58.8 mt -87.19 -21.26 26.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 73' ' ' SER . 94.9 mt -121.87 143.77 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.244 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.78 -88.21 0.84 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.79 -32.45 70.63 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.165 -1.197 . . . . 0.0 108.282 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 91.8 m -59.15 -35.04 72.82 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 47' ' ' LEU . 69.0 mt -65.64 -40.21 92.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.636 ' HE2' ' HB3' ' A' ' 16' ' ' ASP . 89.5 mmm -52.74 -35.01 55.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.95 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.159 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.35 -36.12 78.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.223 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 54.6 mtt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.208 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.927 HD23 ' O ' ' A' ' 9' ' ' TRP . 2.0 mp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.404 0.621 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 62.9 tt0 -54.21 -35.69 62.68 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.077 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.69 15.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.683 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.621 HD21 HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.6 -46.68 36.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.274 -0.891 . . . . 0.0 110.987 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 9' ' ' TRP . 3.6 p-10 -47.78 -29.87 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.258 . . . . 0.0 109.805 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 68.7 mtp -72.66 -36.26 67.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.29 75.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.816 ' HE1' HG23 ' A' ' 19' ' ' ILE . 66.2 t80 -52.47 -37.13 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.46 -47.93 58.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -69.25 -30.77 68.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.039 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 43' ' ' ILE . 8.3 m -69.8 -45.84 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.881 HG21 ' CE1' ' A' ' 22' ' ' PHE . 9.6 p -68.93 -36.66 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -59.69 -40.85 89.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 109.727 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -70.72 -35.02 72.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 74' ' ' VAL . 94.2 mt -58.57 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.793 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.21 -41.64 57.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.672 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.57 61.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -76.77 -20.36 56.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.1 mt-30 -50.01 -37.84 34.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 109.46 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.77 81.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.51 -149.18 24.52 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.4 t0 -66.79 119.72 12.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 119' ' ' ILE . 7.0 tp -74.69 -24.16 58.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.9 64.39 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.6 p -69.1 -38.17 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.235 . . . . 0.0 109.844 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.616 HG22 HD12 ' A' ' 92' ' ' ILE . 54.1 m -54.7 -33.59 61.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.908 -1.12 . . . . 0.0 108.367 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.1 m -57.81 -49.25 77.29 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 68.2 m-20 -70.69 -41.06 72.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.494 -0.754 . . . . 0.0 109.154 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -64.54 -52.2 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.799 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 32.2 mt -72.81 -38.3 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -72.29 -43.22 64.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.81 ' HB3' HG21 ' A' ' 29' ' ' THR . 40.1 t0 -54.97 -45.74 75.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.927 -1.108 . . . . 0.0 109.795 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.81 -35.2 69.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.109 -0.994 . . . . 0.0 109.01 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.86 -40.4 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.563 HG23 ' OH ' ' A' ' 101' ' ' TYR . 52.4 m -67.66 -53.87 24.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.1 m -59.81 -44.08 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -55.65 -46.79 77.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.405 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 96' ' ' LEU . 1.5 m-85 -46.94 -56.6 6.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.73 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.576 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.99 -32.41 67.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.629 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 40.1 mt-30 -64.86 -18.54 65.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 43.0 p -115.16 -59.35 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 111.333 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.761 HG21 ' C ' ' A' ' 7' ' ' THR . 15.9 p -126.16 -43.17 1.81 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.648 -1.283 . . . . 0.0 110.969 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.16 45.37 1.01 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 19.8 t -98.06 163.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.073 -1.251 . . . . 0.0 108.689 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 107' ' ' VAL . 33.1 m -64.03 121.59 13.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.588 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.9 p30 -71.0 -33.69 70.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.057 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 113' ' ' SER . 87.2 p -57.23 -43.72 83.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.967 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.413 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.8 ttt180 -57.22 -54.58 45.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 0.0 110.156 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.845 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 49.0 t80 -75.56 -46.46 31.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 14.8 mt -63.0 -35.65 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 110.15 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.1 t -58.12 -32.84 68.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 96.9 mt-10 -72.34 -40.34 67.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.931 HG12 ' HB1' ' A' ' 71' ' ' ALA . 80.6 mt -69.34 -40.7 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -54.34 -44.76 72.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.0 p -72.98 -33.95 66.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 109.557 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 26.7 mt -67.91 -42.43 81.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 85' ' ' LEU . 65.8 mt -58.01 -39.29 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.388 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.793 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -63.56 -34.58 90.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 13.1 tpp -65.91 -38.32 88.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.68 -39.43 84.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.544 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 52.0 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.788 HG23 ' HB2' ' A' ' 10' ' ' SER . 2.8 t -141.27 151.31 61.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.61 -35.74 21.54 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.598 2.199 . . . . 0.0 112.744 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.577 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -82.13 9.08 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.737 -1.227 . . . . 0.0 109.525 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -95.25 -29.62 14.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 108.577 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.436 ' HG ' ' CG ' ' A' ' 14' ' ' ASN . 2.6 p -120.28 155.01 34.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.018 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 7.2 ttpt -71.53 -41.27 69.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.45 70.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 11' ' ' SER . 15.3 m120 -71.7 -28.9 64.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.339 -0.85 . . . . 0.0 109.941 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.04 -48.77 62.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.953 -1.092 . . . . 0.0 110.323 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 88.7 m-20 -58.57 -56.13 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.84 -42.38 65.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.62 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' HB2' HG21 ' A' ' 103' ' ' THR . 87.6 t80 -58.19 -37.05 74.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 70' ' ' PHE . 20.2 mm -70.92 -48.9 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 109.513 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -61.45 -49.75 75.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 109.753 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -58.36 -34.33 70.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 40.5 t80 -69.68 -35.94 75.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.587 HG23 ' HE3' ' A' ' 40' ' ' MET . 77.4 mt -70.43 -56.14 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.92 -34.52 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.05 -44.66 25.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 110.392 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.683 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.57 -33.08 68.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.01 . . . . 0.0 110.629 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.497 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 57.4 m -60.94 -28.27 68.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.42 7.49 31.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 0.0 110.847 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.955 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.3 m -93.48 -75.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.738 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -72.56 -104.08 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.456 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.8 t -148.42 13.29 0.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.495 -1.003 . . . . 0.0 109.904 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 44.7 m-85 -38.17 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.644 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' SER . 59.7 p -66.1 168.44 8.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.792 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 33.7 tt0 -52.74 -44.68 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -57.43 -41.72 81.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.287 -0.883 . . . . 0.0 109.332 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.463 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 77.9 mm-40 -74.61 -32.25 62.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.156 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.507 ' CE ' ' O ' ' A' ' 32' ' ' PHE . 66.3 mtt -66.2 -33.43 75.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.256 -0.902 . . . . 0.0 108.966 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 95.7 mt-10 -57.26 -40.39 77.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 109.272 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 77.0 m-20 -56.1 -38.6 70.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.071 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.587 ' HE3' HG23 ' A' ' 23' ' ' ILE . 64.4 mtm -62.49 -31.92 72.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.847 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 p -68.6 -23.71 64.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.405 -0.809 . . . . 0.0 109.062 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.5 tp -92.66 -23.39 18.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.055 HG21 ' CB ' ' A' ' 73' ' ' SER . 51.6 mt -132.35 149.27 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 97.15 -74.3 0.68 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.03 -34.93 69.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -1.104 . . . . 0.0 108.203 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -68.14 -34.84 77.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 66' ' ' LEU . 23.9 tp -52.47 -39.24 60.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.417 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 16' ' ' ASP . 70.0 mtm -52.4 -33.75 45.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 108.886 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.27 72.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.311 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.16 80.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.321 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.499 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 51.0 mtt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.255 -0.903 . . . . 0.0 109.271 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 9' ' ' TRP . 14.5 tp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.01 -30.63 66.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HA ' ' HE2' ' A' ' 68' ' ' MET . . . -71.42 -34.5 70.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.292 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 47' ' ' LEU . 2.0 tp -73.68 -39.36 64.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.299 -0.875 . . . . 0.0 109.256 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' TRP . 31.5 t0 -49.46 -46.72 48.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 70.3 mtm -54.24 -39.14 66.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.435 -0.791 . . . . 0.0 109.798 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.84 72.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CD2' HD12 ' A' ' 19' ' ' ILE . 47.4 t80 -60.65 -35.47 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 115' ' ' ILE . . . -69.3 -30.5 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 m -69.3 -46.68 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 109.921 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 1.055 ' CB ' HG21 ' A' ' 43' ' ' ILE . 11.2 t -68.06 -48.49 65.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 92' ' ' ILE . 8.3 p -56.83 -38.53 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.7 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 122' ' ' PHE . . . -70.3 -34.63 72.96 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.242 -0.911 . . . . 0.0 109.46 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -76.26 -47.46 23.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 68.3 mt -53.36 -44.62 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.48 -50.69 11.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.82 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.33 44.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.202 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.5 p -81.4 -21.73 38.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.59 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG2' ' OE1' ' A' ' 36' ' ' GLN . 45.1 mt-30 -50.37 -32.76 18.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 109.557 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.27 11.02 85.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.29 -151.52 27.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.726 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.6 t70 -69.36 114.22 7.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -1.166 . . . . 0.0 109.256 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 119' ' ' ILE . 4.7 tp -62.46 -25.21 67.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.51 71.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.7 p -68.03 -36.88 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.104 -1.233 . . . . 0.0 109.774 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 92' ' ' ILE . 91.1 m -54.6 -32.24 58.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.982 -1.074 . . . . 0.0 108.513 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 24.9 m -60.2 -51.22 70.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 69.6 m-20 -70.59 -35.81 73.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.738 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -68.31 -55.69 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.582 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.742 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 39.6 mt -69.56 -50.49 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -56.93 -40.97 77.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.955 ' HB2' HG21 ' A' ' 29' ' ' THR . 7.1 m-20 -57.99 -54.28 48.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.683 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -68.08 -32.66 73.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 108.851 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.571 ' HB3' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -70.31 -41.05 73.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.732 . . . . 0.0 109.774 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.66 HG23 HD22 ' A' ' 108' ' ' ASN . 21.5 m -68.4 -53.99 20.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.015 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 50.9 m -59.81 -43.26 94.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.208 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -56.09 -46.37 79.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.5 m-85 -46.86 -54.48 9.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -0.87 . . . . 0.0 109.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.31 -31.42 67.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.544 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 60.9 mt-30 -70.77 -18.02 62.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 18' ' ' PHE . 59.1 p -110.82 -59.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 111.08 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 106' ' ' VAL . 18.0 p -126.82 -43.31 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.69 -1.256 . . . . 0.0 110.781 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.89 43.54 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.683 -1.246 . . . . 0.0 109.991 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.672 HG23 ' OG1' ' A' ' 104' ' ' THR . 13.7 t -99.21 169.59 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.104 -1.233 . . . . 0.0 108.62 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 107' ' ' VAL . 29.4 m -69.57 121.66 19.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.376 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.66 HD22 HG23 ' A' ' 97' ' ' THR . 13.0 p30 -70.52 -24.08 62.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.643 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' SER . 39.9 m -60.91 -29.99 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.549 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -69.16 -55.0 11.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.123 . . . . 0.0 110.418 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' A' ' 115' ' ' ILE . 88.4 t80 -75.93 -50.6 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.571 HD11 ' HB3' ' A' ' 96' ' ' LEU . 53.1 mt -56.39 -36.51 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.177 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' SER . 3.9 m -56.69 -39.39 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.944 -1.097 . . . . 0.0 109.044 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.26 -42.13 65.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.282 -0.886 . . . . 0.0 109.233 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.739 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 32.8 mm -62.72 -49.37 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.363 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.523 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 6.8 ttt180 -54.12 -42.68 69.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.012 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.0 m -73.01 -33.42 65.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 115' ' ' ILE . 22.0 mt -68.5 -43.39 76.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.803 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.916 HG22 HD11 ' A' ' 85' ' ' LEU . 23.3 mt -57.89 -43.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -60.58 -34.74 87.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.3 ttm -62.74 -43.5 98.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.143 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE2' ' CB ' ' A' ' 75' ' ' ALA . 84.9 m-85 -59.63 -47.65 84.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.446 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.642 ' C ' HG21 ' A' ' 104' ' ' THR . 36.5 m-20 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.294 0.569 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -157.46 155.54 27.54 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.67 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.2 Cg_endo -69.23 -35.09 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.265 . . . . 0.0 111.386 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.854 ' O ' HD22 ' A' ' 63' ' ' LEU . 35.8 p90 -91.35 -23.65 20.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 108.998 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 63' ' ' LEU . 12.0 m -63.74 -14.47 52.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 108.651 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 73.3 m -140.52 122.58 15.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 109.076 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 13' ' ' ALA . 45.8 pttt -52.53 -43.92 65.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 12' ' ' LYS . . . -63.19 -36.58 84.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 11' ' ' SER . 9.7 t-20 -72.8 -35.22 67.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -66.66 -27.9 68.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' CE ' ' A' ' 48' ' ' MET . 92.3 m-20 -54.73 -56.71 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.69 66.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' HA ' HG21 ' A' ' 103' ' ' THR . 50.8 t80 -71.18 -38.86 72.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.752 HG21 ' C ' ' A' ' 44' ' ' GLY . 13.9 mm -75.45 -47.74 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.896 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.5 -49.96 73.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -62.68 -30.39 71.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.181 -0.949 . . . . 0.0 110.103 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.766 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 29.3 t80 -71.43 -51.92 21.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.481 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 40' ' ' MET . 41.8 mm -61.24 -56.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.041 -1.037 . . . . 0.0 110.453 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -57.31 -38.21 73.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.943 . . . . 0.0 110.135 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.07 -45.94 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.962 . . . . 0.0 110.281 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.545 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -64.51 -37.56 87.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.458 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 65.7 p -59.17 -28.94 67.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -0.983 . . . . 0.0 110.5 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.18 7.36 31.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.999 -1.063 . . . . 0.0 110.745 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 1.01 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.2 m -94.64 -74.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.776 -1.202 . . . . 0.0 110.883 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -73.53 -104.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 33' ' ' SER . 42.5 p -147.74 13.36 1.03 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -1.049 . . . . 0.0 109.742 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 46.0 m-85 -38.34 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' SER . 31.0 m -60.15 162.33 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -53.09 -44.24 67.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.39 -0.819 . . . . 0.0 109.359 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -56.25 -41.39 75.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 84.3 mm-40 -72.34 -31.11 65.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.042 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 65.2 mtt -63.05 -32.39 73.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.32 -50.12 73.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 109.018 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.666 ' HB3' HD12 ' A' ' 23' ' ' ILE . 87.2 mtp -58.51 -37.63 76.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.78 . . . . 0.0 109.157 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.9 p -70.39 -24.12 62.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.233 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 tp -83.42 -20.69 33.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.858 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.05 HG21 ' CB ' ' A' ' 73' ' ' SER . 20.2 mm -120.48 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.345 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.752 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 100.8 -79.71 0.44 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 46' ' ' THR . 7.1 p30 -65.74 -35.93 82.12 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.272 -1.134 . . . . 0.0 108.195 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 60.5 m -62.14 -35.05 77.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.924 HD21 ' HG ' ' A' ' 66' ' ' LEU . 35.0 tp -61.22 -34.45 75.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.513 -0.742 . . . . 0.0 109.214 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 51' ' ' MET . 54.8 mtt -52.73 -37.96 60.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.166 -0.959 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.65 71.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.54 -49.78 51.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.385 -0.822 . . . . 0.0 108.952 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 66' ' ' LEU . 53.5 mtm . . . . . 0 N--CA 1.488 1.435 0 O-C-N 121.398 -0.814 . . . . 0.0 109.209 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.854 HD22 ' O ' ' A' ' 9' ' ' TRP . 10.0 mt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -53.55 -45.28 69.81 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.23 63.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.924 ' HG ' HD21 ' A' ' 47' ' ' LEU . 7.5 tt -70.49 -53.63 15.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.47 -0.769 . . . . 0.0 109.128 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.577 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 22.0 t0 -48.16 -46.89 35.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.2 mtp -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.99 73.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.0 109.5 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.674 ' O ' HG13 ' A' ' 74' ' ' VAL . 57.4 t80 -58.22 -38.32 76.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -68.22 -36.16 79.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 1.05 ' CB ' HG21 ' A' ' 43' ' ' ILE . 19.7 m -70.24 -43.45 70.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.709 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.0 m -68.37 -35.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 119' ' ' ILE . . . -65.16 -39.92 93.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.77 -45.18 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 40' ' ' MET . 91.8 mt -56.67 -46.16 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.666 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -67.55 -51.87 45.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.605 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -58.09 -24.51 58.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -76.3 -20.43 57.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 46.5 mt-30 -51.55 -31.87 25.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 10.27 82.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.45 -160.91 26.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.68 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.7 t70 -69.58 101.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 119' ' ' ILE . 25.9 tp -52.92 -20.36 3.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.627 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.07 -33.97 87.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 84' ' ' ASP . 8.0 p -69.2 -35.81 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.196 . . . . 0.0 109.703 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.666 ' OG1' ' HB1' ' A' ' 78' ' ' ALA . 64.1 m -51.65 -32.15 28.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.034 -1.041 . . . . 0.0 108.623 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 37.5 m -58.33 -45.5 87.99 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 20.5 m120 -70.77 -38.29 73.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.073 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.627 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -69.09 -58.82 3.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 109.557 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.766 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 35.9 mm -61.25 -45.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 112' ' ' ILE . . . -65.86 -49.06 69.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 1.01 ' HB2' HG21 ' A' ' 29' ' ' THR . 86.0 m-20 -55.29 -46.02 76.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.184 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -68.62 -38.72 80.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.0 -42.96 72.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.526 HG22 ' CE2' ' A' ' 101' ' ' TYR . 88.7 m -60.57 -50.93 71.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.722 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 102' ' ' GLN . 31.2 t -60.41 -33.98 73.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.967 . . . . 0.0 109.525 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.4 -44.34 68.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.425 -0.797 . . . . 0.0 109.996 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.0 OUTLIER -47.89 -56.34 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -69.2 -32.11 71.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 98' ' ' SER . 78.4 mm-40 -79.52 -18.49 51.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 18' ' ' PHE . 71.3 p -106.53 -59.15 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.936 -1.103 . . . . 0.0 111.177 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.642 HG21 ' C ' ' A' ' 6' ' ' ASN . 48.1 m -125.14 -42.44 2.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.838 -1.164 . . . . 0.0 111.002 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.1 47.33 1.16 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 17.6 t -110.36 172.22 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.287 -1.125 . . . . 0.0 108.915 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.569 ' H ' HG12 ' A' ' 106' ' ' VAL . 35.1 m -68.59 121.17 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.609 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 19.2 p-10 -71.08 -23.7 62.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.833 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 113' ' ' SER . 20.6 t -66.88 -30.17 70.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 0.0 110.932 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.67 -55.1 14.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.822 -1.174 . . . . 0.0 110.515 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.841 ' HD2' HD21 ' A' ' 96' ' ' LEU . 6.4 t80 -75.79 -49.25 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 110.205 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.599 HG21 ' CB ' ' A' ' 93' ' ' ALA . 20.5 mt -56.3 -36.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' SER . 4.5 m -60.91 -40.81 94.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.74 -38.33 76.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.234 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 118' ' ' LEU . 69.1 mt -69.38 -43.16 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -54.24 -38.99 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.7 m -73.42 -35.9 65.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 109.693 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 115' ' ' ILE . 20.8 mt -65.2 -38.88 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.829 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.961 ' CG2' HD11 ' A' ' 85' ' ' LEU . 65.8 mt -61.67 -42.67 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.91 92.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.658 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 23.3 m-85 -64.34 -34.72 78.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.687 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.2 t -154.46 150.21 21.62 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 41.7 Cg_endo -64.3 -30.65 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 49.1 p90 -88.42 18.74 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.0 109.05 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.5 OUTLIER -105.48 -30.98 9.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -123.59 142.92 50.57 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 0.6 OUTLIER -60.77 -43.77 97.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.946 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.9 m-20 -72.17 -29.57 64.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -65.35 -37.33 86.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.499 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.03 -56.17 12.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.071 -1.018 . . . . 0.0 110.077 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.21 -29.76 15.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 109.567 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 56.3 t80 -69.85 -44.09 70.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.754 HG21 ' C ' ' A' ' 44' ' ' GLY . 18.5 mm -68.64 -44.94 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.196 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -68.25 -50.78 51.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.4 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 51.1 m -58.45 -29.64 66.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.049 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.716 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 25.8 t80 -72.23 -51.92 18.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.129 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.935 HD12 ' HB3' ' A' ' 40' ' ' MET . 19.4 mm -66.21 -55.87 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.007 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -57.44 -36.7 71.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.931 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.96 -44.75 25.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 110.193 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -27.36 68.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 55.1 m -65.21 -31.15 72.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.336 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.4 p-10 -105.93 7.71 32.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.065 -1.022 . . . . 0.0 110.364 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.5 m -89.0 -77.14 0.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.914 -1.116 . . . . 0.0 110.255 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.81 -102.61 0.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -132.95 -62.38 0.81 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.462 -1.022 . . . . 0.0 109.314 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 14.3 m-85 45.54 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.3 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 m -59.37 158.63 9.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -52.42 -40.0 61.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 33' ' ' SER . 19.0 p-10 -61.38 -36.07 79.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.7 mm-40 -67.81 -31.65 71.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.219 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.567 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.8 mtt -63.28 -36.75 84.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 109.001 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 65.5 mm-40 -58.92 -48.7 80.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.114 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -60.56 -46.13 91.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.858 . . . . 0.0 109.021 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.935 ' HB3' HD12 ' A' ' 23' ' ' ILE . 70.9 mtm -61.61 -35.88 79.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.424 -0.797 . . . . 0.0 108.851 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -70.23 -24.1 63.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 46' ' ' THR . 12.1 tp -84.45 -22.07 30.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.836 HG21 ' CB ' ' A' ' 73' ' ' SER . 12.0 mm -118.04 149.4 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.754 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.06 -77.38 1.6 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.91 -39.29 90.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.193 -1.18 . . . . 0.0 108.22 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 84.9 m -63.0 -35.27 79.65 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.099 HD21 ' CD1' ' A' ' 66' ' ' LEU . 29.1 tp -57.82 -36.48 72.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.659 -0.65 . . . . 0.0 109.532 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 94.6 mmm -52.78 -29.46 27.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.252 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.9 76.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.02 86.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.153 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 13.0 mmt . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 108.989 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' TRP . 57.3 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -54.78 -44.54 73.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.945 . . . . 0.0 109.017 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.41 69.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.099 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -74.31 -43.64 55.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.031 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 42.0 t0 -48.53 -43.86 35.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.12 -34.36 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.935 . . . . 0.0 109.813 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.54 79.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 109.816 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.843 ' O ' HG13 ' A' ' 74' ' ' VAL . 86.6 t80 -61.51 -36.86 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.7 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.36 -29.05 65.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.935 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -69.32 -46.98 65.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.167 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.836 ' CB ' HG21 ' A' ' 43' ' ' ILE . 1.1 t -70.07 -45.99 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 70' ' ' PHE . 13.7 m -57.4 -35.41 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -73.8 -40.81 63.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.781 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 80' ' ' SER . 50.1 tt0 -68.47 -43.24 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 109.724 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.602 HG21 ' CG ' ' A' ' 40' ' ' MET . 99.4 mt -56.35 -52.38 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -73.33 -50.62 21.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 0.0 109.841 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.41 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.398 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 90.0 p -81.4 -20.65 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 34.8 mt-30 -48.97 -36.96 18.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 22.29 41.9 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.03 -157.39 13.75 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 76.8 m-20 -62.6 134.4 56.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.099 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 119' ' ' ILE . 6.3 tp -84.95 -19.4 32.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.59 64.82 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -69.99 -44.93 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 109.696 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 87' ' ' VAL . 80.0 m -51.61 -34.75 38.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.975 -1.078 . . . . 0.0 108.493 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 23.8 m -56.2 -48.7 75.9 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 m120 -70.72 -39.3 73.48 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.169 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -65.25 -57.45 8.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.732 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' LEU . 48.2 mt -66.46 -45.97 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.8 -49.02 74.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 0.0 110.059 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.3 m-20 -54.99 -41.68 71.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.363 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -62.62 -44.59 95.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.304 -0.873 . . . . 0.0 109.049 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.963 HD13 HD12 ' A' ' 115' ' ' ILE . 7.1 mt -70.42 -36.01 73.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.505 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.556 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 93.5 m -64.82 -53.7 42.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 110.009 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 14.5 m -62.08 -49.2 76.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.121 -0.987 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.5 -44.37 68.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER -46.96 -55.95 7.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 109.324 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.573 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 4.1 m-85 -71.97 -31.91 66.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.44 -0.787 . . . . 0.0 109.675 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 98' ' ' SER . 65.1 mt-30 -73.19 -18.39 61.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.676 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 99' ' ' ALA . 34.7 p -107.29 -60.22 1.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.936 -1.103 . . . . 0.0 111.173 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.831 ' CG2' HG23 ' A' ' 106' ' ' VAL . 12.3 t -127.05 -43.07 1.69 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.813 -1.179 . . . . 0.0 110.845 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.98 46.82 0.92 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 104' ' ' THR . 57.4 t -103.07 167.86 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.271 -1.135 . . . . 0.0 108.937 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 107' ' ' VAL . 33.5 m -66.07 121.45 15.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.755 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 20.8 p-10 -71.07 -23.74 62.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.428 -0.795 . . . . 0.0 109.939 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 113' ' ' SER . 90.2 p -68.7 -34.84 76.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -62.36 -54.52 39.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.862 -1.148 . . . . 0.0 110.473 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 115' ' ' ILE . 57.4 t80 -75.73 -53.29 8.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 110.204 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 93' ' ' ALA . 21.2 mt -56.36 -28.37 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 109' ' ' SER . 9.6 t -58.81 -42.29 88.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.622 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.48 -36.35 65.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 111' ' ' PHE . 30.8 mt -67.54 -41.22 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.647 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 113' ' ' SER . 31.8 ptt85 -54.04 -43.12 69.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.852 -1.155 . . . . 0.0 109.638 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.492 ' N ' ' CG ' ' A' ' 116' ' ' ARG . 87.0 p -71.44 -33.82 69.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.548 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.8 mt -66.45 -38.12 86.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.766 HG22 HD11 ' A' ' 85' ' ' LEU . 67.3 mt -61.5 -35.71 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.023 . . . . 0.0 109.454 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -67.93 -34.24 81.66 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.0 ttm -60.75 -43.68 97.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.16 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 97.7 m-85 -59.14 -50.17 75.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' O ' ' OG1' ' A' ' 104' ' ' THR . 19.0 m120 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.927 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -135.97 151.75 74.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.436 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.0 Cg_endo -68.66 -35.39 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.561 2.174 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.836 ' O ' HD22 ' A' ' 63' ' ' LEU . 45.3 p90 -91.48 -11.39 37.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 109.082 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -72.05 -5.34 34.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.898 . . . . 0.0 109.413 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 1.9 t -140.79 153.9 46.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.361 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 2.5 ttpm? -73.81 -39.7 63.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.612 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.45 -33.01 42.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.259 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 7' ' ' THR . 34.2 t30 -71.53 -29.47 64.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.79 -43.06 72.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -54.36 -56.33 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.717 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.4 45.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 109.298 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 47.2 t80 -68.73 -52.6 28.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.898 HG23 ' CE1' ' A' ' 70' ' ' PHE . 10.0 mm -60.15 -44.14 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -67.49 -50.87 56.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -57.66 -30.12 65.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.203 -0.936 . . . . 0.0 108.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 19.2 t80 -72.29 -52.21 17.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG12 ' CE ' ' A' ' 40' ' ' MET . 69.4 mt -61.9 -56.12 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.687 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -53.91 -37.24 63.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -51.54 10.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.924 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.67 64.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.105 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.635 ' HB2' ' HE1' ' A' ' 37' ' ' MET . 45.8 p -68.37 -33.41 74.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.249 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -105.67 7.19 32.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 94' ' ' ASP . 8.9 m -87.16 -77.09 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.956 -1.09 . . . . 0.0 110.224 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -101.4 0.61 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 76.5 p -141.32 -53.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.429 -1.042 . . . . 0.0 109.344 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.7 m-85 44.5 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 37' ' ' MET . 32.2 t -59.68 159.97 7.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -52.38 -38.4 58.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.07 -37.18 86.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.115 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.526 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 81.8 mm-40 -76.32 -36.17 58.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.635 ' HE1' ' HB2' ' A' ' 27' ' ' SER . 79.6 mtp -63.97 -37.43 87.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.132 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -56.89 -41.2 77.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.171 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.78 ' HB3' HG23 ' A' ' 77' ' ' ILE . 46.0 t-20 -56.07 -35.08 66.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 108.916 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.52 ' SD ' HD13 ' A' ' 77' ' ' ILE . 92.8 mmm -57.12 -31.69 65.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 m -67.55 -24.08 65.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.915 . . . . 0.0 109.28 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 46' ' ' THR . 66.9 mt -92.08 -28.22 17.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.0 ' HB ' HD11 ' A' ' 77' ' ' ILE . 63.9 mt -116.81 154.99 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.422 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.852 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.16 -89.79 1.62 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -59.58 -32.4 70.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 108.834 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 34.2 m -65.95 -35.08 79.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 108.922 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 66' ' ' LEU . 29.8 tp -54.97 -38.63 68.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.79 . . . . 0.0 109.222 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.9 ttt -52.83 -36.16 58.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.31 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.21 72.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.193 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.83 72.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 64.0 mtm . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.215 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 9' ' ' TRP . 2.6 mt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' MET . 85.1 mt-30 -54.75 -48.29 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.123 -0.986 . . . . 0.0 108.628 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.5 55.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.395 -0.816 . . . . 0.0 109.267 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 47' ' ' LEU . 1.8 tp -61.54 -50.82 71.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.581 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 26.3 t0 -47.99 -37.01 13.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 63.5 mtt -65.84 -32.13 73.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.37 93.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.9 t80 -53.59 -38.93 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.875 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.744 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -68.94 -40.49 78.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.6 m -69.35 -45.64 68.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.776 ' HB3' HD13 ' A' ' 43' ' ' ILE . 12.3 m -70.01 -47.24 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 109.766 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 7.5 p -58.4 -44.16 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.603 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -62.8 -37.24 85.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.0 tt0 -68.41 -43.12 77.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 43' ' ' ILE . 78.8 mt -53.78 -52.46 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.591 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.46 -50.84 10.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.782 . . . . 0.0 109.931 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.58 -22.54 45.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.979 . . . . 0.0 109.266 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.3 p -81.85 -20.59 38.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 50.1 mt-30 -45.96 -35.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 3.79 76.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.18 -162.75 33.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -72.06 118.31 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.134 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.089 HD23 HG22 ' A' ' 119' ' ' ILE . 3.4 mp -62.28 -16.17 52.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.76 -45.74 78.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.3 -47.47 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -1.132 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.591 HG23 ' CB ' ' A' ' 78' ' ' ALA . 44.7 m -53.75 -48.43 69.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 21.6 m -51.27 -47.7 62.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 74.7 m-20 -71.05 -35.32 71.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.443 -0.786 . . . . 0.0 108.93 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.487 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -69.58 -59.13 3.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 0.0 109.689 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 96' ' ' LEU . 69.0 mt -63.98 -49.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.901 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.26 -52.52 65.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.331 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.887 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.8 m-20 -55.4 -43.12 74.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 109.903 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -63.54 -39.5 94.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.205 -0.934 . . . . 0.0 109.723 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD11 HG22 ' A' ' 92' ' ' ILE . 6.2 mt -69.88 -35.87 75.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.797 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -65.46 -53.65 39.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 20.2 m -60.59 -34.03 73.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.825 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -69.52 -46.3 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.5 m-85 -47.12 -56.21 6.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -71.14 -31.78 68.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.828 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 98' ' ' SER . 84.1 mm-40 -73.12 -18.59 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 99' ' ' ALA . 67.5 p -107.45 -59.85 1.77 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.903 -1.123 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -126.82 -42.84 1.73 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.761 -1.212 . . . . 0.0 110.836 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 111.77 45.36 0.83 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 107' ' ' VAL . 6.6 t -102.81 172.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 109.151 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 14.1 m -74.18 120.23 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.797 ' ND2' HG23 ' A' ' 97' ' ' THR . 13.0 p30 -72.07 -29.59 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.645 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 113' ' ' SER . 21.7 m -56.92 -46.09 82.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 110.391 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.97 -53.58 56.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.891 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.98 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.0 -50.49 16.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.756 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.514 HD12 ' OD1' ' A' ' 108' ' ' ASN . 11.5 mt -58.56 -42.63 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.065 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 109' ' ' SER . 48.0 t -55.84 -37.97 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.15 -40.41 82.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.513 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.98 HD11 ' CE2' ' A' ' 111' ' ' PHE . 56.2 mt -72.7 -43.34 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -54.22 -39.74 67.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.368 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.7 t -73.15 -34.12 65.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.8 mt -70.97 -40.71 71.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.089 HG22 HD23 ' A' ' 85' ' ' LEU . 84.6 mt -58.2 -39.65 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.03 -27.34 72.27 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.0 ttm -66.97 -38.68 86.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -1.166 . . . . 0.0 109.502 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -60.14 -37.87 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.529 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.472 ' C ' HG21 ' A' ' 104' ' ' THR . 65.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 10' ' ' SER . 1.5 t -162.25 151.77 13.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.012 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 46.0 Cg_endo -67.49 -27.17 39.78 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.466 2.111 . . . . 0.0 112.695 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -92.52 15.91 13.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.849 -1.157 . . . . 0.0 109.845 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.5 p -105.31 -23.07 12.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.002 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -110.45 160.71 16.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.188 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 51' ' ' MET . 15.6 ttpp -74.69 -40.88 61.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.049 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -83.28 -31.07 27.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 11' ' ' SER . 5.8 t-20 -71.54 -29.38 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.644 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.514 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -73.03 -47.89 40.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.567 ' CB ' ' HE2' ' A' ' 48' ' ' MET . 1.2 p30 -56.79 -49.29 75.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.169 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -55.08 -40.61 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.971 -1.08 . . . . 0.0 109.386 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HA ' HG21 ' A' ' 103' ' ' THR . 72.2 t80 -61.23 -48.57 80.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.028 HG23 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mm -60.88 -44.44 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -50.87 48.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.382 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 38.8 t -55.91 -29.98 60.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 108.765 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 39.1 t80 -72.34 -51.92 18.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.511 -0.743 . . . . 0.0 110.047 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 40' ' ' MET . 76.3 mt -60.26 -56.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -59.85 -35.14 74.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.923 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.14 -45.29 23.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -40.59 91.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.937 . . . . 0.0 110.323 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 82.7 p -57.15 -27.24 61.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.23 6.99 31.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.571 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.972 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.5 m -93.12 -77.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.783 -1.198 . . . . 0.0 110.188 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -81.75 -104.74 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' PHE . 53.0 p -131.31 -61.52 0.91 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.8 m-85 44.02 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 109.236 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m -59.65 162.56 5.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.577 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -52.56 -43.33 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.23 -35.89 76.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.464 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.9 mm-40 -71.7 -35.07 70.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.6 mtt -63.47 -34.23 77.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -63.03 -38.31 90.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 86.3 m-20 -55.83 -39.69 71.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.256 -0.903 . . . . 0.0 109.118 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 23' ' ' ILE . 75.8 mtm -66.16 -32.04 73.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.083 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 46' ' ' THR . 19.5 m -70.31 -23.62 62.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 54.7 mt -97.34 -14.31 21.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 44' ' ' GLY . 74.8 mt -130.78 166.3 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 0.0 109.548 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 64.8 -69.44 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ILE . 41.1 t30 -74.81 -41.06 60.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.213 -1.169 . . . . 0.0 109.23 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 41' ' ' SER . 46.8 m -58.37 -35.24 71.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 108.739 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.74 -31.19 69.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 108.908 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 58.1 mmm -56.81 -29.95 63.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.412 -0.805 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.51 97.36 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -22.88 66.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.537 ' CE ' ' HG2' ' A' ' 12' ' ' LYS . 20.4 ttp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.632 -0.667 . . . . 0.0 109.513 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 6.9 mp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.314 0.578 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.67 -42.16 67.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.46 65.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 108.802 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 tp -74.48 -50.77 16.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.575 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.5 t0 -48.26 -39.68 22.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.7 mmm -71.44 -39.4 71.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.69 87.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.028 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.5 t80 -52.88 -36.94 59.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 109.706 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.916 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -64.55 -39.58 94.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.675 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 88.2 p -69.46 -30.63 68.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.826 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 43' ' ' ILE . 11.5 t -69.96 -44.25 69.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.0 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 71' ' ' ALA . 11.7 m -69.01 -34.63 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.563 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 122' ' ' PHE . . . -69.91 -40.74 75.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.62 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -71.11 -49.36 45.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -53.82 -46.71 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.69 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -53.98 6.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 109.799 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.16 -22.67 52.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.549 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 22.9 m -79.67 -20.72 45.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 37.6 mt-30 -57.19 -34.14 68.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.82 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.25 17.81 73.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.84 -145.62 19.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.579 ' O ' HG12 ' A' ' 87' ' ' VAL . 58.4 t0 -76.0 106.03 7.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -1.111 . . . . 0.0 109.302 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.98 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.8 tp -60.18 -23.07 63.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 109.666 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.16 -39.45 72.47 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.0 p -67.62 -39.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.255 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 24.3 m -51.7 -34.46 38.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.963 -1.085 . . . . 0.0 108.316 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.548 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 6.6 m -57.46 -50.93 71.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' A' ' 94' ' ' ASP . 51.0 t30 -70.24 -40.18 74.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.389 -0.819 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.6 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -62.37 -53.55 53.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.298 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.847 HG22 HD11 ' A' ' 96' ' ' LEU . 57.0 mt -72.56 -51.25 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.89 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.53 -49.23 75.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.972 ' HB2' HG21 ' A' ' 29' ' ' THR . 93.1 m-20 -54.77 -47.68 73.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.213 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -57.02 -46.11 82.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.339 -0.851 . . . . 0.0 109.003 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.847 HD11 HG22 ' A' ' 92' ' ' ILE . 1.8 mt -70.97 -28.61 64.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.548 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.924 HG23 ' OD1' ' A' ' 108' ' ' ASN . 51.7 m -64.46 -54.09 37.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.157 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 87.6 p -66.78 -43.91 82.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 109.438 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.14 -42.71 66.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.5 m-85 -50.49 -56.41 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.123 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 7.5 m-85 -72.07 -31.77 66.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.425 -0.797 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 98' ' ' SER . 28.3 mt-30 -75.71 -17.8 59.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.589 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 18' ' ' PHE . 63.7 p -109.44 -58.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 111.294 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.472 HG21 ' C ' ' A' ' 6' ' ' ASN . 87.2 m -125.76 -42.75 1.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.746 -1.221 . . . . 0.0 111.212 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.77 47.81 1.07 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 107' ' ' VAL . 3.6 t -110.92 172.79 2.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.263 -1.139 . . . . 0.0 109.022 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 107' ' ' VAL . 33.2 m -71.85 121.12 21.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.52 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.924 ' OD1' HG23 ' A' ' 97' ' ' THR . 0.3 OUTLIER -71.7 -29.69 64.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 109.857 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 113' ' ' SER . 47.5 m -55.95 -30.12 61.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.492 -0.755 . . . . 0.0 110.742 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 23.1 tpt180 -71.54 -55.22 8.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 110.374 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.92 -46.6 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HB1' ' A' ' 93' ' ' ALA . 12.5 mt -56.13 -47.15 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.453 -0.779 . . . . 0.0 109.852 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 109' ' ' SER . 28.5 t -55.66 -43.56 76.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 95.0 mt-10 -57.19 -48.35 78.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.223 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.916 HG12 ' HB1' ' A' ' 71' ' ' ALA . 74.5 mt -65.46 -34.08 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.548 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 11.5 ttm180 -52.95 -48.96 66.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -69.75 -33.98 73.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -67.13 -45.61 76.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.682 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.909 HG22 HD11 ' A' ' 85' ' ' LEU . 56.7 mt -57.83 -34.6 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.686 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.865 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -69.02 -31.78 72.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 53.2 ttm -71.36 -39.28 71.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.119 . . . . 0.0 109.791 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.468 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 75.6 m-85 -65.57 -33.62 76.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.346 0.593 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' ' 10' ' ' SER . 3.1 t -157.78 151.38 19.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.093 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 43.9 Cg_endo -67.41 -35.09 24.63 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.783 2.322 . . . . 0.0 113.394 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.587 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -81.34 -7.51 59.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.695 -1.253 . . . . 0.0 110.339 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.89 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 m -88.35 20.14 3.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.656 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -155.69 150.05 25.86 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 1.9 ttpp -73.88 -38.18 64.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -85.85 -33.56 21.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 104' ' ' THR . 9.7 t-20 -71.88 -29.28 64.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -73.0 -44.28 61.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.641 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.6 p30 -54.45 -40.28 68.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -63.05 -44.65 95.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.012 -1.055 . . . . 0.0 109.024 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CE1' HD23 ' A' ' 96' ' ' LEU . 43.1 t80 -60.77 -44.26 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 70' ' ' PHE . 19.0 mm -66.34 -43.36 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.239 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -50.92 51.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.248 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 43.5 m -58.75 -29.42 66.73 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 108.72 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.783 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.8 t80 -71.64 -51.98 20.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.91 ' HA ' ' HE1' ' A' ' 40' ' ' MET . 74.3 mt -63.67 -56.06 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.908 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.4 m -56.04 -37.07 68.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.677 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -49.4 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.777 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -60.36 -24.19 64.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 110.153 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.6 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 57.8 m -67.3 -34.33 77.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 110.079 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -106.08 7.17 31.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.16 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 94' ' ' ASP . 11.8 m -84.19 -75.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -86.97 -99.84 0.83 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -142.04 -54.9 0.45 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -1.074 . . . . 0.0 109.293 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 44.17 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 15.9 m -59.65 159.82 8.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.698 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -52.8 -32.72 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -71.15 -37.95 72.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.326 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.529 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 37.5 mt-30 -76.56 -34.22 58.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.6 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 88.6 mtp -65.04 -34.49 78.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 72.7 mt-10 -56.87 -43.99 81.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.866 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.9 m-20 -55.9 -33.23 64.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.91 ' HE1' ' HA ' ' A' ' 23' ' ' ILE . 82.3 mtp -61.74 -32.55 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -69.91 -24.68 63.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.373 -0.829 . . . . 0.0 109.453 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.1 mp -89.03 -22.43 22.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.81 ' HB ' HD11 ' A' ' 77' ' ' ILE . 86.9 mt -115.57 164.18 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.647 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 73.84 -93.88 0.76 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' OD1' ' CD1' ' A' ' 23' ' ' ILE . 21.2 m120 -52.41 -36.89 55.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -1.185 . . . . 0.0 109.036 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 55.4 m -58.4 -35.31 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 66' ' ' LEU . 74.6 mt -56.88 -36.45 70.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 109.224 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 70.8 mtm -52.95 -40.7 63.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.28 -31.5 71.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.972 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.9 78.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -0.803 . . . . 0.0 109.176 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 35.5 mtt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.067 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.89 HD21 ' O ' ' A' ' 10' ' ' SER . 1.2 tp . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.488 0.661 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -76.81 -46.07 26.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.252 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.24 52.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.266 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 47' ' ' LEU . 17.4 tp -54.94 -50.04 69.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.948 . . . . 0.0 109.028 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 9.8 t0 -48.16 -49.39 32.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.9 mtp -58.81 -43.99 90.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.64 77.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.736 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE1' HG23 ' A' ' 19' ' ' ILE . 77.6 t80 -56.86 -45.2 82.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.44 -36.99 84.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -69.6 -52.05 29.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -0.975 . . . . 0.0 110.023 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.687 ' HB3' HD13 ' A' ' 43' ' ' ILE . 10.9 m -70.25 -35.84 74.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.709 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 8.1 p -66.88 -43.65 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.13 -0.981 . . . . 0.0 109.898 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -63.68 -32.22 73.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.907 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -72.17 -43.1 65.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 109.875 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.866 HG23 ' HB2' ' A' ' 39' ' ' ASN . 64.8 mt -54.47 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.099 -1.001 . . . . 0.0 109.822 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.0 -50.17 12.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.46 -0.775 . . . . 0.0 110.142 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.1 -25.96 61.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.583 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.2 p -76.94 -20.31 56.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.408 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 73.2 mt-30 -46.4 -33.76 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.37 16.11 80.97 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.5 -159.3 19.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.04 105.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -1.164 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.01 HD23 HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -61.21 -18.38 57.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.66 81.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 46.4 t -68.69 -44.81 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 109.547 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.616 HG23 ' CB ' ' A' ' 78' ' ' ALA . 23.9 m -54.52 -50.15 68.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.0 m -51.31 -48.83 62.23 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 24.0 t-20 -70.83 -33.92 71.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 108.983 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -70.37 -59.15 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.509 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.738 HG22 HD11 ' A' ' 96' ' ' LEU . 55.0 mt -63.21 -49.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.828 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.0 -52.23 64.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.77 ' HB3' HG21 ' A' ' 29' ' ' THR . 32.0 t0 -55.23 -50.53 69.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.22 -42.88 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.738 HD11 HG22 ' A' ' 92' ' ' ILE . 7.1 mt -70.26 -41.05 73.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.824 HG23 ' ND2' ' A' ' 108' ' ' ASN . 99.3 m -62.4 -48.64 78.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 28.7 m -64.43 -34.26 77.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 109.483 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.95 -44.99 68.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.9 m-85 -46.97 -56.03 7.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.873 . . . . 0.0 109.698 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.537 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -70.91 -32.09 68.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.762 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 98' ' ' SER . 88.2 mm-40 -75.91 -18.42 59.39 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.781 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 61.2 p -103.81 -59.85 1.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.058 -1.026 . . . . 0.0 111.101 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.781 ' OG1' HG23 ' A' ' 106' ' ' VAL . 12.6 p -126.73 -42.61 1.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.672 -1.268 . . . . 0.0 110.925 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.82 45.25 0.97 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.781 HG23 ' OG1' ' A' ' 104' ' ' THR . 12.1 t -109.83 172.52 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -1.125 . . . . 0.0 109.219 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.2 m -73.68 121.16 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.824 ' ND2' HG23 ' A' ' 97' ' ' THR . 18.0 p30 -70.74 -23.36 62.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.5 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 113' ' ' SER . 23.3 t -54.78 -30.27 56.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.574 -0.704 . . . . 0.0 110.601 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -69.04 -55.0 12.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.878 -1.139 . . . . 0.0 110.234 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 115' ' ' ILE . 59.8 t80 -76.16 -50.4 14.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.564 HD12 ' OD1' ' A' ' 108' ' ' ASN . 14.5 mt -56.35 -42.56 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.139 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 109' ' ' SER . 32.2 t -56.23 -46.86 79.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 109.554 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.41 -49.83 74.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.262 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.885 HG12 ' HB1' ' A' ' 71' ' ' ALA . 89.7 mt -65.93 -34.82 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -54.06 -47.02 72.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 109.52 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.8 p -72.66 -33.9 66.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.63 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.02 -44.16 77.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.01 HG22 HD23 ' A' ' 85' ' ' LEU . 97.5 mt -57.82 -38.83 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.02 -33.79 75.18 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -61.68 -36.87 82.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.491 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 77.1 m-85 -66.23 -36.84 84.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.296 0.569 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.712 ' C ' HG21 ' A' ' 104' ' ' THR . 3.5 t -152.17 151.38 27.57 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.645 ' N ' HG21 ' A' ' 104' ' ' THR . 42.4 Cg_endo -64.8 -35.5 45.07 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 113.01 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.547 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 49.4 p90 -81.69 -2.16 49.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.661 -1.274 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.691 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -82.7 -28.65 30.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 108.688 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 m -118.82 151.11 38.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.484 -0.76 . . . . 0.0 109.161 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' O ' ' OD2' ' A' ' 16' ' ' ASP . 27.0 mtpt -70.95 -36.16 72.49 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.698 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -67.06 -49.52 64.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.932 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.5 m-20 -71.37 -29.16 64.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -66.81 -49.88 64.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.433 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.2 p30 -54.8 -53.38 56.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.028 . . . . 0.0 110.149 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -57.65 -35.72 70.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 0.0 108.863 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 75.5 t80 -61.09 -37.32 82.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.479 -0.763 . . . . 0.0 109.26 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 70' ' ' PHE . 31.6 mm -75.14 -48.44 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.631 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -62.4 -48.28 80.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 2.1 t -60.75 -30.71 70.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.972 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.765 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 44.9 t80 -68.7 -52.0 35.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 0.0 110.186 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.404 HD12 ' ND2' ' A' ' 45' ' ' ASN . 67.2 mt -63.15 -56.02 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.99 . . . . 0.0 109.958 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -59.71 -30.88 69.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.01 -45.37 23.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -70.38 -31.66 69.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 50.3 m -60.5 -30.95 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.5 p-10 -106.29 7.39 31.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.01 . . . . 0.0 110.651 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.995 HG21 ' HB2' ' A' ' 94' ' ' ASP . 29.1 m -89.62 -79.36 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.807 -1.183 . . . . 0.0 110.177 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -81.01 -103.05 0.32 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -132.81 -58.28 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.325 -1.103 . . . . 0.0 109.305 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.4 m-85 43.84 90.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.082 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 11.1 p -59.54 162.99 4.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -52.72 -36.94 58.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.876 . . . . 0.0 109.278 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.21 -45.51 79.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.547 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 4.2 mp0 -63.93 -35.48 80.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.184 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 58.3 mtt -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.081 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 94.8 mt-10 -70.36 -37.46 74.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.113 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -68.75 -44.65 73.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.251 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.545 ' CE ' ' CE1' ' A' ' 32' ' ' PHE . 61.2 mtt -56.85 -31.98 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 108.935 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 p -70.13 -23.35 63.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.38 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 38' ' ' GLU . 62.7 mt -87.88 -26.25 22.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.716 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 73' ' ' SER . 53.4 mt -121.32 157.09 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.449 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.93 -77.2 2.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.404 ' ND2' HD12 ' A' ' 23' ' ' ILE . 95.6 m-20 -65.02 -38.46 90.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -1.162 . . . . 0.0 108.766 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -58.46 -35.1 71.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.06 -34.51 75.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.552 -0.718 . . . . 0.0 109.247 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 61.4 ttp -52.96 -41.95 65.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 109.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.12 74.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 108.583 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.8 66.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 48' ' ' MET . 57.6 mtt . . . . . 0 C--N 1.305 -1.358 0 O-C-N 121.563 -0.711 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 9.8 mp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.219 0.533 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 96.7 mt-30 -54.71 -40.14 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -37.4 68.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.011 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.16 -52.62 11.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.67 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -48.06 -25.26 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.608 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 56.7 mtp -72.71 -27.42 62.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.963 . . . . 0.0 110.023 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -35.56 65.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 110.038 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.615 ' CE1' HG23 ' A' ' 19' ' ' ILE . 88.8 t80 -53.84 -40.71 66.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.792 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.951 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.69 -36.35 83.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 24.8 m -69.23 -34.16 74.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.783 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 43' ' ' ILE . 37.1 m -70.3 -49.63 47.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.874 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' ALA . 19.1 m -57.73 -35.04 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -70.62 -43.35 69.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 0.0 109.691 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.567 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 26.6 mt-30 -66.22 -50.88 62.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.879 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -53.49 -50.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.22 -53.32 7.47 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 110.209 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.63 -24.28 55.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 79.9 p -76.7 -20.23 56.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.547 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 55.2 mt-30 -50.34 -31.54 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 109.51 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.39 14.75 81.68 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.42 -162.88 23.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -1.13 . . . . 0.0 109.437 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.047 HD23 HG22 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -62.21 -20.21 63.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.98 -38.33 65.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.446 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 72.2 t -70.55 -47.5 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.569 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 19.7 m -51.95 -48.72 64.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 116' ' ' ARG . 4.3 m -51.07 -46.25 61.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 81.3 m-20 -71.0 -39.18 72.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.422 -0.799 . . . . 0.0 109.026 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -67.48 -59.2 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.765 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 69.7 mt -60.33 -47.24 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.54 -51.31 65.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.995 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.5 m-20 -60.73 -33.54 73.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.877 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -71.96 -42.59 66.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 108.969 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -70.38 -38.45 74.71 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.508 -0.745 . . . . 0.0 109.777 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.563 HG22 ' CE2' ' A' ' 101' ' ' TYR . 77.8 m -63.85 -51.5 64.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 109.917 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 85.7 p -58.4 -34.78 71.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 0.0 109.774 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.23 -44.56 68.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -46.96 -54.81 9.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.563 ' CE2' HG22 ' A' ' 97' ' ' THR . 3.7 m-85 -72.03 -32.09 66.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 98' ' ' SER . 92.5 mm-40 -77.19 -18.57 57.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 18' ' ' PHE . 81.7 p -104.52 -60.18 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.087 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.712 HG21 ' C ' ' A' ' 7' ' ' THR . 29.6 p -127.16 -43.01 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.207 . . . . 0.0 110.762 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.48 44.62 1.05 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 28.2 t -104.81 170.06 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 108.891 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.586 ' N ' HG12 ' A' ' 106' ' ' VAL . 22.9 m -68.15 121.14 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.61 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 18.9 p-10 -70.59 -23.51 62.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 32.9 t -62.03 -30.56 71.05 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 110.355 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -65.81 -54.51 25.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.831 -1.168 . . . . 0.0 110.343 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 29.1 t80 -75.69 -53.95 7.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.035 . . . . 0.0 110.181 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 54.5 mt -56.92 -34.27 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 12.7 t -55.89 -43.14 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 0.0 109.763 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 74.8 mm-40 -71.73 -38.86 70.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.951 HG12 ' HB1' ' A' ' 71' ' ' ALA . 71.5 mt -59.54 -45.64 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 89' ' ' THR . 62.3 mtp180 -54.2 -49.09 70.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.689 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.8 m -57.85 -33.71 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 0.0 109.071 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 82.3 mt -74.53 -41.88 59.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.047 HG22 HD23 ' A' ' 85' ' ' LEU . 72.2 mt -59.24 -35.65 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.199 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.29 63.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.7 ttm -60.83 -45.1 95.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.147 . . . . 0.0 109.515 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 89.8 m-85 -58.99 -37.28 76.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.489 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.8 mtp -58.45 -36.76 74.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -1.172 . . . . 0.0 109.474 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.34 10.73 79.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.466 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 53.1 tt0 -109.07 156.09 20.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -1.134 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.466 ' N ' ' HG2' ' A' ' 4' ' ' GLN . . . -154.37 153.85 32.31 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 65.5 m-20 -49.35 -33.23 12.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.215 -0.928 . . . . 0.0 109.409 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.662 ' HA ' HG21 ' A' ' 104' ' ' THR . 6.6 t -129.12 150.09 74.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HG3' ' CD2' ' A' ' 18' ' ' PHE . 42.7 Cg_endo -65.3 -31.98 51.92 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.65 2.233 . . . . 0.0 112.216 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.588 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 45.5 p90 -89.35 23.41 2.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.031 -1.043 . . . . 0.0 109.445 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.583 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.72 -33.67 8.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 108.584 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 3.2 t -116.62 161.65 18.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.542 -0.724 . . . . 0.0 109.053 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' CG ' HG13 ' A' ' 58' ' ' ILE . 4.5 ttpm? -72.61 -41.52 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 109.761 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.6 -31.82 57.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.546 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' CG ' ' HA ' ' A' ' 8' ' ' PRO . 20.4 t30 -71.69 -33.01 68.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.96 -37.57 67.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.131 -0.98 . . . . 0.0 110.064 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.683 ' HB3' ' HE1' ' A' ' 48' ' ' MET . 87.7 m-20 -56.25 -56.56 19.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.118 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.01 -42.39 62.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 48.1 t80 -58.33 -41.11 83.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.479 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.681 HG21 ' C ' ' A' ' 44' ' ' GLY . 22.1 mm -67.44 -49.34 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.16 -49.16 78.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 0.0 109.918 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.8 t -62.07 -30.76 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 110.06 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 16.3 t80 -66.75 -44.19 82.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 0.0 109.92 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.837 HG21 ' SD ' ' A' ' 40' ' ' MET . 44.2 mm -71.06 -55.97 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 109.812 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -55.63 -37.54 68.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.825 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -46.25 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.823 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -62.37 -36.71 83.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 91.7 p -66.95 -22.33 65.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.893 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -105.38 7.18 33.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.872 HG21 ' HB2' ' A' ' 94' ' ' ASP . 7.7 m -101.19 -73.24 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 110.241 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -107.21 0.87 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -124.83 -64.93 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -1.112 . . . . 0.0 109.736 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.701 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 34.6 m-85 44.82 72.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.206 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -59.71 165.09 3.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.33 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -52.28 -30.09 26.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.187 -0.945 . . . . 0.0 109.111 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.58 -36.01 80.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 81' ' ' GLN . 43.0 mt-30 -70.96 -33.11 70.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.309 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.548 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 61.8 mtt -63.63 -29.44 70.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' OG ' ' A' ' 41' ' ' SER . 86.7 tt0 -57.0 -37.26 71.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 108.913 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' HG12 ' A' ' 77' ' ' ILE . 79.3 m-20 -58.47 -31.69 68.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.837 ' SD ' HG21 ' A' ' 23' ' ' ILE . 51.2 ttp -55.7 -31.79 62.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.375 -0.828 . . . . 0.0 108.852 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.735 ' OG ' HD12 ' A' ' 42' ' ' LEU . 85.4 p -55.64 -24.17 32.17 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.298 -0.876 . . . . 0.0 108.96 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.9 mp -106.5 -25.37 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.851 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.787 ' HB ' HD11 ' A' ' 77' ' ' ILE . 88.3 mt -124.54 150.98 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.609 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.681 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.34 -108.36 3.54 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -53.08 -23.11 7.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -1.197 . . . . 0.0 108.709 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -68.14 -34.78 76.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 47' ' ' LEU . 2.4 tm? -52.32 -34.61 47.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.683 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 68.2 mtt -58.21 -37.1 74.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.44 -31.39 71.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.41 79.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.897 . . . . 0.0 109.27 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.483 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 61.2 mtt -62.73 -31.12 71.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 109.372 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.52 -30.1 60.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.254 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -68.67 -25.39 64.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 109.204 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.53 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 88.8 mmm -67.44 -29.86 69.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.32 9.27 67.33 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.04 16.34 19.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.559 ' O ' HD13 ' A' ' 58' ' ' ILE . 16.3 ptt85 -127.8 112.48 14.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -1.123 . . . . 0.0 109.498 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.992 HG21 HD11 ' A' ' 63' ' ' LEU . 20.6 mm -116.07 155.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.314 -0.866 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 p -139.95 164.29 38.72 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 48.4 Cg_endo -69.6 -37.19 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.546 2.164 . . . . 0.0 111.629 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -72.7 -33.11 66.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.304 -0.872 . . . . 0.0 109.296 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HD2' HG23 ' A' ' 59' ' ' THR . 29.9 mttm -74.72 -51.37 14.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.992 HD11 HG21 ' A' ' 58' ' ' ILE . 51.2 mt -64.35 -26.98 68.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 57.8 tt0 -56.56 -45.3 81.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.09 -43.79 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.593 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.942 HD21 HD11 ' A' ' 47' ' ' LEU . 13.6 tp -69.01 -40.69 78.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.667 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 41.4 t0 -48.77 -43.89 38.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.7 mtm -64.6 -37.04 86.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.548 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.09 -45.15 79.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.93 ' O ' HG13 ' A' ' 74' ' ' VAL . 92.1 t80 -52.94 -40.5 63.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.46 -44.1 88.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.648 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 87.3 p -69.27 -37.83 78.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 43' ' ' ILE . 79.8 p -70.09 -44.95 68.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.949 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 70' ' ' PHE . 11.7 m -65.97 -34.96 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.343 -0.848 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -69.1 -46.26 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.65 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 72' ' ' SER . 96.4 mt-30 -58.94 -36.13 74.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 109.969 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.787 HD11 ' HB ' ' A' ' 43' ' ' ILE . 72.5 mt -68.81 -54.87 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.701 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.55 -40.82 33.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 110.524 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.89 -28.81 64.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 109.464 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.4 p -80.89 -20.29 42.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HB3' ' NE2' ' A' ' 36' ' ' GLN . 60.2 mm-40 -93.29 117.94 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.639 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.95 101.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -45.01 -36.0 4.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -64.55 92.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 123' ' ' ALA . 6.4 mp -76.11 -8.55 57.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.674 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.2 -44.27 84.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG13 ' N ' ' A' ' 88' ' ' THR . 9.9 p -70.45 -48.29 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.183 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.607 ' N ' HG13 ' A' ' 87' ' ' VAL . 53.4 m -52.37 -36.04 52.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.928 -1.108 . . . . 0.0 108.404 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.493 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 31.9 m -55.53 -49.39 72.77 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 59.6 t30 -70.74 -37.27 73.44 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.21 -59.21 3.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.456 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.805 HG22 HD11 ' A' ' 96' ' ' LEU . 49.2 mt -62.29 -48.92 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -58.97 -51.21 71.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.607 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.872 ' HB2' HG21 ' A' ' 29' ' ' THR . 79.7 m-20 -55.3 -45.36 76.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -59.33 -44.1 92.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.21 -0.931 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.805 HD11 HG22 ' A' ' 92' ' ' ILE . 2.8 mt -70.09 -33.46 71.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.0 m -65.25 -49.04 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.325 -0.859 . . . . 0.0 109.844 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 96.8 p -66.61 -39.69 88.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 0.0 109.813 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 103' ' ' THR . . . -60.85 -40.02 91.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.978 . . . . 0.0 109.599 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.8 m-85 -52.97 -56.47 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.568 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.8 m-85 -72.18 -32.4 66.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.421 -0.799 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 98' ' ' SER . 93.6 mm-40 -70.34 -18.77 63.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.851 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.9 p -107.12 -60.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.116 . . . . 0.0 111.2 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -127.47 -42.84 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.647 -1.283 . . . . 0.0 111.156 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 112.14 46.68 0.74 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 6.7 t -102.87 171.92 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.197 -1.178 . . . . 0.0 108.984 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 106' ' ' VAL . 15.5 m -73.86 120.26 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.598 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 21.1 p-10 -72.18 -29.09 63.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 113' ' ' SER . 94.0 p -58.73 -43.26 90.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 110.502 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.8 ttp85 -57.11 -53.7 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 0.0 110.023 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.108 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.3 t80 -75.19 -53.55 8.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 108' ' ' ASN . 40.9 mt -56.29 -34.33 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.8 t -55.8 -43.15 76.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.043 -1.035 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.78 -36.66 73.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.108 HD11 ' CE2' ' A' ' 111' ' ' PHE . 51.0 mt -72.3 -41.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 116' ' ' ARG . 11.8 ttp85 -54.09 -41.26 68.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -0.84 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.529 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.1 mt -69.61 -43.97 71.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.875 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.704 HG22 HD23 ' A' ' 85' ' ' LEU . 73.0 mt -57.89 -47.24 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.851 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.97 -27.19 64.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.2 ttm -67.62 -42.35 82.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 97.4 m-85 -59.71 -31.96 70.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -59.79 -35.92 75.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 109.558 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.7 -38.58 73.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.29 74.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p -66.01 -25.19 66.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.491 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 86.6 m-20 -73.71 -30.65 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.59 -46.05 90.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.841 HG13 ' CD1' ' A' ' 131' ' ' TYR . 3.3 p -64.18 -31.76 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.465 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.841 ' CD1' HG13 ' A' ' 130' ' ' VAL . 35.9 p90 179.59 175.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.08 124.23 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.3 m -49.7 152.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.538 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -113.72 153.44 28.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.56 -30.22 41.74 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.0 t -115.18 141.36 48.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -1.15 . . . . 0.0 109.5 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.96 -35.23 72.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.141 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.46 16.24 60.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -108.37 144.55 35.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -73.19 138.87 45.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.403 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.21 -20.16 63.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.666 HG23 ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -157.98 156.3 27.9 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 40.8 Cg_endo -64.85 -35.49 44.55 Favored 'Trans proline' 0 C--O 1.216 -0.598 0 C-N-CA 122.804 2.336 . . . . 0.0 112.941 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.589 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -84.56 12.46 6.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.5 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.666 ' CB ' HG23 ' A' ' 7' ' ' THR . 2.2 m -102.36 -19.53 14.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.192 -0.943 . . . . 0.0 108.757 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 66.1 m -119.63 158.06 27.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.432 -0.793 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' CG ' HG13 ' A' ' 58' ' ' ILE . 9.0 ttpt -74.38 -40.31 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.757 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -78.91 -36.65 41.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 4.9 t-20 -72.37 -29.63 63.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.917 . . . . 0.0 109.991 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.33 -51.24 21.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -0.944 . . . . 0.0 110.308 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 13' ' ' ALA . 1.7 p30 -54.95 -46.77 75.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG ' ' A' ' 16' ' ' ASP . . . -58.53 -40.56 83.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -0.97 . . . . 0.0 109.554 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.792 ' HA ' HG21 ' A' ' 103' ' ' THR . 51.5 t80 -63.64 -37.21 86.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 109.803 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.889 HG23 ' CE1' ' A' ' 70' ' ' PHE . 25.1 mm -71.78 -37.14 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 109.691 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -68.12 -49.42 61.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -64.66 -30.67 71.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 110.186 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.918 ' CE2' HD12 ' A' ' 96' ' ' LEU . 37.9 t80 -63.35 -51.51 65.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.98 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.3 mt -60.59 -56.08 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 109.98 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 m -59.67 -32.6 70.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -77.66 -45.66 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.865 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -67.04 -33.21 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 110.054 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.499 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 62.7 m -63.48 -27.35 69.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 7.52 31.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 110.112 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 94' ' ' ASP . 25.8 m -92.58 -77.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.963 -1.085 . . . . 0.0 110.057 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -104.08 0.6 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 4.2 m -131.13 -60.45 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -1.1 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 8.0 m-85 44.25 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 p -59.71 160.39 7.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -52.8 -41.96 64.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -57.88 -36.02 71.8 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.477 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 98.3 mm-40 -69.96 -32.74 71.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.325 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.499 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 65.5 mtt -63.51 -32.0 73.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.247 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.3 -45.26 88.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -55.66 -39.26 70.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.98 ' SD ' HG23 ' A' ' 23' ' ' ILE . 63.2 mtt -57.29 -32.05 66.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.359 -0.838 . . . . 0.0 108.831 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.556 ' OG ' HD12 ' A' ' 42' ' ' LEU . 30.3 p -70.47 -23.52 62.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.35 -0.844 . . . . 0.0 109.39 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.556 HD12 ' OG ' ' A' ' 41' ' ' SER . 6.7 mp -88.49 -23.46 23.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.554 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.008 HG21 ' CB ' ' A' ' 73' ' ' SER . 48.6 mt -131.22 143.0 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.162 -0.961 . . . . 0.0 109.296 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.65 -83.75 0.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.574 HD21 HD12 ' A' ' 23' ' ' ILE . 91.1 m-20 -61.3 -27.09 68.23 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.154 -1.203 . . . . 0.0 108.358 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -68.82 -35.07 76.52 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 66' ' ' LEU . 60.3 mt -53.33 -38.24 63.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.501 -0.75 . . . . 0.0 109.306 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ttt -52.79 -41.35 64.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.63 70.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.0 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.83 -38.0 85.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 109.125 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 54.9 mtt -56.7 -30.63 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.261 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -60.15 -29.36 68.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.197 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.17 -25.64 66.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.432 -0.792 . . . . 0.0 109.244 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.613 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 92.2 mmm -62.55 -27.75 69.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.59 8.29 62.48 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.77 11.98 29.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' ' HE2' ' A' ' 54' ' ' MET . 16.3 ptt180 -124.11 112.4 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.445 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.871 HG21 HD22 ' A' ' 63' ' ' LEU . 26.0 mm -116.54 149.99 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.182 -0.948 . . . . 0.0 109.596 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -137.92 159.54 68.2 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 45.0 Cg_endo -66.75 -52.0 0.8 Allowed 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.622 2.215 . . . . 0.0 111.739 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m -46.26 -52.05 13.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.168 -0.958 . . . . 0.0 109.59 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -81.25 -52.38 7.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.973 . . . . 0.0 110.204 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 58' ' ' ILE . 15.4 tp -55.88 -42.68 76.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.55 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 94.7 mt-30 -55.76 -30.97 62.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.335 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.23 -29.3 68.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 108.958 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 47' ' ' LEU . 10.4 tt -74.14 -45.2 50.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.256 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.578 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.4 t0 -48.66 -42.53 34.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 89.7 mtp -64.39 -45.61 86.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.812 . . . . 0.0 109.598 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.59 78.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.395 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.909 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.5 t80 -53.12 -38.93 63.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.3 -39.76 74.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -68.74 -40.79 79.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.633 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 1.008 ' CB ' HG21 ' A' ' 43' ' ' ILE . 8.9 m -70.05 -47.87 60.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.628 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 70' ' ' PHE . 23.0 m -57.72 -35.08 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.3 -0.875 . . . . 0.0 109.611 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 119' ' ' ILE . . . -72.22 -35.19 68.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.8 tt0 -74.34 -44.15 53.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.82 -47.21 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.51 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.47 -52.8 8.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 109.803 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.86 -29.22 64.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.166 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 27.6 t -69.61 -20.19 63.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.292 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.477 ' OE1' ' HG3' ' A' ' 36' ' ' GLN . 45.2 mt-30 -54.64 -29.93 53.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.6 13.19 80.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.1 -156.94 29.09 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.602 ' O ' HG12 ' A' ' 87' ' ' VAL . 55.9 t0 -70.45 98.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -1.213 . . . . 0.0 109.403 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.048 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.4 tt -57.6 -16.34 10.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.464 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.63 -39.06 95.22 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.7 p -69.77 -37.59 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 109.602 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 78' ' ' ALA . 44.4 m -51.58 -32.06 27.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.088 -1.008 . . . . 0.0 108.735 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.79 HG23 ' HG2' ' A' ' 116' ' ' ARG . 22.1 m -59.94 -47.31 86.33 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 25.9 m120 -70.86 -33.49 70.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.426 -0.796 . . . . 0.0 109.018 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.549 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -71.65 -59.32 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.767 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.717 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 54.8 mt -63.34 -42.53 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -62.86 -52.36 63.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' HB3' HG21 ' A' ' 29' ' ' THR . 34.1 t0 -55.26 -50.48 69.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 109.332 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -55.9 -45.41 78.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.918 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -69.97 -33.85 72.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.897 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -68.97 -49.27 59.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 110.0 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.5 p -62.26 -34.44 76.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.928 . . . . 0.0 109.907 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.83 -42.65 73.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.619 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.3 m-85 -46.94 -54.75 9.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.545 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.4 m-85 -71.66 -32.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 110.491 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 98' ' ' SER . 64.5 mm-40 -80.58 -18.45 48.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 110.129 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 18' ' ' PHE . 54.7 p -101.45 -59.05 1.77 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.055 -1.028 . . . . 0.0 111.053 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.452 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 23.0 m -126.05 -42.67 1.86 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 110.868 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 107.64 46.69 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 107' ' ' VAL . 5.0 t -114.69 172.97 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -1.159 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.605 ' H ' HG12 ' A' ' 106' ' ' VAL . 2.8 m -73.1 120.5 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.306 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.897 ' ND2' HG23 ' A' ' 97' ' ' THR . 12.4 p30 -70.84 -24.14 62.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.615 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 24.8 t -56.07 -30.2 61.62 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.505 -0.747 . . . . 0.0 110.342 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.482 ' HG3' HG23 ' A' ' 107' ' ' VAL . 35.4 mmt180 -67.94 -54.61 17.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.909 -1.119 . . . . 0.0 110.234 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.908 ' CD2' HD21 ' A' ' 96' ' ' LEU . 1.2 t80 -75.4 -54.08 7.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.496 HD12 ' OD1' ' A' ' 108' ' ' ASN . 52.4 mt -56.41 -29.95 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.548 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 6.0 t -58.13 -47.33 83.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.0 -1.063 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 85.5 tt0 -72.22 -37.7 69.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.681 HG12 ' HB1' ' A' ' 71' ' ' ALA . 47.1 mt -56.56 -46.29 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.917 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG23 ' A' ' 89' ' ' THR . 74.3 mtt180 -54.41 -49.12 70.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -59.17 -33.34 70.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.0 109.004 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.488 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 83.8 mt -73.75 -40.85 63.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.461 -0.774 . . . . 0.0 110.232 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.839 HG22 HD21 ' A' ' 85' ' ' LEU . 56.9 mt -61.08 -34.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 0.0 109.595 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.9 -32.45 70.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -65.64 -42.59 91.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.426 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 96.2 m-85 -63.23 -29.03 70.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.048 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -67.83 -32.86 73.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.42 -31.44 70.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.72 61.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 109.379 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.5 p -74.45 -21.41 59.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 0.0 109.342 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.607 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -63.26 -26.31 68.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -73.87 -16.69 61.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.444 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -76.52 -42.62 42.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.235 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.908 HG13 ' CD1' ' A' ' 131' ' ' TYR . 4.4 p -64.51 -29.23 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.908 ' CD1' HG13 ' A' ' 130' ' ' VAL . 41.8 p90 179.15 172.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.03 116.55 21.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.5 m -58.67 156.74 10.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.25 77.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 -166.64 40.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -120.63 148.65 43.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -1.139 . . . . 0.0 109.462 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -57.17 -36.77 71.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.61 58.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 1' ' ' GLY . 93.9 mt-30 -115.17 156.99 24.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -1.126 . . . . 0.0 109.456 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 11' ' ' SER . . . -66.28 140.08 58.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 16.7 m120 -52.68 -20.71 3.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.326 -0.859 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.557 ' OG1' ' CZ2' ' A' ' 9' ' ' TRP . 4.5 t -143.5 152.51 56.96 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.127 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 42.6 Cg_endo -65.04 -35.4 42.88 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.466 2.111 . . . . 0.0 112.787 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.716 ' O ' HD22 ' A' ' 63' ' ' LEU . 49.5 p90 -80.82 7.25 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.626 -1.296 . . . . 0.0 109.737 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 7' ' ' THR . 0.9 OUTLIER -92.31 -20.57 20.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 108.718 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 5' ' ' ALA . 1.5 t -136.69 144.66 44.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 108.949 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HD3' HD11 ' A' ' 58' ' ' ILE . 22.1 mtmm -60.42 -46.43 90.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.145 -0.972 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.3 71.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.355 -0.841 . . . . 0.0 109.476 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 14.1 m120 -72.36 -38.43 68.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 109.63 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -69.39 -51.8 33.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.835 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 48' ' ' MET . 17.2 m-20 -54.37 -51.11 65.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.29 91.35 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.112 -0.993 . . . . 0.0 108.7 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.517 ' CZ ' ' HG ' ' A' ' 96' ' ' LEU . 58.8 t80 -58.56 -37.23 75.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.435 -0.791 . . . . 0.0 109.534 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.773 HD12 ' CD1' ' A' ' 70' ' ' PHE . 20.8 mm -71.01 -37.86 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -68.51 -50.02 55.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -61.26 -30.83 70.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 34.4 t80 -65.12 -49.13 71.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 110.207 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.713 HD12 HD21 ' A' ' 45' ' ' ASN . 77.2 mt -61.99 -56.18 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -0.979 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -60.21 -32.12 70.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.913 . . . . 0.0 109.868 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.84 -44.46 27.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.096 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . . . -69.97 -29.27 66.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.243 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.3 m -64.68 -28.5 69.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.963 . . . . 0.0 110.13 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -105.9 7.49 32.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 110.277 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 20.1 m -90.72 -78.5 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 -103.33 0.39 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.9 t -131.24 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -1.132 . . . . 0.0 109.445 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 12.5 m-85 43.73 88.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.315 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.2 m -59.73 161.05 6.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -52.64 -36.57 56.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.61 -36.05 83.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.452 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 99.8 mm-40 -71.91 -33.97 68.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 109.283 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.64 -33.71 76.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.08 -47.25 85.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.191 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' ND2' HG12 ' A' ' 77' ' ' ILE . 34.5 t-20 -55.65 -40.71 72.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.578 ' HE2' HG12 ' A' ' 23' ' ' ILE . 83.1 mtp -61.49 -31.85 71.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 109.11 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 m -70.3 -23.94 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 ' N ' HD22 ' A' ' 42' ' ' LEU . 4.2 mm? -90.55 -23.26 20.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.922 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.636 HG21 ' CB ' ' A' ' 73' ' ' SER . 64.0 mt -125.0 157.01 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.583 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.704 ' HA2' HD12 ' A' ' 47' ' ' LEU . . . 89.42 -83.85 1.41 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.726 ' OD1' HG22 ' A' ' 19' ' ' ILE . 92.5 m-20 -62.67 -33.87 75.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -1.217 . . . . 0.0 109.009 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -60.51 -35.28 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.362 -0.836 . . . . 0.0 109.232 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.704 HD12 ' HA2' ' A' ' 44' ' ' GLY . 6.5 mt -57.28 -35.77 70.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.811 . . . . 0.0 109.46 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.44 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 69.7 mtm -52.84 -39.92 62.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.274 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.49 -32.93 72.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.875 . . . . 0.0 109.182 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.18 72.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.84 . . . . 0.0 109.206 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.468 ' O ' ' HG2' ' A' ' 54' ' ' MET . 64.6 mtt -56.23 -34.23 66.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.257 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -56.49 -27.92 58.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.194 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -68.77 -23.44 64.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.355 -0.841 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.533 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 75.9 mmm -57.2 -26.62 60.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.71 8.0 88.06 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.1 21.19 9.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.533 ' O ' ' CE ' ' A' ' 54' ' ' MET . 11.8 ptt180 -128.85 111.93 13.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.66 ' CG2' HD12 ' A' ' 63' ' ' LEU . 30.1 mm -118.12 151.3 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 8.5 p -146.3 161.06 40.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 46.7 Cg_endo -68.46 -43.42 4.2 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.629 2.22 . . . . 0.0 111.655 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -62.22 -37.38 85.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.155 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.13 -51.94 9.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.291 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 9' ' ' TRP . 1.0 OUTLIER -62.89 -40.19 96.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.289 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 59.1 tp60 -54.61 -40.11 68.56 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.359 -0.838 . . . . 0.0 108.955 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.85 68.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 108.959 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tp -73.51 -46.65 46.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.279 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.505 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 31.0 t0 -48.08 -46.79 34.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -0.853 . . . . 0.0 109.732 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.55 -38.43 81.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 109.75 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.75 76.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.517 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 19' ' ' ILE . 84.1 t80 -55.23 -35.36 64.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.03 -37.33 85.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.805 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.6 m -67.77 -31.56 71.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.822 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.636 ' CB ' HG21 ' A' ' 43' ' ' ILE . 92.5 p -69.3 -49.12 58.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.897 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' O ' HD11 ' A' ' 92' ' ' ILE . 35.3 m -60.82 -35.01 61.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.436 -0.79 . . . . 0.0 109.982 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.57 -47.56 39.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.749 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.471 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.3 mt-30 -64.73 -50.47 66.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 109.887 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.505 HD13 ' HG2' ' A' ' 40' ' ' MET . 79.2 mt -55.01 -50.84 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 109.907 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.612 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -74.9 -51.86 12.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 109.662 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.815 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.92 -30.81 66.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 92.2 p -72.66 -20.47 61.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.432 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.592 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 83.3 mt-30 -49.3 -40.52 35.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.918 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.15 5.19 66.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -100.05 -155.39 27.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' HG12 ' A' ' 87' ' ' VAL . 53.8 t0 -66.06 105.39 1.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -1.088 . . . . 0.0 109.376 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 119' ' ' ILE . 23.7 tp -67.75 -14.01 62.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.03 -32.41 66.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.2 p -69.88 -35.71 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -1.174 . . . . 0.0 109.527 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 92' ' ' ILE . 73.7 m -51.59 -32.4 28.47 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.1 -1.0 . . . . 0.0 108.679 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 62.8 m -58.65 -46.62 86.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 79.7 m-20 -70.78 -38.24 73.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.467 -0.771 . . . . 0.0 109.096 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -68.32 -56.07 9.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.904 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.76 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 61.4 mt -66.7 -44.05 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.761 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -64.49 -50.85 65.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -0.958 . . . . 0.0 109.892 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.2 m-20 -55.32 -43.13 74.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 109.946 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 26' ' ' ALA . . . -67.91 -40.79 83.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.283 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -70.11 -34.54 73.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.495 -0.753 . . . . 0.0 109.804 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.674 HG23 ' ND2' ' A' ' 108' ' ' ASN . 55.3 m -67.64 -51.13 53.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.03 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 t -60.14 -35.29 74.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 109.887 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.85 -43.29 72.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.598 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -47.1 -54.97 9.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.027 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 5.3 m-85 -71.84 -32.69 67.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.468 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 98' ' ' SER . 96.5 mm-40 -75.9 -18.46 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.217 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 99' ' ' ALA . 55.9 p -104.77 -59.57 1.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.907 -1.12 . . . . 0.0 110.996 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.671 ' OG1' HG23 ' A' ' 106' ' ' VAL . 25.6 p -126.41 -42.81 1.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.702 -1.249 . . . . 0.0 110.921 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.61 46.6 0.96 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.59 -1.29 . . . . 0.0 109.94 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.671 HG23 ' OG1' ' A' ' 104' ' ' THR . 5.7 t -108.22 172.44 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.188 -1.183 . . . . 0.0 109.101 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' H ' HG12 ' A' ' 106' ' ' VAL . 11.3 m -73.4 120.77 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 109.668 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.674 ' ND2' HG23 ' A' ' 97' ' ' THR . 14.4 p30 -71.35 -24.09 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.818 . . . . 0.0 109.779 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 113' ' ' SER . 50.2 m -60.18 -30.66 69.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 0.0 110.332 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -68.31 -54.76 15.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.363 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 115' ' ' ILE . 33.1 t80 -75.75 -50.39 15.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.046 -1.034 . . . . 0.0 109.992 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.633 HG21 ' HB1' ' A' ' 93' ' ' ALA . 34.4 mt -56.43 -39.09 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.27 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' SER . 22.1 m -59.89 -38.53 82.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.999 -1.063 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.45 -39.83 85.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.411 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 111' ' ' PHE . 84.7 mt -70.82 -42.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 16.4 ttt180 -54.34 -42.87 70.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -73.0 -33.76 65.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.964 . . . . 0.0 109.664 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.7 mt -68.93 -42.4 76.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.808 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' A' ' 85' ' ' LEU . 61.9 mt -57.66 -39.65 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.68 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.59 -28.31 73.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -69.09 -36.76 77.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 109.548 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.27 -35.43 80.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.559 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 85' ' ' LEU . . . -63.46 -32.48 73.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -70.64 -35.77 73.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.87 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.85 -32.81 74.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -59.5 -32.27 70.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.59 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -66.98 -19.03 65.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -72.32 -26.41 61.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -65.9 -48.23 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.816 HG23 ' CD1' ' A' ' 131' ' ' TYR . 16.3 m -58.29 -31.49 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.449 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.816 ' CD1' HG23 ' A' ' 130' ' ' VAL . 37.3 p90 -179.2 -175.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.37 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -83.64 119.99 25.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.3 m -51.05 -38.19 50.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.6 63.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.13 6.99 66.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.5 m -60.74 -34.29 74.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -1.122 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.477 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -57.88 -37.64 74.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -1.165 . . . . 0.0 109.417 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.07 145.36 46.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -60.15 -35.81 76.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -1.167 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.07 102.94 1.82 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.166 -0.958 . . . . 0.0 109.553 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 68.3 m-20 -88.31 20.42 3.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.944 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -133.77 151.69 77.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.944 ' HD2' HG22 ' A' ' 7' ' ' THR . 46.5 Cg_endo -67.78 -31.49 31.95 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.73 2.287 . . . . 0.0 111.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.817 ' O ' HD22 ' A' ' 63' ' ' LEU . 40.1 p90 -96.24 -14.26 22.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 m -70.03 -7.22 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -139.6 151.44 46.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.528 ' CG ' HG13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -71.13 -40.28 71.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.567 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.16 -34.58 61.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.349 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 54.3 m-20 -71.56 -29.37 64.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -69.62 -40.85 76.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.775 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -58.73 -56.42 22.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 21' ' ' SER . . . -55.56 -36.17 66.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 8' ' ' PRO . 68.0 t80 -68.01 -48.88 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.092 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' A' ' 70' ' ' PHE . 41.1 mt -66.5 -44.54 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.36 -50.71 51.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.355 -0.841 . . . . 0.0 109.129 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 30.3 t -58.26 -30.31 66.48 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.867 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -72.31 -50.89 23.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.504 -0.748 . . . . 0.0 109.549 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 19' ' ' ILE . 72.1 mt -62.93 -55.91 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 m -57.19 -35.2 69.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.62 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.83 -48.3 16.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 32' ' ' PHE . . . -61.76 -34.61 76.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.775 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 19.3 m -64.1 -27.92 69.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.725 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.93 7.18 31.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.99 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.2 m -91.91 -75.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.081 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 -104.02 0.78 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -132.34 -58.65 0.94 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.37 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 7.5 m-85 44.19 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.202 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -59.59 162.89 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.899 . . . . 0.0 109.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -52.66 -38.15 59.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.21 -37.8 84.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.281 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 72.3 mt-30 -68.24 -35.43 77.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.313 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.508 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 64.8 mtt -64.32 -36.8 85.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.48 -46.89 85.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 109.145 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -58.83 -41.21 86.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 43' ' ' ILE . 80.0 mtp -64.96 -32.05 73.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.1 m -69.99 -24.04 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -95.44 -17.16 21.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 80.8 mt -126.39 161.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -0.999 . . . . 0.0 109.509 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.514 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -79.98 1.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.48 -37.95 89.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -1.116 . . . . 0.0 109.03 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -61.17 -35.36 76.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.289 -0.882 . . . . 0.0 109.038 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 HD23 ' A' ' 66' ' ' LEU . 24.7 tp -56.12 -36.19 67.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.848 . . . . 0.0 109.223 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.438 ' CG ' HD12 ' A' ' 19' ' ' ILE . 93.4 mmm -55.74 -33.01 63.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.13 79.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.96 . . . . 0.0 109.064 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.76 81.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.389 -0.819 . . . . 0.0 109.11 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 1.004 ' HE3' HD12 ' A' ' 58' ' ' ILE . 75.5 mmm -54.73 -34.06 61.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -58.85 -28.85 66.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.208 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -59.58 -31.15 69.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.141 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.648 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 85.3 mmm -57.88 -33.33 68.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.354 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.62 27.38 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.11 15.38 33.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.648 ' O ' ' HE2' ' A' ' 54' ' ' MET . 32.8 ptt180 -133.48 112.33 11.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 0.0 109.572 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.004 HD12 ' HE3' ' A' ' 51' ' ' MET . 37.3 mm -113.73 143.72 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.076 -1.015 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.03 160.76 25.19 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.622 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.67 -42.56 2.38 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.804 2.336 . . . . 0.0 111.699 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 t -67.5 -40.29 85.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.407 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' HD12 ' A' ' 66' ' ' LEU . 58.1 tttm -63.12 -52.15 63.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.374 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.817 HD22 ' O ' ' A' ' 9' ' ' TRP . 3.7 mt -56.99 -30.48 64.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . 63.4 tt0 -54.28 -45.58 72.52 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.21 63.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 108.917 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.716 HD23 HD21 ' A' ' 47' ' ' LEU . 1.6 mt -73.93 -53.9 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.543 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 9' ' ' TRP . 0.8 OUTLIER -48.47 -39.06 21.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.727 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.429 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 92.7 mtp -67.37 -47.35 70.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.23 -44.4 75.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.841 ' CE1' HG23 ' A' ' 19' ' ' ILE . 82.7 t80 -54.17 -40.59 67.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.984 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -59.85 -40.96 90.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.5 t -69.47 -30.63 68.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 43' ' ' ILE . 36.4 m -70.02 -49.57 50.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 22' ' ' PHE . 10.8 m -62.72 -38.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.913 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -73.64 -48.21 34.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.921 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.56 -42.65 92.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 110.202 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 73' ' ' SER . 83.5 mt -61.96 -55.04 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.004 . . . . 0.0 109.984 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.84 -47.2 26.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.45 -0.781 . . . . 0.0 110.184 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 122' ' ' PHE . . . -57.78 -23.85 54.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.8 m -83.04 -20.58 34.73 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.541 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 22.2 tp60 -136.89 104.73 5.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.99 103.62 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.45 93.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 87' ' ' VAL . 82.8 m-20 -106.56 82.15 1.68 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -1.17 . . . . 0.0 109.141 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 123' ' ' ALA . 6.3 tp -43.64 -26.31 0.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.665 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 84' ' ' ASP . . . -61.92 -33.19 84.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 88' ' ' THR . 4.2 p -69.73 -44.52 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.235 . . . . 0.0 109.656 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 92' ' ' ILE . 84.5 m -51.85 -34.98 43.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 108.535 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 1.1 m -56.71 -49.23 75.77 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 76.4 m-20 -70.92 -40.79 71.9 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.39 -0.819 . . . . 0.0 109.065 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -63.31 -53.23 55.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.389 -0.82 . . . . 0.0 109.922 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 96' ' ' LEU . 66.4 mt -72.48 -48.99 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.963 . . . . 0.0 109.952 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.83 -46.74 88.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.907 . . . . 0.0 110.248 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' THR . 89.2 m-20 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 0.0 109.887 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.18 -41.54 84.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.868 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.792 HD11 HG22 ' A' ' 92' ' ' ILE . 5.2 mt -69.64 -39.3 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.717 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 108' ' ' ASN . 38.5 m -61.51 -53.5 55.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.927 . . . . 0.0 110.185 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.6 m -62.82 -38.29 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 109.944 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -62.36 -45.69 92.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.143 -0.973 . . . . 0.0 109.707 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.612 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.69 -56.21 7.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.75 -32.27 67.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.477 -0.764 . . . . 0.0 109.931 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 98' ' ' SER . 79.0 mm-40 -77.37 -18.63 57.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 99' ' ' ALA . 74.1 p -104.66 -60.22 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.978 -1.076 . . . . 0.0 110.913 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.93 HG21 ' C ' ' A' ' 7' ' ' THR . 19.0 p -127.03 -42.75 1.71 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.783 -1.198 . . . . 0.0 110.871 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.09 47.02 0.9 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.675 HG23 ' OG1' ' A' ' 104' ' ' THR . 16.6 t -106.58 172.18 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.175 -1.191 . . . . 0.0 108.944 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.7 m -71.47 119.67 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.106 -0.996 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' A' ' 97' ' ' THR . 22.6 p-10 -72.1 -31.68 66.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.429 -0.795 . . . . 0.0 109.884 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 113' ' ' SER . 14.9 t -57.44 -44.48 84.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -0.817 . . . . 0.0 110.481 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -57.36 -53.55 56.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 109.992 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.693 ' CE2' HD11 ' A' ' 115' ' ' ILE . 63.6 t80 -74.67 -53.94 8.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.978 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 93' ' ' ALA . 28.9 mt -56.34 -37.51 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 110.078 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' SER . 19.2 m -55.79 -48.54 75.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.065 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.96 -42.58 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.08 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.984 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.5 mt -70.97 -34.62 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 17.8 ttt180 -54.03 -45.73 71.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 109.398 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.26 -33.9 65.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.468 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 115' ' ' ILE . 19.2 mt -65.88 -41.08 92.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.799 HG22 HD11 ' A' ' 85' ' ' LEU . 99.0 mt -57.82 -37.13 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.65 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.18 -34.26 64.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.9 -38.09 89.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -1.167 . . . . 0.0 109.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 72.0 m-85 -69.97 -38.25 76.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.909 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -64.0 -32.13 73.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -69.43 -35.52 75.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.389 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.2 t -59.24 -34.88 72.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.415 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -63.56 -20.87 66.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.437 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 93.8 m-20 -73.19 -28.7 62.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -66.04 -42.38 89.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.904 HG13 ' CD1' ' A' ' 131' ' ' TYR . 4.7 p -71.28 -30.94 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.904 ' CD1' HG13 ' A' ' 130' ' ' VAL . 41.8 p90 178.7 168.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.9 118.73 18.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.7 p -63.87 165.03 9.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.497 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.36 -28.72 69.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.48 12.53 58.27 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.9 m -56.66 -34.62 67.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -1.134 . . . . 0.0 109.476 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.7 mtp -126.47 157.69 38.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -1.159 . . . . 0.0 109.504 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.35 -172.09 37.84 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -118.61 148.67 42.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -1.153 . . . . 0.0 109.513 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.578 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -136.28 162.34 33.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 106' ' ' VAL . 25.4 m120 -78.42 -15.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.678 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 9' ' ' TRP . 0.5 OUTLIER -165.11 156.48 12.92 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 38.4 Cg_endo -61.85 -32.25 85.43 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.561 2.174 . . . . 0.0 112.171 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.583 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 19.0 p90 -84.15 9.86 11.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.951 -1.093 . . . . 0.0 109.267 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 7' ' ' THR . 5.4 t -99.86 -22.75 15.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.304 -0.872 . . . . 0.0 108.763 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.578 ' OG ' ' HB2' ' A' ' 5' ' ' ALA . 69.9 m -118.89 157.74 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.468 -0.77 . . . . 0.0 109.113 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.542 ' CG ' HG13 ' A' ' 58' ' ' ILE . 24.1 ttpt -74.25 -40.71 62.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.943 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.19 -35.3 48.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.558 HD22 ' HB3' ' A' ' 5' ' ' ALA . 1.6 m-20 -72.24 -32.55 66.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.61 -47.21 49.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.087 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 68.1 m-20 -54.75 -56.31 20.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.86 . . . . 0.0 109.909 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.9 66.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.111 -0.993 . . . . 0.0 109.159 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 81.5 t80 -62.11 -41.1 97.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.288 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.768 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.8 mm -69.34 -49.11 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 16' ' ' ASP . 39.8 m-80 -62.03 -49.75 74.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 p -59.04 -34.91 72.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.751 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 16.6 t80 -67.14 -36.01 80.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.0 110.161 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 19' ' ' ILE . 66.1 mt -70.13 -56.03 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.17 -0.957 . . . . 0.0 110.315 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -62.7 -33.49 75.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.877 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.9 -44.6 26.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.612 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.8 -29.36 64.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.031 -1.043 . . . . 0.0 110.444 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 2.3 t -60.92 -30.87 70.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.0 110.553 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -106.1 7.4 31.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.012 . . . . 0.0 110.682 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.816 HG21 ' CB ' ' A' ' 94' ' ' ASP . 13.3 m -91.54 -73.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 110.607 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.711 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -76.1 -105.4 0.13 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' PHE . 18.1 m -149.46 13.37 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.461 -1.023 . . . . 0.0 109.805 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 66.0 m-85 -39.77 109.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 86.1 p -72.21 164.22 26.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.581 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -53.29 -35.77 60.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.159 -0.963 . . . . 0.0 109.47 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -68.05 -47.17 69.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 32' ' ' PHE . 68.9 mt-30 -64.7 -33.89 77.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.63 ' SD ' ' SD ' ' A' ' 40' ' ' MET . 92.9 mmm -64.31 -30.13 71.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.03 -40.18 76.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.12 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.15 -42.22 85.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.218 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.708 ' HG3' HD13 ' A' ' 77' ' ' ILE . 58.0 mtt -57.38 -39.06 75.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 109.011 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.3 p -70.42 -23.54 62.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.406 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 tp -87.24 -13.78 42.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.743 HG21 ' CB ' ' A' ' 73' ' ' SER . 61.9 mt -133.45 168.02 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.597 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.606 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 66.53 -68.85 0.16 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ILE . 36.0 t-20 -60.76 -38.94 86.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.228 -1.16 . . . . 0.0 108.859 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 m -62.38 -35.62 79.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 0.0 109.051 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 66' ' ' LEU . 8.7 mp -53.9 -37.49 63.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.271 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.731 ' O ' ' HE2' ' A' ' 51' ' ' MET . 60.7 mtm -52.75 -39.85 62.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.249 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.38 73.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.898 . . . . 0.0 109.041 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.12 -25.97 68.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.363 -0.835 . . . . 0.0 109.246 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.731 ' HE2' ' O ' ' A' ' 48' ' ' MET . 57.0 mtm -54.35 -29.79 49.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.266 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.75 -30.66 65.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.191 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.72 -31.04 72.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.166 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.597 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 86.1 mmm -60.63 -29.24 69.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.364 -0.835 . . . . 0.0 109.313 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.71 12.35 66.77 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.29 25.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.624 ' O ' HD13 ' A' ' 58' ' ' ILE . 11.8 ptt180 -128.31 112.46 14.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -1.18 . . . . 0.0 109.696 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.847 ' CG2' HD22 ' A' ' 63' ' ' LEU . 15.9 mm -116.99 148.91 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -141.58 154.73 66.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.312 -0.868 . . . . 0.0 109.688 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 49.1 Cg_endo -69.38 -11.06 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.68 2.254 . . . . 0.0 111.7 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -82.96 -57.44 3.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.188 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -79.16 -41.69 27.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.301 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.847 HD22 ' CG2' ' A' ' 58' ' ' ILE . 15.0 tp -55.6 -36.47 66.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 51.4 tt0 -55.05 -29.77 58.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.062 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.79 90.97 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.287 -0.883 . . . . 0.0 109.078 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 47' ' ' LEU . 9.4 tt -69.07 -38.16 78.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.119 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 48.2 t0 -50.55 -48.81 57.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.557 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.45 -40.44 97.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.878 . . . . 0.0 109.794 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.53 76.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 109.696 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.785 ' O ' HG13 ' A' ' 74' ' ' VAL . 77.2 t80 -55.71 -35.69 66.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.712 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.56 -36.93 83.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -69.32 -35.67 76.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.764 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.743 ' CB ' HG21 ' A' ' 43' ' ' ILE . 52.8 p -70.2 -49.83 46.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -0.934 . . . . 0.0 109.821 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 70' ' ' PHE . 4.2 m -58.42 -34.94 52.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.297 -0.877 . . . . 0.0 109.584 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.73 -38.87 67.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.677 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -68.04 -49.88 58.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.176 -0.953 . . . . 0.0 109.763 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.708 HD13 ' HG3' ' A' ' 40' ' ' MET . 74.8 mt -55.18 -54.59 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.756 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -69.35 -50.81 42.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 109.855 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.029 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.95 -23.91 55.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.261 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.5 t -81.16 -20.3 41.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.622 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 85.1 mt-30 -48.37 -37.28 16.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.69 9.57 71.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.94 -175.82 22.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 87' ' ' VAL . 23.9 t0 -55.29 123.97 15.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -1.135 . . . . 0.0 109.363 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.029 HD11 ' HA ' ' A' ' 79' ' ' ALA . 1.1 tp -75.79 -19.03 59.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.596 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -56.23 -38.45 77.84 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 84' ' ' ASP . 6.5 p -70.69 -41.07 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -1.195 . . . . 0.0 109.82 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.482 ' N ' HG13 ' A' ' 87' ' ' VAL . 25.8 m -51.65 -33.72 34.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.051 -1.031 . . . . 0.0 108.812 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 43.8 p -58.51 -46.17 87.29 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 26.5 m120 -70.82 -38.25 73.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.711 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -66.29 -58.95 4.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 109.143 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.751 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 22.8 mm -62.08 -43.77 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.625 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -65.45 -44.93 85.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 110.697 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.816 ' CB ' HG21 ' A' ' 29' ' ' THR . 31.8 t0 -55.02 -54.07 47.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.879 -1.138 . . . . 0.0 109.789 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -64.08 -35.82 82.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.14 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.873 HD21 ' CD2' ' A' ' 111' ' ' PHE . 6.0 tp -69.94 -40.23 75.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.321 -0.862 . . . . 0.0 109.603 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.693 HG23 HD22 ' A' ' 108' ' ' ASN . 18.4 m -69.11 -52.6 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.691 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 16.8 m -60.27 -35.35 75.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.727 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -67.72 -39.33 84.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -53.41 -53.37 52.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -71.6 -32.08 67.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.502 -0.749 . . . . 0.0 110.465 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 98' ' ' SER . 70.6 mm-40 -78.84 -18.5 53.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.537 HG21 ' CA ' ' A' ' 18' ' ' PHE . 66.1 p -102.72 -59.35 1.72 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.0 111.108 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.2 m -126.23 -42.54 1.84 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.882 -1.136 . . . . 0.0 110.707 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.58 47.92 1.01 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 6' ' ' ASN . 6.5 t -112.85 172.61 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -1.122 . . . . 0.0 109.322 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 110' ' ' ARG . 5.4 m -72.3 121.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.693 HD22 HG23 ' A' ' 97' ' ' THR . 16.7 p30 -69.9 -23.35 63.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 97.9 p -54.7 -30.6 56.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.592 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.788 ' HG3' HG23 ' A' ' 107' ' ' VAL . 23.6 mtp-105 -67.42 -55.01 15.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.873 ' CD2' HD21 ' A' ' 96' ' ' LEU . 3.0 t80 -75.8 -51.03 13.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.654 ' CG1' HD23 ' A' ' 96' ' ' LEU . 43.7 mt -56.39 -42.23 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 110.412 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' SER . 55.9 m -59.34 -35.26 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.934 -1.104 . . . . 0.0 109.677 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.7 mt-10 -72.65 -47.37 48.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.969 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.712 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -66.24 -40.67 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 0.0 109.762 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -54.37 -46.37 73.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 t -72.31 -34.22 67.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.62 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 118' ' ' LEU . 29.5 mt -68.77 -42.01 78.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' CD2' ' A' ' 85' ' ' LEU . 76.7 mt -59.61 -43.01 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.34 93.8 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 64.6 ttp -54.47 -44.26 72.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.576 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 98.4 m-85 -59.28 -38.92 81.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.805 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -57.23 -33.29 67.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.477 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -70.69 -31.44 68.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.512 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.4 -30.16 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.7 p -74.85 -19.87 59.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.923 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -64.78 -28.39 69.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.554 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -70.71 -6.76 39.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.634 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -79.01 -39.4 34.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.846 HG13 ' CD2' ' A' ' 131' ' ' TYR . 5.6 p -62.89 -29.94 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.641 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.846 ' CD2' HG13 ' A' ' 130' ' ' VAL . 40.2 p90 177.6 159.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.75 118.27 11.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 87.3 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.498 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.52 152.86 28.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.516 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.27 15.48 71.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 99.5 p -115.92 152.76 32.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -1.141 . . . . 0.0 109.448 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.5 mtp -121.97 155.49 35.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.167 . . . . 0.0 109.533 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.87 179.61 52.95 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -65.16 -30.16 71.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -1.16 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.51 154.55 34.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.694 ' C ' HG21 ' A' ' 104' ' ' THR . 72.9 m-20 -90.22 9.43 28.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.629 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -147.54 145.37 21.33 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.1 Cg_endo -70.8 -35.39 9.67 Favored 'Trans proline' 0 C--O 1.212 -0.783 0 C-N-CA 122.401 2.067 . . . . 0.0 111.724 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.878 ' O ' HD23 ' A' ' 63' ' ' LEU . 41.8 p90 -85.72 -26.28 25.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.868 -1.145 . . . . 0.0 109.155 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.413 ' CB ' ' HG1' ' A' ' 7' ' ' THR . 88.2 p -62.8 -12.09 22.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 79.4 p -129.66 150.12 51.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.125 -0.984 . . . . 0.0 109.336 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 16.4 ttpt -74.36 -37.68 63.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.948 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.96 -50.12 63.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.118 -0.989 . . . . 0.0 109.191 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 6.3 m120 -72.42 -28.93 63.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.563 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -63.73 -44.3 93.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.869 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' CE ' ' A' ' 48' ' ' MET . 18.8 t0 -68.59 -50.98 47.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.88 . . . . 0.0 109.628 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.95 -42.29 75.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.554 ' CA ' HG21 ' A' ' 103' ' ' THR . 73.5 t80 -58.89 -37.23 76.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 70' ' ' PHE . 44.0 mt -74.73 -37.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.761 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -68.48 -50.55 51.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.772 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 31.3 t -60.74 -29.18 69.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.342 -0.849 . . . . 0.0 109.102 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.931 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 14.0 t80 -66.55 -51.1 60.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.438 -0.789 . . . . 0.0 109.997 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.017 HD12 ' HB3' ' A' ' 40' ' ' MET . 34.5 mm -64.56 -55.74 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.131 -0.981 . . . . 0.0 109.863 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.9 t -60.29 -34.29 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 110.094 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.36 -45.22 26.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 109.982 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.89 -32.33 73.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.91 . . . . 0.0 110.026 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 37.8 m -63.68 -28.46 69.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.088 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -106.25 7.14 31.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.086 -1.009 . . . . 0.0 110.311 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.604 HG21 ' CB ' ' A' ' 94' ' ' ASP . 21.0 m -91.48 -76.64 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.996 -1.065 . . . . 0.0 110.081 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.98 -104.2 0.57 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 32' ' ' PHE . 31.5 t -134.21 -58.27 0.84 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.324 -1.104 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.2 m-85 44.0 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 109.34 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -59.67 157.66 11.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.598 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -52.52 -30.8 32.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -71.48 -36.0 70.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.319 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 95.2 mm-40 -72.71 -32.29 65.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.26 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.438 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 64.5 mtt -63.96 -30.36 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.182 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.49 -44.3 84.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.699 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.3 m-20 -55.67 -42.07 74.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.955 . . . . 0.0 109.051 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.017 ' HB3' HD12 ' A' ' 23' ' ' ILE . 64.4 mtt -59.66 -32.08 70.14 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.5 p -70.27 -23.72 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.478 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 43' ' ' ILE . 73.7 mt -91.53 -19.92 22.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.927 HG21 ' HB3' ' A' ' 73' ' ' SER . 19.3 mm -129.04 151.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.647 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 86.25 -85.06 1.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.472 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 61.8 t-20 -59.88 -33.33 71.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -1.151 . . . . 0.0 108.533 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -63.06 -35.12 79.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 66' ' ' LEU . 60.1 mt -56.74 -35.1 68.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.097 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 45' ' ' ASN . 56.4 mtt -52.64 -40.91 63.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.047 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.57 73.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.21 -0.931 . . . . 0.0 108.959 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.67 81.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.364 -0.835 . . . . 0.0 109.09 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 67.5 mtt -55.05 -34.91 63.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 0.0 109.267 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.77 -25.13 66.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.081 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -71.02 -28.87 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.238 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.604 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 90.4 mmm -63.74 -30.13 71.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.07 59.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.23 14.41 45.21 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.661 ' O ' HD13 ' A' ' 58' ' ' ILE . 24.5 ptt85 -125.16 112.05 16.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -1.126 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 57' ' ' ARG . 13.7 mm -117.26 154.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.12 -0.988 . . . . 0.0 109.74 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 p -126.67 159.95 61.11 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 50.1 Cg_endo -70.56 -32.64 14.9 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.698 2.265 . . . . 0.0 111.863 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.3 p -70.43 -46.01 64.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.392 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -62.57 -51.13 68.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.858 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.878 HD23 ' O ' ' A' ' 9' ' ' TRP . 3.6 mp -62.02 -38.22 87.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 68' ' ' MET . 48.8 tt0 -54.15 -46.45 72.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.198 -0.939 . . . . 0.0 108.686 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.62 -40.92 66.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.139 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 HD13 ' A' ' 47' ' ' LEU . 32.2 tp -66.49 -52.24 48.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.516 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.8 t0 -47.36 -33.42 5.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 90.9 mtp -71.78 -37.29 70.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.62 -42.28 87.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.642 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.5 t80 -54.98 -37.81 67.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.006 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.66 -42.09 71.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.866 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 86.4 p -68.62 -30.78 69.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.943 . . . . 0.0 109.943 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.927 ' HB3' HG21 ' A' ' 43' ' ' ILE . 26.2 m -69.96 -49.12 54.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.722 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 71' ' ' ALA . 35.5 m -58.48 -34.96 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.564 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -68.75 -38.7 80.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -72.12 -44.13 63.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 39' ' ' ASN . 89.6 mt -54.07 -53.29 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 0.0 109.671 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -75.38 -49.28 19.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.842 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' A' ' 85' ' ' LEU . . . -57.93 -21.07 42.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 109.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 93.3 p -81.72 -20.2 39.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.256 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.559 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 72.3 mt-30 -51.79 -33.77 36.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.38 67.4 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.24 -175.62 33.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 87' ' ' VAL . 32.1 t0 -63.09 122.4 16.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -1.123 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.982 HD22 ' HB2' ' A' ' 123' ' ' ALA . 5.7 mp -71.33 -16.18 62.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.77 -47.75 69.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 88' ' ' THR . 9.8 p -70.47 -46.23 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.302 -1.116 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.605 ' N ' HG13 ' A' ' 87' ' ' VAL . 11.5 m -51.52 -36.27 44.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.075 -1.016 . . . . 0.0 108.393 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 55.0 m -54.96 -46.96 75.09 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.7 m-20 -70.79 -41.55 71.51 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -62.2 -58.77 6.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.615 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.811 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 40.6 mt -64.56 -41.66 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.586 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -66.14 -44.54 83.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -0.934 . . . . 0.0 109.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.604 ' CB ' HG21 ' A' ' 29' ' ' THR . 44.0 t0 -55.08 -50.87 68.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 109.473 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -54.7 -44.15 73.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.887 . . . . 0.0 109.232 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 93' ' ' ALA . 5.2 mt -69.88 -38.68 76.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.209 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.657 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.4 m -62.3 -46.56 88.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 0.0 109.803 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 7.8 m -70.62 -49.18 50.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.35 -44.99 68.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.61 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.11 -55.22 8.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.238 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 97' ' ' THR . 1.9 m-85 -71.97 -31.81 66.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.504 -0.747 . . . . 0.0 109.594 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 98' ' ' SER . 41.9 mt-30 -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.272 -0.893 . . . . 0.0 109.843 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 99' ' ' ALA . 69.8 p -105.94 -60.35 1.65 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.334 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.694 HG21 ' C ' ' A' ' 6' ' ' ASN . 17.1 m -126.92 -42.7 1.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.877 -1.139 . . . . 0.0 110.645 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.21 46.14 1.03 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.3 t -105.69 172.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.306 -1.114 . . . . 0.0 109.053 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.584 ' H ' HG12 ' A' ' 106' ' ' VAL . 23.0 m -73.55 121.01 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.348 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.657 ' ND2' HG23 ' A' ' 97' ' ' THR . 10.5 p30 -71.41 -28.35 63.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 113' ' ' SER . 22.9 t -56.93 -44.65 82.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.361 -0.837 . . . . 0.0 110.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -56.92 -54.15 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.973 -1.079 . . . . 0.0 109.975 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.737 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 69.1 t80 -75.58 -52.13 11.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.537 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.8 mt -56.67 -35.74 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.19 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 109' ' ' SER . 42.3 t -58.93 -30.25 67.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -72.94 -41.74 64.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.006 HG12 ' HB1' ' A' ' 71' ' ' ALA . 93.1 mt -72.59 -39.45 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -54.21 -43.16 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.6 p -72.23 -33.92 67.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -68.61 -45.24 72.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.865 HG22 HD23 ' A' ' 85' ' ' LEU . 64.9 mt -57.86 -44.88 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.22 -34.57 67.53 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.7 ttm -66.96 -42.33 85.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 109.467 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -64.66 -32.35 73.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.982 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -63.17 -33.79 76.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.479 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -70.11 -35.36 74.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.56 80.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.1 p -62.92 -22.8 67.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.411 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.788 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -65.94 -23.92 66.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -66.21 -13.68 60.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -74.62 -46.19 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.945 HG23 ' CD1' ' A' ' 131' ' ' TYR . 19.2 m -60.68 -30.44 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.945 ' CD1' HG23 ' A' ' 130' ' ' VAL . 49.0 p90 178.39 179.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -74.06 117.66 16.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -100.1 145.04 28.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.576 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.26 154.23 37.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.372 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.91 -172.61 53.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -58.16 -34.24 70.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -1.178 . . . . 0.0 109.466 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.5 mtp -58.27 -34.08 70.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -52.62 -32.73 39.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -107.04 145.77 31.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -1.125 . . . . 0.0 109.494 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . . . -76.11 144.68 40.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -62.69 -24.84 67.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -129.85 163.68 45.48 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 49.9 Cg_endo -83.95 -34.23 0.28 Allowed 'Trans proline' 0 C--O 1.211 -0.828 0 C-N-CA 122.526 2.15 . . . . 0.0 111.626 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.606 ' CE3' ' HG2' ' A' ' 8' ' ' PRO . 37.4 p90 -90.27 -23.27 21.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.902 -1.124 . . . . 0.0 109.488 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -60.87 -12.57 11.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 70.5 m -132.01 153.67 50.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.122 -0.986 . . . . 0.0 109.583 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HD2' ' CG ' ' A' ' 51' ' ' MET . 28.9 mtmt -73.88 -39.19 64.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 109.786 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -65.92 -50.33 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.752 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 5' ' ' ALA . 17.1 m120 -72.21 -29.06 63.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -71.35 -55.17 8.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.007 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 1.8 p30 -55.03 -46.8 75.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.507 -0.746 . . . . 0.0 109.882 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.44 -39.82 94.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 80.7 t80 -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 109.419 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' ALA . 33.2 mm -71.03 -44.07 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -65.42 -45.2 84.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 t -67.11 -30.72 70.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 110.256 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.884 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 9.0 t80 -66.31 -46.83 75.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.151 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.912 HD12 ' HB3' ' A' ' 40' ' ' MET . 30.5 mm -64.89 -56.26 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.164 -0.96 . . . . 0.0 110.522 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.5 m -60.85 -31.9 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.98 . . . . 0.0 109.919 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -45.45 24.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.06 -34.1 76.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -0.971 . . . . 0.0 110.362 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.3 m -57.35 -33.52 67.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.322 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -106.06 7.36 31.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.128 -0.983 . . . . 0.0 110.687 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.659 HG21 ' CB ' ' A' ' 94' ' ' ASP . 43.5 m -85.89 -81.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.801 -1.187 . . . . 0.0 110.201 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.14 -101.12 0.24 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -132.46 -61.51 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -1.059 . . . . 0.0 109.212 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.8 m-85 43.94 91.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.307 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.417 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 53.7 p -59.61 161.28 6.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.61 -40.72 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.84 -36.21 76.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.472 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.3 mm-40 -73.2 -32.28 64.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.66 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.6 mtt -63.23 -34.18 77.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.0 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.43 -43.11 91.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.855 . . . . 0.0 109.038 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -59.76 -42.58 93.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.055 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.912 ' HB3' HD12 ' A' ' 23' ' ' ILE . 75.1 mtm -66.75 -32.72 74.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.135 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.4 t -70.25 -24.02 63.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 17.0 tp -87.92 -22.81 24.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.186 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB2' ' A' ' 73' ' ' SER . 37.9 mm -116.15 162.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 90.83 -80.33 1.36 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.0 -38.14 78.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.186 -1.185 . . . . 0.0 108.707 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.7 m -60.17 -35.33 75.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.354 -0.841 . . . . 0.0 108.805 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 66' ' ' LEU . 26.9 tp -59.52 -33.94 72.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.247 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 16' ' ' ASP . 60.3 mmm -56.65 -28.14 59.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.31 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.41 86.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.112 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -22.77 50.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.243 -0.911 . . . . 0.0 108.9 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.543 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 16.6 ttm -54.15 -41.73 68.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -64.07 -26.67 68.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -63.42 -25.46 68.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.859 . . . . 0.0 109.506 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.528 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 81.8 mmm -54.25 -33.99 59.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.14 13.12 79.77 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.33 27.83 7.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' CE ' ' A' ' 54' ' ' MET . 2.5 ptt85 -137.89 112.66 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -1.205 . . . . 0.0 109.673 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.937 ' CG2' HD22 ' A' ' 63' ' ' LEU . 36.9 mm -114.36 140.28 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 109.5 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 62' ' ' LYS . 5.4 t -148.19 149.49 32.4 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.0 109.554 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.533 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 46.0 Cg_endo -66.86 -34.0 31.78 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.653 2.235 . . . . 0.0 111.887 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -66.26 -50.32 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.975 . . . . 0.0 109.45 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.591 ' H ' HG23 ' A' ' 59' ' ' THR . 40.7 mttt -81.42 -46.14 15.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.026 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.937 HD22 ' CG2' ' A' ' 58' ' ' ILE . 5.6 tp -58.96 -48.21 82.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.099 -1.001 . . . . 0.0 109.765 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 91.9 mt-30 -54.68 -35.01 63.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 108.73 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 HD11 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -68.45 -43.56 76.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 27.0 t0 -48.57 -34.88 12.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.787 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.5 -37.31 77.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.91 . . . . 0.0 109.931 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.9 65.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.827 ' O ' HG13 ' A' ' 74' ' ' VAL . 70.7 t80 -67.01 -35.92 80.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.158 -0.964 . . . . 0.0 109.717 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.786 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 25.2 t -69.69 -41.71 75.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 110.023 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB2' HG21 ' A' ' 43' ' ' ILE . 58.0 p -70.09 -47.12 63.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 110.28 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.2 m -57.2 -37.05 54.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.802 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' N ' HG23 ' A' ' 74' ' ' VAL . . . -73.92 -38.32 64.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 0.0 109.819 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 72' ' ' SER . 94.4 mt-30 -70.27 -46.23 64.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.828 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.438 HG21 ' HG3' ' A' ' 40' ' ' MET . 97.2 mt -56.2 -44.74 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 0.0 109.885 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.36 -50.14 12.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.896 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.13 48.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.547 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.8 m -76.2 -20.26 57.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.937 . . . . 0.0 109.457 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 45.6 mt-30 -55.86 -33.16 64.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.672 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.73 21.82 73.66 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.48 -149.41 19.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -72.04 120.65 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.57 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.016 HD11 HG22 ' A' ' 119' ' ' ILE . 5.3 tp -67.69 -18.46 64.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.287 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -28.36 70.25 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.86 -50.06 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.221 -1.164 . . . . 0.0 109.569 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 92' ' ' ILE . 59.6 m -52.32 -49.52 64.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.534 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 56.9 m -51.68 -48.85 63.3 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 108.807 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 77.8 m-20 -70.86 -32.11 69.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.52 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -77.98 -59.04 2.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.763 HG22 HD11 ' A' ' 96' ' ' LEU . 31.3 mt -61.27 -45.88 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.844 . . . . 0.0 109.879 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.107 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' CB ' HG21 ' A' ' 29' ' ' THR . 42.9 t0 -55.14 -53.62 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.884 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.98 -42.98 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.763 HD11 HG22 ' A' ' 92' ' ' ILE . 6.7 mt -69.47 -40.52 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.748 HG23 HD22 ' A' ' 108' ' ' ASN . 76.0 m -62.77 -51.98 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.635 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 22.0 m -62.97 -36.61 84.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.602 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . . . -69.78 -42.81 73.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.671 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.7 m-85 -47.3 -55.98 7.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.53 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.4 m-85 -71.06 -32.17 68.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.553 -0.717 . . . . 0.0 110.042 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 98' ' ' SER . 89.5 mm-40 -78.56 -18.36 54.78 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.884 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 18' ' ' PHE . 72.4 p -102.55 -59.97 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 111.149 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.598 HG21 ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.03 -42.36 1.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.779 -1.2 . . . . 0.0 110.807 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.34 47.93 0.9 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 107' ' ' VAL . 21.5 t -113.25 169.14 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.299 -1.118 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.581 HG23 ' CG ' ' A' ' 110' ' ' ARG . 15.8 m -67.43 121.22 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.856 . . . . 0.0 109.624 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.748 HD22 HG23 ' A' ' 97' ' ' THR . 11.6 p30 -71.14 -23.63 62.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.734 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 113' ' ' SER . 91.3 p -59.29 -33.34 70.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 110.794 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.581 ' CG ' HG23 ' A' ' 107' ' ' VAL . 78.2 mmt-85 -64.1 -55.42 22.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.742 -1.224 . . . . 0.0 110.33 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.2 t80 -76.28 -49.67 16.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.566 HG21 ' HB1' ' A' ' 93' ' ' ALA . 16.2 mt -56.65 -36.71 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 109' ' ' SER . 78.9 p -63.44 -34.79 78.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.04 -1.037 . . . . 0.0 109.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.31 -39.75 74.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.033 HD11 ' CE2' ' A' ' 111' ' ' PHE . 54.3 mt -72.77 -41.99 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -54.46 -42.38 70.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.4 t -72.01 -33.84 68.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.667 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 41.7 mt -68.36 -42.21 79.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.773 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.016 HG22 HD11 ' A' ' 85' ' ' LEU . 62.6 mt -58.51 -41.55 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -66.67 -30.85 76.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -66.99 -39.48 87.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -1.147 . . . . 0.0 109.595 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.433 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 72.3 m-85 -60.59 -52.06 66.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.555 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.08 72.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.165 -0.959 . . . . 0.0 109.552 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 95.9 mt-30 -70.44 -30.51 67.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.447 ' HA ' ' ND2' ' A' ' 128' ' ' ASN . . . -62.78 -35.25 79.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.3 m -56.65 -34.93 67.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.442 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -72.53 -15.37 61.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.509 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 93.3 m-20 -65.8 -27.82 68.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -66.88 -45.52 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.352 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.917 HG13 ' CD1' ' A' ' 131' ' ' TYR . 5.9 p -69.41 -30.87 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.917 ' CD1' HG13 ' A' ' 130' ' ' VAL . 39.7 p90 179.1 166.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.96 119.69 16.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.315 -0.865 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 m -60.35 160.1 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.487 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -154.54 154.03 32.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.58 178.36 52.52 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.2 p -124.16 154.33 40.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -1.112 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.7 mtp -125.4 150.28 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.51 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.11 8.35 61.62 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -120.55 139.31 53.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.95 ' HB1' ' OG ' ' A' ' 10' ' ' SER . . . -59.73 -40.98 89.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.895 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.757 ' O ' HG21 ' A' ' 106' ' ' VAL . 76.4 m-20 53.89 35.62 22.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.444 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 9' ' ' TRP . 0.0 OUTLIER -165.11 145.35 5.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.372 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 46.9 Cg_endo -70.25 -35.12 11.73 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.414 2.076 . . . . 0.0 111.728 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.865 ' O ' HD13 ' A' ' 63' ' ' LEU . 39.5 p90 -85.58 -30.89 22.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 109.058 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.95 ' OG ' ' HB1' ' A' ' 5' ' ' ALA . 87.9 p -58.8 -15.09 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 109.57 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 51.0 m -127.15 143.69 51.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.171 -0.955 . . . . 0.0 109.343 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.49 ' HB2' HG13 ' A' ' 58' ' ' ILE . 4.0 ttpp -71.64 -37.14 70.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -68.45 -48.08 65.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 108.994 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 12.3 m120 -71.56 -28.93 64.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.38 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -63.23 -41.57 99.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.822 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 1.8 p30 -68.71 -50.12 53.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -56.57 -37.42 70.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.89 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.627 ' CA ' HG21 ' A' ' 103' ' ' THR . 69.3 t80 -65.78 -49.36 68.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.02 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.828 HG23 ' HE1' ' A' ' 70' ' ' PHE . 42.0 mt -63.14 -46.94 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -67.75 -50.3 57.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 108.945 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 69.4 m -56.11 -30.04 61.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 108.593 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.827 ' CE1' HG23 ' A' ' 92' ' ' ILE . 46.8 t80 -71.44 -52.2 19.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.538 -0.726 . . . . 0.0 109.624 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 ' HE2' ' A' ' 40' ' ' MET . 56.8 mt -62.62 -55.74 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.643 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -53.76 -40.3 66.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.863 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.85 -46.0 22.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.088 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -60.42 -30.64 69.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 17.4 m -64.75 -31.4 72.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.968 . . . . 0.0 110.014 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -105.96 7.35 32.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.187 -0.946 . . . . 0.0 110.168 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' HB3' ' A' ' 94' ' ' ASP . 19.3 m -88.68 -75.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.95 -1.094 . . . . 0.0 110.054 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -88.49 -102.2 0.96 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -138.13 -55.64 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -1.115 . . . . 0.0 109.353 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.651 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.9 m-85 43.84 87.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.158 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' MET . 9.8 p -59.76 161.24 6.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.66 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -52.62 -31.95 39.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.143 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -70.48 -37.03 74.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.113 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.502 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 82.3 mm-40 -76.19 -34.61 59.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 109.233 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.649 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 71.5 mtp -63.42 -36.73 84.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -56.89 -42.52 80.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.146 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.908 ' HB2' HG23 ' A' ' 77' ' ' ILE . 23.5 m120 -59.5 -37.0 77.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.865 . . . . 0.0 109.052 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.584 ' HA ' HD13 ' A' ' 77' ' ' ILE . 90.8 mtp -65.18 -33.47 76.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.356 -0.84 . . . . 0.0 109.25 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.0 t -70.1 -24.22 63.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.246 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.9 tp -89.03 -20.61 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.747 ' HB ' HD11 ' A' ' 77' ' ' ILE . 65.0 mt -120.03 160.46 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.204 -0.935 . . . . 0.0 109.408 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 76.33 -88.54 0.91 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.17 -37.18 64.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.222 -1.164 . . . . 0.0 109.157 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 89.1 m -58.13 -34.86 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.267 -0.896 . . . . 0.0 108.81 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.71 -35.88 79.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.37 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 38.7 ttm -52.74 -37.56 59.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.291 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.8 -31.11 71.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.245 -0.909 . . . . 0.0 109.122 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.86 81.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.896 . . . . 0.0 109.239 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.427 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 62.9 mtm -60.76 -30.22 69.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 0.0 109.251 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.47 -29.8 69.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.215 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -65.95 -24.02 66.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.244 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.542 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 95.4 mmm -63.96 -33.26 75.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.32 -0.862 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.48 10.55 53.45 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.34 10.52 33.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.6 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.1 ptt180 -125.03 112.3 16.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 109.465 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 57' ' ' ARG . 16.6 mm -116.2 136.54 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.568 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 162.81 19.52 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.565 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.87 -33.4 16.24 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.707 2.271 . . . . 0.0 111.675 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -70.61 -44.42 67.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 9' ' ' TRP . 6.5 mt -71.26 -32.26 68.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.75 -49.62 70.4 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.119 -0.988 . . . . 0.0 108.591 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.52 -47.48 48.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 109.056 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.4 -53.32 59.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.9 t0 -47.87 -35.69 10.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 0.0 109.267 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.2 ttm -72.18 -40.89 67.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.59 91.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.828 ' HE1' HG23 ' A' ' 19' ' ' ILE . 75.0 t80 -54.48 -42.78 71.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.886 ' HB1' ' CG1' ' A' ' 115' ' ' ILE . . . -70.26 -38.19 75.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.764 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 84.3 p -69.17 -46.85 66.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.991 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.659 ' HB3' HD13 ' A' ' 43' ' ' ILE . 4.1 m -70.03 -45.33 67.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 109.96 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.71 ' HA ' HD12 ' A' ' 77' ' ' ILE . 9.8 p -57.71 -35.97 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.749 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -67.35 -36.54 81.62 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.933 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 90.8 mt-30 -69.17 -38.3 78.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.834 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.908 HG23 ' HB2' ' A' ' 39' ' ' ASN . 56.5 mt -56.68 -55.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 109.848 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.68 ' HB3' HD11 ' A' ' 92' ' ' ILE . . . -78.85 -48.53 14.54 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.39 -0.819 . . . . 0.0 109.977 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.87 -22.25 47.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 30.0 t -81.13 -20.92 40.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.892 . . . . 0.0 109.441 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 75.9 mt-30 -44.68 -40.91 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.464 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.81 53.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.96 -158.73 12.77 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 87' ' ' VAL . 83.7 m-20 -54.33 127.48 27.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -1.188 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.783 HD11 HG22 ' A' ' 119' ' ' ILE . 5.5 tp -84.46 -20.87 31.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.71 63.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -68.95 -47.79 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 109.525 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . 22.5 m -51.7 -37.73 52.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.068 . . . . 0.0 108.251 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -55.34 -51.6 66.22 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 62.2 m-20 -70.86 -39.64 72.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -60.19 -55.35 34.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 0.0 109.51 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.827 HG23 ' CE1' ' A' ' 22' ' ' PHE . 43.6 mt -72.23 -49.93 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.455 -0.778 . . . . 0.0 109.852 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -57.09 -46.2 82.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 110.654 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.781 ' HB3' HG21 ' A' ' 29' ' ' THR . 41.8 t0 -54.9 -53.77 51.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.941 -1.099 . . . . 0.0 109.89 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.718 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -57.14 -40.73 77.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.715 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.749 HD11 HG22 ' A' ' 92' ' ' ILE . 15.0 mt -68.13 -41.45 81.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 0.0 109.515 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 ' ND2' ' A' ' 108' ' ' ASN . 88.7 m -58.61 -53.82 54.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.886 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 16.3 m -63.8 -45.14 91.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.13 -45.98 68.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.12 -0.987 . . . . 0.0 109.427 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 2.3 m-85 -47.13 -54.27 10.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.973 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -71.76 -32.05 67.29 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.493 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 98' ' ' SER . 73.1 mt-30 -76.12 -18.51 59.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.821 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 99' ' ' ALA . 47.9 p -105.51 -59.73 1.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.967 -1.083 . . . . 0.0 111.209 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.558 HG21 ' N ' ' A' ' 7' ' ' THR . 5.5 m -126.55 -42.58 1.79 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.83 -1.169 . . . . 0.0 110.784 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.88 47.7 1.0 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.757 HG21 ' O ' ' A' ' 6' ' ' ASN . 48.1 t -112.78 168.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.309 -1.112 . . . . 0.0 108.945 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.8 m -67.29 121.04 15.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.3 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.689 ' ND2' HG23 ' A' ' 97' ' ' THR . 16.1 p-10 -70.53 -23.12 62.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.426 -0.797 . . . . 0.0 109.818 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' SER . 34.0 t -54.45 -30.34 52.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.858 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' A' ' 107' ' ' VAL . 93.5 mtt180 -68.15 -55.31 12.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.817 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 71.4 t80 -76.4 -50.66 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 110.343 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.531 HD11 ' N ' ' A' ' 97' ' ' THR . 17.3 mt -56.17 -45.77 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.836 . . . . 0.0 110.182 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 109' ' ' SER . 63.1 m -55.66 -39.25 70.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.0 109.392 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 80.8 tt0 -62.1 -49.71 74.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.886 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 81.2 mt -67.59 -34.7 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -53.7 -45.69 70.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.38 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.1 t -73.42 -33.68 65.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.314 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 49.1 mt -67.92 -45.51 74.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.783 HG22 HD11 ' A' ' 85' ' ' LEU . 87.5 mt -57.8 -34.54 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.997 . . . . 0.0 109.438 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.76 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -68.23 -36.77 85.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.45 -37.63 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -1.177 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 63.9 m-85 -66.56 -30.48 70.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.648 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -61.46 -35.69 78.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.379 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -70.65 -35.45 72.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.86 -28.24 69.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.0 p -64.67 -28.65 69.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -67.71 -16.78 64.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -63.34 -32.02 73.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 130' ' ' VAL . 46.5 p30 -70.23 -15.07 62.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 2.0 p -58.03 -25.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 0.0 109.414 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.603 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER 177.49 -172.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.24 126.23 41.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.386 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -46.18 -37.79 7.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.368 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.21 72.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.505 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.62 -165.4 46.13 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.9 p -60.56 -27.7 67.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -1.143 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.0 mtm -122.23 153.4 38.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -1.165 . . . . 0.0 109.452 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.29 178.07 47.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -65.71 -21.64 66.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -1.184 . . . . 0.0 109.46 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.48 173.21 14.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.42 -15.77 62.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.743 HG22 ' OG ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -154.8 157.39 32.02 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.868 . . . . 0.0 109.064 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 49.0 Cg_endo -69.03 -34.6 16.64 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.566 2.178 . . . . 0.0 112.633 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.776 ' O ' HD22 ' A' ' 63' ' ' LEU . 48.9 p90 -83.28 1.48 40.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.964 -1.085 . . . . 0.0 110.074 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.743 ' OG ' HG22 ' A' ' 7' ' ' THR . 17.7 m -90.46 -28.26 18.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 108.933 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -104.23 154.58 19.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.352 -0.843 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HG2' ' SD ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -73.53 -37.78 65.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.2 -35.21 25.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.643 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' ND2' ' OG1' ' A' ' 104' ' ' THR . 8.3 t-20 -71.29 -29.17 64.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -72.43 -45.28 60.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 109.952 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' SD ' ' A' ' 48' ' ' MET . 58.6 t0 -56.22 -54.06 49.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.99 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.8 -44.17 63.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.615 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.719 ' CA ' HG21 ' A' ' 103' ' ' THR . 72.8 t80 -56.97 -38.78 73.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.886 HG23 ' CE1' ' A' ' 70' ' ' PHE . 34.4 mm -69.35 -42.93 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.862 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -64.95 -49.24 71.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.029 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 7.6 t -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 t80 -64.28 -52.2 59.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.164 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.942 HD12 ' HB3' ' A' ' 40' ' ' MET . 37.9 mm -58.92 -55.97 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.179 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -64.76 -28.99 69.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.907 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.16 -43.07 29.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -74.25 -29.19 61.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.957 . . . . 0.0 110.298 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 94.9 p -63.86 -27.68 69.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 110.226 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.06 7.26 31.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 0.0 110.5 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.978 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.1 m -92.08 -77.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.17 . . . . 0.0 110.292 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.0 -104.23 0.4 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 32' ' ' PHE . 35.8 t -131.06 -62.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -1.065 . . . . 0.0 109.409 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.799 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 18.6 m-85 43.53 87.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.27 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 37.8 p -59.64 160.51 7.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.918 . . . . 0.0 109.533 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -52.54 -35.78 54.22 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.226 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.12 -36.11 83.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.277 -0.89 . . . . 0.0 109.34 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.4 mm-40 -73.29 -31.88 64.3 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.059 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.437 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 63.9 mtt -63.43 -31.37 72.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.436 -0.79 . . . . 0.0 109.097 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -57.25 -44.71 84.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 109.168 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.607 ' HB2' HG23 ' A' ' 77' ' ' ILE . 69.4 m-20 -56.28 -40.97 75.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.196 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.942 ' HB3' HD12 ' A' ' 23' ' ' ILE . 63.6 mtt -63.02 -32.12 73.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.038 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 m -70.02 -23.5 63.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.166 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.4 tp -89.05 -25.67 21.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.962 HG21 ' CB ' ' A' ' 73' ' ' SER . 62.2 mt -124.86 149.41 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 104.37 -81.01 0.32 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -62.29 -29.16 70.23 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.257 -1.143 . . . . 0.0 108.635 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.8 m -64.22 -35.16 79.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.495 -0.753 . . . . 0.0 108.995 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 mt -54.29 -35.86 63.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 109.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' ' OD2' ' A' ' 16' ' ' ASP . 61.3 ttp -52.68 -40.11 62.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -0.902 . . . . 0.0 109.076 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.22 -36.96 81.34 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.96 -23.95 66.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.541 ' O ' ' CG ' ' A' ' 54' ' ' MET . 65.7 mtt -54.89 -30.01 57.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -75.51 -9.75 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.025 -1.047 . . . . 0.0 109.721 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -36.59 71.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.91 . . . . 0.0 110.148 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.551 ' SD ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.38 -18.31 16.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 109.938 -179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.03 2.68 80.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 114.08 -1.37 24.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 54' ' ' MET . 9.9 ptt180 -115.67 111.62 20.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.068 -1.254 . . . . 0.0 110.019 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.84 ' CG2' HD12 ' A' ' 63' ' ' LEU . 40.9 mm -101.58 143.88 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.564 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 4.1 p -140.76 161.79 52.32 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.343 -0.848 . . . . 0.0 109.255 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 46.6 Cg_endo -67.87 -30.19 33.71 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.631 2.22 . . . . 0.0 111.876 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.6 p -72.14 -35.04 68.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 109.399 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -80.97 -46.77 14.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.84 HD12 ' CG2' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -68.02 -38.34 82.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.633 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 64.7 mt-30 -54.41 -39.25 67.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 108.992 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.37 -36.61 68.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.06 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 66' ' ' LEU . 32.4 tp -74.28 -48.25 29.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.503 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 25.6 t0 -48.08 -37.92 16.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.319 -0.863 . . . . 0.0 109.702 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -72.22 -32.87 67.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.661 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.38 -45.68 89.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.886 ' CE1' HG23 ' A' ' 19' ' ' ILE . 91.3 t80 -53.24 -36.31 60.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.952 . . . . 0.0 109.591 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -70.26 -35.29 73.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 m -69.12 -35.44 76.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.962 ' CB ' HG21 ' A' ' 43' ' ' ILE . 51.9 m -69.99 -49.25 53.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.891 . . . . 0.0 109.714 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 70' ' ' PHE . 16.0 m -58.96 -35.0 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -67.45 -43.39 81.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 80' ' ' SER . 95.5 mt-30 -65.66 -45.85 81.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.3 mt -54.64 -51.42 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 109.692 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.799 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.08 -49.06 14.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.714 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.21 -23.96 57.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 88.9 p -80.58 -20.2 43.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 39.7 mt-30 -52.57 -30.67 32.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.97 19.27 70.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 -164.62 24.62 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.472 ' O ' HG12 ' A' ' 87' ' ' VAL . 84.2 m-20 -60.0 135.68 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -1.176 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.764 HD11 HG22 ' A' ' 119' ' ' ILE . 6.1 tp -84.43 -18.56 35.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.691 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.2 -35.02 64.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 88' ' ' THR . 5.7 p -69.0 -46.47 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 109.584 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.565 ' N ' HG13 ' A' ' 87' ' ' VAL . 93.5 m -51.73 -35.75 44.44 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 108.628 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 44.7 m -56.21 -46.51 79.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 81.7 m-20 -71.01 -40.07 72.01 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.46 -59.08 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.745 HG22 HD11 ' A' ' 96' ' ' LEU . 24.5 mm -63.14 -49.41 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -60.33 -49.98 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.081 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.978 ' HB2' HG21 ' A' ' 29' ' ' THR . 75.7 m-20 -55.26 -44.13 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -61.1 -43.81 98.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.415 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.745 HD11 HG22 ' A' ' 92' ' ' ILE . 2.7 mt -69.95 -38.62 76.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 108' ' ' ASN . 52.7 m -60.72 -51.81 67.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.355 -0.841 . . . . 0.0 110.046 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 15.5 t -60.37 -47.65 85.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.133 -0.979 . . . . 0.0 109.842 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 103' ' ' THR . . . -59.01 -41.73 88.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.595 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -46.58 -53.83 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.121 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -72.06 -31.9 66.56 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.518 -0.739 . . . . 0.0 109.995 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 98' ' ' SER . 42.2 mt-30 -78.33 -18.54 55.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 110.128 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.719 HG21 ' CA ' ' A' ' 18' ' ' PHE . 51.8 p -105.74 -58.75 1.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.917 -1.115 . . . . 0.0 111.284 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.453 ' OG1' ' ND2' ' A' ' 14' ' ' ASN . 91.5 m -125.89 -42.64 1.89 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.676 -1.265 . . . . 0.0 110.737 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.3 48.52 1.05 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 107' ' ' VAL . 4.9 t -111.7 172.64 2.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.39 -1.065 . . . . 0.0 109.117 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.599 ' H ' HG12 ' A' ' 106' ' ' VAL . 27.4 m -72.98 121.01 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 97' ' ' THR . 11.3 p30 -71.22 -29.22 64.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -58.15 -30.53 66.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.404 -0.81 . . . . 0.0 110.693 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -71.05 -54.34 11.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.884 -1.135 . . . . 0.0 109.994 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.121 ' CE2' HD11 ' A' ' 115' ' ' ILE . 56.4 t80 -75.61 -48.44 22.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.807 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 108' ' ' ASN . 13.2 mt -56.28 -37.76 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.853 . . . . 0.0 109.949 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -55.8 -39.87 71.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.455 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 97.6 mt-10 -72.23 -38.82 68.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.121 HD11 ' CE2' ' A' ' 111' ' ' PHE . 49.3 mt -70.91 -43.68 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.2 ttp85 -54.18 -38.14 65.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.84 . . . . 0.0 109.366 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -72.36 -33.85 67.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 66.4 mt -68.7 -38.79 80.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.982 . . . . 0.0 109.953 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.764 HG22 HD11 ' A' ' 85' ' ' LEU . 63.5 mt -57.73 -35.87 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.745 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -70.35 -34.44 68.8 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 49.0 ttm -64.83 -38.61 91.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -1.157 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -64.52 -41.69 96.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.911 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -63.52 -30.18 71.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.329 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 120' ' ' GLY . 98.9 mm-40 -70.64 -31.21 68.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.398 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.24 -37.76 81.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.9 p -61.73 -26.66 68.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.83 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -69.11 -26.27 64.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 82.5 m-20 -57.79 -17.85 18.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -69.01 -49.64 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.371 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.008 HG13 ' CD1' ' A' ' 131' ' ' TYR . 6.3 p -61.55 -30.84 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 1.008 ' CD1' HG13 ' A' ' 130' ' ' VAL . 49.7 p90 178.49 178.18 0.42 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.16 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.406 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -73.44 121.04 19.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.9 m -94.34 157.35 16.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.87 -39.88 79.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 109.39 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.84 -157.39 37.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.9 m -118.25 148.31 42.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.147 . . . . 0.0 109.4 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.481 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -122.95 162.16 22.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.31 -174.39 41.96 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 5' ' ' ALA . 90.5 mm-40 -97.4 155.58 16.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 109.647 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.593 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . 43.25 82.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -63.79 -15.03 57.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.581 ' OG1' ' CE2' ' A' ' 9' ' ' TRP . 9.1 t -136.48 150.61 70.99 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.685 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -65.94 -30.93 47.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.603 2.202 . . . . 0.0 112.904 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.581 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 44.0 p90 -81.34 -1.01 43.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.788 -1.195 . . . . 0.0 110.168 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 78.3 p -89.65 -14.94 33.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.01 -1.056 . . . . 0.0 108.86 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -140.94 149.0 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 109.071 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HD3' ' CG1' ' A' ' 58' ' ' ILE . 31.2 mtmt -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.67 -50.34 72.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.755 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' A' ' 5' ' ' ALA . 6.9 m-20 -72.53 -32.83 66.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.862 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -67.15 -49.02 66.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.989 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.07 -56.07 23.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.938 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.08 -33.84 71.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.002 . . . . 0.0 109.367 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 52.3 t80 -67.64 -37.08 81.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.191 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.861 HG23 ' CE1' ' A' ' 70' ' ' PHE . 17.4 mt -74.04 -38.54 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -68.21 -50.29 55.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 p -59.99 -33.56 72.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.876 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 8.4 t80 -64.1 -35.94 82.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 109.844 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.474 HG12 ' CE ' ' A' ' 40' ' ' MET . 67.6 mt -71.6 -56.03 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.218 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -59.76 -30.79 69.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 109.905 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.09 -43.54 28.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 110.238 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -70.28 -34.46 72.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.185 -0.947 . . . . 0.0 110.396 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.475 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 92.6 p -61.59 -26.77 68.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.045 -1.034 . . . . 0.0 110.084 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -105.87 7.29 32.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.05 -1.031 . . . . 0.0 110.373 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.987 HG21 ' HB2' ' A' ' 94' ' ' ASP . 22.8 m -92.28 -78.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.914 -1.116 . . . . 0.0 110.298 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.37 -104.26 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -130.68 -61.17 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.357 -1.084 . . . . 0.0 109.35 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.599 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 8.9 m-85 44.06 83.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 0.0 109.177 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.3 m -59.56 167.08 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.693 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -52.51 -43.59 65.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -56.19 -36.71 68.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.104 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.446 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 90.7 mm-40 -76.27 -35.4 58.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.475 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 62.4 mtt -63.31 -39.85 95.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.4 -43.12 83.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.039 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.3 m-20 -57.15 -39.93 76.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.134 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.474 ' CE ' HG12 ' A' ' 23' ' ' ILE . 77.0 mmm -58.25 -32.22 68.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 108.921 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 t -70.16 -24.19 63.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 46' ' ' THR . 63.0 mt -91.85 -16.83 26.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.034 HD12 HD11 ' A' ' 77' ' ' ILE . 64.9 mt -119.6 166.45 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.186 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.688 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 68.35 -81.86 0.2 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.45 -40.23 68.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.035 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -60.06 -35.23 74.68 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 108.979 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 47' ' ' LEU . 40.8 mt -55.18 -36.72 66.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.207 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.5 ttp -52.93 -43.16 66.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.902 . . . . 0.0 109.247 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.49 77.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.221 -0.925 . . . . 0.0 108.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . . . -62.51 -23.17 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.529 ' O ' ' CG ' ' A' ' 54' ' ' MET . 15.9 mmt -54.44 -33.41 59.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -74.46 -8.47 56.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.241 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 50' ' ' ALA . 93.4 m-20 -69.89 -32.2 70.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.86 -14.45 46.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.92 -11.53 56.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 130.18 0.39 5.51 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' N ' ' SD ' ' A' ' 54' ' ' MET . 21.6 ptt85 -116.85 113.12 22.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -1.197 . . . . 0.0 110.085 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.824 HG23 ' CD1' ' A' ' 63' ' ' LEU . 44.5 mm -104.55 148.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.256 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -147.3 165.34 19.23 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.18 -0.95 . . . . 0.0 109.808 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 50.2 Cg_endo -70.46 -36.94 8.14 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.852 2.368 . . . . 0.0 111.847 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.4 t -70.39 -34.71 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.751 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -80.96 -48.12 12.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.96 . . . . 0.0 109.797 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.824 ' CD1' HG23 ' A' ' 58' ' ' ILE . 7.4 mp -67.37 -41.54 84.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.808 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 69.6 mt-30 -54.22 -38.45 65.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 108.919 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 -34.79 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.276 -0.89 . . . . 0.0 108.687 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -74.1 -43.67 56.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 0.0 109.136 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 37.5 t0 -47.85 -40.23 20.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.835 . . . . 0.0 109.696 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.8 mtp -67.84 -30.67 70.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.743 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.86 85.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.861 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.8 t80 -54.58 -44.33 72.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 0.0 109.669 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.033 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -38.65 74.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.827 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -69.5 -36.68 76.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.975 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.616 ' HB2' HD13 ' A' ' 43' ' ' ILE . 85.7 p -70.12 -45.06 67.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.0 . . . . 0.0 109.949 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.9 m -63.8 -35.02 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.41 93.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.797 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -68.33 -45.17 73.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.759 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -53.99 -47.65 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -78.49 -49.47 13.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.939 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -57.86 -26.24 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 81' ' ' GLN . 52.3 m -79.19 -20.15 49.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.599 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 79.1 mt-30 -45.2 -39.45 6.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.03 7.47 64.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.67 -159.57 26.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 87' ' ' VAL . 60.1 t0 -64.7 97.91 0.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -1.184 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.939 HD13 ' HA ' ' A' ' 79' ' ' ALA . 20.1 tp -58.89 -15.9 14.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.88 -35.4 84.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 84' ' ' ASP . 5.5 p -70.1 -35.71 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -1.154 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.612 HG22 HD12 ' A' ' 92' ' ' ILE . 53.3 m -51.4 -33.31 29.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.046 -1.034 . . . . 0.0 108.424 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.542 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 3.7 m -57.03 -47.73 80.2 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 73.9 m-20 -70.97 -38.69 72.79 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.403 -0.811 . . . . 0.0 109.168 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -66.14 -53.85 32.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 109.733 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.72 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 62.7 mt -70.45 -45.26 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.727 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.69 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.75 -46.75 83.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.987 ' HB2' HG21 ' A' ' 29' ' ' THR . 76.7 m-20 -55.23 -49.65 71.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.67 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.664 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -67.93 -33.72 75.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.966 . . . . 0.0 108.833 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.78 -42.56 73.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.547 -0.721 . . . . 0.0 109.587 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 101' ' ' TYR . 60.4 m -65.46 -53.82 37.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 83.9 p -57.7 -42.99 84.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -58.3 -46.25 86.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.671 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -47.26 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 109.472 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 97' ' ' THR . 1.8 m-85 -68.57 -32.02 71.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.518 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 33.4 mt-30 -69.63 -18.79 63.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 110.051 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 18' ' ' PHE . 71.9 p -113.5 -59.37 2.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.903 -1.123 . . . . 0.0 111.182 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.58 ' OG1' HG23 ' A' ' 106' ' ' VAL . 29.9 p -125.93 -42.45 1.89 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.764 -1.21 . . . . 0.0 110.639 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 106.61 47.74 1.02 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.59 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 35.1 t -101.19 158.55 4.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -1.149 . . . . 0.0 108.831 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 107' ' ' VAL . 30.4 m -58.35 121.96 7.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.608 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.3 p30 -70.83 -26.7 63.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 113' ' ' SER . 96.4 p -64.15 -31.81 73.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.307 -0.871 . . . . 0.0 110.871 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -66.14 -55.14 17.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.771 -1.205 . . . . 0.0 110.409 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 115' ' ' ILE . 55.1 t80 -75.92 -50.82 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.081 -1.012 . . . . 0.0 109.966 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.69 HG21 ' HB1' ' A' ' 93' ' ' ALA . 22.1 mt -56.28 -40.43 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.4 t -56.13 -38.85 71.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.199 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.82 -49.69 67.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.158 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.033 HG12 ' HB1' ' A' ' 71' ' ' ALA . 96.8 mt -59.13 -34.67 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.149 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.542 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 9.6 ttt180 -53.7 -47.62 70.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.493 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 83.5 p -73.23 -33.92 65.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 115' ' ' ILE . 10.4 mt -66.1 -45.79 79.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.891 ' CG2' HD11 ' A' ' 85' ' ' LEU . 88.9 mt -57.69 -39.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.12 -36.05 64.17 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.4 ttm -58.18 -40.93 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.585 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -63.92 -28.41 69.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.17 77.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -70.66 -34.24 71.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.6 -28.1 69.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.435 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.2 p -66.07 -28.64 68.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -63.17 -22.96 67.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 89.0 m-20 -67.7 -24.81 65.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.51 -49.79 65.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.838 HG23 ' CD1' ' A' ' 131' ' ' TYR . 16.6 m -61.7 -31.87 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.838 ' CD1' HG23 ' A' ' 130' ' ' VAL . 37.6 p90 179.66 171.04 1.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.95 123.51 26.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.528 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 97.3 p -54.04 -29.29 43.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.399 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 150.9 27.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.87 -174.15 49.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.8 m -56.81 -35.59 68.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.148 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.8 mmm -61.92 -31.6 71.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -1.128 . . . . 0.0 109.395 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.29 43.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -69.1 -24.12 64.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.11 136.68 15.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -49.17 -31.93 9.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.83 HG22 ' OG ' ' A' ' 10' ' ' SER . 2.1 t -131.48 151.63 79.07 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 44.3 Cg_endo -66.7 -34.36 32.09 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.487 2.124 . . . . 0.0 112.578 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.59 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -84.33 15.93 3.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.803 -1.186 . . . . 0.0 110.059 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.83 ' OG ' HG22 ' A' ' 7' ' ' THR . 2.5 m -95.26 -34.85 12.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.064 -1.022 . . . . 0.0 108.461 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 14' ' ' ASN . 89.3 p -123.08 161.69 23.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HG3' HG13 ' A' ' 58' ' ' ILE . 22.5 mtmt -74.04 -41.11 62.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.545 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.55 93.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 0.0 109.365 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 8' ' ' PRO . 25.5 t30 -71.6 -40.93 69.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -68.67 -38.64 80.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -0.96 . . . . 0.0 109.877 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -54.96 -56.38 20.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.713 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.58 66.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.079 -1.013 . . . . 0.0 108.987 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 59.2 t80 -61.67 -46.98 87.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.126 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.665 HG21 ' C ' ' A' ' 44' ' ' GLY . 19.8 mm -63.08 -46.23 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.273 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -50.75 53.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.304 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 33.8 t -54.95 -29.85 57.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 108.903 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.608 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 30.7 t80 -72.22 -51.74 19.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 0.0 109.853 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.3 mt -61.81 -55.89 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.048 . . . . 0.0 109.839 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -58.74 -36.55 74.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.892 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.88 -46.5 21.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.935 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -63.25 -33.7 76.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 110.173 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.434 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 45.0 m -64.05 -28.12 69.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 110.02 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.95 7.33 32.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 110.318 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 1.006 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.9 m -92.68 -76.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.865 -1.147 . . . . 0.0 110.187 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -84.67 -104.4 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.4 -59.09 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.347 -1.09 . . . . 0.0 109.371 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 17.8 m-85 44.41 89.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.345 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.434 ' OG ' ' HG2' ' A' ' 36' ' ' GLN . 47.6 p -59.81 161.54 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.629 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -52.7 -41.14 63.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -58.96 -35.55 73.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.228 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CD ' ' HG2' ' A' ' 81' ' ' GLN . 97.5 mm-40 -72.23 -32.37 66.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.255 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.434 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 60.3 mtt -63.45 -34.29 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -58.21 -45.54 87.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.041 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HB2' HG23 ' A' ' 77' ' ' ILE . 85.0 m-20 -56.66 -43.23 80.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.297 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.486 ' O ' ' O ' ' A' ' 43' ' ' ILE . 63.6 mtt -59.47 -32.2 70.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.5 p -70.25 -23.58 62.92 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.243 -0.91 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 12.5 tp -89.71 -25.17 21.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.74 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.982 HG21 ' HB3' ' A' ' 73' ' ' SER . 54.1 mt -125.34 149.75 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.665 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 95.25 -79.66 0.85 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -61.35 -30.59 70.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.265 -1.138 . . . . 0.0 108.454 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.1 m -67.35 -34.79 78.07 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 66' ' ' LEU . 52.6 mt -52.35 -32.9 40.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.449 -0.782 . . . . 0.0 109.181 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.4 ttm -57.46 -47.23 82.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.224 -0.922 . . . . 0.0 108.901 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.85 69.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.213 -0.929 . . . . 0.0 108.808 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.44 83.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.466 ' HE1' HD13 ' A' ' 63' ' ' LEU . 85.3 mmm -54.19 -29.66 46.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.868 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -58.22 -27.27 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.424 -0.798 . . . . 0.0 109.163 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -69.48 -25.63 64.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.266 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.539 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 79.4 mmm -52.04 -22.73 4.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.408 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.19 8.85 87.24 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.46 27.95 7.37 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.561 ' O ' HD13 ' A' ' 58' ' ' ILE . 7.3 ptt85 -136.46 111.77 9.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -1.186 . . . . 0.0 109.599 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.939 ' CG2' HD22 ' A' ' 63' ' ' LEU . 25.0 mm -117.68 139.99 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.655 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 63' ' ' LEU . 17.0 p -147.75 158.29 42.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 64' ' ' GLN . 43.0 Cg_endo -65.55 -52.83 0.91 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.83 2.353 . . . . 0.0 112.07 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.3 m -52.52 -46.58 66.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.952 . . . . 0.0 109.578 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -81.15 -52.71 7.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.974 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.939 HD22 ' CG2' ' A' ' 58' ' ' ILE . 13.5 tp -59.1 -36.5 75.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 109.635 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 65.2 tt0 -55.67 -28.76 57.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.085 -1.01 . . . . 0.0 109.179 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.57 91.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.584 HD23 ' C ' ' A' ' 66' ' ' LEU . 10.5 tt -67.33 -41.38 85.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 38.2 t0 -48.63 -47.85 39.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.52 -39.63 94.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.548 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.44 89.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.68 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.741 ' O ' HG13 ' A' ' 74' ' ' VAL . 87.4 t80 -58.62 -41.58 86.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -63.71 -35.58 81.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.655 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -69.36 -38.68 78.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.666 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.982 ' HB3' HG21 ' A' ' 43' ' ' ILE . 20.4 m -70.24 -48.69 55.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 70' ' ' PHE . 8.5 m -57.35 -34.73 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.254 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -72.94 -41.73 64.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 80' ' ' SER . 96.9 mt-30 -65.24 -50.3 66.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.449 HG23 ' HB2' ' A' ' 39' ' ' ASN . 92.9 mt -53.69 -48.98 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.579 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.54 -52.26 8.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.506 -0.746 . . . . 0.0 109.92 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.97 -23.19 52.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.497 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 90.6 p -81.67 -20.47 39.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 42.9 mt-30 -49.44 -35.11 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 109.381 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.47 9.19 79.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.76 -150.33 26.87 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 87' ' ' VAL . 19.2 t70 -71.23 128.1 34.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -1.204 . . . . 0.0 109.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.739 HD11 HG22 ' A' ' 119' ' ' ILE . 6.2 tp -80.26 -18.67 48.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.862 . . . . 0.0 109.653 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.25 -40.13 61.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 88' ' ' THR . 4.7 p -67.0 -44.28 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -1.212 . . . . 0.0 109.695 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.565 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 28.1 m -51.66 -35.57 42.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 108.352 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 116' ' ' ARG . 6.8 m -54.03 -48.22 70.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.6 m120 -71.12 -39.88 71.76 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -62.12 -54.11 45.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.848 HG22 HD11 ' A' ' 96' ' ' LEU . 77.2 mt -72.24 -48.36 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.291 -0.881 . . . . 0.0 109.732 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.29 -50.77 72.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.243 -0.91 . . . . 0.0 109.938 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 1.006 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.1 m-20 -55.41 -46.71 76.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.095 -1.003 . . . . 0.0 109.612 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -58.5 -43.46 89.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.382 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.848 HD11 HG22 ' A' ' 92' ' ' ILE . 3.8 mt -69.91 -33.3 71.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.518 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.88 HG23 ' ND2' ' A' ' 108' ' ' ASN . 92.7 m -67.57 -53.39 28.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 88.4 p -59.22 -35.55 73.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.689 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -70.01 -43.45 71.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.2 m-85 -47.25 -56.23 7.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.551 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.552 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 8.0 m-85 -72.16 -32.02 66.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.454 -0.779 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 86.5 mm-40 -72.55 -18.74 61.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 72.7 p -103.6 -60.3 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.846 -1.158 . . . . 0.0 111.232 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.544 ' CG2' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -127.12 -42.91 1.68 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.691 -1.256 . . . . 0.0 110.875 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 113.71 45.31 0.72 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 107' ' ' VAL . 10.1 t -106.0 172.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -1.211 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.581 ' H ' HG12 ' A' ' 106' ' ' VAL . 8.7 m -75.01 120.18 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.88 ' ND2' HG23 ' A' ' 97' ' ' THR . 14.3 p30 -71.83 -23.79 61.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -0.903 . . . . 0.0 109.844 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 113' ' ' SER . 29.8 m -59.17 -43.63 92.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 0.0 110.591 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -57.0 -53.58 56.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.986 -1.071 . . . . 0.0 110.027 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 1.153 ' CE2' HD11 ' A' ' 115' ' ' ILE . 70.7 t80 -75.29 -51.72 12.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 109.943 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.528 HG21 ' HB1' ' A' ' 93' ' ' ALA . 16.2 mt -58.71 -36.25 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.275 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 109' ' ' SER . 15.5 m -55.97 -43.3 77.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.048 -1.032 . . . . 0.0 109.83 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -72.04 -36.89 69.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.153 HD11 ' CE2' ' A' ' 111' ' ' PHE . 28.4 mt -62.78 -43.52 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.598 ' HG2' HG23 ' A' ' 89' ' ' THR . 34.6 mtp180 -54.06 -49.3 69.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.4 p -57.46 -33.17 67.69 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 115' ' ' ILE . 6.8 mt -73.51 -40.12 64.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.496 -0.752 . . . . 0.0 110.037 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.739 HG22 HD11 ' A' ' 85' ' ' LEU . 57.8 mt -61.21 -35.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 109.226 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.726 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.38 -34.09 64.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 48.7 ttm -61.99 -44.5 96.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 84.5 m-85 -59.1 -42.76 91.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.646 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -62.76 -30.98 71.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 93.1 mt-30 -68.59 -31.15 70.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.22 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 86.7 p -62.18 -30.26 70.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -64.18 -25.31 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.324 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 131' ' ' TYR . 41.0 t-20 -59.12 -25.15 63.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.43 -23.4 66.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.618 ' CG1' ' CD1' ' A' ' 131' ' ' TYR . 2.1 p -66.87 -26.65 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CD1' ' CG1' ' A' ' 130' ' ' VAL . 0.1 OUTLIER 176.58 174.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.92 128.43 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.004 . . . . 0.0 109.614 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.4 p -53.57 -31.38 46.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.38 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' ' OXT' ' A' ' 137' ' ' GLY . . . -55.32 -36.25 66.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.39 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.62 -166.41 45.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.1 t -58.23 -34.49 70.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -1.118 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.456 ' OXT' ' O ' ' A' ' 134' ' ' ALA . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -128.11 161.21 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -1.165 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.34 11.62 55.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.433 ' HG2' ' N ' ' A' ' 5' ' ' ALA . 64.4 tt0 -107.96 158.91 16.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.138 . . . . 0.0 109.522 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.644 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -154.53 163.56 40.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.349 -0.845 . . . . 0.0 109.508 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -76.74 -8.67 57.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.361 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -154.52 149.99 21.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.165 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HD2' HG22 ' A' ' 7' ' ' THR . 43.6 Cg_endo -67.0 -35.29 26.32 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.356 2.037 . . . . 0.0 111.977 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.831 ' CZ2' HG21 ' A' ' 7' ' ' THR . 45.8 p90 -90.01 -10.71 43.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.451 ' C ' HD23 ' A' ' 63' ' ' LEU . 58.3 m -70.62 -8.9 55.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.79 . . . . 0.0 109.366 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.6 t -143.4 159.03 43.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.584 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HD3' HD11 ' A' ' 58' ' ' ILE . 25.2 mtmt -74.73 -40.76 61.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.46 -50.45 69.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.186 -0.946 . . . . 0.0 109.502 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.644 ' ND2' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -72.21 -29.11 63.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.384 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 11' ' ' SER . . . -71.43 -53.68 13.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -54.82 -56.1 23.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.659 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -37.64 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -0.982 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD1' ' HB1' ' A' ' 99' ' ' ALA . 80.0 t80 -63.44 -38.06 89.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.447 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.85 HG23 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -75.64 -38.3 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -68.33 -50.54 52.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.5 t -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.665 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.807 ' CE1' HG21 ' A' ' 74' ' ' VAL . 25.6 t80 -64.79 -46.81 80.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 110.32 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.445 HG23 ' SD ' ' A' ' 40' ' ' MET . 82.8 mt -65.93 -56.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.161 -0.962 . . . . 0.0 110.251 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.4 p -54.05 -34.14 59.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.92 -47.4 18.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 110.011 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.49 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -62.34 -34.97 77.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.443 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 93.8 p -61.78 -30.1 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.007 . . . . 0.0 110.208 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -106.07 7.47 31.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.469 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.967 HG21 ' HB2' ' A' ' 94' ' ' ASP . 23.4 m -91.16 -78.27 0.4 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.13 . . . . 0.0 110.356 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.74 -103.53 0.38 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 32' ' ' PHE . 17.3 p -131.61 -61.34 0.91 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.317 -1.108 . . . . 0.0 109.45 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 11.4 m-85 44.42 87.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.063 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 p -59.51 162.04 5.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -52.54 -39.66 61.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -60.22 -35.97 76.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.082 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.476 ' HG3' ' OE1' ' A' ' 81' ' ' GLN . 90.2 mm-40 -73.96 -32.62 63.55 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.187 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.443 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 58.1 mtt -63.91 -35.88 82.1 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.003 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -57.12 -49.14 76.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.397 -0.815 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' HG23 ' A' ' 77' ' ' ILE . 74.5 m-20 -55.86 -37.33 68.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.091 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.476 ' HE3' ' CG ' ' A' ' 32' ' ' PHE . 64.1 mtt -57.36 -32.01 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.395 -0.816 . . . . 0.0 108.976 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.7 m -69.79 -24.15 63.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.366 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' THR . 62.0 mt -91.09 -19.71 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.051 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 44' ' ' GLY . 18.9 mm -116.33 167.61 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.825 . . . . 0.0 109.12 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.637 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 69.19 -92.68 0.32 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -53.25 -39.73 64.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -1.14 . . . . 0.0 109.288 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.496 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m -58.71 -38.15 77.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.174 -0.954 . . . . 0.0 108.966 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 66' ' ' LEU . 34.2 tp -55.67 -32.96 63.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.435 -0.791 . . . . 0.0 109.133 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' A' ' 51' ' ' MET . 18.1 ttt -54.85 -31.85 59.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.283 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.86 91.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.673 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.78 -26.44 68.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.389 -0.819 . . . . 0.0 108.919 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.53 ' CG ' ' HD2' ' A' ' 12' ' ' LYS . 28.5 ttm -54.48 -32.94 58.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.423 -0.798 . . . . 0.0 109.225 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -74.38 -26.85 60.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.404 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -60.5 -21.46 62.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.645 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 68.6 mmm -64.28 -43.91 93.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.47 66.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 16.57 13.79 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.645 ' O ' ' HE2' ' A' ' 54' ' ' MET . 28.3 ptt85 -126.78 112.13 15.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -1.18 . . . . 0.0 109.736 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.599 HG23 HD11 ' A' ' 63' ' ' LEU . 28.3 mm -116.3 149.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -148.72 165.97 16.61 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 64' ' ' GLN . 48.8 Cg_endo -69.64 -36.17 11.61 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.65 2.233 . . . . 0.0 111.525 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -68.04 -34.89 77.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.293 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -78.1 -50.82 11.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.405 -0.809 . . . . 0.0 109.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 9' ' ' TRP . 7.0 mp -67.2 -46.27 74.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 33.3 tp60 -53.54 -35.74 61.06 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.11 68.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 47' ' ' LEU . 10.9 mt -74.12 -51.25 16.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 24.3 t70 -46.9 -39.98 13.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 108.561 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 56.1 mtt -72.17 -45.44 60.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.847 . . . . 0.0 108.944 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.42 91.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 108.94 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 19' ' ' ILE . 79.8 t80 -52.19 -43.4 64.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.133 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.967 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.79 -39.07 73.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 109.596 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -69.29 -36.71 77.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.488 ' CB ' HG21 ' A' ' 43' ' ' ILE . 5.9 m -69.98 -44.26 69.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.807 HG21 ' CE1' ' A' ' 22' ' ' PHE . 8.7 p -67.44 -36.77 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.347 -0.846 . . . . 0.0 109.521 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 74' ' ' VAL . . . -61.55 -39.16 90.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.49 -39.66 77.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.647 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 74' ' ' VAL . 72.2 mt -58.1 -49.58 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -77.38 -48.62 16.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 109.621 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.09 -24.89 60.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.1 t -78.17 -20.35 52.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.571 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.5 mt-30 -49.98 -27.62 5.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.527 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.52 77.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.65 -148.18 23.77 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 87' ' ' VAL . 50.7 t0 -67.11 124.21 22.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.31 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.811 HD11 HG22 ' A' ' 119' ' ' ILE . 4.3 tp -81.18 -21.77 39.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.0 109.255 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.1 -34.56 64.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 84' ' ' ASP . 3.6 p -67.11 -42.89 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.105 -1.232 . . . . 0.0 109.72 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.651 HG22 HD12 ' A' ' 92' ' ' ILE . 51.9 m -51.54 -34.65 37.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.987 -1.071 . . . . 0.0 108.321 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 m -56.73 -49.8 74.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.1 m120 -70.61 -38.24 73.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 109.039 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -64.77 -53.4 47.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.612 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.77 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 66.6 mt -72.35 -45.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.866 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.83 -44.94 91.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.967 ' HB2' HG21 ' A' ' 29' ' ' THR . 48.7 m-20 -55.2 -48.51 73.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.953 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.4 -33.67 69.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.9 HD22 HD12 ' A' ' 115' ' ' ILE . 7.2 tp -70.03 -33.68 72.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.912 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 112' ' ' ILE . 98.7 m -69.3 -53.82 17.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 14.3 m -62.51 -33.61 75.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 0.0 109.878 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -63.91 -33.68 76.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.0 m-85 -61.39 -56.25 22.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.558 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.3 m-85 -71.97 -32.1 66.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 109.683 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 98' ' ' SER . 85.3 mm-40 -71.19 -17.99 62.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.848 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 72.0 p -111.06 -59.65 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.074 . . . . 0.0 111.254 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.667 HG21 ' C ' ' A' ' 7' ' ' THR . 26.7 p -126.33 -43.02 1.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.797 -1.189 . . . . 0.0 110.968 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.71 45.93 1.01 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.08 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.598 HG23 ' OG1' ' A' ' 104' ' ' THR . 18.4 t -101.89 171.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.159 -1.201 . . . . 0.0 108.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 107' ' ' VAL . 29.0 m -71.48 120.55 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 0.0 109.799 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.604 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 24.2 p-10 -72.21 -33.32 67.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 109.97 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 113' ' ' SER . 29.8 m -57.82 -33.74 68.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 107' ' ' VAL . 67.1 ttt-85 -67.91 -54.47 18.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.832 -1.168 . . . . 0.0 110.095 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.757 ' CD2' HD21 ' A' ' 96' ' ' LEU . 32.3 t80 -75.46 -47.04 28.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.64 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.898 HG12 HD23 ' A' ' 96' ' ' LEU . 9.5 mt -56.01 -46.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 109' ' ' SER . 60.3 m -55.57 -41.45 73.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.004 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.65 -45.26 89.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.224 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.967 HG12 ' HB1' ' A' ' 71' ' ' ALA . 77.9 mt -66.99 -34.36 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.82 . . . . 0.0 109.162 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.527 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 19.7 ttt-85 -53.54 -49.01 68.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.569 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.0 p -70.16 -34.02 72.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.542 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 115' ' ' ILE . 13.9 mt -66.62 -44.97 80.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 109.668 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 85' ' ' LEU . 89.4 mt -57.66 -42.95 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.788 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -71.28 -36.9 63.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.2 ttp -56.81 -40.38 75.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -1.134 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 60.5 m-85 -62.0 -50.66 71.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.535 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -62.15 -32.73 73.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.462 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -70.61 -32.9 70.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.585 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.51 75.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.885 . . . . 0.0 109.488 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 m -58.74 -33.02 69.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.457 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 131' ' ' TYR . . . -73.15 -15.62 61.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 56.0 t-20 -66.22 -34.43 78.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.21 -51.37 61.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.809 HG13 ' CD2' ' A' ' 131' ' ' TYR . 5.2 p -63.56 -33.95 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.352 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.809 ' CD2' HG13 ' A' ' 130' ' ' VAL . 40.9 p90 -176.94 168.74 2.46 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.338 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.82 115.61 14.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.7 t -63.94 153.4 37.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -109.7 147.74 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -0.906 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.79 149.67 51.46 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.2 m -121.7 148.82 44.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.5 mtt -121.39 154.3 36.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -1.139 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.16 3.61 85.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.77 -29.35 70.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.98 148.13 20.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.583 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.476 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 42.1 p-10 -120.18 24.55 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.761 ' C ' HG21 ' A' ' 104' ' ' THR . 0.0 OUTLIER -146.95 150.14 37.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HG2' ' CE3' ' A' ' 9' ' ' TRP . 48.8 Cg_endo -71.78 -35.07 8.05 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 111.543 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.927 ' O ' HD23 ' A' ' 63' ' ' LEU . 37.6 p90 -88.02 -30.71 19.77 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.011 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 36.0 t -55.63 -25.37 38.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.473 -0.767 . . . . 0.0 109.771 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 1.3 t -113.98 136.64 52.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.971 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HB2' HG13 ' A' ' 58' ' ' ILE . 2.5 ttpp -65.27 -37.79 88.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -70.29 -43.9 69.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 11' ' ' SER . 12.6 m120 -71.6 -29.11 64.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.377 -0.827 . . . . 0.0 109.416 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 8' ' ' PRO . . . -64.81 -44.15 90.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.118 -0.989 . . . . 0.0 110.187 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.636 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 2.7 p30 -64.06 -50.85 66.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.518 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -62.06 -32.86 73.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.025 . . . . 0.0 108.903 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CG ' ' HB2' ' A' ' 8' ' ' PRO . 56.0 t80 -70.45 -43.45 69.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.816 HG23 ' HE1' ' A' ' 70' ' ' PHE . 27.6 mt -73.18 -44.63 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.525 -0.734 . . . . 0.0 109.041 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -68.08 -50.63 53.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.78 . . . . 0.0 109.182 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 74.1 m -57.46 -30.15 64.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 108.606 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' A' ' 74' ' ' VAL . 8.6 t80 -72.01 -50.03 32.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.512 -0.743 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 40' ' ' MET . 50.8 mm -64.94 -55.73 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.141 -0.974 . . . . 0.0 109.652 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -53.86 -39.71 65.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 0.0 109.909 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.416 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -77.72 -46.73 20.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.161 -0.962 . . . . 0.0 109.815 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.556 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -58.9 -35.67 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.085 -1.009 . . . . 0.0 109.703 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.529 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 85.8 p -64.05 -28.41 69.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.84 6.92 32.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.089 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.81 HG21 ' HB3' ' A' ' 94' ' ' ASP . 20.5 m -91.75 -76.9 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.047 -1.033 . . . . 0.0 110.033 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -82.49 -104.68 0.45 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -131.8 -60.49 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -1.126 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.793 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 43.58 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.343 -0.848 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.5 t -59.66 162.81 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -52.63 -39.49 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.373 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.51 -35.96 81.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 91.6 mm-40 -73.65 -32.29 63.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.5 mtt -63.6 -36.51 84.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.91 . . . . 0.0 109.103 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -58.54 -47.41 84.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HB2' HG23 ' A' ' 77' ' ' ILE . 86.3 m-20 -56.14 -45.26 79.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.352 -0.842 . . . . 0.0 109.071 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.0 ' HB3' HD12 ' A' ' 23' ' ' ILE . 56.2 mtm -57.15 -33.66 67.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 108.829 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.3 p -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.306 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' O ' ' OG1' ' A' ' 46' ' ' THR . 58.8 mt -87.19 -21.26 26.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 73' ' ' SER . 94.9 mt -121.87 143.77 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.244 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 98.78 -88.21 0.84 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -59.79 -32.45 70.63 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.165 -1.197 . . . . 0.0 108.282 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 91.8 m -59.15 -35.04 72.82 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 47' ' ' LEU . 69.0 mt -65.64 -40.21 92.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.611 -0.681 . . . . 0.0 109.513 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.636 ' HE2' ' HB3' ' A' ' 16' ' ' ASP . 89.5 mmm -52.74 -35.01 55.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.95 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.159 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.35 -36.12 78.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.884 . . . . 0.0 109.223 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.479 ' SD ' ' HG3' ' A' ' 12' ' ' LYS . 54.6 mtt -60.06 -29.85 68.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.208 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.1 -31.54 67.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.952 . . . . 0.0 109.332 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -63.71 -27.86 69.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.228 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.686 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 92.4 mmm -55.95 -33.93 65.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.56 7.13 56.06 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.16 11.29 24.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.686 ' O ' ' HE2' ' A' ' 54' ' ' MET . 7.4 ptm180 -125.91 113.94 17.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.145 . . . . 0.0 109.523 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 63' ' ' LEU . 16.8 mm -117.04 147.46 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.563 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 160.38 41.06 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.57 -27.09 23.03 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.703 2.269 . . . . 0.0 111.773 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 m -74.55 -48.04 29.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.465 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HG2' ' CD2' ' A' ' 66' ' ' LEU . 38.1 tttm -59.21 -51.55 69.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.345 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.927 HD23 ' O ' ' A' ' 9' ' ' TRP . 2.0 mp -61.48 -41.23 96.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.433 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 62.9 tt0 -54.21 -35.69 62.68 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.322 -0.861 . . . . 0.0 109.077 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.74 -51.69 15.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.683 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.621 HD21 HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.6 -46.68 36.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.274 -0.891 . . . . 0.0 110.987 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 9' ' ' TRP . 3.6 p-10 -47.78 -29.87 3.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.258 . . . . 0.0 109.805 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 68.7 mtp -72.66 -36.26 67.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.59 -34.29 75.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.816 ' HE1' HG23 ' A' ' 19' ' ' ILE . 66.2 t80 -52.47 -37.13 56.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.755 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.46 -47.93 58.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.873 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -69.25 -30.77 68.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.039 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 43' ' ' ILE . 8.3 m -69.8 -45.84 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.881 HG21 ' CE1' ' A' ' 22' ' ' PHE . 9.6 p -68.93 -36.66 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -59.69 -40.85 89.23 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 109.727 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -70.72 -35.02 72.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 74' ' ' VAL . 94.2 mt -58.57 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.793 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -75.21 -41.64 57.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.672 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.57 61.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.5 t -76.77 -20.36 56.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 45.1 mt-30 -50.01 -37.84 34.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 109.46 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.77 81.54 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.51 -149.18 24.52 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.634 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.4 t0 -66.79 119.72 12.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 119' ' ' ILE . 7.0 tp -74.69 -24.16 58.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.9 64.39 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.6 p -69.1 -38.17 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.235 . . . . 0.0 109.844 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.616 HG22 HD12 ' A' ' 92' ' ' ILE . 54.1 m -54.7 -33.59 61.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.908 -1.12 . . . . 0.0 108.367 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.1 m -57.81 -49.25 77.29 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 68.2 m-20 -70.69 -41.06 72.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.494 -0.754 . . . . 0.0 109.154 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.611 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -64.54 -52.2 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -0.88 . . . . 0.0 109.823 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.799 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 32.2 mt -72.81 -38.3 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -72.29 -43.22 64.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.107 -0.996 . . . . 0.0 110.487 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.81 ' HB3' HG21 ' A' ' 29' ' ' THR . 40.1 t0 -54.97 -45.74 75.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.927 -1.108 . . . . 0.0 109.795 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -71.81 -35.2 69.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.109 -0.994 . . . . 0.0 109.01 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.86 -40.4 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.393 -0.817 . . . . 0.0 109.567 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.563 HG23 ' OH ' ' A' ' 101' ' ' TYR . 52.4 m -67.66 -53.87 24.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.1 m -59.81 -44.08 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -55.65 -46.79 77.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.405 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.611 ' CE2' ' CD1' ' A' ' 96' ' ' LEU . 1.5 m-85 -46.94 -56.6 6.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.73 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.576 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.99 -32.41 67.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.629 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 40.1 mt-30 -64.86 -18.54 65.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 8' ' ' PRO . 43.0 p -115.16 -59.35 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 111.333 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.761 HG21 ' C ' ' A' ' 7' ' ' THR . 15.9 p -126.16 -43.17 1.81 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.648 -1.283 . . . . 0.0 110.969 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.16 45.37 1.01 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.604 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 19.8 t -98.06 163.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.073 -1.251 . . . . 0.0 108.689 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 107' ' ' VAL . 33.1 m -64.03 121.59 13.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.588 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 10.9 p30 -71.0 -33.69 70.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.057 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 113' ' ' SER . 87.2 p -57.23 -43.72 83.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.352 -0.843 . . . . 0.0 110.967 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.413 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.8 ttt180 -57.22 -54.58 45.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 0.0 110.156 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.845 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 49.0 t80 -75.56 -46.46 31.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.785 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 14.8 mt -63.0 -35.65 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 110.15 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' SER . 29.1 t -58.12 -32.84 68.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.414 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 96.9 mt-10 -72.34 -40.34 67.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.428 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.931 HG12 ' HB1' ' A' ' 71' ' ' ALA . 80.6 mt -69.34 -40.7 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.424 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -54.34 -44.76 72.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.24 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.0 p -72.98 -33.95 66.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 109.557 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 114' ' ' GLU . 26.7 mt -67.91 -42.43 81.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 85' ' ' LEU . 65.8 mt -58.01 -39.29 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.388 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.793 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -63.56 -34.58 90.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 13.1 tpp -65.91 -38.32 88.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 0.0 109.348 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.68 -39.43 84.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -63.16 -31.45 72.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 120' ' ' GLY . 94.8 mt-30 -64.51 -36.55 84.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.325 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.73 -46.91 77.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.4 p -73.81 -24.3 59.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.381 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.71 -17.67 63.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 26.3 m120 -75.92 -29.29 58.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.88 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -66.59 -44.62 81.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.923 HG13 ' CD1' ' A' ' 131' ' ' TYR . 4.0 p -66.75 -29.56 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.179 -0.951 . . . . 0.0 109.351 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.923 ' CD1' HG13 ' A' ' 130' ' ' VAL . 42.6 p90 178.46 175.65 0.55 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.08 120.07 24.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.334 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.7 m -44.55 162.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.68 -33.87 66.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -84.16 -179.75 51.76 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.4 t -116.99 143.81 45.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -1.117 . . . . 0.0 109.477 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.49 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.0 ttm -109.21 140.69 42.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -1.089 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.85 -0.03 62.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -114.97 148.07 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -1.174 . . . . 0.0 109.468 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 11' ' ' SER . . . -80.38 136.48 36.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 52.0 m-20 -54.04 -26.71 28.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.788 HG23 ' HB2' ' A' ' 10' ' ' SER . 2.8 t -141.27 151.31 61.14 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 0.0 109.149 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 15' ' ' ALA . 46.0 Cg_endo -67.61 -35.74 21.54 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.598 2.199 . . . . 0.0 112.744 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.577 ' CE3' ' OG1' ' A' ' 7' ' ' THR . 48.2 p90 -82.13 9.08 9.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.737 -1.227 . . . . 0.0 109.525 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -95.25 -29.62 14.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 108.577 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 5' ' ' ALA . 2.6 p -120.28 155.01 34.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.018 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 51' ' ' MET . 7.2 ttpt -71.53 -41.27 69.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.93 -49.45 70.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 11' ' ' SER . 15.3 m120 -71.7 -28.9 64.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.339 -0.85 . . . . 0.0 109.941 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.04 -48.77 62.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.953 -1.092 . . . . 0.0 110.323 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 88.7 m-20 -58.57 -56.13 26.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.84 -42.38 65.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.62 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' HB2' HG21 ' A' ' 103' ' ' THR . 87.6 t80 -58.19 -37.05 74.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 70' ' ' PHE . 20.2 mm -70.92 -48.9 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.952 . . . . 0.0 109.513 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -61.45 -49.75 75.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 109.753 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -58.36 -34.33 70.56 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 40.5 t80 -69.68 -35.94 75.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.587 HG23 ' HE3' ' A' ' 40' ' ' MET . 77.4 mt -70.43 -56.14 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.92 -34.52 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -78.05 -44.66 25.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 110.392 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.683 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -71.57 -33.08 68.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.085 -1.01 . . . . 0.0 110.629 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.497 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 57.4 m -60.94 -28.27 68.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.544 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -106.42 7.49 31.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.957 -1.089 . . . . 0.0 110.847 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.955 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.3 m -93.48 -75.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.738 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -72.56 -104.08 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.456 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.8 t -148.42 13.29 0.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.495 -1.003 . . . . 0.0 109.904 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 44.7 m-85 -38.17 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.644 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' SER . 59.7 p -66.1 168.44 8.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.792 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 38' ' ' GLU . 33.7 tt0 -52.74 -44.68 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.239 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -57.43 -41.72 81.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.287 -0.883 . . . . 0.0 109.332 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.463 ' OE1' ' HG2' ' A' ' 81' ' ' GLN . 77.9 mm-40 -74.61 -32.25 62.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.156 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.507 ' CE ' ' O ' ' A' ' 32' ' ' PHE . 66.3 mtt -66.2 -33.43 75.74 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.256 -0.902 . . . . 0.0 108.966 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 95.7 mt-10 -57.26 -40.39 77.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.29 -0.881 . . . . 0.0 109.272 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 77.0 m-20 -56.1 -38.6 70.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.869 . . . . 0.0 109.071 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.587 ' HE3' HG23 ' A' ' 23' ' ' ILE . 64.4 mtm -62.49 -31.92 72.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.847 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 p -68.6 -23.71 64.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.405 -0.809 . . . . 0.0 109.062 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 14.5 tp -92.66 -23.39 18.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.055 HG21 ' CB ' ' A' ' 73' ' ' SER . 51.6 mt -132.35 149.27 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 97.15 -74.3 0.68 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.03 -34.93 69.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -1.104 . . . . 0.0 108.203 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.2 m -68.14 -34.84 77.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 66' ' ' LEU . 23.9 tp -52.47 -39.24 60.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.417 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 16' ' ' ASP . 70.0 mtm -52.4 -33.75 45.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 108.886 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.27 72.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.311 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.16 80.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 109.321 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.499 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 51.0 mtt -56.42 -32.02 64.45 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.255 -0.903 . . . . 0.0 109.271 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -54.23 -33.34 58.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.22 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -62.53 -29.55 70.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.081 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.719 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 87.9 mmm -58.4 -26.93 63.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.817 . . . . 0.0 109.321 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 9.05 70.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.98 17.61 20.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.719 ' O ' ' HE2' ' A' ' 54' ' ' MET . 31.2 ptt85 -127.63 112.27 14.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.888 ' CG2' HD22 ' A' ' 63' ' ' LEU . 15.2 mm -117.52 145.14 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.546 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 3.3 t -134.71 149.01 69.58 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 59' ' ' THR . 45.0 Cg_endo -66.28 -26.95 48.53 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.691 2.261 . . . . 0.0 111.834 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -66.72 -54.52 22.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 59' ' ' THR . 83.6 mttt -81.05 -47.71 13.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.858 . . . . 0.0 109.612 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.888 HD22 ' CG2' ' A' ' 58' ' ' ILE . 14.5 tp -48.84 -39.87 27.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.116 -0.99 . . . . 0.0 109.253 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.01 -30.63 66.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 109.09 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HA ' ' HE2' ' A' ' 68' ' ' MET . . . -71.42 -34.5 70.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.292 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.996 HD21 HD21 ' A' ' 47' ' ' LEU . 2.0 tp -73.68 -39.36 64.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.299 -0.875 . . . . 0.0 109.256 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.531 ' OD2' ' CG ' ' A' ' 9' ' ' TRP . 31.5 t0 -49.46 -46.72 48.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.435 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 70.3 mtm -54.24 -39.14 66.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.435 -0.791 . . . . 0.0 109.798 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.84 72.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CD2' HD12 ' A' ' 19' ' ' ILE . 47.4 t80 -60.65 -35.47 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB1' ' CD1' ' A' ' 115' ' ' ILE . . . -69.3 -30.5 68.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 m -69.3 -46.68 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 109.921 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 1.055 ' CB ' HG21 ' A' ' 43' ' ' ILE . 11.2 t -68.06 -48.49 65.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 92' ' ' ILE . 8.3 p -56.83 -38.53 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.7 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 122' ' ' PHE . . . -70.3 -34.63 72.96 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.242 -0.911 . . . . 0.0 109.46 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -76.26 -47.46 23.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 109.769 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 68.3 mt -53.36 -44.62 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.48 -50.69 11.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.82 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.33 44.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.202 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.5 p -81.4 -21.73 38.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.59 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG2' ' OE1' ' A' ' 36' ' ' GLN . 45.1 mt-30 -50.37 -32.76 18.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.17 -0.956 . . . . 0.0 109.557 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.27 11.02 85.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.29 -151.52 27.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.726 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.6 t70 -69.36 114.22 7.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -1.166 . . . . 0.0 109.256 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 119' ' ' ILE . 4.7 tp -62.46 -25.21 67.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.51 71.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.7 p -68.03 -36.88 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.104 -1.233 . . . . 0.0 109.774 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 92' ' ' ILE . 91.1 m -54.6 -32.24 58.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.982 -1.074 . . . . 0.0 108.513 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 24.9 m -60.2 -51.22 70.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 69.6 m-20 -70.59 -35.81 73.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.738 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -68.31 -55.69 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.582 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.742 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 39.6 mt -69.56 -50.49 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -56.93 -40.97 77.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.955 ' HB2' HG21 ' A' ' 29' ' ' THR . 7.1 m-20 -57.99 -54.28 48.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.046 -1.034 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.683 ' HB2' ' N ' ' A' ' 26' ' ' ALA . . . -68.08 -32.66 73.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 108.851 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.571 ' HB3' HD11 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -70.31 -41.05 73.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.732 . . . . 0.0 109.774 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.66 HG23 HD22 ' A' ' 108' ' ' ASN . 21.5 m -68.4 -53.99 20.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.015 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 50.9 m -59.81 -43.26 94.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.208 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 102' ' ' GLN . . . -56.09 -46.37 79.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.63 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.5 m-85 -46.86 -54.48 9.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -0.87 . . . . 0.0 109.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 1.3 m-85 -71.31 -31.42 67.4 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.544 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 60.9 mt-30 -70.77 -18.02 62.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.615 HG21 ' HB2' ' A' ' 18' ' ' PHE . 59.1 p -110.82 -59.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 111.08 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.672 ' OG1' HG23 ' A' ' 106' ' ' VAL . 18.0 p -126.82 -43.31 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.69 -1.256 . . . . 0.0 110.781 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.89 43.54 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.683 -1.246 . . . . 0.0 109.991 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.672 HG23 ' OG1' ' A' ' 104' ' ' THR . 13.7 t -99.21 169.59 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.104 -1.233 . . . . 0.0 108.62 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 107' ' ' VAL . 29.4 m -69.57 121.66 19.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.376 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.66 HD22 HG23 ' A' ' 97' ' ' THR . 13.0 p30 -70.52 -24.08 62.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.643 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 113' ' ' SER . 39.9 m -60.91 -29.99 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.549 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -69.16 -55.0 11.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.904 -1.123 . . . . 0.0 110.418 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' A' ' 115' ' ' ILE . 88.4 t80 -75.93 -50.6 14.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.571 HD11 ' HB3' ' A' ' 96' ' ' LEU . 53.1 mt -56.39 -36.51 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.177 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 109' ' ' SER . 3.9 m -56.69 -39.39 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.944 -1.097 . . . . 0.0 109.044 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.26 -42.13 65.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.282 -0.886 . . . . 0.0 109.233 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.739 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 32.8 mm -62.72 -49.37 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.363 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.523 ' HD2' ' CG2' ' A' ' 89' ' ' THR . 6.8 ttt180 -54.12 -42.68 69.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.012 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.0 m -73.01 -33.42 65.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 115' ' ' ILE . 22.0 mt -68.5 -43.39 76.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.803 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.916 HG22 HD11 ' A' ' 85' ' ' LEU . 23.3 mt -57.89 -43.53 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 109.539 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.731 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -60.58 -34.74 87.25 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.3 ttm -62.74 -43.5 98.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.143 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE2' ' CB ' ' A' ' 75' ' ' ALA . 84.9 m-85 -59.63 -47.65 84.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.446 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -56.77 -30.67 63.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.62 -32.1 69.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.92 -35.72 73.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.13 -30.5 62.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.401 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -66.08 -19.75 65.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 23.8 m120 -63.1 -23.05 67.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -72.61 -47.54 46.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.331 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.954 HG13 ' CD1' ' A' ' 131' ' ' TYR . 6.3 p -66.86 -29.24 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.954 ' CD1' HG13 ' A' ' 130' ' ' VAL . 42.1 p90 178.24 173.98 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.387 -0.821 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.43 116.43 19.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 59.5 p -70.11 165.55 21.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.75 146.84 47.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.428 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.79 35.88 27.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.1 m -57.01 -35.04 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 109.459 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.963 -1.465 . . . . 0.0 109.481 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.1 mmm -59.11 -35.28 73.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -1.13 . . . . 0.0 109.403 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.52 -157.22 37.97 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -95.79 155.07 16.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.188 . . . . 0.0 109.486 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.626 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -84.46 123.27 30.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.642 ' C ' HG21 ' A' ' 104' ' ' THR . 36.5 m-20 -68.96 -6.54 28.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.566 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.868 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -157.46 155.54 27.54 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.67 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.868 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.2 Cg_endo -69.23 -35.09 14.92 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.265 . . . . 0.0 111.386 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.854 ' O ' HD22 ' A' ' 63' ' ' LEU . 35.8 p90 -91.35 -23.65 20.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 108.998 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.576 ' C ' HD13 ' A' ' 63' ' ' LEU . 12.0 m -63.74 -14.47 52.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 108.651 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 73.3 m -140.52 122.58 15.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 0.0 109.076 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.948 ' HD3' HD11 ' A' ' 58' ' ' ILE . 45.8 pttt -52.53 -43.92 65.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' N ' ' HG3' ' A' ' 12' ' ' LYS . . . -63.19 -36.58 84.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.626 ' ND2' ' HB3' ' A' ' 5' ' ' ALA . 9.7 t-20 -72.8 -35.22 67.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.766 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 8' ' ' PRO . . . -66.66 -27.9 68.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' HA ' ' CE ' ' A' ' 48' ' ' MET . 92.3 m-20 -54.73 -56.71 16.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.69 66.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' HA ' HG21 ' A' ' 103' ' ' THR . 50.8 t80 -71.18 -38.86 72.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.752 HG21 ' C ' ' A' ' 44' ' ' GLY . 13.9 mm -75.45 -47.74 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.522 -0.736 . . . . 0.0 109.896 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.5 -49.96 73.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.281 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -62.68 -30.39 71.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.181 -0.949 . . . . 0.0 110.103 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.766 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 29.3 t80 -71.43 -51.92 21.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.481 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 40' ' ' MET . 41.8 mm -61.24 -56.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.041 -1.037 . . . . 0.0 110.453 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -57.31 -38.21 73.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.943 . . . . 0.0 110.135 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.07 -45.94 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.162 -0.962 . . . . 0.0 110.281 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.545 ' N ' ' HB2' ' A' ' 95' ' ' ALA . . . -64.51 -37.56 87.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.106 -0.996 . . . . 0.0 110.458 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 65.7 p -59.17 -28.94 67.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -0.983 . . . . 0.0 110.5 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.18 7.36 31.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.999 -1.063 . . . . 0.0 110.745 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 1.01 HG21 ' HB2' ' A' ' 94' ' ' ASP . 18.2 m -94.64 -74.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.776 -1.202 . . . . 0.0 110.883 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -73.53 -104.94 0.07 OUTLIER Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.406 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 33' ' ' SER . 42.5 p -147.74 13.36 1.03 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -1.049 . . . . 0.0 109.742 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 78' ' ' ALA . 46.0 m-85 -38.34 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.572 -0.705 . . . . 0.0 109.634 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 31' ' ' SER . 31.0 m -60.15 162.33 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -53.09 -44.24 67.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.39 -0.819 . . . . 0.0 109.359 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -56.25 -41.39 75.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 84.3 mm-40 -72.34 -31.11 65.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.042 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 65.2 mtt -63.05 -32.39 73.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.32 -50.12 73.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.014 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.331 -0.856 . . . . 0.0 109.018 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.666 ' HB3' HD12 ' A' ' 23' ' ' ILE . 87.2 mtp -58.51 -37.63 76.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.78 . . . . 0.0 109.157 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.9 p -70.39 -24.12 62.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 109.233 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.3 tp -83.42 -20.69 33.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.328 -0.858 . . . . 0.0 109.341 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.05 HG21 ' CB ' ' A' ' 73' ' ' SER . 20.2 mm -120.48 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.345 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.752 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 100.8 -79.71 0.44 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 46' ' ' THR . 7.1 p30 -65.74 -35.93 82.12 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.272 -1.134 . . . . 0.0 108.195 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.507 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 60.5 m -62.14 -35.05 77.6 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.924 HD21 ' HG ' ' A' ' 66' ' ' LEU . 35.0 tp -61.22 -34.45 75.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.513 -0.742 . . . . 0.0 109.214 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.528 ' HA ' ' CE ' ' A' ' 51' ' ' MET . 54.8 mtt -52.73 -37.96 60.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.166 -0.959 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.29 -31.65 71.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.54 -49.78 51.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.385 -0.822 . . . . 0.0 108.952 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 66' ' ' LEU . 53.5 mtm -60.76 -29.62 69.52 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.398 -0.814 . . . . 0.0 109.209 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.07 -27.14 68.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -63.16 -32.14 73.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.298 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.609 ' HG3' HD13 ' A' ' 58' ' ' ILE . 98.5 mmm -50.56 -48.24 57.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.398 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.39 15.79 20.16 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.37 3.74 44.06 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' CE ' ' A' ' 54' ' ' MET . 31.6 ptt85 -119.54 112.44 19.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 0.0 109.509 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.948 HD11 ' HD3' ' A' ' 12' ' ' LYS . 13.2 mm -116.21 160.5 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.518 ' OG1' ' CB ' ' A' ' 62' ' ' LYS . 68.5 p -119.34 157.06 52.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.673 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.42 -39.55 5.14 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.777 2.318 . . . . 0.0 111.731 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 76.4 p -74.31 -34.56 63.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.235 -0.916 . . . . 0.0 109.447 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 22.6 tttp -67.8 -49.9 59.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.371 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.854 HD22 ' O ' ' A' ' 9' ' ' TRP . 10.0 mt -62.47 -31.06 71.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 109.405 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -53.55 -45.28 69.81 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.23 63.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.924 ' HG ' HD21 ' A' ' 47' ' ' LEU . 7.5 tt -70.49 -53.63 15.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.47 -0.769 . . . . 0.0 109.128 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.577 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 22.0 t0 -48.16 -46.89 35.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.94 . . . . 0.0 109.398 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.2 mtp -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.4 -48.99 73.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.0 109.5 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.674 ' O ' HG13 ' A' ' 74' ' ' VAL . 57.4 t80 -58.22 -38.32 76.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.308 -0.87 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -68.22 -36.16 79.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.776 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 1.05 ' CB ' HG21 ' A' ' 43' ' ' ILE . 19.7 m -70.24 -43.45 70.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.991 . . . . 0.0 109.709 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 70' ' ' PHE . 6.0 m -68.37 -35.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 119' ' ' ILE . . . -65.16 -39.92 93.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.534 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.77 -45.18 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 40' ' ' MET . 91.8 mt -56.67 -46.16 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.555 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.666 ' HB1' ' OG1' ' A' ' 88' ' ' THR . . . -67.55 -51.87 45.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.605 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 85' ' ' LEU . . . -58.09 -24.51 58.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -76.3 -20.43 57.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 46.5 mt-30 -51.55 -31.87 25.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.27 10.27 82.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.45 -160.91 26.09 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.68 ' O ' HG12 ' A' ' 87' ' ' VAL . 22.7 t70 -69.58 101.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.961 HD11 ' CG2' ' A' ' 119' ' ' ILE . 25.9 tp -52.92 -20.36 3.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.627 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.07 -33.97 87.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 84' ' ' ASP . 8.0 p -69.2 -35.81 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.196 . . . . 0.0 109.703 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.666 ' OG1' ' HB1' ' A' ' 78' ' ' ALA . 64.1 m -51.65 -32.15 28.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.034 -1.041 . . . . 0.0 108.623 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 37.5 m -58.33 -45.5 87.99 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 20.5 m120 -70.77 -38.29 73.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.485 -0.759 . . . . 0.0 109.073 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.627 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -69.09 -58.82 3.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 109.557 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.766 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 35.9 mm -61.25 -45.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.673 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 112' ' ' ILE . . . -65.86 -49.06 69.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.883 . . . . 0.0 110.262 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 1.01 ' HB2' HG21 ' A' ' 29' ' ' THR . 86.0 m-20 -55.29 -46.02 76.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.184 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -68.62 -38.72 80.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.841 HD21 ' HD2' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -70.0 -42.96 72.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.526 HG22 ' CE2' ' A' ' 101' ' ' TYR . 88.7 m -60.57 -50.93 71.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.845 . . . . 0.0 109.722 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 102' ' ' GLN . 31.2 t -60.41 -33.98 73.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.967 . . . . 0.0 109.525 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.4 -44.34 68.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.425 -0.797 . . . . 0.0 109.996 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.0 OUTLIER -47.89 -56.34 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 2.6 m-85 -69.2 -32.11 71.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 98' ' ' SER . 78.4 mm-40 -79.52 -18.49 51.78 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 18' ' ' PHE . 71.3 p -106.53 -59.15 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.936 -1.103 . . . . 0.0 111.177 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.642 HG21 ' C ' ' A' ' 6' ' ' ASN . 48.1 m -125.14 -42.44 2.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.838 -1.164 . . . . 0.0 111.002 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.1 47.33 1.16 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 17.6 t -110.36 172.22 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.287 -1.125 . . . . 0.0 108.915 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.569 ' H ' HG12 ' A' ' 106' ' ' VAL . 35.1 m -68.59 121.17 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.144 -0.973 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.609 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 19.2 p-10 -71.08 -23.7 62.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.833 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 113' ' ' SER . 20.6 t -66.88 -30.17 70.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 0.0 110.932 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.67 -55.1 14.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.822 -1.174 . . . . 0.0 110.515 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.841 ' HD2' HD21 ' A' ' 96' ' ' LEU . 6.4 t80 -75.79 -49.25 18.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.027 -1.046 . . . . 0.0 110.205 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.599 HG21 ' CB ' ' A' ' 93' ' ' ALA . 20.5 mt -56.3 -36.94 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' SER . 4.5 m -60.91 -40.81 94.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -69.74 -38.33 76.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.234 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.65 ' HA ' HD12 ' A' ' 118' ' ' LEU . 69.1 mt -69.38 -43.16 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -54.24 -38.99 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.7 m -73.42 -35.9 65.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 109.693 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 115' ' ' ILE . 20.8 mt -65.2 -38.88 91.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.916 . . . . 0.0 109.829 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.961 ' CG2' HD11 ' A' ' 85' ' ' LEU . 65.8 mt -61.67 -42.67 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.71 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.91 92.82 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.658 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 118' ' ' LEU . 23.3 m-85 -64.34 -34.72 78.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.637 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.687 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -68.74 -31.1 69.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -70.51 -32.86 70.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.489 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.29 67.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.454 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 m -64.0 -33.25 75.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.813 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -67.59 -15.79 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.394 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.25 -21.22 42.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.66 -42.26 86.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 109.376 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.805 HG23 ' CD1' ' A' ' 131' ' ' TYR . 16.0 m -64.14 -32.63 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.805 ' CD1' HG23 ' A' ' 130' ' ' VAL . 34.9 p90 -179.11 174.94 1.01 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.489 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 135' ' ' GLY . . . -80.47 122.58 27.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 m -52.7 -38.35 60.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.48 73.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 132' ' ' ALA . . . 178.87 -176.76 48.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.4 t -122.08 142.36 50.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.497 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.04 -23.12 63.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -1.199 . . . . 0.0 109.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.26 -164.93 40.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -72.65 -3.46 25.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -1.131 . . . . 0.0 109.611 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.632 ' HB3' HD22 ' A' ' 14' ' ' ASN . . . -167.31 155.12 9.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -73.34 -13.4 61.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.453 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' ' CH2' ' A' ' 9' ' ' TRP . 6.2 t -154.46 150.21 21.62 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 41.7 Cg_endo -64.3 -30.65 63.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.594 ' CH2' ' OG1' ' A' ' 7' ' ' THR . 49.1 p90 -88.42 18.74 4.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.0 109.05 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 7' ' ' THR . 0.5 OUTLIER -105.48 -30.98 9.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -123.59 142.92 50.57 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' CG ' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -60.77 -43.77 97.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.946 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.95 75.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.632 HD22 ' HB3' ' A' ' 5' ' ' ALA . 7.9 m-20 -72.17 -29.57 64.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -65.35 -37.33 86.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.064 -1.022 . . . . 0.0 110.499 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.03 -56.17 12.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.071 -1.018 . . . . 0.0 110.077 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.21 -29.76 15.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 109.567 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 56.3 t80 -69.85 -44.09 70.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.754 HG21 ' C ' ' A' ' 44' ' ' GLY . 18.5 mm -68.64 -44.94 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.196 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -68.25 -50.78 51.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.4 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 51.1 m -58.45 -29.64 66.31 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.049 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.716 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 25.8 t80 -72.23 -51.92 18.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.129 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.935 HD12 ' HB3' ' A' ' 40' ' ' MET . 19.4 mm -66.21 -55.87 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 110.007 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -57.44 -36.7 71.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 109.931 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -77.96 -44.75 25.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 110.193 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -27.36 68.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 55.1 m -65.21 -31.15 72.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.336 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.4 p-10 -105.93 7.71 32.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.065 -1.022 . . . . 0.0 110.364 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 94' ' ' ASP . 17.5 m -89.0 -77.14 0.39 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.914 -1.116 . . . . 0.0 110.255 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.81 -102.61 0.56 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -132.95 -62.38 0.81 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.462 -1.022 . . . . 0.0 109.314 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 14.3 m-85 45.54 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.3 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 m -59.37 158.63 9.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -52.42 -40.0 61.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 33' ' ' SER . 19.0 p-10 -61.38 -36.07 79.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.189 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 97.7 mm-40 -67.81 -31.65 71.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.219 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.567 ' HA ' ' HE2' ' A' ' 40' ' ' MET . 61.8 mtt -63.28 -36.75 84.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 109.001 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 65.5 mm-40 -58.92 -48.7 80.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.114 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -60.56 -46.13 91.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.858 . . . . 0.0 109.021 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.935 ' HB3' HD12 ' A' ' 23' ' ' ILE . 70.9 mtm -61.61 -35.88 79.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.424 -0.797 . . . . 0.0 108.851 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -70.23 -24.1 63.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 109.121 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 46' ' ' THR . 12.1 tp -84.45 -22.07 30.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.836 HG21 ' CB ' ' A' ' 73' ' ' SER . 12.0 mm -118.04 149.4 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.754 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 90.06 -77.38 1.6 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.91 -39.29 90.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.193 -1.18 . . . . 0.0 108.22 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 84.9 m -63.0 -35.27 79.65 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.099 HD21 ' CD1' ' A' ' 66' ' ' LEU . 29.1 tp -57.82 -36.48 72.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.659 -0.65 . . . . 0.0 109.532 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 94.6 mmm -52.78 -29.46 27.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.252 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.47 -34.9 76.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.02 86.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.153 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.498 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 13.0 mmt -54.73 -29.8 54.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.258 -0.901 . . . . 0.0 108.989 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -54.69 -33.03 60.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.305 -0.872 . . . . 0.0 109.139 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -62.68 -31.73 72.67 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.193 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.572 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 88.8 mmm -57.48 -27.95 62.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 0.0 109.317 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.14 14.57 58.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.74 22.3 23.99 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' O ' ' HE2' ' A' ' 54' ' ' MET . 25.3 ptt180 -135.51 112.37 10.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -1.09 . . . . 0.0 109.324 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.001 HG21 HD11 ' A' ' 63' ' ' LEU . 28.4 mm -113.76 158.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.021 -1.049 . . . . 0.0 109.824 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 62' ' ' LYS . 3.0 p -126.84 160.57 58.31 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.835 . . . . 0.0 109.541 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 52.4 Cg_endo -72.17 -50.47 0.25 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.756 2.304 . . . . 0.0 111.908 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.2 p -60.35 -35.13 74.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 81.6 mttt -72.7 -52.38 15.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.38 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.001 HD11 HG21 ' A' ' 58' ' ' ILE . 57.3 mt -61.86 -27.34 68.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.021 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -54.78 -44.54 73.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.945 . . . . 0.0 109.017 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.41 69.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.099 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -74.31 -43.64 55.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.031 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 42.0 t0 -48.53 -43.86 35.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.12 -34.36 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.935 . . . . 0.0 109.813 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.54 79.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 0.0 109.816 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.843 ' O ' HG13 ' A' ' 74' ' ' VAL . 86.6 t80 -61.51 -36.86 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.7 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -70.36 -29.05 65.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.935 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -69.32 -46.98 65.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.167 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.836 ' CB ' HG21 ' A' ' 43' ' ' ILE . 1.1 t -70.07 -45.99 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.978 . . . . 0.0 110.147 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 70' ' ' PHE . 13.7 m -57.4 -35.41 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -73.8 -40.81 63.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.781 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 80' ' ' SER . 50.1 tt0 -68.47 -43.24 77.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 109.724 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.602 HG21 ' CG ' ' A' ' 40' ' ' MET . 99.4 mt -56.35 -52.38 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -73.33 -50.62 21.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 0.0 109.841 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -22.41 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.398 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 76' ' ' GLN . 90.0 p -81.4 -20.65 40.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.537 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 78' ' ' ALA . 34.8 mt-30 -48.97 -36.96 18.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 22.29 41.9 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.03 -157.39 13.75 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 87' ' ' VAL . 76.8 m-20 -62.6 134.4 56.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -1.099 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 119' ' ' ILE . 6.3 tp -84.95 -19.4 32.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.19 -33.59 64.82 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 88' ' ' THR . 5.5 p -69.99 -44.93 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -1.208 . . . . 0.0 109.696 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 87' ' ' VAL . 80.0 m -51.61 -34.75 38.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.975 -1.078 . . . . 0.0 108.493 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 23.8 m -56.2 -48.7 75.9 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 22.0 m120 -70.72 -39.3 73.48 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.169 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -65.25 -57.45 8.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.732 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' LEU . 48.2 mt -66.46 -45.97 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.885 . . . . 0.0 109.863 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -63.8 -49.02 74.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 0.0 110.059 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 29' ' ' THR . 91.3 m-20 -54.99 -41.68 71.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.03 . . . . 0.0 109.363 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.736 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -62.62 -44.59 95.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.304 -0.873 . . . . 0.0 109.049 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.963 HD13 HD12 ' A' ' 115' ' ' ILE . 7.1 mt -70.42 -36.01 73.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.505 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.556 ' HA ' ' CB ' ' A' ' 108' ' ' ASN . 93.5 m -64.82 -53.7 42.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 110.009 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 14.5 m -62.08 -49.2 76.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.121 -0.987 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.5 -44.37 68.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.596 ' CD1' ' HB ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER -46.96 -55.95 7.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 109.324 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.573 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 4.1 m-85 -71.97 -31.91 66.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.44 -0.787 . . . . 0.0 109.675 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 98' ' ' SER . 65.1 mt-30 -73.19 -18.39 61.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.676 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 99' ' ' ALA . 34.7 p -107.29 -60.22 1.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.936 -1.103 . . . . 0.0 111.173 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.831 ' CG2' HG23 ' A' ' 106' ' ' VAL . 12.3 t -127.05 -43.07 1.69 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.813 -1.179 . . . . 0.0 110.845 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 108.98 46.82 0.92 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 104' ' ' THR . 57.4 t -103.07 167.86 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.271 -1.135 . . . . 0.0 108.937 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 107' ' ' VAL . 33.5 m -66.07 121.45 15.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.755 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 20.8 p-10 -71.07 -23.74 62.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.428 -0.795 . . . . 0.0 109.939 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 113' ' ' SER . 90.2 p -68.7 -34.84 76.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -62.36 -54.52 39.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.862 -1.148 . . . . 0.0 110.473 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.964 ' CE2' HD11 ' A' ' 115' ' ' ILE . 57.4 t80 -75.73 -53.29 8.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.0 110.204 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 93' ' ' ALA . 21.2 mt -56.36 -28.37 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.131 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 109' ' ' SER . 9.6 t -58.81 -42.29 88.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.089 -1.007 . . . . 0.0 109.622 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.48 -36.35 65.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.964 HD11 ' CE2' ' A' ' 111' ' ' PHE . 30.8 mt -67.54 -41.22 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.132 -0.98 . . . . 0.0 110.647 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 113' ' ' SER . 31.8 ptt85 -54.04 -43.12 69.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.852 -1.155 . . . . 0.0 109.638 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.492 ' N ' ' CG ' ' A' ' 116' ' ' ARG . 87.0 p -71.44 -33.82 69.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.548 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 115' ' ' ILE . 18.8 mt -66.45 -38.12 86.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.766 HG22 HD11 ' A' ' 85' ' ' LEU . 67.3 mt -61.5 -35.71 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.023 . . . . 0.0 109.454 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.674 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -67.93 -34.24 81.66 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.0 ttm -60.75 -43.68 97.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.16 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 75' ' ' ALA . 97.7 m-85 -59.14 -50.17 75.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -54.27 -31.73 54.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.566 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 120' ' ' GLY . 99.6 mm-40 -70.66 -32.67 70.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HA ' ' ND2' ' A' ' 128' ' ' ASN . . . -57.8 -31.85 66.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -35.48 69.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 1.013 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -59.78 -27.95 66.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 125' ' ' ALA . 78.4 m-20 -54.09 -18.78 4.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.86 -35.05 79.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.013 HG12 ' O ' ' A' ' 127' ' ' ALA . 7.5 p -65.48 -29.63 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.604 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.851 ' CD2' HG13 ' A' ' 130' ' ' VAL . 37.1 p90 177.71 160.99 0.51 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.321 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.89 116.67 11.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' ALA . 39.7 p -59.39 158.17 9.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 109.481 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' SER . . . 45.45 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.24 -0.912 . . . . 0.0 109.485 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.02 -173.23 48.55 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -123.43 141.48 51.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -1.144 . . . . 0.0 109.496 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.442 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 65.0 mtt -59.11 -38.09 78.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.459 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.473 ' C ' ' NE2' ' A' ' 4' ' ' GLN . . . 97.51 0.87 59.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' NE2' ' C ' ' A' ' 3' ' ' GLY . 10.0 mp0 -120.67 153.98 36.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -1.191 . . . . 0.0 109.355 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 104' ' ' THR . . . -146.83 92.57 2.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.684 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' O ' ' OG1' ' A' ' 104' ' ' THR . 19.0 m120 -57.97 -17.28 16.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.289 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.927 HG22 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -135.97 151.75 74.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.436 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 7' ' ' THR . 47.0 Cg_endo -68.66 -35.39 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.561 2.174 . . . . 0.0 111.766 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.836 ' O ' HD22 ' A' ' 63' ' ' LEU . 45.3 p90 -91.48 -11.39 37.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 109.082 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.9 m -72.05 -5.34 34.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.264 -0.898 . . . . 0.0 109.413 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' ASN . 1.9 t -140.79 153.9 46.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.361 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.502 ' CG ' HG13 ' A' ' 58' ' ' ILE . 2.5 ttpm? -73.81 -39.7 63.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.612 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.45 -33.01 42.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.259 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 7' ' ' THR . 34.2 t30 -71.53 -29.47 64.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -69.79 -43.06 72.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -54.36 -56.33 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.717 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.9 -35.4 45.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 109.298 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 47.2 t80 -68.73 -52.6 28.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.898 HG23 ' CE1' ' A' ' 70' ' ' PHE . 10.0 mm -60.15 -44.14 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -67.49 -50.87 56.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -57.66 -30.12 65.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.203 -0.936 . . . . 0.0 108.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.743 ' CZ ' HG21 ' A' ' 74' ' ' VAL . 19.2 t80 -72.29 -52.21 17.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.836 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG12 ' CE ' ' A' ' 40' ' ' MET . 69.4 mt -61.9 -56.12 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.988 -1.07 . . . . 0.0 109.687 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m -53.91 -37.24 63.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.92 -51.54 10.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.924 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.67 64.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.105 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.635 ' HB2' ' HE1' ' A' ' 37' ' ' MET . 45.8 p -68.37 -33.41 74.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.249 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -105.67 7.19 32.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.887 HG21 ' HB2' ' A' ' 94' ' ' ASP . 8.9 m -87.16 -77.09 0.34 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.956 -1.09 . . . . 0.0 110.224 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.48 -101.4 0.61 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 76.5 p -141.32 -53.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.429 -1.042 . . . . 0.0 109.344 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.7 m-85 44.5 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 37' ' ' MET . 32.2 t -59.68 159.97 7.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -52.38 -38.4 58.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.07 -37.18 86.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.115 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.526 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 81.8 mm-40 -76.32 -36.17 58.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.635 ' HE1' ' HB2' ' A' ' 27' ' ' SER . 79.6 mtp -63.97 -37.43 87.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.132 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -56.89 -41.2 77.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.171 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.78 ' HB3' HG23 ' A' ' 77' ' ' ILE . 46.0 t-20 -56.07 -35.08 66.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 108.916 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.52 ' SD ' HD13 ' A' ' 77' ' ' ILE . 92.8 mmm -57.12 -31.69 65.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.9 m -67.55 -24.08 65.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.915 . . . . 0.0 109.28 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 46' ' ' THR . 66.9 mt -92.08 -28.22 17.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.0 ' HB ' HD11 ' A' ' 77' ' ' ILE . 63.9 mt -116.81 154.99 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.422 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.852 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.16 -89.79 1.62 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -59.58 -32.4 70.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -1.14 . . . . 0.0 108.834 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 34.2 m -65.95 -35.08 79.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.42 -0.8 . . . . 0.0 108.922 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 66' ' ' LEU . 29.8 tp -54.97 -38.63 68.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.435 -0.79 . . . . 0.0 109.222 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.9 ttt -52.83 -36.16 58.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.31 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.5 -32.21 72.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.193 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.83 72.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HE3' ' A' ' 51' ' ' MET . 64.0 mtm -59.17 -29.91 67.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.215 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.76 -31.66 69.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -60.88 -29.32 69.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.241 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.557 ' HE2' ' O ' ' A' ' 57' ' ' ARG . 89.8 mmm -57.84 -33.18 68.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.364 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.28 12.9 34.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.23 9.55 44.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' O ' ' HE2' ' A' ' 54' ' ' MET . 18.8 ptt180 -125.09 112.28 16.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -1.129 . . . . 0.0 109.551 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG21 HD11 ' A' ' 63' ' ' LEU . 31.3 mm -116.03 142.05 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.51 ' OG1' ' CB ' ' A' ' 62' ' ' LYS . 7.6 p -97.9 157.02 35.32 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.67 -42.11 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.677 2.251 . . . . 0.0 111.59 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 22.9 t -71.67 -36.08 70.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.25 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.51 ' CB ' ' OG1' ' A' ' 59' ' ' THR . 17.1 tttp -64.51 -49.81 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.315 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 9' ' ' TRP . 2.6 mt -57.04 -32.3 66.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' MET . 85.1 mt-30 -54.75 -48.29 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.123 -0.986 . . . . 0.0 108.628 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.5 55.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.395 -0.816 . . . . 0.0 109.267 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 47' ' ' LEU . 1.8 tp -61.54 -50.82 71.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.581 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 26.3 t0 -47.99 -37.01 13.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 63.5 mtt -65.84 -32.13 73.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.37 93.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CE1' HG23 ' A' ' 19' ' ' ILE . 81.9 t80 -53.59 -38.93 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.875 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.744 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -68.94 -40.49 78.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.6 m -69.35 -45.64 68.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.812 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.776 ' HB3' HD13 ' A' ' 43' ' ' ILE . 12.3 m -70.01 -47.24 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.937 . . . . 0.0 109.766 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.743 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 7.5 p -58.4 -44.16 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.603 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -62.8 -37.24 85.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' O ' ' CB ' ' A' ' 80' ' ' SER . 48.0 tt0 -68.41 -43.12 77.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.679 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.0 HD11 ' HB ' ' A' ' 43' ' ' ILE . 78.8 mt -53.78 -52.46 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.591 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.46 -50.84 10.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.448 -0.782 . . . . 0.0 109.931 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -57.58 -22.54 45.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.979 . . . . 0.0 109.266 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.3 p -81.85 -20.59 38.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 50.1 mt-30 -45.96 -35.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 3.79 76.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.18 -162.75 33.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -72.06 118.31 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.134 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.089 HD23 HG22 ' A' ' 119' ' ' ILE . 3.4 mp -62.28 -16.17 52.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.923 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.76 -45.74 78.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.3 -47.47 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -1.132 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.591 HG23 ' CB ' ' A' ' 78' ' ' ALA . 44.7 m -53.75 -48.43 69.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 21.6 m -51.27 -47.7 62.43 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 74.7 m-20 -71.05 -35.32 71.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.443 -0.786 . . . . 0.0 108.93 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.487 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -69.58 -59.13 3.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.462 -0.774 . . . . 0.0 109.689 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 96' ' ' LEU . 69.0 mt -63.98 -49.28 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.901 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.669 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -59.26 -52.52 65.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.331 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.887 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.8 m-20 -55.4 -43.12 74.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 109.903 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -63.54 -39.5 94.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.205 -0.934 . . . . 0.0 109.723 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD11 HG22 ' A' ' 92' ' ' ILE . 6.2 mt -69.88 -35.87 75.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.815 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.797 HG23 ' ND2' ' A' ' 108' ' ' ASN . 94.3 m -65.46 -53.65 39.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 20.2 m -60.59 -34.03 73.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.825 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB1' ' CD1' ' A' ' 18' ' ' PHE . . . -69.52 -46.3 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.605 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 2.5 m-85 -47.12 -56.21 6.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.2 m-85 -71.14 -31.78 68.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 109.828 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 98' ' ' SER . 84.1 mm-40 -73.12 -18.59 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 99' ' ' ALA . 67.5 p -107.45 -59.85 1.77 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.903 -1.123 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.671 HG21 ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -126.82 -42.84 1.73 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.761 -1.212 . . . . 0.0 110.836 -179.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 111.77 45.36 0.83 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 107' ' ' VAL . 6.6 t -102.81 172.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 109.151 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 14.1 m -74.18 120.23 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.797 ' ND2' HG23 ' A' ' 97' ' ' THR . 13.0 p30 -72.07 -29.59 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.645 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 113' ' ' SER . 21.7 m -56.92 -46.09 82.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 110.391 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.97 -53.58 56.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.891 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.98 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.0 -50.49 16.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.099 -1.001 . . . . 0.0 109.756 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.514 HD12 ' OD1' ' A' ' 108' ' ' ASN . 11.5 mt -58.56 -42.63 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 110.065 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 109' ' ' SER . 48.0 t -55.84 -37.97 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.118 -0.989 . . . . 0.0 109.539 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.15 -40.41 82.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.513 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.98 HD11 ' CE2' ' A' ' 111' ' ' PHE . 56.2 mt -72.7 -43.34 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -54.22 -39.74 67.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.368 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.7 t -73.15 -34.12 65.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 115' ' ' ILE . 16.8 mt -70.97 -40.71 71.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.089 HG22 HD23 ' A' ' 85' ' ' LEU . 84.6 mt -58.2 -39.65 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.03 -27.34 72.27 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 54.0 ttm -66.97 -38.68 86.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -1.166 . . . . 0.0 109.502 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -60.14 -37.87 81.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.529 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.94 -32.07 72.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -70.82 -32.02 68.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.47 -28.61 69.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.1 p -61.26 -29.13 69.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.888 ' HB1' ' HA ' ' A' ' 131' ' ' TYR . . . -65.51 -28.33 69.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.607 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' ALA . 87.3 m-20 -44.72 -24.38 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.871 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.575 ' O ' ' CZ ' ' A' ' 131' ' ' TYR . 92.5 m-20 -95.17 -65.82 0.95 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.063 -1.023 . . . . 0.0 110.187 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 13.4 m -98.65 -15.26 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.083 -1.011 . . . . 0.0 111.66 -179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.888 ' HA ' ' HB1' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 43.82 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.176 -0.952 . . . . 0.0 109.947 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . -150.59 86.61 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.931 -1.105 . . . . 0.0 108.966 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 132' ' ' ALA . 37.4 p -43.52 165.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.342 -0.849 . . . . 0.0 109.723 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.71 72.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.93 10.4 55.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.5 m -58.9 -34.0 71.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -1.164 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.2 mmm -109.05 142.22 40.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -51.7 -36.41 40.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -112.46 153.68 27.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.634 ' HB3' HD22 ' A' ' 14' ' ' ASN . . . -66.63 157.32 32.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.938 . . . . 0.0 109.504 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.472 ' C ' HG21 ' A' ' 104' ' ' THR . 65.1 m-20 -77.19 -10.84 59.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.273 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 10' ' ' SER . 1.5 t -162.25 151.77 13.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 109.012 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 46.0 Cg_endo -67.49 -27.17 39.78 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.466 2.111 . . . . 0.0 112.695 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.586 ' CZ2' ' OG1' ' A' ' 7' ' ' THR . 49.2 p90 -92.52 15.91 13.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.849 -1.157 . . . . 0.0 109.845 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 7' ' ' THR . 68.5 p -105.31 -23.07 12.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.002 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -110.45 160.71 16.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.188 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 51' ' ' MET . 15.6 ttpp -74.69 -40.88 61.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.049 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -83.28 -31.07 27.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.634 HD22 ' HB3' ' A' ' 5' ' ' ALA . 5.8 t-20 -71.54 -29.38 64.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.644 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.514 ' CA ' ' O ' ' A' ' 8' ' ' PRO . . . -73.03 -47.89 40.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.567 ' CB ' ' HE2' ' A' ' 48' ' ' MET . 1.2 p30 -56.79 -49.29 75.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.169 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -55.08 -40.61 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.971 -1.08 . . . . 0.0 109.386 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HA ' HG21 ' A' ' 103' ' ' THR . 72.2 t80 -61.23 -48.57 80.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.028 HG23 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mm -60.88 -44.44 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -50.87 48.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.382 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 38.8 t -55.91 -29.98 60.89 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 108.765 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CZ ' HG23 ' A' ' 92' ' ' ILE . 39.1 t80 -72.34 -51.92 18.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.511 -0.743 . . . . 0.0 110.047 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 40' ' ' MET . 76.3 mt -60.26 -56.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m -59.85 -35.14 74.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.923 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.14 -45.29 23.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.226 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -65.82 -40.59 91.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.937 . . . . 0.0 110.323 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB2' ' CE ' ' A' ' 37' ' ' MET . 82.7 p -57.15 -27.24 61.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 110.163 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.23 6.99 31.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.571 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.972 HG21 ' HB2' ' A' ' 94' ' ' ASP . 19.5 m -93.12 -77.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.783 -1.198 . . . . 0.0 110.188 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' HA3' ' HB2' ' A' ' 91' ' ' ALA . . . -81.75 -104.74 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' PHE . 53.0 p -131.31 -61.52 0.91 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 12.8 m-85 44.02 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 109.236 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m -59.65 162.56 5.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.577 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -52.56 -43.33 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.328 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.23 -35.89 76.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.464 ' HG3' ' HG2' ' A' ' 81' ' ' GLN . 96.9 mm-40 -71.7 -35.07 70.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.53 ' CE ' ' HB2' ' A' ' 27' ' ' SER . 64.6 mtt -63.47 -34.23 77.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 72.1 mm-40 -63.03 -38.31 90.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HB3' HG12 ' A' ' 77' ' ' ILE . 86.3 m-20 -55.83 -39.69 71.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.256 -0.903 . . . . 0.0 109.118 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 23' ' ' ILE . 75.8 mtm -66.16 -32.04 73.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.083 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 46' ' ' THR . 19.5 m -70.31 -23.62 62.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 54.7 mt -97.34 -14.31 21.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 44' ' ' GLY . 74.8 mt -130.78 166.3 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 0.0 109.548 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 43' ' ' ILE . . . 64.8 -69.44 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ILE . 41.1 t30 -74.81 -41.06 60.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.213 -1.169 . . . . 0.0 109.23 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 41' ' ' SER . 46.8 m -58.37 -35.24 71.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 108.739 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.74 -31.19 69.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 108.908 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' CB ' ' A' ' 16' ' ' ASP . 58.1 mmm -56.81 -29.95 63.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.412 -0.805 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 52' ' ' ASP . . . -60.7 -42.51 97.36 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -22.88 66.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.537 ' CE ' ' HG2' ' A' ' 12' ' ' LYS . 20.4 ttp -58.7 -30.86 67.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.632 -0.667 . . . . 0.0 109.513 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 50.4 p30 -73.69 -13.36 60.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.286 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 86.5 m-20 -71.04 -28.2 64.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.852 . . . . 0.0 109.184 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.526 ' HG3' ' CD1' ' A' ' 58' ' ' ILE . 90.7 mmm -53.41 -34.43 57.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.476 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.66 4.71 60.44 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.35 10.49 19.82 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.55 ' O ' HD13 ' A' ' 58' ' ' ILE . 9.9 ptt180 -122.92 115.22 21.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -1.162 . . . . 0.0 109.661 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.766 HG21 HD21 ' A' ' 63' ' ' LEU . 22.9 mm -116.68 155.93 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.333 -0.855 . . . . 0.0 109.408 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.744 HG22 ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -143.54 166.27 20.69 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.744 ' HD2' HG22 ' A' ' 59' ' ' THR . 50.5 Cg_endo -70.81 -41.14 3.12 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.672 2.248 . . . . 0.0 111.883 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 77.9 p -65.77 -33.71 76.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -75.63 -50.43 15.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.766 HD21 HG21 ' A' ' 58' ' ' ILE . 6.9 mp -70.16 -33.47 71.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.657 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 60' ' ' PRO . 60.5 tt0 -53.67 -42.16 67.62 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.46 65.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -0.937 . . . . 0.0 108.802 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 tp -74.48 -50.77 16.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.619 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.575 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 20.5 t0 -48.26 -39.68 22.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.674 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.7 mmm -71.44 -39.4 71.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.621 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.69 87.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.028 ' CE1' HG23 ' A' ' 19' ' ' ILE . 84.5 t80 -52.88 -36.94 59.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 109.706 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.916 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -64.55 -39.58 94.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.073 -1.017 . . . . 0.0 109.675 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 88.2 p -69.46 -30.63 68.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.826 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 43' ' ' ILE . 11.5 t -69.96 -44.25 69.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.0 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 71' ' ' ALA . 11.7 m -69.01 -34.63 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.563 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 122' ' ' PHE . . . -69.91 -40.74 75.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.62 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -71.11 -49.36 45.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB3' ' A' ' 39' ' ' ASN . 79.6 mt -53.82 -46.71 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.69 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 88' ' ' THR . . . -78.46 -53.98 6.66 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 109.799 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.16 -22.67 52.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.549 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 22.9 m -79.67 -20.72 45.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' A' ' 36' ' ' GLN . 37.6 mt-30 -57.19 -34.14 68.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.82 . . . . 0.0 109.522 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.25 17.81 73.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.84 -145.62 19.5 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.579 ' O ' HG12 ' A' ' 87' ' ' VAL . 58.4 t0 -76.0 106.03 7.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -1.111 . . . . 0.0 109.302 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.98 HD13 ' HB2' ' A' ' 123' ' ' ALA . 10.8 tp -60.18 -23.07 63.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 109.666 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.16 -39.45 72.47 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 84' ' ' ASP . 2.0 p -67.62 -39.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.255 . . . . 0.0 109.867 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 78' ' ' ALA . 24.3 m -51.7 -34.46 38.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.963 -1.085 . . . . 0.0 108.316 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.548 ' CG2' ' HG3' ' A' ' 116' ' ' ARG . 6.6 m -57.46 -50.93 71.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' A' ' 94' ' ' ASP . 51.0 t30 -70.24 -40.18 74.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.389 -0.819 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.6 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -62.37 -53.55 53.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.298 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.847 HG22 HD11 ' A' ' 96' ' ' LEU . 57.0 mt -72.56 -51.25 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.89 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.53 -49.23 75.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.972 ' HB2' HG21 ' A' ' 29' ' ' THR . 93.1 m-20 -54.77 -47.68 73.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.213 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -57.02 -46.11 82.61 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.339 -0.851 . . . . 0.0 109.003 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.847 HD11 HG22 ' A' ' 92' ' ' ILE . 1.8 mt -70.97 -28.61 64.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.548 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.924 HG23 ' OD1' ' A' ' 108' ' ' ASN . 51.7 m -64.46 -54.09 37.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.157 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 87.6 p -66.78 -43.91 82.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 109.438 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 103' ' ' THR . . . -53.14 -42.71 66.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.5 m-85 -50.49 -56.41 11.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 109.123 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.556 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 7.5 m-85 -72.07 -31.77 66.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.425 -0.797 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 98' ' ' SER . 28.3 mt-30 -75.71 -17.8 59.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 109.589 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 18' ' ' PHE . 63.7 p -109.44 -58.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 111.294 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 5' ' ' ALA . 87.2 m -125.76 -42.75 1.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.746 -1.221 . . . . 0.0 111.212 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 105.77 47.81 1.07 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 107' ' ' VAL . 3.6 t -110.92 172.79 2.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.263 -1.139 . . . . 0.0 109.022 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 107' ' ' VAL . 33.2 m -71.85 121.12 21.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.52 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.924 ' OD1' HG23 ' A' ' 97' ' ' THR . 0.3 OUTLIER -71.7 -29.69 64.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 109.857 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 113' ' ' SER . 47.5 m -55.95 -30.12 61.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.492 -0.755 . . . . 0.0 110.742 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 23.1 tpt180 -71.54 -55.22 8.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 110.374 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 115' ' ' ILE . 75.3 t80 -75.92 -46.6 29.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 109.698 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HB1' ' A' ' 93' ' ' ALA . 12.5 mt -56.13 -47.15 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.453 -0.779 . . . . 0.0 109.852 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 109' ' ' SER . 28.5 t -55.66 -43.56 76.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 95.0 mt-10 -57.19 -48.35 78.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.223 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.916 HG12 ' HB1' ' A' ' 71' ' ' ALA . 74.5 mt -65.46 -34.08 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.548 ' HG3' ' CG2' ' A' ' 89' ' ' THR . 11.5 ttm180 -52.95 -48.96 66.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.342 -0.849 . . . . 0.0 109.625 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.7 t -69.75 -33.98 73.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 115' ' ' ILE . 11.6 mt -67.13 -45.61 76.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.682 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.909 HG22 HD11 ' A' ' 85' ' ' LEU . 56.7 mt -57.83 -34.6 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.686 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.865 ' HA2' HD21 ' A' ' 85' ' ' LEU . . . -69.02 -31.78 72.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 53.2 ttm -71.36 -39.28 71.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.119 . . . . 0.0 109.791 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.468 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 75.6 m-85 -65.57 -33.62 76.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -68.95 -27.72 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.65 -34.05 71.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.83 -33.02 74.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.371 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.1 m -62.72 -30.83 71.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.276 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -68.95 -11.96 61.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.331 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -83.76 -18.51 37.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -77.1 -44.16 31.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.241 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.003 HG13 ' CD2' ' A' ' 131' ' ' TYR . 7.5 p -59.37 -25.78 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 109.194 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 130' ' ' VAL . 39.8 p90 178.3 176.59 0.47 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.213 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.25 117.12 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.237 -0.914 . . . . 0.0 109.657 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.1 t -53.71 -37.07 62.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 0.0 109.307 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.1 -39.33 63.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.98 -162.37 32.51 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.8 p -64.23 -28.1 69.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.37 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.891 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.4 mtm -126.72 161.22 28.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.77 -125.27 25.3 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -111.32 151.47 28.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.264 -1.139 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.12 140.73 52.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -85.91 14.01 6.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.951 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' ' 10' ' ' SER . 3.1 t -157.78 151.38 19.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.093 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 43.9 Cg_endo -67.41 -35.09 24.63 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.783 2.322 . . . . 0.0 113.394 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.587 ' CE2' ' OG1' ' A' ' 7' ' ' THR . 49.5 p90 -81.34 -7.51 59.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.695 -1.253 . . . . 0.0 110.339 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.89 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 m -88.35 20.14 3.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.656 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB3' ' CB ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -155.69 150.05 25.86 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' HB2' HG13 ' A' ' 58' ' ' ILE . 1.9 ttpp -73.88 -38.18 64.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -85.85 -33.56 21.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 104' ' ' THR . 9.7 t-20 -71.88 -29.28 64.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -73.0 -44.28 61.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.641 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.6 p30 -54.45 -40.28 68.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -63.05 -44.65 95.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.012 -1.055 . . . . 0.0 109.024 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CE1' HD23 ' A' ' 96' ' ' LEU . 43.1 t80 -60.77 -44.26 96.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 70' ' ' PHE . 19.0 mm -66.34 -43.36 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.239 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -50.92 51.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.248 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 43.5 m -58.75 -29.42 66.73 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 108.72 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.783 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.8 t80 -71.64 -51.98 20.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.91 ' HA ' ' HE1' ' A' ' 40' ' ' MET . 74.3 mt -63.67 -56.06 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.908 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.4 m -56.04 -37.07 68.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.677 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 29' ' ' THR . . . -77.93 -49.4 14.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.777 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -60.36 -24.19 64.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 110.153 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.6 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 57.8 m -67.3 -34.33 77.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 0.0 110.079 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -106.08 7.17 31.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.16 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 94' ' ' ASP . 11.8 m -84.19 -75.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.036 -1.04 . . . . 0.0 110.173 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -86.97 -99.84 0.83 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -142.04 -54.9 0.45 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -1.074 . . . . 0.0 109.293 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 15.4 m-85 44.17 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.174 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 15.9 m -59.65 159.82 8.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.698 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -52.8 -32.72 45.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -71.15 -37.95 72.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.326 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.529 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 37.5 mt-30 -76.56 -34.22 58.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.191 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.6 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 88.6 mtp -65.04 -34.49 78.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.241 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 72.7 mt-10 -56.87 -43.99 81.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 109.241 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.866 ' HB2' HG23 ' A' ' 77' ' ' ILE . 79.9 m-20 -55.9 -33.23 64.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.91 ' HE1' ' HA ' ' A' ' 23' ' ' ILE . 82.3 mtp -61.74 -32.55 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -69.91 -24.68 63.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.373 -0.829 . . . . 0.0 109.453 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.1 mp -89.03 -22.43 22.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.81 ' HB ' HD11 ' A' ' 77' ' ' ILE . 86.9 mt -115.57 164.18 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.647 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 73.84 -93.88 0.76 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' OD1' ' CD1' ' A' ' 23' ' ' ILE . 21.2 m120 -52.41 -36.89 55.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.186 -1.185 . . . . 0.0 109.036 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 55.4 m -58.4 -35.31 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 66' ' ' LEU . 74.6 mt -56.88 -36.45 70.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 109.224 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 16' ' ' ASP . 70.8 mtm -52.95 -40.7 63.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.28 -31.5 71.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.972 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.9 78.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -0.803 . . . . 0.0 109.176 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 12' ' ' LYS . 35.5 mtt -58.96 -30.93 68.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.11 -25.85 64.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.85 -30.33 70.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.381 -0.824 . . . . 0.0 109.264 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.537 ' CE ' ' O ' ' A' ' 57' ' ' ARG . 94.8 mmm -63.69 -36.15 82.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.69 12.14 48.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.47 12.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' O ' ' CE ' ' A' ' 54' ' ' MET . 17.6 ptt85 -138.1 114.35 10.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.528 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.526 ' CD1' ' HG3' ' A' ' 54' ' ' MET . 25.1 mm -111.38 128.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -89.45 166.57 20.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 47.4 Cg_endo -69.17 -21.35 36.38 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.595 2.196 . . . . 0.0 111.769 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.9 t -74.78 -44.52 49.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.268 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 21.3 mttm -74.02 -30.35 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 0.0 108.855 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.89 HD21 ' O ' ' A' ' 10' ' ' SER . 1.2 tp -49.68 -52.52 30.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.565 -0.709 . . . . 0.0 109.225 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -76.81 -46.07 26.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.252 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 62' ' ' LYS . . . -50.82 -51.24 52.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 47' ' ' LEU . 17.4 tp -54.94 -50.04 69.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.948 . . . . 0.0 109.028 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.489 ' OD2' ' CD2' ' A' ' 9' ' ' TRP . 9.8 t0 -48.16 -49.39 32.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.9 mtp -58.81 -43.99 90.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.843 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.64 77.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.736 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.878 ' CE1' HG23 ' A' ' 19' ' ' ILE . 77.6 t80 -56.86 -45.2 82.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -66.44 -36.99 84.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -69.6 -52.05 29.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -0.975 . . . . 0.0 110.023 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.687 ' HB3' HD13 ' A' ' 43' ' ' ILE . 10.9 m -70.25 -35.84 74.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 110.282 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.709 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 8.1 p -66.88 -43.65 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.13 -0.981 . . . . 0.0 109.898 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' HG13 ' A' ' 74' ' ' VAL . . . -63.68 -32.22 73.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.907 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' CB ' ' A' ' 80' ' ' SER . 94.9 mt-30 -72.17 -43.1 65.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 109.875 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.866 HG23 ' HB2' ' A' ' 39' ' ' ASN . 64.8 mt -54.47 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.099 -1.001 . . . . 0.0 109.822 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' HG23 ' A' ' 88' ' ' THR . . . -78.0 -50.17 12.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.46 -0.775 . . . . 0.0 110.142 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' ALA . . . -58.1 -25.96 61.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.583 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 81.2 p -76.94 -20.31 56.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.408 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.537 ' NE2' ' CD1' ' A' ' 32' ' ' PHE . 73.2 mt-30 -46.4 -33.76 4.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.54 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.37 16.11 80.97 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.5 -159.3 19.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -66.04 105.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -1.164 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.01 HD23 HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -61.21 -18.38 57.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.99 -42.66 81.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 46.4 t -68.69 -44.81 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -1.1 . . . . 0.0 109.547 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.616 HG23 ' CB ' ' A' ' 78' ' ' ALA . 23.9 m -54.52 -50.15 68.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 5.0 m -51.31 -48.83 62.23 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 24.0 t-20 -70.83 -33.92 71.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 108.983 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 29' ' ' THR . . . -70.37 -59.15 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.509 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.738 HG22 HD11 ' A' ' 96' ' ' LEU . 55.0 mt -63.21 -49.9 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.828 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 96' ' ' LEU . . . -56.0 -52.23 64.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.77 ' HB3' HG21 ' A' ' 29' ' ' THR . 32.0 t0 -55.23 -50.53 69.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 22' ' ' PHE . . . -53.22 -42.88 66.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.738 HD11 HG22 ' A' ' 92' ' ' ILE . 7.1 mt -70.26 -41.05 73.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.824 HG23 ' ND2' ' A' ' 108' ' ' ASN . 99.3 m -62.4 -48.64 78.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 28.7 m -64.43 -34.26 77.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 109.483 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.588 ' O ' HG23 ' A' ' 103' ' ' THR . . . -69.95 -44.99 68.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' ASN . 1.9 m-85 -46.97 -56.03 7.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.873 . . . . 0.0 109.698 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.537 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 3.1 m-85 -70.91 -32.09 68.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.762 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 98' ' ' SER . 88.2 mm-40 -75.91 -18.42 59.39 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.781 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 99' ' ' ALA . 61.2 p -103.81 -59.85 1.66 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.058 -1.026 . . . . 0.0 111.101 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.781 ' OG1' HG23 ' A' ' 106' ' ' VAL . 12.6 p -126.73 -42.61 1.76 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.672 -1.268 . . . . 0.0 110.925 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.82 45.25 0.97 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.781 HG23 ' OG1' ' A' ' 104' ' ' THR . 12.1 t -109.83 172.52 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -1.125 . . . . 0.0 109.219 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.2 m -73.68 121.16 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.824 ' ND2' HG23 ' A' ' 97' ' ' THR . 18.0 p30 -70.74 -23.36 62.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.5 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 113' ' ' SER . 23.3 t -54.78 -30.27 56.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.574 -0.704 . . . . 0.0 110.601 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -69.04 -55.0 12.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.878 -1.139 . . . . 0.0 110.234 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 115' ' ' ILE . 59.8 t80 -76.16 -50.4 14.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.564 HD12 ' OD1' ' A' ' 108' ' ' ASN . 14.5 mt -56.35 -42.56 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 110.139 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 109' ' ' SER . 32.2 t -56.23 -46.86 79.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.066 -1.021 . . . . 0.0 109.554 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.41 -49.83 74.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.262 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.885 HG12 ' HB1' ' A' ' 71' ' ' ALA . 89.7 mt -65.93 -34.82 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -54.06 -47.02 72.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 109.52 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.8 p -72.66 -33.9 66.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.63 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -68.02 -44.16 77.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.01 HG22 HD23 ' A' ' 85' ' ' LEU . 97.5 mt -57.82 -38.83 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.624 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.02 -33.79 75.18 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 60.5 ttp -61.68 -36.87 82.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.491 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 77.1 m-85 -66.23 -36.84 84.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 85' ' ' LEU . . . -65.08 -27.99 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -69.98 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.56 72.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.3 p -70.35 -22.46 62.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -67.74 -21.12 65.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 51.3 t-20 -72.36 -27.68 62.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -66.72 -45.74 77.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.895 HG13 ' CD1' ' A' ' 131' ' ' TYR . 3.9 p -65.85 -30.82 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.895 ' CD1' HG13 ' A' ' 130' ' ' VAL . 39.4 p90 178.66 169.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.287 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.86 122.29 23.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 85.5 p -57.94 -28.45 64.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.97 -32.65 54.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.1 -31.89 41.72 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 87.4 p -62.78 -27.5 69.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 109.397 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.6 mtp -59.89 -35.49 74.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -1.105 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.29 -176.09 48.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -139.41 160.18 40.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.766 ' HB2' ' OG ' ' A' ' 11' ' ' SER . . . -66.22 144.09 56.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -62.53 -15.46 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.712 ' C ' HG21 ' A' ' 104' ' ' THR . 3.5 t -152.17 151.38 27.57 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 108.949 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.645 ' N ' HG21 ' A' ' 104' ' ' THR . 42.4 Cg_endo -64.8 -35.5 45.07 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.582 2.188 . . . . 0.0 113.01 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.547 ' CD2' ' OG1' ' A' ' 7' ' ' THR . 49.4 p90 -81.69 -2.16 49.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.661 -1.274 . . . . 0.0 109.653 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.691 ' HB2' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -82.7 -28.65 30.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.044 -1.035 . . . . 0.0 108.688 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.766 ' OG ' ' HB2' ' A' ' 5' ' ' ALA . 70.8 m -118.82 151.11 38.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.484 -0.76 . . . . 0.0 109.161 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD3' HG13 ' A' ' 58' ' ' ILE . 27.0 mtpt -70.95 -36.16 72.49 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.286 -0.884 . . . . 0.0 109.698 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HA ' ' OD2' ' A' ' 16' ' ' ASP . . . -67.06 -49.52 64.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.932 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 7.5 m-20 -71.37 -29.16 64.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.828 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 19' ' ' ILE . . . -66.81 -49.88 64.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.433 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 17' ' ' ALA . 2.2 p30 -54.8 -53.38 56.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.028 . . . . 0.0 110.149 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -57.65 -35.72 70.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 0.0 108.863 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 75.5 t80 -61.09 -37.32 82.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.479 -0.763 . . . . 0.0 109.26 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.615 HG23 ' CE1' ' A' ' 70' ' ' PHE . 31.6 mm -75.14 -48.44 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.631 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -62.4 -48.28 80.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 25' ' ' ALA . 2.1 t -60.75 -30.71 70.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.972 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.765 ' HZ ' HG23 ' A' ' 92' ' ' ILE . 44.9 t80 -68.7 -52.0 35.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 0.0 110.186 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.404 HD12 ' ND2' ' A' ' 45' ' ' ASN . 67.2 mt -63.15 -56.02 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.99 . . . . 0.0 109.958 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -59.71 -30.88 69.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 21' ' ' SER . . . -78.01 -45.37 23.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.943 . . . . 0.0 110.121 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 95' ' ' ALA . . . -70.38 -31.66 69.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB3' ' CE ' ' A' ' 37' ' ' MET . 50.3 m -60.5 -30.95 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 25' ' ' ALA . 32.5 p-10 -106.29 7.39 31.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.01 . . . . 0.0 110.651 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.995 HG21 ' HB2' ' A' ' 94' ' ' ASP . 29.1 m -89.62 -79.36 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.807 -1.183 . . . . 0.0 110.177 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' HA3' ' CG1' ' A' ' 87' ' ' VAL . . . -81.01 -103.05 0.32 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -132.81 -58.28 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.325 -1.103 . . . . 0.0 109.305 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 78' ' ' ALA . 4.4 m-85 43.84 90.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.082 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' N ' ' OE1' ' A' ' 36' ' ' GLN . 11.1 p -59.54 162.99 4.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -52.72 -36.94 58.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -0.876 . . . . 0.0 109.278 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.21 -45.51 79.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.547 ' CG ' ' HG2' ' A' ' 81' ' ' GLN . 4.2 mp0 -63.93 -35.48 80.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.184 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 27' ' ' SER . 58.3 mtt -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.081 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 94.8 mt-10 -70.36 -37.46 74.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.113 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -68.75 -44.65 73.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.86 . . . . 0.0 109.251 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.545 ' CE ' ' CE1' ' A' ' 32' ' ' PHE . 61.2 mtt -56.85 -31.98 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 108.935 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 p -70.13 -23.35 63.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.38 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 38' ' ' GLU . 62.7 mt -87.88 -26.25 22.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.716 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 73' ' ' SER . 53.4 mt -121.32 157.09 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.449 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HG21 ' A' ' 19' ' ' ILE . . . 85.93 -77.2 2.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.404 ' ND2' HD12 ' A' ' 23' ' ' ILE . 95.6 m-20 -65.02 -38.46 90.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -1.162 . . . . 0.0 108.766 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 42' ' ' LEU . 58.3 m -58.46 -35.1 71.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.06 -34.51 75.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.552 -0.718 . . . . 0.0 109.247 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.434 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 61.4 ttp -52.96 -41.95 65.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 109.121 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.12 74.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 108.583 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.8 66.76 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.536 ' O ' ' HG3' ' A' ' 54' ' ' MET . 57.6 mtt -60.05 -29.76 68.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.563 -0.711 . . . . 0.0 109.433 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -76.0 -8.22 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 55' ' ' GLY . 97.6 m-20 -70.84 -42.53 70.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.872 ' HG2' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.29 -21.89 0.1 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.235 -0.916 . . . . 0.0 110.601 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' ' SD ' ' A' ' 54' ' ' MET . . . 85.9 -24.97 7.11 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.481 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 140.8 30.7 0.17 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 20.1 ptt85 -139.28 114.93 9.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.019 -1.283 . . . . 0.0 109.606 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.872 HD11 ' HG2' ' A' ' 54' ' ' MET . 27.6 mm -117.11 147.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.835 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -145.59 169.35 9.91 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 59' ' ' THR . 49.9 Cg_endo -69.6 -48.11 0.82 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.0 112.036 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -60.68 -36.29 78.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.938 . . . . 0.0 109.684 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -75.04 -48.0 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.738 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.796 HD11 HG23 ' A' ' 58' ' ' ILE . 9.8 mp -74.35 -46.16 42.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.721 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 96.7 mt-30 -54.71 -40.14 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.215 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.41 -37.4 68.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.011 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.16 -52.62 11.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.67 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -48.06 -25.26 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.608 -179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 56.7 mtp -72.71 -27.42 62.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.963 . . . . 0.0 110.023 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.42 -35.56 65.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 110.038 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.615 ' CE1' HG23 ' A' ' 19' ' ' ILE . 88.8 t80 -53.84 -40.71 66.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.792 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.951 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -65.69 -36.35 83.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.945 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 24.8 m -69.23 -34.16 74.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.783 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 43' ' ' ILE . 37.1 m -70.3 -49.63 47.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.874 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' ALA . 19.1 m -57.73 -35.04 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -70.62 -43.35 69.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 0.0 109.691 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.567 ' HG2' ' CE1' ' A' ' 122' ' ' PHE . 26.6 mt-30 -66.22 -50.88 62.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.879 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.9 mt -53.49 -50.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 32' ' ' PHE . . . -78.22 -53.32 7.47 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.442 -0.786 . . . . 0.0 110.209 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 75' ' ' ALA . . . -57.63 -24.28 55.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 79.9 p -76.7 -20.23 56.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.261 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.547 ' HG2' ' CG ' ' A' ' 36' ' ' GLN . 55.2 mt-30 -50.34 -31.54 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 109.51 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.39 14.75 81.68 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.42 -162.88 23.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -1.13 . . . . 0.0 109.437 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.047 HD23 HG22 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -62.21 -20.21 63.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.98 -38.33 65.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.446 ' CG1' ' HA3' ' A' ' 30' ' ' GLY . 72.2 t -70.55 -47.5 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.675 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.569 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 19.7 m -51.95 -48.72 64.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 116' ' ' ARG . 4.3 m -51.07 -46.25 61.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 81.3 m-20 -71.0 -39.18 72.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.422 -0.799 . . . . 0.0 109.026 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HA ' ' HB ' ' A' ' 29' ' ' THR . . . -67.48 -59.2 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.765 HG23 ' HZ ' ' A' ' 22' ' ' PHE . 69.7 mt -60.33 -47.24 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' THR . . . -63.54 -51.31 65.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.995 ' HB2' HG21 ' A' ' 29' ' ' THR . 92.5 m-20 -60.73 -33.54 73.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.877 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . . . -71.96 -42.59 66.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 108.969 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -70.38 -38.45 74.71 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.508 -0.745 . . . . 0.0 109.777 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.563 HG22 ' CE2' ' A' ' 101' ' ' TYR . 77.8 m -63.85 -51.5 64.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 109.917 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 85.7 p -58.4 -34.78 71.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 0.0 109.774 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 103' ' ' THR . . . -70.23 -44.56 68.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 108' ' ' ASN . 1.1 m-85 -46.96 -54.81 9.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.563 ' CE2' HG22 ' A' ' 97' ' ' THR . 3.7 m-85 -72.03 -32.09 66.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.815 . . . . 0.0 109.993 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 98' ' ' SER . 92.5 mm-40 -77.19 -18.57 57.65 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 18' ' ' PHE . 81.7 p -104.52 -60.18 1.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.087 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.712 HG21 ' C ' ' A' ' 7' ' ' THR . 29.6 p -127.16 -43.01 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.207 . . . . 0.0 110.762 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 101' ' ' TYR . . . 109.48 44.62 1.05 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 28.2 t -104.81 170.06 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 108.891 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.586 ' N ' HG12 ' A' ' 106' ' ' VAL . 22.9 m -68.15 121.14 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.61 ' HA ' ' CD2' ' A' ' 100' ' ' PHE . 18.9 p-10 -70.59 -23.51 62.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 113' ' ' SER . 32.9 t -62.03 -30.56 71.05 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 110.355 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -65.81 -54.51 25.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.831 -1.168 . . . . 0.0 110.343 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 29.1 t80 -75.69 -53.95 7.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.035 . . . . 0.0 110.181 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.528 ' CD1' ' OG1' ' A' ' 97' ' ' THR . 54.5 mt -56.92 -34.27 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 109' ' ' SER . 12.7 t -55.89 -43.14 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 0.0 109.763 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 74.8 mm-40 -71.73 -38.86 70.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.735 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.951 HG12 ' HB1' ' A' ' 71' ' ' ALA . 71.5 mt -59.54 -45.64 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.616 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 89' ' ' THR . 62.3 mtp180 -54.2 -49.09 70.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.689 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.8 m -57.85 -33.71 68.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.191 -0.943 . . . . 0.0 109.071 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 122' ' ' PHE . 82.3 mt -74.53 -41.88 59.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.047 HG22 HD23 ' A' ' 85' ' ' LEU . 72.2 mt -59.24 -35.65 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.199 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.29 63.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 50.7 ttm -60.83 -45.1 95.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.147 . . . . 0.0 109.515 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 76' ' ' GLN . 89.8 m-85 -58.99 -37.28 76.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 85' ' ' LEU . . . -65.24 -31.66 72.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.489 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -68.27 -33.39 74.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.5 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.89 69.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.376 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -55.81 -36.32 67.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.394 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.881 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -66.85 -25.11 66.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 131' ' ' TYR . 34.7 t30 -58.8 -16.19 15.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.311 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.27 -43.29 78.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.463 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.968 HG23 ' CD1' ' A' ' 131' ' ' TYR . 21.6 m -67.57 -30.13 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.968 ' CD1' HG23 ' A' ' 130' ' ' VAL . 48.9 p90 178.22 -173.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 109.11 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 131' ' ' TYR . . . -77.76 113.66 15.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.157 -0.965 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 134' ' ' ALA . 33.1 t -107.59 139.43 42.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.51 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' SER . . . 48.32 96.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.552 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.41 74.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 58.1 p -71.82 163.81 27.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -1.126 . . . . 0.0 109.436 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.493 -179.998 . . . . . . . . 0 0 . 1 stop_ save_